activity_id,assay_chembl_id,assay_description,assay_type,canonical_smiles,molecule_chembl_id,std_units,IC50,target_chembl_id,pIC50,data_set,SMILES_chiral,SMILES_no_chiral,target,target_category
2067560,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(O)[C@@H]1CCC[C@H]1C(=O)c1ccc(-c2ccc(Nc3nc4ccc(OC(F)(F)F)cc4s3)c(F)c2)cc1,CHEMBL401117,nM,73,CHEMBL6009,7.13667714,DGAT,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc(N=c3[nH]c4ccc(OC(F)(F)F)cc4s3)c(F)c2)cc1,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc(N=c3[nH]c4ccc(OC(F)(F)F)cc4s3)c(F)c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067561,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@@H]3C(=O)O)cc2)cc1,CHEMBL255036,nM,98,CHEMBL6009,7.008773924,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067562,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)[C@H]3CCC[C@@H]3C(=O)O)cc2)cc1,CHEMBL254824,nM,96,CHEMBL6009,7.017728767,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067563,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1ccc2c(c1)OCO2,CHEMBL402926,nM,7,CHEMBL6009,8.15490196,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1ccc2c(c1)OCO2,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1ccc2c(c1)OCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067564,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1ccc(C(F)(F)F)cc1,CHEMBL402721,nM,9,CHEMBL6009,8.045757491,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1ccc(C(F)(F)F)cc1,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1ccc(C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067565,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,N#Cc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)[C@@H]4CCC[C@H]4C(=O)O)cc3)cc2)cc1,CHEMBL254871,nM,35,CHEMBL6009,7.455931956,DGAT,N#Cc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)C4CCCC4C(=O)O)cc3)cc2)cc1,N#Cc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)C4CCCC4C(=O)O)cc3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067566,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)[C@@H]4CCC[C@H]4C(=O)O)cc3)cc2F)cc1,CHEMBL254870,nM,9,CHEMBL6009,8.045757491,DGAT,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)C4CCCC4C(=O)O)cc3)cc2F)cc1,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)C4CCCC4C(=O)O)cc3)cc2F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067567,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,CNC(=O)c1cccc(NC(=O)Nc2ccc(-c3ccc(C(=O)[C@@H]4CCC[C@H]4C(=O)O)cc3)cc2)c1,CHEMBL253610,nM,994,CHEMBL6009,6.002613616,DGAT,CNC(=O)c1cccc(NC(=O)Nc2ccc(-c3ccc(C(=O)C4CCCC4C(=O)O)cc3)cc2)c1,CNC(=O)c1cccc(NC(=O)Nc2ccc(-c3ccc(C(=O)C4CCCC4C(=O)O)cc3)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067568,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1cc(C(F)(F)F)ccc1F,CHEMBL254865,nM,5,CHEMBL6009,8.301029996,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cc(C(F)(F)F)ccc1F,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cc(C(F)(F)F)ccc1F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067569,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1cccc(Cl)c1,CHEMBL404419,nM,6,CHEMBL6009,8.22184875,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cccc(Cl)c1,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cccc(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067570,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1cccc(F)c1,CHEMBL254658,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cccc(F)c1,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cccc(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067571,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1cccc(C(F)(F)F)c1,CHEMBL254445,nM,10,CHEMBL6009,8,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cccc(C(F)(F)F)c1,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1cccc(C(F)(F)F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067572,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1)Nc1ccccc1C(F)(F)F,CHEMBL254444,nM,9,CHEMBL6009,8.045757491,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1ccccc1C(F)(F)F,O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1)Nc1ccccc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2067573,CHEMBL943833,Inhibition of human recombinant DGAT1 expressed in Sf9 cells,B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1,CHEMBL430405,nM,7,CHEMBL6009,8.15490196,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607210,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL473967,nM,15,CHEMBL6009,7.823908741,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607211,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C23CCC(C(=O)O)(CC2)CC3)cc1,CHEMBL515415,nM,28,CHEMBL6009,7.552841969,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CCC(C(=O)O)(CC2)CC3)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CCC(C(=O)O)(CC2)CC3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607212,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C23CCC(CC(=O)O)(CC2)CC3)cc1,CHEMBL473384,nM,15,CHEMBL6009,7.823908741,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CCC(CC(=O)O)(CC2)CC3)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CCC(CC(=O)O)(CC2)CC3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607213,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC(C(=O)O)C12CCC(c3ccc(C4=Nc5c(N)ncnc5OC4(C)C)cc3)(CC1)CC2,CHEMBL513992,nM,28,CHEMBL6009,7.552841969,DGAT,CC(C(=O)O)C12CCC(c3ccc(C4=Nc5c([nH]cnc5=N)OC4(C)C)cc3)(CC1)CC2,CC(C(=O)O)C12CCC(c3ccc(C4=Nc5c([nH]cnc5=N)OC4(C)C)cc3)(CC1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607214,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C23CCCC(C(=O)O)(CC2)CC3)cc1,CHEMBL473385,nM,69,CHEMBL6009,7.161150909,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CCCC(C(=O)O)(CC2)CC3)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CCCC(C(=O)O)(CC2)CC3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607215,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C23CC4CC(CC(CC(=O)O)(C4)C2)C3)cc1,CHEMBL473386,nM,120,CHEMBL6009,6.920818754,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CC4CC(CC(CC(=O)O)(C4)C2)C3)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CC4CC(CC(CC(=O)O)(C4)C2)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
2607216,CHEMBL1022199,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C23CC4CC(CC(C(=O)O)(C4)C2)C3)cc1,CHEMBL473982,nM,250,CHEMBL6009,6.602059991,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CC4CC(CC(C(=O)O)(C4)C2)C3)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C23CC4CC(CC(C(=O)O)(C4)C2)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247151,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1089874,nM,33,CHEMBL6009,7.48148606,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247152,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2nn(-c3ccccc3)cc2C)cc1,CHEMBL1089304,nM,2000,CHEMBL6009,5.698970004,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2nn(-c3ccccc3)cc2C)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2nn(-c3ccccc3)cc2C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247153,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C)cc1,CHEMBL1089875,nM,650,CHEMBL6009,6.187086643,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247154,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(C3CCCCC3)nc2C(F)(F)F)cc1,CHEMBL1092303,nM,220,CHEMBL6009,6.657577319,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(C3CCCCC3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(C3CCCCC3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247155,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccc(Cl)cc3)nc2C(F)(F)F)cc1,CHEMBL1092009,nM,94,CHEMBL6009,7.026872146,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccc(Cl)cc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccc(Cl)cc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247156,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(Cc3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1092008,nM,790,CHEMBL6009,6.102372909,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(Cc3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(Cc3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247157,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccc(OCC)cc3)nc2C(F)(F)F)cc1,CHEMBL1092318,nM,140,CHEMBL6009,6.853871964,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccc(OCC)cc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccc(OCC)cc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247158,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3cccc(OCC)c3)nc2C(F)(F)F)cc1,CHEMBL1089832,nM,44,CHEMBL6009,7.356547324,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3cccc(OCC)c3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3cccc(OCC)c3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247159,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccn3)nc2C(F)(F)F)cc1,CHEMBL1089182,nM,28,CHEMBL6009,7.552841969,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccn3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccn3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247160,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccncc3)nc2C(F)(F)F)cc1,CHEMBL1089508,nM,5500,CHEMBL6009,5.259637311,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccncc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccncc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247161,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3cccnc3)nc2C(F)(F)F)cc1,CHEMBL1089507,nM,1900,CHEMBL6009,5.721246399,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3cccnc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3cccnc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247162,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3O)nc2C(F)(F)F)cc1,CHEMBL1089208,nM,98,CHEMBL6009,7.008773924,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3O)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3O)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247163,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)N[C@@H](CO)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1090544,nM,10000,CHEMBL6009,5,DGAT,CCOc1ccc(C(=O)N[C@@H](CO)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NC(CO)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247164,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)N[C@H](CO)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1090202,nM,10000,CHEMBL6009,5,DGAT,CCOc1ccc(C(=O)N[C@H](CO)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NC(CO)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247165,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NC[C@@H](CO)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1090545,nM,10000,CHEMBL6009,5,DGAT,CCOc1ccc(C(=O)NC[C@@H](CO)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCC(CO)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247166,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NC[C@H](CO)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1091904,nM,10000,CHEMBL6009,5,DGAT,CCOc1ccc(C(=O)NC[C@H](CO)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCC(CO)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247167,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCC(C)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1091906,nM,2800,CHEMBL6009,5.552841969,DGAT,CCOc1ccc(C(=O)NCC(C)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NCC(C)NC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247168,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NC(C)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CHEMBL1091905,nM,5300,CHEMBL6009,5.27572413,DGAT,CCOc1ccc(C(=O)NC(C)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,CCOc1ccc(C(=O)NC(C)CNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247169,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1cccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)c1,CHEMBL1091721,nM,3600,CHEMBL6009,5.443697499,DGAT,CCOc1cccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)c1,CCOc1cccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247170,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,Cl.O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(-n2cccn2)cc1,CHEMBL1090842,nM,79,CHEMBL6009,7.102372909,DGAT,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(-n2cccn2)cc1,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(-n2cccn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247171,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(Cl)cn1,CHEMBL1089168,nM,1300,CHEMBL6009,5.886056648,DGAT,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(Cl)cn1,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247172,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(Cl)nc1,CHEMBL1089169,nM,49,CHEMBL6009,7.30980392,DGAT,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(Cl)nc1,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(Cl)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247173,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(OCC(F)(F)F)nc1,CHEMBL1092385,nM,22,CHEMBL6009,7.657577319,DGAT,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(OCC(F)(F)F)nc1,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(OCC(F)(F)F)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247174,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cn1,CHEMBL1089498,nM,25,CHEMBL6009,7.602059991,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cn1,CCOc1ccc(C(=O)NCCNC(=O)c2cn(-c3ccccc3)nc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247175,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1cc(C)c(C(=O)CCC(=O)Nc2nc(-c3ccccc3)c(Cc3ccccc3)s2)cc1OCC,CHEMBL1088784,nM,8.5,CHEMBL6009,8.070581074,DGAT,CCOc1cc(C)c(C(=O)CCC(=O)N=c2[nH]c(-c3ccccc3)c(Cc3ccccc3)s2)cc1OCC,CCOc1cc(C)c(C(=O)CCC(=O)N=c2[nH]c(-c3ccccc3)c(Cc3ccccc3)s2)cc1OCC,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3247176,CHEMBL1116103,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,CCOc1ccc(C(=O)NCCNC(=O)c2nc(-c3ccccc3)c(Cc3ccccc3)s2)cc1,CHEMBL1089097,nM,700,CHEMBL6009,6.15490196,DGAT,CCOc1ccc(C(=O)NCCNC(=O)c2nc(-c3ccccc3)c(Cc3ccccc3)s2)cc1,CCOc1ccc(C(=O)NCCNC(=O)c2nc(-c3ccccc3)c(Cc3ccccc3)s2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504555,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1257556,nM,120,CHEMBL6009,6.920818754,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504556,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(OC)cc1,CHEMBL1258943,nM,52,CHEMBL6009,7.283996656,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(OC)cc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(OC)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504557,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(OCc2ccccc2)cc1,CHEMBL1256010,nM,60,CHEMBL6009,7.22184875,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(OCc2ccccc2)cc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(OCc2ccccc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504558,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(Cl)cc1,CHEMBL1258708,nM,68,CHEMBL6009,7.167491087,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(Cl)cc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(Cl)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504559,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,C=CCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1257799,nM,75,CHEMBL6009,7.124938737,DGAT,C=CCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,C=CCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504560,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccccc1,CHEMBL1258374,nM,81,CHEMBL6009,7.091514981,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccccc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504561,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCC(F)(F)F,CHEMBL1257800,nM,110,CHEMBL6009,6.958607315,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCC(F)(F)F,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCC(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504562,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1257917,nM,160,CHEMBL6009,6.795880017,DGAT,CCCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504563,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1257918,nM,220,CHEMBL6009,6.657577319,DGAT,CCCCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504565,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CC,CHEMBL1257678,nM,240,CHEMBL6009,6.619788758,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CC,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CC,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504566,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1COC,CHEMBL1258146,nM,240,CHEMBL6009,6.619788758,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1COC,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1COC,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504567,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(-c2ccccc2)cc1,CHEMBL1256009,nM,250,CHEMBL6009,6.602059991,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(-c2ccccc2)cc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(-c2ccccc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504568,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCOC,CHEMBL1258261,nM,270,CHEMBL6009,6.568636236,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCOC,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCOC,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504569,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1cccc(Cl)c1,CHEMBL1258600,nM,290,CHEMBL6009,6.537602002,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1cccc(Cl)c1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1cccc(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504572,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1cccc(OC)c1,CHEMBL1258487,nM,470,CHEMBL6009,6.327902142,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1cccc(OC)c1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1cccc(OC)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504574,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C,CHEMBL1257677,nM,520,CHEMBL6009,6.283996656,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504576,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(O)cc1,CHEMBL1258828,nM,570,CHEMBL6009,6.244125144,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(O)cc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504578,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C1CC1,CHEMBL1258027,nM,620,CHEMBL6009,6.207608311,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C1CC1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C1CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504579,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(N)cc1,CHEMBL1257207,nM,630,CHEMBL6009,6.200659451,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(N)cc1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1-c1ccc(N)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504585,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C1CCC1,CHEMBL1258028,nM,2500,CHEMBL6009,5.602059991,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C1CCC1,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1C1CCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504593,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCN(C)C,CHEMBL1258262,nM,1000,CHEMBL6009,6,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCN(C)C,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCN(C)C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504594,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCO,CHEMBL1258145,nM,1000,CHEMBL6009,6,DGAT,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCO,CCOC(=O)c1c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn2c1CCCO,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504595,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1cn2nc(N3CCOCC3)cc(-c3ccccc3)c2c1C(=O)OCC,CHEMBL1257557,nM,3000,CHEMBL6009,5.522878745,DGAT,CCOC(=O)c1cn2nc(N3CCOCC3)cc(-c3ccccc3)c2c1C(=O)OCC,CCOC(=O)c1cn2nc(N3CCOCC3)cc(-c3ccccc3)c2c1C(=O)OCC,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504596,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3C[C@@H](C)O[C@@H](C)C3)nn12,CHEMBL1257208,nM,3000,CHEMBL6009,5.522878745,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3C[C@@H](C)O[C@@H](C)C3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CC(C)OC(C)C3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504597,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCC3)nn12,CHEMBL1257327,nM,1360,CHEMBL6009,5.866461092,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504598,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCCC3)nn12,CHEMBL1257328,nM,120,CHEMBL6009,6.920818754,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504599,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCCCC3)nn12,CHEMBL1257441,nM,6100,CHEMBL6009,5.214670165,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCCCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCCCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504600,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N(C)C)nn12,CHEMBL1257442,nM,830,CHEMBL6009,6.080921908,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N(C)C)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)cc(N(C)C)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504601,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3F)cc(N3CCOCC3)nn12,CHEMBL1257558,nM,570,CHEMBL6009,6.244125144,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3F)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3F)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504602,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3cccc(F)c3)cc(N3CCOCC3)nn12,CHEMBL1257559,nM,270,CHEMBL6009,6.568636236,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3cccc(F)c3)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3cccc(F)c3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504603,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccc(F)cc3)cc(N3CCOCC3)nn12,CHEMBL1257679,nM,290,CHEMBL6009,6.537602002,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccc(F)cc3)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccc(F)cc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504604,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1cc(N2CCOCC2)nn2c(CCC)c(C(=O)OCC)c(C(=O)OCC)c12,CHEMBL1257680,nM,3000,CHEMBL6009,5.522878745,DGAT,CCCc1cc(N2CCOCC2)nn2c(CCC)c(C(=O)OCC)c(C(=O)OCC)c12,CCCc1cc(N2CCOCC2)nn2c(CCC)c(C(=O)OCC)c(C(=O)OCC)c12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504605,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C(C)(C)C)cc(N3CCOCC3)nn12,CHEMBL1257801,nM,3000,CHEMBL6009,5.522878745,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C(C)(C)C)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C(C)(C)C)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504606,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCC3)cc(N3CCOCC3)nn12,CHEMBL1257802,nM,3000,CHEMBL6009,5.522878745,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCC3)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCC3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504607,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCCC3)cc(N3CCOCC3)nn12,CHEMBL1257919,nM,3000,CHEMBL6009,5.522878745,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCCC3)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCCC3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504608,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCCCC3)cc(N3CCOCC3)nn12,CHEMBL1257920,nM,3000,CHEMBL6009,5.522878745,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCCCC3)cc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(C3CCCCC3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504618,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(C(C)(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258375,nM,48,CHEMBL6009,7.318758763,DGAT,CCCc1c(-c2nc(C(C)(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(C(C)(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504619,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(C3CCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258829,nM,48,CHEMBL6009,7.318758763,DGAT,CCCc1c(-c2nc(C3CCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(C3CCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504621,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(C3CCCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258944,nM,56,CHEMBL6009,7.251811973,DGAT,CCCc1c(-c2nc(C3CCCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(C3CCCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504622,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(C(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258148,nM,57,CHEMBL6009,7.244125144,DGAT,CCCc1c(-c2nc(C(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(C(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504623,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,CHEMBL1258147,nM,65,CHEMBL6009,7.187086643,DGAT,CCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,CCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504625,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,CHEMBL1258263,nM,73,CHEMBL6009,7.13667714,DGAT,CCCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,CCCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504628,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(N3CCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1257209,nM,100,CHEMBL6009,7,DGAT,CCCc1c(-c2nc(N3CCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(N3CCCC3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504630,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(CC)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258030,nM,110,CHEMBL6009,6.958607315,DGAT,CCCc1c(-c2nc(CC)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(CC)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504631,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,CHEMBL1258488,nM,110,CHEMBL6009,6.958607315,DGAT,CCCCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,CCCCCc1noc(-c2c(C(=O)OCC)c3c(-c4ccccc4)cc(N4CCOCC4)nn3c2CCC)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504632,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(Cc3ccccc3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258709,nM,120,CHEMBL6009,6.920818754,DGAT,CCCc1c(-c2nc(Cc3ccccc3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(Cc3ccccc3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504633,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(N(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1257329,nM,140,CHEMBL6009,6.853871964,DGAT,CCCc1c(-c2nc(N(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(N(C)C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504634,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(-c3ccccc3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258601,nM,180,CHEMBL6009,6.744727495,DGAT,CCCc1c(-c2nc(-c3ccccc3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(-c3ccccc3)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504635,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCOC(=O)c1c(-c2nc(CCO)no2)c(CCO)n2nc(N3CCOCC3)cc(-c3ccccc3)c12,CHEMBL1257330,nM,180,CHEMBL6009,6.744727495,DGAT,CCOC(=O)c1c(-c2nc(CCO)no2)c(CCO)n2nc(N3CCOCC3)cc(-c3ccccc3)c12,CCOC(=O)c1c(-c2nc(CCO)no2)c(CCO)n2nc(N3CCOCC3)cc(-c3ccccc3)c12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504641,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(-c2nc(C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CHEMBL1258029,nM,380,CHEMBL6009,6.420216403,DGAT,CCCc1c(-c2nc(C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,CCCc1c(-c2nc(C)no2)c(C(=O)OCC)c2c(-c3ccccc3)cc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3504656,CHEMBL1261338,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs,B,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)nc(N3CCOCC3)nn12,CHEMBL1257443,nM,250,CHEMBL6009,6.602059991,DGAT,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)nc(N3CCOCC3)nn12,CCCc1c(C(=O)OCC)c(C(=O)OCC)c2c(-c3ccccc3)nc(N3CCOCC3)nn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
3590879,CHEMBL1292177,Inhibition of DGAT,B,Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N,CHEMBL1290746,nM,20000,CHEMBL6009,4.698970004,DGAT,Cc1ccc(C(=O)N=c2cco[nH]2)cc1NC(=O)c1c[nH]n(-c2ccccc2F)c1=N,Cc1ccc(C(=O)N=c2cco[nH]2)cc1NC(=O)c1c[nH]n(-c2ccccc2F)c1=N,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173112,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COCCN(C)c1ccc(NC(=O)c2nc(C)oc2C(F)(F)F)cn1,CHEMBL1766814,nM,15100,CHEMBL6009,4.821023053,DGAT,COCCN(C)c1ccc(NC(=O)c2nc(C)oc2C(F)(F)F)cn1,COCCN(C)c1ccc(NC(=O)c2nc(C)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173113,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COCCN(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1766813,nM,38,CHEMBL6009,7.420216403,DGAT,COCCN(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,COCCN(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173114,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COCCN(C)c1ncc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1766816,nM,48,CHEMBL6009,7.318758763,DGAT,COCCN(C)c1ncc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,COCCN(C)c1ncc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173115,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COCCN(C)c1ccc(N(C)C(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1766815,nM,24700,CHEMBL6009,4.607303047,DGAT,COCCN(C)c1ccc(N(C)C(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,COCCN(C)c1ccc(N(C)C(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173116,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COCCN(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CHEMBL1766817,nM,325,CHEMBL6009,6.488116639,DGAT,COCCN(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,COCCN(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173117,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1cnc(N2CC[C@H](O)C2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766883,nM,237,CHEMBL6009,6.625251654,DGAT,O=C(Nc1cnc(N2CC[C@H](O)C2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1cnc(N2CCC(O)C2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173118,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,CCOC1CN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)C1,CHEMBL1766882,nM,68,CHEMBL6009,7.167491087,DGAT,CCOC1CN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)C1,CCOC1CN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173119,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(O)COC1CN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)C1,CHEMBL1766885,nM,202,CHEMBL6009,6.694648631,DGAT,O=C(O)COC1CN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)C1,O=C(O)COC1CN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173120,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(N2CC(F)(F)C2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766884,nM,16,CHEMBL6009,7.795880017,DGAT,O=C(Nc1ccc(N2CC(F)(F)C2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CC(F)(F)C2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173121,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(N2CCN(C(=O)C3CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766886,nM,59,CHEMBL6009,7.229147988,DGAT,O=C(Nc1ccc(N2CCN(C(=O)C3CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)C3CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173122,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,CHEMBL1766887,nM,28,CHEMBL6009,7.552841969,DGAT,COC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,COC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173123,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,CCOC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,CHEMBL1766888,nM,41,CHEMBL6009,7.387216143,DGAT,CCOC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,CCOC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173124,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COC(=O)N1CCN(c2ncc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,CHEMBL1766889,nM,71,CHEMBL6009,7.148741651,DGAT,COC(=O)N1CCN(c2ncc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,COC(=O)N1CCN(c2ncc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173125,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(C2CCN(C(=O)C3CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766890,nM,128,CHEMBL6009,6.89279003,DGAT,O=C(Nc1ccc(C2CCN(C(=O)C3CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(C2CCN(C(=O)C3CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173126,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(N2CCN(C(=O)C3CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766892,nM,136,CHEMBL6009,6.866461092,DGAT,O=C(Nc1ccc(N2CCN(C(=O)C3CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)C3CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173127,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COC(=O)N1CCC(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,CHEMBL1766891,nM,84,CHEMBL6009,7.075720714,DGAT,COC(=O)N1CCC(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,COC(=O)N1CCC(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173128,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,CHEMBL1766893,nM,165,CHEMBL6009,6.782516056,DGAT,COC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,COC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173129,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(C2CCN(C(=O)C3CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766805,nM,67,CHEMBL6009,7.173925197,DGAT,O=C(Nc1ccc(C2CCN(C(=O)C3CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(C2CCN(C(=O)C3CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173130,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,COC(=O)N1CCC(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,CHEMBL1766806,nM,84,CHEMBL6009,7.075720714,DGAT,COC(=O)N1CCC(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,COC(=O)N1CCC(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173131,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(N2CCN(C(=O)[C@H]3CC[C@H](C(=O)O)CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766807,nM,35,CHEMBL6009,7.455931956,DGAT,O=C(Nc1ccc(N2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173132,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(C2CCN(C(=O)[C@H]3CC[C@H](C(=O)O)CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766808,nM,128,CHEMBL6009,6.89279003,DGAT,O=C(Nc1ccc(C2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(C2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173133,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(N2CCN(C(=O)[C@H]3CC[C@H](C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766809,nM,277,CHEMBL6009,6.557520231,DGAT,O=C(Nc1ccc(N2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173134,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(C2CCN(C(=O)[C@H]3CC[C@H](C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766811,nM,57,CHEMBL6009,7.244125144,DGAT,O=C(Nc1ccc(C2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(C2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173135,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(N2CCN(C(=O)[C@H]3CC[C@@H](C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766810,nM,77,CHEMBL6009,7.113509275,DGAT,O=C(Nc1ccc(N2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173136,CHEMBL1767987,Inhibition of human DGAT1 expressed in baculovirus infected insect cells after 1 hr using palmitoyl-1-14C-coenzyme A by phospholipid flashplate assay,B,O=C(Nc1ccc(C2CCN(C(=O)[C@H]3CC[C@@H](C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1766812,nM,82,CHEMBL6009,7.086186148,DGAT,O=C(Nc1ccc(C2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(C2CCN(C(=O)C3CCC(C(=O)O)CC3)CC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173154,CHEMBL1768059,Inhibition of human DGAT1 expressed in baculovirus infected Sf9 cells using [14C]oleoyl-CoA after 15 mins by TLC analysis,B,O=C(NCCNC(=O)c1nc(-c2ccccc2)[nH]c1C(F)(F)F)c1ccc(OCC(F)(F)F)nc1,CHEMBL1766894,nM,44,CHEMBL6009,7.356547324,DGAT,O=C(NCCNC(=O)c1[nH]c(-c2ccccc2)nc1C(F)(F)F)c1ccc(OCC(F)(F)F)nc1,O=C(NCCNC(=O)c1[nH]c(-c2ccccc2)nc1C(F)(F)F)c1ccc(OCC(F)(F)F)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6173160,CHEMBL1768064,Inhibition of human DGAT1,B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1F,CHEMBL1766895,nM,7,CHEMBL6009,8.15490196,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1F,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379700,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,O=C(O)CNC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3)nc2)cc1,CHEMBL1834431,nM,30,CHEMBL6009,7.522878745,DGAT,O=C(O)CNC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1,O=C(O)CNC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379701,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,C[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3)nc2)cc1)C(=O)O,CHEMBL1834432,nM,72,CHEMBL6009,7.142667504,DGAT,CC(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,CC(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379702,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N[C@@H](CO)C(=O)O)cc2)cn1,CHEMBL1834433,nM,28,CHEMBL6009,7.552841969,DGAT,O=C(N=c1ccc(-c2ccc(C(=O)NC(CO)C(=O)O)cc2)c[nH]1)Nc1ccccc1,O=C(N=c1ccc(-c2ccc(C(=O)NC(CO)C(=O)O)cc2)c[nH]1)Nc1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379703,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3)nc2)cc1)C(=O)O,CHEMBL1834434,nM,88,CHEMBL6009,7.055517328,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379704,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3)nc2)cc1)C(=O)O,CHEMBL1834435,nM,51,CHEMBL6009,7.292429824,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379705,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)C[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3)nc2)cc1)C(=O)O,CHEMBL1834436,nM,32,CHEMBL6009,7.494850022,DGAT,CC(C)CC(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,CC(C)CC(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccccc3)[nH]c2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379706,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)nc2)cc1)C(=O)O,CHEMBL1834437,nM,99,CHEMBL6009,7.004364805,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccc(F)cc3)[nH]c2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccc(F)cc3)[nH]c2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379707,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3F)nc2)cc1)C(=O)O,CHEMBL1834438,nM,57,CHEMBL6009,7.244125144,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccc(F)cc3F)[nH]c2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(=NC(=O)Nc3ccc(F)cc3F)[nH]c2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379709,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3F)cn2)cc1)C(=O)O,CHEMBL1834440,nM,14,CHEMBL6009,7.853871964,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3F)cn2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3F)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379710,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cn2)cc1)C(=O)O,CHEMBL1834200,nM,18,CHEMBL6009,7.744727495,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cn2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379711,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cn2)cc1)C(=O)O,CHEMBL1834201,nM,17,CHEMBL6009,7.769551079,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cn2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379712,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3OC(F)(F)F)cn2)cc1)C(=O)O,CHEMBL1834202,nM,64,CHEMBL6009,7.193820026,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3OC(F)(F)F)cn2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccccc3OC(F)(F)F)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379713,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N[C@H](C(=O)O)C(C)C)cc3)nc2)cc1,CHEMBL1834203,nM,25,CHEMBL6009,7.602059991,DGAT,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)NC(C(=O)O)C(C)C)cc3)nc2)cc1,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)NC(C(=O)O)C(C)C)cc3)nc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379714,CHEMBL1838732,Inhibition of human DGAT1 assessed as formation of [14C]-triglyceride using [14C]oleoyl-CoA by liquid scintillation counting,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3F)cn2)cc1)C(=O)O,CHEMBL1834204,nM,14,CHEMBL6009,7.853871964,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3F)cn2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3F)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6379724,CHEMBL1838757,Inhibition of human DGAT1 expressed in Sf9 cells assessed as formation of didecanoylglycerol product after 1 hr using 14C-decanoyl-CoA by beta scintillation counter,B,O=C(O)[C@@H]1CCC[C@H]1C(=O)c1ccc(-c2ccc(Nc3nc4ccc(F)cc4s3)c(F)c2)cc1,CHEMBL1834206,nM,73,CHEMBL6009,7.13667714,DGAT,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc(N=c3[nH]c4ccc(F)cc4s3)c(F)c2)cc1,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc(N=c3[nH]c4ccc(F)cc4s3)c(F)c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390915,CHEMBL1837163,Inhibition of human DGAT1,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CHEMBL1835919,nM,19,CHEMBL6009,7.721246399,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390917,CHEMBL1837163,Inhibition of human DGAT1,B,CC1(C)Oc2ncnc(N)c2NC1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL1835920,nM,265,CHEMBL6009,6.576754126,DGAT,CC1(C)Oc2[nH]cnc(=N)c2NC1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2NC1c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390918,CHEMBL1837163,Inhibition of human DGAT1,B,Nc1ncnc2c1O[C@@H](c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CO2,CHEMBL1834554,nM,10,CHEMBL6009,8,DGAT,N=c1[nH]cnc2c1O[C@@H](c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CO2,N=c1[nH]cnc2c1OC(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390919,CHEMBL1837163,Inhibition of human DGAT1,B,Nc1ncnc2c1O[C@H](c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CO2,CHEMBL1833980,nM,18,CHEMBL6009,7.744727495,DGAT,N=c1[nH]cnc2c1O[C@H](c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CO2,N=c1[nH]cnc2c1OC(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390920,CHEMBL1837163,Inhibition of human DGAT1,B,NC(=O)C[C@H]1CC[C@H](c2ccc([C@H]3COc4ncnc(N)c4O3)cc2)CC1,CHEMBL1834555,nM,98,CHEMBL6009,7.008773924,DGAT,N=c1[nH]cnc2c1O[C@@H](c1ccc([C@H]3CC[C@H](CC(N)=O)CC3)cc1)CO2,N=c1[nH]cnc2c1OC(c1ccc(C3CCC(CC(N)=O)CC3)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390921,CHEMBL1837163,Inhibition of human DGAT1,B,N#CC[C@H]1CC[C@H](c2ccc([C@H]3COc4ncnc(N)c4O3)cc2)CC1,CHEMBL1834556,nM,249,CHEMBL6009,6.603800653,DGAT,N#CC[C@H]1CC[C@H](c2ccc([C@H]3COc4[nH]cnc(=N)c4O3)cc2)CC1,N#CCC1CCC(c2ccc(C3COc4[nH]cnc(=N)c4O3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390922,CHEMBL1837163,Inhibition of human DGAT1,B,Cc1noc(C[C@H]2CC[C@H](c3ccc([C@H]4COc5ncnc(N)c5O4)cc3)CC2)n1,CHEMBL1834557,nM,225,CHEMBL6009,6.647817482,DGAT,Cc1noc(C[C@H]2CC[C@H](c3ccc([C@H]4COc5[nH]cnc(=N)c5O4)cc3)CC2)n1,Cc1noc(CC2CCC(c3ccc(C4COc5[nH]cnc(=N)c5O4)cc3)CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
6390923,CHEMBL1837163,Inhibition of human DGAT1,B,CC1(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)COc2ncnc(N)c2O1,CHEMBL1834558,nM,245,CHEMBL6009,6.610833916,DGAT,CC1(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)COc2[nH]cnc(=N)c2O1,CC1(c2ccc(C3CCC(CC(=O)O)CC3)cc2)COc2[nH]cnc(=N)c2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954206,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CCCn1[nH]c(=O)c2cc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)ccc21,CHEMBL1922582,nM,60,CHEMBL6009,7.22184875,DGAT,CCCn1[nH]c(=O)c2cc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)ccc21,CCCn1[nH]c(=O)c2cc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954209,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CC(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CHEMBL1922585,nM,9900,CHEMBL6009,5.004364805,DGAT,CC(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CC(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954211,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CC(C)Oc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CHEMBL1922587,nM,7400,CHEMBL6009,5.13076828,DGAT,CC(C)Oc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CC(C)Oc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954213,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CCCc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CHEMBL1922589,nM,13900,CHEMBL6009,4.8569852,DGAT,CCCc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,CCCc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954215,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,O=C(Nc1ccc(N2CCOCC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1922676,nM,330,CHEMBL6009,6.48148606,DGAT,O=C(Nc1ccc(N2CCOCC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCOCC2)cc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954216,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1922677,nM,160,CHEMBL6009,6.795880017,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954217,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,O=C(Nc1cnc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1922678,nM,380,CHEMBL6009,6.420216403,DGAT,O=C(Nc1cnc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1cnc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954218,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,O=C(Nc1cnc(N2CCOCC2)s1)c1nc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1922679,nM,100,CHEMBL6009,7,DGAT,O=C(Nc1cnc(N2CCOCC2)s1)c1nc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1cnc(N2CCOCC2)s1)c1nc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954219,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1Cl,CHEMBL1922680,nM,610,CHEMBL6009,6.214670165,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1Cl,O=C(Nc1ccc(N2CCOCC2)nc1)c1nc(-c2ccccc2)oc1Cl,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954220,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CCc1oc(-c2ccccc2)nc1C(=O)Nc1ccc(N2CCOCC2)nc1,CHEMBL1922681,nM,700,CHEMBL6009,6.15490196,DGAT,CCc1oc(-c2ccccc2)nc1C(=O)Nc1ccc(N2CCOCC2)nc1,CCc1oc(-c2ccccc2)nc1C(=O)Nc1ccc(N2CCOCC2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954221,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1cc(-c2ccccc2)oc1C(F)(F)F,CHEMBL1922682,nM,140,CHEMBL6009,6.853871964,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1cc(-c2ccccc2)oc1C(F)(F)F,O=C(Nc1ccc(N2CCOCC2)nc1)c1cc(-c2ccccc2)oc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954222,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,Cc1nc(-c2ccccc2)sc1C(=O)Nc1ccc(N2CCOCC2)nc1,CHEMBL1922683,nM,660,CHEMBL6009,6.180456064,DGAT,Cc1nc(-c2ccccc2)sc1C(=O)Nc1ccc(N2CCOCC2)nc1,Cc1nc(-c2ccccc2)sc1C(=O)Nc1ccc(N2CCOCC2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954223,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,Cc1nc(-c2ccccc2)oc1C(=O)Nc1ccc(N2CCOCC2)nc1,CHEMBL1922684,nM,150,CHEMBL6009,6.823908741,DGAT,Cc1nc(-c2ccccc2)oc1C(=O)Nc1ccc(N2CCOCC2)nc1,Cc1nc(-c2ccccc2)oc1C(=O)Nc1ccc(N2CCOCC2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954224,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,Cc1nc(-c2ccccc2)ncc1C(=O)Nc1ccc(N2CCOCC2)cc1,CHEMBL1922685,nM,43000,CHEMBL6009,4.366531544,DGAT,Cc1nc(-c2ccccc2)ncc1C(=O)Nc1ccc(N2CCOCC2)cc1,Cc1nc(-c2ccccc2)ncc1C(=O)Nc1ccc(N2CCOCC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954225,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CCN(CC)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1922686,nM,253,CHEMBL6009,6.596879479,DGAT,CCN(CC)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CCN(CC)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954226,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,COCCNc1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1922687,nM,407,CHEMBL6009,6.390405591,DGAT,COCCN=c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)c[nH]1,COCCN=c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954227,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CN(CCO)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1922688,nM,554,CHEMBL6009,6.256490235,DGAT,CN(CCO)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CN(CCO)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954229,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,CCN(CCOC)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1922689,nM,653,CHEMBL6009,6.185086819,DGAT,CCN(CCOC)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CCN(CCOC)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
7954230,CHEMBL1924476,Inhibition of human DGAT1 using palmitoyl-1-14C coenzyme A and DAG as substrate after 1 hr by phospholipid flash plate assay,B,COCC(=O)N(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,CHEMBL1922690,nM,699,CHEMBL6009,6.155522824,DGAT,COCC(=O)N(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,COCC(=O)N(C)c1ccc(NC(=O)c2nc(-c3ccccc3)oc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010400,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(Sc1nnc(-c2ccc(NC(=O)c3ccccc3)cc2)n1C)C(=O)O,CHEMBL1939473,nM,350,CHEMBL6009,6.455931956,DGAT,CC(Sc1nnc(-c2ccc(NC(=O)c3ccccc3)cc2)n1C)C(=O)O,CC(Sc1nnc(-c2ccc(NC(=O)c3ccccc3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010401,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1ccc(C(=O)Nc2ccc(-c3nnc(SC(C)C(=O)O)n3C)cc2)cc1,CHEMBL1939474,nM,130,CHEMBL6009,6.886056648,DGAT,Cc1ccc(C(=O)Nc2ccc(-c3nnc(SC(C)C(=O)O)n3C)cc2)cc1,Cc1ccc(C(=O)Nc2ccc(-c3nnc(SC(C)C(=O)O)n3C)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010402,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1ccccc1C(=O)Nc1ccc(-c2nnc(SC(C)C(=O)O)n2C)cc1,CHEMBL1305904,nM,1980,CHEMBL6009,5.70333481,DGAT,Cc1ccccc1C(=O)Nc1ccc(-c2nnc(SC(C)C(=O)O)n2C)cc1,Cc1ccccc1C(=O)Nc1ccc(-c2nnc(SC(C)C(=O)O)n2C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010403,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(Sc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C)C(=O)O,CHEMBL1939475,nM,20,CHEMBL6009,7.698970004,DGAT,CC(Sc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C)C(=O)O,CC(Sc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010404,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(Sc1nnc(-c2ccc(NC(=O)c3cc4ccccc4s3)cc2)n1C)C(=O)O,CHEMBL1939476,nM,13,CHEMBL6009,7.886056648,DGAT,CC(Sc1nnc(-c2ccc(NC(=O)c3cc4ccccc4s3)cc2)n1C)C(=O)O,CC(Sc1nnc(-c2ccc(NC(=O)c3cc4ccccc4s3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010405,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(Sc1nnc(-c2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,CHEMBL1939477,nM,230,CHEMBL6009,6.638272164,DGAT,CC(Sc1nnc(-c2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,CC(Sc1nnc(-c2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010406,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(Sc1nnc(-c2ccc(NC(=O)Cc3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,CHEMBL1939478,nM,38,CHEMBL6009,7.420216403,DGAT,CC(Sc1nnc(-c2ccc(NC(=O)Cc3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,CC(Sc1nnc(-c2ccc(NC(=O)Cc3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010407,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cn1c(SC(C(=O)O)c2ccccc2)nnc1-c1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1,CHEMBL1939479,nM,1120,CHEMBL6009,5.950781977,DGAT,Cn1c(SC(C(=O)O)c2ccccc2)nnc1-c1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1,Cn1c(SC(C(=O)O)c2ccccc2)nnc1-c1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010408,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CCC(Sc1nnc(-c2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,CHEMBL1939480,nM,11,CHEMBL6009,7.958607315,DGAT,CCC(Sc1nnc(-c2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,CCC(Sc1nnc(-c2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010409,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(Oc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C)C(=O)O,CHEMBL1939617,nM,144,CHEMBL6009,6.841637508,DGAT,CC(Oc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C)C(=O)O,CC(Oc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010410,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)cc1,CHEMBL1939630,nM,520,CHEMBL6009,6.283996656,DGAT,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)cc1,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010411,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(C)(COc1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)cn1)C(=O)O,CHEMBL1939631,nM,49,CHEMBL6009,7.30980392,DGAT,CC(C)(COc1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010412,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(C)(COc1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)cc1)C(=O)O,CHEMBL1939632,nM,102,CHEMBL6009,6.991399828,DGAT,CC(C)(COc1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010413,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)cn1,CHEMBL1939629,nM,2420,CHEMBL6009,5.616184634,DGAT,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)cn1,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010414,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)nn1,CHEMBL1939626,nM,373,CHEMBL6009,6.428291168,DGAT,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)nn1,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)nn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010415,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1cnc(OCC(C)(C)C(=O)O)cn1,CHEMBL1939627,nM,117,CHEMBL6009,6.931814138,DGAT,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1cnc(OCC(C)(C)C(=O)O)cn1,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1cnc(OCC(C)(C)C(=O)O)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010416,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)nc1,CHEMBL1939628,nM,97,CHEMBL6009,7.013228266,DGAT,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)nc1,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1ccc(OCC(C)(C)C(=O)O)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010417,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cn1c(OCC(C)(C)C(=O)Nc2ccccc2)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,CHEMBL1939623,nM,110,CHEMBL6009,6.958607315,DGAT,Cn1c(OCC(C)(C)C(=O)Nc2ccccc2)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Cn1c(OCC(C)(C)C(=O)Nc2ccccc2)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010418,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CN(C)CCNC(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,CHEMBL1939624,nM,53,CHEMBL6009,7.27572413,DGAT,CN(C)CCNC(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,CN(C)CCNC(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010419,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1cnc(OCC(C)(C)C(=O)O)nc1,CHEMBL1939625,nM,115,CHEMBL6009,6.93930216,DGAT,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1cnc(OCC(C)(C)C(=O)O)nc1,Cc1cc(NC(=O)c2ccc3ccccc3c2)ccc1-c1cnc(OCC(C)(C)C(=O)O)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010420,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CN(C)C(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,CHEMBL1939621,nM,29,CHEMBL6009,7.537602002,DGAT,CN(C)C(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,CN(C)C(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010421,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,CC(C)NC(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,CHEMBL1939622,nM,39,CHEMBL6009,7.408935393,DGAT,CC(C)NC(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,CC(C)NC(=O)C(C)(C)COc1nnc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)n1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010422,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cn1c(OCC(C)(C)C(=O)O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,CHEMBL1939618,nM,4,CHEMBL6009,8.397940009,DGAT,Cn1c(OCC(C)(C)C(=O)O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Cn1c(OCC(C)(C)C(=O)O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010423,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cn1c(CCC(=O)O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,CHEMBL1939619,nM,167,CHEMBL6009,6.777283529,DGAT,Cn1c(CCC(=O)O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Cn1c(CCC(=O)O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8010424,CHEMBL1943095,Inhibition of human recombinant N-terminus FLAG-tagged DGAT1 expressed in baculovirus infected insect Sf9 cells assessed as triglyceride synthesis,B,Cn1c(OCC(C)(C)C(N)=O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,CHEMBL1939620,nM,28,CHEMBL6009,7.552841969,DGAT,Cn1c(OCC(C)(C)C(N)=O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Cn1c(OCC(C)(C)C(N)=O)nnc1-c1ccc(NC(=O)c2ccc3ccccc3c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
8039699,CHEMBL1954900,Inhibition of full length human microsomal DGAT-1 expressed in baculovirus infected insect Sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CC2,CHEMBL1952025,nM,60,CHEMBL6009,7.22184875,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CC2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841810,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,CN(C(=O)c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1)c1nnc(Cc2ccccc2)s1,CHEMBL2012635,nM,10000,CHEMBL6009,5,DGAT,CN(C(=O)c1ccc(C2CCC(CC(=O)O)CC2)cc1)c1nnc(Cc2ccccc2)s1,CN(C(=O)c1ccc(C2CCC(CC(=O)O)CC2)cc1)c1nnc(Cc2ccccc2)s1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841813,CHEMBL2015972,Inhibition of human recombinant DGAT1 in Chang cells using [14C]-glycerol as substrate assessed as decrease in triglycerides synthesis after 6 hrs by HPLC analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCC4CCCC4)s3)cc2)CC1,CHEMBL2012612,nM,12,CHEMBL6009,7.920818754,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841815,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CC4CCCC4)s3)cc2)CC1,CHEMBL2012614,nM,24,CHEMBL6009,7.619788758,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CC4CCCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CC4CCCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841816,CHEMBL2015972,Inhibition of human recombinant DGAT1 in Chang cells using [14C]-glycerol as substrate assessed as decrease in triglycerides synthesis after 6 hrs by HPLC analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL2012625,nM,29,CHEMBL6009,7.537602002,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841817,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4cccc(F)c4)s3)cc2)CC1,CHEMBL2012628,nM,30,CHEMBL6009,7.522878745,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4cccc(F)c4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4cccc(F)c4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841818,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4cccc(Cl)c4)s3)cc2)CC1,CHEMBL2012631,nM,30,CHEMBL6009,7.522878745,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4cccc(Cl)c4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4cccc(Cl)c4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841820,CHEMBL2015972,Inhibition of human recombinant DGAT1 in Chang cells using [14C]-glycerol as substrate assessed as decrease in triglycerides synthesis after 6 hrs by HPLC analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4F)s3)cc2)CC1,CHEMBL2012629,nM,35,CHEMBL6009,7.455931956,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4F)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4F)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841822,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCC4CCCCC4)s3)cc2)CC1,CHEMBL2012611,nM,40,CHEMBL6009,7.397940009,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCCCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCCCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841823,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(COc4ccc(F)cc4)s3)cc2)CC1,CHEMBL2012622,nM,44,CHEMBL6009,7.356547324,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(COc4ccc(F)cc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(COc4ccc(F)cc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841826,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(COc4ccccc4)s3)cc2)CC1,CHEMBL2012610,nM,47,CHEMBL6009,7.327902142,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(COc4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(COc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841827,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCCc4ccc(F)cc4)s3)cc2)CC1,CHEMBL2012620,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCCc4ccc(F)cc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCCc4ccc(F)cc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841829,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCC4CCC4)s3)cc2)CC1,CHEMBL2012613,nM,65,CHEMBL6009,7.187086643,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841830,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCc4ccc(F)cc4)s3)cc2)CC1,CHEMBL2012619,nM,66,CHEMBL6009,7.180456064,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCc4ccc(F)cc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCc4ccc(F)cc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841831,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCc4ccccc4)s3)cc2)CC1,CHEMBL2012608,nM,70,CHEMBL6009,7.15490196,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCc4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841832,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4Cl)s3)cc2)CC1,CHEMBL2012632,nM,82,CHEMBL6009,7.086186148,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4Cl)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4Cl)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841833,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(-c4ccccc4)s3)cc2)CC1,CHEMBL2012601,nM,85,CHEMBL6009,7.070581074,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(-c4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(-c4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841837,CHEMBL2015972,Inhibition of human recombinant DGAT1 in Chang cells using [14C]-glycerol as substrate assessed as decrease in triglycerides synthesis after 6 hrs by HPLC analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccc(F)cc4)s3)cc2)CC1,CHEMBL2012627,nM,131,CHEMBL6009,6.882728704,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccc(F)cc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccc(F)cc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841838,CHEMBL2015972,Inhibition of human recombinant DGAT1 in Chang cells using [14C]-glycerol as substrate assessed as decrease in triglycerides synthesis after 6 hrs by HPLC analysis,B,COc1ccc(Cc2nnc(NC(=O)c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)s2)cc1,CHEMBL2012626,nM,142,CHEMBL6009,6.847711656,DGAT,COc1ccc(Cc2n[nH]c(=NC(=O)c3ccc(C4CCC(CC(=O)O)CC4)cc3)s2)cc1,COc1ccc(Cc2n[nH]c(=NC(=O)c3ccc(C4CCC(CC(=O)O)CC4)cc3)s2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841839,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(C4(c5ccccc5)CC4)s3)cc2)CC1,CHEMBL2012600,nM,162,CHEMBL6009,6.790484985,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4(c5ccccc5)CC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4(c5ccccc5)CC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841842,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(SCc4ccccc4)s3)cc2)CC1,CHEMBL2012609,nM,218,CHEMBL6009,6.661543506,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(SCc4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(SCc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841843,CHEMBL2015972,Inhibition of human recombinant DGAT1 in Chang cells using [14C]-glycerol as substrate assessed as decrease in triglycerides synthesis after 6 hrs by HPLC analysis,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(Nc3nnc(Cc4ccccc4)s3)cc2)cc1)C(=O)O,CHEMBL2012633,nM,300,CHEMBL6009,6.522878745,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(N=c3[nH]nc(Cc4ccccc4)s3)cc2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(N=c3[nH]nc(Cc4ccccc4)s3)cc2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841844,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)CC[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL2012624,nM,350,CHEMBL6009,6.455931956,DGAT,O=C(O)CCC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,O=C(O)CCC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841846,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(C4(c5ccc(F)cc5)CC4)s3)cc2)CC1,CHEMBL2012617,nM,408,CHEMBL6009,6.389339837,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4(c5ccc(F)cc5)CC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4(c5ccc(F)cc5)CC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841847,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(C4CCCC4)s3)cc2)CC1,CHEMBL2012615,nM,426,CHEMBL6009,6.370590401,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4CCCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4CCCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841848,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,CC(C)Cc1nnc(NC(=O)c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)s1,CHEMBL2012616,nM,498,CHEMBL6009,6.302770657,DGAT,CC(C)Cc1n[nH]c(=NC(=O)c2ccc(C3CCC(CC(=O)O)CC3)cc2)s1,CC(C)Cc1n[nH]c(=NC(=O)c2ccc(C3CCC(CC(=O)O)CC3)cc2)s1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841849,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL2012623,nM,578,CHEMBL6009,6.238072162,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841854,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,COc1ccc(-c2nnc(NC(=O)c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)s2)cc1,CHEMBL2012621,nM,838,CHEMBL6009,6.076755981,DGAT,COc1ccc(-c2n[nH]c(=NC(=O)c3ccc(C4CCC(CC(=O)O)CC4)cc3)s2)cc1,COc1ccc(-c2n[nH]c(=NC(=O)c3ccc(C4CCC(CC(=O)O)CC4)cc3)s2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841855,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(C45CC6CC(CC(C6)C4)C5)s3)cc2)CC1,CHEMBL2012603,nM,970,CHEMBL6009,6.013228266,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C45CC6CC(CC(C6)C4)C5)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C45CC6CC(CC(C6)C4)C5)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841857,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(N4CCOCC4)s3)cc2)CC1,CHEMBL2012604,nM,1190,CHEMBL6009,5.924453039,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(N4CCOCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(N4CCOCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841858,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,CC(C)(C)c1nnc(NC(=O)c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)s1,CHEMBL2012607,nM,1190,CHEMBL6009,5.924453039,DGAT,CC(C)(C)c1n[nH]c(=NC(=O)c2ccc(C3CCC(CC(=O)O)CC3)cc2)s1,CC(C)(C)c1n[nH]c(=NC(=O)c2ccc(C3CCC(CC(=O)O)CC3)cc2)s1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841859,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(C4(c5cccc(F)c5)CC4)s3)cc2)CC1,CHEMBL2012618,nM,2360,CHEMBL6009,5.627087997,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4(c5cccc(F)c5)CC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(C4(c5cccc(F)c5)CC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841860,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Br)s3)cc2)CC1,CHEMBL2012606,nM,2840,CHEMBL6009,5.54668166,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Br)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Br)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841862,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(-c4ccncc4)s3)cc2)CC1,CHEMBL2012602,nM,4770,CHEMBL6009,5.321481621,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(-c4ccncc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(-c4ccncc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841864,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccc(Cl)cc4)s3)cc2)CC1,CHEMBL2012630,nM,5280,CHEMBL6009,5.277366077,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccc(Cl)cc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccc(Cl)cc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841866,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,CS(=O)(=O)c1nnc(NC(=O)c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)s1,CHEMBL2012605,nM,10000,CHEMBL6009,5,DGAT,CS(=O)(=O)c1n[nH]c(=NC(=O)c2ccc(C3CCC(CC(=O)O)CC3)cc2)s1,CS(=O)(=O)c1n[nH]c(=NC(=O)c2ccc(C3CCC(CC(=O)O)CC3)cc2)s1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10841867,CHEMBL2015971,Inhibition of human recombinant DGAT1 expressed in baculovirus infected Sf9 cells after 60 mins by scintillation counting method,B,O=C(O)CC1CCC(c2ccc(Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL2012634,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915157,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)cc1)c1nnc(Nc2ccccc2)o1,CHEMBL2036746,nM,300,CHEMBL6009,6.522878745,DGAT,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=Nc2ccccc2)o1,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=Nc2ccccc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915158,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1nnc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccccc1,CHEMBL2036747,nM,5200,CHEMBL6009,5.283996656,DGAT,O=C(N=c1[nH]nc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccccc1,O=C(N=c1[nH]nc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915160,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)cc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036567,nM,520,CHEMBL6009,6.283996656,DGAT,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915161,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)c(F)c1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036568,nM,460,CHEMBL6009,6.337242168,DGAT,O=C(Nc1ccc(N2CCOCC2)c(F)c1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CCOCC2)c(F)c1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915162,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Cc1cc(NC(=O)c2nnc(Nc3ccccc3F)o2)ccc1N1CCOCC1,CHEMBL2036569,nM,350,CHEMBL6009,6.455931956,DGAT,Cc1cc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)ccc1N1CCOCC1,Cc1cc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)ccc1N1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915163,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)cc1F)c1nnc(Nc2ccccc2F)o1,CHEMBL2036570,nM,30000,CHEMBL6009,4.522878745,DGAT,O=C(Nc1ccc(N2CCOCC2)cc1F)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CCOCC2)cc1F)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915164,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036571,nM,130,CHEMBL6009,6.886056648,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915165,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)cn1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036572,nM,11000,CHEMBL6009,4.958607315,DGAT,O=C(N=c1ccc(N2CCOCC2)c[nH]1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(N=c1ccc(N2CCOCC2)c[nH]1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915166,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCCCC2)cc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036573,nM,190,CHEMBL6009,6.721246399,DGAT,O=C(Nc1ccc(N2CCCCC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CCCCC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915167,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCSCC2)nc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036574,nM,23,CHEMBL6009,7.638272164,DGAT,O=C(Nc1ccc(N2CCSCC2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CCSCC2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915168,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CC[S+]([O-])CC2)nc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036575,nM,3700,CHEMBL6009,5.431798276,DGAT,O=C(Nc1ccc(N2CC[S+]([O-])CC2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(N2CC[S+]([O-])CC2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915169,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CN1CCN(c2ccc(NC(=O)c3nnc(Nc4ccccc4F)o3)cn2)CC1,CHEMBL2036576,nM,460,CHEMBL6009,6.337242168,DGAT,CN1CCN(c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cn2)CC1,CN1CCN(c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915170,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CC(=O)N1CCN(c2ccc(NC(=O)c3nnc(Nc4ccccc4F)o3)cc2)CC1,CHEMBL2036577,nM,540,CHEMBL6009,6.26760624,DGAT,CC(=O)N1CCN(c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)CC1,CC(=O)N1CCN(c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915171,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CCCCc1ccc(NC(=O)c2nnc(Nc3ccccc3F)o2)cc1,CHEMBL2036578,nM,620,CHEMBL6009,6.207608311,DGAT,CCCCc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cc1,CCCCc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915172,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(C2CCCCC2)cc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036579,nM,310,CHEMBL6009,6.508638306,DGAT,O=C(Nc1ccc(C2CCCCC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(C2CCCCC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915173,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(-c2ccccc2)cc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036580,nM,120,CHEMBL6009,6.920818754,DGAT,O=C(Nc1ccc(-c2ccccc2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(-c2ccccc2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915174,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,COc1ccc(NC(=O)c2nnc(Nc3ccccc3F)o2)cn1,CHEMBL2036581,nM,8000,CHEMBL6009,5.096910013,DGAT,COc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cn1,COc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915175,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CCCCOc1ccc(NC(=O)c2nnc(Nc3ccccc3F)o2)cn1,CHEMBL2036582,nM,60,CHEMBL6009,7.22184875,DGAT,CCCCOc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cn1,CCCCOc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915176,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(Oc2ccccc2)nc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036583,nM,6.7,CHEMBL6009,8.173925197,DGAT,O=C(Nc1ccc(Oc2ccccc2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(Oc2ccccc2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915177,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(Oc2cccnc2)nc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036584,nM,410,CHEMBL6009,6.387216143,DGAT,O=C(Nc1ccc(Oc2cccnc2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(Oc2cccnc2)nc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915178,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(Nc2ccccc2)nc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036585,nM,60,CHEMBL6009,7.22184875,DGAT,O=C(Nc1ccc(=Nc2ccccc2)[nH]c1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(=Nc2ccccc2)[nH]c1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915179,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CCCCSc1ccc(NC(=O)c2nnc(Nc3ccccc3F)o2)cc1,CHEMBL2036586,nM,16,CHEMBL6009,7.795880017,DGAT,CCCCSc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cc1,CCCCSc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915180,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2ccccc2)o1,CHEMBL2036587,nM,620,CHEMBL6009,6.207608311,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccccc2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccccc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915181,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(F)c2)o1,CHEMBL2036588,nM,150,CHEMBL6009,6.823908741,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(F)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915182,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2ccc(F)cc2)o1,CHEMBL2036589,nM,840,CHEMBL6009,6.075720714,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccc(F)cc2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccc(F)cc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915183,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2ccc(F)c(F)c2)o1,CHEMBL2036590,nM,340,CHEMBL6009,6.468521083,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915184,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2ccccc2Cl)o1,CHEMBL2036591,nM,1300,CHEMBL6009,5.886056648,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccccc2Cl)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccccc2Cl)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915185,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(Cl)c2)o1,CHEMBL2036592,nM,92,CHEMBL6009,7.036212173,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(Cl)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(Cl)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915186,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2ccc(Cl)cc2)o1,CHEMBL2036593,nM,190,CHEMBL6009,6.721246399,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccc(Cl)cc2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2ccc(Cl)cc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915187,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,COc1cccc(Nc2nnc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,CHEMBL2036594,nM,730,CHEMBL6009,6.13667714,DGAT,COc1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,COc1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915188,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CCOc1cccc(Nc2nnc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,CHEMBL2036595,nM,32,CHEMBL6009,7.494850022,DGAT,CCOc1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,CCOc1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915189,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(Oc3ccccc3)c2)o1,CHEMBL2036596,nM,6.6,CHEMBL6009,8.180456064,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(Oc3ccccc3)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(Oc3ccccc3)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915190,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(OCc3ccccc3)c2)o1,CHEMBL2036597,nM,13,CHEMBL6009,7.886056648,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(OCc3ccccc3)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(OCc3ccccc3)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915191,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(OCc3ccccn3)c2)o1,CHEMBL2036731,nM,540,CHEMBL6009,6.26760624,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(OCc3ccccn3)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(OCc3ccccn3)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915192,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(OCc3cccnc3)c2)o1,CHEMBL2036732,nM,2100,CHEMBL6009,5.677780705,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(OCc3cccnc3)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(OCc3cccnc3)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915193,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Cc1cccc(Nc2nnc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,CHEMBL2036733,nM,170,CHEMBL6009,6.769551079,DGAT,Cc1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,Cc1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915194,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)nc1)c1nnc(Nc2cccc(-c3ccccc3)c2)o1,CHEMBL2036734,nM,5.7,CHEMBL6009,8.244125144,DGAT,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(-c3ccccc3)c2)o1,O=C(Nc1ccc(N2CCOCC2)nc1)c1n[nH]c(=Nc2cccc(-c3ccccc3)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915195,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)c1cccc(Nc2nnc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,CHEMBL2036735,nM,30000,CHEMBL6009,4.522878745,DGAT,O=C(O)c1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,O=C(O)c1cccc(N=c2[nH]nc(C(=O)Nc3ccc(N4CCOCC4)nc3)o2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915196,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1nnc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccc(Cl)cc1,CHEMBL2036736,nM,370,CHEMBL6009,6.431798276,DGAT,O=C(N=c1[nH]nc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccc(Cl)cc1,O=C(N=c1[nH]nc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccc(Cl)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915197,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CC(C)(C(=O)Nc1nnc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccc(Cl)cc1,CHEMBL2036737,nM,520,CHEMBL6009,6.283996656,DGAT,CC(C)(C(=O)N=c1[nH]nc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccc(Cl)cc1,CC(C)(C(=O)N=c1[nH]nc(C(=O)Nc2ccc(N3CCOCC3)cc2)o1)c1ccc(Cl)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915198,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)cc1)c1nnc(NC(=O)C2(c3ccc(Cl)cc3)CCC2)o1,CHEMBL2036738,nM,320,CHEMBL6009,6.494850022,DGAT,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=NC(=O)C2(c3ccc(Cl)cc3)CCC2)o1,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=NC(=O)C2(c3ccc(Cl)cc3)CCC2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915199,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(N2CCOCC2)cc1)c1nnc(NC(=O)C2(c3ccc(Cl)cc3)CCCC2)o1,CHEMBL2036739,nM,180,CHEMBL6009,6.744727495,DGAT,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=NC(=O)C2(c3ccc(Cl)cc3)CCCC2)o1,O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c(=NC(=O)C2(c3ccc(Cl)cc3)CCCC2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915200,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)CCCc1ccc(NC(=O)c2nnc(Nc3ccccc3F)o2)cc1,CHEMBL2036740,nM,3300,CHEMBL6009,5.48148606,DGAT,O=C(O)CCCc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cc1,O=C(O)CCCc1ccc(NC(=O)c2n[nH]c(=Nc3ccccc3F)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915201,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)c1ccc(-c2ccc(NC(=O)c3nnc(Nc4ccccc4F)o3)cc2)cc1,CHEMBL2036741,nM,210,CHEMBL6009,6.677780705,DGAT,O=C(O)c1ccc(-c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)cc1,O=C(O)c1ccc(-c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915202,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)Cc1cccc(-c2ccc(NC(=O)c3nnc(Nc4ccccc4F)o3)cc2)c1,CHEMBL2036742,nM,70,CHEMBL6009,7.15490196,DGAT,O=C(O)Cc1cccc(-c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)c1,O=C(O)Cc1cccc(-c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915203,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)Cc1ccc(-c2ccc(NC(=O)c3nnc(Nc4ccccc4F)o3)cc2)cc1,CHEMBL2036743,nM,80,CHEMBL6009,7.096910013,DGAT,O=C(O)Cc1ccc(-c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)cc1,O=C(O)Cc1ccc(-c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915204,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)Cc1ccc(C2CCC(NC(=O)c3nnc(Nc4ccccc4F)o3)CC2)cc1,CHEMBL2036744,nM,1300,CHEMBL6009,5.886056648,DGAT,O=C(O)Cc1ccc(C2CCC(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)CC2)cc1,O=C(O)Cc1ccc(C2CCC(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915205,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3nnc(Nc4ccccc4F)o3)cc2)CC1,CHEMBL2036745,nM,4.4,CHEMBL6009,8.356547324,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)c3n[nH]c(=Nc4ccccc4F)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915206,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(Nc1ccc(C2CCC(C(=O)O)CC2)cc1)c1nnc(Nc2ccccc2F)o1,CHEMBL2036729,nM,35,CHEMBL6009,7.455931956,DGAT,O=C(Nc1ccc(C2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,O=C(Nc1ccc(C2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2ccccc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10915207,CHEMBL2038283,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cc2)CC1,CHEMBL2036730,nM,0.6,CHEMBL6009,9.22184875,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981275,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,CCOC(=O)Nc1ccc2nc(-c3c(Cl)cccc3Cl)[nH]c2c1,CHEMBL2063278,nM,1300,CHEMBL6009,5.886056648,DGAT,CCOC(=O)Nc1ccc2[nH]c(-c3c(Cl)cccc3Cl)nc2c1,CCOC(=O)Nc1ccc2[nH]c(-c3c(Cl)cccc3Cl)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981276,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,Cc1ccc(NC(=O)c2ccc3nc(-c4c(C)cccc4C)[nH]c3c2)cc1C,CHEMBL2063279,nM,1400,CHEMBL6009,5.853871964,DGAT,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cccc4C)nc3c2)cc1C,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cccc4C)nc3c2)cc1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981277,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,COc1cc(C)c(-c2nc3ccc(C(=O)Nc4ccc(C)c(C)c4)cc3[nH]2)c(C)c1,CHEMBL2063280,nM,500,CHEMBL6009,6.301029996,DGAT,COc1cc(C)c(-c2nc3cc(C(=O)Nc4ccc(C)c(C)c4)ccc3[nH]2)c(C)c1,COc1cc(C)c(-c2nc3cc(C(=O)Nc4ccc(C)c(C)c4)ccc3[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981278,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,Cc1ccc(NC(=O)c2ccc3nc(-c4c(C)cc(OCC(=O)O)cc4C)[nH]c3c2)cc1C,CHEMBL2063281,nM,28,CHEMBL6009,7.552841969,DGAT,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cc(OCC(=O)O)cc4C)nc3c2)cc1C,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cc(OCC(=O)O)cc4C)nc3c2)cc1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981279,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,Cc1ccc(NC(=O)c2ccc3nc(-c4c(C)cc(NCC(=O)O)cc4C)[nH]c3c2)cc1C,CHEMBL2063282,nM,56,CHEMBL6009,7.251811973,DGAT,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cc(NCC(=O)O)cc4C)nc3c2)cc1C,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cc(NCC(=O)O)cc4C)nc3c2)cc1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981280,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,Cc1ccc(NC(=O)c2ccc3nc(-c4c(C)cc(CCC(=O)O)cc4C)[nH]c3c2)cc1C,CHEMBL2063283,nM,28,CHEMBL6009,7.552841969,DGAT,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cc(CCC(=O)O)cc4C)nc3c2)cc1C,Cc1ccc(NC(=O)c2ccc3[nH]c(-c4c(C)cc(CCC(=O)O)cc4C)nc3c2)cc1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
10981281,CHEMBL2065832,Inhibition of human recombinant His6-tagged DGAT1 expressed in insect Sf9 cells,B,Cc1cc(CCC(=O)O)cc(C)c1-c1nc2ccc(C(=O)Nc3ccc(C(C)(C)C)cc3)cc2[nH]1,CHEMBL2063284,nM,39,CHEMBL6009,7.408935393,DGAT,Cc1cc(CCC(=O)O)cc(C)c1-c1nc2cc(C(=O)Nc3ccc(C(C)(C)C)cc3)ccc2[nH]1,Cc1cc(CCC(=O)O)cc(C)c1-c1nc2cc(C(=O)Nc3ccc(C(C)(C)C)cc3)ccc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084430,CHEMBL2168628,Inhibition of human DGAT1 expressed in human HeLa cells assessed as reduction in triglyceride synthesis,B,Nc1c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)cnc2ccnn12,CHEMBL2165819,nM,78,CHEMBL6009,7.107905397,DGAT,N=c1c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)c[nH]c2ccnn12,N=c1c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084445,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,CS(=O)(=O)c1ccc(-c2cnc3ccnn3c2N)cc1,CHEMBL2165818,nM,10000,CHEMBL6009,5,DGAT,CS(=O)(=O)c1ccc(-c2c[nH]c3ccnn3c2=N)cc1,CS(=O)(=O)c1ccc(-c2c[nH]c3ccnn3c2=N)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084446,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,Nc1c(-c2ccc(C(=O)O)cc2)cnc2ccnn12,CHEMBL2165817,nM,10000,CHEMBL6009,5,DGAT,N=c1c(-c2ccc(C(=O)O)cc2)c[nH]c2ccnn12,N=c1c(-c2ccc(C(=O)O)cc2)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084447,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,Nc1c(-c2ccc(C3CCCCC3)cc2)cnc2ccnn12,CHEMBL2165816,nM,110,CHEMBL6009,6.958607315,DGAT,N=c1c(-c2ccc(C3CCCCC3)cc2)c[nH]c2ccnn12,N=c1c(-c2ccc(C3CCCCC3)cc2)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084448,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,CC(C)c1ccc(-c2cnc3ccnn3c2N)cc1,CHEMBL2165815,nM,250,CHEMBL6009,6.602059991,DGAT,CC(C)c1ccc(-c2c[nH]c3ccnn3c2=N)cc1,CC(C)c1ccc(-c2c[nH]c3ccnn3c2=N)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084449,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,Nc1c(-c2ccccc2Br)cnc2ccnn12,CHEMBL2165814,nM,10000,CHEMBL6009,5,DGAT,N=c1c(-c2ccccc2Br)c[nH]c2ccnn12,N=c1c(-c2ccccc2Br)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084450,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,Nc1c(-c2cccc(Br)c2)cnc2ccnn12,CHEMBL2165813,nM,10000,CHEMBL6009,5,DGAT,N=c1c(-c2cccc(Br)c2)c[nH]c2ccnn12,N=c1c(-c2cccc(Br)c2)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084451,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,Nc1c(-c2ccc(Br)cc2)cnc2ccnn12,CHEMBL2165812,nM,1860,CHEMBL6009,5.730487056,DGAT,N=c1c(-c2ccc(Br)cc2)c[nH]c2ccnn12,N=c1c(-c2ccc(Br)cc2)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084452,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,Nc1c(-c2ccccc2)cnc2ccnn12,CHEMBL2165811,nM,10000,CHEMBL6009,5,DGAT,N=c1c(-c2ccccc2)c[nH]c2ccnn12,N=c1c(-c2ccccc2)c[nH]c2ccnn12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084453,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,CC(C)(C)c1ccc(-c2cnc3ccnn3c2N)cc1,CHEMBL2165810,nM,44,CHEMBL6009,7.356547324,DGAT,CC(C)(C)c1ccc(-c2c[nH]c3ccnn3c2=N)cc1,CC(C)(C)c1ccc(-c2c[nH]c3ccnn3c2=N)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12084454,CHEMBL2168632,Inhibition of N-terminal His6-tagged human recombinant DGAT1 expressed in insect cell membrane using [1-14C]decanoyl-CoA substrate by phospholipid flash plate assay,B,CC(C)(C)c1ccc(-c2cncnc2N)cc1,CHEMBL2165809,nM,1580,CHEMBL6009,5.801342913,DGAT,CC(C)(C)c1ccc(-c2c[nH]cnc2=N)cc1,CC(C)(C)c1ccc(-c2c[nH]cnc2=N)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12150735,CHEMBL2183591,Inhibition of DGAT1 in human HuTu80 cells,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178953,nM,10,CHEMBL6009,8,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152604,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc(C34CCC(Cc5nnn[nH]5)(CC3)CC4)cc2)nc1C(N)=O,CHEMBL2178373,nM,40,CHEMBL6009,7.397940009,DGAT,Cc1nc(C)c(-c2ccc(C34CCC(Cc5nn[nH]n5)(CC3)CC4)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C34CCC(Cc5nn[nH]n5)(CC3)CC4)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152605,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc(C34CCC(CC(=O)O)(CC3)CC4)cc2)nc1C(N)=O,CHEMBL2178372,nM,200,CHEMBL6009,6.698970004,DGAT,Cc1nc(C)c(-c2ccc(C34CCC(CC(=O)O)(CC3)CC4)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C34CCC(CC(=O)O)(CC3)CC4)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152606,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc(C34CCC(C(=O)O)(CC3)CC4)cc2)nc1C(N)=O,CHEMBL2178371,nM,80,CHEMBL6009,7.096910013,DGAT,Cc1nc(C)c(-c2ccc(C34CCC(C(=O)O)(CC3)CC4)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C34CCC(C(=O)O)(CC3)CC4)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152607,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@@H](c3nnn[nH]3)CC2)nc1C(N)=O,CHEMBL2178370,nM,120,CHEMBL6009,6.920818754,DGAT,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(c3nn[nH]n3)CC2)nc1C(N)=O,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(c3nn[nH]n3)CC2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152608,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@@H](Cc3nnn[nH]3)CC2)nc1C(N)=O,CHEMBL2178369,nM,30,CHEMBL6009,7.522878745,DGAT,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@@H](Cc3nn[nH]n3)CC2)nc1C(N)=O,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(Cc3nn[nH]n3)CC2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152609,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@@H](C(=O)O)CC2)nc1C(N)=O,CHEMBL2178949,nM,240,CHEMBL6009,6.619788758,DGAT,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(C(=O)O)CC2)nc1C(N)=O,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(C(=O)O)CC2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152610,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@H](C(=O)O)CC2)nc1C(N)=O,CHEMBL2178948,nM,170,CHEMBL6009,6.769551079,DGAT,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(C(=O)O)CC2)nc1C(N)=O,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(C(=O)O)CC2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152611,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@@H](CC(=O)O)CC2)nc1C(N)=O,CHEMBL2178947,nM,30,CHEMBL6009,7.522878745,DGAT,Cc1nc(C)c(-c2ccc3c(c2)CC[C@]32CC[C@@H](CC(=O)O)CC2)nc1C(N)=O,Cc1nc(C)c(-c2ccc3c(c2)CCC32CCC(CC(=O)O)CC2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152612,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@@H](CC(=O)O)CC3)c(Cl)c2)nc1C(N)=O,CHEMBL2178946,nM,70,CHEMBL6009,7.15490196,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(Cl)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(Cl)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152613,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@@H](CC(=O)O)CC3)c(F)c2)nc1C(N)=O,CHEMBL2178945,nM,120,CHEMBL6009,6.920818754,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(F)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(F)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152614,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@@H](CC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178944,nM,430,CHEMBL6009,6.366531544,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152615,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)c(Cl)c2)nc1C(N)=O,CHEMBL2178943,nM,30,CHEMBL6009,7.522878745,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(Cl)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(Cl)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152616,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)c(F)c2)nc1C(N)=O,CHEMBL2178942,nM,60,CHEMBL6009,7.22184875,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(F)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)c(F)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152617,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CCC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178941,nM,120,CHEMBL6009,6.920818754,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CCC(=O)O)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CCC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152618,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](Cc4nnn[nH]4)CC3)cc2)nc1C(N)=O,CHEMBL2178940,nM,60,CHEMBL6009,7.22184875,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(Cc4nn[nH]n4)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(Cc4nn[nH]n4)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152619,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)NS(C)(=O)=O)CC3)cc2)nc1C(N)=O,CHEMBL2178939,nM,100,CHEMBL6009,7,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)NS(C)(=O)=O)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)NS(C)(=O)=O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152620,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CC(C)(NC(=O)C[C@H]1CC[C@H](c2ccc(-c3cncc(C(N)=O)n3)cc2)CC1)C(=O)O,CHEMBL2178938,nM,1100,CHEMBL6009,5.958607315,DGAT,CC(C)(NC(=O)C[C@H]1CC[C@H](c2ccc(-c3cncc(C(N)=O)n3)cc2)CC1)C(=O)O,CC(C)(NC(=O)CC1CCC(c2ccc(-c3cncc(C(N)=O)n3)cc2)CC1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152621,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)NC(C)(C)C(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178937,nM,110,CHEMBL6009,6.958607315,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)NC(C)(C)C(=O)O)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)NC(C)(C)C(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152622,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,NC(=O)C[C@H]1CC[C@H](c2ccc(-c3cncc(C(N)=O)n3)cc2)CC1,CHEMBL2178936,nM,1900,CHEMBL6009,5.721246399,DGAT,NC(=O)C[C@H]1CC[C@H](c2ccc(-c3cncc(C(N)=O)n3)cc2)CC1,NC(=O)CC1CCC(c2ccc(-c3cncc(C(N)=O)n3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152623,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(N)=O)CC3)cc2)nc1C(N)=O,CHEMBL2178935,nM,520,CHEMBL6009,6.283996656,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CC(N)=O)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CC(N)=O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152624,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,NC(=O)c1cncc(-c2ccc([C@H]3CC[C@H](CCO)CC3)cc2)n1,CHEMBL2178934,nM,1200,CHEMBL6009,5.920818754,DGAT,NC(=O)c1cncc(-c2ccc([C@H]3CC[C@H](CCO)CC3)cc2)n1,NC(=O)c1cncc(-c2ccc(C3CCC(CCO)CC3)cc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152625,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CCO)CC3)cc2)nc1C(N)=O,CHEMBL2178933,nM,690,CHEMBL6009,6.161150909,DGAT,Cc1nc(C)c(-c2ccc(C3CCC(CCO)CC3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(C3CCC(CCO)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152626,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(-c2ccccc2)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178932,nM,10000,CHEMBL6009,5,DGAT,Cc1nc(-c2ccccc2)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,Cc1nc(-c2ccccc2)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152627,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C(C)C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178931,nM,10000,CHEMBL6009,5,DGAT,Cc1nc(C(C)C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Cc1nc(C(C)C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152628,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CCc1nc(C)c(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178930,nM,9100,CHEMBL6009,5.040958608,DGAT,CCc1nc(C)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,CCc1nc(C)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152629,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,NC(=O)c1nc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)cnc1N,CHEMBL2178392,nM,10000,CHEMBL6009,5,DGAT,N=c1[nH]cc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,N=c1[nH]cc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152630,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(-c2ccccc2)c(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178391,nM,10000,CHEMBL6009,5,DGAT,Cc1nc(-c2ccccc2)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1nc(-c2ccccc2)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152631,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C(C)C)c(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178390,nM,10000,CHEMBL6009,5,DGAT,Cc1nc(C(C)C)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1nc(C(C)C)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152632,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,CCc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178389,nM,1800,CHEMBL6009,5.744727495,DGAT,CCc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,CCc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152633,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1nc(C(F)F)c(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178388,nM,410,CHEMBL6009,6.387216143,DGAT,Cc1nc(C(F)F)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1nc(C(F)F)c(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152634,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1ccc(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178387,nM,41000,CHEMBL6009,4.387216143,DGAT,Cc1ccc(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,Cc1ccc(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152635,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,NC(=O)c1cccc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)n1,CHEMBL2178386,nM,28000,CHEMBL6009,4.552841969,DGAT,NC(=O)c1cccc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)n1,NC(=O)c1cccc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152636,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,NC(=O)c1cncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)c1,CHEMBL2178385,nM,60000,CHEMBL6009,4.22184875,DGAT,NC(=O)c1cncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)c1,NC(=O)c1cncc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152637,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1ncc(C(N)=S)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178384,nM,110,CHEMBL6009,6.958607315,DGAT,Cc1ncc(C(N)=S)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1ncc(C(N)=S)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152639,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,N=C(N)c1cncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)n1,CHEMBL2178382,nM,33000,CHEMBL6009,4.48148606,DGAT,N=C(N)c1cncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)n1,N=C(N)c1cncc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152647,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1ncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,CHEMBL2178954,nM,590,CHEMBL6009,6.229147988,DGAT,Cc1ncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O,Cc1ncc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152649,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,NC(=O)c1cncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)n1,CHEMBL2178952,nM,1900,CHEMBL6009,5.721246399,DGAT,NC(=O)c1cncc(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)n1,NC(=O)c1cncc(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152650,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1ncc(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL2178951,nM,310,CHEMBL6009,6.508638306,DGAT,Cc1ncc(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1ncc(C(N)=O)nc1-c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12152651,CHEMBL2183606,Inhibition of human recombinant DGAT1 expressed in Sf9 cells by liquid scintillography,B,Cc1ncc(C(N)=O)nc1-c1ccc([C@H]2CC[C@H](C(=O)O)CC2)cc1,CHEMBL2178950,nM,1100,CHEMBL6009,5.958607315,DGAT,Cc1ncc(C(N)=O)nc1-c1ccc(C2CCC(C(=O)O)CC2)cc1,Cc1ncc(C(N)=O)nc1-c1ccc(C2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686345,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,CCCCOc1cccc(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)c1,CHEMBL2334085,nM,41,CHEMBL6009,7.387216143,DGAT,CCCCOc1cccc(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)c1,CCCCOc1cccc(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686346,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(OCc5ccccc5)cc4)cn3)CC2)c1,CHEMBL2334084,nM,149,CHEMBL6009,6.826813732,DGAT,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(OCc5ccccc5)cc4)cn3)CC2)c1,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(OCc5ccccc5)cc4)cn3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686347,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(C(=O)c5ccccc5)cc4)cn3)CC2)c1,CHEMBL2334083,nM,392,CHEMBL6009,6.406713933,DGAT,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(C(=O)c5ccccc5)cc4)cn3)CC2)c1,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(C(=O)c5ccccc5)cc4)cn3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686348,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4cccc(Oc5ccccc5)c4)cn3)CC2)c1,CHEMBL2334082,nM,29,CHEMBL6009,7.537602002,DGAT,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4cccc(Oc5ccccc5)c4)cn3)CC2)c1,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4cccc(Oc5ccccc5)c4)cn3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686349,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(Oc5ccccc5)cc4)cn3)CC2)c1,CHEMBL2334081,nM,54,CHEMBL6009,7.26760624,DGAT,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(Oc5ccccc5)cc4)cn3)CC2)c1,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc(Oc5ccccc5)cc4)cn3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686350,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc5ccccc5n4)cn3)CC2)c1,CHEMBL2334080,nM,460,CHEMBL6009,6.337242168,DGAT,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc5ccccc5n4)cn3)CC2)c1,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc5ccccc5n4)cn3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686351,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc5ccccc5c4)cn3)CC2)c1,CHEMBL2334079,nM,116,CHEMBL6009,6.935542011,DGAT,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc5ccccc5c4)cn3)CC2)c1,O=C(O)c1cccc(OCC2CCN(c3ccc(NC(=O)c4ccc5ccccc5c4)cn3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686352,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCC(COc5cccc(C(=O)O)c5)CC4)nc3)o2)C1,CHEMBL2334078,nM,79,CHEMBL6009,7.102372909,DGAT,CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCC(COc5cccc(C(=O)O)c5)CC4)nc3)o2)C1,CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCC(COc5cccc(C(=O)O)c5)CC4)nc3)o2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686353,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3nccs3)cc12,CHEMBL2334077,nM,194,CHEMBL6009,6.71219827,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3nccs3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3nccs3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686354,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ncco3)cc12,CHEMBL2334076,nM,344,CHEMBL6009,6.463441557,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ncco3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ncco3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686355,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)sc2ccc(-c3ccccc3)cc12,CHEMBL2334075,nM,33,CHEMBL6009,7.48148606,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)sc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)sc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686356,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)c(F)c2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334074,nM,482,CHEMBL6009,6.316952962,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)c(F)c2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)c(F)c2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686357,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)cc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334073,nM,774,CHEMBL6009,6.111259039,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)cc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)cc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686358,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2cnc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334072,nM,240,CHEMBL6009,6.619788758,DGAT,Cc1c(C(=O)Nc2cnc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2cnc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686359,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(CC(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334071,nM,120,CHEMBL6009,6.920818754,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(CC(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(CC(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686360,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CC[C@H](COc4cccc(C(=O)O)c4)C3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334070,nM,119,CHEMBL6009,6.924453039,DGAT,Cc1c(C(=O)Nc2ccc(N3CC[C@H](COc4cccc(C(=O)O)c4)C3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)C3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686361,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CC[C@@H](COc4cccc(C(=O)O)c4)C3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334069,nM,152,CHEMBL6009,6.818156412,DGAT,Cc1c(C(=O)Nc2ccc(N3CC[C@@H](COc4cccc(C(=O)O)c4)C3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)C3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686362,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(OCc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334068,nM,125,CHEMBL6009,6.903089987,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(OCc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(OCc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686363,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4ccc(C(=O)O)cc4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334101,nM,280,CHEMBL6009,6.552841969,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4ccc(C(=O)O)cc4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4ccc(C(=O)O)cc4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686364,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334100,nM,52,CHEMBL6009,7.283996656,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4cccc(C(=O)O)c4)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686365,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCC(COc4ccccc4C(=O)O)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334099,nM,311,CHEMBL6009,6.507239611,DGAT,Cc1c(C(=O)Nc2ccc(N3CCC(COc4ccccc4C(=O)O)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCC(COc4ccccc4C(=O)O)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686366,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4C(=O)O)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334098,nM,70,CHEMBL6009,7.15490196,DGAT,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4C(=O)O)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4C(=O)O)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686367,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1ccc2c(C)c(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)oc2c1C,CHEMBL2334097,nM,24,CHEMBL6009,7.619788758,DGAT,Cc1ccc2c(C)c(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)oc2c1C,Cc1ccc2c(C)c(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)oc2c1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686368,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccc(-c3ccccc3)cc12,CHEMBL2334096,nM,103,CHEMBL6009,6.987162775,DGAT,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccc(-c3ccccc3)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686369,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1ccc2oc(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)c(C)c2c1,CHEMBL2334095,nM,42,CHEMBL6009,7.37675071,DGAT,Cc1ccc2oc(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)c(C)c2c1,Cc1ccc2oc(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)c(C)c2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686370,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,COc1ccc2oc(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)c(C)c2c1,CHEMBL2334094,nM,51,CHEMBL6009,7.292429824,DGAT,COc1ccc2oc(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)c(C)c2c1,COc1ccc2oc(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)nc3)c(C)c2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686371,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccc(F)cc12,CHEMBL2334093,nM,39,CHEMBL6009,7.408935393,DGAT,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccc(F)cc12,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccc(F)cc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686372,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc2ccccc2c1C(F)F,CHEMBL2334092,nM,40,CHEMBL6009,7.397940009,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc2ccccc2c1C(F)F,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc2ccccc2c1C(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686373,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc2ccccc2c1CF,CHEMBL2334091,nM,60,CHEMBL6009,7.22184875,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc2ccccc2c1CF,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc2ccccc2c1CF,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686374,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1cc2ccccc2o1,CHEMBL2334090,nM,145,CHEMBL6009,6.838631998,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1cc2ccccc2o1,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1cc2ccccc2o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686375,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)sc2ccccc12,CHEMBL2334089,nM,55,CHEMBL6009,7.259637311,DGAT,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)sc2ccccc12,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)sc2ccccc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686376,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccccc12,CHEMBL2334088,nM,25,CHEMBL6009,7.602059991,DGAT,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccccc12,Cc1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)oc2ccccc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686377,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,Cn1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)cc2ccccc21,CHEMBL2334087,nM,190,CHEMBL6009,6.721246399,DGAT,Cn1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)cc2ccccc21,Cn1c(C(=O)Nc2ccc(N3CCN(C(=O)Nc4ccccc4F)CC3)nc2)cc2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
12686378,CHEMBL2343709,"Inhibition of human DGAT1 expressed in Sf9 cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-Co A substrates incubated for 2 hrs by scintillation counting method",B,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2334086,nM,513,CHEMBL6009,6.289882635,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3F)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284624,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CC[C@]1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(OC(F)F)cc3)ccc2NC1=O,CHEMBL2376321,nM,10000,CHEMBL6009,5,DGAT,CC[C@]1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(OC(F)F)cc3)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(OC(F)F)cc3)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284625,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CC[C@]1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(C(F)(F)F)cc3)ccc2NC1=O,CHEMBL2376320,nM,10000,CHEMBL6009,5,DGAT,CC[C@]1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(C(F)(F)F)cc3)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(C(F)(F)F)cc3)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284626,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(CC)CNc2ccc(S(=O)(=O)Nc3ccc(F)cc3F)cc2C(=O)N1,CHEMBL2376316,nM,10000,CHEMBL6009,5,DGAT,CCC1(CC)CNc2ccc(S(=O)(=O)Nc3ccc(F)cc3F)cc2C(=O)N1,CCC1(CC)CNc2ccc(S(=O)(=O)Nc3ccc(F)cc3F)cc2C(=O)N1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284627,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)C(=O)Nc2ccc(S(=O)(=O)Nc3ccc(F)cc3F)cc2C(=O)N1C,CHEMBL2376313,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)C(=O)Nc2ccc(S(=O)(=O)Nc3ccc(F)cc3F)cc2C(=O)N1C,CCC1(C)C(=O)Nc2ccc(S(=O)(=O)Nc3ccc(F)cc3F)cc2C(=O)N1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284628,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(Cl)cc3)ccc2N(C)C1=O,CHEMBL2376312,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(Cl)cc3)ccc2N(C)C1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(Cl)cc3)ccc2N(C)C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284629,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)NC(=O)c2cc(S(=O)(=O)N(C)c3ccccc3)ccc2NC1=O,CHEMBL2376311,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)NC(=O)c2cc(S(=O)(=O)N(C)c3ccccc3)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)N(C)c3ccccc3)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284630,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CC[C@]1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(F)cc3F)ccc2NC1=O,CHEMBL2376303,nM,10000,CHEMBL6009,5,DGAT,CC[C@]1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(F)cc3F)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(F)cc3F)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284631,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(OC)cc3)ccc2NC1=O,CHEMBL2376329,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(OC)cc3)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(OC)cc3)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284632,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3Cl)ccc2NC1=O,CHEMBL2376327,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3Cl)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3Cl)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284633,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(Cl)cc3)ccc2NC1=O,CHEMBL2376325,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(Cl)cc3)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccc(Cl)cc3)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13284634,CHEMBL2378958,Inhibition of human recombinant DGAT1 expressed in Sf9 cells using dioleoyl-sn-glycerol and [14C]oleoyl coenzyme A as substrate after 30 mins by liquid scintillation counting,B,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3)ccc2NC1=O,CHEMBL2376322,nM,10000,CHEMBL6009,5,DGAT,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3)ccc2NC1=O,CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3)ccc2NC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364141,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CCC(C#N)(CC)c1ccc(C(=O)Nc2ccc(-c3cnc(C(=O)N[C@H](C(=O)O)C(C)C)s3)cc2)cc1,CHEMBL2403629,nM,101,CHEMBL6009,6.995678626,DGAT,CCC(C#N)(CC)c1ccc(C(=O)Nc2ccc(-c3cnc(C(=O)NC(C(=O)O)C(C)C)s3)cc2)cc1,CCC(C#N)(CC)c1ccc(C(=O)Nc2ccc(-c3cnc(C(=O)NC(C(=O)O)C(C)C)s3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364142,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)c3ccc(C(C)(C)C#N)cc3)cc2)s1)C(=O)O,CHEMBL2403628,nM,97,CHEMBL6009,7.013228266,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)c3ccc(C(C)(C)C#N)cc3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)c3ccc(C(C)(C)C#N)cc3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364143,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CCCCc1ccc(C(=O)Nc2ccc(-c3cnc(C(=O)N[C@H](C(=O)O)C(C)C)s3)cc2)nc1,CHEMBL2403627,nM,49,CHEMBL6009,7.30980392,DGAT,CCCCc1ccc(C(=O)Nc2ccc(-c3cnc(C(=O)NC(C(=O)O)C(C)C)s3)cc2)nc1,CCCCc1ccc(C(=O)Nc2ccc(-c3cnc(C(=O)NC(C(=O)O)C(C)C)s3)cc2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364144,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)C3CCC(F)(F)CC3)cc2)s1)C(=O)O,CHEMBL2403626,nM,82,CHEMBL6009,7.086186148,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)C3CCC(F)(F)CC3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)C3CCC(F)(F)CC3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364145,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)CCC3CCCCC3)cc2)s1)C(=O)O,CHEMBL2403625,nM,37,CHEMBL6009,7.431798276,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)CCC3CCCCC3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)CCC3CCCCC3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364146,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)cc2)s1)C(=O)O,CHEMBL2403624,nM,23,CHEMBL6009,7.638272164,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364147,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3Oc3ccccc3)cc2)s1)C(=O)O,CHEMBL2403623,nM,58,CHEMBL6009,7.236572006,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3Oc3ccccc3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3Oc3ccccc3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364148,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccccc3Oc3ccccc3)cc2)s1)C(=O)O,CHEMBL2403622,nM,23,CHEMBL6009,7.638272164,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccccc3Oc3ccccc3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccccc3Oc3ccccc3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364149,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,Cc1ccc(NC(=O)Nc2ccc(-c3cnc(C(=O)N[C@H](C(=O)O)C(C)C)s3)cc2)cc1C,CHEMBL2403621,nM,20,CHEMBL6009,7.698970004,DGAT,Cc1ccc(NC(=O)Nc2ccc(-c3cnc(C(=O)NC(C(=O)O)C(C)C)s3)cc2)cc1C,Cc1ccc(NC(=O)Nc2ccc(-c3cnc(C(=O)NC(C(=O)O)C(C)C)s3)cc2)cc1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364150,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)s1)C(=O)O,CHEMBL2403620,nM,16,CHEMBL6009,7.795880017,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364151,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)s1)C(=O)O,CHEMBL2403619,nM,22,CHEMBL6009,7.657577319,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364152,CHEMBL2404528,Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counting analysis,B,CC(C)[C@H](NC(=O)c1ncc(-c2ccc(Nc3nc4ccc(F)cc4s3)cc2)s1)C(=O)O,CHEMBL2403617,nM,10,CHEMBL6009,8,DGAT,CC(C)C(NC(=O)c1ncc(-c2ccc(N=c3[nH]c4ccc(F)cc4s3)cc2)s1)C(=O)O,CC(C)C(NC(=O)c1ncc(-c2ccc(N=c3[nH]c4ccc(F)cc4s3)cc2)s1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13364168,CHEMBL2404531,Inhibition of human DGAT1,B,CC(C)[C@H](NC(=O)c1ccc(-c2ccc(Nc3nc4ccc(F)cc4s3)cc2)cc1)C(=O)O,CHEMBL2042351,nM,35,CHEMBL6009,7.455931956,DGAT,CC(C)C(NC(=O)c1ccc(-c2ccc(N=c3[nH]c4ccc(F)cc4s3)cc2)cc1)C(=O)O,CC(C)C(NC(=O)c1ccc(-c2ccc(N=c3[nH]c4ccc(F)cc4s3)cc2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385462,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,CCOC(=O)CC1CCC(c2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)CC1,CHEMBL2409556,nM,1060,CHEMBL6009,5.974694135,DGAT,CCOC(=O)CC1CCC(c2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)CC1,CCOC(=O)CC1CCC(c2ccc(-c3nc4cc([N+](=O)[O-])ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385465,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,Cc1nc(C(=O)Nc2ccc3[nH]c(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)nc3c2)c(C(F)(F)F)o1,CHEMBL2409567,nM,10000,CHEMBL6009,5,DGAT,Cc1nc(C(=O)Nc2ccc3[nH]c(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)nc3c2)c(C(F)(F)F)o1,Cc1nc(C(=O)Nc2ccc3[nH]c(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)nc3c2)c(C(F)(F)F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385466,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,Cc1oc(-c2ccccc2)nc1C(=O)Nc1ccc2[nH]c(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2c1,CHEMBL2409566,nM,10000,CHEMBL6009,5,DGAT,Cc1oc(-c2ccccc2)nc1C(=O)Nc1ccc2[nH]c(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2c1,Cc1oc(-c2ccccc2)nc1C(=O)Nc1ccc2[nH]c(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385467,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cc6ccccc6o5)ccc4[nH]3)cc2)CC1,CHEMBL2409562,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cc6ccccc6o5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cc6ccccc6o5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385468,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cc6ccccc6s5)ccc4[nH]3)cc2)CC1,CHEMBL2409561,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cc6ccccc6s5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cc6ccccc6s5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385469,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccco5)ccc4[nH]3)cc2)CC1,CHEMBL2409559,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccco5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccco5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385470,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cccs5)ccc4[nH]3)cc2)CC1,CHEMBL2409558,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cccs5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cccs5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385471,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccccc5)ccc4[nH]3)cc2)CC1,CHEMBL2409557,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccccc5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccccc5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385472,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=S)Nc5ccccc5)ccc4[nH]3)cc2)CC1,CHEMBL2409666,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=S)Nc5ccccc5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=S)Nc5ccccc5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385473,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,NC(=S)Nc1ccc2[nH]c(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2c1,CHEMBL2409665,nM,10000,CHEMBL6009,5,DGAT,NC(=S)Nc1ccc2[nH]c(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2c1,NC(=S)Nc1ccc2[nH]c(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385474,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)Nc5ccccc5)ccc4[nH]3)cc2)CC1,CHEMBL2409664,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)Nc5ccccc5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)Nc5ccccc5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385502,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6C(F)(F)F)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,CHEMBL2409663,nM,2010,CHEMBL6009,5.696803943,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6C(F)(F)F)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6C(F)(F)F)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385503,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6Cl)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,CHEMBL2409568,nM,1070,CHEMBL6009,5.970616222,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6Cl)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6Cl)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385506,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccc(-c6ccccc6)cc5)ccc4[nH]3)cc2)CC1,CHEMBL2409560,nM,330,CHEMBL6009,6.48148606,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccc(-c6ccccc6)cc5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5ccc(-c6ccccc6)cc5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385509,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,CHEMBL2409564,nM,112,CHEMBL6009,6.950781977,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5nc(-c6ccccc6)oc5C(F)(F)F)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385511,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5noc(-c6ccccc6)n5)ccc4[nH]3)cc2)CC1,CHEMBL2409563,nM,90,CHEMBL6009,7.045757491,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5noc(-c6ccccc6)n5)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5noc(-c6ccccc6)n5)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13385512,CHEMBL2410086,Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis,B,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cn(-c6ccccc6)nc5C(F)(F)F)ccc4[nH]3)cc2)CC1,CHEMBL2409565,nM,49,CHEMBL6009,7.30980392,DGAT,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cn(-c6ccccc6)nc5C(F)(F)F)ccc4[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3nc4cc(NC(=O)c5cn(-c6ccccc6)nc5C(F)(F)F)ccc4[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394374,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cc2)CC1,CHEMBL3037924,nM,167,CHEMBL6009,6.777283529,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394375,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cc2)CC1,CHEMBL3037925,nM,293,CHEMBL6009,6.53313238,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394385,CHEMBL2410611,Inhibition of human ACAT1,B,COc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@H](C(=O)O)CC5)nc4)nc3)nc2n1,CHEMBL2408629,nM,4903,CHEMBL6009,5.309538107,DGAT,COc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,COc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394386,CHEMBL2410611,Inhibition of human ACAT1,B,COc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](C(=O)O)CC5)nc4)nc3)nc2n1,CHEMBL2408628,nM,2475,CHEMBL6009,5.606424797,DGAT,COc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,COc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394387,CHEMBL2410611,Inhibition of human ACAT1,B,Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@H](C(=O)O)CC5)nc4)nc3)nc2n1,CHEMBL2408627,nM,8782,CHEMBL6009,5.056406567,DGAT,Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394388,CHEMBL2410611,Inhibition of human ACAT1,B,Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](C(=O)O)CC5)nc4)nc3)nc2n1,CHEMBL2408626,nM,10000,CHEMBL6009,5,DGAT,Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394389,CHEMBL2410611,Inhibition of human ACAT1,B,CS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@H](C(=O)O)CC5)nc4)nc3)nc2c1,CHEMBL2408625,nM,10000,CHEMBL6009,5,DGAT,CS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,CS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394390,CHEMBL2410611,Inhibition of human ACAT1,B,CS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](C(=O)O)CC5)nc4)nc3)nc2c1,CHEMBL2408624,nM,10000,CHEMBL6009,5,DGAT,CS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,CS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394391,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(OC(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408623,nM,772,CHEMBL6009,6.1123827,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(OC(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(OC(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394392,CHEMBL2410611,Inhibition of human ACAT1,B,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@H](C(=O)O)CC5)nc4)nc3)nc2c1,CHEMBL2408622,nM,10000,CHEMBL6009,5,DGAT,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394393,CHEMBL2410611,Inhibition of human ACAT1,B,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](C(=O)O)CC5)nc4)nc3)nc2c1,CHEMBL2408621,nM,10000,CHEMBL6009,5,DGAT,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(C(=O)O)CC5)nc4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394394,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@H](Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,CHEMBL2408620,nM,8440,CHEMBL6009,5.073657553,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394395,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,CHEMBL2408472,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394396,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@H](Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408471,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394397,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408470,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394398,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@H](Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,CHEMBL2408635,nM,6065,CHEMBL6009,5.217169195,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394399,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,CHEMBL2408634,nM,8080,CHEMBL6009,5.092588639,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394485,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408633,nM,1344,CHEMBL6009,5.871600731,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394486,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408632,nM,3528,CHEMBL6009,5.452471424,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394487,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408631,nM,1232,CHEMBL6009,5.909389292,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13394488,CHEMBL2410611,Inhibition of human ACAT1,B,O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL2408630,nM,1093,CHEMBL6009,5.961379838,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13408705,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CN(C)c1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CHEMBL2414682,nM,3000,CHEMBL6009,5.522878745,DGAT,CN(C)c1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CN(C)c1ncnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13408706,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CNc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CHEMBL2414681,nM,3000,CHEMBL6009,5.522878745,DGAT,CN=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CN=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13408707,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,COc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CHEMBL2414680,nM,3000,CHEMBL6009,5.522878745,DGAT,COc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,COc1ncnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13408708,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,O=C(O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(O)c4C3=O)cc2)CC1,CHEMBL2414679,nM,3000,CHEMBL6009,5.522878745,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=O)c4C3=O)cc2)CC1,O=C(O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=O)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13408709,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1CN(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)C(=O)CO2,CHEMBL2414677,nM,3000,CHEMBL6009,5.522878745,DGAT,N=c1[nH]cnc2c1CN(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)C(=O)CO2,N=c1[nH]cnc2c1CN(c1ccc(C3CCC(CC(=O)O)CC3)cc1)C(=O)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409320,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1C(=O)N(C1CCCC1)CCO2,CHEMBL2414693,nM,92100,CHEMBL6009,4.03574037,DGAT,N=c1[nH]cnc2c1C(=O)N(C1CCCC1)CCO2,N=c1[nH]cnc2c1C(=O)N(C1CCCC1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409321,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4cnon4)CC3)cc1)CCO2,CHEMBL2414663,nM,6750,CHEMBL6009,5.170696227,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4cnon4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4cnon4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409322,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1CN(c1ccc([C@H]3CC[C@H](CCO)CC3)cc1)CCO2,CHEMBL2414676,nM,2960,CHEMBL6009,5.528708289,DGAT,N=c1[nH]cnc2c1CN(c1ccc([C@H]3CC[C@H](CCO)CC3)cc1)CCO2,N=c1[nH]cnc2c1CN(c1ccc(C3CCC(CCO)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409323,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CC(C)(C)[C@H]1CC[C@H](N2CCOc3ncnc(N)c3C2=O)CC1,CHEMBL2414695,nM,2950,CHEMBL6009,5.530177984,DGAT,CC(C)(C)[C@H]1CC[C@H](N2CCOc3[nH]cnc(=N)c3C2=O)CC1,CC(C)(C)C1CCC(N2CCOc3[nH]cnc(=N)c3C2=O)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409324,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1ccc(N2CCOc3ncnc(N)c3C2=O)cc1,CHEMBL2414690,nM,2210,CHEMBL6009,5.655607726,DGAT,Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409326,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccno4)CC3)cc1)CCO2,CHEMBL2414665,nM,1310,CHEMBL6009,5.882728704,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccno4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccno4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409328,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1nccc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CHEMBL2414683,nM,1200,CHEMBL6009,5.920818754,DGAT,N=c1[nH]ccc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,N=c1[nH]ccc2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409330,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccon4)CC3)cc1)CCO2,CHEMBL2414666,nM,830,CHEMBL6009,6.080921908,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccon4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccon4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409333,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](Cc4nn[nH]n4)CC3)cc1)CCO2,CHEMBL2414698,nM,774,CHEMBL6009,6.111259039,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](Cc4nn[nH]n4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(Cc4nn[nH]n4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409336,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,C[C@H]1CN(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)C(=O)c2c(N)ncnc2O1,CHEMBL2414686,nM,625,CHEMBL6009,6.204119983,DGAT,C[C@H]1CN(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)C(=O)c2c([nH]cnc2=N)O1,CC1CN(c2ccc(C3CCC(CC(=O)O)CC3)cc2)C(=O)c2c([nH]cnc2=N)O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409337,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CC(=O)N1CCC(c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414658,nM,609,CHEMBL6009,6.215382707,DGAT,CC(=O)N1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(=O)N1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409338,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CC(C)C(=O)N1CCC(c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414659,nM,601,CHEMBL6009,6.221125528,DGAT,CC(C)C(=O)N1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(C)C(=O)N1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409339,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)[C@H]4CC[C@@H](O)CC4)CC3)cc1)CCO2,CHEMBL2413095,nM,574,CHEMBL6009,6.241088108,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCC(O)CC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCC(O)CC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409341,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCCCC4)CC3)cc1)CCO2,CHEMBL2414661,nM,514,CHEMBL6009,6.289036881,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCCCC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCCCC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409342,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCOCC4)CC3)cc1)CCO2,CHEMBL2414662,nM,470,CHEMBL6009,6.327902142,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCOCC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)C4CCOCC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409344,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CN(CC(=O)O)C(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414697,nM,421,CHEMBL6009,6.375717904,DGAT,CN(CC(=O)O)C(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CN(CC(=O)O)C(=O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409345,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CCOCC(=O)N1CCC(c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414660,nM,393,CHEMBL6009,6.40560745,DGAT,CCOCC(=O)N1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CCOCC(=O)N1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409346,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)[nH]1,CHEMBL2414673,nM,391,CHEMBL6009,6.407823243,DGAT,Cc1n[nH]c(C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1,Cc1n[nH]c(CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409347,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)n1C,CHEMBL2414674,nM,312,CHEMBL6009,6.505845406,DGAT,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1C,Cc1nnc(CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409348,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccccc4)CC3)cc1)CCO2,CHEMBL2414664,nM,276,CHEMBL6009,6.559090918,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccccc4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCN(C(=O)c4ccccc4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409352,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CC(O)C4)CC3)cc1)CCO2,CHEMBL2414657,nM,249,CHEMBL6009,6.603800653,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CC(O)C4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)N4CC(O)C4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409355,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)o1,CHEMBL2414671,nM,210,CHEMBL6009,6.677780705,DGAT,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)o1,Cc1nnc(CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409357,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)s1,CHEMBL2414672,nM,185,CHEMBL6009,6.732828272,DGAT,Cc1nnc(C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)s1,Cc1nnc(CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)s1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409358,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CN1CCN(C(=O)C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)CC1=O,CHEMBL2414655,nM,180,CHEMBL6009,6.744727495,DGAT,CN1CCN(C(=O)C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)CC1=O,CN1CCN(C(=O)CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)CC1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409364,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CC[C@@H](O)C4)CC3)cc1)CCO2,CHEMBL2414653,nM,148,CHEMBL6009,6.829738285,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CC[C@@H](O)C4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)N4CCC(O)C4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409365,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CC1(C)CN(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)C(=O)c2c(N)ncnc2O1,CHEMBL2414685,nM,146,CHEMBL6009,6.835647144,DGAT,CC1(C)CN(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)C(=O)c2c([nH]cnc2=N)O1,CC1(C)CN(c2ccc(C3CCC(CC(=O)O)CC3)cc2)C(=O)c2c([nH]cnc2=N)O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409366,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CC(C)(C)c1ccc(N2CCOc3ncnc(N)c3C2=O)cc1,CHEMBL2414691,nM,134,CHEMBL6009,6.872895202,DGAT,CC(C)(C)c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,CC(C)(C)c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409367,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CCC(=O)O)CC3)cc1)CCO2,CHEMBL2414696,nM,131,CHEMBL6009,6.882728704,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CCC(=O)O)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CCC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409370,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CCCC4)CC3)cc1)CCO2,CHEMBL2414652,nM,110,CHEMBL6009,6.958607315,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CCCC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)N4CCCC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409374,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Nc1ccnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,CHEMBL2414684,nM,99,CHEMBL6009,7.004364805,DGAT,N=c1cc[nH]c2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2,N=c1cc[nH]c2c1C(=O)N(c1ccc(C3CCC(CC(=O)O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409375,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CCOCC4)CC3)cc1)CCO2,CHEMBL2414654,nM,94,CHEMBL6009,7.026872146,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)N4CCOCC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)N4CCOCC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409376,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CCNC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414701,nM,94,CHEMBL6009,7.026872146,DGAT,CCNC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CCNC(=O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409382,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,CC(C)[C@H](CO)NC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414651,nM,85,CHEMBL6009,7.070581074,DGAT,CC(C)[C@H](CO)NC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(C)C(CO)NC(=O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409388,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,Cc1noc(CC[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)n1,CHEMBL2414675,nM,70,CHEMBL6009,7.15490196,DGAT,Cc1noc(CC[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1,Cc1noc(CCC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409389,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CC(C)(N)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414669,nM,70,CHEMBL6009,7.15490196,DGAT,CC(C)(N)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(C)(N)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409391,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,COC1CCN(C(=O)C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)CC1,CHEMBL2414656,nM,66,CHEMBL6009,7.180456064,DGAT,COC1CCN(C(=O)C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)CC1,COC1CCN(C(=O)CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409392,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,N#CC[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414667,nM,64,CHEMBL6009,7.193820026,DGAT,N#CC[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,N#CCC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409393,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)NC4CCCC4)CC3)cc1)CCO2,CHEMBL2414751,nM,64,CHEMBL6009,7.193820026,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)NC4CCCC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(=O)NC4CCCC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409395,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1noc(C[C@H]2CC[C@H](c3ccc(N4CCOc5ncnc(N)c5C4=O)cc3)CC2)n1,CHEMBL2414670,nM,60,CHEMBL6009,7.22184875,DGAT,Cc1noc(C[C@H]2CC[C@H](c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1,Cc1noc(CC2CCC(c3ccc(N4CCOc5[nH]cnc(=N)c5C4=O)cc3)CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409396,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,Cc1nc(N)c2c(n1)OCCN(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)C2=O,CHEMBL2414678,nM,59,CHEMBL6009,7.229147988,DGAT,Cc1nc(=N)c2c([nH]1)OCCN(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)C2=O,Cc1nc(=N)c2c([nH]1)OCCN(c1ccc(C3CCC(CC(=O)O)CC3)cc1)C2=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409398,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,CC(C)(O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414668,nM,54,CHEMBL6009,7.26760624,DGAT,CC(C)(O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(C)(O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409412,CHEMBL2415509,Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addition measured after 5 hrs by scintillation counting analysis,B,NC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414700,nM,34,CHEMBL6009,7.468521083,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(N)=O)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CC(N)=O)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409413,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,COC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL2414699,nM,34,CHEMBL6009,7.468521083,DGAT,COC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,COC(=O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13409437,CHEMBL2415510,Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry,B,C[C@@H]1CN(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)C(=O)c2c(N)ncnc2O1,CHEMBL2414687,nM,19,CHEMBL6009,7.721246399,DGAT,C[C@@H]1CN(c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)C(=O)c2c([nH]cnc2=N)O1,CC1CN(c2ccc(C3CCC(CC(=O)O)CC3)cc2)C(=O)c2c([nH]cnc2=N)O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516078,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(c3ncccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441212,nM,67,CHEMBL6009,7.173925197,DGAT,O=C(Nc1ccc(N2CCN(c3ncccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(c3ncccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516079,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(c3ccccc3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441211,nM,180,CHEMBL6009,6.744727495,DGAT,O=C(Nc1ccc(N2CCN(c3ccccc3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(c3ccccc3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516080,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCC(c3ccccc3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441210,nM,3870,CHEMBL6009,5.412289035,DGAT,O=C(Nc1ccc(N2CCC(c3ccccc3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCC(c3ccccc3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516081,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441209,nM,46,CHEMBL6009,7.337242168,DGAT,O=C(Nc1ccc(N2CCCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516082,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441208,nM,41,CHEMBL6009,7.387216143,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516083,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)NC3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441207,nM,788,CHEMBL6009,6.103473783,DGAT,O=C(Nc1ccc(N2CCN(C(=O)NC3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)NC3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516084,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CC(C)NC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441206,nM,731,CHEMBL6009,6.136082623,DGAT,CC(C)NC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CC(C)NC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516085,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3F)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441205,nM,1381,CHEMBL6009,5.859806321,DGAT,O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3F)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3F)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516086,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)C3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441204,nM,311,CHEMBL6009,6.507239611,DGAT,O=C(Nc1ccc(N2CCN(C(=O)C3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)C3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516087,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441203,nM,5837,CHEMBL6009,5.233810307,DGAT,CCC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CCC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516088,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)Oc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441202,nM,631,CHEMBL6009,6.199970641,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Oc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)Oc3ccccc3Cl)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516089,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)OC3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,CHEMBL2441201,nM,79,CHEMBL6009,7.102372909,DGAT,O=C(Nc1ccc(N2CCN(C(=O)OC3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)OC3CCCC3)CC2)nc1)c1oc(N2CCCCC2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516090,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CC(C)OC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441200,nM,41,CHEMBL6009,7.387216143,DGAT,CC(C)OC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CC(C)OC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516091,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCC(C)CC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441199,nM,228,CHEMBL6009,6.642065153,DGAT,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCC(C)CC4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCC(C)CC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516092,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441024,nM,79,CHEMBL6009,7.102372909,DGAT,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516093,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4C)nc3C(F)(F)F)cn2)CC1,CHEMBL2441023,nM,938,CHEMBL6009,6.027797162,DGAT,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4C)nc3C(F)(F)F)cn2)CC1,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4C)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516094,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441022,nM,1508,CHEMBL6009,5.821598658,DGAT,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516095,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCC(F)(F)CC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441021,nM,4749,CHEMBL6009,5.32339783,DGAT,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCC(F)(F)CC4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCC(F)(F)CC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516096,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4C)nc3C(F)(F)F)cn2)CC1,CHEMBL2441020,nM,93,CHEMBL6009,7.031517051,DGAT,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4C)nc3C(F)(F)F)cn2)CC1,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4C)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516097,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441019,nM,66,CHEMBL6009,7.180456064,DGAT,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516098,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCOCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441018,nM,6870,CHEMBL6009,5.163043263,DGAT,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCOCC4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCOCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516099,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCC4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441017,nM,1708,CHEMBL6009,5.767512134,DGAT,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCC4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(N4CCCC4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516100,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(-c2ccccc2)nc1C(F)(F)F,CHEMBL2441016,nM,103,CHEMBL6009,6.987162775,DGAT,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(-c2ccccc2)nc1C(F)(F)F,O=C(Nc1ccc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1)c1oc(-c2ccccc2)nc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516101,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441015,nM,116,CHEMBL6009,6.935542011,DGAT,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)N1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516102,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CS(=O)(=O)N1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441014,nM,474,CHEMBL6009,6.324221658,DGAT,CS(=O)(=O)N1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CS(=O)(=O)N1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516103,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)CC1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441013,nM,179,CHEMBL6009,6.747146969,DGAT,CCOC(=O)CC1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)CC1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516104,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CHEMBL2441218,nM,84,CHEMBL6009,7.075720714,DGAT,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,CCOC(=O)C1CCN(c2ccc(NC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516105,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)cs2)cn1,CHEMBL2441217,nM,2837,CHEMBL6009,5.547140664,DGAT,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)cs2)cn1,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)cs2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516106,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)oc2C)cn1,CHEMBL2441216,nM,1560,CHEMBL6009,5.806875402,DGAT,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)oc2C)cn1,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)oc2C)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516107,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)c(C(F)(F)F)s2)cn1,CHEMBL2441215,nM,1616,CHEMBL6009,5.791558644,DGAT,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)c(C(F)(F)F)s2)cn1,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)c(C(F)(F)F)s2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516108,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)n(-c3ccccc3)c2C)cn1,CHEMBL2441214,nM,1712,CHEMBL6009,5.76649624,DGAT,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)n(-c3ccccc3)c2C)cn1,COCCN(C)c1ccc(NC(=O)c2cc(-c3ccccc3)n(-c3ccccc3)c2C)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13516109,CHEMBL2444934,"Inhibition of human DGAT-1 expressed in insect Sf9 cell microsomes using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA as substrate after 2 hrs",B,COCCN(C)c1ccc(NC(=O)c2oc(-c3ccccc3)nc2C(F)(F)F)cn1,CHEMBL2441213,nM,85,CHEMBL6009,7.070581074,DGAT,COCCN(C)c1ccc(NC(=O)c2oc(-c3ccccc3)nc2C(F)(F)F)cn1,COCCN(C)c1ccc(NC(=O)c2oc(-c3ccccc3)nc2C(F)(F)F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967597,CHEMBL3135863,Inhibition of DGAT1 in human HuTu80 cells assessed as reduction in triglyceride levels,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cn2)CC1,CHEMBL3133005,nM,4,CHEMBL6009,8.397940009,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967691,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3nnc(Nc4cc(F)c(F)cc4F)o3)cc2)CC1,CHEMBL3133009,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(NC(=O)c3n[nH]c(=Nc4cc(F)c(F)cc4F)o3)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)c3n[nH]c(=Nc4cc(F)c(F)cc4F)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967692,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1cnc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1F)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133008,nM,6,CHEMBL6009,8.22184875,DGAT,O=C(Nc1cnc(OC2CCC(C(=O)O)CC2)cc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1cnc(OC2CCC(C(=O)O)CC2)cc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967693,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)nc1F)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133007,nM,4,CHEMBL6009,8.397940009,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)nc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)nc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967694,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)nc1F)c1nnc(Nc2ccc(F)c(F)c2)o1,CHEMBL3133006,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)nc1F)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)nc1F)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967696,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(O)c1ccc(Oc2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cn2)cc1,CHEMBL3133017,nM,5,CHEMBL6009,8.301029996,DGAT,O=C(O)c1ccc(Oc2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn2)cc1,O=C(O)c1ccc(Oc2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967697,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)c(F)c1)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133016,nM,8,CHEMBL6009,8.096910013,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)c(F)c1)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)c(F)c1)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967698,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@H](C(=O)O)CC2)cc1F)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133015,nM,15,CHEMBL6009,7.823908741,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967699,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1F)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133014,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1F)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967700,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)nc1)c1nnc(Nc2ccc(F)c(F)c2)o1,CHEMBL3133013,nM,5,CHEMBL6009,8.301029996,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)nc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)nc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967701,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@H](C(=O)O)CC2)cc1)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133012,nM,8,CHEMBL6009,8.096910013,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967702,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1)c1nnc(Nc2cc(F)c(F)cc2F)o1,CHEMBL3133011,nM,7,CHEMBL6009,8.15490196,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2cc(F)c(F)cc2F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967703,CHEMBL3136000,Inhibition of human DGAT1,B,N#Cc1ccc(Nc2nnc(C(=O)Nc3ccc(O[C@H]4CC[C@@H](C(=O)O)CC4)cc3)o2)cc1,CHEMBL3132863,nM,18,CHEMBL6009,7.744727495,DGAT,N#Cc1ccc(N=c2[nH]nc(C(=O)Nc3ccc(OC4CCC(C(=O)O)CC4)cc3)o2)cc1,N#Cc1ccc(N=c2[nH]nc(C(=O)Nc3ccc(OC4CCC(C(=O)O)CC4)cc3)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967704,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1)c1nnc(Nc2ccc(F)cc2)o1,CHEMBL3133010,nM,5,CHEMBL6009,8.301029996,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2ccc(F)cc2)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2ccc(F)cc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967705,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(Nc1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1)c1nnc(Nc2ccc(F)c(F)c2)o1,CHEMBL3133084,nM,4,CHEMBL6009,8.397940009,DGAT,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,O=C(Nc1ccc(OC2CCC(C(=O)O)CC2)cc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967706,CHEMBL3136000,Inhibition of human DGAT1,B,O=C(O)c1cccc(Oc2ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cc2)c1,CHEMBL3133083,nM,140,CHEMBL6009,6.853871964,DGAT,O=C(O)c1cccc(Oc2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cc2)c1,O=C(O)c1cccc(Oc2ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13967732,CHEMBL3136006,Inhibition of DGAT1-mediated triglyceride synthesis in human HuTu80 cells,B,Cc1nc(C)c(-c2ccc(-c3ccc([C@H](C)C(=O)O)cc3Cl)c(F)c2)nc1C(N)=O,CHEMBL3133093,nM,3.981,CHEMBL6009,8.400007822,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3Cl)c(F)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3Cl)c(F)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968430,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc([C@H](C)C(=O)O)cc3Cl)cc2)nc1C(N)=O,CHEMBL3133092,nM,12.59,CHEMBL6009,7.89997427,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3Cl)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3Cl)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968431,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3Cl)c(Cl)c2)nc1C(N)=O,CHEMBL3133091,nM,7.943,CHEMBL6009,8.100015437,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3Cl)c(Cl)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3Cl)c(Cl)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968432,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc([C@@H](C)C(=O)O)cc3)cc2)nc1C(N)=O,CHEMBL3133090,nM,794.33,CHEMBL6009,6.099999035,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968433,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc([C@H](C)C(=O)O)cc3)cc2)nc1C(N)=O,CHEMBL3133089,nM,199.53,CHEMBL6009,6.699991797,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(C(C)C(=O)O)cc3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968434,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3F)cc2)nc1C(N)=O,CHEMBL3133088,nM,25.12,CHEMBL6009,7.599980365,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3F)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3F)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968435,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1cc(CC(=O)O)ccc1-c1ccc(-c2nc(C(N)=O)c(C)nc2C)cc1,CHEMBL3133087,nM,19.95,CHEMBL6009,7.7000571,DGAT,Cc1cc(CC(=O)O)ccc1-c1ccc(-c2nc(C(N)=O)c(C)nc2C)cc1,Cc1cc(CC(=O)O)ccc1-c1ccc(-c2nc(C(N)=O)c(C)nc2C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968436,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(C#N)c2)nc1C(N)=O,CHEMBL3133086,nM,316.23,CHEMBL6009,6.499996932,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(C#N)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(C#N)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968437,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,COc1cc(-c2nc(C(N)=O)c(C)nc2C)ccc1-c1ccc(CC(=O)O)cc1,CHEMBL3133085,nM,6309.57,CHEMBL6009,5.200000237,DGAT,COc1cc(-c2nc(C(N)=O)c(C)nc2C)ccc1-c1ccc(CC(=O)O)cc1,COc1cc(-c2nc(C(N)=O)c(C)nc2C)ccc1-c1ccc(CC(=O)O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968438,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(F)c2)nc1C(N)=O,CHEMBL3133095,nM,125.89,CHEMBL6009,6.900008766,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(F)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(F)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968439,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1cc(-c2nc(C(N)=O)c(C)nc2C)ccc1-c1ccc(CC(=O)O)cc1,CHEMBL3133096,nM,125.89,CHEMBL6009,6.900008766,DGAT,Cc1cc(-c2nc(C(N)=O)c(C)nc2C)ccc1-c1ccc(CC(=O)O)cc1,Cc1cc(-c2nc(C(N)=O)c(C)nc2C)ccc1-c1ccc(CC(=O)O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968440,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)c(Cl)c3)cc2)nc1C(N)=O,CHEMBL3133097,nM,1258.93,CHEMBL6009,5.899998417,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)c(Cl)c3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)c(Cl)c3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968441,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3Cl)cc2)nc1C(N)=O,CHEMBL3133098,nM,6.31,CHEMBL6009,8.199970641,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3Cl)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3Cl)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968442,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(Cl)c2)nc1C(N)=O,CHEMBL3133094,nM,100,CHEMBL6009,7,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(Cl)c2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)c(Cl)c2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968443,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)nc1C(N)=O,CHEMBL3133099,nM,6309.57,CHEMBL6009,5.200000237,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2Cl)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
13968444,CHEMBL3136463,Inhibition of recombinant human DGAT1 expressed in sf9 cell membrane assessed as inhibition of radioactive trioleoylglycerol formation after 30 mins by liquid scintillation counting,B,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)nc1C(N)=O,CHEMBL3133100,nM,630.96,CHEMBL6009,6.199998172,DGAT,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)nc1C(N)=O,Cc1nc(C)c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)nc1C(N)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534385,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccccc3F)cc1)CCO2,CHEMBL3222262,nM,7.7,CHEMBL6009,8.113509275,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3F)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3F)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534388,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)O)cc3Cl)cc1)CCO2,CHEMBL3222230,nM,25.12,CHEMBL6009,7.599980365,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)O)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)O)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534389,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,NC(=O)Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222231,nM,31.62,CHEMBL6009,7.500038134,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(N)=O)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(N)=O)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534390,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CC[C@@H](O)C4)cc3Cl)cc1)CCO2,CHEMBL3222232,nM,19.95,CHEMBL6009,7.7000571,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CC[C@@H](O)C4)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CCC(O)C4)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534391,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CC(O)C4)cc3Cl)cc1)CCO2,CHEMBL3222233,nM,39.81,CHEMBL6009,7.400007822,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CC(O)C4)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CC(O)C4)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534392,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CCNC(=O)C4)cc3Cl)cc1)CCO2,CHEMBL3222234,nM,50.12,CHEMBL6009,7.299988938,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CCNC(=O)C4)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CC(=O)N4CCNC(=O)C4)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534393,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CS(=O)(=O)Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222235,nM,39.81,CHEMBL6009,7.400007822,DGAT,CS(=O)(=O)Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,CS(=O)(=O)Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534394,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CC(=O)N(C)Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222236,nM,50.12,CHEMBL6009,7.299988938,DGAT,CC(=O)N(C)Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,CC(=O)N(C)Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534395,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CC(=O)NCc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222237,nM,50.12,CHEMBL6009,7.299988938,DGAT,CC(=O)NCc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,CC(=O)NCc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534396,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CN(Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1)S(C)(=O)=O,CHEMBL3222238,nM,31.62,CHEMBL6009,7.500038134,DGAT,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)S(C)(=O)=O,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)S(C)(=O)=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534397,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CS(=O)(=O)NCc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222239,nM,31.62,CHEMBL6009,7.500038134,DGAT,CS(=O)(=O)NCc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,CS(=O)(=O)NCc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534398,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(Cn4cccnc4=O)cc3Cl)cc1)CCO2,CHEMBL3222240,nM,79.43,CHEMBL6009,7.100015437,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(Cn4cccnc4=O)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(Cn4cccnc4=O)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534399,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(CN4CC[C@H](O)C4=O)cc3Cl)cc1)CCO2,CHEMBL3222241,nM,63.1,CHEMBL6009,7.199970641,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CN4CCC(=O)C4O)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CN4CCC(=O)C4O)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534400,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CN(Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1)C(=O)CN,CHEMBL3222242,nM,39.81,CHEMBL6009,7.400007822,DGAT,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)C(=O)CN,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)C(=O)CN,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534401,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CN(Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1)C(=O)CCN,CHEMBL3222243,nM,50.12,CHEMBL6009,7.299988938,DGAT,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)C(=O)CCN,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)C(=O)CCN,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534402,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,CN(Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1)C(=O)CCCN,CHEMBL3222244,nM,50.12,CHEMBL6009,7.299988938,DGAT,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)C(=O)CCCN,CN(Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1)C(=O)CCCN,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534403,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccccc3Cl)cc1)CCO2,CHEMBL3222245,nM,15.85,CHEMBL6009,7.799970733,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534404,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,N#Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222246,nM,50.12,CHEMBL6009,7.299988938,DGAT,N#Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,N#Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534405,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Cc1ccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c(Cl)c1,CHEMBL3222247,nM,5.012,CHEMBL6009,8.299988938,DGAT,Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Cc1ccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534406,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(CO)cc3Cl)cc1)CCO2,CHEMBL3222248,nM,25.12,CHEMBL6009,7.599980365,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CO)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(CO)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534407,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(C(F)F)cc3Cl)cc1)CCO2,CHEMBL3222249,nM,19.95,CHEMBL6009,7.7000571,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(C(F)F)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(C(F)F)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534408,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccc(Cl)cc3Cl)cc1)CCO2,CHEMBL3222250,nM,10,CHEMBL6009,8,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(Cl)cc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccc(Cl)cc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534409,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3cccc(Cl)c3Cl)cc1)CCO2,CHEMBL3222251,nM,79.43,CHEMBL6009,7.100015437,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3cccc(Cl)c3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3cccc(Cl)c3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534410,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,N#Cc1cccc(-c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)c1Cl,CHEMBL3222252,nM,316.23,CHEMBL6009,6.499996932,DGAT,N#Cc1cccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c1Cl,N#Cc1cccc(-c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)c1Cl,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534411,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3cc(Cl)ccc3Cl)cc1)CCO2,CHEMBL3222253,nM,15.85,CHEMBL6009,7.799970733,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3cc(Cl)ccc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3cc(Cl)ccc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534412,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccccc3)cc1)CCO2,CHEMBL3222254,nM,251.19,CHEMBL6009,6.599997654,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534413,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Cc1ccccc1-c1ccc(N2CCOc3ncnc(N)c3C2=O)cc1,CHEMBL3222255,nM,39.81,CHEMBL6009,7.400007822,DGAT,Cc1ccccc1-c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Cc1ccccc1-c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534414,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3c(F)cccc3F)cc1)CCO2,CHEMBL3222256,nM,15.85,CHEMBL6009,7.799970733,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3c(F)cccc3F)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3c(F)cccc3F)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534415,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ccccc3Cl)c(F)c1)CCO2,CHEMBL3222257,nM,10,CHEMBL6009,8,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3Cl)c(F)c1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ccccc3Cl)c(F)c1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534416,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Cc1cccc(Cl)c1-c1ccc(N2CCOc3ncnc(N)c3C2=O)cc1,CHEMBL3222258,nM,19.95,CHEMBL6009,7.7000571,DGAT,Cc1cccc(Cl)c1-c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Cc1cccc(Cl)c1-c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534417,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3c(F)cccc3F)c(F)c1)CCO2,CHEMBL3222259,nM,15.85,CHEMBL6009,7.799970733,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3c(F)cccc3F)c(F)c1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3c(F)cccc3F)c(F)c1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14534418,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,Nc1ncnc2c1C(=O)N(c1ccc(-c3ncccc3Cl)cc1)CCO2,CHEMBL3222260,nM,79.43,CHEMBL6009,7.100015437,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ncccc3Cl)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(-c3ncccc3Cl)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14536538,CHEMBL3222770,Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation counting,B,N#Cc1cccc(Cl)c1-c1ccc(N2CCOc3ncnc(N)c3C2=O)cc1,CHEMBL3222261,nM,31.62,CHEMBL6009,7.500038134,DGAT,N#Cc1cccc(Cl)c1-c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,N#Cc1cccc(Cl)c1-c1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567927,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(N[C@H]1CC[C@H](C(=O)O)CC1)c1ncc(-c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)s1,CHEMBL3235422,nM,72.85,CHEMBL6009,7.137570444,DGAT,O=C(NC1CCC(C(=O)O)CC1)c1ncc(-c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)s1,O=C(NC1CCC(C(=O)O)CC1)c1ncc(-c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)s1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567928,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1)c1cc(F)cc(F)c1,CHEMBL3235423,nM,75.59,CHEMBL6009,7.121535655,DGAT,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)c1cc(F)cc(F)c1,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)c1cc(F)cc(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567930,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1)Nc1cc(F)cc(F)c1,CHEMBL3235425,nM,34.15,CHEMBL6009,7.466609292,DGAT,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1cc(F)cc(F)c1,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1cc(F)cc(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567931,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,COc1ccccc1NC(=O)Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1,CHEMBL3235426,nM,149.9,CHEMBL6009,6.824198367,DGAT,COc1ccccc1NC(=O)Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1,COc1ccccc1NC(=O)Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567932,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1)Nc1ccccc1F,CHEMBL3235427,nM,14.8,CHEMBL6009,7.829738285,DGAT,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1ccccc1F,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1ccccc1F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567933,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1)Nc1ccccc1Cl,CHEMBL3235428,nM,20.4,CHEMBL6009,7.690369833,DGAT,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1ccccc1Cl,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1ccccc1Cl,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567934,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1)Nc1ccc(F)cc1F,CHEMBL3235429,nM,38.88,CHEMBL6009,7.410273744,DGAT,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1ccc(F)cc1F,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1ccc(F)cc1F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567935,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1)Nc1cc(F)c(F)cc1F,CHEMBL3235430,nM,26.2,CHEMBL6009,7.581698709,DGAT,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1cc(F)c(F)cc1F,O=C(Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1)Nc1cc(F)c(F)cc1F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14567936,CHEMBL3239898,"Inhibition of human DGAT1 using 1,2-diacylglycerol/[14C]-oleoyl CoA as substrate assessed as [14C]-triglyceride formation after 10 mins by scintillation counting analysis",B,O=C(Nc1ccccc1)Nc1ccc(-c2cnc(C(=O)N[C@H]3CC[C@H](C(=O)O)CC3)s2)cc1,CHEMBL3235431,nM,54.85,CHEMBL6009,7.260823368,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1,O=C(Nc1ccccc1)Nc1ccc(-c2cnc(C(=O)NC3CCC(C(=O)O)CC3)s2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572838,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Nc1ncnc2c1N=C(c1ccc(Br)cc1)CO2,CHEMBL3235281,nM,580,CHEMBL6009,6.236572006,DGAT,N=c1[nH]cnc2c1N=C(c1ccc(Br)cc1)CO2,N=c1[nH]cnc2c1N=C(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572839,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Cc1nc(N)c2c(n1)OCC(c1ccc(Br)cc1)=N2,CHEMBL3235282,nM,810,CHEMBL6009,6.091514981,DGAT,Cc1nc(=N)c2c([nH]1)OCC(c1ccc(Br)cc1)=N2,Cc1nc(=N)c2c([nH]1)OCC(c1ccc(Br)cc1)=N2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572840,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Nc1nc(N)c2c(n1)OCC(c1ccc(Br)cc1)=N2,CHEMBL3235283,nM,10000,CHEMBL6009,5,DGAT,N=c1[nH]c2c(c(=N)[nH]1)N=C(c1ccc(Br)cc1)CO2,N=c1[nH]c2c(c(=N)[nH]1)N=C(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572841,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CN(C)c1nc(N)c2c(n1)OCC(c1ccc(Br)cc1)=N2,CHEMBL3235284,nM,10000,CHEMBL6009,5,DGAT,CN(C)c1nc(=N)c2c([nH]1)OCC(c1ccc(Br)cc1)=N2,CN(C)c1nc(=N)c2c([nH]1)OCC(c1ccc(Br)cc1)=N2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572842,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Nc1nc(O)nc2c1N=C(c1ccc(Br)cc1)CO2,CHEMBL3235285,nM,10000,CHEMBL6009,5,DGAT,N=c1[nH]c(=O)[nH]c2c1N=C(c1ccc(Br)cc1)CO2,N=c1[nH]c(=O)[nH]c2c1N=C(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572843,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CNc1ncnc2c1N=C(c1ccc(Br)cc1)CO2,CHEMBL3235286,nM,10000,CHEMBL6009,5,DGAT,CN=c1[nH]cnc2c1N=C(c1ccc(Br)cc1)CO2,CN=c1[nH]cnc2c1N=C(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572844,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CN(C)c1ncnc2c1N=C(c1ccc(Br)cc1)CO2,CHEMBL3235287,nM,10000,CHEMBL6009,5,DGAT,CN(C)c1ncnc2c1N=C(c1ccc(Br)cc1)CO2,CN(C)c1ncnc2c1N=C(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572845,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Nc1cccc2c1N=C(c1ccc(Br)cc1)CO2,CHEMBL3235288,nM,10000,CHEMBL6009,5,DGAT,Nc1cccc2c1N=C(c1ccc(Br)cc1)CO2,Nc1cccc2c1N=C(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572846,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1Oc2ncnc(N)c2N=C1c1ccc(Br)cc1,CHEMBL3235289,nM,390,CHEMBL6009,6.408935393,DGAT,CC1Oc2[nH]cnc(=N)c2N=C1c1ccc(Br)cc1,CC1Oc2[nH]cnc(=N)c2N=C1c1ccc(Br)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572847,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(Br)cc1,CHEMBL3235290,nM,210,CHEMBL6009,6.677780705,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(Br)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(Br)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572848,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Nc1ncnc2c1NC(c1ccc(Br)cc1)CO2,CHEMBL3235291,nM,490,CHEMBL6009,6.30980392,DGAT,N=c1[nH]cnc2c1NC(c1ccc(Br)cc1)CO2,N=c1[nH]cnc2c1NC(c1ccc(Br)cc1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572849,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,C[C@H]1Oc2ncnc(N)c2N[C@H]1c1ccc(Br)cc1,CHEMBL3235292,nM,7500,CHEMBL6009,5.124938737,DGAT,C[C@H]1Oc2[nH]cnc(=N)c2N[C@H]1c1ccc(Br)cc1,CC1Oc2[nH]cnc(=N)c2NC1c1ccc(Br)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572850,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2NC1c1ccc(Br)cc1,CHEMBL3235293,nM,5900,CHEMBL6009,5.229147988,DGAT,CC1(C)Oc2[nH]cnc(=N)c2NC1c1ccc(Br)cc1,CC1(C)Oc2[nH]cnc(=N)c2NC1c1ccc(Br)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572851,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccccc1,CHEMBL3235294,nM,2900,CHEMBL6009,5.537602002,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccccc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572852,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(Cl)cc1,CHEMBL3235295,nM,390,CHEMBL6009,6.408935393,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(Cl)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(Cl)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572853,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(F)cc1,CHEMBL3235296,nM,3300,CHEMBL6009,5.48148606,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(F)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572854,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Cc1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1,CHEMBL3235297,nM,410,CHEMBL6009,6.387216143,DGAT,Cc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Cc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572855,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CCc1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1,CHEMBL3235298,nM,160,CHEMBL6009,6.795880017,DGAT,CCc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,CCc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572856,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CCCc1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1,CHEMBL3235299,nM,90,CHEMBL6009,7.045757491,DGAT,CCCc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,CCCc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572857,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CCCCc1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1,CHEMBL3235300,nM,150,CHEMBL6009,6.823908741,DGAT,CCCCc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,CCCCc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572858,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC(C)c1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1,CHEMBL3235301,nM,90,CHEMBL6009,7.045757491,DGAT,CC(C)c1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,CC(C)c1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572859,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C(C)(C)C)cc1,CHEMBL3235302,nM,60,CHEMBL6009,7.22184875,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C(C)(C)C)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C(C)(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572860,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C2CCCCC2)cc1,CHEMBL3235303,nM,60,CHEMBL6009,7.22184875,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCCCC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCCCC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572861,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(-c2ccccc2)cc1,CHEMBL3235304,nM,220,CHEMBL6009,6.657577319,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(-c2ccccc2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(-c2ccccc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572862,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(O)cc1,CHEMBL3235305,nM,7900,CHEMBL6009,5.102372909,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(O)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572863,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,COc1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1,CHEMBL3235306,nM,570,CHEMBL6009,6.244125144,DGAT,COc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,COc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572864,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(N2CCCCC2)cc1,CHEMBL3235307,nM,130,CHEMBL6009,6.886056648,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(N2CCCCC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(N2CCCCC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572865,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(N2CCOCC2)cc1,CHEMBL3235308,nM,610,CHEMBL6009,6.214670165,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(N2CCOCC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(N2CCOCC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572866,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C(C)(C)C(=O)O)cc1,CHEMBL3235309,nM,50,CHEMBL6009,7.301029996,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C(C)(C)C(=O)O)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C(C)(C)C(=O)O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572867,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C2CCC(=O)CC2)cc1,CHEMBL3235310,nM,120,CHEMBL6009,6.920818754,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(=O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(=O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572868,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](O)CC2)cc1,CHEMBL3235311,nM,50,CHEMBL6009,7.301029996,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572869,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C2CCC(F)(F)CC2)cc1,CHEMBL3235312,nM,60,CHEMBL6009,7.22184875,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(F)(F)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(F)(F)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572870,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](C(=O)O)CC2)cc1,CHEMBL3235313,nM,10,CHEMBL6009,8,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(C(=O)O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572871,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CCC(=O)O)CC2)cc1,CHEMBL3235314,nM,6,CHEMBL6009,8.22184875,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CCC(=O)O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CCC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572872,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc(-c2ccc(CC(=O)O)cc2)cc1,CHEMBL3235315,nM,6,CHEMBL6009,8.22184875,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(-c2ccc(CC(=O)O)cc2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(-c2ccc(CC(=O)O)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572873,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Cc1nc(N)c2c(n1)OC(C)(C)C(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)=N2,CHEMBL3235316,nM,8,CHEMBL6009,8.096910013,DGAT,Cc1nc(=N)c2c([nH]1)OC(C)(C)C(c1ccc(C3CCC(CC(=O)O)CC3)cc1)=N2,Cc1nc(=N)c2c([nH]1)OC(C)(C)C(c1ccc(C3CCC(CC(=O)O)CC3)cc1)=N2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572874,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2nc(C(F)(F)F)nc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL3235317,nM,5,CHEMBL6009,8.301029996,DGAT,CC1(C)Oc2[nH]c(C(F)(F)F)nc(=N)c2N=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1,CC1(C)Oc2[nH]c(C(F)(F)F)nc(=N)c2N=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572875,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(N)=O)CC2)cc1,CHEMBL3235318,nM,15,CHEMBL6009,7.823908741,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CC(N)=O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CC(N)=O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572876,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](Cc3nnn[nH]3)CC2)cc1,CHEMBL3235319,nM,7,CHEMBL6009,8.15490196,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(Cc3nn[nH]n3)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(Cc3nn[nH]n3)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572877,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CS(N)(=O)=O)CC2)cc1,CHEMBL3235320,nM,20,CHEMBL6009,7.698970004,DGAT,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CS(N)(=O)=O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2N=C1c1ccc(C2CCC(CS(N)(=O)=O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572878,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2nc(C(F)(F)F)nc(N)c2N=C1c1ccc2c(c1)CC[C@]21CC[C@@H](CC(=O)O)CC1,CHEMBL3235321,nM,4,CHEMBL6009,8.397940009,DGAT,CC1(C)Oc2[nH]c(C(F)(F)F)nc(=N)c2N=C1c1ccc2c(c1)CC[C@]21CC[C@@H](CC(=O)O)CC1,CC1(C)Oc2[nH]c(C(F)(F)F)nc(=N)c2N=C1c1ccc2c(c1)CCC21CCC(CC(=O)O)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572879,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2C=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CHEMBL3235322,nM,8,CHEMBL6009,8.096910013,DGAT,CC1(C)Oc2[nH]cnc(=N)c2C=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1,CC1(C)Oc2[nH]cnc(=N)c2C=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572880,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,CC1(C)Oc2ncnc(N)c2C=C1c1ccc2c(c1)CC[C@]21CC[C@@H](CC(=O)O)CC1,CHEMBL3235323,nM,13,CHEMBL6009,7.886056648,DGAT,CC1(C)Oc2[nH]cnc(=N)c2C=C1c1ccc2c(c1)CC[C@]21CC[C@@H](CC(=O)O)CC1,CC1(C)Oc2[nH]cnc(=N)c2C=C1c1ccc2c(c1)CCC21CCC(CC(=O)O)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14572881,CHEMBL3240807,Inhibition of human liver flag-tagged DGAT1 expressed in baculovirus infected insect cells after 2 hrs by SPA,B,Cc1nc(N)c2c(n1)OC(C)(C)C(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)=C2,CHEMBL3235324,nM,50,CHEMBL6009,7.301029996,DGAT,Cc1nc(=N)c2c([nH]1)OC(C)(C)C(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)=C2,Cc1nc(=N)c2c([nH]1)OC(C)(C)C(c1ccc(C3CCC(CC(=O)O)CC3)cc1)=C2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596043,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccc(-c2ccc(C(=O)[C@@H]3CCC[C@H]3C(=O)O)cc2)cc1F,CHEMBL3233871,nM,36,CHEMBL6009,7.443697499,DGAT,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1F,O=C(Nc1ccc(OC(F)(F)F)cc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596045,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(ccn4C(=O)Nc4ccccc4)c3)cc2)CC1,CHEMBL3233872,nM,37,CHEMBL6009,7.431798276,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(ccn4C(=O)Nc4ccccc4)c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(ccn4C(=O)Nc4ccccc4)c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596046,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4oc(Nc5ccccc5)nc4c3)cc2)CC1,CHEMBL3233873,nM,2393,CHEMBL6009,5.621057301,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4oc(=Nc5ccccc5)[nH]c4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4oc(=Nc5ccccc5)[nH]c4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596047,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4nc(Nc5ccccc5)ncc4c3)cc2)CC1,CHEMBL3233874,nM,5548,CHEMBL6009,5.255863548,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4[nH]c(=Nc5ccccc5)ncc4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4[nH]c(=Nc5ccccc5)ncc4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596048,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5)[nH]c4c3)cc2)CC1,CHEMBL3233875,nM,2030,CHEMBL6009,5.692503962,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4[nH]c(C(=O)Nc5ccccc5)nc4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4[nH]c(C(=O)Nc5ccccc5)nc4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596049,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(cnn4C(=O)Nc4ccccc4)c3)cc2)CC1,CHEMBL3233876,nM,2735,CHEMBL6009,5.563042669,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(cnn4C(=O)Nc4ccccc4)c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(cnn4C(=O)Nc4ccccc4)c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596050,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4cc(C(=O)Nc5ccccc5)[nH]c4c3)cc2)CC1,CHEMBL3233877,nM,448,CHEMBL6009,6.348721986,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4cc(C(=O)Nc5ccccc5)[nH]c4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4cc(C(=O)Nc5ccccc5)[nH]c4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596051,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)c[nH]c4c3)cc2)CC1,CHEMBL3233878,nM,180,CHEMBL6009,6.744727495,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)c[nH]c4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)c[nH]c4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596052,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)CCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3233879,nM,160,CHEMBL6009,6.795880017,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)CCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)CCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596053,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)C(=O)CCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3233880,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)C(=O)CCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)C(=O)CCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596054,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)NCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3233881,nM,7257,CHEMBL6009,5.139242877,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)NCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)NCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596055,CHEMBL3239091,Inhibition of human DGAT1,B,CN1CCN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2C1,CHEMBL3233882,nM,10000,CHEMBL6009,5,DGAT,CN1CCN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2C1,CN1CCN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596056,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)CCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3233883,nM,56,CHEMBL6009,7.251811973,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)CCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)CCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596057,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3233884,nM,65,CHEMBL6009,7.187086643,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596058,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)cc2)CC1,CHEMBL3233885,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596059,CHEMBL3239091,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)ccnc4c3)cc2)CC1,CHEMBL3233886,nM,41,CHEMBL6009,7.387216143,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)ccnc4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(C(=O)Nc5ccccc5)ccnc4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596060,CHEMBL3239091,Inhibition of human DGAT1,B,CC(C)c1cccc(NC(=O)c2ccnc3cc(-c4ccc([C@H]5CC[C@H](CC(=O)O)CC5)cc4)ccc23)c1,CHEMBL3233887,nM,58,CHEMBL6009,7.236572006,DGAT,CC(C)c1cccc(NC(=O)c2ccnc3cc(-c4ccc([C@H]5CC[C@H](CC(=O)O)CC5)cc4)ccc23)c1,CC(C)c1cccc(NC(=O)c2ccnc3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596061,CHEMBL3239091,Inhibition of human DGAT1,B,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2n1,CHEMBL3233888,nM,28,CHEMBL6009,7.552841969,DGAT,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2n1,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596062,CHEMBL3239091,Inhibition of human DGAT1,B,Cc1cc(C(=O)NCCCCCc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2n1,CHEMBL3233889,nM,12,CHEMBL6009,7.920818754,DGAT,Cc1cc(C(=O)NCCCCCc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2n1,Cc1cc(C(=O)NCCCCCc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596063,CHEMBL3239091,Inhibition of human DGAT1,B,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2n1,CHEMBL3233890,nM,275,CHEMBL6009,6.560667306,DGAT,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2n1,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14596064,CHEMBL3239091,Inhibition of human DGAT1,B,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)[n+]([O-])c3)cc2n1,CHEMBL3233891,nM,122,CHEMBL6009,6.913640169,DGAT,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)[n+]([O-])c3)cc2n1,Cc1cc(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)[n+]([O-])c3)cc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741984,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cccc4c3OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3287858,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cccc4c3OCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cccc4c3OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741985,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)N(C(=O)Nc3ccccc3)CCO4)cc2)CC1,CHEMBL3287859,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)N(C(=O)Nc3ccccc3)CCO4)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)N(C(=O)Nc3ccccc3)CCO4)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741986,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cnc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3287860,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cnc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cnc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741987,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CC1Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc2N(C(=O)Nc2ccccc2)C1=O,CHEMBL3287863,nM,10000,CHEMBL6009,5,DGAT,CC1Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc2N(C(=O)Nc2ccccc2)C1=O,CC1Oc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2N(C(=O)Nc2ccccc2)C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741988,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4S(=O)(=O)Cc3ccccc3)cc2)CC1,CHEMBL3287871,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4S(=O)(=O)Cc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4S(=O)(=O)Cc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741989,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4c3nc4ccccc4o3)cc2)CC1,CHEMBL3287872,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4c3nc4ccccc4o3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4c3nc4ccccc4o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14741990,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C(=O)O)cc2)CC1,CHEMBL3287879,nM,10000,CHEMBL6009,5,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C(=O)O)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C(=O)O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742050,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C(F)(F)F)cc2)CC1,CHEMBL3287876,nM,20,CHEMBL6009,7.698970004,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742051,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3C(F)(F)F)cc2)CC1,CHEMBL3287878,nM,20,CHEMBL6009,7.698970004,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742056,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCCCCCCNC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287884,nM,32,CHEMBL6009,7.494850022,DGAT,CCCCCCCNC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CCCCCCCNC(=O)N1CCOc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742057,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCc1ccccc1NC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287875,nM,33,CHEMBL6009,7.48148606,DGAT,CCc1ccccc1NC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CCc1ccccc1NC(=O)N1CCOc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742068,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,C[C@@H]1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CHEMBL3287865,nM,43,CHEMBL6009,7.366531544,DGAT,C[C@@H]1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742076,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3287890,nM,52,CHEMBL6009,7.283996656,DGAT,O=C(O)C[C@H]1CC[C@@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742080,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287898,nM,64,CHEMBL6009,7.193820026,DGAT,CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CCc1ccccc1NC(=O)N1CC(C)Oc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742084,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCOc1ccc(NC(=O)N2CCOc3cc(-c4ccc([C@H]5CC[C@H](CC(=O)O)CC5)cc4)ccc32)cc1,CHEMBL3287874,nM,69,CHEMBL6009,7.161150909,DGAT,CCOc1ccc(NC(=O)N2CCOc3cc(-c4ccc([C@H]5CC[C@H](CC(=O)O)CC5)cc4)ccc32)cc1,CCOc1ccc(NC(=O)N2CCOc3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc32)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742089,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCc1ccccc1NC(=O)N1C[C@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287897,nM,85,CHEMBL6009,7.070581074,DGAT,CCc1ccccc1NC(=O)N1C[C@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CCc1ccccc1NC(=O)N1CC(C)Oc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742093,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CHEMBL3287864,nM,91,CHEMBL6009,7.040958608,DGAT,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742094,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)NCCCCc3ccccc3)cc2)CC1,CHEMBL3287882,nM,91,CHEMBL6009,7.040958608,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)NCCCCc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)NCCCCc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742100,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CHEMBL3287894,nM,100,CHEMBL6009,7,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742101,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CHEMBL3287867,nM,110,CHEMBL6009,6.958607315,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742102,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCc1ccccc1NC(=O)N1CC(C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287896,nM,110,CHEMBL6009,6.958607315,DGAT,CCc1ccccc1NC(=O)N1CC(C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CCc1ccccc1NC(=O)N1CC(C)Oc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742106,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CC(C)c1ccccc1NC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287877,nM,140,CHEMBL6009,6.853871964,DGAT,CC(C)c1ccccc1NC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CC(C)c1ccccc1NC(=O)N1CCOc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742115,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)NC3CCCCC3)cc2)CC1,CHEMBL3287883,nM,230,CHEMBL6009,6.638272164,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)NC3CCCCC3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)NC3CCCCC3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742117,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4(C(=O)O)CCC4)nc3)cc2O1,CHEMBL3287893,nM,290,CHEMBL6009,6.537602002,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4(C(=O)O)CCC4)nc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4(C(=O)O)CCC4)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742118,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1)NO,CHEMBL3287886,nM,300,CHEMBL6009,6.522878745,DGAT,O=C(Nc1ccccc1)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(O)=NO)CC4)cc3)ccc21,O=C(Nc1ccccc1)N1CCOc2cc(-c3ccc(C4CCC(CC(O)=NO)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742121,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(Nc1ccccc1)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](Cc5nnn[nH]5)CC4)cc3)ccc21,CHEMBL3287887,nM,360,CHEMBL6009,6.443697499,DGAT,O=C(Nc1ccccc1)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](Cc5nn[nH]n5)CC4)cc3)ccc21,O=C(Nc1ccccc1)N1CCOc2cc(-c3ccc(C4CCC(Cc5nn[nH]n5)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742123,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4(C(=O)O)CC4)nc3)cc2O1,CHEMBL3287892,nM,410,CHEMBL6009,6.387216143,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4(C(=O)O)CC4)nc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4(C(=O)O)CC4)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742125,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CHEMBL3287868,nM,450,CHEMBL6009,6.346787486,DGAT,CCCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CCCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742126,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,C[C@H]1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CHEMBL3287866,nM,530,CHEMBL6009,6.27572413,DGAT,C[C@H]1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742128,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CC(C)C1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CHEMBL3286412,nM,560,CHEMBL6009,6.251811973,DGAT,CC(C)C1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)cc2O1,CC(C)C1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742129,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Cc3ccccc3)cc2)CC1,CHEMBL3287869,nM,580,CHEMBL6009,6.236572006,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Cc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Cc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742130,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)NCc3ccccc3)cc2)CC1,CHEMBL3287881,nM,580,CHEMBL6009,6.236572006,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)NCc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)NCc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742131,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)[C@@H]1CCC[C@H]1C(=O)c1ccc(-c2ccc3c(c2)OCCN3C(=O)Nc2ccccc2)cc1,CHEMBL3287889,nM,630,CHEMBL6009,6.200659451,DGAT,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc3c(c2)OCCN3C(=O)Nc2ccccc2)cc1,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc3c(c2)OCCN3C(=O)Nc2ccccc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742133,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3cnc(OCC(C)(C)C(=O)O)nc3)cc2O1,CHEMBL3287895,nM,640,CHEMBL6009,6.193820026,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3cnc(OCC(C)(C)C(=O)O)nc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3cnc(OCC(C)(C)C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742135,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC[C@H]4C[C@@H]4C(=O)O)nc3)cc2O1,CHEMBL3287891,nM,860,CHEMBL6009,6.065501549,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC[C@H]4CC4C(=O)O)nc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC4CC4C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742137,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CC(C(=O)O)[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3287885,nM,950,CHEMBL6009,6.022276395,DGAT,CC(C(=O)O)[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CC(C(=O)O)C1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742139,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)CC1,CHEMBL3287873,nM,1700,CHEMBL6009,5.769551079,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742140,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(n3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3287861,nM,1900,CHEMBL6009,5.721246399,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(n3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4c(n3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742141,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CC1COc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc2N1C(=O)Nc1ccccc1,CHEMBL3287862,nM,3100,CHEMBL6009,5.508638306,DGAT,CC1COc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc2N1C(=O)Nc1ccccc1,CC1COc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2N1C(=O)Nc1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742142,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,CS(=O)(=O)NC(=O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CHEMBL3287888,nM,3100,CHEMBL6009,5.508638306,DGAT,CS(=O)(=O)NC(=O)C[C@H]1CC[C@H](c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,CS(=O)(=O)NC(=O)CC1CCC(c2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742143,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,N[C@H](C(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21)c1ccccc1,CHEMBL3287870,nM,3700,CHEMBL6009,5.431798276,DGAT,NC(C(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21)c1ccccc1,NC(C(=O)N1CCOc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21)c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742145,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,Nc1ccccc1NC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,CHEMBL3287880,nM,6100,CHEMBL6009,5.214670165,DGAT,Nc1ccccc1NC(=O)N1CCOc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,Nc1ccccc1NC(=O)N1CCOc2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
14742154,CHEMBL3294188,"Inhibition of human DGAT1 expressed in Sf9 insect cells using 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA substrate by scintillation counting analysis",B,O=C(O)[C@@H]1CCC[C@H]1C(=O)c1ccc(-c2ccc3c(ccn3C(=O)Nc3ccccc3)c2)cc1,CHEMBL3288152,nM,2900,CHEMBL6009,5.537602002,DGAT,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc3c(ccn3C(=O)Nc3ccccc3)c2)cc1,O=C(O)C1CCCC1C(=O)c1ccc(-c2ccc3c(ccn3C(=O)Nc3ccccc3)c2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15088224,CHEMBL3386692,Inhibition of human DGAT1,B,O=C(O)[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL3342775,nM,3.9,CHEMBL6009,8.408935393,DGAT,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15088225,CHEMBL3386692,Inhibition of human DGAT1,B,O=C(O)[C@H]1CC[C@@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL3342774,nM,2.5,CHEMBL6009,8.602059991,DGAT,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15088226,CHEMBL3386692,Inhibition of human DGAT1,B,O=C(O)[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,CHEMBL3342773,nM,2.9,CHEMBL6009,8.537602002,DGAT,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15088227,CHEMBL3386692,Inhibition of human DGAT1,B,O=C(O)[C@H]1CC[C@@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,CHEMBL3342772,nM,2.2,CHEMBL6009,8.657577319,DGAT,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15088228,CHEMBL3386692,Inhibition of human DGAT1,B,O=C(O)[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL3342771,nM,15,CHEMBL6009,7.823908741,DGAT,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15088229,CHEMBL3386692,Inhibition of human DGAT1,B,O=C(O)[C@H]1CC[C@@H](OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL3342770,nM,5.8,CHEMBL6009,8.236572006,DGAT,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)C1CCC(OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15617103,CHEMBL3583806,In vitro inhibition of full length human DGAT1 transfected in Sf-21 cells using [1-14C]oleoyl-CoA assessed as incorporation of radioactivity into lipid by TLC assay,B,CC(=O)Nc1cc(S(=O)(=O)Nc2ccc(F)cc2F)cc2c1N(CCc1ccccc1)CC2,CHEMBL3581716,nM,30000,CHEMBL6009,4.522878745,DGAT,CC(=O)Nc1cc(S(=O)(=O)Nc2ccc(F)cc2F)cc2c1N(CCc1ccccc1)CC2,CC(=O)Nc1cc(S(=O)(=O)Nc2ccc(F)cc2F)cc2c1N(CCc1ccccc1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15698673,CHEMBL3616242,"Inhibition of DGAT1 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into TG using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates",B,COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)NCCc4cccc(F)c4)cc3C2)c1,CHEMBL3613703,nM,31622.78,CHEMBL6009,4.499999953,DGAT,COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)NCCc4cccc(F)c4)cc3C2)c1,COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)NCCc4cccc(F)c4)cc3C2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15698721,CHEMBL3616242,"Inhibition of DGAT1 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into TG using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates",B,COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)Nc4cnn(C5CCC5)n4)cc3C2)c1,CHEMBL3613709,nM,50000,CHEMBL6009,4.301029996,DGAT,COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)N=c4cnn(C5CCC5)[nH]4)cc3C2)c1,COc1cccc(CC(=O)N2Cc3ccc(S(=O)(=O)N=c4cnn(C5CCC5)[nH]4)cc3C2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705169,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2c(F)cccc2F)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613357,nM,170,CHEMBL6009,6.769551079,DGAT,O=C(NCCNC(=O)c1ccc(-c2c(F)cccc2F)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2c(F)cccc2F)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705170,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2c(Cl)cccc2Cl)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613356,nM,280,CHEMBL6009,6.552841969,DGAT,O=C(NCCNC(=O)c1ccc(-c2c(Cl)cccc2Cl)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2c(Cl)cccc2Cl)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705171,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,Cc1cccc(C)c1-c1ccc(C(=O)NCCNC(=O)c2ccc(O[C@H]3C4CC5CC3C[C@](C(=O)O)(C5)C4)cc2)cc1,CHEMBL3613355,nM,105,CHEMBL6009,6.978810701,DGAT,Cc1cccc(C)c1-c1ccc(C(=O)NCCNC(=O)c2ccc(O[C@H]3C4CC5CC3C[C@](C(=O)O)(C5)C4)cc2)cc1,Cc1cccc(C)c1-c1ccc(C(=O)NCCNC(=O)c2ccc(OC3C4CC5CC3CC(C(=O)O)(C5)C4)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705172,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2ccccc2)c(Cl)c1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613354,nM,300,CHEMBL6009,6.522878745,DGAT,O=C(NCCNC(=O)c1ccc(-c2ccccc2)c(Cl)c1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2ccccc2)c(Cl)c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705173,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2ccccc2Cl)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613353,nM,500,CHEMBL6009,6.301029996,DGAT,O=C(NCCNC(=O)c1ccc(-c2ccccc2Cl)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2ccccc2Cl)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705174,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2ccccc2C(F)(F)F)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613352,nM,500,CHEMBL6009,6.301029996,DGAT,O=C(NCCNC(=O)c1ccc(-c2ccccc2C(F)(F)F)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2ccccc2C(F)(F)F)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705175,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,Cc1ccccc1-c1ccc(C(=O)NCCNC(=O)c2ccc(O[C@H]3C4CC5CC3C[C@](C(=O)O)(C5)C4)cc2)cc1,CHEMBL3613351,nM,32,CHEMBL6009,7.494850022,DGAT,Cc1ccccc1-c1ccc(C(=O)NCCNC(=O)c2ccc(O[C@H]3C4CC5CC3C[C@](C(=O)O)(C5)C4)cc2)cc1,Cc1ccccc1-c1ccc(C(=O)NCCNC(=O)c2ccc(OC3C4CC5CC3CC(C(=O)O)(C5)C4)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705176,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@@](C(=O)O)(C4)C3)cc1,CHEMBL3613350,nM,25,CHEMBL6009,7.602059991,DGAT,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705177,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613349,nM,5,CHEMBL6009,8.301029996,DGAT,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705178,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(O[C@H]2C3CC4CC2C[C@@](C(=O)O)(C4)C3)cc1,CHEMBL3613348,nM,48,CHEMBL6009,7.318758763,DGAT,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(O[C@H]2C3CC4CC2C[C@@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705179,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,CHEMBL3613347,nM,44,CHEMBL6009,7.356547324,DGAT,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(O[C@H]2C3CC4CC2C[C@](C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705180,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613346,nM,10000,CHEMBL6009,5,DGAT,O=C(NCCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705181,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613345,nM,10000,CHEMBL6009,5,DGAT,O=C(NCCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705182,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(O)CC1C2CC3CC1CC(Oc1ccc(C(=O)NCCNC(=O)c4ccc(-c5ccccc5)cc4)cc1)(C3)C2,CHEMBL3613344,nM,159,CHEMBL6009,6.798602876,DGAT,O=C(O)CC1C2CC3CC1CC(Oc1ccc(C(=O)NCCNC(=O)c4ccc(-c5ccccc5)cc4)cc1)(C3)C2,O=C(O)CC1C2CC3CC1CC(Oc1ccc(C(=O)NCCNC(=O)c4ccc(-c5ccccc5)cc4)cc1)(C3)C2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705183,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(O)CC1C2CC3CC1CC(Oc1ccc(C(=O)NCCNC(=O)c4ccc5ccccc5c4)cc1)(C3)C2,CHEMBL3613343,nM,500,CHEMBL6009,6.301029996,DGAT,O=C(O)CC1C2CC3CC1CC(Oc1ccc(C(=O)NCCNC(=O)c4ccc5ccccc5c4)cc1)(C3)C2,O=C(O)CC1C2CC3CC1CC(Oc1ccc(C(=O)NCCNC(=O)c4ccc5ccccc5c4)cc1)(C3)C2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705184,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613342,nM,10000,CHEMBL6009,5,DGAT,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1cn(-c2ccccc2)nc1C(F)(F)F)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705185,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1nc(-c2ccccc2)oc1C(F)(F)F)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613341,nM,89,CHEMBL6009,7.050609993,DGAT,O=C(NCCNC(=O)c1nc(-c2ccccc2)oc1C(F)(F)F)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1nc(-c2ccccc2)oc1C(F)(F)F)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705186,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613340,nM,12,CHEMBL6009,7.920818754,DGAT,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc(-c2ccccc2)cc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705187,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613339,nM,34,CHEMBL6009,7.468521083,DGAT,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCNC(=O)c1ccc2ccccc2c1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705188,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1)c1ccccc1,CHEMBL3613338,nM,50000,CHEMBL6009,4.301029996,DGAT,O=C(NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1)c1ccccc1,O=C(NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1)c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705189,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNS(=O)(=O)c1ccccc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613337,nM,50000,CHEMBL6009,4.301029996,DGAT,O=C(NCCNS(=O)(=O)c1ccccc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,O=C(NCCNS(=O)(=O)c1ccccc1)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705190,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,O=C(NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1)Nc1ccccc1,CHEMBL3613336,nM,201,CHEMBL6009,6.696803943,DGAT,O=C(NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1)Nc1ccccc1,O=C(NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1)Nc1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705191,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613335,nM,50000,CHEMBL6009,4.301029996,DGAT,NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
15705192,CHEMBL3616153,Inhibition of human DGAT1 expressed in human Hep3B cells incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay,B,CC(C)(C)OC(=O)NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CHEMBL3613334,nM,539,CHEMBL6009,6.268411235,DGAT,CC(C)(C)OC(=O)NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,CC(C)(C)OC(=O)NCCNC(=O)c1ccc(OC2C3CC4CC2CC(C(=O)O)(C4)C3)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386253,CHEMBL3737419,Inhibition of DGAT1 (unknown origin) by CPM assay,B,COc1cccc(-c2ccc(CNC(=O)Nc3cccc(Cl)c3Cl)c3cnccc23)c1,CHEMBL3736092,nM,10000,CHEMBL6009,5,DGAT,COc1cccc(-c2ccc(CNC(=O)Nc3cccc(Cl)c3Cl)c3cnccc23)c1,COc1cccc(-c2ccc(CNC(=O)Nc3cccc(Cl)c3Cl)c3cnccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386272,CHEMBL3737426,Inhibition of human DGAT1 by CPM assay,B,Cc1noc([C@H]2C[C@@H]2C(=O)NCc2ccc(-c3cccc(OC(F)(F)F)c3)c3c2CN(C(=O)NC(C)(C)C)CC3)n1,CHEMBL3734797,nM,10000,CHEMBL6009,5,DGAT,Cc1noc(C2CC2C(=O)NCc2ccc(-c3cccc(OC(F)(F)F)c3)c3c2CN(C(=O)NC(C)(C)C)CC3)n1,Cc1noc(C2CC2C(=O)NCc2ccc(-c3cccc(OC(F)(F)F)c3)c3c2CN(C(=O)NC(C)(C)C)CC3)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411044,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(COC4CCCC4)s3)cc2)CC1,CHEMBL3740753,nM,38,CHEMBL6009,7.420216403,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(COC4CCCC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(COC4CCCC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411045,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCC4CCCO4)s3)cc2)CC1,CHEMBL3741427,nM,144,CHEMBL6009,6.841637508,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCCO4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCCO4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411046,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(CCC4CCOC4)s3)cc2)CC1,CHEMBL3741457,nM,233,CHEMBL6009,6.632644079,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCOC4)s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(CCC4CCOC4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411047,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Cc2ccccc2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3741569,nM,16,CHEMBL6009,7.795880017,DGAT,O=C(N=c1[nH]nc(Cc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]nc(Cc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411048,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Cc2ccccc2)s1)c1ccc(O[C@H]2CC[C@H](C(=O)O)CC2)cc1,CHEMBL3740040,nM,280,CHEMBL6009,6.552841969,DGAT,O=C(N=c1[nH]nc(Cc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]nc(Cc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411049,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Cc2cc(F)cc(F)c2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3741095,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(N=c1[nH]nc(Cc2cc(F)cc(F)c2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]nc(Cc2cc(F)cc(F)c2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411050,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Cc2cc(F)cc(F)c2)s1)c1ccc(O[C@H]2CC[C@H](C(=O)O)CC2)cc1,CHEMBL3741896,nM,160,CHEMBL6009,6.795880017,DGAT,O=C(N=c1[nH]nc(Cc2cc(F)cc(F)c2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]nc(Cc2cc(F)cc(F)c2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411051,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(COC2CCCC2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3741333,nM,12,CHEMBL6009,7.920818754,DGAT,O=C(N=c1[nH]nc(COC2CCCC2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]nc(COC2CCCC2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411052,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Cc2ccccc2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)nc1,CHEMBL3741723,nM,45,CHEMBL6009,7.346787486,DGAT,O=C(N=c1[nH]nc(Cc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)nc1,O=C(N=c1[nH]nc(Cc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411053,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Cc2cccc(Cl)c2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)nc1,CHEMBL3741943,nM,55,CHEMBL6009,7.259637311,DGAT,O=C(N=c1[nH]nc(Cc2cccc(Cl)c2)s1)c1ccc(OC2CCC(C(=O)O)CC2)nc1,O=C(N=c1[nH]nc(Cc2cccc(Cl)c2)s1)c1ccc(OC2CCC(C(=O)O)CC2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411054,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(NC2CCCC2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3739742,nM,22,CHEMBL6009,7.657577319,DGAT,O=C(N=c1[nH][nH]c(=NC2CCCC2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH][nH]c(=NC2CCCC2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411055,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nnc(Nc2ccccc2)s1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3741505,nM,4,CHEMBL6009,8.397940009,DGAT,O=C(N=c1[nH][nH]c(=Nc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH][nH]c(=Nc2ccccc2)s1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411058,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccc(F)cc4)o3)cc2)CC1,CHEMBL3741500,nM,1390,CHEMBL6009,5.8569852,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccc(F)cc4)o3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccc(F)cc4)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411059,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3noc(Cc4ccccc4)n3)cc2)CC1,CHEMBL3741082,nM,286,CHEMBL6009,6.543633967,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3nc(Cc4ccccc4)o[nH]3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3nc(Cc4ccccc4)o[nH]3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411060,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nc(Cc4ccccc4)no3)cc2)CC1,CHEMBL3740823,nM,253,CHEMBL6009,6.596879479,DGAT,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]c(Cc4ccccc4)no3)cc2)CC1,O=C(O)CC1CCC(c2ccc(C(=O)N=c3[nH]c(Cc4ccccc4)no3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411061,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nc(Cc2ccccc2)no1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3740607,nM,57,CHEMBL6009,7.244125144,DGAT,O=C(N=c1[nH]c(Cc2ccccc2)no1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]c(Cc2ccccc2)no1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411062,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(Nc1nc(Cc2cc(F)cc(F)c2)no1)c1ccc(O[C@H]2CC[C@@H](C(=O)O)CC2)cc1,CHEMBL3741016,nM,120,CHEMBL6009,6.920818754,DGAT,O=C(N=c1[nH]c(Cc2cc(F)cc(F)c2)no1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,O=C(N=c1[nH]c(Cc2cc(F)cc(F)c2)no1)c1ccc(OC2CCC(C(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411063,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,NC(=O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL3742009,nM,48,CHEMBL6009,7.318758763,DGAT,NC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,NC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411064,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,CC(C)(O)CNC(=O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL3742053,nM,92,CHEMBL6009,7.036212173,DGAT,CC(C)(O)CNC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,CC(C)(O)CNC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411065,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1)NCC(O)CO,CHEMBL3741306,nM,81,CHEMBL6009,7.091514981,DGAT,O=C(CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1)NCC(O)CO,O=C(CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1)NCC(O)CO,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411066,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,COCCNC(=O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL3740571,nM,88,CHEMBL6009,7.055517328,DGAT,COCCNC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,COCCNC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411067,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,O=C(C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1)NCCN1CCOCC1,CHEMBL3742222,nM,122,CHEMBL6009,6.913640169,DGAT,O=C(CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1)NCCN1CCOCC1,O=C(CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1)NCCN1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16411068,CHEMBL3742563,"Inhibition of recombinant human DGAT-1 using 1,2,di(cis-9-octadecenoyl)-sn-glycerol as substrate by Microbeta counter",B,CN(C)CCNC(=O)C[C@H]1CC[C@H](c2ccc(C(=O)Nc3nnc(Cc4ccccc4)s3)cc2)CC1,CHEMBL3741542,nM,279,CHEMBL6009,6.554395797,DGAT,CN(C)CCNC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,CN(C)CCNC(=O)CC1CCC(c2ccc(C(=O)N=c3[nH]nc(Cc4ccccc4)s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459172,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC(C)C[C@H](OC(=O)C(C)(C)C)C(=O)NC1(C(=O)N[C@@H](CCc2ccccc2)C(=O)OC(C)(C)C)CCCC1,CHEMBL3758618,nM,7,CHEMBL6009,8.15490196,DGAT,CC(C)CC(OC(=O)C(C)(C)C)C(=O)NC1(C(=O)NC(CCc2ccccc2)C(=O)OC(C)(C)C)CCCC1,CC(C)CC(OC(=O)C(C)(C)C)C(=O)NC1(C(=O)NC(CCc2ccccc2)C(=O)OC(C)(C)C)CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459179,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC(C)C[C@H](OC(=O)C(C)(C)C)C(=O)NC1(C(=O)N[C@@H](CCc2ccccc2)c2nc(C3CC3)no2)CCCC1,CHEMBL3759363,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)CC(OC(=O)C(C)(C)C)C(=O)NC1(C(=O)NC(CCc2ccccc2)c2nc(C3CC3)no2)CCCC1,CC(C)CC(OC(=O)C(C)(C)C)C(=O)NC1(C(=O)NC(CCc2ccccc2)c2nc(C3CC3)no2)CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459187,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CCOC[C@H](CCc1ccccc1)NC(=O)C1(NC(=O)CC2C3CC4CC(C3)CC2C4)CCCC1,CHEMBL3759790,nM,27,CHEMBL6009,7.568636236,DGAT,CCOC[C@H](CCc1ccccc1)NC(=O)C1(NC(=O)CC2C3CC4CC(C3)CC2C4)CCCC1,CCOCC(CCc1ccccc1)NC(=O)C1(NC(=O)CC2C3CC4CC(C3)CC2C4)CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459193,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CCOC[C@H](CCc1ccccc1)NS(=O)(=O)c1cccc(NC(=O)[C@H](CC(C)C)OC(=O)C(C)(C)C)c1,CHEMBL3759264,nM,10000,CHEMBL6009,5,DGAT,CCOC[C@H](CCc1ccccc1)NS(=O)(=O)c1cccc(NC(=O)C(CC(C)C)OC(=O)C(C)(C)C)c1,CCOCC(CCc1ccccc1)NS(=O)(=O)c1cccc(NC(=O)C(CC(C)C)OC(=O)C(C)(C)C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459199,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC1(C(=O)NC(C)(C)C(=O)Nc2nc(C(C)(C)C)n(-c3ccc(F)cc3)n2)CC1,CHEMBL3759291,nM,10000,CHEMBL6009,5,DGAT,CC1(C(=O)NC(C)(C)C(=O)N=c2nc(C(C)(C)C)n(-c3ccc(F)cc3)[nH]2)CC1,CC1(C(=O)NC(C)(C)C(=O)N=c2nc(C(C)(C)C)n(-c3ccc(F)cc3)[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459201,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)Nc1nc(C(C)(C)C)n(-c2ccc(F)cc2)n1,CHEMBL3759017,nM,4800,CHEMBL6009,5.318758763,DGAT,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)N=c1nc(C(C)(C)C)n(-c2ccc(F)cc2)[nH]1,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)N=c1nc(C(C)(C)C)n(-c2ccc(F)cc2)[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459203,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC(C)(NC(=O)c1ccc(F)cc1)C(=O)Nc1nc(C(C)(C)C)n(-c2ccc(F)cc2)n1,CHEMBL3758531,nM,3500,CHEMBL6009,5.455931956,DGAT,CC(C)(NC(=O)c1ccc(F)cc1)C(=O)N=c1nc(C(C)(C)C)n(-c2ccc(F)cc2)[nH]1,CC(C)(NC(=O)c1ccc(F)cc1)C(=O)N=c1nc(C(C)(C)C)n(-c2ccc(F)cc2)[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459205,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)Nc1nc(C(C)(C)c2ccc(F)cc2)n(-c2ccc(F)cc2)n1,CHEMBL3758551,nM,1400,CHEMBL6009,5.853871964,DGAT,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)N=c1nc(C(C)(C)c2ccc(F)cc2)n(-c2ccc(F)cc2)[nH]1,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)N=c1nc(C(C)(C)c2ccc(F)cc2)n(-c2ccc(F)cc2)[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459207,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)Nc1nc(-c2ccc(F)cc2)n(-c2ccc(F)cc2)n1,CHEMBL3759584,nM,760,CHEMBL6009,6.119186408,DGAT,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)N=c1nc(-c2ccc(F)cc2)n(-c2ccc(F)cc2)[nH]1,CC(C)(NC(=O)C1(C(F)(F)F)CC1)C(=O)N=c1nc(-c2ccc(F)cc2)n(-c2ccc(F)cc2)[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16459209,CHEMBL3761636,Inhibition of human recombinant 6His-tagged DAGT1 expressed in fall armyworm Sf9 cells using diolein and oleoyl-CoA incubated for 30 mins by LC/MS/MS analysis,B,Cc1cc(F)ccc1-n1nc(NC(=O)C(C)(C)NC(=O)C2(C(F)(F)F)CC2)nc1-c1ccc(F)cc1,CHEMBL3759471,nM,62,CHEMBL6009,7.207608311,DGAT,Cc1cc(F)ccc1-n1[nH]c(=NC(=O)C(C)(C)NC(=O)C2(C(F)(F)F)CC2)nc1-c1ccc(F)cc1,Cc1cc(F)ccc1-n1[nH]c(=NC(=O)C(C)(C)NC(=O)C2(C(F)(F)F)CC2)nc1-c1ccc(F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623300,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,O=C(O)C1CCC(Oc2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cn2)CC1,CHEMBL3670335,nM,60,CHEMBL6009,7.22184875,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccccc3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623301,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)cc2O1,CHEMBL3670336,nM,156,CHEMBL6009,6.806875402,DGAT,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)cc2O1,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623302,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)cc2O1,CHEMBL3670337,nM,36,CHEMBL6009,7.443697499,DGAT,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)cc2O1,CCC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623304,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CCc1ccccc1NC(=O)N1CCOc2cc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)ccc21,CHEMBL3670338,nM,67,CHEMBL6009,7.173925197,DGAT,CCc1ccccc1NC(=O)N1CCOc2cc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)ccc21,CCc1ccccc1NC(=O)N1CCOc2cc(-c3ccc(OC4CCC(C(=O)O)CC4)nc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623305,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,O=C(O)C1CCC(Oc2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3C(F)(F)F)cn2)CC1,CHEMBL3670339,nM,85,CHEMBL6009,7.070581074,DGAT,O=C(O)C1CCC(Oc2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3C(F)(F)F)cn2)CC1,O=C(O)C1CCC(Oc2ccc(-c3ccc4c(c3)OCCN4C(=O)Nc3ccc(F)cc3C(F)(F)F)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623306,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CC(C)(COc1ccc(-c2ccc3c(c2)OCCN3C(=O)Nc2ccccc2)cn1)C(=O)O,CHEMBL3670340,nM,138,CHEMBL6009,6.860120914,DGAT,CC(C)(COc1ccc(-c2ccc3c(c2)OCCN3C(=O)Nc2ccccc2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc3c(c2)OCCN3C(=O)Nc2ccccc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623307,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CHEMBL3670341,nM,254,CHEMBL6009,6.595166283,DGAT,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CC1CN(C(=O)Nc2ccccc2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623309,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CCC1CN(C(=O)Nc2ccc(Cl)cc2F)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CHEMBL3670342,nM,118,CHEMBL6009,6.928117993,DGAT,CCC1CN(C(=O)Nc2ccc(Cl)cc2F)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CCC1CN(C(=O)Nc2ccc(Cl)cc2F)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623310,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CC1CN(C(=O)Nc2ccc(F)c(Cl)c2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CHEMBL3670343,nM,119,CHEMBL6009,6.924453039,DGAT,CC1CN(C(=O)Nc2ccc(F)c(Cl)c2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CC1CN(C(=O)Nc2ccc(F)c(Cl)c2)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623311,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CCCc1ccccc1NC(=O)c1cc(C)nc2cc(-c3ccc(OCC(C)(C)C(=O)O)nc3)ccc12,CHEMBL3670344,nM,280,CHEMBL6009,6.552841969,DGAT,CCCc1ccccc1NC(=O)c1cc(C)nc2cc(-c3ccc(OCC(C)(C)C(=O)O)nc3)ccc12,CCCc1ccccc1NC(=O)c1cc(C)nc2cc(-c3ccc(OCC(C)(C)C(=O)O)nc3)ccc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623313,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,CCCCCCNC(=O)N1CC(C)Oc2cc(-c3ccc(OCC(C)(C)C(=O)O)nc3)ccc21,CHEMBL3670345,nM,87,CHEMBL6009,7.060480747,DGAT,CCCCCCNC(=O)N1CC(C)Oc2cc(-c3ccc(OCC(C)(C)C(=O)O)nc3)ccc21,CCCCCCNC(=O)N1CC(C)Oc2cc(-c3ccc(OCC(C)(C)C(=O)O)nc3)ccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17623314,CHEMBL3706267,"Biological Assay: The in vitro assay to identify DGAT1 inhibitors uses human DGAT1 enzyme expressed in Sf9 insect cells prepared as microsomes. The reaction was initiated by the addition of the combined substrates 1,2-dioleoyl-sn-glycerol and [14C]-palmitoyl-CoA and incubated with test compounds and microsomal membranes for 2 hours at room temperature. The assay was stopped by adding 0.5 mg wheat germ agglutinin beads in assay buffer with 1% Brij-35 and 1% 3-cholamidopropyldimethyl-ammonio-1-propane sulfonate. Plates were sealed with TopSeal and incubated for 18 hours to allow the radioactive triglyceride product to come into proximity with the bead.",B,C[C@@H]1CN(C(=O)Nc2ccc(Cl)cc2F)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CHEMBL3670346,nM,131,CHEMBL6009,6.882728704,DGAT,C[C@@H]1CN(C(=O)Nc2ccc(Cl)cc2F)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,CC1CN(C(=O)Nc2ccc(Cl)cc2F)c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)cc2O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17658031,CHEMBL3706126,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at RT and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5.The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000x g for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,O=C(O)CC1CCC(c2ccc(-c3cnc(Nc4ccc(C(F)(F)F)cc4Cl)o3)cc2)CC1,CHEMBL3653963,nM,600,CHEMBL6009,6.22184875,DGAT,O=C(O)CC1CCC(c2ccc(-c3c[nH]c(=Nc4ccc(C(F)(F)F)cc4Cl)o3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3c[nH]c(=Nc4ccc(C(F)(F)F)cc4Cl)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17658032,CHEMBL3706126,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at RT and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5.The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000x g for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,O=C(O)CCc1ccc(-c2ccc(-c3cnc(Nc4cccc(Cl)c4)o3)cc2)cc1,CHEMBL3657595,nM,1400,CHEMBL6009,5.853871964,DGAT,O=C(O)CCc1ccc(-c2ccc(-c3c[nH]c(=Nc4cccc(Cl)c4)o3)cc2)cc1,O=C(O)CCc1ccc(-c2ccc(-c3c[nH]c(=Nc4cccc(Cl)c4)o3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17658033,CHEMBL3706126,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at RT and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5.The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000x g for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,O=C(O)CCC(=O)N1CC=C(c2ccc(-c3cnc(Nc4cccc(Cl)c4)o3)cc2)CC1,CHEMBL3657596,nM,11000,CHEMBL6009,4.958607315,DGAT,O=C(O)CCC(=O)N1CC=C(c2ccc(-c3c[nH]c(=Nc4cccc(Cl)c4)o3)cc2)CC1,O=C(O)CCC(=O)N1CC=C(c2ccc(-c3c[nH]c(=Nc4cccc(Cl)c4)o3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17658034,CHEMBL3706126,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at RT and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5.The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000x g for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,O=C(O)CCNC(=O)c1ccc(-c2ccc(Nc3cccc(Cl)c3)nn2)cc1,CHEMBL3657597,nM,230,CHEMBL6009,6.638272164,DGAT,O=C(O)CCNC(=O)c1ccc(-c2ccc(=Nc3cccc(Cl)c3)[nH]n2)cc1,O=C(O)CCNC(=O)c1ccc(-c2ccc(=Nc3cccc(Cl)c3)[nH]n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17685543,CHEMBL3705580,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at room temperature and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5. The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000xg for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,Cc1nc(C(=O)Nc2ccc(-c3ccc(C4CCC(CC(=O)O)OC4)cc3)cc2)c(C(F)(F)F)o1,CHEMBL3701234,nM,1400,CHEMBL6009,5.853871964,DGAT,Cc1nc(C(=O)Nc2ccc(-c3ccc(C4CCC(CC(=O)O)OC4)cc3)cc2)c(C(F)(F)F)o1,Cc1nc(C(=O)Nc2ccc(-c3ccc(C4CCC(CC(=O)O)OC4)cc3)cc2)c(C(F)(F)F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17685548,CHEMBL3705580,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at room temperature and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5. The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000xg for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,O=C(O)CC1CCC(c2ccc(-c3ccc(Nc4nnc(C5CCC5)o4)cc3)cc2)CO1,CHEMBL3701235,nM,310,CHEMBL6009,6.508638306,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)o4)cc3)cc2)CO1,O=C(O)CC1CCC(c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)o4)cc3)cc2)CO1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17685549,CHEMBL3705580,"Inhibition Assay: The enzyme preparation used in this assay is a membrane preparation from Sf9 cells overexpressing human (His)6DGAT1. During all steps samples were chilled to 4 C. Sf9 cells expressing human (His)6DGAT1 were thawed at room temperature and re-suspended at a 10:1 ratio (mL buffer/g of cells) in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5. The re-suspended pellet was homogenized for 1 min using a Brinkman PT 10/35 homogenizer with a 20 mm generator. Cells were lysed using Avestin Emulsiflex (chilled to 4 C.) at 10000-15000 psi. Lysate was centrifuged at 100,000xg for 1 h at 4 C. Supernatant was removed and pellets were re-suspended in 50 mM HEPES, 1x Complete Protease Inhibitor, pH 7.5 at 1/6 the volume of supernatant. Re-suspended pellets were pooled and homogenized with 10 strokes of a Glas-Col motor driven teflon pestle on setting 70. The protein concentration of the membrane preparation was quantified using BCA protein assay with 1% SDS.",B,O=C(O)CC1CCC(c2ccc(-c3ccc(Nc4nnc(C5CCC5)o4)cc3)cc2)OC1,CHEMBL3701236,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)o4)cc3)cc2)OC1,O=C(O)CC1CCC(c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)o4)cc3)cc2)OC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745154,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,CHEMBL3898804,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745155,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(C(F)(F)F)cc5)cn4c3)cc2)CC1,CHEMBL3975150,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(C(F)(F)F)cc5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(C(F)(F)F)cc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745156,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,CHEMBL3904271,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745157,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(C(F)(F)F)cc5)cn4c3)cc2)CC1,CHEMBL3986561,nM,150,CHEMBL6009,6.823908741,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(C(F)(F)F)cc5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(C(F)(F)F)cc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745158,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(OC(F)(F)F)c5)cn4c3)cc2)CC1,CHEMBL3913282,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(OC(F)(F)F)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(OC(F)(F)F)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745159,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(C(F)(F)F)c5)cn4c3)cc2)CC1,CHEMBL3951406,nM,75,CHEMBL6009,7.124938737,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(C(F)(F)F)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(C(F)(F)F)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745160,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5cccc(OC(F)(F)F)c5)cn4c3)cc2)CC1,CHEMBL3980342,nM,175,CHEMBL6009,6.756961951,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5cccc(OC(F)(F)F)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5cccc(OC(F)(F)F)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745161,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,CHEMBL3968580,nM,125,CHEMBL6009,6.903089987,DGAT,CC(C)(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,CC(C)(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745162,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5cc(OC(F)(F)F)ccc5F)cn4c3)cc2)CC1,CHEMBL3939042,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5cc(OC(F)(F)F)ccc5F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5cc(OC(F)(F)F)ccc5F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745163,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(F)c(OC(F)(F)F)c5)cn4c3)cc2)CC1,CHEMBL3947698,nM,75,CHEMBL6009,7.124938737,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(F)c(OC(F)(F)F)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(F)c(OC(F)(F)F)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745164,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(C(F)(F)F)c(F)c5)cn4c3)cc2)CC1,CHEMBL3923387,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(C(F)(F)F)c(F)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(C(F)(F)F)c(F)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745165,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,CHEMBL3964409,nM,25,CHEMBL6009,7.602059991,DGAT,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745166,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(F)c(Cl)c5)cn4c3)cc2)CC1,CHEMBL3905096,nM,25.4,CHEMBL6009,7.595166283,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(F)c(Cl)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(F)c(Cl)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745167,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc6c(c5)OCO6)cn4c3)cc2)CC1,CHEMBL3947894,nM,37.9,CHEMBL6009,7.42136079,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc6c(c5)OCO6)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc6c(c5)OCO6)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745168,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(Cl)c(Cl)c5)cn4c3)cc2)CC1,CHEMBL3930018,nM,17.8,CHEMBL6009,7.749579998,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(Cl)c(Cl)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(Cl)c(Cl)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745169,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(Cl)c5)cn4c3)cc2)CC1,CHEMBL3975967,nM,7,CHEMBL6009,8.15490196,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(Cl)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cccc(Cl)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745170,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(F)c(Cl)c5)cn4c3)cc2)CC1,CHEMBL3946651,nM,34.5,CHEMBL6009,7.462180905,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(F)c(Cl)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(F)c(Cl)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745171,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccc(OC(F)(F)F)cc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3913931,nM,10,CHEMBL6009,8,DGAT,COc1ccc(OC(F)(F)F)cc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,COc1ccc(OC(F)(F)F)cc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745172,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,CHEMBL3893192,nM,10,CHEMBL6009,8,DGAT,CC(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,CC(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745173,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)(NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1)c1ccc(F)cc1,CHEMBL3929522,nM,4,CHEMBL6009,8.397940009,DGAT,CC(C)(NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1)c1ccc(F)cc1,CC(C)(NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1)c1ccc(F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745174,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NC5(c6cc(F)ccc6F)CC5)cn4c3)cc2)CC1,CHEMBL3957095,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NC5(c6cc(F)ccc6F)CC5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NC5(c6cc(F)ccc6F)CC5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745175,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1cccc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3924760,nM,12.7,CHEMBL6009,7.896196279,DGAT,Cc1cccc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Cc1cccc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745176,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1OC,CHEMBL3951829,nM,25,CHEMBL6009,7.602059991,DGAT,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1OC,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)cc1OC,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745177,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1)c1ccccc1,CHEMBL3915108,nM,38.3,CHEMBL6009,7.416801226,DGAT,CC(NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1)c1ccccc1,CC(NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1)c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745178,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(Oc6ccc(F)cc6)cc5)cn4c3)cc2)CC1,CHEMBL3918850,nM,16.8,CHEMBL6009,7.774690718,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(Oc6ccc(F)cc6)cc5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(Oc6ccc(F)cc6)cc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745179,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc6c(c5)OCCCO6)cn4c3)cc2)CC1,CHEMBL3949646,nM,29.5,CHEMBL6009,7.530177984,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc6c(c5)OCCCO6)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc6c(c5)OCCCO6)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745180,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cccc5Cl)cn4c3)cc2)CC1,CHEMBL3925063,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cccc5Cl)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cccc5Cl)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745181,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(Cl)cccc5Cl)cn4c3)cc2)CC1,CHEMBL3944787,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(Cl)cccc5Cl)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(Cl)cccc5Cl)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745182,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cccc5F)cn4c3)cc2)CC1,CHEMBL3913331,nM,25,CHEMBL6009,7.602059991,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cccc5F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cccc5F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745183,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(Cl)cccc5C(F)(F)F)cn4c3)cc2)CC1,CHEMBL3935847,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(Cl)cccc5C(F)(F)F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(Cl)cccc5C(F)(F)F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745184,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccccc5)cn4c3)cc2)CC1,CHEMBL3907882,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccccc5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccccc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745185,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1ccccc1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3931131,nM,1,CHEMBL6009,9,DGAT,Cc1ccccc1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Cc1ccccc1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745186,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(F)cc5C(F)(F)F)cn4c3)cc2)CC1,CHEMBL3906663,nM,250,CHEMBL6009,6.602059991,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(F)cc5C(F)(F)F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccc(F)cc5C(F)(F)F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745187,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5C(F)(F)F)cn4c3)cc2)CC1,CHEMBL3961251,nM,150,CHEMBL6009,6.823908741,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5C(F)(F)F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5C(F)(F)F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745188,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5F)cn4c3)cc2)CC1,CHEMBL3906146,nM,200,CHEMBL6009,6.698970004,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5ccccc5F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745189,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccccc1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3952318,nM,100,CHEMBL6009,7,DGAT,COc1ccccc1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,COc1ccccc1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745190,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1ccccc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3921111,nM,10,CHEMBL6009,8,DGAT,Cc1ccccc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Cc1ccccc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745191,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1cccc(C)c1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3975722,nM,200,CHEMBL6009,6.698970004,DGAT,Cc1cccc(C)c1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Cc1cccc(C)c1NC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745192,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cc(F)ccc5F)cn4c3)cc2)CC1,CHEMBL3904934,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cc(F)ccc5F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cc(F)ccc5F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745193,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cc(F)c(F)c(F)c5)cn4c3)cc2)CC1,CHEMBL3987192,nM,1,CHEMBL6009,9,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cc(F)c(F)c(F)c5)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)Nc5cc(F)c(F)c(F)c5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745194,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccccc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3938680,nM,25,CHEMBL6009,7.602059991,DGAT,COc1ccccc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,COc1ccccc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745195,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cc(Cl)cc5F)cn4c3)cc2)CC1,CHEMBL3931946,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cc(Cl)cc5F)cn4c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5c(F)cc(Cl)cc5F)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745196,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1cc(Cl)cc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,CHEMBL3959437,nM,10,CHEMBL6009,8,DGAT,Cc1cc(Cl)cc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Cc1cc(Cl)cc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745197,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1cc(C)c(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)c(C)c1,CHEMBL3982441,nM,25,CHEMBL6009,7.602059991,DGAT,Cc1cc(C)c(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)c(C)c1,Cc1cc(C)c(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)ccc3n2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745198,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1ccc(CNC(=O)c2nc3ccc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)cn3n2)cc1,CHEMBL3899459,nM,50,CHEMBL6009,7.301029996,DGAT,Cc1ccc(CNC(=O)c2nc3ccc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)cn3n2)cc1,Cc1ccc(CNC(=O)c2nc3ccc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)cn3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745199,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc([C@H]5CC[C@H](CC(=O)O)CC5)cc4)sc3n2)cc1,CHEMBL3910570,nM,1,CHEMBL6009,9,DGAT,CC(C)(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc([C@H]5CC[C@H](CC(=O)O)CC5)cc4)sc3n2)cc1,CC(C)(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745200,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)Nc5cccc(Cl)c5)nc4s3)cc2)CC1,CHEMBL3890924,nM,10,CHEMBL6009,8,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)Nc5cccc(Cl)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)Nc5cccc(Cl)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745201,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)c(Cl)c5)nc4s3)cc2)CC1,CHEMBL3960357,nM,225,CHEMBL6009,6.647817482,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)c(Cl)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)c(Cl)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745202,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5ccc(F)c(Cl)c5)nc4s3)cc2)CC1,CHEMBL3889645,nM,10,CHEMBL6009,8,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5ccc(F)c(Cl)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(F)c(Cl)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745203,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5cccc(OC(F)(F)F)c5)nc4s3)cc2)CC1,CHEMBL3954376,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5cccc(OC(F)(F)F)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5cccc(OC(F)(F)F)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745204,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5cc(OC(F)(F)F)ccc5F)nc4s3)cc2)CC1,CHEMBL3895120,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5cc(OC(F)(F)F)ccc5F)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5cc(OC(F)(F)F)ccc5F)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745205,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)Nc5cccc(OC(F)(F)F)c5)nc4s3)cc2)CC1,CHEMBL3959678,nM,10,CHEMBL6009,8,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)Nc5cccc(OC(F)(F)F)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)Nc5cccc(OC(F)(F)F)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745206,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,CHEMBL3932164,nM,25,CHEMBL6009,7.602059991,DGAT,CC(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,CC(C)c1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745207,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NC5(c6cc(F)ccc6F)CC5)nc4s3)cc2)CC1,CHEMBL3970724,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NC5(c6cc(F)ccc6F)CC5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NC5(c6cc(F)ccc6F)CC5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745208,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccc(OC(F)(F)F)cc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)sc2n1,CHEMBL3944627,nM,10,CHEMBL6009,8,DGAT,COc1ccc(OC(F)(F)F)cc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)sc2n1,COc1ccc(OC(F)(F)F)cc1CNC(=O)c1cn2cc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)sc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745209,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)cc5)nc4s3)cc2)CC1,CHEMBL3979987,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)cc5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)cc5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745210,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,CHEMBL3951034,nM,10,CHEMBL6009,8,DGAT,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,COc1ccc(CNC(=O)c2cn3cc(-c4ccc(C5CCC(CC(=O)O)CC5)cc4)sc3n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745211,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc6c(c5)OCO6)nc4s3)cc2)CC1,CHEMBL3894416,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc6c(c5)OCO6)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc6c(c5)OCO6)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745212,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(F)c(OC(F)(F)F)c5)nc4s3)cc2)CC1,CHEMBL3953719,nM,25,CHEMBL6009,7.602059991,DGAT,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(F)c(OC(F)(F)F)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(F)c(OC(F)(F)F)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745213,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)Nc5ccc(F)c(Cl)c5)nc4s3)cc2)CC1,CHEMBL3986701,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)Nc5ccc(F)c(Cl)c5)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)Nc5ccc(F)c(Cl)c5)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745214,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(Cl)cccc5Cl)nc4s3)cc2)CC1,CHEMBL3916966,nM,10,CHEMBL6009,8,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(Cl)cccc5Cl)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5c(Cl)cccc5Cl)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745215,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(F)cccc5Cl)nc4s3)cc2)CC1,CHEMBL3943944,nM,10,CHEMBL6009,8,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(F)cccc5Cl)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5c(F)cccc5Cl)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745216,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(F)cccc5F)nc4s3)cc2)CC1,CHEMBL3970069,nM,25,CHEMBL6009,7.602059991,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(F)cccc5F)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5c(F)cccc5F)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745217,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(F)cc(Cl)cc5F)nc4s3)cc2)CC1,CHEMBL3946463,nM,10,CHEMBL6009,8,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3cn4cc(C(=O)NCc5c(F)cc(Cl)cc5F)nc4s3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5c(F)cc(Cl)cc5F)nc4s3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745218,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)(C(=O)O)C1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccccc5)cn4c3)cc2)CC1,CHEMBL3958979,nM,10,CHEMBL6009,8,DGAT,CC(C)(C(=O)O)C1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccccc5)cn4c3)cc2)CC1,CC(C)(C(=O)O)C1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccccc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745219,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,CC(C)(C(=O)O)C1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,CHEMBL3955659,nM,10,CHEMBL6009,8,DGAT,CC(C)(C(=O)O)C1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,CC(C)(C(=O)O)C1CCC(c2ccc(-c3ccc4nc(C(=O)NCc5ccc(OC(F)(F)F)cc5)cn4c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17745220,CHEMBL3888061,"Inhibition Assay: Â Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2 and 0.04% bovine serum albumin (BSA)] containing 500 uM of enzyme substrate (didecanoyl glycerol) and 7.5 uM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid-coated radiometric assay plate. A small aliquot of cell lysate having human DGAT1 activity (5 ug/well) obtained in above, of human liver microsomes having human DGAT1 activity (5 ug/well), or of mouse liver microsomes having mouse DGAT1 activity (5 ug/well) was added to the assay plate to start the reaction, and the reaction was allowed to proceed for 60 minutes at 25° C. The reaction was terminated upon the addition of an equal volume (100 uL) of isopropanol. The plates were sealed, incubated overnight and counted the next morning on a liquid scintillation counter and luminometer.",B,Cc1cccc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(C(C)(C)C(=O)O)CC4)cc3)ccc2n1,CHEMBL3890019,nM,25,CHEMBL6009,7.602059991,DGAT,Cc1cccc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(C(C)(C)C(=O)O)CC4)cc3)ccc2n1,Cc1cccc(Cl)c1CNC(=O)c1cn2cc(-c3ccc(C4CCC(C(C)(C)C(=O)O)CC4)cc3)ccc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759036,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(CNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3901785,nM,1.76,CHEMBL6009,8.754487332,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(CNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(CNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759038,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3924320,nM,1.05,CHEMBL6009,8.978810701,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759040,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3896316,nM,0.54,CHEMBL6009,9.26760624,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759042,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3785201,nM,0.46,CHEMBL6009,9.337242168,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759044,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3930993,nM,2.29,CHEMBL6009,8.640164518,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759046,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCOCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3786507,nM,3.29,CHEMBL6009,8.482804102,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759048,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3987169,nM,37.3,CHEMBL6009,7.428291168,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759050,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,COCc1cn(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)nn1,CHEMBL3904903,nM,30.5,CHEMBL6009,7.515700161,DGAT,COCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,COCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759052,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,COCCOCCOCc1cn(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)nn1,CHEMBL3975698,nM,40.8,CHEMBL6009,7.389339837,DGAT,COCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,COCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759054,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,COCCOCCOCCOCCOCc1cn(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)nn1,CHEMBL1234976,nM,30.2,CHEMBL6009,7.519993057,DGAT,COCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,COCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759056,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,COCCOCCOCCOCCOCCOCCOCCOCCOCc1cn(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)nn1,CHEMBL3967216,nM,131,CHEMBL6009,6.882728704,DGAT,COCCOCCOCCOCCOCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,COCCOCCOCCOCCOCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759058,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCc1cn(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)nn1,CHEMBL3890469,nM,165.2,CHEMBL6009,6.781989957,DGAT,COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCc1cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759060,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCNc2ccccc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,CHEMBL3959542,nM,1.78,CHEMBL6009,8.749579998,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccccc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccccc2[N+](=O)[O-])nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759062,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCNc2ccc([N+](=O)[O-])cc2)nn1)C(=O)O)C(=O)O,CHEMBL3921693,nM,1.36,CHEMBL6009,8.866461092,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccc([N+](=O)[O-])cc2)nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccc([N+](=O)[O-])cc2)nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759064,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCNc2ccccc2)nn1)C(=O)O)C(=O)O,CHEMBL3897166,nM,16.6,CHEMBL6009,7.779891912,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccccc2)nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNc2ccccc2)nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759066,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,COc1ccc(NCCOCCOCc2cn(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)nn2)cc1,CHEMBL3976145,nM,21.9,CHEMBL6009,7.659555885,DGAT,COc1ccc(NCCOCCOCc2cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn2)cc1,COc1ccc(NCCOCCOCc2cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17759068,CHEMBL3888266,"PMSA Inhibition Assay: For IC50 measurements, inhibitors were dissolved in Reaction Buffer containing 40 μM NAAG to a final volume of 100 μL. Then, 25 μL of this solution was transferred to each of three wells in a microtiter plate, and 5 μL aliquots were serially diluted into 20 μL of solution containing 40 μM NAAG over 10 wells (5-fold dilutions). Inhibitor concentration therefore ranged over 6 orders of magnitude in these experiments. rhPSMA (20 ng/mL in Reaction Buffer, 20 μL, R&D Research) was then added to each well. The plate was incubated at room temperature for 15 min, and then heated to 95 °C. for 3 minutes. The plate was allowed to cool to room temperature, and glutamic acid levels were measured using a commercially available Amplex® − Red Glutamic Acid/Glutamate Oxidase Assay Kit (Invitrogen). Fluorescence intensities were measured using a Synergy 2 multiwell plate reader (Biotek), fitted with excitation and emission filters of 545 nm and 590 nm, respectively. Ki values were obtained from IC50 values using the Cheng-Prusoff equation, a substrate concentration of 20 μM, and a Km value of 0.925 μM.",B,O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCn1cc(COCCOCCNC2CCCCC2)nn1)C(=O)O)C(=O)O,CHEMBL3905383,nM,342.3,CHEMBL6009,6.465593101,DGAT,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNC2CCCCC2)nn1)C(=O)O)C(=O)O,O=C(O)CCC(NC(=O)NC(CCCCn1cc(COCCOCCNC2CCCCC2)nn1)C(=O)O)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760052,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CHEMBL3912448,nM,4.2,CHEMBL6009,8.37675071,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760053,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,CHEMBL3943341,nM,2.9,CHEMBL6009,8.537602002,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760054,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)cc2)ncc1-c1nc(C(F)(F)F)c[nH]1,CHEMBL3914389,nM,24,CHEMBL6009,7.619788758,DGAT,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)cc2)ncc1-c1nc(C(F)(F)F)c[nH]1,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)cc2)ncc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760055,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CHEMBL3898176,nM,25,CHEMBL6009,7.602059991,DGAT,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760056,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cn1,CHEMBL3971012,nM,5.2,CHEMBL6009,8.283996656,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760057,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)CCCOc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)cc1,CHEMBL3914151,nM,43,CHEMBL6009,7.366531544,DGAT,O=C(O)CCCOc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1,O=C(O)CCCOc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760058,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cn1)C(=O)O,CHEMBL3947594,nM,2.3,CHEMBL6009,8.638272164,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760059,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)CCCCOc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)cc1,CHEMBL3955944,nM,12,CHEMBL6009,7.920818754,DGAT,O=C(O)CCCCOc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1,O=C(O)CCCCOc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760060,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)C1(COc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cn2)CCCC1,CHEMBL3950644,nM,3.3,CHEMBL6009,8.48148606,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cn2)CCCC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cn2)CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760061,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CHEMBL3908438,nM,4,CHEMBL6009,8.397940009,DGAT,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760062,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)C1(COc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CCOCC1,CHEMBL3967059,nM,8.6,CHEMBL6009,8.065501549,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CCOCC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760063,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cn1)C(=O)O,CHEMBL3922835,nM,0.76,CHEMBL6009,9.119186408,DGAT,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760064,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)CCc1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)[nH]1,CHEMBL3890764,nM,21,CHEMBL6009,7.677780705,DGAT,CC(C)CCc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,CC(C)CCc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760065,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(CC4CC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3899741,nM,20,CHEMBL6009,7.698970004,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(CC4CC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(CC4CC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760066,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)c1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)[nH]1,CHEMBL3964857,nM,20,CHEMBL6009,7.698970004,DGAT,CCC(CC)c1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,CCC(CC)c1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760067,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4CCCCCC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3942302,nM,16,CHEMBL6009,7.795880017,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CCCCCC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CCCCCC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760068,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4CC(F)(F)C4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3954462,nM,14,CHEMBL6009,7.853871964,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CC(F)(F)C4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CC(F)(F)C4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760069,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)cc2)ncc1-c1ncc(C2(C(F)(F)F)CC2)[nH]1,CHEMBL3982450,nM,79.7,CHEMBL6009,7.098541679,DGAT,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)cc2)ncc1-c1nc(C2(C(F)(F)F)CC2)c[nH]1,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)cc2)ncc1-c1nc(C2(C(F)(F)F)CC2)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760070,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CC3)[nH]2)c(C)c1,CHEMBL3925154,nM,4.4,CHEMBL6009,8.356547324,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760071,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CC3)[nH]2)cc1,CHEMBL3969207,nM,0.63,CHEMBL6009,9.200659451,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760072,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CCC3)[nH]2)cc1,CHEMBL3974443,nM,2.6,CHEMBL6009,8.585026652,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760073,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1ncc(C2(C(F)(F)F)CCC2)[nH]1,CHEMBL3948342,nM,48,CHEMBL6009,7.318758763,DGAT,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C2(C(F)(F)F)CCC2)c[nH]1,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C2(C(F)(F)F)CCC2)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760074,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4(C(F)(F)F)CC4)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3909308,nM,2.4,CHEMBL6009,8.619788758,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)c(F)c2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760075,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(C)(C)C(F)(F)F)[nH]2)nc1,CHEMBL3900283,nM,11,CHEMBL6009,7.958607315,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760076,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C4(C(F)(F)F)CC4)[nH]3)cc2)cn1)C(=O)O,CHEMBL3923689,nM,31,CHEMBL6009,7.508638306,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)cc2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)cc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760077,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C4(C(F)(F)F)CC4)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3914659,nM,47,CHEMBL6009,7.327902142,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)c(F)c2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760078,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(C)(C)C(F)(F)F)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3942745,nM,13,CHEMBL6009,7.886056648,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760079,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,COC(=O)C(C)(C)COc1ccc(-c2ccc(-c3ncc(C4CCC4)[nH]3)cn2)cc1,CHEMBL3906452,nM,3.8,CHEMBL6009,8.420216403,DGAT,COC(=O)C(C)(C)COc1ccc(-c2ccc(-c3nc(C4CCC4)c[nH]3)cn2)cc1,COC(=O)C(C)(C)COc1ccc(-c2ccc(-c3nc(C4CCC4)c[nH]3)cn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760080,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(C)(C)C)[nH]3)cn2)cc1)C(=O)O,CHEMBL3894006,nM,16,CHEMBL6009,7.795880017,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(C)(C)C)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(C)(C)C)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760081,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)Cc1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)nc2)[nH]1,CHEMBL3959701,nM,2.4,CHEMBL6009,8.619788758,DGAT,CC(C)Cc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)nc2)n1,CC(C)Cc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)nc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760082,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,CHEMBL3978087,nM,4.2,CHEMBL6009,8.37675071,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760083,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,CHEMBL3969728,nM,1.2,CHEMBL6009,8.920818754,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760084,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)cc1)CC(=O)O,CHEMBL3931399,nM,2,CHEMBL6009,8.698970004,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)CC(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760085,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cc2)cn1)C(=O)O,CHEMBL3940438,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760086,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)C(F)(F)F)[nH]3)cn2)cc1)C(=O)O,CHEMBL3917023,nM,2.7,CHEMBL6009,8.568636236,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760087,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CC2)ccc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cn1,CHEMBL3926015,nM,13,CHEMBL6009,7.886056648,DGAT,Cc1cc(OCC2(C(=O)O)CC2)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC2(C(=O)O)CC2)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760088,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cc1,CHEMBL3951927,nM,2.1,CHEMBL6009,8.677780705,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760089,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)c(F)c1F)C(=O)O,CHEMBL3923853,nM,2.2,CHEMBL6009,8.657577319,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)c(F)c1F)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)c(F)c1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760090,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)c(C)c1,CHEMBL3929252,nM,0.78,CHEMBL6009,9.107905397,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760091,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cc2F)cn1)C(=O)O,CHEMBL3938297,nM,5.8,CHEMBL6009,8.236572006,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2F)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2F)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760092,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)c(C)c1,CHEMBL3963843,nM,12,CHEMBL6009,7.920818754,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760093,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cc1F)C(=O)O,CHEMBL3959186,nM,4.6,CHEMBL6009,8.337242168,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760094,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,CHEMBL3959785,nM,30,CHEMBL6009,7.522878745,DGAT,CCc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,CCc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760095,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nn2)cc1)C(=O)O,CHEMBL3964018,nM,32,CHEMBL6009,7.494850022,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760096,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(C(=O)O)c1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1,CHEMBL3935204,nM,5.3,CHEMBL6009,8.27572413,DGAT,CC(C)(C(=O)O)c1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1,CC(C)(C(=O)O)c1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760097,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3939904,nM,10,CHEMBL6009,8,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760098,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1)C(=O)O,CHEMBL3926765,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760099,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)cn1,CHEMBL3982315,nM,1.7,CHEMBL6009,8.769551079,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760100,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,CHEMBL3977515,nM,4.7,CHEMBL6009,8.327902142,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760101,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,CHEMBL3933893,nM,1.6,CHEMBL6009,8.795880017,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760102,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,CHEMBL3921484,nM,0.82,CHEMBL6009,9.086186148,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760103,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC(C)C)[nH]2)c(C)c1,CHEMBL3945930,nM,4.8,CHEMBL6009,8.318758763,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760104,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2cnc(OCC(C)(C)C(=O)O)nc2)ccc1-c1ncc(C(F)(F)F)[nH]1,CHEMBL3891949,nM,19,CHEMBL6009,7.721246399,DGAT,Cc1cc(-c2cnc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C(F)(F)F)c[nH]1,Cc1cc(-c2cnc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760105,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)c(F)c1,CHEMBL3929034,nM,1.4,CHEMBL6009,8.853871964,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760106,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC3CC3)[nH]2)c(C)c1,CHEMBL3934471,nM,2.2,CHEMBL6009,8.657577319,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760107,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C4(C(F)(F)F)CC4)[nH]3)cc2)cc1F)C(=O)O,CHEMBL3943448,nM,5.5,CHEMBL6009,8.259637311,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)cc2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)cc2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760108,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,[C-]#[N+]c1cc(-c2cnc(OCC(C)(C)C(=O)O)cc2C)ccc1-c1ncc(C(F)(F)F)[nH]1,CHEMBL3953308,nM,2.3,CHEMBL6009,8.638272164,DGAT,[C-]#[N+]c1cc(-c2cnc(OCC(C)(C)C(=O)O)cc2C)ccc1-c1nc(C(F)(F)F)c[nH]1,[C-]#[N+]c1cc(-c2cnc(OCC(C)(C)C(=O)O)cc2C)ccc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760109,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(C)(C)C(F)(F)F)[nH]2)c(F)c1,CHEMBL3924258,nM,4.5,CHEMBL6009,8.346787486,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760110,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC(C)C)[nH]2)nc1,CHEMBL3936748,nM,3.8,CHEMBL6009,8.420216403,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760111,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC(C)C)[nH]2)c(F)c1,CHEMBL3965300,nM,4.5,CHEMBL6009,8.346787486,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760112,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC3CC3)[nH]2)c(Cl)c1,CHEMBL3946724,nM,5.4,CHEMBL6009,8.26760624,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)c(Cl)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760113,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)c(C)c1,CHEMBL3890697,nM,3.5,CHEMBL6009,8.455931956,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760114,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)c(Cl)c1,CHEMBL3905268,nM,2.2,CHEMBL6009,8.657577319,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760115,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1cc(C)c(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cn1)C(=O)O,CHEMBL3985288,nM,2.6,CHEMBL6009,8.585026652,DGAT,CCC(CC)(COc1cc(C)c(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,CCC(CC)(COc1cc(C)c(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760116,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,COc1cc(-c2cnc(OCC(C)(C)C(=O)O)cc2C)ccc1-c1ncc(C(F)(F)F)[nH]1,CHEMBL3939069,nM,11,CHEMBL6009,7.958607315,DGAT,COc1cc(-c2cnc(OCC(C)(C)C(=O)O)cc2C)ccc1-c1nc(C(F)(F)F)c[nH]1,COc1cc(-c2cnc(OCC(C)(C)C(=O)O)cc2C)ccc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760117,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)c(C2CC2)c1,CHEMBL3930069,nM,39,CHEMBL6009,7.408935393,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(C2CC2)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(C2CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760118,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)c(F)c1,CHEMBL3957661,nM,1.6,CHEMBL6009,8.795880017,DGAT,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760119,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)c(Cl)c1,CHEMBL3898541,nM,1,CHEMBL6009,9,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760120,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)c(F)c1,CHEMBL3893124,nM,2,CHEMBL6009,8.698970004,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760121,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)c(Cl)c1,CHEMBL3920064,nM,3.5,CHEMBL6009,8.455931956,DGAT,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760122,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2cnc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3907566,nM,3.1,CHEMBL6009,8.508638306,DGAT,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760123,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(C)(C)C(F)(F)F)[nH]3)cc2)cc1F)C(=O)O,CHEMBL3934416,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)cc2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)cc2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760125,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)cn1,CHEMBL3915120,nM,3.5,CHEMBL6009,8.455931956,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760126,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(C)(C)C(F)(F)F)[nH]3)cn2)cc1)C(=O)O,CHEMBL3982370,nM,23,CHEMBL6009,7.638272164,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760127,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1F)C(=O)O,CHEMBL3981264,nM,2,CHEMBL6009,8.698970004,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1F)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760128,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4(C(F)(F)F)CC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3942391,nM,8.9,CHEMBL6009,8.050609993,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760129,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)ccc1OCC(C)(C)C(=O)O,CHEMBL3951118,nM,21,CHEMBL6009,7.677780705,DGAT,Cc1cc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)ccc1OCC(C)(C)C(=O)O,Cc1cc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)ccc1OCC(C)(C)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760130,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1nc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cn1,CHEMBL3899840,nM,9.1,CHEMBL6009,8.040958608,DGAT,Cc1nc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1nc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760131,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(CC(F)F)[nH]3)cn2)cc1)C(=O)O,CHEMBL3936969,nM,14,CHEMBL6009,7.853871964,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(CC(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(CC(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760132,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)C1(COc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CCC1,CHEMBL3920659,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CCC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760133,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)C1(COc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)nc3)cn2)CCCC1,CHEMBL3890288,nM,28,CHEMBL6009,7.552841969,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)nc3)cn2)CCCC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)nc3)cn2)CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760134,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(CCOc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)cc1)C(=O)O,CHEMBL3979626,nM,6.7,CHEMBL6009,8.173925197,DGAT,CC(C)(CCOc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(CCOc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760135,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)C1(COc2ccc(-c3ccc(-c4ncc(C(F)(F)F)[nH]4)cn3)cc2)CCCC1,CHEMBL3932855,nM,8.3,CHEMBL6009,8.080921908,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CCCC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760136,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)cn1)C(=O)O,CHEMBL3895784,nM,3.1,CHEMBL6009,8.508638306,DGAT,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cn1)C(=O)O,CCC(CC)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760137,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(CCC(F)(F)F)[nH]3)cn2)cc1)C(=O)O,CHEMBL3954010,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(CCC(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(CCC(F)(F)F)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760138,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)Cc1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)[nH]1,CHEMBL3959840,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)Cc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,CC(C)Cc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760139,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)c1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)[nH]1,CHEMBL3967461,nM,19,CHEMBL6009,7.721246399,DGAT,CC(C)c1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,CC(C)c1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760140,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(CCC4CC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3975974,nM,15,CHEMBL6009,7.823908741,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(CCC4CC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(CCC4CC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760141,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCCc1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)[nH]1,CHEMBL3917865,nM,11,CHEMBL6009,7.958607315,DGAT,CCCc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,CCCc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760142,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4CCC(F)(F)CC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3926823,nM,16,CHEMBL6009,7.795880017,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CCC(F)(F)CC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CCC(F)(F)CC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760143,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CC3)[nH]2)nc1,CHEMBL3912533,nM,5.4,CHEMBL6009,8.26760624,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760144,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1ncc(C2(C(F)(F)F)CC2)[nH]1,CHEMBL3949411,nM,36,CHEMBL6009,7.443697499,DGAT,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C2(C(F)(F)F)CC2)c[nH]1,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C2(C(F)(F)F)CC2)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760145,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(C)(C)C(F)(F)F)[nH]2)cc1,CHEMBL3941053,nM,3.7,CHEMBL6009,8.431798276,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760146,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CCC3)[nH]2)c(C)c1,CHEMBL3907035,nM,5.7,CHEMBL6009,8.244125144,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760147,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(C)(C)C(F)(F)F)[nH]2)c(C)c1,CHEMBL3923952,nM,26,CHEMBL6009,7.585026652,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(C)(C)C(F)(F)F)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760148,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CCC3)[nH]2)nc1,CHEMBL3976421,nM,11,CHEMBL6009,7.958607315,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760149,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C4(C(F)(F)F)CCC4)[nH]3)cc2)cn1)C(=O)O,CHEMBL3971415,nM,14,CHEMBL6009,7.853871964,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CCC4)c[nH]3)cc2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CCC4)c[nH]3)cc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760150,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C(C)(C)C(F)(F)F)[nH]3)cc2)cn1)C(=O)O,CHEMBL3947669,nM,47,CHEMBL6009,7.327902142,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C(C)(C)C(F)(F)F)c[nH]3)cc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760151,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CCC3)[nH]2)c(F)c1,CHEMBL3984478,nM,1.8,CHEMBL6009,8.744727495,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CCC3)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760152,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C3(C(F)(F)F)CC3)[nH]2)c(F)c1,CHEMBL3911336,nM,1.5,CHEMBL6009,8.823908741,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760153,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4CCCCC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3930933,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CCCCC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4CCCCC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760154,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCc1cnc(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)[nH]1,CHEMBL3922011,nM,17,CHEMBL6009,7.769551079,DGAT,CCc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,CCc1c[nH]c(-c2ccc(-c3ccc(OCC(C)(C)C(=O)O)cc3)nc2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760155,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CC1,CHEMBL3916523,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc(C(F)(F)F)c[nH]4)cn3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760156,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,CHEMBL3907562,nM,0.96,CHEMBL6009,9.017728767,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760157,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cn2)c(F)c1)C(=O)O,CHEMBL3963423,nM,2.7,CHEMBL6009,8.568636236,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)c(F)c1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cn2)c(F)c1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760158,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cn1)C(=O)O,CHEMBL3903422,nM,3.8,CHEMBL6009,8.420216403,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760159,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cc1)C(=O)O,CHEMBL3915914,nM,26,CHEMBL6009,7.585026652,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760160,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ccc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cn1,CHEMBL3986757,nM,8.1,CHEMBL6009,8.091514981,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC2(C(=O)O)CCC2)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760161,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cn1,CHEMBL3919429,nM,3.1,CHEMBL6009,8.508638306,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760162,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1nc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)cc1,CHEMBL3985953,nM,21,CHEMBL6009,7.677780705,DGAT,Cc1nc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1,Cc1nc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760163,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3951565,nM,1.5,CHEMBL6009,8.823908741,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760164,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1ncc(C(F)(F)F)[nH]1,CHEMBL3960273,nM,3.8,CHEMBL6009,8.420216403,DGAT,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C(F)(F)F)c[nH]1,Cc1cc(-c2ccc(OCC(C)(C)C(=O)O)nc2)ccc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760165,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2F)cn1)C(=O)O,CHEMBL3959521,nM,3.1,CHEMBL6009,8.508638306,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2F)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2F)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760166,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(Cl)c2)cc1F)C(=O)O,CHEMBL3976365,nM,3,CHEMBL6009,8.522878745,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(Cl)c2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(Cl)c2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760167,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2)cc1F)C(=O)O,CHEMBL3893712,nM,2,CHEMBL6009,8.698970004,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760168,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,COc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,CHEMBL3935788,nM,21,CHEMBL6009,7.677780705,DGAT,COc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,COc1cc(OCC(C)(C)C(=O)O)ccc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760169,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2ccc(-c3ncc(C4(C(F)(F)F)CCC4)[nH]3)cn2)cc1)C(=O)O,CHEMBL3923337,nM,5.8,CHEMBL6009,8.236572006,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc(C4(C(F)(F)F)CCC4)c[nH]3)cn2)cc1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc(C4(C(F)(F)F)CCC4)c[nH]3)cn2)cc1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760170,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)cc2)cc1F)C(=O)O,CHEMBL3914327,nM,0.87,CHEMBL6009,9.060480747,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760171,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cn1)C(=O)O,CHEMBL3908968,nM,23,CHEMBL6009,7.638272164,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760173,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC3CC3)[nH]2)c(F)c1,CHEMBL3943945,nM,3.1,CHEMBL6009,8.508638306,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760174,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,CHEMBL3913687,nM,0.75,CHEMBL6009,9.124938737,DGAT,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC2(C(=O)O)CCC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760175,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,CHEMBL3957934,nM,2.9,CHEMBL6009,8.537602002,DGAT,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760176,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C3(C(F)(F)F)CC3)[nH]2)c(C)c1,CHEMBL3949283,nM,74,CHEMBL6009,7.13076828,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)c(C)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C3(C(F)(F)F)CC3)c[nH]2)c(C)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760177,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC(C)C)[nH]2)cc1,CHEMBL3978456,nM,3.6,CHEMBL6009,8.443697499,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760178,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)nc2)cn1)C(=O)O,CHEMBL3960945,nM,75,CHEMBL6009,7.124938737,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)nc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760179,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC3CC3)[nH]2)cc1,CHEMBL3966083,nM,1.2,CHEMBL6009,8.920818754,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760180,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(-c2cnc(OCC(C)(C)C(=O)O)c(F)c2)ccc1-c1ncc(C(F)(F)F)[nH]1,CHEMBL3906507,nM,19,CHEMBL6009,7.721246399,DGAT,Cc1cc(-c2cnc(OCC(C)(C)C(=O)O)c(F)c2)ccc1-c1nc(C(F)(F)F)c[nH]1,Cc1cc(-c2cnc(OCC(C)(C)C(=O)O)c(F)c2)ccc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760181,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)c(Cl)c1,CHEMBL3919047,nM,1.3,CHEMBL6009,8.886056648,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760183,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)nc1,CHEMBL3951974,nM,3.5,CHEMBL6009,8.455931956,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760184,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC3CC3)[nH]2)nc1,CHEMBL3929798,nM,8.9,CHEMBL6009,8.050609993,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC3CC3)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760185,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(CC(C)C)[nH]2)c(Cl)c1,CHEMBL3937856,nM,1.8,CHEMBL6009,8.744727495,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)c(Cl)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(CC(C)C)c[nH]2)c(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760186,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)cc1,CHEMBL3946671,nM,3.4,CHEMBL6009,8.468521083,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)cc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760187,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)c(F)c1,CHEMBL3918770,nM,2.1,CHEMBL6009,8.677780705,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760188,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)nc1,CHEMBL3962002,nM,1.7,CHEMBL6009,8.769551079,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)nc1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760189,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1cnc(-c2ccc(-c3ncc(C4(C(F)(F)F)CC4)[nH]3)nc2)cn1)C(=O)O,CHEMBL3941585,nM,64,CHEMBL6009,7.193820026,DGAT,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)nc2)cn1)C(=O)O,CC(C)(COc1cnc(-c2ccc(-c3nc(C4(C(F)(F)F)CC4)c[nH]3)nc2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760190,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)c(C(F)(F)F)c1,CHEMBL3914531,nM,83,CHEMBL6009,7.080921908,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(C(F)(F)F)c1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)c(C(F)(F)F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760191,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2ncc(C(F)(F)F)[nH]2)nc1,CHEMBL3942239,nM,3.9,CHEMBL6009,8.408935393,DGAT,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1ccc(-c2nc(C(F)(F)F)c[nH]2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760192,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1cc(C)c(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3917489,nM,1.5,CHEMBL6009,8.823908741,DGAT,CCC(CC)(COc1cc(C)c(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,CCC(CC)(COc1cc(C)c(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760193,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1cnc(-c2ncc(C(F)(F)F)[nH]2)c(F)c1,CHEMBL3938083,nM,1.9,CHEMBL6009,8.721246399,DGAT,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Cc1cc(OCC2(C(=O)O)CC2)ncc1-c1cnc(-c2nc(C(F)(F)F)c[nH]2)c(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760194,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1cc(C)c(-c2cnc(-c3ncc(C(F)(F)F)[nH]3)c(F)c2)cn1)C(=O)O,CHEMBL3921131,nM,1.7,CHEMBL6009,8.769551079,DGAT,CCC(CC)(COc1cc(C)c(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,CCC(CC)(COc1cc(C)c(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)c(F)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760195,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CCC(CC)(COc1cc(C)c(-c2ccc(-c3ncc(C(F)(F)F)[nH]3)c(Cl)c2)cn1)C(=O)O,CHEMBL3944469,nM,2.1,CHEMBL6009,8.677780705,DGAT,CCC(CC)(COc1cc(C)c(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(Cl)c2)cn1)C(=O)O,CCC(CC)(COc1cc(C)c(-c2ccc(-c3nc(C(F)(F)F)c[nH]3)c(Cl)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760196,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ccc(-c2cnc(-c3ncc(C(F)(F)F)[nH]3)c(Cl)c2)cn1)C(=O)O,CHEMBL3935513,nM,7.6,CHEMBL6009,8.119186408,DGAT,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)c(Cl)c2)cn1)C(=O)O,CC(C)(COc1ccc(-c2cnc(-c3nc(C(F)(F)F)c[nH]3)c(Cl)c2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760197,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,CC(C)(COc1ncc(-c2ccc(-c3ncc(C4(C(F)(F)F)CCC4)[nH]3)cc2)cc1F)C(=O)O,CHEMBL3896545,nM,11,CHEMBL6009,7.958607315,DGAT,CC(C)(COc1ncc(-c2ccc(-c3nc(C4(C(F)(F)F)CCC4)c[nH]3)cc2)cc1F)C(=O)O,CC(C)(COc1ncc(-c2ccc(-c3nc(C4(C(F)(F)F)CCC4)c[nH]3)cc2)cc1F)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760198,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,COc1cc(-c2cnc(OCC3(C(=O)O)CCC3)cc2C)cnc1-c1ncc(C(F)(F)F)[nH]1,CHEMBL3919355,nM,8.3,CHEMBL6009,8.080921908,DGAT,COc1cc(-c2cnc(OCC3(C(=O)O)CCC3)cc2C)cnc1-c1nc(C(F)(F)F)c[nH]1,COc1cc(-c2cnc(OCC3(C(=O)O)CCC3)cc2C)cnc1-c1nc(C(F)(F)F)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17760199,CHEMBL3888275,"DGAT1 Inhibitory Assay: As a buffer to be used in the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH 7.4), 200 mM Sucrose, 20 mM MgCl2, 0.125% Bovine Serum Albumin (BSA) were used. To the buffer were added Test compound with a predetermined concentration as well as 15 μM dioleoylglycerol, 5 μM [14C]-palmitoyl-CoA, 100 μg protein/nth DGAT1 highly expressed-expresSF+® microsome, 0.75% acetone, and 1% dimethylsulfoxide, and triglyceride (TG) synthetic reaction was carried out at 30 °C. for 20 minutes with a volume of 100 μL. 90 μL of the reaction solution was added to 810 μL of methanol to stop the reaction. The reaction solution was added to Oasie® μElution plate (available from Waters Corporation), and eluted with 150 μL of a mixed solution of acetonitrile: isopropanol (=2:3). To elute was added 150 μL of MicroScinti™-40 (available from PerkinElmer Inc.), and after thoroughly stirring the mixture, a [14C]-TG amount formed by the reaction was quantitated by measuring the same using TopCount™-NXT (available from PerkinElmer Inc.).",B,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2ncc(C(F)(F)C(F)(F)F)[nH]2)cn1,CHEMBL3981667,nM,1.7,CHEMBL6009,8.769551079,DGAT,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)cn1,Cc1cc(OCC(C)(C)C(=O)O)ncc1-c1cnc(-c2nc(C(F)(F)C(F)(F)F)c[nH]2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762821,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,CCOc1ccc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)cc1,CHEMBL3917636,nM,50,CHEMBL6009,7.301029996,DGAT,CCOc1ccc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)cc1,CCOc1ccc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762822,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,CHEMBL3983896,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762823,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,CHEMBL3956166,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762824,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Cl)oc3C(F)(F)F)cc2)CC1,CHEMBL3928575,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Cl)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Cl)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762825,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,CHEMBL3957825,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3oc(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762826,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,Cc1ccc(-c2nc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)c(C(F)(F)F)o2)cc1,CHEMBL3933801,nM,100,CHEMBL6009,7,DGAT,Cc1ccc(-c2nc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)c(C(F)(F)F)o2)cc1,Cc1ccc(-c2nc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)c(C(F)(F)F)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762827,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,Cc1ccccc1-c1nc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)c(C(F)(F)F)o1,CHEMBL3949186,nM,100,CHEMBL6009,7,DGAT,Cc1ccccc1-c1nc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)c(C(F)(F)F)o1,Cc1ccccc1-c1nc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)c(C(F)(F)F)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762828,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C([O-])CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1.[Na+],CHEMBL3921370,nM,500,CHEMBL6009,6.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762829,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(Br)cc4)oc3C(F)(F)F)cc2)CC1,CHEMBL3943849,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(Br)cc4)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(Br)cc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762830,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,Cc1oc(-c2ccccc2)nc1C(=O)NCCC(=O)Nc1ccc(C2CCC(CC(=O)O)CC2)cc1,CHEMBL3929311,nM,100,CHEMBL6009,7,DGAT,Cc1oc(-c2ccccc2)nc1C(=O)NCCC(=O)Nc1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1oc(-c2ccccc2)nc1C(=O)NCCC(=O)Nc1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762831,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,Cc1nc(-c2ccccc2)sc1C(=O)NCCC(=O)Nc1ccc(C2CCC(CC(=O)O)CC2)cc1,CHEMBL3978017,nM,500,CHEMBL6009,6.301029996,DGAT,Cc1nc(-c2ccccc2)sc1C(=O)NCCC(=O)Nc1ccc(C2CCC(CC(=O)O)CC2)cc1,Cc1nc(-c2ccccc2)sc1C(=O)NCCC(=O)Nc1ccc(C2CCC(CC(=O)O)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762832,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3sc(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,CHEMBL3906924,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3sc(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3sc(-c4ccccc4)nc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762833,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,NC(=O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,CHEMBL3922460,nM,50,CHEMBL6009,7.301029996,DGAT,NC(=O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,NC(=O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762834,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,Cc1ccc(-n2cc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)c(C(F)(F)F)n2)cc1,CHEMBL3940394,nM,100,CHEMBL6009,7,DGAT,Cc1ccc(-n2cc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)c(C(F)(F)F)n2)cc1,Cc1ccc(-n2cc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)c(C(F)(F)F)n2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762835,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccc(Cl)cc4)nc3C(F)(F)F)cc2)CC1,CHEMBL3895567,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccc(Cl)cc4)nc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccc(Cl)cc4)nc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762836,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccccc4Cl)nc3C(F)(F)F)cc2)CC1,CHEMBL3923564,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccccc4Cl)nc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3cn(-c4ccccc4Cl)nc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762837,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(F)cc4)oc3C(F)(F)F)cc2)CC1,CHEMBL3946569,nM,500,CHEMBL6009,6.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(F)cc4)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(F)cc4)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762838,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(OCC4CC4)cc3)cc2)CC1,CHEMBL3935729,nM,500,CHEMBL6009,6.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(OCC4CC4)cc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(OCC4CC4)cc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762839,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4F)oc3C(F)(F)F)cc2)CC1,CHEMBL3910067,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4F)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4F)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762840,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(Cl)cc4Cl)oc3C(F)(F)F)cc2)CC1,CHEMBL3938005,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(Cl)cc4Cl)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccc(Cl)cc4Cl)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762841,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Br)oc3C(F)(F)F)cc2)CC1,CHEMBL3892432,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Br)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Br)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762842,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4C(F)(F)F)oc3C(F)(F)F)cc2)CC1,CHEMBL3946809,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4C(F)(F)F)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4C(F)(F)F)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762843,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(Cl)cccc4Cl)oc3C(F)(F)F)cc2)CC1,CHEMBL3924072,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(Cl)cccc4Cl)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(Cl)cccc4Cl)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762845,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(F)cccc4Cl)oc3C(F)(F)F)cc2)CC1,CHEMBL3898539,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(F)cccc4Cl)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(F)cccc4Cl)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762846,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,Cc1cccc(C)c1-c1ccc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)cc1,CHEMBL3969730,nM,100,CHEMBL6009,7,DGAT,Cc1cccc(C)c1-c1ccc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)cc1,Cc1cccc(C)c1-c1ccc(C(=O)NCCC(=O)Nc2ccc(C3CCC(CC(=O)O)CC3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762848,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(-c4ccccc4Cl)cc3)cc2)CC1,CHEMBL3952198,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(-c4ccccc4Cl)cc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(-c4ccccc4Cl)cc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762849,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3Cl)cc2)CC1,CHEMBL3982120,nM,100,CHEMBL6009,7,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3Cl)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4)oc3Cl)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762850,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,CCc1ccc(-c2ccc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2)cc1,CHEMBL3953390,nM,50,CHEMBL6009,7.301029996,DGAT,CCc1ccc(-c2ccc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2)cc1,CCc1ccc(-c2ccc(C(=O)NCCC(=O)Nc3ccc(C4CCC(CC(=O)O)CC4)cc3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762851,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(-c4ccccc4)c(Cl)c3)cc2)CC1,CHEMBL3893123,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(-c4ccccc4)c(Cl)c3)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3ccc(-c4ccccc4)c(Cl)c3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762852,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Cl)oc3Cl)cc2)CC1,CHEMBL3917409,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Cl)oc3Cl)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4ccccc4Cl)oc3Cl)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17762853,CHEMBL3888341,"Enzyme Inhibition Assay: Human DGAT-1 activity was determined as follows: Assay buffer [20 mM HEPES (pH 7.4), 100 mM MgCl2, 0.04% BSA] containing 500 μM of enzyme substrate (didecanoyl glycerol) and 7.5 μM radiolabeled acyl-CoA substrate ([14C]decanoyl-CoA) was added to each well of a phospholipid FlashPlate (PerkinElmer Life Sciences). A small aliquot of lysate (5 μg/well) or mouse liver microsome (0.1 mg/well) was added to start the reaction, which was allowed to proceed in a 20° C. bath for 1 hour. and maintained overnight at room temperature. Next day, measurement was performed by Wallac 1450 Microbeta Trilux Liquid Scintillation Counter and Luminometer (PerkinElmer Life Science). In the control group, 0.1% DMSO was only added, and for the background value, 0.1% DMSO was only added without the cell fragment having the over-expressed human DGAT1 (5 μg/well) or the liver microsome of mice (0.1 mg/well), which was the same as the control group.",B,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(Cl)cc(F)cc4Cl)oc3C(F)(F)F)cc2)CC1,CHEMBL3906305,nM,50,CHEMBL6009,7.301029996,DGAT,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(Cl)cc(F)cc4Cl)oc3C(F)(F)F)cc2)CC1,O=C(O)CC1CCC(c2ccc(NC(=O)CCNC(=O)c3nc(-c4c(Cl)cc(F)cc4Cl)oc3C(F)(F)F)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073804,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,COc1ccc(-c2nnc(-c3ccc4nc(-c5c(C)cc(CC(C)(C)C(=O)O)cc5C)[nH]c4c3)o2)cc1,CHEMBL4074410,nM,17,CHEMBL6009,7.769551079,DGAT,COc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(C)cc(CC(C)(C)C(=O)O)cc5C)nc4c3)o2)cc1,COc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(C)cc(CC(C)(C)C(=O)O)cc5C)nc4c3)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073805,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,COc1ccc(-c2nnc(-c3ccc4nc(-c5c(C)cc(CCC(=O)O)cc5C)[nH]c4c3)o2)cc1,CHEMBL4061308,nM,10,CHEMBL6009,8,DGAT,COc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(C)cc(CCC(=O)O)cc5C)nc4c3)o2)cc1,COc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(C)cc(CCC(=O)O)cc5C)nc4c3)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073806,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,Cc1cc(CC(C)(C)C(=O)O)cc(C)c1-c1nc2ccc(C(=O)Nc3ccc4ccccc4n3)cc2[nH]1,CHEMBL4088335,nM,32,CHEMBL6009,7.494850022,DGAT,Cc1cc(CC(C)(C)C(=O)O)cc(C)c1-c1nc2cc(C(=O)N=c3ccc4ccccc4[nH]3)ccc2[nH]1,Cc1cc(CC(C)(C)C(=O)O)cc(C)c1-c1nc2cc(C(=O)N=c3ccc4ccccc4[nH]3)ccc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073807,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,Cc1cc(CCC(=O)O)cc(C)c1-c1nc2ccc(C(=O)Nc3ccc4ccccc4n3)cc2[nH]1,CHEMBL1683001,nM,14,CHEMBL6009,7.853871964,DGAT,Cc1cc(CCC(=O)O)cc(C)c1-c1nc2cc(C(=O)N=c3ccc4ccccc4[nH]3)ccc2[nH]1,Cc1cc(CCC(=O)O)cc(C)c1-c1nc2cc(C(=O)N=c3ccc4ccccc4[nH]3)ccc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073808,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,COc1ccc(-c2nnc(-c3ccc4nc(-c5c(Cl)cccc5Cl)[nH]c4c3)o2)cc1,CHEMBL4103025,nM,23,CHEMBL6009,7.638272164,DGAT,COc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(Cl)cccc5Cl)nc4c3)o2)cc1,COc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(Cl)cccc5Cl)nc4c3)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073809,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,Clc1ccc(-c2nnc(-c3ccc4nc(-c5c(Cl)cccc5Cl)[nH]c4c3)o2)cc1,CHEMBL4062866,nM,47,CHEMBL6009,7.327902142,DGAT,Clc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(Cl)cccc5Cl)nc4c3)o2)cc1,Clc1ccc(-c2nnc(-c3ccc4[nH]c(-c5c(Cl)cccc5Cl)nc4c3)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073810,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,Clc1ccc(-c2cnc(-c3ccc4nc(-c5c(Cl)cccc5Cl)[nH]c4c3)o2)cc1,CHEMBL4060245,nM,132,CHEMBL6009,6.879426069,DGAT,Clc1ccc(-c2cnc(-c3ccc4[nH]c(-c5c(Cl)cccc5Cl)nc4c3)o2)cc1,Clc1ccc(-c2cnc(-c3ccc4[nH]c(-c5c(Cl)cccc5Cl)nc4c3)o2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18073811,CHEMBL4015894,Inhibition of recombinant human His6-tagged DGAT1 expressed in Sf9 insect cell membranes assessed as inhibition of triglyceride formation using diolein/oleyl-CoA as substrate after 30 mins by LC/MS/MS analysis,B,O=C(Nc1ccc(Cl)cc1)c1ccc2nc(-c3c(Cl)cccc3Cl)[nH]c2c1,CHEMBL4088473,nM,280,CHEMBL6009,6.552841969,DGAT,O=C(Nc1ccc(Cl)cc1)c1ccc2[nH]c(-c3c(Cl)cccc3Cl)nc2c1,O=C(Nc1ccc(Cl)cc1)c1ccc2[nH]c(-c3c(Cl)cccc3Cl)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205696,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1,CHEMBL4099177,nM,23.4,CHEMBL6009,7.630784143,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205699,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N3CCC[C@@H]3C(=O)O)nc2)cc1,CHEMBL4084613,nM,39.9,CHEMBL6009,7.399027104,DGAT,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205701,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1)Nc1ccccc1C(F)(F)F,CHEMBL4102892,nM,59.2,CHEMBL6009,7.227678293,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1ccccc1C(F)(F)F,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1ccccc1C(F)(F)F,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205702,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1)Nc1cccc(C(F)(F)F)c1,CHEMBL4092694,nM,3.5,CHEMBL6009,8.455931956,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1cccc(C(F)(F)F)c1,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1cccc(C(F)(F)F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205703,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1)Nc1ccc(C(F)(F)F)cc1,CHEMBL4065011,nM,30.3,CHEMBL6009,7.518557371,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1ccc(C(F)(F)F)cc1,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1ccc(C(F)(F)F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205704,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,COc1ccccc1NC(=O)Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1,CHEMBL4066063,nM,15.9,CHEMBL6009,7.798602876,DGAT,COc1ccccc1NC(=O)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,COc1ccccc1NC(=O)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205705,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,COc1cccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N4CCC[C@H]4C(=O)O)nc3)cc2)c1,CHEMBL4087443,nM,32.1,CHEMBL6009,7.493494968,DGAT,COc1cccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N4CCCC4C(=O)O)nc3)cc2)c1,COc1cccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N4CCCC4C(=O)O)nc3)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205706,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N4CCC[C@H]4C(=O)O)nc3)cc2)cc1,CHEMBL4074675,nM,18.4,CHEMBL6009,7.735182177,DGAT,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N4CCCC4C(=O)O)nc3)cc2)cc1,COc1ccc(NC(=O)Nc2ccc(-c3ccc(C(=O)N4CCCC4C(=O)O)nc3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205707,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1)Nc1ccccc1Cl,CHEMBL4095138,nM,8.5,CHEMBL6009,8.070581074,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1ccccc1Cl,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1ccccc1Cl,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205708,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1)Nc1cccc(Cl)c1,CHEMBL4096065,nM,3.7,CHEMBL6009,8.431798276,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1cccc(Cl)c1,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1cccc(Cl)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205709,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1,CHEMBL4068759,nM,8.8,CHEMBL6009,8.055517328,DGAT,O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,O=C(Nc1ccc(Cl)cc1)Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18205710,CHEMBL4044623,"Inhibition of recombinant full length human DGAT1 expressed in Sf9 insect cells using 1,2-didecanoyl-sn-glycerol as substrate after 60 mins in presence of palmitoyl-1-14C coenzyme A by scintillation counting",B,O=C(Nc1ccc(-c2ccc(C(=O)N3CCC[C@H]3C(=O)O)nc2)cc1)Nc1cccc(F)c1,CHEMBL4075629,nM,37.7,CHEMBL6009,7.42365865,DGAT,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1cccc(F)c1,O=C(Nc1ccc(-c2ccc(C(=O)N3CCCC3C(=O)O)nc2)cc1)Nc1cccc(F)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231398,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC(c5ccccn5)CC4)nc3)nc2c1,CHEMBL4073652,nM,62,CHEMBL6009,7.207608311,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC(c5ccccn5)CC4)nc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC(c5ccccn5)CC4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231399,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,N#Cc1ccc(N2C(=O)NC3(CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C2=O)cc1,CHEMBL4083438,nM,377,CHEMBL6009,6.42365865,DGAT,N#Cc1ccc(N2C(=O)NC3(CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C2=O)cc1,N#Cc1ccc(N2C(=O)NC3(CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231400,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)O2,CHEMBL4102164,nM,137,CHEMBL6009,6.863279433,DGAT,CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)O2,CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)O2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231401,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(C4CC4)c4ccccc45)nc3)nc2c1,CHEMBL4064025,nM,643,CHEMBL6009,6.191789027,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(C4CC4)c4ccccc45)nc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(C4CC4)c4ccccc45)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231402,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,OC(c1cccnc1)C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4091789,nM,74,CHEMBL6009,7.13076828,DGAT,OC(c1cccnc1)C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,OC(c1cccnc1)C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231403,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Cc1nc2c(cc1Cl)C(C(C)(C)c1ncnn1C)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4084523,nM,5136,CHEMBL6009,5.289374985,DGAT,Cc1nc2c(cc1Cl)C(C(C)(C)c1ncnn1C)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Cc1nc2c(cc1Cl)C(C(C)(C)c1ncnn1C)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231404,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1Nc2ccccc2C2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,CHEMBL4102481,nM,301,CHEMBL6009,6.521433504,DGAT,O=C1Nc2ccccc2C2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,O=C1Nc2ccccc2C2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231405,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,CC(C)CC1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,CHEMBL4074225,nM,7036,CHEMBL6009,5.152674169,DGAT,CC(C)CC1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,CC(C)CC1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231406,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=S1(=O)CCC(N2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,CHEMBL4094731,nM,131,CHEMBL6009,6.882728704,DGAT,O=S1(=O)CCC(N2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,O=S1(=O)CCC(N2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231407,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC(c5ccccc5)(c5ccccc5)CC4)nc3)nc2c1,CHEMBL4065604,nM,1642,CHEMBL6009,5.784626847,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC(c5ccccc5)(c5ccccc5)CC4)nc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC(c5ccccc5)(c5ccccc5)CC4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231408,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,COc1ccc2[nH]cc(C3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)c2c1,CHEMBL4087031,nM,2957,CHEMBL6009,5.529148675,DGAT,COc1ccc2[nH]cc(C3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)c2c1,COc1ccc2[nH]cc(C3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)c2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231409,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1Cc1ccc(F)cc1,CHEMBL4103424,nM,330,CHEMBL6009,6.48148606,DGAT,O=C1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1Cc1ccc(F)cc1,O=C1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1Cc1ccc(F)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231410,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Cc1cc2c(cc1Cl)C1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)OC2C(C)(C)C#N,CHEMBL4079170,nM,2200,CHEMBL6009,5.657577319,DGAT,Cc1cc2c(cc1Cl)C1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)OC2C(C)(C)C#N,Cc1cc2c(cc1Cl)C1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)OC2C(C)(C)C#N,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231411,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(Cc4ccccc4)c4ccccc45)nc3)nc2c1,CHEMBL4095661,nM,7543,CHEMBL6009,5.122455892,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(Cc4ccccc4)c4ccccc45)nc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(Cc4ccccc4)c4ccccc45)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231412,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Cc1cc2c(cc1Cl)C1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)OC2(C)C(C)(C)C#N,CHEMBL4068306,nM,3775,CHEMBL6009,5.423083044,DGAT,Cc1cc2c(cc1Cl)C1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)OC2(C)C(C)(C)C#N,Cc1cc2c(cc1Cl)C1(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC1)OC2(C)C(C)(C)C#N,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231413,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Fc1ccccc1CC1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,CHEMBL4072505,nM,6584,CHEMBL6009,5.181510178,DGAT,Fc1ccccc1CC1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,Fc1ccccc1CC1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231414,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,CS(=O)(=O)C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4099424,nM,216,CHEMBL6009,6.665546249,DGAT,CS(=O)(=O)C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CS(=O)(=O)C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231415,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1NCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,CHEMBL4078557,nM,697,CHEMBL6009,6.156767222,DGAT,O=C1NCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,O=C1NCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231416,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CN1c1ccccc1,CHEMBL4102837,nM,1407,CHEMBL6009,5.851705903,DGAT,O=C1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CN1c1ccccc1,O=C1OC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CN1c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231417,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,CS(=O)(=O)N1CC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,CHEMBL4067662,nM,68,CHEMBL6009,7.167491087,DGAT,CS(=O)(=O)N1CC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,CS(=O)(=O)N1CC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)c2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231418,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,CC(=O)NC1(c2ccccc2)CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL4095073,nM,151,CHEMBL6009,6.821023053,DGAT,CC(=O)NC1(c2ccccc2)CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CC(=O)NC1(c2ccccc2)CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231419,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1C=C(c2ccccc2)C2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,CHEMBL4094175,nM,966,CHEMBL6009,6.015022874,DGAT,O=C1C=C(c2ccccc2)C2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,O=C1C=C(c2ccccc2)C2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231420,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,OCCC1(c2ccccc2)CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4073542,nM,95,CHEMBL6009,7.022276395,DGAT,OCCC1(c2ccccc2)CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,OCCC1(c2ccccc2)CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231421,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CCC1(C2CCCCC2)CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4086411,nM,207,CHEMBL6009,6.684029655,DGAT,O=C(O)CCC1(C2CCCCC2)CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,O=C(O)CCC1(C2CCCCC2)CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231422,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Fc1cccc(CC2OC3(CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)c3ccccc32)c1,CHEMBL4064949,nM,4249,CHEMBL6009,5.371713269,DGAT,Fc1cccc(CC2OC3(CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)c3ccccc32)c1,Fc1cccc(CC2OC3(CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)c3ccccc32)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231423,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(Cc4cc(Cl)cc(Cl)c4)c4ccccc45)nc3)nc2c1,CHEMBL4076449,nM,8704,CHEMBL6009,5.060281118,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(Cc4cc(Cl)cc(Cl)c4)c4ccccc45)nc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OC(Cc4cc(Cl)cc(Cl)c4)c4ccccc45)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231424,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)C1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,CHEMBL4088615,nM,17,CHEMBL6009,7.769551079,DGAT,O=C(O)C1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,O=C(O)C1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231425,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CC1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,CHEMBL4100640,nM,6,CHEMBL6009,8.22184875,DGAT,O=C(O)CC1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,O=C(O)CC1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231426,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CCC1CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL4073839,nM,36,CHEMBL6009,7.443697499,DGAT,O=C(O)CCC1CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)CCC1CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231427,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)C1CC2(CCN(C3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC2)Oc2ccccc21,CHEMBL4075548,nM,6,CHEMBL6009,8.22184875,DGAT,O=C(O)C1CC2(CCN(C3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC2)Oc2ccccc21,O=C(O)C1CC2(CCN(C3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC2)Oc2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231428,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Cc1ccc2c(c1)C(CC(=O)O)CC21CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL4084190,nM,25,CHEMBL6009,7.602059991,DGAT,Cc1ccc2c(c1)C(CC(=O)O)CC21CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Cc1ccc2c(c1)C(CC(=O)O)CC21CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231429,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CCC1(c2ccc(Cl)cc2)CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL4071125,nM,29,CHEMBL6009,7.537602002,DGAT,O=C(O)CCC1(c2ccc(Cl)cc2)CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)CCC1(c2ccc(Cl)cc2)CCN(C2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231430,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)c1ccc2c(c1)C(=O)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4091946,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(O)c1ccc2c(c1)C(=O)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,O=C(O)c1ccc2c(c1)C(=O)OC21CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231431,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2ncccc21,CHEMBL4081676,nM,10,CHEMBL6009,8,DGAT,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2ncccc21,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2ncccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231432,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Clc1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OCc4ccccc45)nc3)nc2c1,CHEMBL4099685,nM,137,CHEMBL6009,6.863279433,DGAT,Clc1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OCc4ccccc45)nc3)nc2c1,Clc1ccc2[nH]c(-c3ccc(N4CCC5(CC4)OCc4ccccc45)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231434,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2cnccc21,CHEMBL4063213,nM,66,CHEMBL6009,7.180456064,DGAT,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2cnccc21,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2cnccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231438,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Clc1ccc2[nH]c(-c3ccc(N4C[C@@H]5C[C@H]4CN5c4ccccc4)nc3)nc2c1,CHEMBL4068070,nM,10000,CHEMBL6009,5,DGAT,Clc1ccc2[nH]c(-c3ccc(N4C[C@@H]5C[C@H]4CN5c4ccccc4)nc3)nc2c1,Clc1ccc2[nH]c(-c3ccc(N4CC5CC4CN5c4ccccc4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231439,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2ccccc21,CHEMBL4087759,nM,52,CHEMBL6009,7.283996656,DGAT,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2ccccc21,O=C1OC2(CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)c2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231440,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,Cc1cccc(Cl)c1NC(=O)N1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4094276,nM,89,CHEMBL6009,7.050609993,DGAT,Cc1cccc(Cl)c1NC(=O)N1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Cc1cccc(Cl)c1NC(=O)N1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231441,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=c1[nH]c2ncccc2n1C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4065065,nM,102,CHEMBL6009,6.991399828,DGAT,O=c1[nH]c2ncccc2n1C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,O=c1[nH]c2ncccc2n1C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231442,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)[C@@H]1CCCC[C@H]1C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,CHEMBL4086509,nM,29,CHEMBL6009,7.537602002,DGAT,O=C(O)C1CCCC[C@H]1C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,O=C(O)C1CCCCC1C1CCN(c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231443,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CN1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,CHEMBL4105361,nM,10000,CHEMBL6009,5,DGAT,O=C(O)CN1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,O=C(O)CN1CCC2(CC1)CCN(c1ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cn1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231444,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CO1,CHEMBL4067085,nM,364,CHEMBL6009,6.438898616,DGAT,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CO1,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CO1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231445,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,CHEMBL4069786,nM,19,CHEMBL6009,7.721246399,DGAT,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,O=C(O)C1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231446,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CC1CCOC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,CHEMBL4075203,nM,73,CHEMBL6009,7.13667714,DGAT,O=C(O)CC1CCOC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,O=C(O)CC1CCOC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231447,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,CHEMBL4060355,nM,33,CHEMBL6009,7.48148606,DGAT,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)OC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231448,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,CHEMBL4082282,nM,23,CHEMBL6009,7.638272164,DGAT,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,O=C(O)CC1CCC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)O1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231449,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)CC1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,CHEMBL4087688,nM,10,CHEMBL6009,8,DGAT,O=C(O)CC1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,O=C(O)CC1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231450,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)C[C@@H]1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,CHEMBL4066339,nM,18,CHEMBL6009,7.744727495,DGAT,O=C(O)C[C@@H]1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,O=C(O)CC1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18231451,CHEMBL4050156,Inhibition of human DGAT1 expressed in yeast membrane fraction assessed as inhibition of triglyceride formation using diolein/oleoyl-CoA as substrate measured after 1 hr by 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin based fluorescence analysis,B,O=C(O)C[C@H]1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,CHEMBL4079801,nM,19,CHEMBL6009,7.721246399,DGAT,O=C(O)C[C@H]1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,O=C(O)CC1COC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18234939,CHEMBL4050982,Inhibition of DGAT1 (unknown origin) by HTS assay,B,O=C(O)C1CC2(CCN(c3ccc(-c4nc5ccc(C(F)(F)F)cc5[nH]4)cn3)CC2)Oc2ccccc21,CHEMBL4085865,nM,6,CHEMBL6009,8.22184875,DGAT,O=C(O)C1CC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)Oc2ccccc21,O=C(O)C1CC2(CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)Oc2ccccc21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289476,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc([C@@H]2Oc3c(N)ncnc3OC2(C)C)cc1)CC(=O)O,CHEMBL4129284,nM,1929,CHEMBL6009,5.714667772,DGAT,CC(C)(C#Cc1ccc([C@@H]2Oc3c([nH]cnc3=N)OC2(C)C)cc1)CC(=O)O,CC(C)(C#Cc1ccc(C2Oc3c([nH]cnc3=N)OC2(C)C)cc1)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289477,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(C2Nc3c(N)ncnc3OC2(C)C)cc1)CC(=O)O,CHEMBL4129119,nM,5502,CHEMBL6009,5.259479414,DGAT,CC(C)(C#Cc1ccc(C2Nc3c([nH]cnc3=N)OC2(C)C)cc1)CC(=O)O,CC(C)(C#Cc1ccc(C2Nc3c([nH]cnc3=N)OC2(C)C)cc1)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289478,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(C2=Nc3c(N)ncnc3OC2(C)C)cc1)CC(=O)O,CHEMBL4127767,nM,429,CHEMBL6009,6.367542708,DGAT,CC(C)(C#Cc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1)CC(=O)O,CC(C)(C#Cc1ccc(C2=Nc3c([nH]cnc3=N)OC2(C)C)cc1)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289481,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(-c2ccc(Nc3ccc(C(F)(F)F)nc3)cn2)cc1)CC(=O)O,CHEMBL4129506,nM,468,CHEMBL6009,6.329754147,DGAT,CC(C)(C#Cc1ccc(-c2ccc(Nc3ccc(C(F)(F)F)nc3)cn2)cc1)CC(=O)O,CC(C)(C#Cc1ccc(-c2ccc(Nc3ccc(C(F)(F)F)nc3)cn2)cc1)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289494,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,Cc1cc(N2CCOc3ncnc(N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,CHEMBL4128291,nM,55,CHEMBL6009,7.259637311,DGAT,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289504,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(N2CCOc3ncnc(N)c3C2=O)cc1)CC(=O)O,CHEMBL4130328,nM,281,CHEMBL6009,6.55129368,DGAT,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1)CC(=O)O,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289527,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,Cc1cc(C#CC(C)(C)CC(=O)O)ccc1N1CCOc2ncnc(N)c2C1=O,CHEMBL4128377,nM,1241,CHEMBL6009,5.906228219,DGAT,Cc1cc(C#CC(C)(C)CC(=O)O)ccc1N1CCOc2[nH]cnc(=N)c2C1=O,Cc1cc(C#CC(C)(C)CC(=O)O)ccc1N1CCOc2[nH]cnc(=N)c2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289528,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(N2CCOc3ncnc(N)c3C2=O)cc1F)CC(=O)O,CHEMBL4129520,nM,74,CHEMBL6009,7.13076828,DGAT,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1F)CC(=O)O,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1F)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289529,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(N2CCOc3ncnc(N)c3C2=O)cc1Cl)CC(=O)O,CHEMBL4128144,nM,94,CHEMBL6009,7.026872146,DGAT,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1Cl)CC(=O)O,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1Cl)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289530,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,Cc1cc(N2CCOc3ncnc(N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,CHEMBL4126331,nM,21,CHEMBL6009,7.677780705,DGAT,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289532,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(N2CCOc3ncnc(N)c3C2=O)cc1OC(F)(F)F)CC(=O)O,CHEMBL4126431,nM,44,CHEMBL6009,7.356547324,DGAT,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1OC(F)(F)F)CC(=O)O,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1OC(F)(F)F)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289533,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,COc1cc(N2CCOc3ncnc(N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,CHEMBL4130041,nM,387,CHEMBL6009,6.412289035,DGAT,COc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,COc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289535,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1ccc(N2CCOc3ncnc(N)c3C2=O)cc1C(F)(F)F)CC(=O)O,CHEMBL4128918,nM,30,CHEMBL6009,7.522878745,DGAT,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1C(F)(F)F)CC(=O)O,CC(C)(C#Cc1ccc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1C(F)(F)F)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289536,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,Cc1cc(N2CCOc3ncnc(N)c3C2=O)cc(Cl)c1C#CC(C)(C)CC(=O)O,CHEMBL4127235,nM,25,CHEMBL6009,7.602059991,DGAT,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(Cl)c1C#CC(C)(C)CC(=O)O,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(Cl)c1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289537,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CCc1cc(N2CCOc3ncnc(N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,CHEMBL4126176,nM,21,CHEMBL6009,7.677780705,DGAT,CCc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,CCc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289538,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CCc1cc(N2CCOc3ncnc(N)c3C2=O)cc(CC)c1C#CC(C)(C)CC(=O)O,CHEMBL4129633,nM,15,CHEMBL6009,7.823908741,DGAT,CCc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(CC)c1C#CC(C)(C)CC(=O)O,CCc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(CC)c1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289539,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CCc1cc(N2CCOc3ncnc(N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,CHEMBL4126345,nM,210,CHEMBL6009,6.677780705,DGAT,CCc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,CCc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)ccc1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289540,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(C)(C#Cc1c(Cl)cc(N2CCOc3ncnc(N)c3C2=O)cc1Cl)CC(=O)O,CHEMBL4130032,nM,14,CHEMBL6009,7.853871964,DGAT,CC(C)(C#Cc1c(Cl)cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1Cl)CC(=O)O,CC(C)(C#Cc1c(Cl)cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc1Cl)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289541,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,Cc1cc(N2CCOc3ncnc(N)c3C2=O)cc(F)c1C#CC(C)(C)CC(=O)O,CHEMBL4128662,nM,35,CHEMBL6009,7.455931956,DGAT,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(F)c1C#CC(C)(C)CC(=O)O,Cc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(F)c1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289542,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,COc1cc(N2CCOc3ncnc(N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,CHEMBL4128819,nM,120,CHEMBL6009,6.920818754,DGAT,COc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,COc1cc(N2CCOc3[nH]cnc(=N)c3C2=O)cc(C)c1C#CC(C)(C)CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18289543,CHEMBL4122228,Inhibition of human DGAT1 expressed in insect cell membranes using diacylglycerol/[14C]-oleoyl-CoA as substrate preincubated for 10 mins followed by [14C]-oleoyl-CoA addition measured after 15 mins by scintillation counting method,B,CC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL4126883,nM,32,CHEMBL6009,7.494850022,DGAT,CC(=O)C[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(=O)CC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377195,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,O=C(O)CC1CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CHEMBL4159638,nM,2820,CHEMBL6009,5.549750892,DGAT,O=C(O)CC1CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,O=C(O)CC1CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377196,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CHEMBL4171021,nM,126,CHEMBL6009,6.899629455,DGAT,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377197,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CHEMBL4162124,nM,63,CHEMBL6009,7.200659451,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377198,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CHEMBL4172800,nM,16,CHEMBL6009,7.795880017,DGAT,CCCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CCCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377199,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,O=C(O)CC1(CC(F)(F)F)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,CHEMBL4176181,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(O)CC1(CC(F)(F)F)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,O=C(O)CC1(CC(F)(F)F)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377200,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CHEMBL4168991,nM,3,CHEMBL6009,8.522878745,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377201,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)ccc2C1=O,CHEMBL4161067,nM,16,CHEMBL6009,7.795880017,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377202,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2C1=O,CHEMBL4172357,nM,6,CHEMBL6009,8.22184875,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377203,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(OC)c4)cc3)ccc2C1=O,CHEMBL4164478,nM,50,CHEMBL6009,7.301029996,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(OC)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(OC)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377204,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)ccc2C1=O,CHEMBL4175767,nM,32,CHEMBL6009,7.494850022,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377205,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)ccc2C1=O,CHEMBL4167907,nM,20,CHEMBL6009,7.698970004,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377206,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,CHEMBL4163300,nM,2,CHEMBL6009,8.698970004,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377207,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(C)cc4)cc3)ccc2C1=O,CHEMBL4171202,nM,10,CHEMBL6009,8,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(C)cc4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(C)cc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377208,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)ccc2C1=O,CHEMBL4159930,nM,126,CHEMBL6009,6.899629455,DGAT,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377209,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CHEMBL4167845,nM,32,CHEMBL6009,7.494850022,DGAT,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377210,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,Cc1cccc(NC(=O)Nc2ccc(-c3ccc4c(c3)CCC(C)(CC(=O)O)C4=O)cc2)c1,CHEMBL4170153,nM,63,CHEMBL6009,7.200659451,DGAT,Cc1cccc(NC(=O)Nc2ccc(-c3ccc4c(c3)CCC(C)(CC(=O)O)C4=O)cc2)c1,Cc1cccc(NC(=O)Nc2ccc(-c3ccc4c(c3)CCC(C)(CC(=O)O)C4=O)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377211,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2C1=O,CHEMBL4159532,nM,16,CHEMBL6009,7.795880017,DGAT,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2C1=O,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377212,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,COc1cccc(NC(=O)Nc2ccc(-c3ccc4c(c3)CCC(C)(CC(=O)O)C4=O)cc2)c1,CHEMBL4166743,nM,200,CHEMBL6009,6.698970004,DGAT,COc1cccc(NC(=O)Nc2ccc(-c3ccc4c(c3)CCC(C)(CC(=O)O)C4=O)cc2)c1,COc1cccc(NC(=O)Nc2ccc(-c3ccc4c(c3)CCC(C)(CC(=O)O)C4=O)cc2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377213,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)ccc2C1=O,CHEMBL4174644,nM,63,CHEMBL6009,7.200659451,DGAT,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)ccc2C1=O,CC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377214,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CHEMBL4176968,nM,2.5,CHEMBL6009,8.602059991,DGAT,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377215,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC[C@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CHEMBL4166344,nM,126,CHEMBL6009,6.899629455,DGAT,CC[C@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377216,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,CHEMBL4174767,nM,2,CHEMBL6009,8.698970004,DGAT,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377217,CHEMBL4144917,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 15 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,CC[C@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,CHEMBL4166868,nM,158,CHEMBL6009,6.801342913,DGAT,CC[C@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377253,CHEMBL4144920,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and [3H]-labelled decanoyl-CoA as substrates pretreated for 30 mins in presence of C10-DAG followed by [3H]-labelled decanoyl-CoA addition measured after 60 mins by microbeta counting method,B,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3Cl)ccc2C1=O,CHEMBL4171309,nM,8,CHEMBL6009,8.096910013,DGAT,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3Cl)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3Cl)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377254,CHEMBL4144920,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and [3H]-labelled decanoyl-CoA as substrates pretreated for 30 mins in presence of C10-DAG followed by [3H]-labelled decanoyl-CoA addition measured after 60 mins by microbeta counting method,B,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(F)c(F)c4)cc3Cl)ccc2C1=O,CHEMBL4163414,nM,20,CHEMBL6009,7.698970004,DGAT,CC[C@@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(F)c(F)c4)cc3Cl)ccc2C1=O,CCC1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(F)c(F)c4)cc3Cl)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377255,CHEMBL4144920,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and [3H]-labelled decanoyl-CoA as substrates pretreated for 30 mins in presence of C10-DAG followed by [3H]-labelled decanoyl-CoA addition measured after 60 mins by microbeta counting method,B,O=C(O)C[C@]1(CC(F)(F)F)CCc2cc(-c3cnc(NC(=O)Nc4cccc(C(F)(F)F)c4)cn3)ccc2C1=O,CHEMBL4163009,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(O)C[C@]1(CC(F)(F)F)CCc2cc(-c3c[nH]c(=NC(=O)Nc4cccc(C(F)(F)F)c4)cn3)ccc2C1=O,O=C(O)CC1(CC(F)(F)F)CCc2cc(-c3c[nH]c(=NC(=O)Nc4cccc(C(F)(F)F)c4)cn3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377256,CHEMBL4144920,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and [3H]-labelled decanoyl-CoA as substrates pretreated for 30 mins in presence of C10-DAG followed by [3H]-labelled decanoyl-CoA addition measured after 60 mins by microbeta counting method,B,O=C(O)C[C@]1(CC(F)(F)F)CCc2cc(-c3cnc(NC(=O)Nc4ccc(F)c(F)c4)cn3)ccc2C1=O,CHEMBL4173715,nM,3,CHEMBL6009,8.522878745,DGAT,O=C(O)C[C@]1(CC(F)(F)F)CCc2cc(-c3c[nH]c(=NC(=O)Nc4ccc(F)c(F)c4)cn3)ccc2C1=O,O=C(O)CC1(CC(F)(F)F)CCc2cc(-c3c[nH]c(=NC(=O)Nc4ccc(F)c(F)c4)cn3)ccc2C1=O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18377380,CHEMBL4144982,Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 30 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay,B,O=C(O)CC1CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1,CHEMBL4164949,nM,5100,CHEMBL6009,5.292429824,DGAT,O=C(O)CC1CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1,O=C(O)CC1CCc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)ccc2C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18721801,CHEMBL4258223,Inhibition of DGAT1 (unknown origin),B,CS(=O)(=O)NC[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL4285961,nM,39.81,CHEMBL6009,7.400007822,DGAT,CS(=O)(=O)NC[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CS(=O)(=O)NCC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18721803,CHEMBL4258223,Inhibition of DGAT1 (unknown origin),B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CNC(=O)C4CCC4)CC3)cc1)CCO2,CHEMBL4286856,nM,50.12,CHEMBL6009,7.299988938,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CNC(=O)C4CCC4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CNC(=O)C4CCC4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18721804,CHEMBL4258223,Inhibition of DGAT1 (unknown origin),B,CC(C)C(=O)NC[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL4279051,nM,100,CHEMBL6009,7,DGAT,CC(C)C(=O)NC[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(C)C(=O)NCC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18721805,CHEMBL4258223,Inhibition of DGAT1 (unknown origin),B,CC(=O)NC[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL4291404,nM,100,CHEMBL6009,7,DGAT,CC(=O)NC[C@H]1CC[C@H](c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,CC(=O)NCC1CCC(c2ccc(N3CCOc4[nH]cnc(=N)c4C3=O)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18721806,CHEMBL4258223,Inhibition of DGAT1 (unknown origin),B,Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CNC(=O)C4CCCO4)CC3)cc1)CCO2,CHEMBL4284984,nM,125.89,CHEMBL6009,6.900008766,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CNC(=O)C4CCCO4)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CNC(=O)C4CCCO4)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18721807,CHEMBL4258223,Inhibition of DGAT1 (unknown origin),B,NC[C@H]1CC[C@H](c2ccc(N3CCOc4ncnc(N)c4C3=O)cc2)CC1,CHEMBL4291171,nM,199.53,CHEMBL6009,6.699991797,DGAT,N=c1[nH]cnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CN)CC3)cc1)CCO2,N=c1[nH]cnc2c1C(=O)N(c1ccc(C3CCC(CN)CC3)cc1)CCO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18738819,CHEMBL4261863,Inhibition of DGAT1 (unknown origin),B,CC(c1nc2cnc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CHEMBL4280459,nM,50000,CHEMBL6009,4.301029996,DGAT,CC(c1nc2cnc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CC(c1nc2cnc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18738820,CHEMBL4261863,Inhibition of DGAT1 (unknown origin),B,C[C@@H](c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CHEMBL3893203,nM,50000,CHEMBL6009,4.301029996,DGAT,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855078,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1,CHEMBL2364624,nM,55,CHEMBL6009,7.259637311,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855079,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,Cc1nnc(Nc2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)nc2)o1,CHEMBL4439533,nM,540,CHEMBL6009,6.26760624,DGAT,Cc1n[nH]c(=Nc2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)nc2)o1,Cc1n[nH]c(=Nc2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855080,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,CCc1nnc(Nc2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)nc2)o1,CHEMBL4540189,nM,150,CHEMBL6009,6.823908741,DGAT,CCc1n[nH]c(=Nc2ccc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)nc2)o1,CCc1n[nH]c(=Nc2ccc(-c3ccc(C4CCC(CC(=O)O)CC4)cc3)nc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855081,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4nnc(C5CCC5)o4)cn3)cc2)CC1,CHEMBL4434994,nM,41,CHEMBL6009,7.387216143,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)o4)cn3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)o4)cn3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855082,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4nnc(C5CCC5)s4)cn3)cc2)CC1,CHEMBL4554065,nM,9,CHEMBL6009,8.045757491,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)s4)cn3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(N=c4[nH]nc(C5CCC5)s4)cn3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855083,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,CC(C)c1nnc(Nc2ccc(-c3ccc(N4CCC(CC(=O)O)CC4)cc3)nc2)o1,CHEMBL4475779,nM,12600,CHEMBL6009,4.899629455,DGAT,CC(C)c1n[nH]c(=Nc2ccc(-c3ccc(N4CCC(CC(=O)O)CC4)cc3)nc2)o1,CC(C)c1n[nH]c(=Nc2ccc(-c3ccc(N4CCC(CC(=O)O)CC4)cc3)nc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855084,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,O=C(O)CC12CCC(c3ccc(-c4ccc(Nc5nnc(C6CCC6)o5)cn4)cc3)(CC1)CO2,CHEMBL4563171,nM,120,CHEMBL6009,6.920818754,DGAT,O=C(O)CC12CCC(c3ccc(-c4ccc(N=c5[nH]nc(C6CCC6)o5)cn4)cc3)(CC1)CO2,O=C(O)CC12CCC(c3ccc(-c4ccc(N=c5[nH]nc(C6CCC6)o5)cn4)cc3)(CC1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855085,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,O=C(O)CC12CCC(c3ccc(-c4ccc(Nc5nnc(C6CCC6)o5)cc4)cc3)(CC1)CO2,CHEMBL4446248,nM,83,CHEMBL6009,7.080921908,DGAT,O=C(O)CC12CCC(c3ccc(-c4ccc(N=c5[nH]nc(C6CCC6)o5)cc4)cc3)(CC1)CO2,O=C(O)CC12CCC(c3ccc(-c4ccc(N=c5[nH]nc(C6CCC6)o5)cc4)cc3)(CC1)CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855086,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,CCc1nc(C)c(C(=O)Nc2ccc(-c3ccc(C45CCC(CC(=O)O)(CC4)OC5)cc3)nc2)o1,CHEMBL4555623,nM,390,CHEMBL6009,6.408935393,DGAT,CCc1nc(C)c(C(=O)Nc2ccc(-c3ccc(C45CCC(CC(=O)O)(CC4)OC5)cc3)nc2)o1,CCc1nc(C)c(C(=O)Nc2ccc(-c3ccc(C45CCC(CC(=O)O)(CC4)OC5)cc3)nc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18855087,CHEMBL4307349,Inhibition of recombinant human his-tagged DGAT1 expressed in Sf9 insect cells using oleoyl-CoA and diolein as substrates incubated for 30 mins by LC/MS/MS analysis,B,CCc1nc(C)c(C(=O)Nc2ccc(-c3ccc(C45CCC(CC(=O)O)(CC4)OC5)cc3)cc2)o1,CHEMBL4463125,nM,540,CHEMBL6009,6.26760624,DGAT,CCc1nc(C)c(C(=O)Nc2ccc(-c3ccc(C45CCC(CC(=O)O)(CC4)OC5)cc3)cc2)o1,CCc1nc(C)c(C(=O)Nc2ccc(-c3ccc(C45CCC(CC(=O)O)(CC4)OC5)cc3)cc2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18914016,CHEMBL4321462,Inhibition of human DGAT1,B,O=C(O)[C@@H]1[C@@H]2C[C@@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]21,CHEMBL4590029,nM,5.9,CHEMBL6009,8.229147988,DGAT,O=C(O)C1[C@H]2C[C@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]12,O=C(O)C1C2CC(OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18914017,CHEMBL4321462,Inhibition of human DGAT1,B,O=C(O)[C@@H]1[C@@H]2C[C@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]21,CHEMBL4456692,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(O)C1[C@H]2C[C@@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]12,O=C(O)C1C2CC(OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18914018,CHEMBL4321462,Inhibition of human DGAT1,B,O=C(O)[C@H]1[C@@H]2C[C@@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]21,CHEMBL4554849,nM,3.8,CHEMBL6009,8.420216403,DGAT,O=C(O)C1[C@H]2C[C@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]12,O=C(O)C1C2CC(OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18914019,CHEMBL4321462,Inhibition of human DGAT1,B,O=C(O)[C@H]1[C@@H]2C[C@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]21,CHEMBL4591140,nM,2,CHEMBL6009,8.698970004,DGAT,O=C(O)C1[C@H]2C[C@@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]12,O=C(O)C1C2CC(OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)CC21,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207296,CHEMBL4392490,Inhibition of human DGAT1,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1,CHEMBL4541477,nM,1327,CHEMBL6009,5.877129077,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207297,CHEMBL4392490,Inhibition of human DGAT1,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4cccnc4)cc3)nc2c1,CHEMBL4525823,nM,127,CHEMBL6009,6.896196279,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4cccnc4)cc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4cccnc4)cc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207298,CHEMBL4392490,Inhibition of human DGAT1,B,Oc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cn1,CHEMBL4443018,nM,6.4,CHEMBL6009,8.193820026,DGAT,O=c1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)c[nH]1,O=c1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207299,CHEMBL4392490,Inhibition of human DGAT1,B,N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1,CHEMBL4472207,nM,98,CHEMBL6009,7.008773924,DGAT,N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1,N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207300,CHEMBL4392490,Inhibition of human DGAT1,B,N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cn1,CHEMBL4456729,nM,38,CHEMBL6009,7.420216403,DGAT,N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cn1,N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207301,CHEMBL4392490,Inhibition of human DGAT1,B,Oc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1,CHEMBL4575608,nM,451,CHEMBL6009,6.345823458,DGAT,Oc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1,Oc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207302,CHEMBL4392490,Inhibition of human DGAT1,B,CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1,CHEMBL4453601,nM,66,CHEMBL6009,7.180456064,DGAT,CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1,CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207303,CHEMBL4392490,Inhibition of human DGAT1,B,CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cn2)CC1,CHEMBL4447657,nM,70,CHEMBL6009,7.15490196,DGAT,CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cn2)CC1,CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207304,CHEMBL4392490,Inhibition of human DGAT1,B,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccc(N5CCOCC5)nc4)cc3)nc2c1,CHEMBL4574644,nM,65,CHEMBL6009,7.187086643,DGAT,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccc(N5CCOCC5)nc4)cc3)nc2c1,FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccc(N5CCOCC5)nc4)cc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207305,CHEMBL4392490,Inhibition of human DGAT1,B,CC1(C(=O)O)CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4476596,nM,2.5,CHEMBL6009,8.602059991,DGAT,CC1(C(=O)O)CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CC1(C(=O)O)CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207306,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1(CNc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4534257,nM,2.9,CHEMBL6009,8.537602002,DGAT,O=C(O)C1(CN=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)CC1,O=C(O)C1(CN=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207307,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1CCCCC1Nc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1,CHEMBL4554202,nM,4.2,CHEMBL6009,8.37675071,DGAT,O=C(O)C1CCCCC1N=c1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)c[nH]1,O=C(O)C1CCCCC1N=c1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)c[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207308,CHEMBL4392490,Inhibition of human DGAT1,B,CC1(C)CN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1CC(=O)O,CHEMBL4562424,nM,4.5,CHEMBL6009,8.346787486,DGAT,CC1(C)CN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1CC(=O)O,CC1(C)CN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1CC(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207309,CHEMBL4392490,Inhibition of human DGAT1,B,CC1(C(=O)O)CCCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,CHEMBL4516271,nM,4.5,CHEMBL6009,8.346787486,DGAT,CC1(C(=O)O)CCCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,CC1(C(=O)O)CCCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207310,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1CCC(Nc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4461413,nM,5.4,CHEMBL6009,8.26760624,DGAT,O=C(O)C1CCC(N=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)CC1,O=C(O)C1CCC(N=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207311,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)c1ccc(CNc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)cc1,CHEMBL4577468,nM,9.6,CHEMBL6009,8.017728767,DGAT,O=C(O)c1ccc(CN=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)cc1,O=C(O)c1ccc(CN=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207312,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)CC1CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4450287,nM,10.2,CHEMBL6009,7.991399828,DGAT,O=C(O)CC1CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207313,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1CC(Nc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,CHEMBL4453600,nM,22,CHEMBL6009,7.657577319,DGAT,O=C(O)C1CC(N=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)C1,O=C(O)C1CC(N=c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)c[nH]2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207314,CHEMBL4392490,Inhibition of human DGAT1,B,CC(C)(COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1)C(=O)O,CHEMBL4585408,nM,0.7,CHEMBL6009,9.15490196,DGAT,CC(C)(COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1)C(=O)O,CC(C)(COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1)C(=O)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207315,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)c1ccc(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)cc1,CHEMBL4467163,nM,1.3,CHEMBL6009,8.886056648,DGAT,O=C(O)c1ccc(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)cc1,O=C(O)c1ccc(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207317,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1,CHEMBL4460750,nM,1.7,CHEMBL6009,8.769551079,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207319,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4461148,nM,3.1,CHEMBL6009,8.508638306,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207320,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1CC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,CHEMBL4467830,nM,3.5,CHEMBL6009,8.455931956,DGAT,O=C(O)C1CC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,O=C(O)C1CC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207321,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1CC1COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1,CHEMBL4527253,nM,3.6,CHEMBL6009,8.443697499,DGAT,O=C(O)C1CC1COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1,O=C(O)C1CC1COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207322,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)COC1,CHEMBL4527223,nM,5.3,CHEMBL6009,8.27572413,DGAT,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)COC1,O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)COC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207323,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4453443,nM,1.3,CHEMBL6009,8.886056648,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207324,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4452940,nM,1.6,CHEMBL6009,8.795880017,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207325,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,CHEMBL4543944,nM,1.7,CHEMBL6009,8.769551079,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207326,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)cn2)CC1,CHEMBL4458847,nM,2.1,CHEMBL6009,8.677780705,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207327,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,CHEMBL4483357,nM,2.4,CHEMBL6009,8.619788758,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207328,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)cn2)CC1,CHEMBL4592144,nM,3.2,CHEMBL6009,8.494850022,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207329,CHEMBL4392490,Inhibition of human DGAT1,B,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2c1,CHEMBL4561313,nM,3.6,CHEMBL6009,8.443697499,DGAT,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2c1,N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(CC(=O)O)CC5)nc4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207330,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,CHEMBL4443023,nM,5.2,CHEMBL6009,8.283996656,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207331,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)cn2)CC1,CHEMBL4530290,nM,7,CHEMBL6009,8.15490196,DGAT,O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)cn2)CC1,O=C(O)CC1CCC(Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)cn2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207332,CHEMBL4392490,Inhibition of human DGAT1,B,COc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2n1,CHEMBL4453213,nM,11.6,CHEMBL6009,7.935542011,DGAT,COc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2n1,COc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(CC(=O)O)CC5)nc4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207333,CHEMBL4392490,Inhibition of human DGAT1,B,Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2n1,CHEMBL4542552,nM,30.8,CHEMBL6009,7.511449283,DGAT,Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2n1,Cc1ccc2[nH]c(-c3ccc(-c4ccc(OC5CCC(CC(=O)O)CC5)nc4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207334,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,CHEMBL4572398,nM,2,CHEMBL6009,8.698970004,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207335,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,CHEMBL4473500,nM,3.1,CHEMBL6009,8.508638306,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207336,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)CC2)CC1,CHEMBL4464262,nM,4.1,CHEMBL6009,8.387216143,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207337,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)CC2)CC1,CHEMBL4592655,nM,6.5,CHEMBL6009,8.187086643,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207338,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5c(F)cccc5[nH]4)cn3)CC2)CC1,CHEMBL4461166,nM,8,CHEMBL6009,8.096910013,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5c(F)cccc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5c(F)cccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207339,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5ccccc5[nH]4)cn3)CC2)CC1,CHEMBL4469452,nM,15.2,CHEMBL6009,7.818156412,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5ccccc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5ccccc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207340,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)CC2)CC1,CHEMBL4531344,nM,23.6,CHEMBL6009,7.627087997,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207341,CHEMBL4392490,Inhibition of human DGAT1,B,N#Cc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2c1,CHEMBL4452750,nM,26.1,CHEMBL6009,7.583359493,DGAT,N#Cc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2c1,N#Cc1ccc2[nH]c(-c3ccc(N4CCC(OC5CCC(CC(=O)O)CC5)CC4)nc3)nc2c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207342,CHEMBL4392490,Inhibition of human DGAT1,B,COc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2n1,CHEMBL4524803,nM,50.5,CHEMBL6009,7.296708622,DGAT,COc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2n1,COc1ccc2[nH]c(-c3ccc(N4CCC(OC5CCC(CC(=O)O)CC5)CC4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207343,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)CC2)CC1,CHEMBL4462458,nM,61.3,CHEMBL6009,7.212539525,DGAT,O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)CC2)CC1,O=C(O)CC1CCC(OC2CCN(c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)CC2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207344,CHEMBL4392490,Inhibition of human DGAT1,B,Cc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2n1,CHEMBL4565611,nM,442.5,CHEMBL6009,6.354086725,DGAT,Cc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2n1,Cc1ccc2[nH]c(-c3ccc(N4CCC(OC5CCC(CC(=O)O)CC5)CC4)nc3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207345,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1,CHEMBL4557603,nM,2.3,CHEMBL6009,8.638272164,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19207346,CHEMBL4392490,Inhibition of human DGAT1,B,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cc3)cc2)CC1,CHEMBL4531443,nM,1.7,CHEMBL6009,8.769551079,DGAT,O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cc3)cc2)CC1,O=C(O)CC1CCC(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cc3)cc2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23315398,CHEMBL4845067,Inhibition of human DGAT1,B,COc1ccc(NC(=O)C2=C(c3ccc(C)cc3)C[C@](c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)NC2=O)cc1,CHEMBL3893594,nM,33000,CHEMBL6009,4.48148606,DGAT,COc1ccc(NC(=O)C2=C(c3ccc(C)cc3)C[C@](c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)NC2=O)cc1,COc1ccc(NC(=O)C2=C(c3ccc(C)cc3)CC(c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)NC2=O)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23315399,CHEMBL4845067,Inhibition of human DGAT1,B,Cc1ccc(C2=C(c3nn[nH]n3)C(O)=N[C@@](c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,CHEMBL3912712,nM,33000,CHEMBL6009,4.48148606,DGAT,Cc1ccc(C2=C(c3nn[nH]n3)C(=O)N[C@@](c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,Cc1ccc(C2=C(c3nn[nH]n3)C(=O)NC(c3ccc(OCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23315400,CHEMBL4845067,Inhibition of human DGAT1,B,Cc1ccc(C2=C(c3nnn[nH]3)C(=O)N[C@@](c3ccc(OCCCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,CHEMBL4878564,nM,33000,CHEMBL6009,4.48148606,DGAT,Cc1ccc(C2=C(c3nn[nH]n3)C(=O)N[C@@](c3ccc(OCCCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,Cc1ccc(C2=C(c3nn[nH]n3)C(=O)NC(c3ccc(OCCCCCC(F)(F)F)cc3)(C(F)(F)F)C2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23360470,CHEMBL4883183,Thin Layer Chromatography (TLC) assay (human DGAT1),B,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,CHEMBL4455357,nM,30000,CHEMBL6009,4.522878745,DGAT,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670835,CHEMBL5099712,"Inhibition of human DGAT1 using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into diacylglycerol preincubated for 30 mins followed by substrate addition and measured after 30 to 90 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@H]3CCOC3)cn2)c1,CHEMBL4760665,nM,50000,CHEMBL6009,4.301029996,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@H]3CCOC3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCOC3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670836,CHEMBL5099712,"Inhibition of human DGAT1 using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into diacylglycerol preincubated for 30 mins followed by substrate addition and measured after 30 to 90 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC(C)(C)CO)cn2)c1,CHEMBL5178371,nM,50000,CHEMBL6009,4.301029996,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC(C)(C)CO)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC(C)(C)CO)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24842803,CHEMBL5145928,Inhibition of recombinant human DGAT1 expressed in Sf9 cell membrane assessed as inhibition of triglyceride synthesis incubated for 1 hrs by LC-MS-based mass spectrophotometric analysis,B,O=C(O)CC1CCC2(CC1)CCC(c1ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cc1)CC2,CHEMBL5174434,nM,48,CHEMBL6009,7.318758763,DGAT,O=C(O)CC1CCC2(CC1)CCC(c1ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cc1)CC2,O=C(O)CC1CCC2(CC1)CCC(c1ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cc1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24842804,CHEMBL5145928,Inhibition of recombinant human DGAT1 expressed in Sf9 cell membrane assessed as inhibition of triglyceride synthesis incubated for 1 hrs by LC-MS-based mass spectrophotometric analysis,B,O=C(O)CC1CCC2(CC1)CCC(c1ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cn1)CC2,CHEMBL5202474,nM,22,CHEMBL6009,7.657577319,DGAT,O=C(O)CC1CCC2(CC1)CCC(c1ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn1)CC2,O=C(O)CC1CCC2(CC1)CCC(c1ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24842805,CHEMBL5145928,Inhibition of recombinant human DGAT1 expressed in Sf9 cell membrane assessed as inhibition of triglyceride synthesis incubated for 1 hrs by LC-MS-based mass spectrophotometric analysis,B,O=C(O)CC1CCC2(CC1)CCN(c1ccc(NC(=O)c3nnc(Nc4ccc(F)c(F)c4)o3)cn1)CC2,CHEMBL5203276,nM,23,CHEMBL6009,7.638272164,DGAT,O=C(O)CC1CCC2(CC1)CCN(c1ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn1)CC2,O=C(O)CC1CCC2(CC1)CCN(c1ccc(NC(=O)c3n[nH]c(=Nc4ccc(F)c(F)c4)o3)cn1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24842806,CHEMBL5145928,Inhibition of recombinant human DGAT1 expressed in Sf9 cell membrane assessed as inhibition of triglyceride synthesis incubated for 1 hrs by LC-MS-based mass spectrophotometric analysis,B,O=C(Nc1ccc(C2CCC3(CC2)CC(C(=O)O)C3)cc1)c1nnc(Nc2ccc(F)c(F)c2)o1,CHEMBL5207578,nM,11,CHEMBL6009,7.958607315,DGAT,O=C(Nc1ccc(C2CCC3(CC2)CC(C(=O)O)C3)cc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,O=C(Nc1ccc(C2CCC3(CC2)CC(C(=O)O)C3)cc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24842807,CHEMBL5145928,Inhibition of recombinant human DGAT1 expressed in Sf9 cell membrane assessed as inhibition of triglyceride synthesis incubated for 1 hrs by LC-MS-based mass spectrophotometric analysis,B,O=C(Nc1ccc(N2CCC3(CC2)CC(C(=O)O)C3)nc1)c1nnc(Nc2ccc(F)c(F)c2)o1,CHEMBL5204128,nM,20,CHEMBL6009,7.698970004,DGAT,O=C(Nc1ccc(N2CCC3(CC2)CC(C(=O)O)C3)nc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,O=C(Nc1ccc(N2CCC3(CC2)CC(C(=O)O)C3)nc1)c1n[nH]c(=Nc2ccc(F)c(F)c2)o1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24842809,CHEMBL5145928,Inhibition of recombinant human DGAT1 expressed in Sf9 cell membrane assessed as inhibition of triglyceride synthesis incubated for 1 hrs by LC-MS-based mass spectrophotometric analysis,B,O=C(O)CC1CCC2(CC1)CCC(NC(=O)c1nnc(Nc3ccc(F)c(F)c3)o1)CC2,CHEMBL5175038,nM,1300,CHEMBL6009,5.886056648,DGAT,O=C(O)CC1CCC2(CC1)CCC(NC(=O)c1n[nH]c(=Nc3ccc(F)c(F)c3)o1)CC2,O=C(O)CC1CCC2(CC1)CCC(NC(=O)c1n[nH]c(=Nc3ccc(F)c(F)c3)o1)CC2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386207,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,O=C(NCc1ccc(Cl)c2ccncc12)Nc1cccc(Cl)c1Cl,CHEMBL3735532,nM,12000,CHEMBL5853,4.920818754,DGAT,O=C(NCc1ccc(Cl)c2ccncc12)Nc1cccc(Cl)c1Cl,O=C(NCc1ccc(Cl)c2ccncc12)Nc1cccc(Cl)c1Cl,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386208,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CN)c3cnccc23)c1,CHEMBL3735953,nM,50000,CHEMBL5853,4.301029996,DGAT,COc1cccc(-c2ccc(CN)c3cnccc23)c1,COc1cccc(-c2ccc(CN)c3cnccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386209,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)C3CC34CCCCC4)c3cnccc23)c1,CHEMBL3735758,nM,180,CHEMBL5853,6.744727495,DGAT,COc1cccc(-c2ccc(CNC(=O)C3CC34CCCCC4)c3cnccc23)c1,COc1cccc(-c2ccc(CNC(=O)C3CC34CCCCC4)c3cnccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386210,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3cnccc23)c1,CHEMBL3734770,nM,600,CHEMBL5853,6.22184875,DGAT,COc1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3cnccc23)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3cnccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386211,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(NC(=O)[C@@H]3C[C@H]3c3nc(C)no3)c3cnccc23)c1,CHEMBL3735591,nM,500,CHEMBL5853,6.301029996,DGAT,COc1cccc(-c2ccc(NC(=O)C3CC3c3nc(C)no3)c3cnccc23)c1,COc1cccc(-c2ccc(NC(=O)C3CC3c3nc(C)no3)c3cnccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386212,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,O=C(NCc1ccc(-c2cccc(OC(F)(F)F)c2)c2ccncc12)[C@@H]1C[C@H]1c1ccccc1,CHEMBL3735666,nM,2200,CHEMBL5853,5.657577319,DGAT,O=C(NCc1ccc(-c2cccc(OC(F)(F)F)c2)c2ccncc12)C1C[C@H]1c1ccccc1,O=C(NCc1ccc(-c2cccc(OC(F)(F)F)c2)c2ccncc12)C1CC1c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386213,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COC(=O)c1cccc(-c2ccc(CNC(=O)Nc3cccc(Cl)c3Cl)c3cnccc23)c1,CHEMBL3736062,nM,120,CHEMBL5853,6.920818754,DGAT,COC(=O)c1cccc(-c2ccc(CNC(=O)Nc3cccc(Cl)c3Cl)c3cnccc23)c1,COC(=O)c1cccc(-c2ccc(CNC(=O)Nc3cccc(Cl)c3Cl)c3cnccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386214,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COC(=O)c1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3ccccc23)c1,CHEMBL3736485,nM,140,CHEMBL5853,6.853871964,DGAT,COC(=O)c1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3ccccc23)c1,COC(=O)c1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3ccccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386215,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3ccncc23)c1,CHEMBL3736151,nM,1600,CHEMBL5853,5.795880017,DGAT,COc1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3ccncc23)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3ccncc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386216,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3ncccc23)c1,CHEMBL3736366,nM,300,CHEMBL5853,6.522878745,DGAT,COc1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3ncccc23)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3ncccc23)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386217,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3c2CCN(C(=O)OC(C)(C)C)C3)c1,CHEMBL3735235,nM,60,CHEMBL5853,7.22184875,DGAT,COc1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3c2CCN(C(=O)OC(C)(C)C)C3)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3c2CCN(C(=O)OC(C)(C)C)C3)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386218,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3c2CCN(C(C)=O)C3)c1,CHEMBL3735388,nM,3460,CHEMBL5853,5.460923901,DGAT,COc1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3c2CCN(C(C)=O)C3)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3c2CCN(C(C)=O)C3)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386219,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@@H]3C[C@H]3c3ccccc3)c3c2CCN(C(=O)NC(C)(C)C)C3)c1,CHEMBL3734764,nM,4,CHEMBL5853,8.397940009,DGAT,COc1cccc(-c2ccc(CNC(=O)C3C[C@H]3c3ccccc3)c3c2CCN(C(=O)NC(C)(C)C)C3)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3ccccc3)c3c2CCN(C(=O)NC(C)(C)C)C3)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
16386220,CHEMBL3737415,Inhibition of human DGAT2 expressed in Sf9 cell membranes assessed as triolein formation by LC/MS/MS analysis using oleoyl-CoA as substrate,B,COc1cccc(-c2ccc(CNC(=O)[C@H]3C[C@@H]3c3nc(C)no3)c3c2CCN(C(=O)NC(C)(C)C)C3)c1,CHEMBL3734847,nM,3,CHEMBL5853,8.522878745,DGAT,COc1cccc(-c2ccc(CNC(=O)C3CC3c3nc(C)no3)c3c2CCN(C(=O)NC(C)(C)C)C3)c1,COc1cccc(-c2ccc(CNC(=O)C3CC3c3nc(C)no3)c3c2CCN(C(=O)NC(C)(C)C)C3)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752446,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(OC(F)(F)F)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107035,nM,1.7,CHEMBL5853,8.769551079,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)(F)F)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)(F)F)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752447,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)Cc1csc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4114076,nM,2.71,CHEMBL5853,8.567030709,DGAT,CC(C)Cc1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CC(C)Cc1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752448,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(-n5cccn5)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114844,nM,4.82,CHEMBL5853,8.316952962,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(-n5cccn5)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(-n5cccn5)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752449,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)c1csc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4115512,nM,6.64,CHEMBL5853,8.177831921,DGAT,CC(C)c1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CC(C)c1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752450,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4113506,nM,8.24,CHEMBL5853,8.084072788,DGAT,Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752451,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(-c5cnco5)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108722,nM,11.5,CHEMBL5853,7.93930216,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(-c5cnco5)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(-c5cnco5)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752452,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cncc(Cl)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115576,nM,16.3,CHEMBL5853,7.787812396,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(Cl)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(Cl)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752453,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CNS(=O)(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4108255,nM,21.1,CHEMBL5853,7.675717545,DGAT,CNS(=O)(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CNS(=O)(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752454,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cnn(-c5ccccc5)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109777,nM,22.1,CHEMBL5853,7.655607726,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cnn(-c5ccccc5)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cnn(-c5ccccc5)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752455,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(N5CCCC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113042,nM,29.2,CHEMBL5853,7.534617149,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(N5CCCC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(N5CCCC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752456,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1csc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4115249,nM,35,CHEMBL5853,7.455931956,DGAT,Cc1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Cc1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752457,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc5ccnn45)[nH]c3n2)C1)N1CCCC1,CHEMBL4106957,nM,54.7,CHEMBL5853,7.262012674,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc5ccnn45)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc5ccnn45)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752458,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#Cc1ccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)cc1,CHEMBL4112678,nM,63.6,CHEMBL5853,7.196542884,DGAT,N#Cc1ccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)cc1,N#Cc1ccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752459,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(O)c1cc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)ccn1,CHEMBL4109903,nM,72.8,CHEMBL5853,7.137868621,DGAT,CC(C)(O)c1cc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)ccn1,CC(C)(O)c1cc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)ccn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752460,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(NC5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108726,nM,89.6,CHEMBL5853,7.04769199,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cc[nH]c(=NC5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cc[nH]c(=NC5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752461,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#Cc1cncc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4113402,nM,102,CHEMBL5853,6.991399828,DGAT,N#Cc1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,N#Cc1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752462,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1nc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)cs1,CHEMBL4113634,nM,118,CHEMBL5853,6.928117993,DGAT,Cc1nc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)cs1,Cc1nc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)cs1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752463,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc([C@H]4C[C@H]4c4ccccc4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109255,nM,196,CHEMBL5853,6.707743929,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4C[C@H]4c4ccccc4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4CC4c4ccccc4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752464,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccc5nccn5c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112602,nM,208,CHEMBL5853,6.681936665,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccc5nccn5c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccc5nccn5c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752465,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cn1cc(Cl)c(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4108916,nM,221,CHEMBL5853,6.655607726,DGAT,Cn1cc(Cl)c(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Cn1cc(Cl)c(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752466,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccccc4F)[nH]c3n2)C1)N1CCCC1,CHEMBL4112431,nM,346,CHEMBL5853,6.460923901,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccccc4F)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccccc4F)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752467,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(c1ccccc1)c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4110905,nM,357,CHEMBL5853,6.447331784,DGAT,CC(C)(c1ccccc1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,CC(C)(c1ccccc1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752468,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1O,CHEMBL4112021,nM,432,CHEMBL5853,6.364516253,DGAT,CC(C)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1O,CC(C)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752469,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(C)c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4112831,nM,731,CHEMBL5853,6.136082623,DGAT,CC(C)(C)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,CC(C)(C)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752470,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(N5CCOCC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113476,nM,297,CHEMBL5853,6.527243551,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(N5CCOCC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(N5CCOCC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752471,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4CCCCC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4111889,nM,1050,CHEMBL5853,5.978810701,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4CCCCC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4CCCCC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752472,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C1COc2ccc(-c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)cc2N1,CHEMBL4107135,nM,1390,CHEMBL5853,5.8569852,DGAT,O=C1COc2ccc(-c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)cc2N1,O=C1COc2ccc(-c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)cc2N1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752473,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(CC4CCCCC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4106735,nM,1500,CHEMBL5853,5.823908741,DGAT,O=C(C1CCCN(c2ccc3[nH]c(CC4CCCCC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(CC4CCCCC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752474,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4110137,nM,4370,CHEMBL5853,5.359518563,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752475,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CS(=O)(=O)Nc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4110579,nM,1400,CHEMBL5853,5.853871964,DGAT,CS(=O)(=O)Nc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CS(=O)(=O)Nc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752476,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(C)OCc1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4107853,nM,286,CHEMBL5853,6.543633967,DGAT,CC(C)(C)OCc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,CC(C)(C)OCc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752477,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCc1cc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)no1,CHEMBL4108174,nM,239,CHEMBL5853,6.621602099,DGAT,CCc1cc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)no1,CCc1cc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)no1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752478,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cncc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4107286,nM,97,CHEMBL5853,7.013228266,DGAT,Cc1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Cc1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752479,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccc(OC(F)(F)F)cc4)[nH]c3n2)C1)N1CCCC1,CHEMBL4110253,nM,24.8,CHEMBL5853,7.605548319,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccc(OC(F)(F)F)cc4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccc(OC(F)(F)F)cc4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752480,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(F)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114945,nM,21.2,CHEMBL5853,7.673664139,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(F)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(F)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752481,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4107041,nM,20.7,CHEMBL5853,7.684029655,DGAT,COc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,COc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752482,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4110880,nM,12.6,CHEMBL5853,7.899629455,DGAT,COc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,COc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752483,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(N5CCCC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114546,nM,7.81,CHEMBL5853,8.107348966,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(N5CCCC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(N5CCCC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752484,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4coc(-c5ccccc5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108326,nM,6.85,CHEMBL5853,8.164309429,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4coc(-c5ccccc5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4coc(-c5ccccc5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752485,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCc1csc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4112999,nM,6.47,CHEMBL5853,8.189095719,DGAT,CCc1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CCc1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752486,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(Cl)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112256,nM,4.56,CHEMBL5853,8.341035157,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(Cl)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(Cl)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752487,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(C)c1csc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4106571,nM,3.18,CHEMBL5853,8.49757288,DGAT,CC(C)(C)c1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CC(C)(C)c1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752488,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(OC(F)F)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112953,nM,7.41,CHEMBL5853,8.130181792,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752489,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4108000,nM,36.5,CHEMBL5853,7.437707136,DGAT,Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752490,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(Cc4ccc(Cl)cc4)[nH]c3n2)C1)N1CCCC1,CHEMBL4106928,nM,188,CHEMBL5853,6.725842151,DGAT,O=C(C1CCCN(c2ccc3[nH]c(Cc4ccc(Cl)cc4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(Cc4ccc(Cl)cc4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752491,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#Cc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4108794,nM,34.5,CHEMBL5853,7.462180905,DGAT,N#Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,N#Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752492,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(COc4ccc(Cl)cc4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113618,nM,10.7,CHEMBL5853,7.970616222,DGAT,O=C(C1CCCN(c2ccc3[nH]c(COc4ccc(Cl)cc4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(COc4ccc(Cl)cc4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752493,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4Cc5ccccc5C4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115256,nM,197,CHEMBL5853,6.705533774,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4Cc5ccccc5C4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4Cc5ccccc5C4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752494,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(Cc4ccccc4Cl)[nH]c3n2)C1)N1CCCC1,CHEMBL4112631,nM,460,CHEMBL5853,6.337242168,DGAT,O=C(C1CCCN(c2ccc3[nH]c(Cc4ccccc4Cl)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(Cc4ccccc4Cl)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752495,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5ccccc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113076,nM,69.7,CHEMBL5853,7.156767222,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccccc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccccc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752496,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(Cn4cccn4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108258,nM,1570,CHEMBL5853,5.804100348,DGAT,O=C(C1CCCN(c2ccc3[nH]c(Cn4cccn4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(Cn4cccn4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752497,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4CCC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113096,nM,2530,CHEMBL5853,5.596879479,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4CCC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4CCC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752498,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C(NCc1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)c1ccccc1,CHEMBL4114517,nM,2750,CHEMBL5853,5.560667306,DGAT,O=C(NCc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)c1ccccc1,O=C(NCc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)c1ccccc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752499,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(Cn4cc(C(F)(F)F)nn4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109411,nM,1120,CHEMBL5853,5.950781977,DGAT,O=C(C1CCCN(c2ccc3[nH]c(Cn4cc(C(F)(F)F)nn4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(Cn4cc(C(F)(F)F)nn4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752500,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1oc(C2CC2)nc1Cc1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4107320,nM,166,CHEMBL5853,6.779891912,DGAT,Cc1oc(C2CC2)nc1Cc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Cc1oc(C2CC2)nc1Cc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752501,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cccc(=O)n1Cc1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4114565,nM,702,CHEMBL5853,6.153662888,DGAT,Cc1cccc(=O)n1Cc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Cc1cccc(=O)n1Cc1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752502,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cccn1,CHEMBL4113044,nM,363,CHEMBL5853,6.440093375,DGAT,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cccn1,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cccn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752503,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1ccc(C2CCCN(c3ccc4nc(-c5ccnc(C6CC6)n5)[nH]c4n3)C2)nc1,CHEMBL3930457,nM,858,CHEMBL5853,6.066512712,DGAT,c1ccc(C2CCCN(c3ccc4[nH]c(-c5ccnc(C6CC6)n5)nc4n3)C2)nc1,c1ccc(C2CCCN(c3ccc4[nH]c(-c5ccnc(C6CC6)n5)nc4n3)C2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752504,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)C(=O)[C@@H]1CCCN(c2ccc3nc(-c4cccc(OC(F)F)c4)[nH]c3n2)C1,CHEMBL4111552,nM,892,CHEMBL5853,6.049635146,DGAT,CN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)C1,CN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752505,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)COC(=O)N1CCCC(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)C1,CHEMBL4109893,nM,86.4,CHEMBL5853,7.063486258,DGAT,CC(C)COC(=O)N1CCCC(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)C1,CC(C)COC(=O)N1CCCC(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752506,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C(C1CCCC1)N1CCCC(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)C1,CHEMBL4111596,nM,241,CHEMBL5853,6.617982957,DGAT,O=C(C1CCCC1)N1CCCC(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)C1,O=C(C1CCCN(c2ccc3[nH]c(C4CCCN(C(=O)C5CCCC5)C4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752507,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C(C1CCCC1)N1CCC(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)CC1,CHEMBL4108750,nM,122,CHEMBL5853,6.913640169,DGAT,O=C(C1CCCC1)N1CCC(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,O=C(C1CCCC1)N1CCC(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752508,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCCS(=O)(=O)N1CCCC(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)C1,CHEMBL4110483,nM,113,CHEMBL5853,6.946921557,DGAT,CCCS(=O)(=O)N1CCCC(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)C1,CCCS(=O)(=O)N1CCCC(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752509,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CC[C@H](F)C1,CHEMBL4113053,nM,59.3,CHEMBL5853,7.226945307,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC[C@H](F)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752510,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCC[C@@H]1CO,CHEMBL4115181,nM,1050,CHEMBL5853,5.978810701,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC[C@@H]1CO,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1CO,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752511,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CCCN1C(=O)[C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1,CHEMBL4109549,nM,58.2,CHEMBL5853,7.235077015,DGAT,C[C@@H]1CCCN1C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,CC1CCCN1C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752512,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1C[C@@H](F)[C@H](F)C1,CHEMBL4111728,nM,54.7,CHEMBL5853,7.262012674,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1C[C@@H](F)[C@H](F)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC(F)C(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752513,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CC[C@@H](F)C1,CHEMBL4114554,nM,35.4,CHEMBL5853,7.450996738,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC[C@@H](F)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752514,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCOCC1,CHEMBL4108613,nM,162,CHEMBL5853,6.790484985,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCOCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752515,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)C(=O)[C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1,CHEMBL4111190,nM,1470,CHEMBL5853,5.832682665,DGAT,CN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,CN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752516,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cnn(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CHEMBL4111571,nM,104,CHEMBL5853,6.982966661,DGAT,Cc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Cc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752517,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(F)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4110807,nM,96.9,CHEMBL5853,7.013676223,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(F)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(F)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752518,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#Cc1cccc(Cc2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4113602,nM,974,CHEMBL5853,6.011441043,DGAT,N#Cc1cccc(Cc2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,N#Cc1cccc(Cc2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752519,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#Cc1ccc(Cc2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)cc1,CHEMBL4110393,nM,764,CHEMBL5853,6.116906641,DGAT,N#Cc1ccc(Cc2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)cc1,N#Cc1ccc(Cc2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752520,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#Cc1cnn(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CHEMBL4110541,nM,227,CHEMBL5853,6.643974143,DGAT,N#Cc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,N#Cc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752521,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(C6CC6)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109528,nM,107,CHEMBL5853,6.970616222,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(C6CC6)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(C6CC6)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752522,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(C(F)(F)F)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114952,nM,83.8,CHEMBL5853,7.076755981,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(C(F)(F)F)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(C(F)(F)F)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752523,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cccn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113118,nM,230,CHEMBL5853,6.638272164,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cccn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cccn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752524,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cccn5)CCC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113976,nM,1400,CHEMBL5853,5.853871964,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cccn5)CCC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cccn5)CCC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752525,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5cccnc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109229,nM,204,CHEMBL5853,6.690369833,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cccnc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cccnc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752526,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5ccccn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107229,nM,165,CHEMBL5853,6.782516056,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccccn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccccn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752527,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(Cc5ccccc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115624,nM,128,CHEMBL5853,6.89279003,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(Cc5ccccc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(Cc5ccccc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752528,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4nc(C5CC5)cs4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107221,nM,9.55,CHEMBL5853,8.019996628,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4nc(C5CC5)cs4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4nc(C5CC5)cs4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752529,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(Cc5ccccc5)COC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112469,nM,1160,CHEMBL5853,5.935542011,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(Cc5ccccc5)COC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(Cc5ccccc5)COC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752530,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cc(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)on1,CHEMBL4106648,nM,288,CHEMBL5853,6.540607512,DGAT,Cc1cc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)on1,Cc1cc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)on1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752531,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cc(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)no1,CHEMBL4108044,nM,102,CHEMBL5853,6.991399828,DGAT,Cc1cc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)no1,Cc1cc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)no1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752532,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5cccnc5)CCC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112888,nM,190,CHEMBL5853,6.721246399,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cccnc5)CCC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cccnc5)CCC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752533,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1ccn(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)n1,CHEMBL4113729,nM,546,CHEMBL5853,6.262807357,DGAT,Cc1ccn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)n1,Cc1ccn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752534,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1ccnn1C1(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)CC1,CHEMBL4110671,nM,315,CHEMBL5853,6.501689446,DGAT,Cc1ccnn1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Cc1ccnn1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752535,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5cncnc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107057,nM,312,CHEMBL5853,6.505845406,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cncnc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cncnc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752536,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1ccccc1C1(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)CC1,CHEMBL4112324,nM,242,CHEMBL5853,6.616184634,DGAT,COc1ccccc1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,COc1ccccc1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752537,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5ccon5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108196,nM,202,CHEMBL5853,6.694648631,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccon5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccon5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752538,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1ccc(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)cc1,CHEMBL4110457,nM,107,CHEMBL5853,6.970616222,DGAT,COc1ccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)cc1,COc1ccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752539,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113893,nM,18.2,CHEMBL5853,7.739928612,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752540,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCOC(=O)c1cc(OC)nc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4109323,nM,37.3,CHEMBL5853,7.428291168,DGAT,CCOC(=O)c1cc(OC)nc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CCOC(=O)c1cc(OC)nc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752541,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cccc(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CHEMBL4114201,nM,96.9,CHEMBL5853,7.013676223,DGAT,Cc1cccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Cc1cccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752542,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cc(C5CC5)ccn4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115637,nM,94.4,CHEMBL5853,7.025028006,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cc(C5CC5)ccn4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cc(C5CC5)ccn4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752543,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4nccc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108299,nM,72.5,CHEMBL5853,7.139661993,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4nccc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4nccc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752544,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CNS(=O)(=O)c1cncc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4113043,nM,47.8,CHEMBL5853,7.320572103,DGAT,CNS(=O)(=O)c1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CNS(=O)(=O)c1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752545,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cncc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109929,nM,60.5,CHEMBL5853,7.218244625,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752546,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1cccc(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CHEMBL4107636,nM,99.6,CHEMBL5853,7.001740662,DGAT,COc1cccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,COc1cccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752547,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1ccc(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)cc1,CHEMBL4108733,nM,73.7,CHEMBL5853,7.132532512,DGAT,Cc1ccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)cc1,Cc1ccc(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)cc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752548,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cn1nccc1C1(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)CC1,CHEMBL4108463,nM,190,CHEMBL5853,6.721246399,DGAT,Cn1nccc1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Cn1nccc1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752549,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCOC(=O)c1cc(CC)nc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4110443,nM,28.9,CHEMBL5853,7.539102157,DGAT,CCOC(=O)c1cc(CC)nc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CCOC(=O)c1cc(CC)nc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752550,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5ccc(C(F)(F)F)cc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115482,nM,5.68,CHEMBL5853,8.245651664,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccc(C(F)(F)F)cc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccc(C(F)(F)F)cc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752551,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cncc(C5CC5)n4)[nH]c3n2)C1)N1CCOCC1,CHEMBL4107539,nM,153,CHEMBL5853,6.815308569,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C5CC5)n4)nc3n2)C1)N1CCOCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C5CC5)n4)nc3n2)C1)N1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752552,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ncc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112783,nM,28.7,CHEMBL5853,7.542118103,DGAT,O=C(C1CCCN(c2ncc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ncc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752553,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4098964,nM,13.8,CHEMBL5853,7.860120914,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752555,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COC(=O)Cc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4113012,nM,41.5,CHEMBL5853,7.381951903,DGAT,COC(=O)Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,COC(=O)Cc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752556,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C5(O)COC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115070,nM,697,CHEMBL5853,6.156767222,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5(O)COC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5(O)COC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752557,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C(F)(F)F)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112343,nM,9.23,CHEMBL5853,8.034798299,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C(F)(F)F)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C(F)(F)F)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752558,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cncc(F)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112367,nM,137,CHEMBL5853,6.863279433,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(F)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(F)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752559,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,NS(=O)(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4108068,nM,90.3,CHEMBL5853,7.04431225,DGAT,NS(=O)(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,NS(=O)(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752560,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4114096,nM,67.9,CHEMBL5853,7.168130226,DGAT,CC(C)(O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CC(C)(O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752561,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccccc4)[nH]c3n2)C1)N1CCCC1,CHEMBL4111459,nM,66.2,CHEMBL5853,7.179142011,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccccc4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccccc4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752562,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(Cc4cccc(Cl)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114868,nM,409,CHEMBL5853,6.388276692,DGAT,O=C(C1CCCN(c2ccc3[nH]c(Cc4cccc(Cl)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(Cc4cccc(Cl)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752563,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4coc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109291,nM,301,CHEMBL5853,6.521433504,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4coc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4coc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752564,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4112322,nM,22.2,CHEMBL5853,7.653647026,DGAT,CN(C)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CN(C)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752565,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(N5CCC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109736,nM,21.5,CHEMBL5853,7.66756154,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(N5CCC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(N5CCC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752566,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(OC(F)F)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115600,nM,14.3,CHEMBL5853,7.844663963,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)F)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(OC(F)F)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752567,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C(F)F)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109197,nM,10.9,CHEMBL5853,7.962573502,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C(F)F)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C(F)F)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752568,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COC(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4108192,nM,276,CHEMBL5853,6.559090918,DGAT,COC(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,COC(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752569,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCOC(=O)C1(c2cccc(-c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)c2)CC1,CHEMBL4109153,nM,5.27,CHEMBL5853,8.278189385,DGAT,CCOC(=O)C1(c2cccc(-c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)c2)CC1,CCOC(=O)C1(c2cccc(-c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)c2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752570,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COC(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4107187,nM,54,CHEMBL5853,7.26760624,DGAT,COC(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,COC(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752571,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1cc(C(=O)O)cc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4115326,nM,3470,CHEMBL5853,5.459670525,DGAT,COc1cc(C(=O)O)cc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,COc1cc(C(=O)O)cc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752572,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CS(=O)(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4114028,nM,235,CHEMBL5853,6.628932138,DGAT,CS(=O)(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CS(=O)(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752573,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCOC(=O)CCc1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4112473,nM,7.16,CHEMBL5853,8.145086978,DGAT,CCOC(=O)CCc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CCOC(=O)CCc1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752574,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCN(CC)C(=O)c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4110408,nM,4540,CHEMBL5853,5.342944147,DGAT,CCN(CC)C(=O)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,CCN(CC)C(=O)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752575,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C(Nc1ccccn1)c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4115337,nM,1900,CHEMBL5853,5.721246399,DGAT,O=C(N=c1cccc[nH]1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,O=C(N=c1cccc[nH]1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752576,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCC(F)(F)C1,CHEMBL4107277,nM,34.4,CHEMBL5853,7.463441557,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC(F)(F)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC(F)(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752577,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CC[C@H](O)C1,CHEMBL4107546,nM,695,CHEMBL5853,6.158015195,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC[C@H](O)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC(O)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752578,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,CHEMBL3950553,nM,252,CHEMBL5853,6.598599459,DGAT,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752579,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1cc(-c2nc3ccc(N4CCC[C@@H](c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,CHEMBL4107583,nM,210,CHEMBL5853,6.677780705,DGAT,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752580,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1cc(-c2nc3ccc(N4CCC[C@H](c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,CHEMBL3920774,nM,4240,CHEMBL5853,5.372634143,DGAT,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,c1cc(-c2nc3ccc(N4CCCC(c5ncc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752581,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2nc3[nH]c(-c4ccnc(C5CC5)n4)nc3cc2F)C1)N1CCCC1,CHEMBL4113426,nM,6.32,CHEMBL5853,8.199282922,DGAT,O=C(C1CCCN(c2nc3[nH]c(-c4ccnc(C5CC5)n4)nc3cc2F)C1)N1CCCC1,O=C(C1CCCN(c2nc3[nH]c(-c4ccnc(C5CC5)n4)nc3cc2F)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752582,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(N5CCOCC5=O)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114260,nM,1280,CHEMBL5853,5.89279003,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(N5CCOCC5=O)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(N5CCOCC5=O)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752583,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2cnc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4111437,nM,71.6,CHEMBL5853,7.145086978,DGAT,O=C(C1CCCN(c2cnc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2cnc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752584,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C5(O)CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108495,nM,62.3,CHEMBL5853,7.205511953,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5(O)CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5(O)CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752585,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(O)c1csc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4112145,nM,207,CHEMBL5853,6.684029655,DGAT,CC(C)(O)c1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CC(C)(O)c1csc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752586,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)CCO1)N1CCCC1,CHEMBL4112275,nM,354,CHEMBL5853,6.450996738,DGAT,O=C(C1CN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)CCO1)N1CCCC1,O=C(C1CN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)CCO1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752587,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ccc3nc(-c4cccc(C5CC5)n4)[nH]c3n2)CCO1)N1CCCC1,CHEMBL4111041,nM,24.8,CHEMBL5853,7.605548319,DGAT,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)CCO1)N1CCCC1,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)CCO1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752588,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ccc3nc(-c4cccc(C(F)(F)F)n4)[nH]c3n2)CCO1)N1CCCC1,CHEMBL4107306,nM,511,CHEMBL5853,6.2915791,DGAT,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C(F)(F)F)n4)nc3n2)CCO1)N1CCCC1,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C(F)(F)F)n4)nc3n2)CCO1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752589,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,FC(F)Oc1cccc(-c2nc3ccc(N4CCO[C@H](c5ccccn5)C4)nc3[nH]2)c1,CHEMBL3963923,nM,411,CHEMBL5853,6.386158178,DGAT,FC(F)Oc1cccc(-c2nc3ccc(N4CCO[C@H](c5ccccn5)C4)nc3[nH]2)c1,FC(F)Oc1cccc(-c2nc3ccc(N4CCOC(c5ccccn5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752590,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ccc3nc(-c4cncc(C5CC5)n4)[nH]c3n2)CCO1)N1CCCC1,CHEMBL4115165,nM,401,CHEMBL5853,6.396855627,DGAT,O=C(C1CN(c2ccc3[nH]c(-c4cncc(C5CC5)n4)nc3n2)CCO1)N1CCCC1,O=C(C1CN(c2ccc3[nH]c(-c4cncc(C5CC5)n4)nc3n2)CCO1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752591,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CCC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113194,nM,9.21,CHEMBL5853,8.03574037,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CCC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CCC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752592,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cncc(C(F)(F)F)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115555,nM,187,CHEMBL5853,6.728158393,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C(F)(F)F)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C(F)(F)F)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752593,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4nccc(C5CC5)n4)[nH]c3n2)C1)N1CCOCC1,CHEMBL4107653,nM,766,CHEMBL5853,6.11577123,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4nccc(C5CC5)n4)nc3n2)C1)N1CCOCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4nccc(C5CC5)n4)nc3n2)C1)N1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752594,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)C(=O)[C@@H]1CCCN(c2ccc3nc(-c4cccc(C5CC5)n4)[nH]c3n2)C1,CHEMBL4108080,nM,47.3,CHEMBL5853,7.325138859,DGAT,CN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1,CN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752595,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Clc1cccc(-c2nc3ccc(N4CCO[C@H](c5ccccn5)C4)nc3[nH]2)c1,CHEMBL3954058,nM,285,CHEMBL5853,6.54515514,DGAT,Clc1cccc(-c2nc3ccc(N4CCO[C@H](c5ccccn5)C4)nc3[nH]2)c1,Clc1cccc(-c2nc3ccc(N4CCOC(c5ccccn5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752596,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112049,nM,48.1,CHEMBL5853,7.317854924,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752599,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,N#CC1(c2cccc(-c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)n2)CC1,CHEMBL4112235,nM,275,CHEMBL5853,6.560667306,DGAT,N#CC1(c2cccc(-c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)n2)CC1,N#CC1(c2cccc(-c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)n2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752600,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(c1ccccc1)c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4110367,nM,211,CHEMBL5853,6.675717545,DGAT,CC(c1ccccc1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,CC(c1ccccc1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752601,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C5CC5)n4)[nH]c3n2)C1)N1CC=CC1,CHEMBL4114492,nM,3.58,CHEMBL5853,8.446116973,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1)N1CC=CC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1)N1CC=CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752602,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ncc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108006,nM,28.2,CHEMBL5853,7.549750892,DGAT,O=C(C1CCCN(c2ncc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ncc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752604,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5ccncc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114421,nM,218,CHEMBL5853,6.661543506,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccncc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ccncc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752605,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cc1cc(N2CCC[C@@H](C(=O)N3CCCC3)C2)nc2[nH]c(-c3ccnc(C4CC4)n3)nc12,CHEMBL4115013,nM,434,CHEMBL5853,6.36251027,DGAT,Cc1cc(N2CCCC(C(=O)N3CCCC3)C2)nc2[nH]c(-c3ccnc(C4CC4)n3)nc12,Cc1cc(N2CCCC(C(=O)N3CCCC3)C2)nc2[nH]c(-c3ccnc(C4CC4)n3)nc12,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752606,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(-c5nnn[nH]5)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107122,nM,3400,CHEMBL5853,5.468521083,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(-c5nn[nH]n5)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(-c5nn[nH]n5)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752607,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)C(=O)[C@H]1CN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)CC(F)(F)C1,CHEMBL4108947,nM,2800,CHEMBL5853,5.552841969,DGAT,CN(C)C(=O)C1CN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)CC(F)(F)C1,CN(C)C(=O)C1CN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)CC(F)(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752608,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)C(=O)[C@@H]1CN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)CC(F)(F)C1,CHEMBL3919023,nM,16500,CHEMBL5853,4.782516056,DGAT,CN(C)C(=O)C1CN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)CC(F)(F)C1,CN(C)C(=O)C1CN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)CC(F)(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752609,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C(F)(F)c4ccccc4)[nH]c3n2)C1)N1CCCC1,CHEMBL4115075,nM,2280,CHEMBL5853,5.642065153,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C(F)(F)c4ccccc4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C(F)(F)c4ccccc4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752610,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1cc(-c2nc3ccc(N4CCC[C@H](c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,CHEMBL3894192,nM,1390,CHEMBL5853,5.8569852,DGAT,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752611,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)c1,CHEMBL3963076,nM,292,CHEMBL5853,6.534617149,DGAT,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)c1,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752612,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,c1cc(-c2nc3ccc(N4CCC[C@H](c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)c1,CHEMBL3963685,nM,161,CHEMBL5853,6.793174124,DGAT,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)c1,c1cc(-c2nc3ccc(N4CCCC(c5nnc6n5CCC6)C4)nc3[nH]2)nc(C2CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752613,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,NC(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4113825,nM,83,CHEMBL5853,7.080921908,DGAT,NC(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,NC(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752614,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(C)C(=O)c1cccc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)n1,CHEMBL4108587,nM,1250,CHEMBL5853,5.903089987,DGAT,CN(C)C(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,CN(C)C(=O)c1cccc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752615,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CC2CC1CO2,CHEMBL4110183,nM,1170,CHEMBL5853,5.931814138,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC2CC1CO2,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC2CC1CO2,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752616,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ccc3nc(-c4cccc(C(F)F)n4)[nH]c3n2)CCO1)N1CCCC1,CHEMBL4107196,nM,91.3,CHEMBL5853,7.039529222,DGAT,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C(F)F)n4)nc3n2)CCO1)N1CCCC1,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C(F)F)n4)nc3n2)CCO1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752617,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CC(F)(F)C1,CHEMBL4112665,nM,73.4,CHEMBL5853,7.13430394,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC(F)(F)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CC(F)(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752618,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H]1CO[C@@H](c2ccccn2)CN1c1ccc2nc(-c3cccc(Cl)c3)[nH]c2n1,CHEMBL3951872,nM,953,CHEMBL5853,6.020907099,DGAT,C[C@H]1CO[C@@H](c2ccccn2)CN1c1ccc2[nH]c(-c3cccc(Cl)c3)nc2n1,CC1COC(c2ccccn2)CN1c1ccc2[nH]c(-c3cccc(Cl)c3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752619,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CS(=O)(=O)c1cncc(-c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)c1,CHEMBL4107032,nM,512,CHEMBL5853,6.290730039,DGAT,CS(=O)(=O)c1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,CS(=O)(=O)c1cncc(-c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752620,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CCN(c2ccc3nc(-c4cccc(OC(F)F)c4)[nH]c3n2)C[C@@H]1C(=O)N(C)C,CHEMBL4110075,nM,434,CHEMBL5853,6.36251027,DGAT,C[C@@H]1CCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)CC1C(=O)N(C)C,CC1CCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)CC1C(=O)N(C)C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752621,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CCN(c2ccc3nc(-c4cccc(OC(F)F)c4)[nH]c3n2)C[C@H]1C(=O)N(C)C,CHEMBL4107498,nM,17400,CHEMBL5853,4.759450752,DGAT,C[C@@H]1CCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)CC1C(=O)N(C)C,CC1CCN(c2ccc3[nH]c(-c4cccc(OC(F)F)c4)nc3n2)CC1C(=O)N(C)C,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752623,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cncc(C5CC5)c4)[nH]c3n2)C1)N1CCCC1,CHEMBL4109385,nM,37.5,CHEMBL5853,7.425968732,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C5CC5)c4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4cncc(C5CC5)c4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752624,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4cccc(C5CC5)n4)[nH]c3n2)C1)N1CCC(F)(F)C1,CHEMBL4111585,nM,15.2,CHEMBL5853,7.818156412,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1)N1CCC(F)(F)C1,O=C(C1CCCN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)C1)N1CCC(F)(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752625,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CCN(C)C(=O)[C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1,CHEMBL4115059,nM,231,CHEMBL5853,6.63638802,DGAT,CCN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,CCN(C)C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752626,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ccc3nc(-c4cccc(C5CC5)n4)[nH]c3n2)CCO1)N1CCOCC1,CHEMBL4109404,nM,162,CHEMBL5853,6.790484985,DGAT,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)CCO1)N1CCOCC1,O=C(C1CN(c2ccc3[nH]c(-c4cccc(C5CC5)n4)nc3n2)CCO1)N1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752627,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ncc3nc(-c4cccc(C(F)(F)F)n4)[nH]c3n2)C1)N1CCCC1,CHEMBL4111916,nM,10.5,CHEMBL5853,7.978810701,DGAT,O=C(C1CCCN(c2ncc3[nH]c(-c4cccc(C(F)(F)F)n4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ncc3[nH]c(-c4cccc(C(F)(F)F)n4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752628,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CC(C)(c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CHEMBL4115123,nM,31.4,CHEMBL5853,7.503070352,DGAT,CC(C)(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CC(C)(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752629,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CSc1cnn(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CHEMBL4108716,nM,34.1,CHEMBL5853,7.467245621,DGAT,CSc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CSc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752631,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL3891499,nM,6600,CHEMBL5853,5.180456064,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752632,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H](c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(F)cn1,CHEMBL3930155,nM,88.6,CHEMBL5853,7.052566278,DGAT,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(F)cn1,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752633,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H](c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(F)cn1,CHEMBL4108951,nM,128,CHEMBL5853,6.89279003,DGAT,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(F)cn1,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(F)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752634,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,COc1cnn(C2(c3nc4ccc(N5CCC[C@@H](C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,CHEMBL4108647,nM,101,CHEMBL5853,6.995678626,DGAT,COc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,COc1cnn(C2(c3nc4ccc(N5CCCC(C(=O)N6CCCC6)C5)nc4[nH]3)CC2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752635,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5coc(C6CC6)n5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107655,nM,142,CHEMBL5853,6.847711656,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5coc(C6CC6)n5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5coc(C6CC6)n5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752638,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H](c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CHEMBL4108600,nM,33.7,CHEMBL5853,7.472370099,DGAT,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752639,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H](c1nc2cnc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CHEMBL3894990,nM,43,CHEMBL5853,7.366531544,DGAT,CC(c1nc2cnc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CC(c1nc2cnc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752640,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H](c1nc2cnc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CHEMBL4110005,nM,18.9,CHEMBL5853,7.723538196,DGAT,CC(c1nc2cnc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,CC(c1nc2cnc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752641,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CC(F)(F)C1,CHEMBL4114023,nM,74.2,CHEMBL5853,7.129596095,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CC(F)(F)C1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CC(F)(F)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752642,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CCCN1C(=O)[C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1,CHEMBL4114906,nM,91,CHEMBL5853,7.040958608,DGAT,C[C@@H]1CCCN1C(=O)C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1,CC1CCCN1C(=O)C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752643,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H]1CCCN1C(=O)[C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1,CHEMBL3909393,nM,321,CHEMBL5853,6.493494968,DGAT,C[C@H]1CCCN1C(=O)C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1,CC1CCCN1C(=O)C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752644,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5cnccn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107534,nM,176,CHEMBL5853,6.754487332,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cnccn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cnccn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752645,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5ncccn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112996,nM,656,CHEMBL5853,6.183096161,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ncccn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5ncccn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752646,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCC1,CHEMBL4106849,nM,188,CHEMBL5853,6.725842151,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752647,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCOCC1,CHEMBL4110809,nM,246,CHEMBL5853,6.609064893,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCOCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCOCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752648,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CCN(c2ncc3nc(C4(n5cccn5)CC4)[nH]c3n2)C[C@@H]1C(=O)N1CCCC1,CHEMBL4107225,nM,702,CHEMBL5853,6.153662888,DGAT,C[C@@H]1CCN(c2ncc3[nH]c(C4(n5cccn5)CC4)nc3n2)CC1C(=O)N1CCCC1,CC1CCN(c2ncc3[nH]c(C4(n5cccn5)CC4)nc3n2)CC1C(=O)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752649,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H]1CCN(c2ncc3nc(C4(n5cccn5)CC4)[nH]c3n2)C[C@@H]1C(=O)N1CCCC1,CHEMBL3903958,nM,37400,CHEMBL5853,4.427128398,DGAT,C[C@H]1CCN(c2ncc3[nH]c(C4(n5cccn5)CC4)nc3n2)CC1C(=O)N1CCCC1,CC1CCN(c2ncc3[nH]c(C4(n5cccn5)CC4)nc3n2)CC1C(=O)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752650,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ncc3nc(C4(n5cc(F)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4112762,nM,101,CHEMBL5853,6.995678626,DGAT,O=C(C1CCCN(c2ncc3[nH]c(C4(n5cc(F)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ncc3[nH]c(C4(n5cc(F)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752651,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ncc3nc(C4(n5cccn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4108476,nM,342,CHEMBL5853,6.465973894,DGAT,O=C(C1CCCN(c2ncc3[nH]c(C4(n5cccn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ncc3[nH]c(C4(n5cccn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752652,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C(Nc1ccc(C(F)(F)F)nc1)c1nc2ccc(N3CCC[C@@H](C(=O)N4CCCC4)C3)nc2[nH]1,CHEMBL4110844,nM,845,CHEMBL5853,6.073143291,DGAT,O=C(Nc1ccc(C(F)(F)F)nc1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,O=C(Nc1ccc(C(F)(F)F)nc1)c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752653,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CC=CC1,CHEMBL4111278,nM,18.9,CHEMBL5853,7.723538196,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CC=CC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CC=CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752654,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@H]1CN(c2ncc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)CCO1)N1CCCC1,CHEMBL4110539,nM,161,CHEMBL5853,6.793174124,DGAT,O=C(C1CN(c2ncc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)CCO1)N1CCCC1,O=C(C1CN(c2ncc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)CCO1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752655,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5nccn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4114566,nM,396,CHEMBL5853,6.402304814,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5nccn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5nccn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752656,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(n5ccnc5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4107414,nM,483,CHEMBL5853,6.316052869,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5ccnc5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5ccnc5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752657,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H]1CC[C@@H](C(=O)N2CCCC2)CN1c1ccc2nc(C3(n4cc(Cl)cn4)CC3)[nH]c2n1,CHEMBL3947663,nM,9200,CHEMBL5853,5.036212173,DGAT,C[C@H]1CCC(C(=O)N2CCCC2)CN1c1ccc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,CC1CCC(C(=O)N2CCCC2)CN1c1ccc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752658,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CC[C@@H](C(=O)N2CCCC2)CN1c1ccc2nc(C3(n4cc(Cl)cn4)CC3)[nH]c2n1,CHEMBL4110625,nM,131,CHEMBL5853,6.882728704,DGAT,C[C@@H]1CCC(C(=O)N2CCCC2)CN1c1ccc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,CC1CCC(C(=O)N2CCCC2)CN1c1ccc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752659,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@H]1CC[C@@H](C(=O)N2CCCC2)CN1c1ncc2nc(C3(n4cc(Cl)cn4)CC3)[nH]c2n1,CHEMBL3941164,nM,2310,CHEMBL5853,5.63638802,DGAT,C[C@H]1CCC(C(=O)N2CCCC2)CN1c1ncc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,CC1CCC(C(=O)N2CCCC2)CN1c1ncc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752660,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,C[C@@H]1CC[C@@H](C(=O)N2CCCC2)CN1c1ncc2nc(C3(n4cc(Cl)cn4)CC3)[nH]c2n1,CHEMBL4111752,nM,82.8,CHEMBL5853,7.081969663,DGAT,C[C@@H]1CCC(C(=O)N2CCCC2)CN1c1ncc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,CC1CCC(C(=O)N2CCCC2)CN1c1ncc2[nH]c(C3(n4cc(Cl)cn4)CC3)nc2n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752661,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1)N1CCC1,CHEMBL4111132,nM,270,CHEMBL5853,6.568636236,DGAT,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC1,O=C(C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1)N1CCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752662,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,CN(CC1CC1)C(=O)[C@@H]1CCCN(c2ccc3nc(-c4ccnc(C5CC5)n4)[nH]c3n2)C1,CHEMBL4113001,nM,290,CHEMBL5853,6.537602002,DGAT,CN(CC1CC1)C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,CN(CC1CC1)C(=O)C1CCCN(c2ccc3[nH]c(-c4ccnc(C5CC5)n4)nc3n2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752663,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,O=C([C@@H]1CCCN(c2ccc3nc(C4(c5cccnn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4113662,nM,531,CHEMBL5853,6.274905479,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cccnn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(c5cccnn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
17752664,CHEMBL3888181,"In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.",B,Cn1ncnc1C1(c2nc3ccc(N4CCC[C@@H](C(=O)N5CCCC5)C4)nc3[nH]2)CC1,CHEMBL4106752,nM,1370,CHEMBL5853,5.863279433,DGAT,Cn1ncnc1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Cn1ncnc1C1(c2nc3ccc(N4CCCC(C(=O)N5CCCC5)C4)nc3[nH]2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
18738848,CHEMBL4261855,Inhibition of human DGAT2,B,CS(=O)(=O)O.O=C([C@@H]1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCCC1,CHEMBL4278523,nM,17,CHEMBL5853,7.769551079,DGAT,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,O=C(C1CCCN(c2ccc3[nH]c(C4(n5cc(Cl)cn5)CC4)nc3n2)C1)N1CCCC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19005367,CHEMBL4344285,Inhibition of recombinant FLAG-tagged human DGAT2 expressed in SF9 cells after 1 hr by TopCount assay,B,CN1CCN(c2nc(CNc3ncc(Cl)cn3)cc(Oc3ccc(CS(N)(=O)=O)cc3)n2)CC1,CHEMBL4530491,nM,579,CHEMBL5853,6.237321436,DGAT,CN1CCN(c2nc(CN=c3ncc(Cl)c[nH]3)cc(Oc3ccc(CS(N)(=O)=O)cc3)n2)CC1,CN1CCN(c2nc(CN=c3ncc(Cl)c[nH]3)cc(Oc3ccc(CS(N)(=O)=O)cc3)n2)CC1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19005368,CHEMBL4344285,Inhibition of recombinant FLAG-tagged human DGAT2 expressed in SF9 cells after 1 hr by TopCount assay,B,CCOc1cccnc1Cc1cncc(-c2ncc(C(=O)N[C@H]3CCOC3)cn2)c1,CHEMBL4456029,nM,17,CHEMBL5853,7.769551079,DGAT,CCOc1cccnc1Cc1cncc(-c2ncc(C(=O)N[C@H]3CCOC3)cn2)c1,CCOc1cccnc1Cc1cncc(-c2ncc(C(=O)NC3CCOC3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
19115265,CHEMBL4371686,Inhibition of recombinant human DGAT2,B,CC(C)(C)c1cc(C(C)(C)C)nc(N2CCn3c(nnc3-c3ccc(OC(F)(F)F)cc3)C2)n1,CHEMBL4452833,nM,30000,CHEMBL5853,4.522878745,DGAT,CC(C)(C)c1cc(C(C)(C)C)nc(N2CCn3c(nnc3-c3ccc(OC(F)(F)F)cc3)C2)n1,CC(C)(C)c1cc(C(C)(C)C)nc(N2CCn3c(nnc3-c3ccc(OC(F)(F)F)cc3)C2)n1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23234156,CHEMBL4827630,Inhibition of DGAT2 in human hepatocytes using [14C]-glycerol as substrate preincubated for 15 mins followed by substrate addition and measured after 3 hrs by thin layer chromatography,B,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNC[C@@H](F)C3)cn2)c1,CHEMBL4877520,nM,4.1,CHEMBL5853,8.387216143,DGAT,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNC[C@@H](F)C3)cn2)c1,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)NC3CNCC(F)C3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23234157,CHEMBL4827630,Inhibition of DGAT2 in human hepatocytes using [14C]-glycerol as substrate preincubated for 15 mins followed by substrate addition and measured after 3 hrs by thin layer chromatography,B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNCC[C@@H]3F)cn2)c1,CHEMBL4867621,nM,23,CHEMBL5853,7.638272164,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNCC[C@@H]3F)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CNCCC3F)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23234158,CHEMBL4827630,Inhibition of DGAT2 in human hepatocytes using [14C]-glycerol as substrate preincubated for 15 mins followed by substrate addition and measured after 3 hrs by thin layer chromatography,B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNC[C@@H](F)C3)cn2)c1,CHEMBL4875314,nM,11,CHEMBL5853,7.958607315,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNC[C@@H](F)C3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CNCC(F)C3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23234159,CHEMBL4827630,Inhibition of DGAT2 in human hepatocytes using [14C]-glycerol as substrate preincubated for 15 mins followed by substrate addition and measured after 3 hrs by thin layer chromatography,B,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNCC[C@H]3F)cn2)c1,CHEMBL4868285,nM,2.4,CHEMBL5853,8.619788758,DGAT,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNCC[C@H]3F)cn2)c1,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)NC3CNCCC3F)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23234160,CHEMBL4827630,Inhibition of DGAT2 in human hepatocytes using [14C]-glycerol as substrate preincubated for 15 mins followed by substrate addition and measured after 3 hrs by thin layer chromatography,B,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)N[C@H]3CNCC[C@@H]3F)cn2)c1.O=CO,CHEMBL4845799,nM,3.8,CHEMBL5853,8.420216403,DGAT,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)N[C@H]3CNCC[C@@H]3F)cn2)c1,CCOc1cc(F)cnc1Oc1cncc(-c2ncc(C(=O)NC3CNCCC3F)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
23234161,CHEMBL4827630,Inhibition of DGAT2 in human hepatocytes using [14C]-glycerol as substrate preincubated for 15 mins followed by substrate addition and measured after 3 hrs by thin layer chromatography,B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNCC(F)(F)C3)cn2)c1,CHEMBL4873964,nM,20,CHEMBL5853,7.698970004,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CNCC(F)(F)C3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CNCC(F)(F)C3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670789,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1ccccc1O[C@@H]1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1,CHEMBL5190860,nM,7.9,CHEMBL5853,8.102372909,DGAT,CCOc1ccccc1O[C@@H]1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1,CCOc1ccccc1OC1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670790,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1O[C@@H]1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1,CHEMBL5207410,nM,31.8,CHEMBL5853,7.49757288,DGAT,CCOc1cccnc1O[C@@H]1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1,CCOc1cccnc1OC1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670792,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3(CO)CCOC3)cn2)c1,CHEMBL5172773,nM,29.5,CHEMBL5853,7.530177984,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3(CO)CCOC3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3(CO)CCOC3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670795,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CCOC3)cn2)c1,CHEMBL5202498,nM,200,CHEMBL5853,6.698970004,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)N[C@@H]3CCOC3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCOC3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670796,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCCOC3)cn2)c1,CHEMBL5176366,nM,11.5,CHEMBL5853,7.93930216,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCCOC3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCCOC3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670797,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCOCC3)cn2)c1,CHEMBL5171697,nM,353,CHEMBL5853,6.452225295,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCOCC3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCOCC3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670798,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCS(=O)(=O)C3)cn2)c1,CHEMBL5183303,nM,196,CHEMBL5853,6.707743929,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCS(=O)(=O)C3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CCS(=O)(=O)C3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670799,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CC(=O)N(C)C3)cn2)c1,CHEMBL5173066,nM,501,CHEMBL5853,6.300162274,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CC(=O)N(C)C3)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC3CC(=O)N(C)C3)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670800,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCNC(=O)c1cnc(-c2cncc(Oc3ncccc3OCC)c2)nc1,CHEMBL5176043,nM,84.6,CHEMBL5853,7.072629637,DGAT,CCNC(=O)c1cnc(-c2cncc(Oc3ncccc3OCC)c2)nc1,CCNC(=O)c1cnc(-c2cncc(Oc3ncccc3OCC)c2)nc1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670801,CHEMBL5099705,"Inhibition of human DGAT2 expressed in Sf9 insect cell membrane using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates assessed as incorporation of [1-14C]decanoyl into triacylglycerol preincubated for 120 mins followed by substrate addition and measured after 40 mins by scintillation counting method",B,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC(C)(C)CS(C)(=O)=O)cn2)c1,CHEMBL5188261,nM,35.4,CHEMBL5853,7.450996738,DGAT,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC(C)(C)CS(C)(=O)=O)cn2)c1,CCOc1cccnc1Oc1cncc(-c2ncc(C(=O)NC(C)(C)CS(C)(=O)=O)cn2)c1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24670910,CHEMBL5099763,Inhibition of DGAT2 (unknown origin),B,CCOc1ccccc1O[C@@H]1CCCN(c2ncc(C(=O)NCc3cccc(C(=O)O)c3)cn2)C1,CHEMBL5179535,nM,91.8,CHEMBL5853,7.037157319,DGAT,CCOc1ccccc1O[C@@H]1CCCN(c2ncc(C(=O)NCc3cccc(C(=O)O)c3)cn2)C1,CCOc1ccccc1OC1CCCN(c2ncc(C(=O)NCc3cccc(C(=O)O)c3)cn2)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24770039,CHEMBL5126025,Inhibition of human DGAT2 expressed in sf9 insect cell membrane assessed as reduction in 13C18-triolein product formation using 13C oleoyl-CoA as substrate by LC-MS/MS analysis,B,CC1(NC(=O)c2ccc3c(c2)n(-c2ccc(F)cc2)c(=O)n3-c2cccc(OC(F)F)c2)CS(=O)(=O)C1,CHEMBL5184213,nM,1.8,CHEMBL5853,8.744727495,DGAT,CC1(NC(=O)c2ccc3c(c2)n(-c2ccc(F)cc2)c(=O)n3-c2cccc(OC(F)F)c2)CS(=O)(=O)C1,CC1(NC(=O)c2ccc3c(c2)n(-c2ccc(F)cc2)c(=O)n3-c2cccc(OC(F)F)c2)CS(=O)(=O)C1,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24770040,CHEMBL5126025,Inhibition of human DGAT2 expressed in sf9 insect cell membrane assessed as reduction in 13C18-triolein product formation using 13C oleoyl-CoA as substrate by LC-MS/MS analysis,B,CC(n1c(=O)n(-c2cc(OC(F)F)ccc2F)c2ccc(C(=O)NC3(C)CS(=O)(=O)C3)cc21)C(C)(C)O,CHEMBL5203547,nM,0.7,CHEMBL5853,9.15490196,DGAT,CC(n1c(=O)n(-c2cc(OC(F)F)ccc2F)c2ccc(C(=O)NC3(C)CS(=O)(=O)C3)cc21)C(C)(C)O,CC(n1c(=O)n(-c2cc(OC(F)F)ccc2F)c2ccc(C(=O)NC3(C)CS(=O)(=O)C3)cc21)C(C)(C)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24770041,CHEMBL5126025,Inhibition of human DGAT2 expressed in sf9 insect cell membrane assessed as reduction in 13C18-triolein product formation using 13C oleoyl-CoA as substrate by LC-MS/MS analysis,B,CC(n1c(=O)n(-c2cc(OC(F)F)ccc2F)c2ccc(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CHEMBL5179522,nM,1.1,CHEMBL5853,8.958607315,DGAT,CC(n1c(=O)n(-c2cc(OC(F)F)ccc2F)c2ccc(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CC(n1c(=O)n(-c2cc(OC(F)F)ccc2F)c2ccc(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24770042,CHEMBL5126025,Inhibition of human DGAT2 expressed in sf9 insect cell membrane assessed as reduction in 13C18-triolein product formation using 13C oleoyl-CoA as substrate by LC-MS/MS analysis,B,CC(n1c(=O)n(-c2cccc(OC(F)F)c2)c2ccc(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CHEMBL5188169,nM,1.6,CHEMBL5853,8.795880017,DGAT,CC(n1c(=O)n(-c2cccc(OC(F)F)c2)c2ccc(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CC(n1c(=O)n(-c2cccc(OC(F)F)c2)c2ccc(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24770043,CHEMBL5126025,Inhibition of human DGAT2 expressed in sf9 insect cell membrane assessed as reduction in 13C18-triolein product formation using 13C oleoyl-CoA as substrate by LC-MS/MS analysis,B,CC(n1c(=O)n(-c2cc(OC(F)(F)F)ccc2F)c2cc(F)c(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CHEMBL5202996,nM,1,CHEMBL5853,9,DGAT,CC(n1c(=O)n(-c2cc(OC(F)(F)F)ccc2F)c2cc(F)c(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CC(n1c(=O)n(-c2cc(OC(F)(F)F)ccc2F)c2cc(F)c(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
24770044,CHEMBL5126025,Inhibition of human DGAT2 expressed in sf9 insect cell membrane assessed as reduction in 13C18-triolein product formation using 13C oleoyl-CoA as substrate by LC-MS/MS analysis,B,CC(n1c(=O)n(-c2cc(OCC(F)F)ccc2F)c2cc(F)c(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CHEMBL5194578,nM,1.5,CHEMBL5853,8.823908741,DGAT,CC(n1c(=O)n(-c2cc(OCC(F)F)ccc2F)c2cc(F)c(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,CC(n1c(=O)n(-c2cc(OCC(F)F)ccc2F)c2cc(F)c(C(=O)NC3(C)CCS(=O)(=O)CC3)cc21)C(C)(C)O,Diacylglycerol acyltransferase (DGAT),Diacylglycerol acyltransferase (DGAT)
106644,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,C[C@H](N)C(=O)N1CCCC1,CHEMBL443622,nM,41000,CHEMBL284,4.387216143,DPPIV,CC(N)C(=O)N1CCCC1,CC(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
106647,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,O=C([C@@H]1CCCN1)N1CCCC1,CHEMBL403882,nM,15000,CHEMBL284,4.823908741,DPPIV,O=C(C1CCCN1)N1CCCC1,O=C(C1CCCN1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
111673,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,NC(Cc1ccc(O)cc1)C(=O)N1CCCC1,CHEMBL317126,nM,14000,CHEMBL284,4.853871964,DPPIV,NC(Cc1ccc(O)cc1)C(=O)N1CCCC1,NC(Cc1ccc(O)cc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
113099,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CC(C)[C@H](N)C(=O)N1CCCC1,CHEMBL383705,nM,4000,CHEMBL284,5.397940009,DPPIV,CC(C)C(N)C(=O)N1CCCC1,CC(C)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
121780,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,N[C@@H](CC1CCCCC1)C(=O)N1CCCC1,CHEMBL98008,nM,17000,CHEMBL284,4.769551079,DPPIV,NC(CC1CCCCC1)C(=O)N1CCCC1,NC(CC1CCCCC1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
127135,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,NC(Cc1c[nH]cn1)C(=O)N1CCCC1,CHEMBL317944,nM,23210,CHEMBL284,4.63432486,DPPIV,NC(Cc1c[nH]cn1)C(=O)N1CCCC1,NC(Cc1c[nH]cn1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
128208,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CCC(C)C(N)C(=O)N1CCCCC1,CHEMBL93507,nM,67000,CHEMBL284,4.173925197,DPPIV,CCC(C)C(N)C(=O)N1CCCCC1,CCC(C)C(N)C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
129486,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,NC(Cc1ccccc1)C(=O)N1CCCC1,CHEMBL93931,nM,21000,CHEMBL284,4.677780705,DPPIV,NC(Cc1ccccc1)C(=O)N1CCCC1,NC(Cc1ccccc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
140459,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CC[C@H](C)[C@H](N)C(=O)N1CCCC1,CHEMBL503274,nM,4000,CHEMBL284,5.397940009,DPPIV,CCC(C)C(N)C(=O)N1CCCC1,CCC(C)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
141671,CHEMBL666573,In vitro inhibition of human Dipeptidylpeptidase IV.,B,NCCCCC(N)C(=O)N1CCCC1,CHEMBL328694,nM,39000,CHEMBL284,4.408935393,DPPIV,NCCCCC(N)C(=O)N1CCCC1,NCCCCC(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
148825,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL1790478,nM,190,CHEMBL284,6.721246399,DPPIV,CC(=O)C(N)C(O)N1CCC[C@H]1B(O)O,CC(=O)C(N)C(O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
149953,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL66032,nM,11,CHEMBL284,7.958607315,DPPIV,CCC(N)C(=O)N1CCC[C@H]1B(O)O,CCC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
149954,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,NCCCC[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL63726,nM,95,CHEMBL284,7.022276395,DPPIV,NCCCCC(N)C(=O)N1CCC[C@H]1B(O)O,NCCCCC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
153638,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL303131,nM,17000,CHEMBL284,4.769551079,DPPIV,NC(Cc1c[nH]cn1)C(=O)N1CCC[C@H]1B(O)O,NC(Cc1c[nH]cn1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
154815,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,O=C([C@@H]1CCN1)N1CCC[C@H]1B(O)O,CHEMBL292342,nM,250,CHEMBL284,6.602059991,DPPIV,O=C(C1CCN1)N1CCC[C@H]1B(O)O,O=C(C1CCN1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
158513,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC(C)C[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL63698,nM,44,CHEMBL284,7.356547324,DPPIV,CC(C)CC(N)C(=O)N1CCC[C@H]1B(O)O,CC(C)CC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
158514,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCC[C@H]1B(O)O)c1ccccc1,CHEMBL291428,nM,63,CHEMBL284,7.200659451,DPPIV,NC(C(=O)N1CCC[C@H]1B(O)O)c1ccccc1,NC(C(=O)N1CCCC1B(O)O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
159693,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC(C)(N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL66189,nM,30000,CHEMBL284,4.522878745,DPPIV,CC(C)(N)C(=O)N1CCC[C@H]1B(O)O,CC(C)(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
165758,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL1790483,nM,25,CHEMBL284,7.602059991,DPPIV,CCC(C)C(N)C(=O)N1CCC[C@H]1B(O)O,CCC(C)C(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
168408,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL67279,nM,26,CHEMBL284,7.585026652,DPPIV,CC(C)C(N)C(=O)N1CCC[C@H]1B(O)O,CC(C)C(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
168411,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,C[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL63860,nM,15,CHEMBL284,7.823908741,DPPIV,CC(N)C(=O)N1CCC[C@H]1B(O)O,CC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
172023,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,NCC(=O)N1CCC[C@H]1B(O)O,CHEMBL67089,nM,16000,CHEMBL284,4.795880017,DPPIV,NCC(=O)N1CCC[C@H]1B(O)O,NCC(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
173235,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC(C)[C@@H](N)C(=O)N1CCC[C@@H]1B(O)O,CHEMBL65406,nM,4000,CHEMBL284,5.397940009,DPPIV,CC(C)C(N)C(=O)N1CCC[C@@H]1B(O)O,CC(C)C(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
173238,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL304007,nM,32,CHEMBL284,7.494850022,DPPIV,NC(Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1B(O)O,NC(Cc1ccc(O)cc1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
176780,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL63652,nM,70,CHEMBL284,7.15490196,DPPIV,NC(Cc1ccccc1)C(=O)N1CCC[C@H]1B(O)O,NC(Cc1ccccc1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
178094,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,CC(C)(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL63406,nM,60,CHEMBL284,7.22184875,DPPIV,CC(C)(C)C(N)C(=O)N1CCC[C@H]1B(O)O,CC(C)(C)C(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
180579,CHEMBL665783,In vitro for inhibition of Dipeptidylpeptidase IV.,B,O=C([C@@H]1CCCN1)N1CCC[C@H]1B(O)O,CHEMBL63895,nM,20,CHEMBL284,7.698970004,DPPIV,O=C(C1CCCN1)N1CCC[C@H]1B(O)O,O=C(C1CCCN1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
270838,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,O=C([C@@H]1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL1182947,nM,32000,CHEMBL284,4.494850022,DPPIV,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
272162,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.O=C([C@@H]1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL273694,nM,10000,CHEMBL284,5,DPPIV,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
272163,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL265344,nM,400,CHEMBL284,6.397940009,DPPIV,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
273306,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,COP(=O)(Oc1ccccc1-c1ccccc1O)C1CCCN1C(=O)[C@@H]1CCCN1.Cl,CHEMBL9237,nM,47000,CHEMBL284,4.327902142,DPPIV,COP(=O)(Oc1ccccc1-c1ccccc1O)C1CCCN1C(=O)C1CCCN1,COP(=O)(Oc1ccccc1-c1ccccc1O)C1CCCN1C(=O)C1CCCN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
275679,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.O=C([C@@H]1CCCN1)N1CCCC1P1(=O)Oc2ccccc2-c2ccccc2O1,CHEMBL9724,nM,31000,CHEMBL284,4.508638306,DPPIV,O=C(C1CCCN1)N1CCCC1P1(=O)Oc2ccccc2-c2ccccc2O1,O=C(C1CCCN1)N1CCCC1P1(=O)Oc2ccccc2-c2ccccc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
277073,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,COc1ccc(OP(=O)(Oc2ccc(OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL9561,nM,22000,CHEMBL284,4.657577319,DPPIV,COc1ccc(OP(=O)(Oc2ccc(OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,COc1ccc(OP(=O)(Oc2ccc(OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
277076,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,COC(=O)CCNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCCC(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL9238,nM,36,CHEMBL284,7.443697499,DPPIV,COC(=O)CCNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCCC(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,COC(=O)CCNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCCC(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
282949,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.NCC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)CN)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CHEMBL9512,nM,500,CHEMBL284,6.301029996,DPPIV,NCC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)CN)cc2)C2CCCN2C(=O)C2CCCN2)cc1,NCC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)CN)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
282952,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,C[C@H](N)C(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)[C@@H](C)N)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL269209,nM,600,CHEMBL284,6.22184875,DPPIV,CC(N)C(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)C(C)N)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CC(N)C(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)C(C)N)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
286460,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.O=C([C@H]1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL273851,nM,5000,CHEMBL284,5.301029996,DPPIV,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
290166,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CCCNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL9295,nM,30,CHEMBL284,7.522878745,DPPIV,CCCNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CCCNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
291262,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.O=C(CNC(=O)c1ccccc1)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)CNC(=O)c3ccccc3)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CHEMBL269757,nM,700,CHEMBL284,6.15490196,DPPIV,O=C(CNC(=O)c1ccccc1)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)CNC(=O)c3ccccc3)cc2)C2CCCN2C(=O)C2CCCN2)cc1,O=C(CNC(=O)c1ccccc1)Nc1ccc(OP(=O)(Oc2ccc(NC(=O)CNC(=O)c3ccccc3)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
292601,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CC(=O)Nc1cccc(OP(=O)(Oc2cccc(NC(C)=O)c2)C2CCCN2C(=O)C2CCCN2)c1.Cl,CHEMBL9263,nM,800,CHEMBL284,6.096910013,DPPIV,CC(=O)Nc1cccc(OP(=O)(Oc2cccc(NC(C)=O)c2)C2CCCN2C(=O)C2CCCN2)c1,CC(=O)Nc1cccc(OP(=O)(Oc2cccc(NC(C)=O)c2)C2CCCN2C(=O)C2CCCN2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
296408,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CS(=O)(=O)Nc1ccc(OP(=O)(Oc2ccc(NS(C)(=O)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL9433,nM,400,CHEMBL284,6.397940009,DPPIV,CS(=O)(=O)Nc1ccc(OP(=O)(Oc2ccc(NS(C)(=O)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CS(=O)(=O)Nc1ccc(OP(=O)(Oc2ccc(NS(C)(=O)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
297737,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,COC(=O)C(Cc1ccc(OP(=O)(Oc2ccc(CC(NC(C)=O)C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1)NC(C)=O.Cl,CHEMBL268527,nM,1400,CHEMBL284,5.853871964,DPPIV,COC(=O)C(Cc1ccc(OP(=O)(Oc2ccc(CC(NC(C)=O)C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1)NC(C)=O,COC(=O)C(Cc1ccc(OP(=O)(Oc2ccc(CC(NC(C)=O)C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1)NC(C)=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
298915,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,COC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL9408,nM,16,CHEMBL284,7.795880017,DPPIV,COC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,COC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
301601,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.NC(=O)Nc1cccc(OP(=O)(OC2=CC=CC(NC(N)=O)C2)C2CCCN2C(=O)C2CCCN2)c1,CHEMBL430281,nM,2300,CHEMBL284,5.638272164,DPPIV,NC(=O)Nc1cccc(OP(=O)(OC2=CC=CC(NC(N)=O)C2)C2CCCN2C(=O)C2CCCN2)c1,NC(=O)Nc1cccc(OP(=O)(OC2=CC=CC(NC(N)=O)C2)C2CCCN2C(=O)C2CCCN2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
301604,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1.Cl,CHEMBL274829,nM,23,CHEMBL284,7.638272164,DPPIV,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
302763,CHEMBL666617,In vitro inhibition of human Dipeptidylpeptidase IV.,B,Cl.O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccc(NN2CCCC2)cc1)Oc1ccc(NN2CCCC2)cc1,CHEMBL9527,nM,5000,CHEMBL284,5.301029996,DPPIV,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccc(NN2CCCC2)cc1)Oc1ccc(NN2CCCC2)cc1,O=C(C1CCCN1)N1CCCC1P(=O)(Oc1ccc(NN2CCCC2)cc1)Oc1ccc(NN2CCCC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
304307,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)C1CCCCC1,CHEMBL278393,nM,320,CHEMBL284,6.494850022,DPPIV,NC(C(=O)N1CCCC1)C1CCCCC1,NC(C(=O)N1CCCC1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
305623,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,CC[C@H](C)[C@H](N)C(=O)N1CCSC1,CHEMBL98408,nM,420,CHEMBL284,6.37675071,DPPIV,CCC(C)C(N)C(=O)N1CCSC1,CCC(C)C(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
306963,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL1682974,nM,33,CHEMBL284,7.48148606,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
308219,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1,CHEMBL22359,nM,53,CHEMBL284,7.27572413,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
308225,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL22679,nM,94,CHEMBL284,7.026872146,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
309669,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N#Cc1cccc(S(=O)(=O)N[C@H]2CC[C@H]([C@H](N)C(=O)N3CCSC3)CC2)c1,CHEMBL3084936,nM,24,CHEMBL284,7.619788758,DPPIV,N#Cc1cccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCSC3)CC2)c1,N#Cc1cccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCSC3)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
309671,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL3084942,nM,18,CHEMBL284,7.744727495,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc3ccccc3c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc3ccccc3c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
309673,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2cccc3ccccc23)CC1,CHEMBL3084949,nM,15,CHEMBL284,7.823908741,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2cccc3ccccc23)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2cccc3ccccc23)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
309679,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)Nc2ccc(F)c(F)c2)CC1,CHEMBL3084939,nM,35,CHEMBL284,7.455931956,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(F)c(F)c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(F)c(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
310881,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(I)cc2)CC1,CHEMBL3084935,nM,23,CHEMBL284,7.638272164,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc(I)cc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc(I)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
310883,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)c(F)c2F)CC1,CHEMBL3084943,nM,24,CHEMBL284,7.619788758,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc(F)c(F)c2F)CC1,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc(F)c(F)c2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
312313,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)Nc2ccc(Cl)c(Cl)c2)CC1,CHEMBL3084954,nM,17,CHEMBL284,7.769551079,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(Cl)c(Cl)c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(Cl)c(Cl)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
314912,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,CN(C)C(=O)Nc1ccc(S(=O)(=O)N[C@H]2CC[C@H]([C@H](N)C(=O)N3CCSC3)CC2)cc1,CHEMBL3084937,nM,7.5,CHEMBL284,8.124938737,DPPIV,CN(C)C(=O)Nc1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCSC3)CC2)cc1,CN(C)C(=O)Nc1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCSC3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
318589,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,CN(C)C(=O)Nc1ccc(S(=O)(=O)N[C@H]2CC[C@H]([C@H](N)C(=O)N3CCCC3)CC2)cc1,CHEMBL3084938,nM,26,CHEMBL284,7.585026652,DPPIV,CN(C)C(=O)Nc1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCCC3)CC2)cc1,CN(C)C(=O)Nc1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCCC3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
319705,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1,CHEMBL25437,nM,88,CHEMBL284,7.055517328,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
320945,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1,CHEMBL278558,nM,190,CHEMBL284,6.721246399,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
322177,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL23176,nM,25,CHEMBL284,7.602059991,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
323637,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)c2cncc3ccccc23)CC1,CHEMBL3084940,nM,64,CHEMBL284,7.193820026,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2cncc3ccccc23)CC1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2cncc3ccccc23)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
324718,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc(Cl)c(Cl)c2)CC1,CHEMBL3084946,nM,38,CHEMBL284,7.420216403,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(Cl)c(Cl)c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(Cl)c(Cl)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
325933,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,CHEMBL142703,nM,34,CHEMBL284,7.468521083,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,N#CC1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
325935,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc(I)cc2)CC1,CHEMBL3084947,nM,33,CHEMBL284,7.48148606,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(I)cc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc(I)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
327148,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N#Cc1ccc(NCCNCC(=O)N2CCC[C@H]2C#N)nc1,CHEMBL77538,nM,22,CHEMBL284,7.657577319,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2CCC[C@H]2C#N)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2CCCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
327150,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)OCc2cccc3ccccc23)CC1,CHEMBL3084952,nM,17,CHEMBL284,7.769551079,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2cccc3ccccc23)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2cccc3ccccc23)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
331193,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2cnc3ccccc3c2)CC1,CHEMBL3084956,nM,9,CHEMBL284,8.045757491,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2cnc3ccccc3c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2cnc3ccccc3c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
331195,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL23979,nM,89,CHEMBL284,7.050609993,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
334012,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc3ccccc3c2)CC1,CHEMBL3084948,nM,21,CHEMBL284,7.677780705,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc3ccccc3c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccc3ccccc3c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
335217,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,CHEMBL3084955,nM,55,CHEMBL284,7.259637311,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
335219,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)c(F)c2F)CC1,CHEMBL3084941,nM,98,CHEMBL284,7.008773924,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(F)c(F)c2F)CC1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(F)c(F)c2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
335221,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(NS(=O)(=O)CC(F)(F)F)cc2)CC1,CHEMBL497992,nM,2.6,CHEMBL284,8.585026652,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(NS(=O)(=O)CC(F)(F)F)cc2)CC1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(NS(=O)(=O)CC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
336424,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)Nc2ccc(I)cc2)CC1,CHEMBL3084953,nM,10,CHEMBL284,8,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(I)cc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2ccc(I)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
337683,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)c2cccc3ccccc23)CC1,CHEMBL3084944,nM,46,CHEMBL284,7.337242168,DPPIV,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2cccc3ccccc23)CC1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2cccc3ccccc23)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
341675,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL25211,nM,22,CHEMBL284,7.657577319,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCSC1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
341681,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)OCc2ccc3ccccc3c2)CC1,CHEMBL3084951,nM,20,CHEMBL284,7.698970004,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2ccc3ccccc3c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2ccc3ccccc3c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
344023,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](N)CC1,CHEMBL3084945,nM,2700,CHEMBL284,5.568636236,DPPIV,NC(C(=O)N1CCSC1)[C@H]1CC[C@H](N)CC1,NC1CCC(C(N)C(=O)N2CCSC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
344025,CHEMBL664532,Inhibitory activity against dipeptidylpeptidase IV.,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)OCc2ccc(Cl)c(Cl)c2)CC1,CHEMBL3084950,nM,29,CHEMBL284,7.537602002,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2ccc(Cl)c(Cl)c2)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)OCc2ccc(Cl)c(Cl)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
431858,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2cc(OC)c(OC)cc12.Cl,CHEMBL544475,nM,3400,CHEMBL284,5.468521083,DPPIV,CCOC(=O)c1cnc(CN)c2cc(OC)c(OC)cc12,CCOC(=O)c1cnc(CN)c2cc(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
434431,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,COc1cc2c(CO)cnc(CN)c2cc1OC.Cl,CHEMBL554880,nM,31800,CHEMBL284,4.49757288,DPPIV,COc1cc2c(CO)cnc(CN)c2cc1OC,COc1cc2c(CO)cnc(CN)c2cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
438306,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCCNC(=O)c1cnc(CN)c2cc(OC)c(OC)cc12.Cl,CHEMBL539758,nM,51400,CHEMBL284,4.289036881,DPPIV,CCCNC(=O)c1cnc(CN)c2cc(OC)c(OC)cc12,CCCNC(=O)c1cnc(CN)c2cc(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
440903,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)Nc1cnc(CN)c2cc(OC)c(OC)cc12.Cl,CHEMBL553407,nM,2300,CHEMBL284,5.638272164,DPPIV,CCOC(=O)Nc1cnc(CN)c2cc(OC)c(OC)cc12,CCOC(=O)Nc1cnc(CN)c2cc(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
443618,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2cc(OC)c(OCC)cc12.Cl,CHEMBL544717,nM,4700,CHEMBL284,5.327902142,DPPIV,CCOC(=O)c1cnc(CN)c2cc(OC)c(OCC)cc12,CCOC(=O)c1cnc(CN)c2cc(OC)c(OCC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
443980,CHEMBL664030,In vitro inhibitory activity against Dipeptidyl peptidase IV (DPP-IV) extracted from Caco-2 cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)C1CCCCC1,CHEMBL307636,nM,2,CHEMBL284,8.698970004,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)C1CCCCC1,N#CC1CCCN1C(=O)C(N)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
447741,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCCOc1cc2c(CN)ncc(C(=O)OCC)c2cc1OC.Cl,CHEMBL543062,nM,8400,CHEMBL284,5.075720714,DPPIV,CCCOc1cc2c(CN)ncc(C(=O)OCC)c2cc1OC,CCCOc1cc2c(CN)ncc(C(=O)OCC)c2cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
450327,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2c(OC)ccc(OC)c12.Cl,CHEMBL544950,nM,2400,CHEMBL284,5.619788758,DPPIV,CCOC(=O)c1cnc(CN)c2c(OC)ccc(OC)c12,CCOC(=O)c1cnc(CN)c2c(OC)ccc(OC)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
451597,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)CCc1cnc(CN)c2cc(OC)c(OC)cc12.O=C(O)C(F)(F)F,CHEMBL288207,nM,52600,CHEMBL284,4.279014256,DPPIV,CCOC(=O)CCc1cnc(CN)c2cc(OC)c(OC)cc12,CCOC(=O)CCc1cnc(CN)c2cc(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
454219,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2cc(OCC)c(OC)cc12.Cl,CHEMBL554683,nM,6700,CHEMBL284,5.173925197,DPPIV,CCOC(=O)c1cnc(CN)c2cc(OCC)c(OC)cc12,CCOC(=O)c1cnc(CN)c2cc(OCC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
460743,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)/C=C/c1cnc(CN)c2cc(OC)c(OC)cc12.O=C(O)C(F)(F)F,CHEMBL41114,nM,18000,CHEMBL284,4.744727495,DPPIV,CCOC(=O)CCc1cnc(C=N)c2cc(OC)c(OC)cc12,CCOC(=O)CCc1cnc(C=N)c2cc(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
462020,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2cc(O)c(OC)cc12.Cl,CHEMBL544478,nM,14000,CHEMBL284,4.853871964,DPPIV,CCOC(=O)c1cnc(CN)c2cc(O)c(OC)cc12,CCOC(=O)c1cnc(CN)c2cc(O)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
465901,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)Cc1cnc(CN)c2cc(OC)c(OC)cc12.Cl,CHEMBL544241,nM,17000,CHEMBL284,4.769551079,DPPIV,CCOC(=O)Cc1cnc(CN)c2cc(OC)c(OC)cc12,CCOC(=O)Cc1cnc(CN)c2cc(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
467213,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2cc(OC)c(OC)c(OC)c12.Cl,CHEMBL539500,nM,18000,CHEMBL284,4.744727495,DPPIV,CCOC(=O)c1cnc(CN)c2cc(OC)c(OC)c(OC)c12,CCOC(=O)c1cnc(CN)c2cc(OC)c(OC)c(OC)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
468572,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2c(OC)cc(OC)cc12.Cl,CHEMBL555560,nM,320,CHEMBL284,6.494850022,DPPIV,CCOC(=O)c1cnc(CN)c2c(OC)cc(OC)cc12,CCOC(=O)c1cnc(CN)c2c(OC)cc(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
470429,CHEMBL664030,In vitro inhibitory activity against Dipeptidyl peptidase IV (DPP-IV) extracted from Caco-2 cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ccc([N+](=O)[O-])cn1,CHEMBL77539,nM,8,CHEMBL284,8.096910013,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCN=c1ccc([N+](=O)[O-])c[nH]1,N#CC1CCCN1C(=O)CNCCN=c1ccc([N+](=O)[O-])c[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
471409,CHEMBL666616,In vitro inhibition of Dipeptidylpeptidase IV from Caco-2 (human colon carcinoma) cells.,B,CCOC(=O)c1cnc(CN)c2c(OC)c(OC)c(OC)cc12.Cl,CHEMBL539243,nM,1100,CHEMBL284,5.958607315,DPPIV,CCOC(=O)c1cnc(CN)c2c(OC)c(OC)c(OC)cc12,CCOC(=O)c1cnc(CN)c2c(OC)c(OC)c(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
473917,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,Cc1cccc(C)c1N1C(=O)c2ccc(N)cc2C1=O,CHEMBL283880,nM,87870.82238,CHEMBL284,4.056155309,DPPIV,Cc1cccc(C)c1N1C(=O)c2ccc(N)cc2C1=O,Cc1cccc(C)c1N1C(=O)c2ccc(N)cc2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
473923,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CC(C)c1cccc(C(C)C)c1N1C(=O)c2c(F)c(F)c(F)c(F)c2C1=S,CHEMBL151999,nM,30347.40188,CHEMBL284,4.517878484,DPPIV,CC(C)c1cccc(C(C)C)c1N1C(=O)c2c(F)c(F)c(F)c(F)c2C1=S,CC(C)c1cccc(C(C)C)c1N1C(=O)c2c(F)c(F)c(F)c(F)c2C1=S,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
478635,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccc(O)cc2C1=O,CHEMBL313952,nM,65864.33802,CHEMBL284,4.181349669,DPPIV,CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccc(O)cc2C1=O,CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccc(O)cc2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
487078,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,Cc1cccc(C)c1N1C(=O)c2cccc(N)c2C1=O,CHEMBL315471,nM,60082.61359,CHEMBL284,4.221251184,DPPIV,Cc1cccc(C)c1N1C(=O)c2cccc(N)c2C1=O,Cc1cccc(C)c1N1C(=O)c2cccc(N)c2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
488322,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CC(C)c1cccc(C(C)C)c1N1C(=O)c2cccc(O)c2C1=O,CHEMBL88474,nM,43600.33643,CHEMBL284,4.36051016,DPPIV,CC(C)c1cccc(C(C)C)c1N1C(=O)c2cccc(O)c2C1=O,CC(C)c1cccc(C(C)C)c1N1C(=O)c2cccc(O)c2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
503777,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CCc1cccc(CC)c1N1C(=O)c2ccc(O)cc2C1=O,CHEMBL88953,nM,43340.17295,CHEMBL284,4.36310936,DPPIV,CCc1cccc(CC)c1N1C(=O)c2ccc(O)cc2C1=O,CCc1cccc(CC)c1N1C(=O)c2ccc(O)cc2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
506071,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccccc2C1=S,CHEMBL329471,nM,57812.22466,CHEMBL284,4.237980318,DPPIV,CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccccc2C1=S,CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccccc2C1=S,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
506077,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,O=C(C1CCC[C@H]1B(O)O)[C@@H]1CCCN1,CHEMBL151461,nM,88596.20031,CHEMBL284,4.052584904,DPPIV,O=C(C1CCCN1)C1CCC[C@H]1B(O)O,O=C(C1CCCN1)C1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
509849,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CCc1cccc(CC)c1N1C(=O)c2cccc(O)c2C1=O,CHEMBL153096,nM,43340.17295,CHEMBL284,4.36310936,DPPIV,CCc1cccc(CC)c1N1C(=O)c2cccc(O)c2C1=O,CCc1cccc(CC)c1N1C(=O)c2cccc(O)c2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
509855,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,Cc1cccc(C)c1N1C(=O)c2ccc(O)cc2C1=O,CHEMBL424612,nM,74078.50825,CHEMBL284,4.130307772,DPPIV,Cc1cccc(C)c1N1C(=O)c2ccc(O)cc2C1=O,Cc1cccc(C)c1N1C(=O)c2ccc(O)cc2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
510947,CHEMBL666618,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV) in human acute lymphoblastic leukemia MOLT-4 cell line,B,CC(C)c1cccc(C(C)C)c1N1C(=S)c2c(F)c(F)c(F)c(F)c2C1=S,CHEMBL153037,nM,36695.99916,CHEMBL284,4.435381283,DPPIV,CC(C)c1cccc(C(C)C)c1N1C(=S)c2c(F)c(F)c(F)c(F)c2C1=S,CC(C)c1cccc(C(C)C)c1N1C(=S)c2c(F)c(F)c(F)c(F)c2C1=S,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
553346,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@@H](OC(=O)Nc2ccc(I)cc2)C1,CHEMBL169758,nM,660,CHEMBL284,6.180456064,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](OC(=O)Nc2ccc(I)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(OC(=O)Nc2ccc(I)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
553350,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CS(=O)(=O)c1ccc(S(=O)(=O)N[C@H]2CC[C@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL168986,nM,130,CHEMBL284,6.886056648,DPPIV,CS(=O)(=O)c1ccc(S(=O)(=O)N[C@H]2CCC(C(N)C(=O)N3CCCC3)C2)cc1,CS(=O)(=O)c1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
555724,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,CHEMBL366751,nM,550,CHEMBL284,6.259637311,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
555728,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@H](OC(=O)Nc2ccc(I)cc2)C1,CHEMBL172276,nM,670,CHEMBL284,6.173925197,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](OC(=O)Nc2ccc(I)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(OC(=O)Nc2ccc(I)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
555732,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@@H]2CCC[C@H]([C@H](N)C(=O)N3CCSC3)C2)cc1,CHEMBL171033,nM,83,CHEMBL284,7.080921908,DPPIV,COc1ccc(NC(=O)O[C@@H]2CCCC(C(N)C(=O)N3CCSC3)C2)cc1,COc1ccc(NC(=O)OC2CCCC(C(N)C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
555736,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CS(=O)(=O)NCCS(=O)(=O)N[C@@H]1CC[C@@H]([C@H](N)C(=O)N2CCCC2)C1,CHEMBL439836,nM,71,CHEMBL284,7.148741651,DPPIV,CS(=O)(=O)NCCS(=O)(=O)N[C@@H]1CCC(C(N)C(=O)N2CCCC2)C1,CS(=O)(=O)NCCS(=O)(=O)NC1CCC(C(N)C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
556901,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@@H](OC(=O)Nc2ccc(Cl)c(Cl)c2)C1,CHEMBL352343,nM,280,CHEMBL284,6.552841969,DPPIV,NC(C(=O)N1CCSC1)C1CC[C@@H](OC(=O)Nc2ccc(Cl)c(Cl)c2)C1,NC(C(=O)N1CCSC1)C1CCC(OC(=O)Nc2ccc(Cl)c(Cl)c2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
556905,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@@H](NS(=O)(=O)c2ccc(C(=O)O)cc2)C1,CHEMBL169962,nM,110,CHEMBL284,6.958607315,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NS(=O)(=O)c2ccc(C(=O)O)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(C(=O)O)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
559352,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@H]2CCC[C@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL352737,nM,480,CHEMBL284,6.318758763,DPPIV,COc1ccc(NC(=O)O[C@H]2CCCC(C(N)C(=O)N3CCCC3)C2)cc1,COc1ccc(NC(=O)OC2CCCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
560504,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](O)C1,CHEMBL368156,nM,840,CHEMBL284,6.075720714,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](O)C1,NC(C(=O)N1CCCC1)C1CCC(O)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
561472,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(C(=O)O)cc2)C1,CHEMBL171437,nM,72,CHEMBL284,7.142667504,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](NS(=O)(=O)c2ccc(C(=O)O)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(C(=O)O)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
562735,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CS(=O)(=O)c1ccc(S(=O)(=O)N[C@H]2CC[C@@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL433732,nM,420,CHEMBL284,6.37675071,DPPIV,CS(=O)(=O)c1ccc(S(=O)(=O)N[C@H]2CCC(C(N)C(=O)N3CCCC3)C2)cc1,CS(=O)(=O)c1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
565044,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@@H](NC(=O)Nc2cccc3ccccc23)C1,CHEMBL354576,nM,110,CHEMBL284,6.958607315,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NC(=O)Nc2cccc3ccccc23)C1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)Nc2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
565048,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,CHEMBL168866,nM,170,CHEMBL284,6.769551079,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
566179,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@@H](OC(=O)Nc2cccc(F)c2)C1,CHEMBL172631,nM,210,CHEMBL284,6.677780705,DPPIV,NC(C(=O)N1CCSC1)C1CC[C@@H](OC(=O)Nc2cccc(F)c2)C1,NC(C(=O)N1CCSC1)C1CCC(OC(=O)Nc2cccc(F)c2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
570039,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@@H](C(=O)N1CCSC1)[C@H]1CC[C@@H](OC(=O)Nc2cccc3ccccc23)C1,CHEMBL171430,nM,1700,CHEMBL284,5.769551079,DPPIV,NC(C(=O)N1CCSC1)C1CC[C@@H](OC(=O)Nc2cccc3ccccc23)C1,NC(C(=O)N1CCSC1)C1CCC(OC(=O)Nc2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
570043,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CS(=O)(=O)c1ccc(S(=O)(=O)N[C@@H]2CC[C@@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL169204,nM,13,CHEMBL284,7.886056648,DPPIV,CS(=O)(=O)c1ccc(S(=O)(=O)N[C@@H]2CCC(C(N)C(=O)N3CCCC3)C2)cc1,CS(=O)(=O)c1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
570047,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@@H]2CCC[C@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL355203,nM,180,CHEMBL284,6.744727495,DPPIV,COc1ccc(NC(=O)O[C@@H]2CCCC(C(N)C(=O)N3CCCC3)C2)cc1,COc1ccc(NC(=O)OC2CCCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
571347,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,CHEMBL171342,nM,83,CHEMBL284,7.080921908,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
571351,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CN(C)S(=O)(=O)c1ccc(S(=O)(=O)N[C@H]2CC[C@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL354936,nM,110,CHEMBL284,6.958607315,DPPIV,CN(C)S(=O)(=O)c1ccc(S(=O)(=O)N[C@H]2CCC(C(N)C(=O)N3CCCC3)C2)cc1,CN(C)S(=O)(=O)c1ccc(S(=O)(=O)NC2CCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
572554,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@@H](NC(=O)c2cccc3ccccc23)C1,CHEMBL169812,nM,230,CHEMBL284,6.638272164,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NC(=O)c2cccc3ccccc23)C1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)c2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
572558,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@@H](C(=O)N1CCSC1)[C@H]1CC[C@@H](OC(=O)Nc2cccc(F)c2)C1,CHEMBL172624,nM,1200,CHEMBL284,5.920818754,DPPIV,NC(C(=O)N1CCSC1)C1CC[C@@H](OC(=O)Nc2cccc(F)c2)C1,NC(C(=O)N1CCSC1)C1CCC(OC(=O)Nc2cccc(F)c2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
572562,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@H]2CC[C@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL355716,nM,270,CHEMBL284,6.568636236,DPPIV,COc1ccc(NC(=O)O[C@H]2CCC(C(N)C(=O)N3CCCC3)C2)cc1,COc1ccc(NC(=O)OC2CCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
573776,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2cccc3ccccc23)C1,CHEMBL353840,nM,47,CHEMBL284,7.327902142,DPPIV,NC(C(=O)N1CCSC1)C1CC[C@H](NC(=O)c2cccc3ccccc23)C1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
574920,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@@H](NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,CHEMBL169179,nM,46,CHEMBL284,7.337242168,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
576145,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@@H](OC(=O)Nc2ccccc2-c2ccccc2)C1,CHEMBL172730,nM,3900,CHEMBL284,5.408935393,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](OC(=O)Nc2ccccc2-c2ccccc2)C1,NC(C(=O)N1CCCC1)C1CCC(OC(=O)Nc2ccccc2-c2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
576149,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1,CHEMBL168281,nM,220,CHEMBL284,6.657577319,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](NS(=O)(=O)c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
577507,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@H](NC(=O)Nc2cccc3ccccc23)C1,CHEMBL171609,nM,440,CHEMBL284,6.356547324,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](NC(=O)Nc2cccc3ccccc23)C1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)Nc2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
577511,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CO[C@@H]1CCC[C@H]([C@H](N)C(=O)N2CCCC2)C1,CHEMBL352632,nM,870,CHEMBL284,6.060480747,DPPIV,CO[C@@H]1CCCC(C(N)C(=O)N2CCCC2)C1,COC1CCCC(C(N)C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
578735,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CS(=O)(=O)c1ccccc1S(=O)(=O)N[C@H]1CC[C@H]([C@H](N)C(=O)N2CCCC2)C1,CHEMBL355248,nM,150,CHEMBL284,6.823908741,DPPIV,CS(=O)(=O)c1ccccc1S(=O)(=O)N[C@H]1CCC(C(N)C(=O)N2CCCC2)C1,CS(=O)(=O)c1ccccc1S(=O)(=O)NC1CCC(C(N)C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
578739,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CCC[C@H](OC(=O)Nc2ccc(I)cc2)C1,CHEMBL170051,nM,330,CHEMBL284,6.48148606,DPPIV,NC(C(=O)N1CCCC1)C1CCC[C@H](OC(=O)Nc2ccc(I)cc2)C1,NC(C(=O)N1CCCC1)C1CCCC(OC(=O)Nc2ccc(I)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
579989,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CCC[C@@H](OC(=O)Nc2ccc(I)cc2)C1,CHEMBL171733,nM,110,CHEMBL284,6.958607315,DPPIV,NC(C(=O)N1CCCC1)C1CCC[C@@H](OC(=O)Nc2ccc(I)cc2)C1,NC(C(=O)N1CCCC1)C1CCCC(OC(=O)Nc2ccc(I)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
579993,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CCC[C@H](O)C1,CHEMBL355051,nM,290,CHEMBL284,6.537602002,DPPIV,NC(C(=O)N1CCCC1)C1CCC[C@H](O)C1,NC(C(=O)N1CCCC1)C1CCCC(O)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
579997,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@H]2CCC[C@H]([C@H](N)C(=O)N3CCSC3)C2)cc1,CHEMBL433533,nM,420,CHEMBL284,6.37675071,DPPIV,COc1ccc(NC(=O)O[C@H]2CCCC(C(N)C(=O)N3CCSC3)C2)cc1,COc1ccc(NC(=O)OC2CCCC(C(N)C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
581025,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@H](NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,CHEMBL171290,nM,250,CHEMBL284,6.602059991,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(NS(=O)(=O)c2ccc(S(N)(=O)=O)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
582253,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@@H](O)C1,CHEMBL355244,nM,4600,CHEMBL284,5.337242168,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](O)C1,NC(C(=O)N1CCCC1)C1CCC(O)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
582257,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@@H]2CC[C@H]([C@H](N)C(=O)N3CCSC3)C2)cc1,CHEMBL352354,nM,240,CHEMBL284,6.619788758,DPPIV,COc1ccc(NC(=O)O[C@@H]2CCC(C(N)C(=O)N3CCSC3)C2)cc1,COc1ccc(NC(=O)OC2CCC(C(N)C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
583468,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@@H](OC(=O)Nc2ccc(I)cc2)C1,CHEMBL352402,nM,110,CHEMBL284,6.958607315,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](OC(=O)Nc2ccc(I)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(OC(=O)Nc2ccc(I)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
584771,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)Nc2cccc3ccccc23)C1,CHEMBL352520,nM,43,CHEMBL284,7.366531544,DPPIV,NC(C(=O)N1CCSC1)C1CC[C@H](NC(=O)Nc2cccc3ccccc23)C1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)Nc2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
586038,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](OC(=O)Nc2ccc(I)cc2)C1,CHEMBL172057,nM,180,CHEMBL284,6.744727495,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@H](OC(=O)Nc2ccc(I)cc2)C1,NC(C(=O)N1CCCC1)C1CCC(OC(=O)Nc2ccc(I)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
588536,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,COc1ccc(NC(=O)O[C@@H]2CC[C@H]([C@H](N)C(=O)N3CCCC3)C2)cc1,CHEMBL353590,nM,1100,CHEMBL284,5.958607315,DPPIV,COc1ccc(NC(=O)O[C@@H]2CCC(C(N)C(=O)N3CCCC3)C2)cc1,COc1ccc(NC(=O)OC2CCC(C(N)C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
588540,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCC1)[C@@H]1CC[C@@H](NC(=O)Nc2cccc3ccccc23)C1,CHEMBL355479,nM,94,CHEMBL284,7.026872146,DPPIV,NC(C(=O)N1CCCC1)C1CC[C@@H](NC(=O)Nc2cccc3ccccc23)C1,NC(C(=O)N1CCCC1)C1CCC(NC(=O)Nc2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
589781,CHEMBL664928,Inhibitory activity against human recombinant Dipeptidylpeptidase IV,B,CS(=O)(=O)NCCS(=O)(=O)N[C@H]1CC[C@H]([C@H](N)C(=O)N2CCCC2)C1,CHEMBL352548,nM,95,CHEMBL284,7.022276395,DPPIV,CS(=O)(=O)NCCS(=O)(=O)N[C@H]1CCC(C(N)C(=O)N2CCCC2)C1,CS(=O)(=O)NCCS(=O)(=O)NC1CCC(C(N)C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
671629,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1,CHEMBL22310,nM,48,CHEMBL284,7.318758763,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
672809,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1C[C@H](F)[C@@H](F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL22545,nM,830,CHEMBL284,6.080921908,DPPIV,NC(C(=O)N1C[C@H](F)[C@@H](F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CC(F)C(F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
674220,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCSC1)C1CCCCC1,CHEMBL23223,nM,89,CHEMBL284,7.050609993,DPPIV,NC(C(=O)N1CCSC1)C1CCCCC1,NC(C(=O)N1CCSC1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
675584,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1C[C@@H](F)[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL23051,nM,270,CHEMBL284,6.568636236,DPPIV,NC(C(=O)N1C[C@@H](F)[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CC(F)C(F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
678255,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NC(=O)c2ccccc2C(F)(F)F)CC1,CHEMBL23880,nM,210,CHEMBL284,6.677780705,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
679295,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1C[C@@H](F)[C@H](F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL416008,nM,360,CHEMBL284,6.443697499,DPPIV,NC(C(=O)N1C[C@@H](F)[C@H](F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CC(F)C(F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
679297,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL281561,nM,75,CHEMBL284,7.124938737,DPPIV,NC(C(=O)N1CC[C@@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
679300,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1,CHEMBL283309,nM,58,CHEMBL284,7.236572006,DPPIV,NC(C(=O)N1CC[C@@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
683561,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCC(F)(F)C1)C1CCCCC1,CHEMBL280658,nM,73,CHEMBL284,7.13667714,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCCCC1,NC(C(=O)N1CCC(F)(F)C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
685040,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccccc2C(F)(F)F)CC1,CHEMBL283368,nM,67,CHEMBL284,7.173925197,DPPIV,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,NC(C(=O)N1CCSC1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
685045,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL277693,nM,88,CHEMBL284,7.055517328,DPPIV,NC(C(=O)N1CC[C@@H](F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
686322,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL281178,nM,35,CHEMBL284,7.455931956,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
694013,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1,CHEMBL23110,nM,55,CHEMBL284,7.259637311,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
694016,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NC(=O)c2ccccc2C(F)(F)F)CC1,CHEMBL23879,nM,250,CHEMBL284,6.602059991,DPPIV,NC(C(=O)N1CC[C@@H](F)C1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
694018,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1C[C@@H](F)[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1,CHEMBL277193,nM,250,CHEMBL284,6.602059991,DPPIV,NC(C(=O)N1C[C@@H](F)[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,NC(C(=O)N1CC(F)C(F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
699829,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@@H](F)C1)C1CCCCC1,CHEMBL23981,nM,340,CHEMBL284,6.468521083,DPPIV,NC(C(=O)N1CC[C@@H](F)C1)C1CCCCC1,NC(C(=O)N1CCC(F)C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
702335,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL279944,nM,27,CHEMBL284,7.568636236,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
702338,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1C[C@H](F)[C@@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL431885,nM,870,CHEMBL284,6.060480747,DPPIV,NC(C(=O)N1C[C@H](F)[C@@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CC(F)C(F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
703648,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1,CHEMBL23660,nM,54,CHEMBL284,7.26760624,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
706252,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1,CHEMBL23924,nM,110,CHEMBL284,6.958607315,DPPIV,NC(C(=O)N1CC[C@@H](F)C1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NC(=O)c2ccc(F)c(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
706255,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,CHEMBL423108,nM,23,CHEMBL284,7.638272164,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
708829,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NC(=O)c2ccccc2C(F)(F)F)CC1,CHEMBL277635,nM,70,CHEMBL284,7.15490196,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NC(=O)c2ccccc2C(F)(F)F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
710210,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1,CHEMBL22294,nM,21,CHEMBL284,7.677780705,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,NC(C(=O)N1CCC(F)(F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
711472,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1,CHEMBL23891,nM,56,CHEMBL284,7.251811973,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NC(=O)OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
712808,CHEMBL664925,Inhibitory activity against human Dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)C1CCCCC1,CHEMBL22511,nM,170,CHEMBL284,6.769551079,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCCCC1,NC(C(=O)N1CCC(F)C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
714042,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccccc1,CHEMBL289562,nM,42000,CHEMBL284,4.37675071,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
716188,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,CCC(C)C(N)C(=O)N1CCSC1,CHEMBL357606,nM,1700,CHEMBL284,5.769551079,DPPIV,CCC(C)C(N)C(=O)N1CCSC1,CCC(C)C(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
716408,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1ccccc1-c1nc(-c2ccccc2)nc(N)c1CN,CHEMBL37229,nM,1500,CHEMBL284,5.823908741,DPPIV,COc1ccccc1-c1[nH]c(-c2ccccc2)nc(=N)c1CN,COc1ccccc1-c1[nH]c(-c2ccccc2)nc(=N)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
717762,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2F)nc1-c1ccc(Cl)cc1Cl,CHEMBL37536,nM,47,CHEMBL284,7.327902142,DPPIV,N=c1[nH]c(-c2ccccc2F)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccccc2F)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
718995,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2cccc(C(F)(F)F)c2)nc1-c1ccc(Cl)cc1Cl,CHEMBL37654,nM,130,CHEMBL284,6.886056648,DPPIV,N=c1[nH]c(-c2cccc(C(F)(F)F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2cccc(C(F)(F)F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
719828,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,CCC(C)C(N)C(=O)N1CCC(F)C1,CHEMBL148261,nM,3500,CHEMBL284,5.455931956,DPPIV,CCC(C)C(N)C(=O)N1CCC(F)C1,CCC(C)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
720080,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccc(C(F)(F)F)cc2)nc1-c1ccc(Cl)cc1Cl,CHEMBL34764,nM,180,CHEMBL284,6.744727495,DPPIV,N=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
721092,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,Cc1cccc(-c2nc(-c3ccccc3)nc(N)c2CN)c1,CHEMBL287534,nM,20000,CHEMBL284,4.698970004,DPPIV,Cc1cccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)c1,Cc1cccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
722184,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccc(Cl)cc1,CHEMBL34603,nM,1400,CHEMBL284,5.853871964,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(Cl)cc2)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(Cl)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
723371,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccccc1Cl,CHEMBL36333,nM,2500,CHEMBL284,5.602059991,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2Cl)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
723372,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1cccc(F)c1,CHEMBL35451,nM,40000,CHEMBL284,4.397940009,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2cccc(F)c2)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2cccc(F)c2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
725444,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,NC(CO)C(=O)N1CCCCC1,CHEMBL146995,nM,67000,CHEMBL284,4.173925197,DPPIV,NC(C=O)C(O)N1CCCCC1,NC(C=O)C(O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
725750,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,Cc1ccc(-c2nc(-c3ccccc3)nc(N)c2CN)cc1,CHEMBL38165,nM,1000,CHEMBL284,6,DPPIV,Cc1ccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)cc1,Cc1ccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
727009,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccccc1C(F)(F)F,CHEMBL288171,nM,14000,CHEMBL284,4.853871964,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2C(F)(F)F)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2C(F)(F)F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
728267,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccc(F)cc2)nc1-c1ccc(Cl)cc1Cl,CHEMBL34842,nM,0.2,CHEMBL284,9.698970004,DPPIV,N=c1[nH]c(-c2ccc(F)cc2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccc(F)cc2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
729165,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,C[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL319514,nM,200,CHEMBL284,6.698970004,DPPIV,CC(N)C(=O)N1CCC[C@H]1C#N,CC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
729422,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1ccc(-c2nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)n2)cc1,CHEMBL37289,nM,100,CHEMBL284,7,DPPIV,COc1ccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)cc1,COc1ccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
730496,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1cc(OC)cc(-c2nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)n2)c1,CHEMBL34062,nM,0.1,CHEMBL284,10,DPPIV,COc1cc(OC)cc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)c1,COc1cc(OC)cc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
730517,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccc2c(c1)OCO2,CHEMBL37980,nM,10000,CHEMBL284,5,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccc3c(c2)OCO3)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccc3c(c2)OCO3)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
731658,CHEMBL664926,Inhibitory activity against hydrolysis of Gly-Pro-pNa by CD26 (Dipeptidyl peptidase IV) purified from CEM H01 cells,B,C[S+](C)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N2.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F,CHEMBL277390,nM,12,CHEMBL284,7.920818754,DPPIV,C[S+](C)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,C[S+](C)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
731729,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccc(Cl)cc2)nc1-c1ccc(Cl)cc1Cl,CHEMBL37687,nM,53,CHEMBL284,7.27572413,DPPIV,N=c1[nH]c(-c2ccc(Cl)cc2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccc(Cl)cc2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
731798,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccc(F)c(F)c2)nc1-c1ccc(Cl)cc1Cl,CHEMBL37960,nM,3,CHEMBL284,8.522878745,DPPIV,N=c1[nH]c(-c2ccc(F)c(F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccc(F)c(F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
733806,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN,CHEMBL461912,nM,320,CHEMBL284,6.494850022,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCCCN,N#CC1CCCN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
734130,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1cccc(Cl)c1,CHEMBL416787,nM,31000,CHEMBL284,4.508638306,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2cccc(Cl)c2)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2cccc(Cl)c2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
735220,CHEMBL664926,Inhibitory activity against hydrolysis of Gly-Pro-pNa by CD26 (Dipeptidyl peptidase IV) purified from CEM H01 cells,B,CCCCCCCC[S+](CCCCCCCC)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N2.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F,CHEMBL67680,nM,30,CHEMBL284,7.522878745,DPPIV,CCCCCCCC[S+](CCCCCCCC)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,CCCCCCCC[S+](CCCCCCCC)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
735314,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2cccc(F)c2)nc1-c1ccc(Cl)cc1Cl,CHEMBL36666,nM,0.2,CHEMBL284,9.698970004,DPPIV,N=c1[nH]c(-c2cccc(F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2cccc(F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
738098,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccccc1F,CHEMBL287847,nM,14000,CHEMBL284,4.853871964,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2F)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccccc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
738099,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2cccc(Cl)c2)nc1-c1ccc(Cl)cc1Cl,CHEMBL37655,nM,240,CHEMBL284,6.619788758,DPPIV,N=c1[nH]c(-c2cccc(Cl)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2cccc(Cl)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
739035,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,CCC(C)C(N)C(=O)N1CCC1,CHEMBL346877,nM,50400,CHEMBL284,4.297569464,DPPIV,CCC(C)C(N)C(=O)N1CCC1,CCC(C)C(N)C(=O)N1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
739267,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1cccc(-c2nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)n2)c1,CHEMBL37748,nM,340,CHEMBL284,6.468521083,DPPIV,COc1cccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)c1,COc1cccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
740215,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,N#CC1CCCCN1C(=O)C(N)CCCCN,CHEMBL145813,nM,51000,CHEMBL284,4.292429824,DPPIV,N#CC1CCCCN1C(=O)C(N)CCCCN,N#CC1CCCCN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
741858,CHEMBL664926,Inhibitory activity against hydrolysis of Gly-Pro-pNa by CD26 (Dipeptidyl peptidase IV) purified from CEM H01 cells,B,CC(=O)OCc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N2.O=C(O)C(F)(F)F,CHEMBL1160335,nM,1500,CHEMBL284,5.823908741,DPPIV,CC(=O)OCc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,CC(=O)OCc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
741860,CHEMBL664926,Inhibitory activity against hydrolysis of Gly-Pro-pNa by CD26 (Dipeptidyl peptidase IV) purified from CEM H01 cells,B,N[C@H]1CCCCNC(=O)CNC(=O)CNC(=O)c2cc(ccc2COc2ccccc2)NC(=O)[C@@H]2CCCN2C1=O,CHEMBL305759,nM,10000,CHEMBL284,5,DPPIV,NC1CCCCNC(=O)CNC(=O)CNC(=O)c2cc(ccc2COc2ccccc2)NC(=O)C2CCCN2C1=O,NC1CCCCNC(=O)CNC(=O)CNC(=O)c2cc(ccc2COc2ccccc2)NC(=O)C2CCCN2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
741951,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1ccc(-c2nc(-c3ccccc3)nc(N)c2CN)cc1,CHEMBL36282,nM,47000,CHEMBL284,4.327902142,DPPIV,COc1ccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)cc1,COc1ccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
741952,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccc(C(F)(F)F)cc1,CHEMBL35000,nM,1100,CHEMBL284,5.958607315,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(C(F)(F)F)cc2)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(C(F)(F)F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
743295,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,Cc1ccccc1-c1nc(N)c(CN)c(-c2ccc(Cl)cc2Cl)n1,CHEMBL37645,nM,1750,CHEMBL284,5.756961951,DPPIV,Cc1ccccc1-c1nc(-c2ccc(Cl)cc2Cl)c(CN)c(=N)[nH]1,Cc1ccccc1-c1nc(-c2ccc(Cl)cc2Cl)c(CN)c(=N)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
743296,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,Cc1cccc(-c2nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)n2)c1,CHEMBL35116,nM,0.9,CHEMBL284,9.045757491,DPPIV,Cc1cccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)c1,Cc1cccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
744541,CHEMBL664926,Inhibitory activity against hydrolysis of Gly-Pro-pNa by CD26 (Dipeptidyl peptidase IV) purified from CEM H01 cells,B,C[S+](C)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N2.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F,CHEMBL302602,nM,3,CHEMBL284,8.522878745,DPPIV,C[S+](C)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,C[S+](C)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
744615,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1cccc(-c2nc(-c3ccccc3)nc(N)c2CN)c1,CHEMBL290620,nM,80000,CHEMBL284,4.096910013,DPPIV,COc1cccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)c1,COc1cccc(-c2[nH]c(-c3ccccc3)nc(=N)c2CN)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
745932,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,COc1ccccc1-c1nc(N)c(CN)c(-c2ccc(Cl)cc2Cl)n1,CHEMBL34779,nM,350,CHEMBL284,6.455931956,DPPIV,COc1ccccc1-c1nc(-c2ccc(Cl)cc2Cl)c(CN)c(=N)[nH]1,COc1ccccc1-c1nc(-c2ccc(Cl)cc2Cl)c(CN)c(=N)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
747134,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,Cc1ccc(-c2nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)n2)cc1,CHEMBL34972,nM,90,CHEMBL284,7.045757491,DPPIV,Cc1ccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)cc1,Cc1ccc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
748208,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,CCC(C)C(N)C(=O)N1CCC(O)C1,CHEMBL147691,nM,93000,CHEMBL284,4.031517051,DPPIV,CCC(C)C(N)C(=O)N1CCC(O)C1,CCC(C)C(N)C(=O)N1CCC(O)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
748476,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccc(Cl)cc1Cl,CHEMBL36020,nM,10,CHEMBL284,8,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
749655,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,Cc1ccccc1-c1nc(-c2ccccc2)nc(N)c1CN,CHEMBL35016,nM,1500,CHEMBL284,5.823908741,DPPIV,Cc1ccccc1-c1[nH]c(-c2ccccc2)nc(=N)c1CN,Cc1ccccc1-c1[nH]c(-c2ccccc2)nc(=N)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
750576,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,CCC(C)C(N)C(=O)N1CC=CCC1,CHEMBL444537,nM,52000,CHEMBL284,4.283996656,DPPIV,CCC(C)C(N)C(=O)N1CC=CCC1,CCC(C)C(N)C(=O)N1CC=CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
750582,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,NC(N)=NCCCC(N)C(=O)N1CCCCC1,CHEMBL145862,nM,18100,CHEMBL284,4.742321425,DPPIV,N=C(N)NCCCC(N)C(=O)N1CCCCC1,N=C(N)NCCCC(N)C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
750594,CHEMBL664534,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),B,NCCCC(N)C(=O)N1CCSC1,CHEMBL148954,nM,81000,CHEMBL284,4.091514981,DPPIV,NCCCC(N)C(=O)N1CCSC1,NCCCC(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
750779,CHEMBL664926,Inhibitory activity against hydrolysis of Gly-Pro-pNa by CD26 (Dipeptidyl peptidase IV) purified from CEM H01 cells,B,CCCC[S+](CCCC)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N2.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F,CHEMBL67679,nM,20,CHEMBL284,7.698970004,DPPIV,CCCC[S+](CCCC)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,CCCC[S+](CCCC)Cc1ccc2cc1C(=O)NCC(=O)NCC(=O)NCCCCC(N)C(=O)N1CCCC1C(=O)N2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
750855,CHEMBL664533,Inhibitory activity against Dipeptidylpeptidase IV mediated cleavage of Ala-Pro-7-amido-4-tri-fluoromethylcoumarin in a fluorogenic assay,F,NCc1c(N)nc(-c2ccccc2)nc1-c1ccc(F)cc1,CHEMBL286301,nM,18000,CHEMBL284,4.744727495,DPPIV,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(F)cc2)c1CN,N=c1[nH]c(-c2ccccc2)nc(-c2ccc(F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
828426,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ncccn1,CHEMBL329909,nM,163,CHEMBL284,6.787812396,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCN=c1nccc[nH]1,N#CC1CCCN1C(=O)CNCCN=c1nccc[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
828427,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCC1,CHEMBL96229,nM,24200,CHEMBL284,4.616184634,DPPIV,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCC1,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
828428,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(=O)O[C@@]12C[C@@H]3C[C@@H](C[C@](NCC(=O)N4CCC[C@H]4C#N)(C3)C1)C2,CHEMBL3084822,nM,70,CHEMBL284,7.15490196,DPPIV,CC(=O)O[C@@]12C[C@@H]3C[C@@H](C[C@](NCC(=O)N4CCC[C@H]4C#N)(C3)C1)C2,CC(=O)OC12CC3CC(CC(NCC(=O)N4CCCC4C#N)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
829594,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3,CHEMBL316832,nM,598,CHEMBL284,6.223298816,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3,N#CC1CCCN1C(=O)CNCC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
830764,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ccccc1,CHEMBL94597,nM,298,CHEMBL284,6.525783736,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCNc1ccccc1,N#CC1CCCN1C(=O)CNCCNc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
830765,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCNCC(=O)N1CCC[C@H]1C#N,CHEMBL330670,nM,444,CHEMBL284,6.35261703,DPPIV,CCNCC(=O)N1CCC[C@H]1C#N,CCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
830766,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCCCCCCNCC(=O)N1CCC[C@H]1C#N,CHEMBL94147,nM,291,CHEMBL284,6.536107011,DPPIV,CCCCCCCNCC(=O)N1CCC[C@H]1C#N,CCCCCCCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
830767,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CHEMBL94908,nM,105,CHEMBL284,6.978810701,DPPIV,CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CCC(C)(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
830768,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCC(c1ccccc1)c1ccccc1,CHEMBL327264,nM,377,CHEMBL284,6.42365865,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(c1ccccc1)c1ccccc1,N#CC1CCCN1C(=O)CNCCC(c1ccccc1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
831882,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@H]1CCCN1C(=O)CCNCCNc1ccc([N+](=O)[O-])cn1,CHEMBL94046,nM,18700,CHEMBL284,4.728158393,DPPIV,N#C[C@H]1CCCN1C(=O)CCNCCN=c1ccc([N+](=O)[O-])c[nH]1,N#CC1CCCN1C(=O)CCNCCN=c1ccc([N+](=O)[O-])c[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
831883,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCCCCCCCCCC1,CHEMBL93847,nM,338,CHEMBL284,6.4710833,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCCCCCCCCCC1,N#CC1CCCN1C(=O)CNC1CCCCCCCCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
831884,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(N)(CO)C(O)NCC(=O)N1CCC[C@H]1C#N,CHEMBL96607,nM,372,CHEMBL284,6.42945706,DPPIV,CC(N)(CO)C(O)NCC(=O)N1CCC[C@H]1C#N,CC(N)(CO)C(O)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
831885,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCc1ccccc1,CHEMBL96942,nM,305,CHEMBL284,6.515700161,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCc1ccccc1,N#CC1CCCN1C(=O)CNCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
831886,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](Nc2ccc(C(F)(F)F)cn2)CC1,CHEMBL3084816,nM,7,CHEMBL284,8.15490196,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](N=c2ccc(C(F)(F)F)c[nH]2)CC1,N#CC1CCCN1C(=O)CNC1CCC(N=c2ccc(C(F)(F)F)c[nH]2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
831887,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCc2ccccc2C1,CHEMBL328613,nM,26100,CHEMBL284,4.583359493,DPPIV,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCc2ccccc2C1,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
832925,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CN[C@H](C(=O)N1CCC[C@H]1C#N)C(C)C,CHEMBL313423,nM,9610,CHEMBL284,5.017276612,DPPIV,CNC(C(=O)N1CCC[C@H]1C#N)C(C)C,CNC(C(=O)N1CCCC1C#N)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
832926,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@](NCC(=O)N1CCC[C@H]1C#N)(C3)C2,CHEMBL3084814,nM,17,CHEMBL284,7.769551079,DPPIV,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@](NCC(=O)N1CCC[C@H]1C#N)(C3)C2,CC12CC3CC(C)(C1)CC(NCC(=O)N1CCCC1C#N)(C3)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
835423,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)NCC(=O)N1CCC[C@H]1C#N,CHEMBL96748,nM,192,CHEMBL284,6.716698771,DPPIV,CC(C)NCC(=O)N1CCC[C@H]1C#N,CC(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
835424,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCCCCNCC(=O)N1CCC[C@H]1C#N,CHEMBL96160,nM,266,CHEMBL284,6.575118363,DPPIV,CCCCCNCC(=O)N1CCC[C@H]1C#N,CCCCCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
835425,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCCCCO,CHEMBL96299,nM,346,CHEMBL284,6.460923901,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCCCCO,N#CC1CCCN1C(=O)CNCCCCCO,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
836546,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1Cc2ccccc2C1,CHEMBL328994,nM,133,CHEMBL284,6.876148359,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1Cc2ccccc2C1,N#CC1CCCN1C(=O)CNC1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
837821,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ccc(Cl)cn1,CHEMBL93354,nM,36,CHEMBL284,7.443697499,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCN=c1ccc(Cl)c[nH]1,N#CC1CCCN1C(=O)CNCCN=c1ccc(Cl)c[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
837822,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC1(C)C2CC(CNCC(=O)N3CCC[C@H]3C#N)CC1C2,CHEMBL96071,nM,242,CHEMBL284,6.616184634,DPPIV,CC1(C)C2CC(CNCC(=O)N3CCC[C@H]3C#N)CC1C2,CC1(C)C2CC(CNCC(=O)N3CCCC3C#N)CC1C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
837823,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCN(c2nc3ccccc3s2)CC1,CHEMBL328794,nM,228,CHEMBL284,6.642065153,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCN(c2nc3ccccc3s2)CC1,N#CC1CCCN1C(=O)CNC1CCN(c2nc3ccccc3s2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
839039,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CC2CCC1C2,CHEMBL330373,nM,15,CHEMBL284,7.823908741,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CC2CCC1C2,N#CC1CCCN1C(=O)CNC1CC2CCC1C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
839040,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCCCC1,CHEMBL318511,nM,52600,CHEMBL284,4.279014256,DPPIV,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCCCC1,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
841574,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCOc1ccccc1,CHEMBL321509,nM,635,CHEMBL284,6.197226275,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCOc1ccccc1,N#CC1CCCN1C(=O)CNCCOc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
841575,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL96666,nM,2,CHEMBL284,8.698970004,DPPIV,CC(C)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
842721,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1(CO)CCCC1,CHEMBL95088,nM,26,CHEMBL284,7.585026652,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1(CO)CCCC1,N#CC1CCCN1C(=O)CNC1(CO)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
842722,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](Nc2nc3ccccc3s2)CC1,CHEMBL3084820,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](N=c2[nH]c3ccccc3s2)CC1,N#CC1CCCN1C(=O)CNC1CCC(N=c2[nH]c3ccccc3s2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
843894,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ncccc1C(F)(F)F,CHEMBL329282,nM,989,CHEMBL284,6.004803708,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCN=c1[nH]cccc1C(F)(F)F,N#CC1CCCN1C(=O)CNCCN=c1[nH]cccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
843896,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCN(C(=O)C2CCCCC2)CC1,CHEMBL319798,nM,23,CHEMBL284,7.638272164,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCN(C(=O)C2CCCCC2)CC1,N#CC1CCCN1C(=O)CNC1CCN(C(=O)C2CCCCC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
843897,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2,CHEMBL96892,nM,13,CHEMBL284,7.886056648,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2,N#CC1CCCN1C(=O)CNC1C2CC3CC(C2)CC1C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
845176,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1(CO)CCCCC1,CHEMBL92028,nM,104,CHEMBL284,6.982966661,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1(CO)CCCCC1,N#CC1CCCN1C(=O)CNC1(CO)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
845177,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCc1ccccc1,CHEMBL96453,nM,988,CHEMBL284,6.005243055,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCc1ccccc1,N#CC1CCCN1C(=O)CNCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
845178,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](NC(=O)C2CCCCC2)CC1,CHEMBL3084819,nM,18,CHEMBL284,7.744727495,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](NC(=O)C2CCCCC2)CC1,N#CC1CCCN1C(=O)CNC1CCC(NC(=O)C2CCCCC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
846338,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H](NC1CCCCC1)C1CCCCC1,CHEMBL330623,nM,18600,CHEMBL284,4.730487056,DPPIV,N#C[C@@H]1CCCN1C(=O)C(NC1CCCCC1)C1CCCCC1,N#CC1CCCN1C(=O)C(NC1CCCCC1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
846339,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCCCCCC1,CHEMBL96593,nM,53,CHEMBL284,7.27572413,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCCCCCC1,N#CC1CCCN1C(=O)CNC1CCCCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
846340,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCCCCCNCC(=O)N1CCC[C@H]1C#N,CHEMBL96491,nM,282,CHEMBL284,6.549750892,DPPIV,CCCCCCNCC(=O)N1CCC[C@H]1C#N,CCCCCCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
846341,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](Oc2ccc(Cl)cc2)CC1,CHEMBL3084821,nM,14,CHEMBL284,7.853871964,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@H]1CC[C@H](Oc2ccc(Cl)cc2)CC1,N#CC1CCCN1C(=O)CNC1CCC(Oc2ccc(Cl)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
847450,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCC(CO)NCC(=O)N1CCC[C@H]1C#N,CHEMBL92710,nM,256,CHEMBL284,6.591760035,DPPIV,CCC(CO)NCC(=O)N1CCC[C@H]1C#N,CCC(CO)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
847451,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@]12C[C@H]3C[C@@H](C1)C[C@](OC(=O)NC1CCCCC1)(C3)C2,CHEMBL3084817,nM,64,CHEMBL284,7.193820026,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@]12C[C@H]3C[C@@H](C1)C[C@](OC(=O)NC1CCCCC1)(C3)C2,N#CC1CCCN1C(=O)CNC12CC3CC(C1)CC(OC(=O)NC1CCCCC1)(C3)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
848675,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCC1,CHEMBL94312,nM,80,CHEMBL284,7.096910013,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCC1,N#CC1CCCN1C(=O)CNC1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
848676,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3,CHEMBL319080,nM,3,CHEMBL284,8.522878745,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3,N#CC1CCCN1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
848677,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,COc1ccc(NC(=O)O[C@@]23C[C@@H]4C[C@@H](C[C@](NCC(=O)N5CCC[C@H]5C#N)(C4)C2)C3)cc1,CHEMBL3084824,nM,149,CHEMBL284,6.826813732,DPPIV,COc1ccc(NC(=O)O[C@@]23C[C@@H]4C[C@@H](C[C@](NCC(=O)N5CCC[C@H]5C#N)(C4)C2)C3)cc1,COc1ccc(NC(=O)OC23CC4CC(CC(NCC(=O)N5CCCC5C#N)(C4)C2)C3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
848678,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)N(C(=O)O[C@@]12C[C@@H]3C[C@@H](C[C@](NCC(=O)N4CCC[C@H]4C#N)(C3)C1)C2)C(C)C,CHEMBL3084818,nM,183,CHEMBL284,6.73754891,DPPIV,CC(C)N(C(=O)O[C@@]12C[C@@H]3C[C@@H](C[C@](NCC(=O)N4CCC[C@H]4C#N)(C3)C1)C2)C(C)C,CC(C)N(C(=O)OC12CC3CC(CC(NCC(=O)N4CCCC4C#N)(C3)C1)C2)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
849806,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCN(c2ccc(C(F)(F)F)cn2)CC1,CHEMBL330426,nM,296,CHEMBL284,6.528708289,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCN(c2ccc(C(F)(F)F)cn2)CC1,N#CC1CCCN1C(=O)CNC1CCN(c2ccc(C(F)(F)F)cn2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
850959,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCCc1ccccc1,CHEMBL96890,nM,491,CHEMBL284,6.308918508,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCCc1ccccc1,N#CC1CCCN1C(=O)CNCCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
850960,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCCCCC1,CHEMBL323130,nM,63,CHEMBL284,7.200659451,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCCCCC1,N#CC1CCCN1C(=O)CNC1CCCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
850961,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@]12C[C@@H]3C[C@@H](C[C@@](O)(C3)C1)C2,CHEMBL3084811,nM,3.5,CHEMBL284,8.455931956,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@]12C[C@@H]3C[C@@H](C[C@@](O)(C3)C1)C2,N#CC1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
852081,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCCC1,CHEMBL93034,nM,7000,CHEMBL284,5.15490196,DPPIV,O=C(CNC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3)N1CCCC1,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
853114,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCC(CC)NCC(=O)N1CCC[C@H]1C#N,CHEMBL330326,nM,398,CHEMBL284,6.400116928,DPPIV,CCC(CC)NCC(=O)N1CCC[C@H]1C#N,CCC(CC)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
853115,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(Cc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL96908,nM,24,CHEMBL284,7.619788758,DPPIV,CC(C)(Cc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(Cc1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
853116,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(CNc1ccc(C#N)cn1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL327166,nM,29,CHEMBL284,7.537602002,DPPIV,CC(C)(CN=c1ccc(C#N)c[nH]1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CN=c1ccc(C#N)c[nH]1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
854332,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC1C(NCC(=O)N2CCC[C@H]2C#N)CC2CC1C2(C)C,CHEMBL96459,nM,16,CHEMBL284,7.795880017,DPPIV,CC1C(NCC(=O)N2CCC[C@H]2C#N)CC2CC1C2(C)C,CC1C(NCC(=O)N2CCCC2C#N)CC2CC1C2(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
856538,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ccc(C(F)(F)F)cn1,CHEMBL330717,nM,83,CHEMBL284,7.080921908,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCN=c1ccc(C(F)(F)F)c[nH]1,N#CC1CCCN1C(=O)CNCCN=c1ccc(C(F)(F)F)c[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
856539,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCCCC1,CHEMBL431425,nM,64,CHEMBL284,7.193820026,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCCCC1,N#CC1CCCN1C(=O)CNC1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
856540,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CC1,CHEMBL96080,nM,612,CHEMBL284,6.213248578,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CC1,N#CC1CCCN1C(=O)CNC1CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
856541,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCCCNCC(=O)N1CCC[C@H]1C#N,CHEMBL317787,nM,261,CHEMBL284,6.583359493,DPPIV,CCCCNCC(=O)N1CCC[C@H]1C#N,CCCCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
856542,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(C)CCNCC(=O)N1CCC[C@H]1C#N,CHEMBL94647,nM,466,CHEMBL284,6.331614083,DPPIV,CC(C)(C)CCNCC(=O)N1CCC[C@H]1C#N,CC(C)(C)CCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
856543,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(N)C(O)NCC(=O)N1CCC[C@H]1C#N,CHEMBL323129,nM,218,CHEMBL284,6.661543506,DPPIV,CC(C)(N)C(O)NCC(=O)N1CCC[C@H]1C#N,CC(C)(N)C(O)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
857650,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#Cc1ccc(NCCNCC(=O)N2CCC[C@@H]2C#N)nc1,CHEMBL322903,nM,1170,CHEMBL284,5.931814138,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2CCC[C@@H]2C#N)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2CCCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
858931,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CN[C@]12C[C@H]3C[C@@H](C1)C[C@](OC(=O)Nc1ccccc1)(C3)C2,CHEMBL3084823,nM,62,CHEMBL284,7.207608311,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@]12C[C@H]3C[C@@H](C1)C[C@](OC(=O)Nc1ccccc1)(C3)C2,N#CC1CCCN1C(=O)CNC12CC3CC(C1)CC(OC(=O)Nc1ccccc1)(C3)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
860082,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#Cc1ccc(N[C@H]2CC[C@H](NCC(=O)N3CCC[C@H]3C#N)CC2)nc1,CHEMBL3084815,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccc(=N[C@H]2CC[C@H](NCC(=O)N3CCC[C@H]3C#N)CC2)[nH]c1,N#Cc1ccc(=NC2CCC(NCC(=O)N3CCCC3C#N)CC2)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
860085,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(C)NC(=O)O[C@@]12C[C@@H]3C[C@@H](C[C@](NCC(=O)N4CCC[C@H]4C#N)(C3)C1)C2,CHEMBL3084825,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)(C)NC(=O)O[C@@]12C[C@@H]3C[C@@H](C[C@](NCC(=O)N4CCC[C@H]4C#N)(C3)C1)C2,CC(C)(C)NC(=O)OC12CC3CC(CC(NCC(=O)N4CCCC4C#N)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
861103,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCCNc1ccccn1,CHEMBL92711,nM,33,CHEMBL284,7.48148606,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCN=c1cccc[nH]1,N#CC1CCCN1C(=O)CNCCN=c1cccc[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
861104,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,O=C(CNCCNc1ccc([N+](=O)[O-])cn1)N1CCSC1,CHEMBL96183,nM,3000,CHEMBL284,5.522878745,DPPIV,O=C(CNCCN=c1ccc([N+](=O)[O-])c[nH]1)N1CCSC1,O=C(CNCCN=c1ccc([N+](=O)[O-])c[nH]1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
861105,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNC1CCCC1,CHEMBL95089,nM,54,CHEMBL284,7.26760624,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC1CCCC1,N#CC1CCCN1C(=O)CNC1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
861106,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(C)CC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CHEMBL94630,nM,123,CHEMBL284,6.910094889,DPPIV,CC(C)(C)CC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CC(C)(C)CC(C)(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
862264,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#Cc1ccc(NCCCNCC(=O)N2CCC[C@H]2C#N)nc1,CHEMBL318775,nM,102,CHEMBL284,6.991399828,DPPIV,N#Cc1ccc(=NCCCNCC(=O)N2CCC[C@H]2C#N)[nH]c1,N#Cc1ccc(=NCCCNCC(=O)N2CCCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
862265,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#Cc1ccc(NCCN2CC(=O)N3CCC[C@H]3C2=N)nc1,CHEMBL321724,nM,1540,CHEMBL284,5.812479279,DPPIV,N#Cc1ccc(=NCCN2CC(=O)N3CCCC3C2=N)[nH]c1,N#Cc1ccc(=NCCN2CC(=O)N3CCCC3C2=N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
862266,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,N#C[C@@H]1CCCN1C(=O)CNCc1cccc2ccccc12,CHEMBL96577,nM,436,CHEMBL284,6.360513511,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCc1cccc2ccccc12,N#CC1CCCN1C(=O)CNCc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
863470,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,O=C(CNCCNc1ccc([N+](=O)[O-])cn1)N1CCCC1,CHEMBL96814,nM,7400,CHEMBL284,5.13076828,DPPIV,O=C(CNCCN=c1ccc([N+](=O)[O-])c[nH]1)N1CCCC1,O=C(CNCCN=c1ccc([N+](=O)[O-])c[nH]1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
863471,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CCCNCC(=O)N1CCC[C@H]1C#N,CHEMBL320143,nM,475,CHEMBL284,6.32330639,DPPIV,CCCNCC(=O)N1CCC[C@H]1C#N,CCCNCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
864833,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CHEMBL96937,nM,35,CHEMBL284,7.455931956,DPPIV,CC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CC(C)(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
864835,CHEMBL664029,Inhibition of human dipeptidyl peptidase IV (DPP IV) obtained from human colonic carcinoma cells,B,CC[C@@]12C[C@H]3C[C@@H](C1)C[C@@](NCC(=O)N1CCC[C@H]1C#N)(C3)C2,CHEMBL3084812,nM,7,CHEMBL284,8.15490196,DPPIV,CC[C@@]12C[C@H]3C[C@@H](C1)C[C@@](NCC(=O)N1CCC[C@H]1C#N)(C3)C2,CCC12CC3CC(C1)CC(NCC(=O)N1CCCC1C#N)(C3)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
953956,CHEMBL666619,Inhibition of human Dipeptidylpeptidase IV (DPP IV),B,N[C@@H](CCNCc1ccc(Cl)cc1)C(=O)N1CCC(F)CC1,CHEMBL99506,nM,70000,CHEMBL284,4.15490196,DPPIV,NC(CCNCc1ccc(Cl)cc1)C(=O)N1CCC(F)CC1,NC(CCNCc1ccc(Cl)cc1)C(=O)N1CCC(F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
955310,CHEMBL666619,Inhibition of human Dipeptidylpeptidase IV (DPP IV),B,N#CC1CCCCN1C(=O)[C@@H](N)CCNCc1ccc(Cl)cc1,CHEMBL319350,nM,13000,CHEMBL284,4.886056648,DPPIV,N#CC1CCCCN1C(=O)C(N)CCNCc1ccc(Cl)cc1,N#CC1CCCCN1C(=O)C(N)CCNCc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
962858,CHEMBL666619,Inhibition of human Dipeptidylpeptidase IV (DPP IV),B,N[C@@H](CCNC1CCNCC1)C(=O)N1CCCCC1,CHEMBL328197,nM,64000,CHEMBL284,4.193820026,DPPIV,NC(CCNC1CCNCC1)C(=O)N1CCCCC1,NC(CCNC1CCNCC1)C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
966815,CHEMBL666619,Inhibition of human Dipeptidylpeptidase IV (DPP IV),B,N[C@@H](CCNc1ncccc1[N+](=O)[O-])C(=O)N1CCCCC1,CHEMBL316487,nM,56000,CHEMBL284,4.251811973,DPPIV,NC(CCN=c1[nH]cccc1[N+](=O)[O-])C(=O)N1CCCCC1,NC(CCN=c1[nH]cccc1[N+](=O)[O-])C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
979170,CHEMBL666619,Inhibition of human Dipeptidylpeptidase IV (DPP IV),B,N#CC1CCCCN1C(=O)[C@@H](N)CCNCc1ccccc1,CHEMBL329314,nM,68000,CHEMBL284,4.167491087,DPPIV,N#CC1CCCCN1C(=O)C(N)CCNCc1ccccc1,N#CC1CCCCN1C(=O)C(N)CCNCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1171912,CHEMBL664929,Inhibitory concentration against Dipeptidyl peptidase IV (DPP IV),B,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,CHEMBL37260,nM,5700,CHEMBL284,5.244125144,DPPIV,NC(Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2CC1C(=O)O,NC(Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2CC1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1174573,CHEMBL664929,Inhibitory concentration against Dipeptidyl peptidase IV (DPP IV),B,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O,CHEMBL290598,nM,7000,CHEMBL284,5.15490196,DPPIV,NC(Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2CC1C(=O)NC(CCC(=O)O)C(=O)O,NC(Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2CC1C(=O)NC(CCC(=O)O)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1177340,CHEMBL664929,Inhibitory concentration against Dipeptidyl peptidase IV (DPP IV),B,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2C[C@H]1C(=O)N[C@@H](CO)C(=O)O,CHEMBL432081,nM,7900,CHEMBL284,5.102372909,DPPIV,NC(Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2CC1C(=O)NC(C=O)C(O)O,NC(Cc1c[nH]c2ccccc12)C(=O)N1Cc2ccccc2CC1C(=O)NC(C=O)C(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1403166,CHEMBL832779,Inhibitory concentration against human Dipeptidylpeptidase IV,B,N#CC1CCC/C1=C(/F)CNC12CC3CC(CC(C3)C1)C2,CHEMBL177980,nM,12000,CHEMBL284,4.920818754,DPPIV,N#CC1CCC/C1=C(/F)CNC12CC3CC(CC(C3)C1)C2,N#CC1CCCC1=C(F)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1403172,CHEMBL832779,Inhibitory concentration against human Dipeptidylpeptidase IV,B,N#CC1CCC/C1=C(\F)CNC12CC3CC(CC(C3)C1)C2,CHEMBL180514,nM,15000,CHEMBL284,4.823908741,DPPIV,N#CC1CCC/C1=C(\F)CNC12CC3CC(CC(C3)C1)C2,N#CC1CCCC1=C(F)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1403176,CHEMBL832779,Inhibitory concentration against human Dipeptidylpeptidase IV,B,N#C[C@@H]1CCCC1C(=O)CNCCc1ccccc1,CHEMBL175034,nM,2130,CHEMBL284,5.671620397,DPPIV,N#C[C@@H]1CCCC1C(=O)CNCCc1ccccc1,N#CC1CCCC1C(=O)CNCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1403179,CHEMBL832779,Inhibitory concentration against human Dipeptidylpeptidase IV,B,N#C[C@@H]1CCCC1C(=O)CNC12CC3CC(CC(C3)C1)C2,CHEMBL179771,nM,350,CHEMBL284,6.455931956,DPPIV,N#C[C@@H]1CCCC1C(=O)CNC12CC3CC(CC(C3)C1)C2,N#CC1CCCC1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1403181,CHEMBL832779,Inhibitory concentration against human Dipeptidylpeptidase IV,B,N#C[C@@H]1CCCC1C(=O)CNCc1ccc(F)cc1,CHEMBL179687,nM,3700,CHEMBL284,5.431798276,DPPIV,N#C[C@@H]1CCCC1C(=O)CNCc1ccc(F)cc1,N#CC1CCCC1C(=O)CNCc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1411934,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2cnnc2C1)Cc1ccc(F)c(F)c1,CHEMBL537625,nM,455,CHEMBL284,6.341988603,DPPIV,N[C@@H](CC(=O)N1CCn2cnnc2C1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCn2cnnc2C1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1411938,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,CCc1nnc2n1CCN(C(=O)C[C@H](N)Cc1ccc(F)c(F)c1)C2.Cl,CHEMBL537844,nM,231,CHEMBL284,6.63638802,DPPIV,CCc1nnc2n1CCN(C(=O)C[C@H](N)Cc1ccc(F)c(F)c1)C2,CCc1nnc2n1CCN(C(=O)CC(N)Cc1ccc(F)c(F)c1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412054,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)c(F)c1,CHEMBL558196,nM,128,CHEMBL284,6.89279003,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412063,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)ccc1F,CHEMBL537400,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412072,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL539077,nM,18,CHEMBL284,7.744727495,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412194,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2cnnc2C1)Cc1cc(F)c(F)cc1F,CHEMBL557187,nM,68,CHEMBL284,7.167491087,DPPIV,N[C@@H](CC(=O)N1CCn2cnnc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2cnnc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412204,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL558585,nM,71,CHEMBL284,7.148741651,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412213,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)ccc1F,CHEMBL559011,nM,103,CHEMBL284,6.987162775,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412315,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccccc1)Cc1ccccc1F,CHEMBL175872,nM,139,CHEMBL284,6.8569852,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCNCC1Cc1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1412316,CHEMBL829504,In vitro inhibitory concentration was measured against dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNCC1)Cc1ccc(F)c(F)c1,CHEMBL366549,nM,3100,CHEMBL284,5.508638306,DPPIV,N[C@@H](CC(=O)N1CCNCC1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCNCC1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1428995,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1Cc2ccccc2C1)C1CCCCC1,CHEMBL440021,nM,15000,CHEMBL284,4.823908741,DPPIV,NC(C(=O)N1Cc2ccccc2C1)C1CCCCC1,NC(C(=O)N1Cc2ccccc2C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1428998,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,NC(CC(=O)N1CCc2ccccc2C1)C(=O)N1Cc2ccccc2C1,CHEMBL179845,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCc2ccccc2C1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCc2ccccc2C1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1429001,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,COc1cc2c(cc1OC)CN(C(=O)CC(N)C(=O)N1Cc3ccccc3C1)CC2,CHEMBL361107,nM,100000,CHEMBL284,4,DPPIV,COc1cc2c(cc1OC)CN(C(=O)CC(N)C(=O)N1Cc3ccccc3C1)CC2,COc1cc2c(cc1OC)CN(C(=O)CC(N)C(=O)N1Cc3ccccc3C1)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1429004,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,CHEMBL367368,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1430611,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)N1CCc2ccccc2C1,CHEMBL179289,nM,63,CHEMBL284,7.200659451,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CC(=O)N1CCc2ccccc2C1,N#CC1CCCN1C(=O)C(N)CC(=O)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1430614,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL362018,nM,274,CHEMBL284,6.562249437,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,N#CC1CCCN1C(=O)C(N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1430617,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCc2ccccc2C1)C1CCCCC1,CHEMBL361235,nM,100000,CHEMBL284,4,DPPIV,NC(C(=O)N1CCc2ccccc2C1)C1CCCCC1,NC(C(=O)N1CCc2ccccc2C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1430620,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N#C[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)C1CCCCC1,CHEMBL361551,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1Cc2ccccc2CN1C(=O)C(N)C1CCCCC1,N#CC1Cc2ccccc2CN1C(=O)C(N)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1430623,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCc2ccccc2C1)c1ccccc1,CHEMBL361758,nM,100000,CHEMBL284,4,DPPIV,NC(C(=O)N1CCc2ccccc2C1)c1ccccc1,NC(C(=O)N1CCc2ccccc2C1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1431029,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,Fc1ccc(N2CCc3ccccc3C2)cc1F,CHEMBL180664,nM,100000,CHEMBL284,4,DPPIV,Fc1ccc(N2CCc3ccccc3C2)cc1F,Fc1ccc(N2CCc3ccccc3C2)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1431033,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,O=C([C@@H]1CCCN1)N1CCc2ccccc2C1,CHEMBL179996,nM,100000,CHEMBL284,4,DPPIV,O=C(C1CCCN1)N1CCc2ccccc2C1,O=C(C1CCCN1)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1431036,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N#C[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12,CHEMBL180000,nM,13000,CHEMBL284,4.886056648,DPPIV,N#C[C@@H]1Cc2ccccc2CN1C(=O)C(N)Cc1c[nH]c2ccccc12,N#CC1Cc2ccccc2CN1C(=O)C(N)Cc1c[nH]c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1431039,CHEMBL830917,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CCCCC1)C1CCCCC1,CHEMBL361863,nM,31000,CHEMBL284,4.508638306,DPPIV,NC(C(=O)N1CCCCC1)C1CCCCC1,NC(C(=O)N1CCCCC1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444889,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccccc1,CHEMBL184262,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccccc1,NC(CC(=O)N1CCSC1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444891,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)c1ccccc1,CHEMBL364780,nM,100000,CHEMBL284,4,DPPIV,N[C@@H](CC(=O)N1CCSC1)c1ccccc1,NC(CC(=O)N1CCSC1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444892,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@H](CCc1ccccc1)CC(=O)N1CCSC1,CHEMBL362364,nM,16480,CHEMBL284,4.783042793,DPPIV,N[C@H](CCc1ccccc1)CC(=O)N1CCSC1,NC(CCc1ccccc1)CC(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444893,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccccn1,CHEMBL185020,nM,39640,CHEMBL284,4.401866354,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccccn1,NC(CC(=O)N1CCSC1)Cc1ccccn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444894,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1cccnc1,CHEMBL185332,nM,44860,CHEMBL284,4.348140731,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1cccnc1,NC(CC(=O)N1CCSC1)Cc1cccnc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444895,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccncc1,CHEMBL183947,nM,51000,CHEMBL284,4.292429824,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccncc1,NC(CC(=O)N1CCSC1)Cc1ccncc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444896,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccsc1,CHEMBL183517,nM,5700,CHEMBL284,5.244125144,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccsc1,NC(CC(=O)N1CCSC1)Cc1ccsc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444897,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccoc1,CHEMBL181239,nM,46910,CHEMBL284,4.328734567,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccoc1,NC(CC(=O)N1CCSC1)Cc1ccoc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444898,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)CC1CCCC1,CHEMBL182168,nM,27470,CHEMBL284,4.561141341,DPPIV,N[C@@H](CC(=O)N1CCSC1)CC1CCCC1,NC(CC(=O)N1CCSC1)CC1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1444899,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)CC1CCCCC1,CHEMBL362140,nM,33000,CHEMBL284,4.48148606,DPPIV,N[C@@H](CC(=O)N1CCSC1)CC1CCCCC1,NC(CC(=O)N1CCSC1)CC1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1447094,CHEMBL829578,Inhibitory concentration against dipeptidyl peptidase IV in Caco-2 cell assay,F,CCC(C)[C@@H](N)C(=O)N1N=CCC1C#N,CHEMBL184572,nM,80,CHEMBL284,7.096910013,DPPIV,CCC(C)C(N)C(=O)N1N=CCC1C#N,CCC(C)C(N)C(=O)N1N=CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1447110,CHEMBL829577,Inhibitory concentration against dipeptidyl peptidase IV in Caco-2 cell assay,F,N#Cc1ccc(NCCNCC(=O)N2N=CCC2C#N)nc1,CHEMBL184651,nM,410,CHEMBL284,6.387216143,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2N=CCC2C#N)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2N=CCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1447212,CHEMBL829577,Inhibitory concentration against dipeptidyl peptidase IV in Caco-2 cell assay,F,N#Cc1ccc(NCCNCC(=O)N2N=CC[C@@H]2C#N)nc1,CHEMBL185222,nM,2620,CHEMBL284,5.581698709,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2N=CC[C@@H]2C#N)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2N=CCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1447613,CHEMBL832675,Inhibitory concentration against dipeptidyl peptidase IV in Caco-2 cell assay,F,N#Cc1ccc(NCCNCC(=O)N2N=CC[C@H]2C#N)nc1,CHEMBL363542,nM,200,CHEMBL284,6.698970004,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2N=CC[C@H]2C#N)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2N=CCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449086,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCCC[C@H]1Cc1ccccc1)Cc1ccccc1F,CHEMBL186611,nM,1040,CHEMBL284,5.982966661,DPPIV,N[C@@H](CC(=O)N1CCCC[C@H]1Cc1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCCCC1Cc1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449088,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNCC1)Cc1ccccc1F,CHEMBL184624,nM,3700,CHEMBL284,5.431798276,DPPIV,N[C@@H](CC(=O)N1CCNCC1)Cc1ccccc1F,NC(CC(=O)N1CCNCC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449090,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,C[C@@H]1CNCCN1C(=O)C[C@H](N)Cc1ccccc1F,CHEMBL264551,nM,1600,CHEMBL284,5.795880017,DPPIV,C[C@@H]1CNCCN1C(=O)C[C@H](N)Cc1ccccc1F,CC1CNCCN1C(=O)CC(N)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449092,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CC(C)[C@@H]1CNCCN1C(=O)C[C@H](N)Cc1ccccc1F,CHEMBL360488,nM,922,CHEMBL284,6.035269079,DPPIV,CC(C)[C@@H]1CNCCN1C(=O)C[C@H](N)Cc1ccccc1F,CC(C)C1CNCCN1C(=O)CC(N)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449094,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1c1ccc(F)cc1)Cc1ccccc1F,CHEMBL182861,nM,610,CHEMBL284,6.214670165,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1c1ccc(F)cc1)Cc1ccccc1F,NC(CC(=O)N1CCNCC1c1ccc(F)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449096,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1cscn1)Cc1ccccc1F,CHEMBL185482,nM,143,CHEMBL284,6.844663963,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1cscn1)Cc1ccccc1F,NC(CC(=O)N1CCNCC1Cc1cscn1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449098,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1cccnc1)Cc1ccccc1F,CHEMBL184808,nM,155,CHEMBL284,6.809668302,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1cccnc1)Cc1ccccc1F,NC(CC(=O)N1CCNCC1Cc1cccnc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449100,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccc(F)cc1)Cc1ccccc1F,CHEMBL184902,nM,166,CHEMBL284,6.779891912,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccc(F)cc1)Cc1ccccc1F,NC(CC(=O)N1CCNCC1Cc1ccc(F)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449103,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccccc1)Cc1cc(F)ccc1F,CHEMBL369738,nM,51,CHEMBL284,7.292429824,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccccc1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCNCC1Cc1ccccc1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449105,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL184636,nM,19,CHEMBL284,7.721246399,DPPIV,N[C@@H](CC(=O)N1CCNC[C@H]1Cc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCNCC1Cc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449254,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,COc1cc(OC)cc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN(C)C)c(N(C)C)n2)c1,CHEMBL186877,nM,0.1,CHEMBL284,10,DPPIV,COc1cc(OC)cc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN(C)C)c(N(C)C)n2)c1,COc1cc(OC)cc(-c2nc(-c3ccc(Cl)cc3Cl)c(CN(C)C)c(N(C)C)n2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449255,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1)Cc1ccccc1,CHEMBL184738,nM,1900,CHEMBL284,5.721246399,DPPIV,N[C@@H](CC(=O)N1CCCC1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1)Cc1ccccc1,NC(CC(=O)N1CCCC1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449883,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccccc1F,CHEMBL187118,nM,931,CHEMBL284,6.031050319,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccccc1F,NC(CC(=O)N1CCSC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449885,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,Cc1ccccc1C[C@@H](N)CC(=O)N1CCSC1,CHEMBL185351,nM,981,CHEMBL284,6.008330993,DPPIV,Cc1ccccc1C[C@@H](N)CC(=O)N1CCSC1,Cc1ccccc1CC(N)CC(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1449887,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N#Cc1ccccc1C[C@@H](N)CC(=O)N1CCSC1,CHEMBL185121,nM,2519,CHEMBL284,5.598771833,DPPIV,N#Cc1ccccc1C[C@@H](N)CC(=O)N1CCSC1,N#Cc1ccccc1CC(N)CC(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450279,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccccc1C(F)(F)F,CHEMBL185601,nM,2263,CHEMBL284,5.645315446,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccccc1C(F)(F)F,NC(CC(=O)N1CCSC1)Cc1ccccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450281,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1cccc(F)c1,CHEMBL182544,nM,2026,CHEMBL284,5.693360559,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1cccc(F)c1,NC(CC(=O)N1CCSC1)Cc1cccc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450283,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N#Cc1cccc(C[C@@H](N)CC(=O)N2CCSC2)c1,CHEMBL405786,nM,8951,CHEMBL284,5.048128443,DPPIV,N#Cc1cccc(C[C@@H](N)CC(=O)N2CCSC2)c1,N#Cc1cccc(CC(N)CC(=O)N2CCSC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450285,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1cccc(C(F)(F)F)c1,CHEMBL185538,nM,3611,CHEMBL284,5.442372512,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1cccc(C(F)(F)F)c1,NC(CC(=O)N1CCSC1)Cc1cccc(C(F)(F)F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450287,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(F)cc1,CHEMBL363879,nM,3279,CHEMBL284,5.484258583,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(F)cc1,NC(CC(=O)N1CCSC1)Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450289,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(Cl)cc1,CHEMBL184442,nM,3028,CHEMBL284,5.518844129,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(Cl)cc1,NC(CC(=O)N1CCSC1)Cc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450291,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(I)cc1,CHEMBL366278,nM,10700,CHEMBL284,4.970616222,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(I)cc1,NC(CC(=O)N1CCSC1)Cc1ccc(I)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450293,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(C(F)(F)F)cc1,CHEMBL184259,nM,7688,CHEMBL284,5.114186625,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(C(F)(F)F)cc1,NC(CC(=O)N1CCSC1)Cc1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450295,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N#Cc1ccc(C[C@@H](N)CC(=O)N2CCSC2)cc1,CHEMBL365066,nM,14860,CHEMBL284,4.827981191,DPPIV,N#Cc1ccc(C[C@@H](N)CC(=O)N2CCSC2)cc1,N#Cc1ccc(CC(N)CC(=O)N2CCSC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450390,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc([N+](=O)[O-])cc1,CHEMBL184937,nM,1552,CHEMBL284,5.809108283,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc([N+](=O)[O-])cc1,NC(CC(=O)N1CCSC1)Cc1ccc([N+](=O)[O-])cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450392,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(F)c(F)c1,CHEMBL184986,nM,1700,CHEMBL284,5.769551079,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCSC1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450394,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1cccc(F)c1F,CHEMBL184961,nM,9400,CHEMBL284,5.026872146,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1cccc(F)c1F,NC(CC(=O)N1CCSC1)Cc1cccc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450396,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(F)cc1F,CHEMBL184912,nM,589,CHEMBL284,6.229884705,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(F)cc1F,NC(CC(=O)N1CCSC1)Cc1ccc(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450398,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1cc(F)ccc1F,CHEMBL433572,nM,270,CHEMBL284,6.568636236,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCSC1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450406,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1c(F)cccc1F,CHEMBL360396,nM,8476,CHEMBL284,5.071809052,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1c(F)cccc1F,NC(CC(=O)N1CCSC1)Cc1c(F)cccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450408,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(Cl)c(Cl)c1,CHEMBL184928,nM,2026,CHEMBL284,5.693360559,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1ccc(Cl)c(Cl)c1,NC(CC(=O)N1CCSC1)Cc1ccc(Cl)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450410,CHEMBL827095,Inhibitory concentration against Dipeptidyl peptidase IV,B,N[C@@H](CC(=O)N1CCSC1)Cc1cc(F)c(F)cc1F,CHEMBL363319,nM,119,CHEMBL284,6.924453039,DPPIV,N[C@@H](CC(=O)N1CCSC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450811,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C[C@@H](N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,CHEMBL186032,nM,11000,CHEMBL284,4.958607315,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C[C@@H](N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(CC(N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450812,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,CHEMBL184040,nM,134,CHEMBL284,6.872895202,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450814,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,CHEMBL263946,nM,44,CHEMBL284,7.356547324,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450816,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,CHEMBL187293,nM,34,CHEMBL284,7.468521083,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450818,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@@H](N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,CHEMBL365414,nM,35000,CHEMBL284,4.455931956,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@@H](N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccccc3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450820,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@@H](N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,CHEMBL184672,nM,36000,CHEMBL284,4.443697499,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@@H](N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450822,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@@H](N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,CHEMBL362538,nM,19000,CHEMBL284,4.721246399,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@@H](N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450824,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccc(F)c(F)c3)[C@H](Cc3ccccc3)C2)c1,CHEMBL360425,nM,30,CHEMBL284,7.522878745,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccc(F)c(F)c3)[C@H](Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450826,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3F)[C@H](Cc3ccccc3)C2)c1,CHEMBL183207,nM,14,CHEMBL284,7.853871964,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3F)[C@H](Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450830,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccc(F)c(F)c3)[C@@H](Cc3ccccc3)C2)c1,CHEMBL360167,nM,1100,CHEMBL284,5.958607315,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccc(F)c(F)c3)[C@@H](Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccc(F)c(F)c3)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450931,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3F)[C@@H](Cc3ccccc3)C2)c1,CHEMBL364385,nM,690,CHEMBL284,6.161150909,DPPIV,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)C[C@H](N)Cc3ccccc3F)[C@@H](Cc3ccccc3)C2)c1,CS(=O)(=O)Nc1cccc(NC(=O)CN2CCN(C(=O)CC(N)Cc3ccccc3F)C(Cc3ccccc3)C2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450933,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCN(Cc2ccccc2)C[C@H]1Cc1ccccc1)Cc1ccccc1F,CHEMBL184380,nM,405,CHEMBL284,6.392544977,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccccc2)C[C@H]1Cc1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCN(Cc2ccccc2)CC1Cc1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450935,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,NC(=O)CN1CCN(C(=O)C[C@H](N)Cc2ccccc2F)[C@H](Cc2ccccc2)C1,CHEMBL185067,nM,114,CHEMBL284,6.943095149,DPPIV,NC(=O)CN1CCN(C(=O)C[C@H](N)Cc2ccccc2F)[C@H](Cc2ccccc2)C1,NC(=O)CN1CCN(C(=O)CC(N)Cc2ccccc2F)C(Cc2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450937,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,CN1CCN(C(=O)C[C@H](N)Cc2ccccc2F)[C@H](Cc2ccccc2)C1,CHEMBL184071,nM,225,CHEMBL284,6.647817482,DPPIV,CN1CCN(C(=O)C[C@H](N)Cc2ccccc2F)[C@H](Cc2ccccc2)C1,CN1CCN(C(=O)CC(N)Cc2ccccc2F)C(Cc2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1450941,CHEMBL877465,Inhibitory concentration against Dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCOC[C@H]1Cc1ccccc1)Cc1ccccc1F,CHEMBL186610,nM,108,CHEMBL284,6.966576245,DPPIV,N[C@@H](CC(=O)N1CCOC[C@H]1Cc1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCOCC1Cc1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451031,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@H](Oc1ccc(CNC(=O)[C@@H]2CSCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL366290,nM,0.3,CHEMBL284,9.522878745,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CSCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CSCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451032,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)C(N)C2CCCCC2)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL183418,nM,7200,CHEMBL284,5.142667504,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)C(N)C2CCCCC2)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)C(N)C2CCCCC2)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451414,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1)Cc1ccccc1,CHEMBL186649,nM,1900,CHEMBL284,5.721246399,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1)Cc1ccccc1,NC(CC(=O)N1CCCC1C(=O)NCc1cc(Cl)ccc1OCC(=O)NC1CC1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451881,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(C(=O)N1CCC[C@H]1C(=O)NCc1ccccc1C(=O)O)C1CCCCC1.O=C(O)C(F)(F)F,CHEMBL365875,nM,3600,CHEMBL284,5.443697499,DPPIV,NC(C(=O)N1CCCC1C(=O)NCc1ccccc1C(=O)O)C1CCCCC1,NC(C(=O)N1CCCC1C(=O)NCc1ccccc1C(=O)O)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451882,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(C(=O)N1CCC[C@H]1C(=O)NCc1cccc(C(=O)O)c1)C1CCCCC1.O=C(O)C(F)(F)F,CHEMBL365834,nM,3300,CHEMBL284,5.48148606,DPPIV,NC(C(=O)N1CCCC1C(=O)NCc1cccc(C(=O)O)c1)C1CCCCC1,NC(C(=O)N1CCCC1C(=O)NCc1cccc(C(=O)O)c1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451883,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(C(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=O)O)cc1)C1CCCCC1.O=C(O)C(F)(F)F,CHEMBL187699,nM,4200,CHEMBL284,5.37675071,DPPIV,NC(C(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)C1CCCCC1,NC(C(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451884,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccccc1C(=O)O)Cc1ccccc1.O=C(O)C(F)(F)F,CHEMBL183098,nM,1200,CHEMBL284,5.920818754,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccccc1C(=O)O)Cc1ccccc1,NC(CC(=O)N1CCCC1C(=O)NCc1ccccc1C(=O)O)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451885,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1cccc(C(=O)O)c1)Cc1ccccc1.O=C(O)C(F)(F)F,CHEMBL184593,nM,1200,CHEMBL284,5.920818754,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1cccc(C(=O)O)c1)Cc1ccccc1,NC(CC(=O)N1CCCC1C(=O)NCc1cccc(C(=O)O)c1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451886,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccccc1.O=C(O)C(F)(F)F,CHEMBL425347,nM,510,CHEMBL284,6.292429824,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccccc1,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1451887,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccc(F)c(F)c1.O=C(O)C(F)(F)F,CHEMBL182223,nM,75,CHEMBL284,7.124938737,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452002,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL366049,nM,54,CHEMBL284,7.26760624,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452003,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccccc1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL186596,nM,539,CHEMBL284,6.268411235,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCc1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452004,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL435882,nM,721,CHEMBL284,6.142064735,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452016,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,COC(=O)Cc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1.O=C(O)C(F)(F)F,CHEMBL185244,nM,170,CHEMBL284,6.769551079,DPPIV,COC(=O)Cc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1,COC(=O)Cc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452017,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCCCCc1nn[nH]n1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL184346,nM,39,CHEMBL284,7.408935393,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCCCCc1nn[nH]n1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCCCCc1nn[nH]n1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452400,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCCCCc1c[nH]cn1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL361263,nM,1640,CHEMBL284,5.785156152,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCCCCc1c[nH]cn1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCCCCc1c[nH]cn1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452401,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL186787,nM,118,CHEMBL284,6.928117993,DPPIV,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452402,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL183736,nM,18,CHEMBL284,7.744727495,DPPIV,CC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452403,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CCC(Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL365010,nM,7.1,CHEMBL284,8.148741651,DPPIV,CCC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CCC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452404,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CCCC(Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL365836,nM,10,CHEMBL284,8,DPPIV,CCCC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CCCC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452405,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)C(Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL365837,nM,3.7,CHEMBL284,8.431798276,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452406,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CCCCC(Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL365838,nM,5.1,CHEMBL284,8.292429824,DPPIV,CCCCC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CCCCC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452407,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,C[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL187963,nM,82,CHEMBL284,7.086186148,DPPIV,CC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452408,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,C[C@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL366286,nM,12,CHEMBL284,7.920818754,DPPIV,CC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CC(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452409,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL365231,nM,13,CHEMBL284,7.886056648,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452410,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL364100,nM,1.8,CHEMBL284,8.744727495,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452411,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccccc2)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL364101,nM,18,CHEMBL284,7.744727495,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452412,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL364102,nM,0.48,CHEMBL284,9.318758763,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452524,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL364103,nM,1.6,CHEMBL284,8.795880017,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452527,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2c(F)c(F)c(F)c(F)c2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL183289,nM,8.2,CHEMBL284,8.086186148,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2c(F)c(F)c(F)c(F)c2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2c(F)c(F)c(F)c(F)c2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452918,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccc(C(F)(F)F)cc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL364140,nM,0.83,CHEMBL284,9.080921908,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccc(C(F)(F)F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccc(C(F)(F)F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452919,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cc(F)c(C(F)(F)F)cc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL184177,nM,9.5,CHEMBL284,8.022276395,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)c(C(F)(F)F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)c(C(F)(F)F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452920,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,Cc1ccc(F)cc1CC(N)CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(O[C@@H](C(=O)O)C(C)C)cc1.O=C(O)C(F)(F)F,CHEMBL366047,nM,33,CHEMBL284,7.48148606,DPPIV,Cc1ccc(F)cc1CC(N)CC(=O)N1CCCC1C(=O)NCc1ccc(OC(C(=O)O)C(C)C)cc1,Cc1ccc(F)cc1CC(N)CC(=O)N1CCCC1C(=O)NCc1ccc(OC(C(=O)O)C(C)C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452921,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2ccc(F)cc2Cl)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL366048,nM,1.7,CHEMBL284,8.769551079,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccc(F)cc2Cl)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccc(F)cc2Cl)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452922,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cc(Cl)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL184527,nM,1.6,CHEMBL284,8.795880017,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(Cl)ccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(Cl)ccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452923,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cc(C(F)(F)F)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL184630,nM,12,CHEMBL284,7.920818754,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(C(F)(F)F)ccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(C(F)(F)F)ccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452924,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,CC(C)[C@@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CC(N)Cc2cccc(OC(F)(F)F)c2)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL365280,nM,295,CHEMBL284,6.530177984,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cccc(OC(F)(F)F)c2)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cccc(OC(F)(F)F)c2)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452925,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CSC[C@H]1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1.O=C(O)C(F)(F)F,CHEMBL451492,nM,161,CHEMBL284,6.793174124,DPPIV,NC(CC(=O)N1CSCC1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1,NC(CC(=O)N1CSCC1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452926,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,COC(=O)Cc1ccc(CNC(=O)[C@@H]2CSCN2C(=O)CC(N)Cc2ccccc2F)cc1.O=C(O)C(F)(F)F,CHEMBL186482,nM,87,CHEMBL284,7.060480747,DPPIV,COC(=O)Cc1ccc(CNC(=O)C2CSCN2C(=O)CC(N)Cc2ccccc2F)cc1,COC(=O)Cc1ccc(CNC(=O)C2CSCN2C(=O)CC(N)Cc2ccccc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1452939,CHEMBL831703,Inhibition of human recombinant Dipeptidylpeptidase IV,B,NC(CC(=O)N1CSC[C@H]1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1F.O=C(O)C(F)(F)F,CHEMBL183060,nM,37,CHEMBL284,7.431798276,DPPIV,NC(CC(=O)N1CSCC1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1F,NC(CC(=O)N1CSCC1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1463620,CHEMBL827834,Inhibitory concentration against dipeptidylpeptidase IV,B,COc1ccc2c(c1)CN[C@H](C(=O)N1CCC[C@H]1C#N)C2,CHEMBL186566,nM,4,CHEMBL284,8.397940009,DPPIV,COc1ccc2c(c1)CNC(C(=O)N1CCC[C@H]1C#N)C2,COc1ccc2c(c1)CNC(C(=O)N1CCCC1C#N)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1463624,CHEMBL827834,Inhibitory concentration against dipeptidylpeptidase IV,B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL365000,nM,5,CHEMBL284,8.301029996,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1463625,CHEMBL827834,Inhibitory concentration against dipeptidylpeptidase IV,B,CCOC(=O)c1cnc(CN)c2c(OC)cc(OC)cc12,CHEMBL186406,nM,320,CHEMBL284,6.494850022,DPPIV,CCOC(=O)c1cnc(CN)c2c(OC)cc(OC)cc12,CCOC(=O)c1cnc(CN)c2c(OC)cc(OC)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1463626,CHEMBL827834,Inhibitory concentration against dipeptidylpeptidase IV,B,CC(=O)Nc1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,CHEMBL186308,nM,250,CHEMBL284,6.602059991,DPPIV,CC(=O)Nc1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,CC(=O)Nc1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1463629,CHEMBL827834,Inhibitory concentration against dipeptidylpeptidase IV,B,CC(C)(C)[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL363250,nM,7,CHEMBL284,8.15490196,DPPIV,CC(C)(C)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)(C)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479733,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@@H](Cc1ccc(-c2ccc(F)cc2)cc1)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL189645,nM,980,CHEMBL284,6.008773924,DPPIV,NC(Cc1ccc(-c2ccc(F)cc2)cc1)C(=O)N1CC[C@H](F)C1,NC(Cc1ccc(-c2ccc(F)cc2)cc1)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479737,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL189881,nM,64,CHEMBL284,7.193820026,DPPIV,CC(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479853,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](CO)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL365567,nM,390,CHEMBL284,6.408935393,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(CO)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(CO)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479857,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL189046,nM,1600,CHEMBL284,5.795880017,DPPIV,CN(C)CC(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)CC(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479861,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](CN1CCCC1)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL190031,nM,3500,CHEMBL284,5.455931956,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(CN1CCCC1)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(CN1CCCC1)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479865,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](C(=O)O)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL191327,nM,6.6,CHEMBL284,8.180456064,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(C(=O)O)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(C(=O)O)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479872,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,COC(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL372004,nM,220,CHEMBL284,6.657577319,DPPIV,COC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,COC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479876,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,NC(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191208,nM,110,CHEMBL284,6.958607315,DPPIV,NC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,NC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479880,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CNC(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL190752,nM,37,CHEMBL284,7.431798276,DPPIV,CNC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CNC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1479893,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191067,nM,12,CHEMBL284,7.920818754,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480024,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](Cn1cnnn1)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL359581,nM,192,CHEMBL284,6.716698771,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(Cn1cnnn1)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(Cn1cnnn1)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480028,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CCNC(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL189067,nM,110,CHEMBL284,6.958607315,DPPIV,CCNC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CCNC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480032,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CC(C)NC(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL188643,nM,99,CHEMBL284,7.004364805,DPPIV,CC(C)NC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(C)NC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480036,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](C(=O)NC1CC1)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL190788,nM,71,CHEMBL284,7.148741651,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(C(=O)NC1CC1)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(C(=O)NC1CC1)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480040,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](C(=O)NCCO)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL190593,nM,94,CHEMBL284,7.026872146,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(C(=O)NCCO)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(C(=O)NCCO)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480044,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](C(=O)Nn1cnnn1)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL188444,nM,11,CHEMBL284,7.958607315,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(C(=O)Nn1cnnn1)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(C(=O)Nn1cnnn1)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480051,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CCN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL425558,nM,20,CHEMBL284,7.698970004,DPPIV,CCN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CCN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480167,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CCN(CC)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL364939,nM,59,CHEMBL284,7.229147988,DPPIV,CCN(CC)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CCN(CC)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480171,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](C(=O)N1CCC1)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL188043,nM,44,CHEMBL284,7.356547324,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(C(=O)N1CCC1)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(C(=O)N1CCC1)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480178,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,N[C@H](C(=O)N1CC[C@H](F)C1)[C@@H](C(=O)N1CCCC1)c1ccc(-c2ccc(F)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL191258,nM,9.2,CHEMBL284,8.036212173,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C(C(=O)N1CCCC1)c1ccc(-c2ccc(F)cc2)cc1,NC(C(=O)N1CCC(F)C1)C(C(=O)N1CCCC1)c1ccc(-c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480185,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CON(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370755,nM,45,CHEMBL284,7.346787486,DPPIV,CON(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CON(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480189,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)NC(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL371588,nM,67,CHEMBL284,7.173925197,DPPIV,CN(C)NC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)NC(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480193,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCC1.O=C(O)C(F)(F)F,CHEMBL370509,nM,100,CHEMBL284,7,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480197,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC(F)C1.O=C(O)C(F)(F)F,CHEMBL363115,nM,17,CHEMBL284,7.769551079,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC(F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480201,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL364355,nM,29,CHEMBL284,7.537602002,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC(F)(F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480205,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL190466,nM,7.5,CHEMBL284,8.124938737,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCCC1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480324,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@@H](F)C1.O=C(O)C(F)(F)F,CHEMBL372486,nM,30,CHEMBL284,7.522878745,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480328,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL191337,nM,27,CHEMBL284,7.568636236,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)(F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480332,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCSC1.O=C(O)C(F)(F)F,CHEMBL190863,nM,9.1,CHEMBL284,8.040958608,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCSC1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480339,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCS(=O)(=O)C1.O=C(O)C(F)(F)F,CHEMBL365967,nM,230,CHEMBL284,6.638272164,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCS(=O)(=O)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCS(=O)(=O)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480343,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL189055,nM,3.3,CHEMBL284,8.48148606,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC[C@H]1C#N,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480347,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCCCC1.O=C(O)C(F)(F)F,CHEMBL190923,nM,550,CHEMBL284,6.259637311,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCCCC1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480351,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCOCC1.O=C(O)C(F)(F)F,CHEMBL371347,nM,520,CHEMBL284,6.283996656,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCOCC1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCOCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480355,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL188096,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480359,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)c(F)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL190217,nM,21,CHEMBL284,7.677780705,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)c(F)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)c(F)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480363,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2cc(F)ccc2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191486,nM,56,CHEMBL284,7.251811973,DPPIV,CN(C)C(=O)C(c1ccc(-c2cc(F)ccc2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2cc(F)ccc2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480367,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2cccc(C#N)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL190269,nM,43,CHEMBL284,7.366531544,DPPIV,CN(C)C(=O)C(c1ccc(-c2cccc(C#N)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2cccc(C#N)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480489,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2cccc(-n3cnnn3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191473,nM,2.2,CHEMBL284,8.657577319,DPPIV,CN(C)C(=O)C(c1ccc(-c2cccc(-n3cnnn3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2cccc(-n3cnnn3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480496,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370677,nM,21,CHEMBL284,7.677780705,DPPIV,CN(C)C(=O)C(c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480503,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2cccc(-[n+]3ccccc3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C([O-])C(F)(F)F,CHEMBL541919,nM,19,CHEMBL284,7.721246399,DPPIV,CN(C)C(=O)C(c1ccc(-c2cccc(-[n+]3ccccc3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2cccc(-[n+]3ccccc3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1480507,CHEMBL827856,Inhibitory concentration against dipeptidylpeptidase IV,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(-[n+]3ccccc3)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C([O-])C(F)(F)F,CHEMBL552503,nM,20,CHEMBL284,7.698970004,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(-[n+]3ccccc3)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(-[n+]3ccccc3)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485682,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1cc2c(cc1OC)CN(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2,CHEMBL369883,nM,63,CHEMBL284,7.200659451,DPPIV,COc1cc2c(cc1OC)CN(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)CN(C(=O)CC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485712,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1cc2c(cc1OC)C(CCO)N(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2,CHEMBL193105,nM,45,CHEMBL284,7.346787486,DPPIV,COc1cc2c(cc1OC)C(CCO)N(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)C(CCO)N(C(=O)CC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485714,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1cc2c(cc1OC)C(C(C)C)N(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2,CHEMBL192116,nM,47,CHEMBL284,7.327902142,DPPIV,COc1cc2c(cc1OC)C(C(C)C)N(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)C(C(C)C)N(C(=O)CC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485949,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1cc2c(cc1OC)C(C(C)(C)C)N(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2,CHEMBL373148,nM,73,CHEMBL284,7.13667714,DPPIV,COc1cc2c(cc1OC)C(C(C)(C)C)N(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)C(C(C)(C)C)N(C(=O)CC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485951,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1ccc2c(c1)CCN(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)C2C(C)(C)C,CHEMBL193202,nM,72,CHEMBL284,7.142667504,DPPIV,COc1ccc2c(c1)CCN(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)C2C(C)(C)C,COc1ccc2c(c1)CCN(C(=O)CC(N)C(=O)N1CCCC1C#N)C2C(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485953,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1ccc2c(c1)C(C(C)(C)C)N(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2,CHEMBL191866,nM,195,CHEMBL284,6.709965389,DPPIV,COc1ccc2c(c1)C(C(C)(C)C)N(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1ccc2c(c1)C(C(C)(C)C)N(C(=O)CC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485971,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,N#Cc1ccc[n+](N2CCN(C(=O)C[C@H](N)C(=O)N3CCC[C@H]3C#N)CC2)c1,CHEMBL364922,nM,87,CHEMBL284,7.060480747,DPPIV,N#Cc1ccc[n+](N2CCN(C(=O)CC(N)C(=O)N3CCC[C@H]3C#N)CC2)c1,N#Cc1ccc[n+](N2CCN(C(=O)CC(N)C(=O)N3CCCC3C#N)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485973,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)N1CCN(C(=O)c2ccccc2)CC1,CHEMBL190029,nM,123,CHEMBL284,6.910094889,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CC(=O)N1CCN(C(=O)c2ccccc2)CC1,N#CC1CCCN1C(=O)C(N)CC(=O)N1CCN(C(=O)c2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485975,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)NCc1ccccc1,CHEMBL365113,nM,238,CHEMBL284,6.623423043,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CC(=O)NCc1ccccc1,N#CC1CCCN1C(=O)C(N)CC(=O)NCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1485985,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1cc2c(cc1OC)C(Cc1ccccc1)N(C(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2,CHEMBL190183,nM,97,CHEMBL284,7.013228266,DPPIV,COc1cc2c(cc1OC)C(Cc1ccccc1)N(C(=O)CC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)C(Cc1ccccc1)N(C(=O)CC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1488473,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,CC(C)C(NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL191274,nM,212,CHEMBL284,6.673664139,DPPIV,CC(C)C(NC(=O)CC(N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CC(C)C(NC(=O)CC(N)C(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1488475,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,CC(C)(C)C(NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL189220,nM,251,CHEMBL284,6.600326279,DPPIV,CC(C)(C)C(NC(=O)CC(N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CC(C)(C)C(NC(=O)CC(N)C(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1488477,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COc1ccc(CCNC(=O)C[C@H](N)C(=O)N2CCC[C@H]2C#N)cc1OC,CHEMBL191577,nM,116,CHEMBL284,6.935542011,DPPIV,COc1ccc(CCNC(=O)CC(N)C(=O)N2CCC[C@H]2C#N)cc1OC,COc1ccc(CCNC(=O)CC(N)C(=O)N2CCCC2C#N)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1488577,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)NC(Cc1ccccc1)c1ccccc1,CHEMBL359759,nM,252,CHEMBL284,6.598599459,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CC(=O)NC(Cc1ccccc1)c1ccccc1,N#CC1CCCN1C(=O)C(N)CC(=O)NC(Cc1ccccc1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1488600,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,COCC(Cc1ccccc1)NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL192733,nM,182,CHEMBL284,6.739928612,DPPIV,COCC(Cc1ccccc1)NC(=O)CC(N)C(=O)N1CCC[C@H]1C#N,COCC(Cc1ccccc1)NC(=O)CC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1488602,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,CC(C)C(Cc1ccccc1)NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL193106,nM,305,CHEMBL284,6.515700161,DPPIV,CC(C)C(Cc1ccccc1)NC(=O)CC(N)C(=O)N1CCC[C@H]1C#N,CC(C)C(Cc1ccccc1)NC(=O)CC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1489233,CHEMBL829475,Inhibitory concentration against Dipeptidylpeptidase IV [DPP-IV],B,CCC(NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL189258,nM,140,CHEMBL284,6.853871964,DPPIV,CCC(NC(=O)CC(N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CCC(NC(=O)CC(N)C(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495788,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](NS(=O)(=O)c2ccccc2)CN1,CHEMBL193168,nM,6.7,CHEMBL284,8.173925197,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](NS(=O)(=O)c2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(NS(=O)(=O)c2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495793,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,COc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1,CHEMBL195063,nM,0.33,CHEMBL284,9.48148606,DPPIV,COc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1,COc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495795,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,COc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1OC,CHEMBL433811,nM,0.28,CHEMBL284,9.552841969,DPPIV,COc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1OC,COc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495797,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#Cc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1,CHEMBL371143,nM,0.19,CHEMBL284,9.721246399,DPPIV,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1,N#Cc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495799,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](Nc2ccc([N+](=O)[O-])cc2)CN1,CHEMBL370540,nM,0.18,CHEMBL284,9.744727495,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](Nc2ccc([N+](=O)[O-])cc2)CN1,N#CC1CCCN1C(=O)C1CC(Nc2ccc([N+](=O)[O-])cc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495801,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#Cc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1C#N,CHEMBL370046,nM,0.13,CHEMBL284,9.886056648,DPPIV,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1C#N,N#Cc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495803,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#Cc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1Cl,CHEMBL194717,nM,0.13,CHEMBL284,9.886056648,DPPIV,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1Cl,N#Cc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495811,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,CC[C@@H](C)[C@H](N)C(=O)N1CCSC1,CHEMBL191775,nM,460,CHEMBL284,6.337242168,DPPIV,CCC(C)C(N)C(=O)N1CCSC1,CCC(C)C(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495814,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccccc1)[C@H](N)C(=O)N1CCSC1,CHEMBL192983,nM,968,CHEMBL284,6.014124643,DPPIV,CC(c1ccccc1)C(N)C(=O)N1CCSC1,CC(c1ccccc1)C(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495820,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccccc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL362973,nM,1400,CHEMBL284,5.853871964,DPPIV,CC(c1ccccc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccccc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495824,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccccc1F)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL362976,nM,1100,CHEMBL284,5.958607315,DPPIV,CC(c1ccccc1F)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccccc1F)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495914,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(Cl)cc1F)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370734,nM,480,CHEMBL284,6.318758763,DPPIV,CC(c1ccc(Cl)cc1F)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(Cl)cc1F)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495918,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(F)cc1Cl)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195862,nM,4200,CHEMBL284,5.37675071,DPPIV,CC(c1ccc(F)cc1Cl)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(F)cc1Cl)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495922,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(F)cc1C(F)(F)F)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191652,nM,54000,CHEMBL284,4.26760624,DPPIV,CC(c1ccc(F)cc1C(F)(F)F)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(F)cc1C(F)(F)F)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495926,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1cccc(F)c1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191823,nM,3700,CHEMBL284,5.431798276,DPPIV,CC(c1cccc(F)c1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1cccc(F)c1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495930,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1cccc(Cl)c1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL192781,nM,1100,CHEMBL284,5.958607315,DPPIV,CC(c1cccc(Cl)c1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1cccc(Cl)c1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495934,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1cc(F)cc(F)c1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195270,nM,3700,CHEMBL284,5.431798276,DPPIV,CC(c1cc(F)cc(F)c1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1cc(F)cc(F)c1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495938,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(F)c(F)c1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL366173,nM,1100,CHEMBL284,5.958607315,DPPIV,CC(c1ccc(F)c(F)c1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(F)c(F)c1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495943,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(F)c(Cl)c1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL364093,nM,2800,CHEMBL284,5.552841969,DPPIV,CC(c1ccc(F)c(Cl)c1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(F)c(Cl)c1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1495950,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL365575,nM,280,CHEMBL284,6.552841969,DPPIV,CC(c1ccc(F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496042,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(Br)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191354,nM,250,CHEMBL284,6.602059991,DPPIV,CC(c1ccc(Br)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(Br)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496046,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(Cl)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL190454,nM,170,CHEMBL284,6.769551079,DPPIV,CC(c1ccc(Cl)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(Cl)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496050,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,CSc1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL192365,nM,360,CHEMBL284,6.443697499,DPPIV,CSc1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,CSc1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496054,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(C(F)(F)F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL194489,nM,600,CHEMBL284,6.22184875,DPPIV,CC(c1ccc(C(F)(F)F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(C(F)(F)F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496058,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(S(C)(=O)=O)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370079,nM,3600,CHEMBL284,5.443697499,DPPIV,CC(c1ccc(S(C)(=O)=O)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(S(C)(=O)=O)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496062,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,COc1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL369888,nM,770,CHEMBL284,6.113509275,DPPIV,COc1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,COc1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496066,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccccc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191933,nM,120,CHEMBL284,6.920818754,DPPIV,CC(c1ccc(-c2ccccc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccccc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496070,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccccc2)c(F)c1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL365996,nM,2000,CHEMBL284,5.698970004,DPPIV,CC(c1ccc(-c2ccccc2)c(F)c1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccccc2)c(F)c1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496074,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(N2CCCCC2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL362930,nM,7900,CHEMBL284,5.102372909,DPPIV,CC(c1ccc(N2CCCCC2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(N2CCCCC2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496174,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(C(=O)[n+]2ccc[nH]2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C([O-])C(F)(F)F,CHEMBL552788,nM,1700,CHEMBL284,5.769551079,DPPIV,CC(c1ccc(C(=O)[n+]2ccc[nH]2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(C(=O)[n+]2ccc[nH]2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496178,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2nccs2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL192396,nM,1500,CHEMBL284,5.823908741,DPPIV,CC(c1ccc(-c2nccs2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2nccs2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496182,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccccn2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191858,nM,240,CHEMBL284,6.619788758,DPPIV,CC(c1ccc(-c2ccccn2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccccn2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496186,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccnc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195205,nM,110,CHEMBL284,6.958607315,DPPIV,CC(c1ccc(-c2cccnc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccnc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496190,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccncc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL371846,nM,110,CHEMBL284,6.958607315,DPPIV,CC(c1ccc(-c2ccncc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccncc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496194,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cncnc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL192449,nM,580,CHEMBL284,6.236572006,DPPIV,CC(c1ccc(-c2cncnc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cncnc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496198,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccccc2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370240,nM,100,CHEMBL284,7,DPPIV,CC(c1ccc(-c2ccccc2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccccc2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496202,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccccc2Cl)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191769,nM,86,CHEMBL284,7.065501549,DPPIV,CC(c1ccc(-c2ccccc2Cl)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccccc2Cl)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496206,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,COc1ccccc1-c1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL365953,nM,110,CHEMBL284,6.958607315,DPPIV,COc1ccccc1-c1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,COc1ccccc1-c1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496210,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccccc2C(F)(F)F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL425375,nM,130,CHEMBL284,6.886056648,DPPIV,CC(c1ccc(-c2ccccc2C(F)(F)F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccccc2C(F)(F)F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496316,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,Cc1ccccc1-c1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL372472,nM,150,CHEMBL284,6.823908741,DPPIV,Cc1ccccc1-c1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,Cc1ccccc1-c1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496320,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,CCOC(=O)c1cccc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)c1.O=C(O)C(F)(F)F,CHEMBL192425,nM,75,CHEMBL284,7.124938737,DPPIV,CCOC(=O)c1cccc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)c1,CCOC(=O)c1cccc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496324,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(NS(C)(=O)=O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL263326,nM,150,CHEMBL284,6.823908741,DPPIV,CC(c1ccc(-c2cccc(NS(C)(=O)=O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(NS(C)(=O)=O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496328,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(C(=O)O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195755,nM,56,CHEMBL284,7.251811973,DPPIV,CC(c1ccc(-c2cccc(C(=O)O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(C(=O)O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496336,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL365780,nM,110,CHEMBL284,6.958607315,DPPIV,CC(c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496340,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(S(N)(=O)=O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL366031,nM,140,CHEMBL284,6.853871964,DPPIV,CC(c1ccc(-c2cccc(S(N)(=O)=O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(S(N)(=O)=O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496344,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(NS(=O)(=O)C(F)(F)F)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL192117,nM,27,CHEMBL284,7.568636236,DPPIV,CC(c1ccc(-c2cccc(NS(=O)(=O)C(F)(F)F)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(NS(=O)(=O)C(F)(F)F)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1496348,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(C(N)=O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL192421,nM,100,CHEMBL284,7,DPPIV,CC(c1ccc(-c2cccc(C(N)=O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(C(N)=O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497096,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL192980,nM,510,CHEMBL284,6.292429824,DPPIV,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497809,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#Cc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)nc1,CHEMBL195420,nM,0.25,CHEMBL284,9.602059991,DPPIV,N#Cc1ccc(=N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)[nH]c1,N#Cc1ccc(=NC2CNC(C(=O)N3CCCC3C#N)C2)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497811,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#Cc1ccc(N[C@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)nc1,CHEMBL192165,nM,6.6,CHEMBL284,8.180456064,DPPIV,N#Cc1ccc(=N[C@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)[nH]c1,N#Cc1ccc(=NC2CNC(C(=O)N3CCCC3C#N)C2)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497822,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1,CHEMBL381626,nM,2.9,CHEMBL284,8.537602002,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CCCN1,N#CC1CCCN1C(=O)C1CCCN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497826,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](N)CN1,CHEMBL191699,nM,9.7,CHEMBL284,8.013228266,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](N)CN1,N#CC1CCCN1C(=O)C1CC(N)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497828,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](NC2CCCCC2)CN1,CHEMBL192882,nM,3,CHEMBL284,8.522878745,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](NC2CCCCC2)CN1,N#CC1CCCN1C(=O)C1CC(NC2CCCCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497830,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](Nc2ccccc2)CN1,CHEMBL195335,nM,0.53,CHEMBL284,9.27572413,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](Nc2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(Nc2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497832,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](NCc2ccccc2)CN1,CHEMBL195804,nM,4.6,CHEMBL284,8.337242168,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](NCc2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(NCc2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497834,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](NCCc2ccccc2)CN1,CHEMBL194993,nM,1.9,CHEMBL284,8.721246399,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](NCCc2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(NCCc2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497836,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](NC(=O)c2ccccc2)CN1,CHEMBL539939,nM,5.5,CHEMBL284,8.259637311,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](NC(=O)c2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(NC(=O)c2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1497838,CHEMBL876981,Inhibitory concentration against human dipeptidylpeptidase IV,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](NC(=O)Nc2ccccc2)CN1,CHEMBL371585,nM,1.5,CHEMBL284,8.823908741,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](NC(=O)Nc2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(NC(=O)Nc2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500100,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3n[nH]c(O)n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195905,nM,95,CHEMBL284,7.022276395,DPPIV,CC(c1ccc(-c2cccc(-c3n[nH]c(=O)[nH]3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3n[nH]c(=O)[nH]3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500121,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3c[nH]c(O)n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL364057,nM,110,CHEMBL284,6.958607315,DPPIV,CC(c1ccc(-c2cccc(-c3c[nH]c(=O)[nH]3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3c[nH]c(=O)[nH]3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500378,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3nc[nH]n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL190979,nM,98,CHEMBL284,7.008773924,DPPIV,CC(c1ccc(-c2cccc(-c3nc[nH]n3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3nc[nH]n3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500382,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3noc(C4CC4)n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370033,nM,140,CHEMBL284,6.853871964,DPPIV,CC(c1ccc(-c2cccc(-c3noc(C4CC4)n3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3noc(C4CC4)n3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500759,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3nn[nH]n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195378,nM,6,CHEMBL284,8.22184875,DPPIV,CC(c1ccc(-c2cccc(-c3nn[nH]n3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3nn[nH]n3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500770,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3noc(O)n3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL370072,nM,3,CHEMBL284,8.522878745,DPPIV,CC(c1ccc(-c2cccc(-c3nc(=O)o[nH]3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3nc(=O)o[nH]3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500970,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,COc1ccc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL195443,nM,130,CHEMBL284,6.886056648,DPPIV,COc1ccc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cc1,COc1ccc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1500974,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,Cc1ccc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL191514,nM,390,CHEMBL284,6.408935393,DPPIV,Cc1ccc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cc1,Cc1ccc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501222,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccc(NS(C)(=O)=O)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL193887,nM,710,CHEMBL284,6.148741651,DPPIV,CC(c1ccc(-c2ccc(NS(C)(=O)=O)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(NS(C)(=O)=O)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501226,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,CCOC(=O)c1ccc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL363175,nM,440,CHEMBL284,6.356547324,DPPIV,CCOC(=O)c1ccc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cc1,CCOC(=O)c1ccc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501481,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccc(C(=O)O)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191906,nM,370,CHEMBL284,6.431798276,DPPIV,CC(c1ccc(-c2ccc(C(=O)O)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(C(=O)O)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501485,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL194437,nM,420,CHEMBL284,6.37675071,DPPIV,CC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501501,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cc(F)cc(F)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL191812,nM,240,CHEMBL284,6.619788758,DPPIV,CC(c1ccc(-c2cc(F)cc(F)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cc(F)cc(F)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501750,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cc(F)ccc2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL278729,nM,150,CHEMBL284,6.823908741,DPPIV,CC(c1ccc(-c2cc(F)ccc2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cc(F)ccc2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1501769,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccc(F)c(F)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195173,nM,60,CHEMBL284,7.22184875,DPPIV,CC(c1ccc(-c2ccc(F)c(F)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(F)c(F)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1502020,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2ccc(F)cc2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL363584,nM,37,CHEMBL284,7.431798276,DPPIV,CC(c1ccc(-c2ccc(F)cc2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(F)cc2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1502038,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-n3cnnn3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195739,nM,140,CHEMBL284,6.853871964,DPPIV,CC(c1ccc(-c2cccc(-n3cnnn3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-n3cnnn3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1502055,CHEMBL827816,Inhibitory concentration against dipeptidylpeptidase IV was determined,B,C[C@@H](c1ccc(-c2cccc(-c3nnco3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL195667,nM,69,CHEMBL284,7.161150909,DPPIV,CC(c1ccc(-c2cccc(-c3nnco3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(-c3nnco3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519561,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cc1[nH]nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL426469,nM,250,CHEMBL284,6.602059991,DPPIV,Cc1[nH]nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cc1[nH]nc2c1CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519565,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2n[nH]c(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,CHEMBL197413,nM,110,CHEMBL284,6.958607315,DPPIV,N[C@@H](CC(=O)N1CCc2[nH]nc(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2[nH]nc(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519569,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc(C(F)(F)F)c2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL195721,nM,130,CHEMBL284,6.886056648,DPPIV,Cn1nc(C(F)(F)F)c2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cn1nc(C(F)(F)F)c2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519573,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc2c(c1C(F)(F)F)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL191805,nM,150,CHEMBL284,6.823908741,DPPIV,Cn1nc2c(c1C(F)(F)F)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cn1nc2c(c1C(F)(F)F)CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519577,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2c(c(C(F)(F)F)nn2CC(F)(F)F)C1)Cc1cc(F)ccc1F,CHEMBL196010,nM,180,CHEMBL284,6.744727495,DPPIV,N[C@@H](CC(=O)N1CCc2c(c(C(F)(F)F)nn2CC(F)(F)F)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2c(c(C(F)(F)F)nn2CC(F)(F)F)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519581,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2nn(CC(F)(F)F)c(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,CHEMBL194979,nM,150,CHEMBL284,6.823908741,DPPIV,N[C@@H](CC(=O)N1CCc2nn(CC(F)(F)F)c(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2nn(CC(F)(F)F)c(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519585,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cc1nn(-c2ccc(F)cc2)c2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL193885,nM,350,CHEMBL284,6.455931956,DPPIV,Cc1nn(-c2ccc(F)cc2)c2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cc1nn(-c2ccc(F)cc2)c2c1CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519704,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cc1c2c(nn1-c1ccc(F)cc1)CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL196114,nM,160,CHEMBL284,6.795880017,DPPIV,Cc1c2c(nn1-c1ccc(F)cc1)CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cc1c2c(nn1-c1ccc(F)cc1)CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519708,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2n[nH]c(C(F)(F)C(F)(F)F)c2C1)Cc1cc(F)ccc1F,CHEMBL370269,nM,160,CHEMBL284,6.795880017,DPPIV,N[C@@H](CC(=O)N1CCc2[nH]nc(C(F)(F)C(F)(F)F)c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2[nH]nc(C(F)(F)C(F)(F)F)c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519712,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc(C(F)(F)C(F)(F)F)c2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL369894,nM,220,CHEMBL284,6.657577319,DPPIV,Cn1nc(C(F)(F)C(F)(F)F)c2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cn1nc(C(F)(F)C(F)(F)F)c2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519717,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc2c(c1C(F)(F)C(F)(F)F)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL366166,nM,300,CHEMBL284,6.522878745,DPPIV,Cn1nc2c(c1C(F)(F)C(F)(F)F)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cn1nc2c(c1C(F)(F)C(F)(F)F)CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519721,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2n[nH]c(-c3ccc(F)cc3)c2C1)Cc1cc(F)ccc1F,CHEMBL373268,nM,270,CHEMBL284,6.568636236,DPPIV,N[C@@H](CC(=O)N1CCc2[nH]nc(-c3ccc(F)cc3)c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2[nH]nc(-c3ccc(F)cc3)c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519725,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc(-c2ccc(F)cc2)c2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL193802,nM,780,CHEMBL284,6.107905397,DPPIV,Cn1nc(-c2ccc(F)cc2)c2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cn1nc(-c2ccc(F)cc2)c2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519729,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc2c(c1-c1ccc(F)cc1)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL197301,nM,150,CHEMBL284,6.823908741,DPPIV,Cn1nc2c(c1-c1ccc(F)cc1)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cn1nc2c(c1-c1ccc(F)cc1)CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519733,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2noc(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,CHEMBL363606,nM,130,CHEMBL284,6.886056648,DPPIV,N[C@@H](CC(=O)N1CCc2noc(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2noc(C(F)(F)F)c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519737,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2c(n[nH]c2C(F)(F)F)C1)Cc1cc(F)ccc1F,CHEMBL197300,nM,39,CHEMBL284,7.408935393,DPPIV,N[C@@H](CC(=O)N1CCc2c(C(F)(F)F)n[nH]c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2c(C(F)(F)F)n[nH]c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519741,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc(C(F)(F)F)c2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL196938,nM,72,CHEMBL284,7.142667504,DPPIV,Cn1nc(C(F)(F)F)c2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cn1nc(C(F)(F)F)c2c1CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519855,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cn1nc2c(c1C(F)(F)F)CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL371521,nM,130,CHEMBL284,6.886056648,DPPIV,Cn1nc2c(c1C(F)(F)F)CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cn1nc2c(c1C(F)(F)F)CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519859,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2c(C3CC3)n[nH]c2C1)Cc1cc(F)ccc1F,CHEMBL425905,nM,160,CHEMBL284,6.795880017,DPPIV,N[C@@H](CC(=O)N1CCc2c(C3CC3)n[nH]c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2c(C3CC3)n[nH]c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519863,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2c(noc2C(F)(F)F)C1)Cc1cc(F)ccc1F,CHEMBL195984,nM,85,CHEMBL284,7.070581074,DPPIV,N[C@@H](CC(=O)N1CCc2c(noc2C(F)(F)F)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2c(noc2C(F)(F)F)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519868,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCCc2n[nH]c(C(F)(F)F)c21)Cc1cc(F)ccc1F,CHEMBL364461,nM,590,CHEMBL284,6.229147988,DPPIV,N[C@@H](CC(=O)N1CCCc2[nH]nc(C(F)(F)F)c21)Cc1cc(F)ccc1F,NC(CC(=O)N1CCCc2[nH]nc(C(F)(F)F)c21)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519872,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,Cc1nc2c(s1)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL196333,nM,480,CHEMBL284,6.318758763,DPPIV,Cc1nc2c(s1)CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cc1nc2c(s1)CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519876,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2nc(C(F)(F)F)sc2C1)Cc1cc(F)ccc1F,CHEMBL426649,nM,310,CHEMBL284,6.508638306,DPPIV,N[C@@H](CC(=O)N1CCc2nc(C(F)(F)F)sc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2nc(C(F)(F)F)sc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519880,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2nc(-c3ccc(F)cc3)sc2C1)Cc1cc(F)ccc1F,CHEMBL195547,nM,360,CHEMBL284,6.443697499,DPPIV,N[C@@H](CC(=O)N1CCc2nc(-c3ccc(F)cc3)sc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2nc(-c3ccc(F)cc3)sc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519884,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2nc(-c3ccc(C(F)(F)F)cc3)sc2C1)Cc1cc(F)ccc1F,CHEMBL197352,nM,260,CHEMBL284,6.585026652,DPPIV,N[C@@H](CC(=O)N1CCc2nc(-c3ccc(C(F)(F)F)cc3)sc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2nc(-c3ccc(C(F)(F)F)cc3)sc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519888,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,CSc1ccc(-c2nc3c(s2)CN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)CC3)cc1,CHEMBL425200,nM,380,CHEMBL284,6.420216403,DPPIV,CSc1ccc(-c2nc3c(s2)CN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)CC3)cc1,CSc1ccc(-c2nc3c(s2)CN(C(=O)CC(N)Cc2cc(F)ccc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1519892,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,CS(=O)(=O)c1ccc(-c2nc3c(s2)CN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)CC3)cc1,CHEMBL372078,nM,130,CHEMBL284,6.886056648,DPPIV,CS(=O)(=O)c1ccc(-c2nc3c(s2)CN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)CC3)cc1,CS(=O)(=O)c1ccc(-c2nc3c(s2)CN(C(=O)CC(N)Cc2cc(F)ccc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1520005,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2nc(C3CC3)oc2C1)Cc1cc(F)ccc1F,CHEMBL425380,nM,290,CHEMBL284,6.537602002,DPPIV,N[C@@H](CC(=O)N1CCc2nc(C3CC3)oc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2nc(C3CC3)oc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1520009,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2sc(C(F)(F)F)nc2C1)Cc1cc(F)ccc1F,CHEMBL363375,nM,95000,CHEMBL284,4.022276395,DPPIV,N[C@@H](CC(=O)N1CCc2sc(C(F)(F)F)nc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2sc(C(F)(F)F)nc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1520016,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2sc(-c3ccc(F)cc3)nc2C1)Cc1cc(F)ccc1F,CHEMBL195030,nM,26,CHEMBL284,7.585026652,DPPIV,N[C@@H](CC(=O)N1CCc2sc(-c3ccc(F)cc3)nc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2sc(-c3ccc(F)cc3)nc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1520024,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C1)Cc1cc(F)ccc1F,CHEMBL381665,nM,13,CHEMBL284,7.886056648,DPPIV,N[C@@H](CC(=O)N1CCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1520028,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,CS(=O)(=O)c1ccc(-c2nc3c(s2)CCN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)C3)cc1,CHEMBL196881,nM,1.4,CHEMBL284,8.853871964,DPPIV,CS(=O)(=O)c1ccc(-c2nc3c(s2)CCN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)C3)cc1,CS(=O)(=O)c1ccc(-c2nc3c(s2)CCN(C(=O)CC(N)Cc2cc(F)ccc2F)C3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1520035,CHEMBL829336,Inhibitory concentration against human dipeptidylpeptidase IV,B,N[C@@H](CC(=O)N1CCc2oc(C3CC3)nc2C1)Cc1cc(F)ccc1F,CHEMBL197082,nM,180,CHEMBL284,6.744727495,DPPIV,N[C@@H](CC(=O)N1CCc2oc(C3CC3)nc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2oc(C3CC3)nc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603590,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CC1)N1CCC[C@H]1B(O)O,CHEMBL381200,nM,130,CHEMBL284,6.886056648,DPPIV,O=C(CNC1CC1)N1CCC[C@H]1B(O)O,O=C(CNC1CC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603593,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CCC1)N1CCC[C@H]1B(O)O,CHEMBL382980,nM,75,CHEMBL284,7.124938737,DPPIV,O=C(CNC1CCC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603596,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CCCC1)N1CCC[C@H]1B(O)O,CHEMBL371429,nM,25,CHEMBL284,7.602059991,DPPIV,O=C(CNC1CCCC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCCC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603599,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CCCCC1)N1CCC[C@H]1B(O)O,CHEMBL371130,nM,27,CHEMBL284,7.568636236,DPPIV,O=C(CNC1CCCCC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCCCC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603602,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CCCCCCC1)N1CCC[C@H]1B(O)O,CHEMBL382974,nM,27,CHEMBL284,7.568636236,DPPIV,O=C(CNC1CCCCCCC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCCCCCC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603605,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CCCCCCCCC1)N1CCC[C@H]1B(O)O,CHEMBL196267,nM,58,CHEMBL284,7.236572006,DPPIV,O=C(CNC1CCCCCCCCC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCCCCCCCC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603608,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCC[C@@H]1B(O)O,CHEMBL373269,nM,8,CHEMBL284,8.096910013,DPPIV,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCC[C@@H]1B(O)O,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603611,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,CCCCCC12CCC(NCC(=O)N3CCC[C@H]3B(O)O)(CC1)CC2,CHEMBL372180,nM,61,CHEMBL284,7.214670165,DPPIV,CCCCCC12CCC(NCC(=O)N3CCC[C@H]3B(O)O)(CC1)CC2,CCCCCC12CCC(NCC(=O)N3CCCC3B(O)O)(CC1)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603620,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,CC(C)[C@@H](NC1CCCCC1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL434184,nM,16000,CHEMBL284,4.795880017,DPPIV,CC(C)C(NC1CCCCC1)C(=O)N1CCC[C@H]1B(O)O,CC(C)C(NC1CCCCC1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603626,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,C[C@@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL196120,nM,0.8,CHEMBL284,9.096910013,DPPIV,CC(N)C(=O)N1CCC[C@H]1B(O)O,CC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603629,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1C2CC3CC(C2)CC1C3)N1CCC[C@@H]1B(O)O,CHEMBL427012,nM,12,CHEMBL284,7.920818754,DPPIV,O=C(CNC1C2CC3CC(C2)CC1C3)N1CCC[C@@H]1B(O)O,O=C(CNC1C2CC3CC(C2)CC1C3)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603632,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,CC12CC3(C)CC(C)(C1)CC(NCC(=O)N1CCC[C@@H]1B(O)O)(C2)C3,CHEMBL381444,nM,560,CHEMBL284,6.251811973,DPPIV,CC12CC3(C)CC(C)(C1)CC(NCC(=O)N1CCC[C@@H]1B(O)O)(C2)C3,CC12CC3(C)CC(C)(C1)CC(NCC(=O)N1CCCC1B(O)O)(C2)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603635,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,CN(CC(=O)N1CCC[C@@H]1B(O)O)C1C2CC3CC(C2)CC1C3,CHEMBL196188,nM,1600,CHEMBL284,5.795880017,DPPIV,CN(CC(=O)N1CCC[C@@H]1B(O)O)C1C2CC3CC(C2)CC1C3,CN(CC(=O)N1CCCC1B(O)O)C1C2CC3CC(C2)CC1C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603638,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CCCCCC1)N1CCC[C@H]1B(O)O,CHEMBL196933,nM,7.8,CHEMBL284,8.107905397,DPPIV,O=C(CNC1CCCCCC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCCCCC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603671,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@@H](NC(=O)[C@@H](N)CC)B(O)O,CHEMBL195271,nM,32000,CHEMBL284,4.494850022,DPPIV,CCCC[C@@H](NC(=O)C(N)CC)B(O)O,CCCCC(NC(=O)C(N)CC)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603676,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@@H](NC(=O)[C@@H](N)CCC)B(O)O,CHEMBL196180,nM,810,CHEMBL284,6.091514981,DPPIV,CCCC[C@@H](NC(=O)C(N)CCC)B(O)O,CCCCC(NC(=O)C(N)CCC)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603687,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@@H](NC(=O)[C@@H](N)CCCC)B(O)O,CHEMBL194249,nM,370,CHEMBL284,6.431798276,DPPIV,CCCCC(N)C(=O)N[C@H](CCCC)B(O)O,CCCCC(NC(=O)C(N)CCCC)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603692,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@@H](NC(=O)[C@@H](N)C(C)C)B(O)O,CHEMBL194250,nM,17000,CHEMBL284,4.769551079,DPPIV,CCCC[C@@H](NC(=O)C(N)C(C)C)B(O)O,CCCCC(NC(=O)C(N)C(C)C)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603697,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@@H](NC(=O)[C@@H](N)CN)B(O)O,CHEMBL196461,nM,2000,CHEMBL284,5.698970004,DPPIV,CCCC[C@@H](NC(=O)C(N)CN)B(O)O,CCCCC(NC(=O)C(N)CN)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603710,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@@H](NC(=O)[C@@H](N)CCCN)B(O)O,CHEMBL373319,nM,1200,CHEMBL284,5.920818754,DPPIV,CCCC[C@@H](NC(=O)C(N)CCCN)B(O)O,CCCCC(NC(=O)C(N)CCCN)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603725,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CCCC[C@H](N)C(=O)N1CCC[C@@H]1B(O)O,CHEMBL194852,nM,4.5,CHEMBL284,8.346787486,DPPIV,CCCCC(N)C(=O)N1CCC[C@@H]1B(O)O,CCCCC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603730,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,NCC[C@H](N)C(=O)N1CCC[C@@H]1B(O)O,CHEMBL194428,nM,15,CHEMBL284,7.823908741,DPPIV,NCCC(N)C(=O)N1CCC[C@@H]1B(O)O,NCCC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603735,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CC(C)[C@H](N)C(=O)N1CCC[C@@H]1B(O)O,CHEMBL195189,nM,0.3,CHEMBL284,9.522878745,DPPIV,CC(C)C(N)C(=O)N1CCC[C@@H]1B(O)O,CC(C)C(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1603759,CHEMBL881764,Inhibitory concentration against human dipeptidylpeptidase 4,B,CC(C)[C@H](N)C(=O)N[C@@H](C)B(O)O,CHEMBL365322,nM,0.89,CHEMBL284,9.050609993,DPPIV,CC(C)C(N)C(=O)N[C@@H](C)B(O)O,CC(NC(=O)C(N)C(C)C)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1615070,CHEMBL880567,Inhibitory activity against human DPP4 using Gly-Pro-AMC in fluorometric assay,B,O=C(CNC1CC2CCCC1C2)N1CCC[C@H]1C(O)O,CHEMBL362922,nM,25,CHEMBL284,7.602059991,DPPIV,O=C(CNC1CC2CCCC1C2)N1CCC[C@H]1C(O)O,O=C(CNC1CC2CCCC1C2)N1CCCC1C(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669224,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)(CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL202711,nM,1108,CHEMBL284,5.95546024,DPPIV,CC(C)(CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669225,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)(CC(=O)N1Cc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL201644,nM,15,CHEMBL284,7.823908741,DPPIV,CC(C)(CC(=O)N1Cc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1Cc2ccccc2C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669226,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)(CC(=O)N1CCc2cc(F)cc(F)c2C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL425756,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)(CC(=O)N1CCc2cc(F)cc(F)c2C1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCc2cc(F)cc(F)c2C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669227,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)(CC(=O)N1CCc2cc(F)ccc2C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL380902,nM,30,CHEMBL284,7.522878745,DPPIV,CC(C)(CC(=O)N1CCc2cc(F)ccc2C1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCc2cc(F)ccc2C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669228,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)(CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL201424,nM,49,CHEMBL284,7.30980392,DPPIV,CC(C)(CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669229,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)[C@@H](CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL201398,nM,811,CHEMBL284,6.090979146,DPPIV,CC(C)[C@@H](CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CC(C)C(CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669230,CHEMBL859540,Inhibitory activity against DPP4,B,C[C@@H](CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL425585,nM,54,CHEMBL284,7.26760624,DPPIV,C[C@@H](CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCC[C@H]1C#N,CC(CC(=O)N1CCc2ccccc2C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669231,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCCC(=O)N1CCc2ccccc2C1,CHEMBL371057,nM,428,CHEMBL284,6.368556231,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCCC(=O)N1CCc2ccccc2C1,N#CC1CCCN1C(=O)CNCCCC(=O)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669232,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)Nc1ccccc1,CHEMBL371480,nM,298,CHEMBL284,6.525783736,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)Nc1ccccc1,N#CC1CCCN1C(=O)CNCCC(=O)Nc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669233,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCCc1ccccc1,CHEMBL201544,nM,564,CHEMBL284,6.248720896,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCCc1ccccc1,N#CC1CCCN1C(=O)CNCCC(=O)NCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669234,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)(NC(=O)CCNCC(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL201158,nM,119,CHEMBL284,6.924453039,DPPIV,CC(C)(NC(=O)CCNCC(=O)N1CCC[C@H]1C#N)c1ccccc1,CC(C)(NC(=O)CCNCC(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669235,CHEMBL859540,Inhibitory activity against DPP4,B,CC(C)C(NC(=O)CCNCC(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL372391,nM,784,CHEMBL284,6.105683937,DPPIV,CC(C)C(NC(=O)CCNCC(=O)N1CCC[C@H]1C#N)c1ccccc1,CC(C)C(NC(=O)CCNCC(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669236,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCc1cc(F)cc(F)c1,CHEMBL382847,nM,369,CHEMBL284,6.432973634,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCc1cc(F)cc(F)c1,N#CC1CCCN1C(=O)CNCCC(=O)NCc1cc(F)cc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669237,CHEMBL859540,Inhibitory activity against DPP4,B,CCC(NC(=O)CCNCC(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL201695,nM,447,CHEMBL284,6.349692477,DPPIV,CCC(NC(=O)CCNCC(=O)N1CCC[C@H]1C#N)c1ccccc1,CCC(NC(=O)CCNCC(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669238,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCc1ccc([N+](=O)[O-])cc1,CHEMBL203032,nM,317,CHEMBL284,6.498940738,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCc1ccc([N+](=O)[O-])cc1,N#CC1CCCN1C(=O)CNCCC(=O)NCc1ccc([N+](=O)[O-])cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669239,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCc1ccccc1,CHEMBL382907,nM,452,CHEMBL284,6.344861565,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)NCc1ccccc1,N#CC1CCCN1C(=O)CNCCC(=O)NCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669240,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCN(c2nc3ccccc3s2)CC1,CHEMBL383841,nM,527,CHEMBL284,6.278189385,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCN(c2nc3ccccc3s2)CC1,N#CC1CCCN1C(=O)CNCCC(=O)N1CCN(c2nc3ccccc3s2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669241,CHEMBL859540,Inhibitory activity against DPP4,B,CC(=O)Nc1ccc(S(=O)(=O)N2CCN(C(=O)CCNCC(=O)N3CCC[C@H]3C#N)CC2)cc1,CHEMBL201753,nM,1418,CHEMBL284,5.848323769,DPPIV,CC(=O)Nc1ccc(S(=O)(=O)N2CCN(C(=O)CCNCC(=O)N3CCC[C@H]3C#N)CC2)cc1,CC(=O)Nc1ccc(S(=O)(=O)N2CCN(C(=O)CCNCC(=O)N3CCCC3C#N)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669242,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCN(C(=O)c2cc(F)cc(F)c2)CC1,CHEMBL372746,nM,676,CHEMBL284,6.170053304,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCN(C(=O)c2cc(F)cc(F)c2)CC1,N#CC1CCCN1C(=O)CNCCC(=O)N1CCN(C(=O)c2cc(F)cc(F)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669243,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1Cc2ccccc2C1,CHEMBL381530,nM,132,CHEMBL284,6.879426069,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1Cc2ccccc2C1,N#CC1CCCN1C(=O)CNCCC(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669244,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCc2cc(F)ccc2C1,CHEMBL203084,nM,83,CHEMBL284,7.080921908,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCc2cc(F)ccc2C1,N#CC1CCCN1C(=O)CNCCC(=O)N1CCc2cc(F)ccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669245,CHEMBL859540,Inhibitory activity against DPP4,B,COc1cc2c(cc1OC)CN(C(=O)CCNCC(=O)N1CCC[C@H]1C#N)CC2,CHEMBL424854,nM,651,CHEMBL284,6.186419011,DPPIV,COc1cc2c(cc1OC)CN(C(=O)CCNCC(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)CN(C(=O)CCNCC(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669246,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCc2ccccc2C1,CHEMBL200103,nM,116,CHEMBL284,6.935542011,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCCC(=O)N1CCc2ccccc2C1,N#CC1CCCN1C(=O)CNCCC(=O)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1669247,CHEMBL859540,Inhibitory activity against DPP4,B,N#C[C@@H]1CCCN1C(=O)CNCC(=O)N1CCc2ccccc2C1,CHEMBL371907,nM,3236,CHEMBL284,5.489991487,DPPIV,N#C[C@@H]1CCCN1C(=O)CNCC(=O)N1CCc2ccccc2C1,N#CC1CCCN1C(=O)CNCC(=O)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692682,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(O)nc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL381145,nM,25,CHEMBL284,7.602059991,DPPIV,CC(c1ccc(-c2ccc(=O)[nH]c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(=O)[nH]c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692792,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CCC(F)CC1.O=C(O)C(F)(F)F,CHEMBL202634,nM,1100,CHEMBL284,5.958607315,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)CC1,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692793,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CC(F)C1.O=C(O)C(F)(F)F,CHEMBL378597,nM,31,CHEMBL284,7.508638306,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CC(F)C1,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692794,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CCSC1.O=C(O)C(F)(F)F,CHEMBL377724,nM,26,CHEMBL284,7.585026652,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCSC1,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692795,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL203379,nM,48,CHEMBL284,7.318758763,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCCC1,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692796,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL206501,nM,26,CHEMBL284,7.585026652,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692797,CHEMBL867703,Inhibition of DPP4,B,CCOC(=O)Nc1c(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cn(C)c(=O)c1F.O=C(O)C(F)(F)F,CHEMBL438265,nM,120,CHEMBL284,6.920818754,DPPIV,CCOC(=O)Nc1c(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cn(C)c(=O)c1F,CCOC(=O)Nc1c(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)cn(C)c(=O)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692798,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2cn(C)c(=O)c(Cl)c2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL203267,nM,37,CHEMBL284,7.431798276,DPPIV,CC(c1ccc(-c2cn(C)c(=O)c(Cl)c2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cn(C)c(=O)c(Cl)c2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692799,CHEMBL867703,Inhibition of DPP4,B,COc1cc(=O)n(C)cc1-c1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL380496,nM,67,CHEMBL284,7.173925197,DPPIV,COc1cc(=O)n(C)cc1-c1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,COc1cc(=O)n(C)cc1-c1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692800,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2cn(C)c(=O)cc2CO)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL203169,nM,38,CHEMBL284,7.420216403,DPPIV,CC(c1ccc(-c2cn(C)c(=O)cc2CO)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cn(C)c(=O)cc2CO)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692801,CHEMBL867703,Inhibition of DPP4,B,Cc1cc(=O)n(C)cc1-c1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL425039,nM,52,CHEMBL284,7.283996656,DPPIV,Cc1cc(=O)n(C)cc1-c1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,Cc1cc(=O)n(C)cc1-c1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692802,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2cn(C)c(=O)cc2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL424687,nM,61,CHEMBL284,7.214670165,DPPIV,CC(c1ccc(-c2cn(C)c(=O)cc2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cn(C)c(=O)cc2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692803,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2cc(Br)c(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL383651,nM,69,CHEMBL284,7.161150909,DPPIV,CC(c1ccc(-c2cc(Br)c(=O)n(C)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cc(Br)c(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692804,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2cc(F)c(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL203736,nM,49,CHEMBL284,7.30980392,DPPIV,CC(c1ccc(-c2cc(F)c(=O)n(C)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cc(F)c(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692805,CHEMBL867703,Inhibition of DPP4,B,Cc1c(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cc(Br)c(=O)n1C.O=C(O)C(F)(F)F,CHEMBL203323,nM,570,CHEMBL284,6.244125144,DPPIV,Cc1c(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cc(Br)c(=O)n1C,Cc1c(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)cc(Br)c(=O)n1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692806,CHEMBL867703,Inhibition of DPP4,B,Cc1c(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)ccc(=O)n1C.O=C(O)C(F)(F)F,CHEMBL206252,nM,320,CHEMBL284,6.494850022,DPPIV,Cc1c(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)ccc(=O)n1C,Cc1c(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)ccc(=O)n1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692807,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2F)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL205872,nM,29,CHEMBL284,7.537602002,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2F)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(=O)n(C)c2F)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692808,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(-c3ccc(F)cc3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL206172,nM,229,CHEMBL284,6.640164518,DPPIV,CC(c1ccc(-c2ccc(=O)n(-c3ccc(F)cc3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(=O)n(-c3ccc(F)cc3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692809,CHEMBL867703,Inhibition of DPP4,B,CCOC(=O)C(F)(F)n1cc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)ccc1=O.O=C(O)C(F)(F)F,CHEMBL438258,nM,92,CHEMBL284,7.036212173,DPPIV,CCOC(=O)C(F)(F)n1cc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)ccc1=O,CCOC(=O)C(F)(F)n1cc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)ccc1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692810,CHEMBL867703,Inhibition of DPP4,B,CCOC(=O)Cn1cc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)ccc1=O.O=C(O)C(F)(F)F,CHEMBL382674,nM,90,CHEMBL284,7.045757491,DPPIV,CCOC(=O)Cn1cc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)ccc1=O,CCOC(=O)Cn1cc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)ccc1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692811,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(CC3CC3)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL383323,nM,117,CHEMBL284,6.931814138,DPPIV,CC(c1ccc(-c2ccc(=O)n(CC3CC3)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(=O)n(CC3CC3)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692812,CHEMBL867703,Inhibition of DPP4,B,CCn1cc(-c2ccc([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)ccc1=O.O=C(O)C(F)(F)F,CHEMBL206792,nM,74,CHEMBL284,7.13076828,DPPIV,CCn1cc(-c2ccc(C(C)C(N)C(=O)N3CC[C@H](F)C3)cc2)ccc1=O,CCn1cc(-c2ccc(C(C)C(N)C(=O)N3CCC(F)C3)cc2)ccc1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1692813,CHEMBL867703,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL206383,nM,34,CHEMBL284,7.468521083,DPPIV,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693536,CHEMBL862302,Inhibition of DPP4,B,NCC1(c2ccccc2)CCCC1,CHEMBL382127,nM,40000,CHEMBL284,4.397940009,DPPIV,NCC1(c2ccccc2)CCCC1,NCC1(c2ccccc2)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693626,CHEMBL862302,Inhibition of DPP4,B,NCC(c1ccccc1Cl)N1CCOCC1,CHEMBL382382,nM,30000,CHEMBL284,4.522878745,DPPIV,NCC(c1ccccc1Cl)N1CCOCC1,NCC(c1ccccc1Cl)N1CCOCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693627,CHEMBL862302,Inhibition of DPP4,B,NCc1cccnc1-c1ccccc1Cl,CHEMBL378152,nM,3300,CHEMBL284,5.48148606,DPPIV,NCc1cccnc1-c1ccccc1Cl,NCc1cccnc1-c1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693628,CHEMBL862302,Inhibition of DPP4,B,NCc1ccccc1-c1ccccc1Cl,CHEMBL206496,nM,2300,CHEMBL284,5.638272164,DPPIV,NCc1ccccc1-c1ccccc1Cl,NCc1ccccc1-c1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693629,CHEMBL862302,Inhibition of DPP4,B,NCc1c(Cl)cccc1Oc1ccccc1,CHEMBL203105,nM,37000,CHEMBL284,4.431798276,DPPIV,NCc1c(Cl)cccc1Oc1ccccc1,NCc1c(Cl)cccc1Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693630,CHEMBL862302,Inhibition of DPP4,B,N[C@H](c1ccccc1)[C@@H](N)c1ccccc1,CHEMBL206743,nM,75000,CHEMBL284,4.124938737,DPPIV,N[C@H](c1ccccc1)[C@@H](N)c1ccccc1,NC(c1ccccc1)C(N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1693631,CHEMBL862302,Inhibition of DPP4,B,N[C@H](c1ccccc1)[C@H](N)c1ccccc1,CHEMBL381340,nM,45000,CHEMBL284,4.346787486,DPPIV,N[C@H](c1ccccc1)[C@H](N)c1ccccc1,NC(c1ccccc1)C(N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1698111,CHEMBL866563,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1)Cc1ccccc1F,CHEMBL425584,nM,90,CHEMBL284,7.045757491,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1698112,CHEMBL866563,Inhibition of DPP4 by continuous fluorimetric assay,B,NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)C[C@H](N)Cc1ccccc1F,CHEMBL381806,nM,23,CHEMBL284,7.638272164,DPPIV,NC(=O)C1Cc2ccccc2CN1C(=O)C[C@H](N)Cc1ccccc1F,NC(=O)C1Cc2ccccc2CN1C(=O)CC(N)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717903,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC1C3)C2,CHEMBL383488,nM,72,CHEMBL284,7.142667504,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC1C3)C2,N#CC1CCC(C#N)N1C(=O)CNC12CC3CC(CC1C3)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717904,CHEMBL867558,Inhibition of human recombinant DPP4,B,C[C@@H]1CC(C)(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)C[C@@H]1C,CHEMBL206954,nM,3000,CHEMBL284,5.522878745,DPPIV,C[C@@H]1CC(C)(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)C[C@@H]1C,CC1CC(C)(NCC(=O)N2C(C#N)CCC2C#N)CC1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717905,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCC(C)(C)C1CCC(C)(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)C1,CHEMBL207896,nM,3000,CHEMBL284,5.522878745,DPPIV,CCC(C)(C)C1CCC(C)(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)C1,CCC(C)(C)C1CCC(C)(NCC(=O)N2C(C#N)CCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717906,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(C)C(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL378712,nM,3000,CHEMBL284,5.522878745,DPPIV,CC(C)(C)C(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC(C)(C)C(C)(C)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717907,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)COC(C)(C)OC1,CHEMBL208850,nM,3000,CHEMBL284,5.522878745,DPPIV,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)COC(C)(C)OC1,CC1(NCC(=O)N2C(C#N)CCC2C#N)COC(C)(C)OC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717908,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CCCO)CCCCC1,CHEMBL377672,nM,3000,CHEMBL284,5.522878745,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CCCO)CCCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(CCCO)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717909,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(Cc2ccccc2)CCCCC1,CHEMBL378421,nM,3000,CHEMBL284,5.522878745,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(Cc2ccccc2)CCCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(Cc2ccccc2)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717910,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCSC1,CHEMBL383087,nM,3000,CHEMBL284,5.522878745,DPPIV,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCSC1,CC1(NCC(=O)N2C(C#N)CCC2C#N)CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717911,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC1(C)CCCC1(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL427036,nM,3000,CHEMBL284,5.522878745,DPPIV,CC1(C)CCCC1(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC1(C)CCCC1(C)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717912,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)Cc2ccccc2C1,CHEMBL382045,nM,875,CHEMBL284,6.057991947,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)Cc2ccccc2C1,N#CC1CCC(C#N)N1C(=O)CNC1(CO)Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717913,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC1CCC(C)(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)C1,CHEMBL207620,nM,771,CHEMBL284,6.112945622,DPPIV,CC1CCC(C)(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)C1,CC1CCC(C)(NCC(=O)N2C(C#N)CCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717914,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1C[C@H](O)CN1C(=O)CNC12CC3CC(CC(C3)C1)C2,CHEMBL378958,nM,30000,CHEMBL284,4.522878745,DPPIV,N#C[C@@H]1C[C@H](O)CN1C(=O)CNC12CC3CC(CC(C3)C1)C2,N#CC1CC(O)CN1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717915,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](c2ccccc2)N1C(=O)CNC1(CO)CCCC1,CHEMBL210328,nM,30000,CHEMBL284,4.522878745,DPPIV,N#C[C@@H]1CC[C@H](c2ccccc2)N1C(=O)CNC1(CO)CCCC1,N#CC1CCC(c2ccccc2)N1C(=O)CNC1(CO)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717916,CHEMBL867558,Inhibition of human recombinant DPP4,B,C[C@H]1CC[C@@H](C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,CHEMBL379948,nM,30000,CHEMBL284,4.522878745,DPPIV,C[C@H]1CC[C@@H](C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,CC1CCC(C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717917,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,CHEMBL379500,nM,30000,CHEMBL284,4.522878745,DPPIV,N#C[C@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,N#CC1CCC(C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717918,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCC1,CHEMBL438067,nM,30000,CHEMBL284,4.522878745,DPPIV,N#C[C@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(CO)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717919,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CCO)CCCC1,CHEMBL209934,nM,3000,CHEMBL284,5.522878745,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CCO)CCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(CCO)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717920,CHEMBL867558,Inhibition of human recombinant DPP4,B,COC(=O)C1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL209933,nM,3000,CHEMBL284,5.522878745,DPPIV,COC(=O)C1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,COC(=O)C1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717921,CHEMBL867558,Inhibition of human recombinant DPP4,B,CNC(=O)C1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL379947,nM,3000,CHEMBL284,5.522878745,DPPIV,CNC(=O)C1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CNC(=O)C1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717922,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(C)C(=O)CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL378750,nM,1860,CHEMBL284,5.730487056,DPPIV,CC(C)(C)C(=O)CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CC(C)(C)C(=O)CC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717923,CHEMBL867558,Inhibition of human recombinant DPP4,B,COCCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL208756,nM,955,CHEMBL284,6.019996628,DPPIV,COCCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,COCCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717924,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(COC2CCCCC2)CCCC1,CHEMBL377749,nM,702,CHEMBL284,6.153662888,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(COC2CCCCC2)CCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(COC2CCCCC2)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717925,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)COCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL378709,nM,454,CHEMBL284,6.342944147,DPPIV,CC(C)COCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CC(C)COCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717926,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL381111,nM,201,CHEMBL284,6.696803943,DPPIV,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717927,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCCOCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL208657,nM,123,CHEMBL284,6.910094889,DPPIV,CCCOCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CCCOCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717928,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCCCOCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL209994,nM,91,CHEMBL284,7.040958608,DPPIV,CCCCOCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CCCCOCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717929,CHEMBL867558,Inhibition of human recombinant DPP4,B,COCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL379086,nM,84,CHEMBL284,7.075720714,DPPIV,COCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,COCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717930,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCOCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CHEMBL209191,nM,64,CHEMBL284,7.193820026,DPPIV,CCOCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCC1,CCOCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717931,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL208288,nM,3000,CHEMBL284,5.522878745,DPPIV,CCC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CCC(C)(C)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717932,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCC(C)(CC)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL209768,nM,3000,CHEMBL284,5.522878745,DPPIV,CCC(C)(CC)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CCC(C)(CC)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717933,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)C(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL209764,nM,3000,CHEMBL284,5.522878745,DPPIV,CC(C)C(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC(C)C(C)(C)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717934,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3(F)CC(F)(CC(F)(C3)C1)C2,CHEMBL208744,nM,3000,CHEMBL284,5.522878745,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3(F)CC(F)(CC(F)(C3)C1)C2,N#CC1CCC(C#N)N1C(=O)CNC12CC3(F)CC(F)(CC(F)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717935,CHEMBL867558,Inhibition of human recombinant DPP4,B,CCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCCC1,CHEMBL209344,nM,3000,CHEMBL284,5.522878745,DPPIV,CCC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCCC1,CCC1(NCC(=O)N2C(C#N)CCC2C#N)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717936,CHEMBL867558,Inhibition of human recombinant DPP4,B,C#CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCCC1,CHEMBL380870,nM,3000,CHEMBL284,5.522878745,DPPIV,C#CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCCC1,C#CC1(NCC(=O)N2C(C#N)CCC2C#N)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717937,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCOCC1,CHEMBL380681,nM,1220,CHEMBL284,5.913640169,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCOCC1,N#CC1CCC(C#N)N1C(=O)CNC1(CO)CCOCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717938,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(Cc2ccccc2)CCC1,CHEMBL209127,nM,1160,CHEMBL284,5.935542011,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(Cc2ccccc2)CCC1,N#CC1CCC(C#N)N1C(=O)CNC1(Cc2ccccc2)CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717939,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(CO)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL379260,nM,1110,CHEMBL284,5.954677021,DPPIV,CC(C)(CO)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC(C)(CO)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717940,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCCC1,CHEMBL377058,nM,689,CHEMBL284,6.161780778,DPPIV,CC1(NCC(=O)N2[C@H](C#N)CC[C@@H]2C#N)CCCCC1,CC1(NCC(=O)N2C(C#N)CCC2C#N)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717941,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCCC1,CHEMBL208952,nM,687,CHEMBL284,6.163043263,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(CO)CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717942,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL208902,nM,663,CHEMBL284,6.178486472,DPPIV,CC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC(C)(C)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717943,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL209058,nM,651,CHEMBL284,6.186419011,DPPIV,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717944,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N)c1ccccc1,CHEMBL210259,nM,261,CHEMBL284,6.583359493,DPPIV,CC(C)(NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N)c1ccccc1,CC(C)(NCC(=O)N1C(C#N)CCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717945,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CN[C@H]1C[C@@H]2CC[C@H]1C2,CHEMBL211024,nM,237,CHEMBL284,6.625251654,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CN[C@H]1C[C@@H]2CC[C@H]1C2,N#CC1CCC(C#N)N1C(=O)CNC1CC2CCC1C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717946,CHEMBL867558,Inhibition of human recombinant DPP4,B,CC(C)(C)CC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CHEMBL377320,nM,208,CHEMBL284,6.681936665,DPPIV,CC(C)(C)CC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#N,CC(C)(C)CC(C)(C)NCC(=O)N1C(C#N)CCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717947,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(c2ccccc2)CCC1,CHEMBL208673,nM,164,CHEMBL284,6.785156152,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(c2ccccc2)CCC1,N#CC1CCC(C#N)N1C(=O)CNC1(c2ccccc2)CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717948,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,CHEMBL207980,nM,106,CHEMBL284,6.974694135,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,N#CC1CCC(C#N)N1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717949,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCC1,CHEMBL379522,nM,104,CHEMBL284,6.982966661,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC1(CO)CCCC1,N#CC1CCC(C#N)N1C(=O)CNC1(CO)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1717950,CHEMBL867558,Inhibition of human recombinant DPP4,B,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,CHEMBL207912,nM,74,CHEMBL284,7.13076828,DPPIV,N#C[C@@H]1CC[C@H](C#N)N1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,N#CC1CCC(C#N)N1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722836,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3nccc3n2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL208957,nM,7.5,CHEMBL284,8.124938737,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccn3nccc3n2)cc1)C(N)C(=O)N1CCC(F)(F)C1,CN(C)C(=O)C(c1ccc(-c2ccn3nccc3n2)cc1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722847,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3ncnc3c2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL210829,nM,6.2,CHEMBL284,8.207608311,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccn3ncnc3c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,CN(C)C(=O)C(c1ccc(-c2ccn3ncnc3c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722848,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.Cl,CHEMBL537869,nM,8.8,CHEMBL284,8.055517328,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722849,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL209064,nM,6.3,CHEMBL284,8.200659451,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722850,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL378048,nM,5.2,CHEMBL284,8.283996656,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCCC1,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722851,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CC(F)C1.O=C(O)C(F)(F)F,CHEMBL210974,nM,2.7,CHEMBL284,8.568636236,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CC(F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722852,CHEMBL866326,Inhibition of DPP4,B,Cc1cc(-c2ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cn2ncnc12.O=C(O)C(F)(F)F,CHEMBL210621,nM,150,CHEMBL284,6.823908741,DPPIV,Cc1cc(-c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cn2ncnc12,Cc1cc(-c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)C3)cc2)cn2ncnc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722853,CHEMBL866326,Inhibition of DPP4,B,Cc1c(-c2ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)ccc2ncnn12.O=C(O)C(F)(F)F,CHEMBL209111,nM,8.6,CHEMBL284,8.065501549,DPPIV,Cc1c(-c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CC[C@H](F)C3)cc2)ccc2ncnn12,Cc1c(-c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)C3)cc2)ccc2ncnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722854,CHEMBL866326,Inhibition of DPP4,B,Cc1nc2ccc(-c3ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N4CC[C@H](F)C4)cc3)cn2n1.O=C(O)C(F)(F)F,CHEMBL209710,nM,22,CHEMBL284,7.657577319,DPPIV,Cc1nc2ccc(-c3ccc(C(C(=O)N(C)C)C(N)C(=O)N4CC[C@H](F)C4)cc3)cn2n1,Cc1nc2ccc(-c3ccc(C(C(=O)N(C)C)C(N)C(=O)N4CCC(F)C4)cc3)cn2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722855,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3nccn3n2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL379702,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3nccn3n2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3nccn3n2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722856,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3nccc3n2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL210459,nM,8,CHEMBL284,8.096910013,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccn3nccc3n2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccn3nccc3n2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722857,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccn3ncnc3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL210999,nM,5.3,CHEMBL284,8.27572413,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccn3ncnc3c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccn3ncnc3c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722858,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL377221,nM,4.3,CHEMBL284,8.366531544,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722859,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3nncn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL207348,nM,4.1,CHEMBL284,8.387216143,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3nncn3c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3nncn3c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722860,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3nccn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL378673,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3nccn3c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3nccn3c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1722861,CHEMBL866326,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(=O)n(C)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL209162,nM,8,CHEMBL284,8.096910013,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(=O)n(C)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727613,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1Cc2ccccc2C1,CHEMBL379261,nM,109,CHEMBL284,6.962573502,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccccc2C1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727617,CHEMBL859770,Inhibition of DPP4,B,CC1(C)N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1Cc2ccccc2C1,CHEMBL210522,nM,984,CHEMBL284,6.007004902,DPPIV,CC1(C)NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1Cc2ccccc2C1,CC1(C)NC(C(=O)N2CCCC2C#N)CC1C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727618,CHEMBL859770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2Cc3ccccc3C2)CN1,CHEMBL210995,nM,1.7,CHEMBL284,8.769551079,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2Cc3ccccc3C2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2Cc3ccccc3C2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727619,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCC(F)(F)C2)C1)N1Cc2ccccc2C1,CHEMBL427219,nM,129,CHEMBL284,6.88941029,DPPIV,O=C(C1CNC(C(=O)N2CCC(F)(F)C2)C1)N1Cc2ccccc2C1,O=C(C1CNC(C(=O)N2CCC(F)(F)C2)C1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727620,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CC[C@@H](F)C2)C1)N1Cc2ccccc2C1,CHEMBL378086,nM,228,CHEMBL284,6.642065153,DPPIV,O=C(C1CNC(C(=O)N2CC[C@@H](F)C2)C1)N1Cc2ccccc2C1,O=C(C1CNC(C(=O)N2CCC(F)C2)C1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727621,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CC[C@H](F)C2)C1)N1Cc2ccccc2C1,CHEMBL210590,nM,245,CHEMBL284,6.610833916,DPPIV,O=C(C1CNC(C(=O)N2CC[C@H](F)C2)C1)N1Cc2ccccc2C1,O=C(C1CNC(C(=O)N2CCC(F)C2)C1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727622,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCSC2)C1)N1Cc2ccccc2C1,CHEMBL210353,nM,84,CHEMBL284,7.075720714,DPPIV,O=C(C1CNC(C(=O)N2CCSC2)C1)N1Cc2ccccc2C1,O=C(C1CNC(C(=O)N2CCSC2)C1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727624,CHEMBL859770,Inhibition of DPP4,B,O=C(NCCc1ccccc1)[C@@H]1CN[C@H](C(=O)N2CCCC2)C1,CHEMBL210941,nM,2587,CHEMBL284,5.587203571,DPPIV,O=C(NCCc1ccccc1)C1CNC(C(=O)N2CCCC2)C1,O=C(NCCc1ccccc1)C1CNC(C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727625,CHEMBL859770,Inhibition of DPP4,B,O=C(NCc1ccccc1)[C@@H]1CN[C@H](C(=O)N2CCCC2)C1,CHEMBL210920,nM,1957,CHEMBL284,5.708409174,DPPIV,O=C(NCc1ccccc1)C1CNC(C(=O)N2CCCC2)C1,O=C(NCc1ccccc1)C1CNC(C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727626,CHEMBL859770,Inhibition of DPP4,B,O=C(Nc1ccccc1)[C@@H]1CN[C@H](C(=O)N2CCCC2)C1,CHEMBL380240,nM,4130,CHEMBL284,5.384049948,DPPIV,O=C(Nc1ccccc1)C1CNC(C(=O)N2CCCC2)C1,O=C(Nc1ccccc1)C1CNC(C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727627,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1Cc2cc(Cl)c(Cl)cc2C1,CHEMBL377776,nM,144,CHEMBL284,6.841637508,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2cc(Cl)c(Cl)cc2C1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2cc(Cl)c(Cl)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727628,CHEMBL859770,Inhibition of DPP4,B,Cc1ccc2c(c1)CN(C(=O)[C@@H]1CN[C@H](C(=O)N3CCCC3)C1)C2,CHEMBL209981,nM,72,CHEMBL284,7.142667504,DPPIV,Cc1ccc2c(c1)CN(C(=O)C1CNC(C(=O)N3CCCC3)C1)C2,Cc1ccc2c(c1)CN(C(=O)C1CNC(C(=O)N3CCCC3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727629,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1Cc2ccc(C(F)(F)F)cc2C1,CHEMBL210718,nM,73,CHEMBL284,7.13667714,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccc(C(F)(F)F)cc2C1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccc(C(F)(F)F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727630,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1Cc2ccc(Cl)cc2C1,CHEMBL208964,nM,50,CHEMBL284,7.301029996,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccc(Cl)cc2C1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccc(Cl)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1727631,CHEMBL859770,Inhibition of DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1Cc2ccc(F)cc2C1,CHEMBL210225,nM,73,CHEMBL284,7.13667714,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccc(F)cc2C1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1Cc2ccc(F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1765614,CHEMBL856332,Inhibition of DPP4,B,CC[C@@H](C[C@H](N)C(=O)N1CCCCC1)NCc1ccc(Cl)cc1,CHEMBL215244,nM,100000,CHEMBL284,4,DPPIV,CC[C@@H](CC(N)C(=O)N1CCCCC1)NCc1ccc(Cl)cc1,CCC(CC(N)C(=O)N1CCCCC1)NCc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792418,CHEMBL907097,Inhibition of h-DPPIV,B,CN1C(=O)C=C(N2CCC[C@@H](N)C2)C(Cc2ccccc2C#N)C1=O,CHEMBL216253,nM,4,CHEMBL284,8.397940009,DPPIV,Cn1c(O)c(Cc2ccccc2C#N)c(N2CCC[C@@H](N)C2)cc1=O,Cn1c(O)c(Cc2ccccc2C#N)c(N2CCCC(N)C2)cc1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792470,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL1422,nM,18,CHEMBL284,7.744727495,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792471,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)ccc1F,CHEMBL216186,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792472,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@@H]1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL217051,nM,7.2,CHEMBL284,8.142667504,DPPIV,CC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792473,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@@H]1C(=O)NCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL384816,nM,160,CHEMBL284,6.795880017,DPPIV,CC1C(=O)NCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1C(=O)NCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792474,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL217015,nM,89,CHEMBL284,7.050609993,DPPIV,CC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792475,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL217016,nM,14,CHEMBL284,7.853871964,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792476,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL385711,nM,6.6,CHEMBL284,8.180456064,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792477,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL217005,nM,150,CHEMBL284,6.823908741,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792478,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@H]1C(=O)NCCCN1C(=O)C[C@@H](N)Cc1cc(F)c(F)cc1F,CHEMBL216234,nM,2300,CHEMBL284,5.638272164,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792479,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,C[C@@H]1C(=O)NCCCN1C(=O)C[C@@H](N)Cc1cc(F)c(F)cc1F,CHEMBL384382,nM,67000,CHEMBL284,4.173925197,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792480,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCCNC(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL216643,nM,140,CHEMBL284,6.853871964,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCNC(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792481,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,CC[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL218459,nM,16,CHEMBL284,7.795880017,DPPIV,CCC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792482,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCCNC(=O)[C@H]1Cc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL386380,nM,0.91,CHEMBL284,9.040958608,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1Cc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCNC(=O)C1Cc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792483,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCCNC(=O)[C@H]1Cc1ccccn1)Cc1cc(F)c(F)cc1F,CHEMBL216178,nM,0.49,CHEMBL284,9.30980392,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1Cc1ccccn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCNC(=O)C1Cc1ccccn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792484,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCCNC(=O)[C@H]1Cc1cnccn1)Cc1cc(F)c(F)cc1F,CHEMBL217702,nM,0.29,CHEMBL284,9.537602002,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1Cc1cnccn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCNC(=O)C1Cc1cnccn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792485,CHEMBL907105,In vitro inhibition of human DPP-4 activity,B,N[C@@H](CC(=O)N1CCCNC(=O)[C@H]1CC(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL217271,nM,2.6,CHEMBL284,8.585026652,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792887,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)Nc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL216383,nM,207,CHEMBL284,6.684029655,DPPIV,CC(C)(CC(=O)Nc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)Nc1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792888,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)Nc1ccc(F)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL385637,nM,197,CHEMBL284,6.705533774,DPPIV,CC(C)(CC(=O)Nc1ccc(F)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)Nc1ccc(F)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792889,CHEMBL908237,In vitro inhibition of DPP-4,B,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1,CHEMBL384985,nM,253,CHEMBL284,6.596879479,DPPIV,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792890,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)Nc1ccc(F)c(F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL386326,nM,225,CHEMBL284,6.647817482,DPPIV,CC(C)(CC(=O)Nc1ccc(F)c(F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)Nc1ccc(F)c(F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792891,CHEMBL908237,In vitro inhibition of DPP-4,B,Cc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1C,CHEMBL385394,nM,174,CHEMBL284,6.759450752,DPPIV,Cc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1C,Cc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)cc1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792892,CHEMBL908237,In vitro inhibition of DPP-4,B,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1OC,CHEMBL217198,nM,116,CHEMBL284,6.935542011,DPPIV,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1OC,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792893,CHEMBL908237,In vitro inhibition of DPP-4,B,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)c(OC)c1OC,CHEMBL217059,nM,127,CHEMBL284,6.896196279,DPPIV,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)c(OC)c1OC,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)c(OC)c1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792894,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)Nc1ccc(-c2ccccc2)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL217060,nM,269,CHEMBL284,6.57024772,DPPIV,CC(C)(CC(=O)Nc1ccc(-c2ccccc2)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)Nc1ccc(-c2ccccc2)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792896,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL216377,nM,239,CHEMBL284,6.621602099,DPPIV,CC(C)(CC(=O)NCc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCc1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792897,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCc1ccc(C(F)(F)F)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL216453,nM,190,CHEMBL284,6.721246399,DPPIV,CC(C)(CC(=O)NCc1ccc(C(F)(F)F)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCc1ccc(C(F)(F)F)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792898,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCc1ccccn1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL216296,nM,433,CHEMBL284,6.363512104,DPPIV,CC(C)(CC(=O)NCc1ccccn1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCc1ccccn1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792901,CHEMBL908237,In vitro inhibition of DPP-4,B,C[C@H](CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL216203,nM,911,CHEMBL284,6.040481623,DPPIV,C[C@H](CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792902,CHEMBL908237,In vitro inhibition of DPP-4,B,C[C@@H](CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL217245,nM,42,CHEMBL284,7.37675071,DPPIV,C[C@@H](CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(CC(=O)NC(C)(C)c1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792904,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCCc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL274770,nM,144,CHEMBL284,6.841637508,DPPIV,CC(C)(CC(=O)NCCc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCCc1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792905,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NC(C)(C)Cc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL217212,nM,1300,CHEMBL284,5.886056648,DPPIV,CC(C)(CC(=O)NC(C)(C)Cc1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC(C)(C)Cc1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792906,CHEMBL908237,In vitro inhibition of DPP-4,B,Cc1ccc(CCNC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1,CHEMBL217339,nM,252,CHEMBL284,6.598599459,DPPIV,Cc1ccc(CCNC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1,Cc1ccc(CCNC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792907,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCCc1ccc(C(F)(F)F)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL274103,nM,236,CHEMBL284,6.627087997,DPPIV,CC(C)(CC(=O)NCCc1ccc(C(F)(F)F)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCCc1ccc(C(F)(F)F)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792908,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCCc1cccc(C(F)(F)F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL384493,nM,247,CHEMBL284,6.607303047,DPPIV,CC(C)(CC(=O)NCCc1cccc(C(F)(F)F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCCc1cccc(C(F)(F)F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792909,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCCc1ccccc1C(F)(F)F)NCC(=O)N1CCC[C@H]1C#N,CHEMBL216878,nM,320,CHEMBL284,6.494850022,DPPIV,CC(C)(CC(=O)NCCc1ccccc1C(F)(F)F)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCCc1ccccc1C(F)(F)F)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792910,CHEMBL908237,In vitro inhibition of DPP-4,B,COc1ccc(CCNC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1OC,CHEMBL217290,nM,232,CHEMBL284,6.634512015,DPPIV,COc1ccc(CCNC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1OC,COc1ccc(CCNC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792911,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCCc1ccc(Cl)c(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL218393,nM,181,CHEMBL284,6.742321425,DPPIV,CC(C)(CC(=O)NCCc1ccc(Cl)c(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCCc1ccc(Cl)c(Cl)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1792912,CHEMBL908237,In vitro inhibition of DPP-4,B,CC(C)(CC(=O)NCCc1ccccn1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL218026,nM,118,CHEMBL284,6.928117993,DPPIV,CC(C)(CC(=O)NCCc1ccccn1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NCCc1ccccn1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793031,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)cc1,CHEMBL218289,nM,84,CHEMBL284,7.075720714,DPPIV,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)cc1,CC(CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793032,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccccc1,CHEMBL217388,nM,280,CHEMBL284,6.552841969,DPPIV,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccccc1,CC(CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793033,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)c(F)c1,CHEMBL217017,nM,39,CHEMBL284,7.408935393,DPPIV,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)c(F)c1,CC(CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793034,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccccc1F,CHEMBL217532,nM,3800,CHEMBL284,5.420216403,DPPIV,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccccc1F,CC(CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793035,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(Cl)cc1,CHEMBL217801,nM,820,CHEMBL284,6.086186148,DPPIV,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(Cl)cc1,CC(CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793036,CHEMBL908251,Inhibition of DPP-IV,B,Cc1ccc(C(=O)CN[C@H](C)CCc2ccc(C(N)=O)cc2)cc1,CHEMBL386895,nM,21000,CHEMBL284,4.677780705,DPPIV,Cc1ccc(C(=O)CN[C@H](C)CCc2ccc(C(N)=O)cc2)cc1,Cc1ccc(C(=O)CNC(C)CCc2ccc(C(N)=O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793037,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccsc1,CHEMBL554090,nM,110,CHEMBL284,6.958607315,DPPIV,C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccsc1,CC(CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccsc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793038,CHEMBL908251,Inhibition of DPP-IV,B,C[C@H](COc1ccc(C(N)=O)cc1)NCC(=O)c1ccsc1,CHEMBL553006,nM,340,CHEMBL284,6.468521083,DPPIV,C[C@H](COc1ccc(C(N)=O)cc1)NCC(=O)c1ccsc1,CC(COc1ccc(C(N)=O)cc1)NCC(=O)c1ccsc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793039,CHEMBL908251,Inhibition of DPP-IV,B,NC(=O)c1ccc(OCC2(NCC(=O)c3ccsc3)CCCC2)cc1,CHEMBL541664,nM,5,CHEMBL284,8.301029996,DPPIV,NC(=O)c1ccc(OCC2(NCC(=O)c3ccsc3)CCCC2)cc1,NC(=O)c1ccc(OCC2(NCC(=O)c3ccsc3)CCCC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793258,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccccc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL216854,nM,19700,CHEMBL284,4.705533774,DPPIV,CC(c1nc(-c2ccccc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccccc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793260,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL374936,nM,122,CHEMBL284,6.913640169,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793261,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(N)(=O)=O)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL219602,nM,190,CHEMBL284,6.721246399,DPPIV,CC(c1nc(-c2ccc(S(N)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(N)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793262,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL218882,nM,330,CHEMBL284,6.48148606,DPPIV,CC(c1nc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793263,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(C(F)(F)F)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL220301,nM,1610,CHEMBL284,5.793174124,DPPIV,CC(c1nc(-c2ccc(C(F)(F)F)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(C(F)(F)F)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793264,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(OC(F)(F)F)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL220249,nM,1790,CHEMBL284,5.747146969,DPPIV,CC(c1nc(-c2ccc(OC(F)(F)F)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(OC(F)(F)F)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793265,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(Cl)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL220021,nM,3820,CHEMBL284,5.417936637,DPPIV,CC(c1nc(-c2ccc(Cl)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(Cl)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793266,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2cccc(C(F)(F)F)c2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL375875,nM,15600,CHEMBL284,4.806875402,DPPIV,CC(c1nc(-c2cccc(C(F)(F)F)c2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2cccc(C(F)(F)F)c2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793267,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccccc2Cl)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL375414,nM,990,CHEMBL284,6.004364805,DPPIV,CC(c1nc(-c2ccccc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccccc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793268,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccccc2C(F)(F)F)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL219370,nM,4820,CHEMBL284,5.316952962,DPPIV,CC(c1nc(-c2ccccc2C(F)(F)F)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccccc2C(F)(F)F)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793269,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccccc2F)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL219369,nM,4790,CHEMBL284,5.319664487,DPPIV,CC(c1nc(-c2ccccc2F)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccccc2F)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793270,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccccc2OC(F)(F)F)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL426335,nM,12400,CHEMBL284,4.906578315,DPPIV,CC(c1nc(-c2ccccc2OC(F)(F)F)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccccc2OC(F)(F)F)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793271,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccccc2C(F)F)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL216774,nM,1820,CHEMBL284,5.739928612,DPPIV,CC(c1nc(-c2ccccc2C(F)F)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccccc2C(F)F)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793284,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2F)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL219278,nM,43,CHEMBL284,7.366531544,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2F)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2F)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793285,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL216835,nM,17,CHEMBL284,7.769551079,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793286,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL386812,nM,8,CHEMBL284,8.096910013,DPPIV,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793287,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(F)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL216855,nM,830,CHEMBL284,6.080921908,DPPIV,CC(c1nc(-c2ccc(F)cc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(F)cc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793288,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(Br)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL374703,nM,160,CHEMBL284,6.795880017,DPPIV,CC(c1nc(-c2ccc(Br)cc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(Br)cc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793289,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL438992,nM,200,CHEMBL284,6.698970004,DPPIV,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793290,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(F)cc2F)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL374032,nM,4590,CHEMBL284,5.338187314,DPPIV,CC(c1nc(-c2ccc(F)cc2F)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(F)cc2F)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793291,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2cc(Cl)cc(Cl)c2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL219382,nM,7360,CHEMBL284,5.133122186,DPPIV,CC(c1nc(-c2cc(Cl)cc(Cl)c2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2cc(Cl)cc(Cl)c2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793292,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(NS(C)(=O)=O)cc2)no1)[C@H](N)C(=O)N1CCCC1,CHEMBL218911,nM,520,CHEMBL284,6.283996656,DPPIV,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793302,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CCC(F)(F)C1.O=C(O)C(F)(F)F,CHEMBL375146,nM,19,CHEMBL284,7.721246399,DPPIV,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)(F)C1,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793303,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CC[C@@H](F)C1.O=C(O)C(F)(F)F,CHEMBL218776,nM,19,CHEMBL284,7.721246399,DPPIV,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CC[C@@H](F)C1,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793304,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL387333,nM,19,CHEMBL284,7.721246399,DPPIV,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793305,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1n[nH]c(-c2ccc(Cl)cc2Cl)n1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL218306,nM,3050,CHEMBL284,5.515700161,DPPIV,CC(c1n[nH]c(-c2ccc(Cl)cc2Cl)n1)C(N)C(=O)N1CCCC1,CC(c1n[nH]c(-c2ccc(Cl)cc2Cl)n1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793306,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(Cl)cc2Cl)co1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL218254,nM,1830,CHEMBL284,5.73754891,DPPIV,CC(c1nc(-c2ccc(Cl)cc2Cl)co1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(Cl)cc2Cl)co1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793307,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1noc(-c2ccc(Cl)cc2Cl)n1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL220404,nM,1210,CHEMBL284,5.91721463,DPPIV,CC(c1noc(-c2ccc(Cl)cc2Cl)n1)C(N)C(=O)N1CCCC1,CC(c1noc(-c2ccc(Cl)cc2Cl)n1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793308,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nnc(-c2ccc(Cl)cc2Cl)o1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL220402,nM,560,CHEMBL284,6.251811973,DPPIV,CC(c1nnc(-c2ccc(Cl)cc2Cl)o1)C(N)C(=O)N1CCCC1,CC(c1nnc(-c2ccc(Cl)cc2Cl)o1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793316,CHEMBL856512,Inhibition of DPP4,B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(=O)N3CC[C@H](F)C3)n2)c(F)c1.O=C(O)C(F)(F)F,CHEMBL375745,nM,19,CHEMBL284,7.721246399,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(=O)N3CC[C@H](F)C3)n2)c(F)c1,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(=O)N3CCC(F)C3)n2)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793317,CHEMBL856512,Inhibition of DPP4,B,Cc1cc(S(C)(=O)=O)ccc1-c1noc([C@@H](CC2CC2)[C@H](N)C(=O)N2CC[C@H](F)C2)n1.O=C(O)C(F)(F)F,CHEMBL219434,nM,31,CHEMBL284,7.508638306,DPPIV,Cc1cc(S(C)(=O)=O)ccc1-c1noc(C(CC2CC2)C(N)C(=O)N2CC[C@H](F)C2)n1,Cc1cc(S(C)(=O)=O)ccc1-c1noc(C(CC2CC2)C(N)C(=O)N2CCC(F)C2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793318,CHEMBL856512,Inhibition of DPP4,B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(=O)N3CC[C@H](F)C3)n2)cc1.O=C(O)C(F)(F)F,CHEMBL375442,nM,52,CHEMBL284,7.283996656,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(=O)N3CC[C@H](F)C3)n2)cc1,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(=O)N3CCC(F)C3)n2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793319,CHEMBL856512,Inhibition of DPP4,B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CCO)[C@H](N)C(=O)N3CC[C@H](F)C3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL220357,nM,70,CHEMBL284,7.15490196,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CCO)C(N)C(=O)N3CC[C@H](F)C3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CCO)C(N)C(=O)N3CCC(F)C3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793320,CHEMBL856512,Inhibition of DPP4,B,CC(C)C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL219371,nM,13,CHEMBL284,7.886056648,DPPIV,CC(C)CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CC[C@H](F)C1,CC(C)CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793321,CHEMBL856512,Inhibition of DPP4,B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(=O)N3CC[C@H](F)C3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL376498,nM,13,CHEMBL284,7.886056648,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(=O)N3CC[C@H](F)C3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(=O)N3CCC(F)C3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1793322,CHEMBL856512,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL435320,nM,40,CHEMBL284,7.397940009,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855500,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](Nc2ccccc2)CN1)N1CCSC1,CHEMBL223114,nM,147,CHEMBL284,6.832682665,DPPIV,O=C(C1C[C@H](Nc2ccccc2)CN1)N1CCSC1,O=C(C1CC(Nc2ccccc2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855501,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCc3cc(Br)ccc32)CN1)N1CCSC1,CHEMBL223916,nM,6.5,CHEMBL284,8.187086643,DPPIV,O=C(C1C[C@H](N2CCc3cc(Br)ccc32)CN1)N1CCSC1,O=C(C1CC(N2CCc3cc(Br)ccc32)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855502,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](Nc2ccc(Cl)cc2)CN1)N1CCSC1,CHEMBL223915,nM,45.4,CHEMBL284,7.342944147,DPPIV,O=C(C1C[C@H](Nc2ccc(Cl)cc2)CN1)N1CCSC1,O=C(C1CC(Nc2ccc(Cl)cc2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855503,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCc3cc(Cl)ccc32)CN1)N1CCSC1,CHEMBL390512,nM,7,CHEMBL284,8.15490196,DPPIV,O=C(C1C[C@H](N2CCc3cc(Cl)ccc32)CN1)N1CCSC1,O=C(C1CC(N2CCc3cc(Cl)ccc32)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855504,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCc3cc(F)ccc32)CN1)N1CCSC1,CHEMBL223914,nM,5.8,CHEMBL284,8.236572006,DPPIV,O=C(C1C[C@H](N2CCc3cc(F)ccc32)CN1)N1CCSC1,O=C(C1CC(N2CCc3cc(F)ccc32)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855505,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,COc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL411561,nM,51.5,CHEMBL284,7.288192771,DPPIV,COc1ccc(N[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,COc1ccc(NC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855506,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,COc1ccc2c(c1)CCN2[C@@H]1CN[C@H](C(=O)N2CCSC2)C1,CHEMBL388111,nM,4.8,CHEMBL284,8.318758763,DPPIV,COc1ccc2c(c1)CCN2[C@@H]1CNC(C(=O)N2CCSC2)C1,COc1ccc2c(c1)CCN2C1CNC(C(=O)N2CCSC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855507,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](Nc2ccc([N+](=O)[O-])cc2)CN1)N1CCSC1,CHEMBL224346,nM,19.2,CHEMBL284,7.716698771,DPPIV,O=C(C1C[C@H](Nc2ccc([N+](=O)[O-])cc2)CN1)N1CCSC1,O=C(C1CC(Nc2ccc([N+](=O)[O-])cc2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855508,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCc3cc([N+](=O)[O-])ccc32)CN1)N1CCSC1,CHEMBL225493,nM,7.9,CHEMBL284,8.102372909,DPPIV,O=C(C1C[C@H](N2CCc3cc([N+](=O)[O-])ccc32)CN1)N1CCSC1,O=C(C1CC(N2CCc3cc([N+](=O)[O-])ccc32)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855509,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCc3ccccc32)CN1)N1CCSC1,CHEMBL389244,nM,11,CHEMBL284,7.958607315,DPPIV,O=C(C1C[C@H](N2CCc3ccccc32)CN1)N1CCSC1,O=C(C1CC(N2CCc3ccccc32)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855510,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCCc3ccccc32)CN1)N1CCSC1,CHEMBL223865,nM,112,CHEMBL284,6.950781977,DPPIV,O=C(C1C[C@H](N2CCCc3ccccc32)CN1)N1CCSC1,O=C(C1CC(N2CCCc3ccccc32)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855511,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2Cc3ccccc3C2)CN1)N1CCSC1,CHEMBL227615,nM,26.4,CHEMBL284,7.578396073,DPPIV,O=C(C1C[C@H](N2Cc3ccccc3C2)CN1)N1CCSC1,O=C(C1CC(N2Cc3ccccc3C2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855512,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(CN(C(=O)c2ccc(C#N)cc2)[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL228032,nM,228,CHEMBL284,6.642065153,DPPIV,N#Cc1ccc(CN(C(=O)c2ccc(C#N)cc2)[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(CN(C(=O)c2ccc(C#N)cc2)C2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855513,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(CN(CCO)[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL226771,nM,17,CHEMBL284,7.769551079,DPPIV,N#Cc1ccc(CN(CCO)[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(CN(CCO)C2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855514,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(CN(CC(=O)O)[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL227482,nM,16.8,CHEMBL284,7.774690718,DPPIV,N#Cc1ccc(CN(CC(=O)O)[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(CN(CC(=O)O)C2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855515,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(CN(CC(N)=O)[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL228243,nM,13.9,CHEMBL284,7.8569852,DPPIV,N#Cc1ccc(CN(CC(N)=O)[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(CN(CC(N)=O)C2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855516,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,CCOC(=O)CN(Cc1ccc(C#N)cc1)[C@@H]1CN[C@H](C(=O)N2CCSC2)C1,CHEMBL389624,nM,13.6,CHEMBL284,7.866461092,DPPIV,CCOC(=O)CN(Cc1ccc(C#N)cc1)[C@@H]1CNC(C(=O)N2CCSC2)C1,CCOC(=O)CN(Cc1ccc(C#N)cc1)C1CNC(C(=O)N2CCSC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855517,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL228021,nM,6.4,CHEMBL284,8.193820026,DPPIV,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(CN(Cc2ccc(C#N)cc2)C2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855518,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,CCCCN(Cc1ccc(C#N)cc1)[C@@H]1CN[C@H](C(=O)N2CCSC2)C1,CHEMBL389848,nM,9.1,CHEMBL284,8.040958608,DPPIV,CCCCN(Cc1ccc(C#N)cc1)[C@@H]1CNC(C(=O)N2CCSC2)C1,CCCCN(Cc1ccc(C#N)cc1)C1CNC(C(=O)N2CCSC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855519,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)N(Cc1ccc(C#N)cc1)[C@@H]1CN[C@H](C(=O)N2CCSC2)C1,CHEMBL227800,nM,7.1,CHEMBL284,8.148741651,DPPIV,CC(C)N(Cc1ccc(C#N)cc1)[C@@H]1CNC(C(=O)N2CCSC2)C1,CC(C)N(Cc1ccc(C#N)cc1)C1CNC(C(=O)N2CCSC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855520,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,CN(Cc1ccc(C#N)cc1)[C@@H]1CN[C@H](C(=O)N2CCSC2)C1,CHEMBL227737,nM,9.6,CHEMBL284,8.017728767,DPPIV,CN(Cc1ccc(C#N)cc1)[C@@H]1CNC(C(=O)N2CCSC2)C1,CN(Cc1ccc(C#N)cc1)C1CNC(C(=O)N2CCSC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855521,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(C(=O)O[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL387666,nM,300,CHEMBL284,6.522878745,DPPIV,N#Cc1ccc(C(=O)O[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(C(=O)OC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855522,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C(O[C@@H]1CN[C@H](C(=O)N2CCSC2)C1)c1ccccc1,CHEMBL227867,nM,300,CHEMBL284,6.522878745,DPPIV,O=C(O[C@@H]1CNC(C(=O)N2CCSC2)C1)c1ccccc1,O=C(OC1CNC(C(=O)N2CCSC2)C1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855523,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(NC(=O)N[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL227418,nM,85.9,CHEMBL284,7.066006836,DPPIV,N#Cc1ccc(NC(=O)N[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(NC(=O)NC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855524,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C(Nc1ccccc1)N[C@@H]1CN[C@H](C(=O)N2CCSC2)C1,CHEMBL376562,nM,154,CHEMBL284,6.812479279,DPPIV,O=C(Nc1ccccc1)N[C@@H]1CNC(C(=O)N2CCSC2)C1,O=C(Nc1ccccc1)NC1CNC(C(=O)N2CCSC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855525,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(S(=O)(=O)N[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL389906,nM,300,CHEMBL284,6.522878745,DPPIV,N#Cc1ccc(S(=O)(=O)N[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(S(=O)(=O)NC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855526,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](NS(=O)(=O)c2ccccc2)CN1)N1CCSC1,CHEMBL224421,nM,300,CHEMBL284,6.522878745,DPPIV,O=C(C1C[C@H](NS(=O)(=O)c2ccccc2)CN1)N1CCSC1,O=C(C1CC(NS(=O)(=O)c2ccccc2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855527,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(C(=O)N[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL441559,nM,37.2,CHEMBL284,7.42945706,DPPIV,N#Cc1ccc(C(=O)N[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(C(=O)NC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855528,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C(N[C@@H]1CN[C@H](C(=O)N2CCSC2)C1)c1ccccc1,CHEMBL376587,nM,300,CHEMBL284,6.522878745,DPPIV,O=C(N[C@@H]1CNC(C(=O)N2CCSC2)C1)c1ccccc1,O=C(NC1CNC(C(=O)N2CCSC2)C1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855529,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(CN[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL223497,nM,34,CHEMBL284,7.468521083,DPPIV,N#Cc1ccc(CN[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(CNC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855530,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](NCc2ccccc2)CN1)N1CCSC1,CHEMBL223060,nM,181,CHEMBL284,6.742321425,DPPIV,O=C(C1C[C@H](NCc2ccccc2)CN1)N1CCSC1,O=C(C1CC(NCc2ccccc2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855531,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)cc1,CHEMBL374688,nM,25.2,CHEMBL284,7.598599459,DPPIV,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCSC3)C2)cc1,N#Cc1ccc(NC2CNC(C(=O)N3CCSC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855564,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(N[C@@H]2CN[C@H](C(=O)N3CCSC3)C2)nc1,CHEMBL390513,nM,25.4,CHEMBL284,7.595166283,DPPIV,N#Cc1ccc(=N[C@@H]2CNC(C(=O)N3CCSC3)C2)[nH]c1,N#Cc1ccc(=NC2CNC(C(=O)N3CCSC3)C2)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855565,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1CCCN1)N1CCSC1,CHEMBL224435,nM,558,CHEMBL284,6.253365801,DPPIV,O=C(C1CCCN1)N1CCSC1,O=C(C1CCCN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1855618,CHEMBL915599,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(NCCNCC(=O)N2CCSC2)nc1,CHEMBL224419,nM,270,CHEMBL284,6.568636236,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2CCSC2)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2CCSC2)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861676,CHEMBL913151,Inhibition of human placental DPP4 at pH 2,B,C[C@@H](B(O)O)N1CC[C@@H](N)C1=O,CHEMBL2068511,nM,5.3,CHEMBL284,8.27572413,DPPIV,C[C@@H](B(O)O)N1CCC(N)C1=O,CC(B(O)O)N1CCC(N)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861685,CHEMBL913151,Inhibition of human placental DPP4 at pH 2,B,C[C@@H](B(O)O)N1CC[C@H](N)C1=O,CHEMBL2068512,nM,480,CHEMBL284,6.318758763,DPPIV,C[C@@H](B(O)O)N1CCC(N)C1=O,CC(B(O)O)N1CCC(N)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861947,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccccc2c1=O,CHEMBL227954,nM,13,CHEMBL284,7.886056648,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccccc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2ccccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861952,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cc(N3CCOCC3)c(F)cc2c1=O,CHEMBL227356,nM,18,CHEMBL284,7.744727495,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cc(N3CCOCC3)c(F)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2cc(N3CCOCC3)c(F)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861953,CHEMBL916662,Inhibition of human DPP4,B,COc1cccc2c(=O)n(Cc3ccccc3C#N)c(N3CCCC(N)C3)nc12,CHEMBL390776,nM,30,CHEMBL284,7.522878745,DPPIV,COc1cccc2c(=O)n(Cc3ccccc3C#N)c(N3CCCC(N)C3)nc12,COc1cccc2c(=O)n(Cc3ccccc3C#N)c(N3CCCC(N)C3)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861954,CHEMBL916662,Inhibition of human DPP4,B,COc1cc2nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c(=O)c2cc1OC,CHEMBL227089,nM,19,CHEMBL284,7.721246399,DPPIV,COc1cc2nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c(=O)c2cc1OC,COc1cc2nc(N3CCCC(N)C3)n(Cc3ccccc3C#N)c(=O)c2cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861955,CHEMBL916662,Inhibition of human DPP4,B,COc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc2cc1F,CHEMBL375508,nM,4,CHEMBL284,8.397940009,DPPIV,COc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc2cc1F,COc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCCC(N)C3)nc2cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861956,CHEMBL916662,Inhibition of human DPP4,B,COc1ccc2nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c(=O)c2c1,CHEMBL227670,nM,8,CHEMBL284,8.096910013,DPPIV,COc1ccc2nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c(=O)c2c1,COc1ccc2nc(N3CCCC(N)C3)n(Cc3ccccc3C#N)c(=O)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861957,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccc(Br)cc2c1=O,CHEMBL227676,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccc(Br)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2ccc(Br)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861958,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Cl)cc(Cl)cc2c1=O,CHEMBL390529,nM,13,CHEMBL284,7.886056648,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Cl)cc(Cl)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c(Cl)cc(Cl)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861959,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c(Cl)cccc2c1=O,CHEMBL387552,nM,29,CHEMBL284,7.537602002,DPPIV,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c(Cl)cccc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c(Cl)cccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861960,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cc(Cl)ccc2c1=O,CHEMBL228004,nM,15,CHEMBL284,7.823908741,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cc(Cl)ccc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861961,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccc(Cl)cc2c1=O,CHEMBL389074,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccc(Cl)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2ccc(Cl)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861962,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccc(F)cc2c1=O,CHEMBL425483,nM,4,CHEMBL284,8.397940009,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccc(F)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2ccc(F)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1861963,CHEMBL916662,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cccc(F)c2c1=O,CHEMBL227464,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cccc(F)c2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2cccc(F)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896352,CHEMBL887398,Inhibition of DPP4,B,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL427257,nM,11.5,CHEMBL284,7.93930216,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896353,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N[C@H](Cc2ccccc2F)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL439394,nM,126,CHEMBL284,6.899629455,DPPIV,CC1C(=O)N[C@H](Cc2ccccc2F)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NC(Cc2ccccc2F)CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896354,CHEMBL887398,Inhibition of DPP4,B,CC[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)[C@H](C)C(=O)N1,CHEMBL230601,nM,29.6,CHEMBL284,7.528708289,DPPIV,CC[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C(C)C(=O)N1,CCC1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C(C)C(=O)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896355,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N[C@H](C(F)(F)F)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL230603,nM,139,CHEMBL284,6.8569852,DPPIV,CC1C(=O)N[C@H](C(F)(F)F)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NC(C(F)(F)F)CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896356,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)[C@H](Cc2ccccn2)C(=O)N1,CHEMBL230602,nM,11,CHEMBL284,7.958607315,DPPIV,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C(Cc2ccccn2)C(=O)N1,CC1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C(Cc2ccccn2)C(=O)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896357,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)[C@H](Cc2ccccc2F)C(=O)N1,CHEMBL395798,nM,2.77,CHEMBL284,8.557520231,DPPIV,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C(Cc2ccccc2F)C(=O)N1,CC1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C(Cc2ccccc2F)C(=O)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896358,CHEMBL887398,Inhibition of DPP4,B,Cc1ccccc1C[C@@H]1C(=O)N[C@H](C)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL394837,nM,1.49,CHEMBL284,8.826813732,DPPIV,Cc1ccccc1CC1C(=O)N[C@H](C)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,Cc1ccccc1CC1C(=O)NC(C)CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896359,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)[C@H](CC(F)(F)F)C(=O)N1,CHEMBL230497,nM,34.3,CHEMBL284,7.46470588,DPPIV,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C(CC(F)(F)F)C(=O)N1,CC1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C(CC(F)(F)F)C(=O)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896360,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N[C@@H](C)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL394836,nM,397,CHEMBL284,6.401209493,DPPIV,CC1C(=O)N[C@@H](C)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C(C)C(=O)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896361,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)[C@H](C)C(=O)N1,CHEMBL230496,nM,15.1,CHEMBL284,7.821023053,DPPIV,CC1C(=O)N[C@H](C)CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C(C)C(=O)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896362,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)NCC(C)(C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL394594,nM,142,CHEMBL284,6.847711656,DPPIV,CC1C(=O)NCC(C)(C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NCC(C)(C)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896363,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1CNC(=O)[C@@H](CC(F)(F)F)N(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C1,CHEMBL230495,nM,143,CHEMBL284,6.844663963,DPPIV,C[C@@H]1CNC(=O)C(CC(F)(F)F)N(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C1,CC1CNC(=O)C(CC(F)(F)F)N(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896364,CHEMBL887398,Inhibition of DPP4,B,C[C@H]1CNC(=O)[C@@H](CC(F)(F)F)N(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C1,CHEMBL230389,nM,24.6,CHEMBL284,7.609064893,DPPIV,C[C@H]1CNC(=O)C(CC(F)(F)F)N(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C1,CC1CNC(=O)C(CC(F)(F)F)N(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896365,CHEMBL887398,Inhibition of DPP4,B,CC[C@@H]1C(=O)NC[C@@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL397242,nM,60.3,CHEMBL284,7.219682688,DPPIV,CCC1C(=O)NC[C@@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCC1C(=O)NCC(C)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896366,CHEMBL887398,Inhibition of DPP4,B,CC[C@@H]1C(=O)NC[C@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL230388,nM,37.3,CHEMBL284,7.428291168,DPPIV,CCC1C(=O)NC[C@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCC1C(=O)NCC(C)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896367,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1CNC(=O)[C@@H](C)N(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C1,CHEMBL397241,nM,33,CHEMBL284,7.48148606,DPPIV,CC1C(=O)NC[C@@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1CNC(=O)C(C)N(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896368,CHEMBL887398,Inhibition of DPP4,B,C[C@H]1CNC(=O)[C@@H](C)N(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C1,CHEMBL230387,nM,9.7,CHEMBL284,8.013228266,DPPIV,CC1C(=O)NC[C@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1CNC(=O)C(C)N(C(=O)CC(N)Cc2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896369,CHEMBL887398,Inhibition of DPP4,B,CC1CCNC(=O)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL397010,nM,1050,CHEMBL284,5.978810701,DPPIV,CC1CCNC(=O)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1CCNC(=O)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896371,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(C(C)(C)C)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL230283,nM,9.6,CHEMBL284,8.017728767,DPPIV,CC1C(=O)N(C(C)(C)C)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)N(C(C)(C)C)CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896372,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(C2CC2)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL230282,nM,8,CHEMBL284,8.096910013,DPPIV,CC1C(=O)N(C2CC2)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)N(C2CC2)CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896373,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(CC(F)(F)F)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL390886,nM,19.2,CHEMBL284,7.716698771,DPPIV,CC1C(=O)N(CC(F)(F)F)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)N(CC(F)(F)F)CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896374,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(CCOCc2ccccc2)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL395004,nM,10.5,CHEMBL284,7.978810701,DPPIV,CC1C(=O)N(CCOCc2ccccc2)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)N(CCOCc2ccccc2)CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896375,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(CCO)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL231117,nM,15.1,CHEMBL284,7.821023053,DPPIV,CC1C(=O)N(CCO)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)N(CCO)CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896376,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(C)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL231011,nM,11.5,CHEMBL284,7.93930216,DPPIV,CC1C(=O)N(C)CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)N(C)CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896377,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(C2CC2)CCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL390885,nM,9,CHEMBL284,8.045757491,DPPIV,CC1C(=O)N(C2CC2)CCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1C(=O)N(C2CC2)CCCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896378,CHEMBL887398,Inhibition of DPP4,B,C[C@@H]1C(=O)N(CC(=O)O)CCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL231010,nM,69.9,CHEMBL284,7.155522824,DPPIV,CC1C(=O)N(CC(=O)O)CCCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1C(=O)N(CC(=O)O)CCCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896379,CHEMBL887398,Inhibition of DPP4,B,COC(=O)CN1CCCN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)[C@H](C)C1=O,CHEMBL390884,nM,11.6,CHEMBL284,7.935542011,DPPIV,COC(=O)CN1CCCN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)C(C)C1=O,COC(=O)CN1CCCN(C(=O)CC(N)Cc2cc(F)ccc2F)C(C)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896380,CHEMBL887398,Inhibition of DPP4,B,CCN1CCCN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)[C@H](C)C1=O,CHEMBL231009,nM,20.7,CHEMBL284,7.684029655,DPPIV,CCN1CCCN(C(=O)C[C@H](N)Cc2cc(F)ccc2F)C(C)C1=O,CCN1CCCN(C(=O)CC(N)Cc2cc(F)ccc2F)C(C)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1896382,CHEMBL887398,Inhibition of DPP4,B,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL390853,nM,6.6,CHEMBL284,8.180456064,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897530,CHEMBL887585,Inhibition of DPP4,B,CN(C)C(=O)[C@H](c1ccc(-c2ccc(F)cc2)cc1)[C@@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL231151,nM,1460,CHEMBL284,5.835647144,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897531,CHEMBL887585,Inhibition of DPP4,B,C=CCC(C(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL396789,nM,1995,CHEMBL284,5.7000571,DPPIV,C=CCC(C(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H](N)Cc1cc(F)c(F)cc1F,C=CCC(C(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897532,CHEMBL887585,Inhibition of DPP4,B,C=COCC(=O)N1CCN(C(=O)C[C@H](N)Cc2ccccc2F)CC1,CHEMBL230095,nM,2209,CHEMBL284,5.655804284,DPPIV,C=COCC(=O)N1CCN(C(=O)C[C@H](N)Cc2ccccc2F)CC1,C=COCC(=O)N1CCN(C(=O)CC(N)Cc2ccccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897533,CHEMBL887585,Inhibition of DPP4,B,CC(C)[C@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CHEMBL395762,nM,2,CHEMBL284,8.698970004,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897534,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2cc(C(F)(F)F)nc2C1c1ccc(F)cc1)Cc1ccc(F)c(F)c1,CHEMBL231050,nM,1397,CHEMBL284,5.854803594,DPPIV,N[C@@H](CC(=O)N1CCn2cc(C(F)(F)F)nc2C1c1ccc(F)cc1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCn2cc(C(F)(F)F)nc2C1c1ccc(F)cc1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897535,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nccc21)Cc1cc(F)ccc1F,CHEMBL395546,nM,1325,CHEMBL284,5.877784122,DPPIV,N[C@@H](CC(=O)N1CCn2nccc21)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2nccc21)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897536,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCN(c2ccc(Cl)cc2)CC1)Cc1ccccc1F,CHEMBL410187,nM,1247,CHEMBL284,5.904133547,DPPIV,N[C@@H](CC(=O)N1CCN(c2ccc(Cl)cc2)CC1)Cc1ccccc1F,NC(CC(=O)N1CCN(c2ccc(Cl)cc2)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897537,CHEMBL887585,Inhibition of DPP4,B,N[C@H](C(=O)N1CCC(F)(F)C1)[C@@H]1CCN(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,CHEMBL231654,nM,995,CHEMBL284,6.002176919,DPPIV,NC(C(=O)N1CCC(F)(F)C1)C1CCN(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,NC(C(=O)N1CCC(F)(F)C1)C1CCN(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897538,CHEMBL887585,Inhibition of DPP4,B,COc1cc(CNC(=O)[C@@H]2CCCN2C(=O)C[C@H](N)Cc2ccccc2F)ccc1O,CHEMBL396195,nM,864,CHEMBL284,6.063486258,DPPIV,COc1cc(CNC(=O)C2CCCN2C(=O)C[C@H](N)Cc2ccccc2F)ccc1O,COc1cc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2ccccc2F)ccc1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897539,CHEMBL887585,Inhibition of DPP4,B,CSc1cc(F)c(C[C@@H](N)CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)cc1F,CHEMBL231653,nM,780,CHEMBL284,6.107905397,DPPIV,CSc1cc(F)c(C[C@@H](N)CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)cc1F,CSc1cc(F)c(CC(N)CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897540,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F,CHEMBL231552,nM,731,CHEMBL284,6.136082623,DPPIV,N[C@@H](CC(=O)N1CCCC1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCc1ccc(C(F)(F)F)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897541,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1C(=O)NCc1ccccc1)Cc1ccccc1F,CHEMBL231551,nM,539,CHEMBL284,6.268411235,DPPIV,N[C@@H](CC(=O)N1CCCC1C(=O)NCc1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1C(=O)NCc1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897542,CHEMBL887585,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CCOCC1,CHEMBL388900,nM,520,CHEMBL284,6.283996656,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCOCC1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCOCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897543,CHEMBL887585,Inhibition of DPP4,B,O=C([C@@H]1Cc2ccc(-c3cccc(-c4nnn[nH]4)c3)cc2CN1)N1CC[C@H](F)C1,CHEMBL230938,nM,310,CHEMBL284,6.508638306,DPPIV,O=C(C1Cc2ccc(-c3cccc(-c4nn[nH]n4)c3)cc2CN1)N1CC[C@H](F)C1,O=C(C1Cc2ccc(-c3cccc(-c4nn[nH]n4)c3)cc2CN1)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897544,CHEMBL887585,Inhibition of DPP4,B,COC(=O)Cc1ccc(CNC(=O)[C@@H]2CSCN2C(=O)C[C@H](N)Cc2ccccc2F)cc1,CHEMBL230937,nM,170,CHEMBL284,6.769551079,DPPIV,COC(=O)Cc1ccc(CNC(=O)C2CSCN2C(=O)C[C@H](N)Cc2ccccc2F)cc1,COC(=O)Cc1ccc(CNC(=O)C2CSCN2C(=O)CC(N)Cc2ccccc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897546,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CSC[C@H]1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1F,CHEMBL230840,nM,37,CHEMBL284,7.431798276,DPPIV,N[C@@H](CC(=O)N1CSCC1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1F,NC(CC(=O)N1CSCC1C(=O)NCc1ccc(CC(=O)O)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897547,CHEMBL887585,Inhibition of DPP4,B,Cc1ccc(F)cc1C[C@@H](N)CC(=O)N1CCC[C@H]1C(=O)NCc1ccc(O[C@H](C(=O)O)C(C)C)cc1,CHEMBL230839,nM,33,CHEMBL284,7.48148606,DPPIV,Cc1ccc(F)cc1C[C@@H](N)CC(=O)N1CCCC1C(=O)NCc1ccc(OC(C(=O)O)C(C)C)cc1,Cc1ccc(F)cc1CC(N)CC(=O)N1CCCC1C(=O)NCc1ccc(OC(C(=O)O)C(C)C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897548,CHEMBL887585,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(Cl)ccc1F,CHEMBL427261,nM,21,CHEMBL284,7.677780705,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(Cl)ccc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(Cl)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1897549,CHEMBL887585,Inhibition of DPP4,B,CC(C)[C@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)c(F)c2F)cc1)C(=O)O,CHEMBL397716,nM,8,CHEMBL284,8.096910013,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)c(F)c2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)c(F)c2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905784,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccccc2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL390193,nM,210,CHEMBL284,6.677780705,DPPIV,N[C@H]1CN(c2ccccc2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccccc2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905788,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nnc(-c4ccc(F)cc4)n3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL228312,nM,16,CHEMBL284,7.795880017,DPPIV,N[C@H]1CN(c2ccc3nnc(-c4ccc(F)cc4)n3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nnc(-c4ccc(F)cc4)n3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905789,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL228311,nM,9,CHEMBL284,8.045757491,DPPIV,N[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nnc(C(F)(F)F)n3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905790,CHEMBL888507,Inhibition of DPP4,B,CCc1nnc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn12.O=C(O)C(F)(F)F,CHEMBL390080,nM,6,CHEMBL284,8.22184875,DPPIV,CCc1nnc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn12,CCc1nnc2ccc(N3CCC(c4cc(F)c(F)cc4F)C(N)C3)nn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905791,CHEMBL888507,Inhibition of DPP4,B,Cc1nnc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn12.O=C(O)C(F)(F)F,CHEMBL231497,nM,6,CHEMBL284,8.22184875,DPPIV,Cc1nnc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn12,Cc1nnc2ccc(N3CCC(c4cc(F)c(F)cc4F)C(N)C3)nn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905792,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nncn3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231496,nM,31,CHEMBL284,7.508638306,DPPIV,N[C@H]1CN(c2ccc3nncn3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nncn3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905793,CHEMBL888507,Inhibition of DPP4,B,Cn1nc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn2c1=O.O=C(O)C(F)(F)F,CHEMBL390241,nM,5,CHEMBL284,8.301029996,DPPIV,Cn1nc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nn2c1=O,Cn1nc2ccc(N3CCC(c4cc(F)c(F)cc4F)C(N)C3)nn2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905794,CHEMBL888507,Inhibition of DPP4,B,Cc1cc(=O)n2nc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ccc2n1.O=C(O)C(F)(F)F,CHEMBL231397,nM,8,CHEMBL284,8.096910013,DPPIV,Cc1cc(=O)n2nc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ccc2n1,Cc1cc(=O)n2nc(N3CCC(c4cc(F)c(F)cc4F)C(N)C3)ccc2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905795,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nc(=O)ccn3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231396,nM,1.2,CHEMBL284,8.920818754,DPPIV,N[C@H]1CN(c2ccc3nc(=O)ccn3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nc(=O)ccn3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905796,CHEMBL888507,Inhibition of DPP4,B,Cc1nc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nc2c(=O)[nH]1.O=C(O)C(F)(F)F,CHEMBL231395,nM,7,CHEMBL284,8.15490196,DPPIV,Cc1nc(=O)c2nc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ccc2[nH]1,Cc1nc(=O)c2nc(N3CCC(c4cc(F)c(F)cc4F)C(N)C3)ccc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905797,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3ncnc(C4CC4)c3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231295,nM,8,CHEMBL284,8.096910013,DPPIV,N[C@H]1CN(c2ccc3ncnc(C4CC4)c3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3ncnc(C4CC4)c3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905798,CHEMBL888507,Inhibition of DPP4,B,Cn1c(C2CC2)nc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nc21.O=C(O)C(F)(F)F,CHEMBL389804,nM,2,CHEMBL284,8.698970004,DPPIV,Cn1c(C2CC2)nc2ccc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)nc21,Cn1c(C2CC2)nc2ccc(N3CCC(c4cc(F)c(F)cc4F)C(N)C3)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905799,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccn3cnnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231294,nM,26,CHEMBL284,7.585026652,DPPIV,N[C@H]1CN(c2ccn3cnnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccn3cnnc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905800,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231293,nM,5,CHEMBL284,8.301029996,DPPIV,N[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nc(C(F)(F)F)nn3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905801,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nc(C(F)(F)F)cn3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL389803,nM,22,CHEMBL284,7.657577319,DPPIV,N[C@H]1CN(c2ccc3nc(C(F)(F)F)cn3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nc(C(F)(F)F)cn3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905802,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cnc3nccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231196,nM,13,CHEMBL284,7.886056648,DPPIV,N[C@H]1CN(c2cnc3nccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cnc3nccnc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905803,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cnc3cncnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231195,nM,43,CHEMBL284,7.366531544,DPPIV,N[C@H]1CN(c2cnc3cncnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cnc3cncnc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905804,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cnc3cccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231194,nM,130,CHEMBL284,6.886056648,DPPIV,N[C@H]1CN(c2cnc3cccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cnc3cccnc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905805,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cnc3ccccc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL389538,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@H]1CN(c2cnc3ccccc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cnc3ccccc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905806,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3nccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231092,nM,7,CHEMBL284,8.15490196,DPPIV,N[C@H]1CN(c2ccc3nccnc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3nccnc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905807,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2nccc3ccccc23)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231091,nM,3700,CHEMBL284,5.431798276,DPPIV,N[C@H]1CN(c2nccc3ccccc23)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2nccc3ccccc23)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905808,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc3ccccc3n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL389537,nM,54,CHEMBL284,7.26760624,DPPIV,N[C@H]1CN(c2ccc3ccccc3n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc3ccccc3n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905809,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cccnn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL231090,nM,63,CHEMBL284,7.200659451,DPPIV,N[C@H]1CN(c2cccnn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cccnn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905810,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cnccn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL230985,nM,82,CHEMBL284,7.086186148,DPPIV,N[C@H]1CN(c2cnccn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cnccn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905811,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ncccn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL427259,nM,90,CHEMBL284,7.045757491,DPPIV,N[C@H]1CN(c2ncccn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ncccn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905812,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccncn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL230984,nM,37,CHEMBL284,7.431798276,DPPIV,N[C@H]1CN(c2ccncn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccncn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905813,CHEMBL888507,Inhibition of DPP4,B,N#Cc1ccc(N2CC[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)nc1.O=C(O)C(F)(F)F,CHEMBL230883,nM,14,CHEMBL284,7.853871964,DPPIV,N#Cc1ccc(N2CC[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)nc1,N#Cc1ccc(N2CCC(c3cc(F)c(F)cc3F)C(N)C2)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905814,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ncccc2C(F)(F)F)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL230449,nM,650,CHEMBL284,6.187086643,DPPIV,N[C@H]1CN(c2ncccc2C(F)(F)F)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ncccc2C(F)(F)F)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905815,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cc(C(F)(F)F)ccn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL389602,nM,463,CHEMBL284,6.334419009,DPPIV,N[C@H]1CN(c2cc(C(F)(F)F)ccn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(C(F)(F)F)ccn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905816,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL274740,nM,67,CHEMBL284,7.173925197,DPPIV,N[C@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc(C(F)(F)F)cn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905817,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cccc(C(F)(F)F)n2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL230342,nM,111,CHEMBL284,6.954677021,DPPIV,N[C@H]1CN(c2cccc(C(F)(F)F)n2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cccc(C(F)(F)F)n2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905818,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccncc2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL390194,nM,125,CHEMBL284,6.903089987,DPPIV,N[C@H]1CN(c2ccncc2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccncc2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905819,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2cccnc2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL230341,nM,144,CHEMBL284,6.841637508,DPPIV,N[C@H]1CN(c2cccnc2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cccnc2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1905820,CHEMBL888507,Inhibition of DPP4,B,N[C@H]1CN(c2ccccn2)CC[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL230340,nM,58,CHEMBL284,7.236572006,DPPIV,N[C@H]1CN(c2ccccn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccccn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1935647,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1Cc2ccccc2C1,CHEMBL233127,nM,5.6,CHEMBL284,8.251811973,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1Cc2ccccc2C1,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944662,CHEMBL892394,Inhibition of human DPP4,B,Cc1cc(C)c([C@@H]2CN[C@H](C(=O)N3CCC[C@H]3C#N)C2)c(C)c1O,CHEMBL389324,nM,5.3,CHEMBL284,8.27572413,DPPIV,Cc1cc(C)c([C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)c(C)c1O,Cc1cc(C)c(C2CNC(C(=O)N3CCCC3C#N)C2)c(C)c1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944663,CHEMBL892394,Inhibition of human DPP4,B,COc1c(O)ccc(C)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL244010,nM,7.1,CHEMBL284,8.148741651,DPPIV,COc1c(O)ccc(C)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,COc1c(O)ccc(C)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944664,CHEMBL892394,Inhibition of human DPP4,B,Cc1ccc(O)c(C)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL413797,nM,4.9,CHEMBL284,8.30980392,DPPIV,Cc1ccc(O)c(C)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,Cc1ccc(O)c(C)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944665,CHEMBL892394,Inhibition of human DPP4,B,CCOc1cc(O)cc(OCC)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL244009,nM,22,CHEMBL284,7.657577319,DPPIV,CCOc1cc(O)cc(OCC)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCOc1cc(O)cc(OCC)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944666,CHEMBL892394,Inhibition of human DPP4,B,CCc1cc(O)cc(C)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL390418,nM,8.9,CHEMBL284,8.050609993,DPPIV,CCc1cc(O)cc(C)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCc1cc(O)cc(C)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944667,CHEMBL892394,Inhibition of human DPP4,B,COc1cc(O)cc(OC)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL244008,nM,23,CHEMBL284,7.638272164,DPPIV,COc1cc(O)cc(OC)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,COc1cc(O)cc(OC)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944668,CHEMBL892394,Inhibition of human DPP4,B,COc1cc(O)cc(C)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL243800,nM,8.3,CHEMBL284,8.080921908,DPPIV,COc1cc(O)cc(C)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,COc1cc(O)cc(C)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944669,CHEMBL892394,Inhibition of human DPP4,B,Cc1cc(O)cc(C)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL243799,nM,3.3,CHEMBL284,8.48148606,DPPIV,Cc1cc(O)cc(C)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,Cc1cc(O)cc(C)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944670,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](c2ccc(O)cc2)CN1,CHEMBL390221,nM,2.5,CHEMBL284,8.602059991,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](c2ccc(O)cc2)CN1,N#CC1CCCN1C(=O)C1CC(c2ccc(O)cc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944671,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](c2cccc(O)c2)CN1,CHEMBL243798,nM,3.9,CHEMBL284,8.408935393,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](c2cccc(O)c2)CN1,N#CC1CCCN1C(=O)C1CC(c2cccc(O)c2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944672,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](c2ccccc2O)CN1,CHEMBL245059,nM,9.1,CHEMBL284,8.040958608,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](c2ccccc2O)CN1,N#CC1CCCN1C(=O)C1CC(c2ccccc2O)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944673,CHEMBL892394,Inhibition of human DPP4,B,Cc1cccc(C)c1[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL396513,nM,6.1,CHEMBL284,8.214670165,DPPIV,Cc1cccc(C)c1[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,Cc1cccc(C)c1C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944674,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](c2ccccc2)CN1,CHEMBL244843,nM,16,CHEMBL284,7.795880017,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@@H](c2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(c2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944675,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](c2ccccc2)CN1,CHEMBL396512,nM,3.5,CHEMBL284,8.455931956,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](c2ccccc2)CN1,N#CC1CCCN1C(=O)C1CC(c2ccccc2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944676,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CC(C2C3CC4CC(C3)CC2C4)CN1,CHEMBL389138,nM,7.8,CHEMBL284,8.107905397,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C2C3CC4CC(C3)CC2C4)CN1,N#CC1CCCN1C(=O)C1CC(C2C3CC4CC(C3)CC2C4)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944677,CHEMBL892394,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C2CCCCC2)CN1,CHEMBL242492,nM,2.4,CHEMBL284,8.619788758,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](C2CCCCC2)CN1,N#CC1CCCN1C(=O)C1CC(C2CCCCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944678,CHEMBL892394,Inhibition of human DPP4,B,CC(C)C[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL242987,nM,2.9,CHEMBL284,8.537602002,DPPIV,CC(C)C[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,CC(C)CC1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944679,CHEMBL892394,Inhibition of human DPP4,B,C=C(C)C[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL437570,nM,5.7,CHEMBL284,8.244125144,DPPIV,C=C(C)C[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,C=C(C)CC1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944680,CHEMBL892394,Inhibition of human DPP4,B,CCC[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL242985,nM,3.4,CHEMBL284,8.468521083,DPPIV,CCC[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCCC1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1944681,CHEMBL892394,Inhibition of human DPP4,B,C=CC[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL245069,nM,3.5,CHEMBL284,8.455931956,DPPIV,C=CC[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,C=CCC1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1947253,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1CCSCC1,CHEMBL394165,nM,6.2,CHEMBL284,8.207608311,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1CCSCC1,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N1CCSCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948879,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(N)=O)CN1,CHEMBL232315,nM,7.7,CHEMBL284,8.113509275,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(N)=O)CN1,N#CC1CCCN1C(=O)C1CC(C(N)=O)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948880,CHEMBL892415,Inhibition of human DPP4,B,CN(C)C(=O)CC[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL232311,nM,2.4,CHEMBL284,8.619788758,DPPIV,CN(C)C(=O)CC[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,CN(C)C(=O)CCC1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948881,CHEMBL892415,Inhibition of human DPP4,B,CN(C)C(=O)C[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL391558,nM,4.5,CHEMBL284,8.346787486,DPPIV,CN(C)C(=O)C[C@@H]1CNC(C(=O)N2CCC[C@H]2C#N)C1,CN(C)C(=O)CC1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948882,CHEMBL892415,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL232103,nM,1.8,CHEMBL284,8.744727495,DPPIV,CN(C)C(=O)C1CNC(C(=O)N2CCC[C@H]2C#N)C1,CN(C)C(=O)C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948883,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](CC(=O)O)CN1,CHEMBL234158,nM,16,CHEMBL284,7.795880017,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](CC(=O)O)CN1,N#CC1CCCN1C(=O)C1CC(CC(=O)O)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948884,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](CCO)CN1,CHEMBL395919,nM,3.8,CHEMBL284,8.420216403,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](CCO)CN1,N#CC1CCCN1C(=O)C1CC(CCO)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948885,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](CO)CN1,CHEMBL234356,nM,6.3,CHEMBL284,8.200659451,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](CO)CN1,N#CC1CCCN1C(=O)C1CC(CO)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948898,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1CCOCC1,CHEMBL429258,nM,20,CHEMBL284,7.698970004,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1CCOCC1,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N1CCOCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948899,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1CCCCC1,CHEMBL232920,nM,13,CHEMBL284,7.886056648,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1CCCCC1,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948900,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1CCCC1,CHEMBL393957,nM,6.5,CHEMBL284,8.187086643,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1CCCC1,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948901,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N1CCC1,CHEMBL232919,nM,13,CHEMBL284,7.886056648,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N1CCC1,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948902,CHEMBL892415,Inhibition of human DPP4,B,CCN(C)C(=O)[C@H]1C[C@@H](C(=O)N2CCC[C@H]2C#N)N[C@H]1C,CHEMBL394932,nM,15,CHEMBL284,7.823908741,DPPIV,CCN(C)C(=O)C1CC(C(=O)N2CCC[C@H]2C#N)N[C@H]1C,CCN(C)C(=O)C1CC(C(=O)N2CCCC2C#N)NC1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948903,CHEMBL892415,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N(C)C,CHEMBL232914,nM,10,CHEMBL284,8,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N(C)C,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948904,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCSCC2)CN1,CHEMBL400615,nM,4.8,CHEMBL284,8.318758763,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCSCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCSCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948905,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCOCC2)CN1,CHEMBL415647,nM,4.3,CHEMBL284,8.366531544,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCOCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCOCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948906,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCCCCCC2)CN1,CHEMBL232716,nM,11,CHEMBL284,7.958607315,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCCCCCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCCCCCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948907,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCCCCC2)CN1,CHEMBL400614,nM,8.3,CHEMBL284,8.080921908,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCCCCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCCCCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948908,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCCCC2)CN1,CHEMBL400613,nM,4.9,CHEMBL284,8.30980392,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCCCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCCCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948909,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCCC2)CN1,CHEMBL428369,nM,5.6,CHEMBL284,8.251811973,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948910,CHEMBL892415,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](C(=O)N2CCC2)CN1,CHEMBL234373,nM,4,CHEMBL284,8.397940009,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CC(C(=O)N2CCC2)CN1,N#CC1CCCN1C(=O)C1CC(C(=O)N2CCC2)CN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948911,CHEMBL892415,Inhibition of human DPP4,B,CCN(CC)C(=O)[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL393498,nM,6,CHEMBL284,8.22184875,DPPIV,CCN(CC)C(=O)C1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCN(CC)C(=O)C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948912,CHEMBL892415,Inhibition of human DPP4,B,CCN(C)C(=O)[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL234163,nM,4.9,CHEMBL284,8.30980392,DPPIV,CCN(C)C(=O)C1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCN(C)C(=O)C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948913,CHEMBL892415,Inhibition of human DPP4,B,CCCNC(=O)[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL434960,nM,5.7,CHEMBL284,8.244125144,DPPIV,CCCNC(=O)C1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCCNC(=O)C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948914,CHEMBL892415,Inhibition of human DPP4,B,CCNC(=O)[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL232316,nM,4.4,CHEMBL284,8.356547324,DPPIV,CCNC(=O)C1CNC(C(=O)N2CCC[C@H]2C#N)C1,CCNC(=O)C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1948915,CHEMBL892415,Inhibition of human DPP4,B,CNC(=O)[C@@H]1CN[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL391559,nM,3.5,CHEMBL284,8.455931956,DPPIV,CNC(=O)C1CNC(C(=O)N2CCC[C@H]2C#N)C1,CNC(=O)C1CNC(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958901,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1F,CHEMBL388475,nM,98,CHEMBL284,7.008773924,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958904,CHEMBL893277,Inhibition of DPP4 activity,B,CC(C)(C)NC(=O)c1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2,CHEMBL233891,nM,234,CHEMBL284,6.630784143,DPPIV,CC(C)(C)NC(=O)c1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2,CC(C)(C)NC(=O)c1nnc2n1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958905,CHEMBL893277,Inhibition of DPP4 activity,B,CCOC(=O)c1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2,CHEMBL233686,nM,219,CHEMBL284,6.659555885,DPPIV,CCOC(=O)c1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2,CCOC(=O)c1nnc2n1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958906,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL390240,nM,29,CHEMBL284,7.537602002,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958907,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C2CC2)C1)Cc1cc(F)c(F)cc1F,CHEMBL390239,nM,30,CHEMBL284,7.522878745,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C2CC2)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C2CC2)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958908,CHEMBL893277,Inhibition of DPP4 activity,B,CCc1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2,CHEMBL233685,nM,37,CHEMBL284,7.431798276,DPPIV,CCc1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2,CCc1nnc2n1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958909,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(CO)nnc2C1)Cc1cc(F)ccc1F,CHEMBL233684,nM,69,CHEMBL284,7.161150909,DPPIV,N[C@@H](CC(=O)N1CCn2c(CO)nnc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(CO)nnc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958910,CHEMBL893277,Inhibition of DPP4 activity,B,CCOC(=O)c1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL389600,nM,190,CHEMBL284,6.721246399,DPPIV,CCOC(=O)c1nnc2n1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CCOC(=O)c1nnc2n1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958911,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2-c2ccncc2)C1)Cc1cc(F)ccc1F,CHEMBL233474,nM,65,CHEMBL284,7.187086643,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2-c2ccncc2)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(nnc2-c2ccncc2)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958912,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2-c2ccc(F)cc2F)C1)Cc1cc(F)ccc1F,CHEMBL389599,nM,30,CHEMBL284,7.522878745,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2-c2ccc(F)cc2F)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(nnc2-c2ccc(F)cc2F)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958913,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2-c2ccc(F)cc2)C1)Cc1cc(F)ccc1F,CHEMBL233472,nM,60,CHEMBL284,7.22184875,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2-c2ccc(F)cc2)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCn2c(nnc2-c2ccc(F)cc2)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958914,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1Cl,CHEMBL233058,nM,84,CHEMBL284,7.075720714,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1Cl,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958915,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(Cl)cc1F,CHEMBL232845,nM,76,CHEMBL284,7.119186408,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(Cl)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(Cl)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958917,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(Cl)ccc1Cl,CHEMBL232648,nM,180,CHEMBL284,6.744727495,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(Cl)ccc1Cl,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(Cl)ccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958918,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)cc1Cl,CHEMBL235120,nM,23,CHEMBL284,7.638272164,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)cc1Cl,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958919,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)c(Cl)c1,CHEMBL388433,nM,1580,CHEMBL284,5.801342913,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)c(Cl)c1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958920,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)cc1,CHEMBL243231,nM,264,CHEMBL284,6.578396073,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)cc1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958921,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(Cl)c1,CHEMBL243230,nM,59,CHEMBL284,7.229147988,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(Cl)c1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958922,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1Cl,CHEMBL388431,nM,145,CHEMBL284,6.838631998,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1Cl,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958923,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(C(F)(F)F)cc1,CHEMBL245181,nM,511,CHEMBL284,6.2915791,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(C(F)(F)F)cc1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958924,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(C(F)(F)F)c1,CHEMBL243227,nM,366,CHEMBL284,6.436518915,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(C(F)(F)F)c1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(C(F)(F)F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958925,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1C(F)(F)F,CHEMBL397744,nM,486,CHEMBL284,6.313363731,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1C(F)(F)F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958926,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)c(F)c(F)c(F)c1F,CHEMBL397743,nM,1018,CHEMBL284,5.992252222,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)c(F)c(F)c(F)c1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)c(F)c(F)c(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958928,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)cc(F)cc1F,CHEMBL394834,nM,87,CHEMBL284,7.060480747,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)cc(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)cc(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958929,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)ccc(F)c1F,CHEMBL394833,nM,151,CHEMBL284,6.821023053,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)ccc(F)c1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1c(F)ccc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958930,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)cc(F)c1F,CHEMBL243872,nM,805,CHEMBL284,6.09420412,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)cc(F)c1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)cc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958932,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)cc1F,CHEMBL389151,nM,82,CHEMBL284,7.086186148,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958933,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)c(F)c1,CHEMBL242813,nM,128,CHEMBL284,6.89279003,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)c(F)c1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958934,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)cc1,CHEMBL242811,nM,272,CHEMBL284,6.565431096,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)cc1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1958935,CHEMBL893277,Inhibition of DPP4 activity,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(F)c1,CHEMBL232262,nM,135,CHEMBL284,6.869666232,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(F)c1,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cccc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1960111,CHEMBL893216,Inhibition of DPP4,B,N[C@H]1C[C@H](N2CCn3c(nnc3C(F)(F)F)C2)CCC1c1cc(F)c(F)cc1F,CHEMBL232191,nM,140,CHEMBL284,6.853871964,DPPIV,N[C@H]1C[C@H](N2CCn3c(nnc3C(F)(F)F)C2)CCC1c1cc(F)c(F)cc1F,NC1CC(N2CCn3c(nnc3C(F)(F)F)C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1960112,CHEMBL893216,Inhibition of DPP4,B,N[C@H]1C[C@@H](N2CCn3c(C(F)(F)F)cnc3C2)CCC1c1cc(F)c(F)cc1F,CHEMBL234635,nM,21,CHEMBL284,7.677780705,DPPIV,N[C@H]1C[C@@H](N2CCn3c(C(F)(F)F)cnc3C2)CCC1c1cc(F)c(F)cc1F,NC1CC(N2CCn3c(C(F)(F)F)cnc3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1962327,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(C)c3)CN1CC2,CHEMBL400624,nM,13,CHEMBL284,7.886056648,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(C)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(C)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963686,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1N,CHEMBL234412,nM,520,CHEMBL284,6.283996656,DPPIV,CCCC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1N,CCCCC1CN2CCc3cc(OC)c(OC)cc3C2CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963687,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cccc(Cl)c3)CN1CC2,CHEMBL232595,nM,4,CHEMBL284,8.397940009,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cccc(Cl)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(Cl)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963688,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3cccc(Cl)c3)CN1CC2,CHEMBL429982,nM,50,CHEMBL284,7.301029996,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3cccc(Cl)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(Cl)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963689,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cccc(C)c3)CN1CC2,CHEMBL391070,nM,4,CHEMBL284,8.397940009,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cccc(C)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(C)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963690,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3cccc(C)c3)CN1CC2,CHEMBL234431,nM,32,CHEMBL284,7.494850022,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3cccc(C)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(C)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963691,CHEMBL893070,Inhibition of human DPP4,B,COc1cccc([C@H]2CN3CCc4cc(OC)c(OC)cc4[C@@H]3C[C@H]2N)c1,CHEMBL234430,nM,650,CHEMBL284,6.187086643,DPPIV,COc1cccc([C@H]2CN3CCc4cc(OC)c(OC)cc4[C@@H]3C[C@H]2N)c1,COc1cccc(C2CN3CCc4cc(OC)c(OC)cc4C3CC2N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963692,CHEMBL893070,Inhibition of human DPP4,B,COc1cccc([C@H]2CN3CCc4cc(OC)c(OC)cc4[C@@H]3C[C@@H]2N)c1,CHEMBL540711,nM,5130,CHEMBL284,5.289882635,DPPIV,COc1cccc([C@H]2CN3CCc4cc(OC)c(OC)cc4[C@@H]3C[C@@H]2N)c1,COc1cccc(C2CN3CCc4cc(OC)c(OC)cc4C3CC2N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963693,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccc(C)c(C)c3)CN1CC2,CHEMBL392085,nM,3730,CHEMBL284,5.428291168,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccc(C)c(C)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccc(C)c(C)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963694,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccc(C)c(C)c3)CN1CC2,CHEMBL234238,nM,9380,CHEMBL284,5.027797162,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccc(C)c(C)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccc(C)c(C)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963695,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccc(C)cc3)CN1CC2,CHEMBL234048,nM,370,CHEMBL284,6.431798276,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccc(C)cc3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccc(C)cc3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963696,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccc(C)cc3)CN1CC2,CHEMBL392084,nM,10590,CHEMBL284,4.97510404,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccc(C)cc3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccc(C)cc3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963697,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccccn3)CN1CC2,CHEMBL234047,nM,1520,CHEMBL284,5.818156412,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccccn3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccccn3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963698,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccccn3)CN1CC2,CHEMBL392083,nM,990,CHEMBL284,6.004364805,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccccn3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccccn3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963699,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3ccccc3)CN1CC2,CHEMBL234046,nM,220,CHEMBL284,6.657577319,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3ccccc3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccccc3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963700,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccccc3)CN1CC2,CHEMBL428894,nM,200,CHEMBL284,6.698970004,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3ccccc3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccccc3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963701,CHEMBL893070,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccccc3)CN1CC2,CHEMBL391037,nM,270,CHEMBL284,6.568636236,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@@H](N)[C@@H](c3ccccc3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3ccccc3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963702,CHEMBL893070,Inhibition of human DPP4,B,COc1ccc(N2CCC(N)C(c3ccccn3)C2)cc1OC,CHEMBL231996,nM,8900,CHEMBL284,5.050609993,DPPIV,COc1ccc(N2CCC(N)C(c3ccccn3)C2)cc1OC,COc1ccc(N2CCC(N)C(c3ccccn3)C2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963703,CHEMBL893070,Inhibition of human DPP4,B,COc1cccc(C2CN(c3ccc(OC)c(OC)c3)CCC2N)c1,CHEMBL231995,nM,25600,CHEMBL284,4.591760035,DPPIV,COc1cccc(C2CN(c3ccc(OC)c(OC)c3)CCC2N)c1,COc1cccc(C2CN(c3ccc(OC)c(OC)c3)CCC2N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963704,CHEMBL893070,Inhibition of human DPP4,B,COc1ccc(N2CCC(N)C(c3cccc(C)c3)C2)cc1OC,CHEMBL231994,nM,600,CHEMBL284,6.22184875,DPPIV,COc1ccc(N2CCC(N)C(c3cccc(C)c3)C2)cc1OC,COc1ccc(N2CCC(N)C(c3cccc(C)c3)C2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963705,CHEMBL893070,Inhibition of human DPP4,B,COc1ccc(N2CCC(N)C(c3ccc(C)c(C)c3)C2)cc1OC,CHEMBL397353,nM,31300,CHEMBL284,4.504455662,DPPIV,COc1ccc(N2CCC(N)C(c3ccc(C)c(C)c3)C2)cc1OC,COc1ccc(N2CCC(N)C(c3ccc(C)c(C)c3)C2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963706,CHEMBL893070,Inhibition of human DPP4,B,COc1ccc(N2CCC(N)C(c3ccc(C)cc3)C2)cc1OC,CHEMBL234616,nM,14800,CHEMBL284,4.829738285,DPPIV,COc1ccc(N2CCC(N)C(c3ccc(C)cc3)C2)cc1OC,COc1ccc(N2CCC(N)C(c3ccc(C)cc3)C2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963707,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(c2cccc3ccccc23)CCC1N,CHEMBL234615,nM,5300,CHEMBL284,5.27572413,DPPIV,CCCCC1CN(c2cccc3ccccc23)CCC1N,CCCCC1CN(c2cccc3ccccc23)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963708,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(c2cccc3c2CCCC3)CCC1N,CHEMBL397144,nM,13600,CHEMBL284,4.866461092,DPPIV,CCCCC1CN(c2cccc3c2CCCC3)CCC1N,CCCCC1CN(c2cccc3c2CCCC3)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963709,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@@H]1CN(c2ccc3ccccc3c2)CC[C@H]1N,CHEMBL234614,nM,9400,CHEMBL284,5.026872146,DPPIV,CCCC[C@@H]1CN(c2ccc3ccccc3c2)CC[C@H]1N,CCCCC1CN(c2ccc3ccccc3c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963710,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccc3ccccc3c2)CC[C@H]1N,CHEMBL394507,nM,1500,CHEMBL284,5.823908741,DPPIV,CCCC[C@H]1CN(c2ccc3ccccc3c2)CC[C@H]1N,CCCCC1CN(c2ccc3ccccc3c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963711,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccc(Cl)c(Cl)c2)CC[C@H]1N,CHEMBL234613,nM,3300,CHEMBL284,5.48148606,DPPIV,CCCC[C@H]1CN(c2ccc(Cl)c(Cl)c2)CC[C@H]1N,CCCCC1CN(c2ccc(Cl)c(Cl)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963712,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@@H]1CN(c2cc(OC)c(OC)c(OC)c2)CC[C@H]1N,CHEMBL234429,nM,18400,CHEMBL284,4.735182177,DPPIV,CCCC[C@@H]1CN(c2cc(OC)c(OC)c(OC)c2)CC[C@H]1N,CCCCC1CN(c2cc(OC)c(OC)c(OC)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963713,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2cc(OC)c(OC)c(OC)c2)CC[C@H]1N,CHEMBL396136,nM,2300,CHEMBL284,5.638272164,DPPIV,CCCC[C@H]1CN(c2cc(OC)c(OC)c(OC)c2)CC[C@H]1N,CCCCC1CN(c2cc(OC)c(OC)c(OC)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963714,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@@H]1CN(c2ccc(OC)c(OC)c2)CC[C@H]1N,CHEMBL234428,nM,26000,CHEMBL284,4.585026652,DPPIV,CCCC[C@@H]1CN(c2ccc(OC)c(OC)c2)CC[C@H]1N,CCCCC1CN(c2ccc(OC)c(OC)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963715,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccc(OC)c(OC)c2)CCC1N,CHEMBL234427,nM,4900,CHEMBL284,5.30980392,DPPIV,CCCC[C@H]1CN(c2ccc(OC)c(OC)c2)CCC1N,CCCCC1CN(c2ccc(OC)c(OC)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963716,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(c2ccc(Cl)c(C(F)(F)F)c2)CCC1N,CHEMBL234426,nM,2600,CHEMBL284,5.585026652,DPPIV,CCCCC1CN(c2ccc(Cl)c(C(F)(F)F)c2)CCC1N,CCCCC1CN(c2ccc(Cl)c(C(F)(F)F)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963717,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccc(Cl)c(C(F)(F)F)c2)CC[C@H]1N,CHEMBL443316,nM,2800,CHEMBL284,5.552841969,DPPIV,CCCC[C@H]1CN(c2ccc(Cl)c(C(F)(F)F)c2)CC[C@H]1N,CCCCC1CN(c2ccc(Cl)c(C(F)(F)F)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963719,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccc(OC)c(-c3ccccc3)c2)CC[C@H]1N,CHEMBL234235,nM,5800,CHEMBL284,5.236572006,DPPIV,CCCC[C@H]1CN(c2ccc(OC)c(-c3ccccc3)c2)CC[C@H]1N,CCCCC1CN(c2ccc(OC)c(-c3ccccc3)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963720,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(c2cc(OC)cc(C(F)(F)F)c2)CCC1N,CHEMBL234233,nM,8400,CHEMBL284,5.075720714,DPPIV,CCCCC1CN(c2cc(OC)cc(C(F)(F)F)c2)CCC1N,CCCCC1CN(c2cc(OC)cc(C(F)(F)F)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963721,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2cc(OC)cc(C(F)(F)F)c2)CC[C@H]1N,CHEMBL234045,nM,2100,CHEMBL284,5.677780705,DPPIV,CCCC[C@H]1CN(c2cc(OC)cc(C(F)(F)F)c2)CC[C@H]1N,CCCCC1CN(c2cc(OC)cc(C(F)(F)F)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963722,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCC1N,CHEMBL234043,nM,13400,CHEMBL284,4.872895202,DPPIV,CCCCC1CN(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCC1N,CCCCC1CN(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963723,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@@H]1CN(c2ccc(Oc3ccccc3)cc2)CC[C@H]1N,CHEMBL396857,nM,15000,CHEMBL284,4.823908741,DPPIV,CCCC[C@@H]1CN(c2ccc(Oc3ccccc3)cc2)CC[C@H]1N,CCCCC1CN(c2ccc(Oc3ccccc3)cc2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963724,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccc(Oc3ccccc3)cc2)CC[C@H]1N,CHEMBL234611,nM,6300,CHEMBL284,5.200659451,DPPIV,CCCC[C@H]1CN(c2ccc(Oc3ccccc3)cc2)CC[C@H]1N,CCCCC1CN(c2ccc(Oc3ccccc3)cc2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963725,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@@H]1CN(c2ccccc2)CC[C@H]1N,CHEMBL234610,nM,35700,CHEMBL284,4.447331784,DPPIV,CCCC[C@@H]1CN(c2ccccc2)CC[C@H]1N,CCCCC1CN(c2ccccc2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963726,CHEMBL893070,Inhibition of human DPP4,B,CCCC[C@H]1CN(c2ccccc2)CC[C@H]1N,CHEMBL394662,nM,3500,CHEMBL284,5.455931956,DPPIV,CCCC[C@H]1CN(c2ccccc2)CC[C@H]1N,CCCCC1CN(c2ccccc2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963727,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(C(c2ccccc2)c2ccccc2)CCC1N,CHEMBL234414,nM,18600,CHEMBL284,4.730487056,DPPIV,CCCCC1CN(C(c2ccccc2)c2ccccc2)CCC1N,CCCCC1CN(C(c2ccccc2)c2ccccc2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1963728,CHEMBL893070,Inhibition of human DPP4,B,CCCCC1CN(C2CCCCC2)CCC1N,CHEMBL234413,nM,45200,CHEMBL284,4.344861565,DPPIV,CCCCC1CN(C2CCCCC2)CCC1N,CCCCC1CN(C2CCCCC2)CCC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1968158,CHEMBL896429,Inhibition of DPP4,B,N[C@H]1C[C@@H](N2Cc3cncnc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL233564,nM,0.67,CHEMBL284,9.173925197,DPPIV,N[C@H]1C[C@@H](N2Cc3cncnc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cncnc3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1968159,CHEMBL896429,Inhibition of DPP4,B,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL233563,nM,5.3,CHEMBL284,8.27572413,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnc(C4CC4)nc3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1968160,CHEMBL896429,Inhibition of DPP4,B,N[C@H]1C[C@@H](N2Cc3ccccc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL392924,nM,6.6,CHEMBL284,8.180456064,DPPIV,N[C@H]1C[C@@H](N2Cc3ccccc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3ccccc3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1968161,CHEMBL896429,Inhibition of DPP4,B,N[C@H]1C[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL233360,nM,21,CHEMBL284,7.677780705,DPPIV,N[C@H]1C[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2CCn3c(nnc3C(F)(F)F)C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970024,CHEMBL895494,Inhibition of human DPP4,B,Cc1nc(C(=O)[C@@H]2CCCN2C(=O)CNC(C)(C)CO)no1,CHEMBL234911,nM,77,CHEMBL284,7.113509275,DPPIV,Cc1nc(C(=O)C2CCCN2C(=O)CNC(C)(C)CO)no1,Cc1nc(C(=O)C2CCCN2C(=O)CNC(C)(C)CO)no1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970028,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1C[C@@H](F)C[C@H]1C(=O)c1nnc(C(C)(C)C)o1,CHEMBL393947,nM,25,CHEMBL284,7.602059991,DPPIV,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1C[C@@H](F)CC1C(=O)c1nnc(C(C)(C)C)o1,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1CC(F)CC1C(=O)c1nnc(C(C)(C)C)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970029,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(CO)NCC(=O)N1C[C@@H](F)C[C@H]1C(=O)c1nnc(C(C)(C)C)o1,CHEMBL232185,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)(CO)NCC(=O)N1C[C@@H](F)CC1C(=O)c1nnc(C(C)(C)C)o1,CC(C)(CO)NCC(=O)N1CC(F)CC1C(=O)c1nnc(C(C)(C)C)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970030,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(CO)NCC(=O)N1CCC[C@H]1C(=O)c1nnc(C(C)(C)C)o1,CHEMBL232759,nM,47,CHEMBL284,7.327902142,DPPIV,CC(C)(CO)NCC(=O)N1CCCC1C(=O)c1nnc(C(C)(C)C)o1,CC(C)(CO)NCC(=O)N1CCCC1C(=O)c1nnc(C(C)(C)C)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970031,CHEMBL895494,Inhibition of human DPP4,B,Cc1nnc(C(=O)[C@@H]2CCCN2C(=O)CNC(C)(C)CO)o1,CHEMBL232572,nM,255,CHEMBL284,6.59345982,DPPIV,Cc1nnc(C(=O)C2CCCN2C(=O)CNC(C)(C)CO)o1,Cc1nnc(C(=O)C2CCCN2C(=O)CNC(C)(C)CO)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970032,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(C)NCC(=O)N1CCC[C@H]1C(=O)c1nnc(C2(C)CCCCC2)o1,CHEMBL232571,nM,10,CHEMBL284,8,DPPIV,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1nnc(C2(C)CCCCC2)o1,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1nnc(C2(C)CCCCC2)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970033,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C(=O)c1nnc(C2CCCCC2)o1,CHEMBL391645,nM,30,CHEMBL284,7.522878745,DPPIV,CC(C)(C)NCC(=O)N1C[C@@H](F)CC1C(=O)c1nnc(C2CCCCC2)o1,CC(C)(C)NCC(=O)N1CC(F)CC1C(=O)c1nnc(C2CCCCC2)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970034,CHEMBL895494,Inhibition of human DPP4,B,Cc1cc(C)c(-c2nnc(C(=O)[C@@H]3CCCN3C(=O)CNC(C)(C)C)o2)c(C)c1,CHEMBL232570,nM,17,CHEMBL284,7.769551079,DPPIV,Cc1cc(C)c(-c2nnc(C(=O)C3CCCN3C(=O)CNC(C)(C)C)o2)c(C)c1,Cc1cc(C)c(-c2nnc(C(=O)C3CCCN3C(=O)CNC(C)(C)C)o2)c(C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970035,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(C)NCC(=O)N1CCC[C@H]1C(=O)c1nnc(C(C)(C)C)o1,CHEMBL395166,nM,56,CHEMBL284,7.251811973,DPPIV,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1nnc(C(C)(C)C)o1,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1nnc(C(C)(C)C)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970036,CHEMBL895494,Inhibition of human DPP4,B,CCC(C)(C)c1nnc(C(=O)[C@@H]2C[C@H](F)CN2C(=O)CNC(C)(C)C)o1,CHEMBL399408,nM,20,CHEMBL284,7.698970004,DPPIV,CCC(C)(C)c1nnc(C(=O)C2C[C@H](F)CN2C(=O)CNC(C)(C)C)o1,CCC(C)(C)c1nnc(C(=O)C2CC(F)CN2C(=O)CNC(C)(C)C)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970037,CHEMBL895494,Inhibition of human DPP4,B,Cc1nnc(C(=O)[C@@H]2CCCN2C(=O)CNC23CC4CC(CC(O)(C4)C2)C3)o1,CHEMBL391269,nM,339,CHEMBL284,6.469800302,DPPIV,Cc1nnc(C(=O)C2CCCN2C(=O)CNC23CC4CC(CC(O)(C4)C2)C3)o1,Cc1nnc(C(=O)C2CCCN2C(=O)CNC23CC4CC(CC(O)(C4)C2)C3)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970038,CHEMBL895494,Inhibition of human DPP4,B,Cc1nnc(C(=O)[C@@H]2CC(F)(F)CN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,CHEMBL233337,nM,680,CHEMBL284,6.167491087,DPPIV,Cc1nnc(C(=O)C2CC(F)(F)CN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Cc1nnc(C(=O)C2CC(F)(F)CN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970039,CHEMBL895494,Inhibition of human DPP4,B,Cc1nnc(C(=O)[C@@H]2C[C@H](F)CN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,CHEMBL233136,nM,53,CHEMBL284,7.27572413,DPPIV,Cc1nnc(C(=O)C2C[C@H](F)CN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Cc1nnc(C(=O)C2CC(F)CN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970040,CHEMBL895494,Inhibition of human DPP4,B,Cc1nnc(C(=O)[C@@H]2CCCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,CHEMBL232725,nM,84,CHEMBL284,7.075720714,DPPIV,Cc1nnc(C(=O)C2CCCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Cc1nnc(C(=O)C2CCCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970041,CHEMBL895494,Inhibition of human DPP4,B,Cc1nnc(C(=O)[C@@H]2CSCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,CHEMBL232111,nM,224,CHEMBL284,6.649751982,DPPIV,Cc1nnc(C(=O)C2CSCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Cc1nnc(C(=O)C2CSCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970042,CHEMBL895494,Inhibition of human DPP4,B,Cc1nc(C(=O)[C@@H]2CCCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)no1,CHEMBL233996,nM,210,CHEMBL284,6.677780705,DPPIV,Cc1nc(C(=O)C2CCCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)no1,Cc1nc(C(=O)C2CCCN2C(=O)CNC23CC4CC(CC(C4)C2)C3)no1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970043,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(C)NCC(=O)N1CCC[C@H]1C(=O)c1noc(C2(C)CCCCC2)n1,CHEMBL232586,nM,95,CHEMBL284,7.022276395,DPPIV,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1noc(C2(C)CCCCC2)n1,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1noc(C2(C)CCCCC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970044,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(C)NCC(=O)N1CCC[C@H]1C(=O)c1noc(-c2ccc(F)cc2)n1,CHEMBL399615,nM,15,CHEMBL284,7.823908741,DPPIV,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1noc(-c2ccc(F)cc2)n1,CC(C)(C)NCC(=O)N1CCCC1C(=O)c1noc(-c2ccc(F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970045,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C(=O)c1noc(C(C)(C)C)n1,CHEMBL392552,nM,63,CHEMBL284,7.200659451,DPPIV,CC(C)(C)NCC(=O)N1C[C@@H](F)CC1C(=O)c1noc(C(C)(C)C)n1,CC(C)(C)NCC(=O)N1CC(F)CC1C(=O)c1noc(C(C)(C)C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970046,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1CCC[C@H]1C(=O)c1ncon1,CHEMBL232153,nM,35,CHEMBL284,7.455931956,DPPIV,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1CCCC1C(=O)c1ncon1,CC(C)(Cc1ccc(F)cc1)NCC(=O)N1CCCC1C(=O)c1ncon1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970047,CHEMBL895494,Inhibition of human DPP4,B,Cc1nc(C(=O)[C@@H]2CCCN2C(=O)CNC(C)(C)C(=O)O)no1,CHEMBL231698,nM,7939,CHEMBL284,5.100234198,DPPIV,Cc1nc(C(=O)C2CCCN2C(=O)CNC(C)(C)C(=O)O)no1,Cc1nc(C(=O)C2CCCN2C(=O)CNC(C)(C)C(=O)O)no1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970048,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(CO)NCC(=O)N1CCC[C@H]1C(=O)c1noc(C(C)(C)C)n1,CHEMBL231697,nM,223,CHEMBL284,6.651695137,DPPIV,CC(C)(CO)NCC(=O)N1CCCC1C(=O)c1noc(C(C)(C)C)n1,CC(C)(CO)NCC(=O)N1CCCC1C(=O)c1noc(C(C)(C)C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1970049,CHEMBL895494,Inhibition of human DPP4,B,CC(C)(CO)NCC(=O)N1C[C@@H](F)C[C@H]1C(=O)c1noc(C(C)(C)C)n1,CHEMBL391929,nM,67,CHEMBL284,7.173925197,DPPIV,CC(C)(CO)NCC(=O)N1C[C@@H](F)CC1C(=O)c1noc(C(C)(C)C)n1,CC(C)(CO)NCC(=O)N1CC(F)CC1C(=O)c1noc(C(C)(C)C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985685,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccccc1[C@@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@@H]1N,CHEMBL438309,nM,200,CHEMBL284,6.698970004,DPPIV,COc1ccccc1[C@@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@@H]1N,COc1ccccc1C1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985686,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccc(F)cc1,CHEMBL236507,nM,140,CHEMBL284,6.853871964,DPPIV,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccc(F)cc1,NC1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985687,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccccc1,CHEMBL237568,nM,150,CHEMBL284,6.823908741,DPPIV,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccccc1,NC1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985688,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccccc1[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@@H]1N,CHEMBL237567,nM,2000,CHEMBL284,5.698970004,DPPIV,COc1ccccc1[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@@H]1N,COc1ccccc1C1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985689,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccc(Cl)c(Cl)c1,CHEMBL399409,nM,1000,CHEMBL284,6,DPPIV,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccc(Cl)c(Cl)c1,NC1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1c1ccc(Cl)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985690,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccccc3)ncn2)C[C@@H]1c1ccccc1,CHEMBL237758,nM,790,CHEMBL284,6.102372909,DPPIV,N[C@H]1CN(c2cc(-c3ccccc3)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(-c3ccccc3)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985691,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(Cl)c3)ncn2)C[C@@H]1c1ccccc1,CHEMBL392697,nM,2900,CHEMBL284,5.537602002,DPPIV,N[C@H]1CN(c2cc(-c3cccc(Cl)c3)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(-c3cccc(Cl)c3)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985692,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccc(-c2cc(N3C[C@H](c4ccccc4)[C@@H](N)C3)ncn2)cc1,CHEMBL235201,nM,2300,CHEMBL284,5.638272164,DPPIV,COc1ccc(-c2cc(N3C[C@H](c4ccccc4)[C@@H](N)C3)ncn2)cc1,COc1ccc(-c2cc(N3CC(N)C(c4ccccc4)C3)ncn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985693,CHEMBL899730,Inhibition of human recombinant DPP4,B,N#Cc1cccc(-c2cc(N3C[C@H](c4ccccc4)[C@@H](N)C3)ncn2)c1,CHEMBL392696,nM,1400,CHEMBL284,5.853871964,DPPIV,N#Cc1cccc(-c2cc(N3C[C@H](c4ccccc4)[C@@H](N)C3)ncn2)c1,N#Cc1cccc(-c2cc(N3CC(N)C(c4ccccc4)C3)ncn2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985694,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccccc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL236705,nM,21,CHEMBL284,7.677780705,DPPIV,N[C@H]1CN(c2cc(-c3ccccc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3ccccc3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985695,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cn1,CHEMBL237786,nM,37,CHEMBL284,7.431798276,DPPIV,COc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cn1,COc1ccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985696,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccnc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL237785,nM,31,CHEMBL284,7.508638306,DPPIV,N[C@H]1CN(c2cc(-c3cccnc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccnc3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985697,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(O)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL237569,nM,70,CHEMBL284,7.15490196,DPPIV,N[C@H]1CN(c2cc(-c3cccc(O)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(O)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985698,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc([N+](=O)[O-])c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL399207,nM,120,CHEMBL284,6.920818754,DPPIV,N[C@H]1CN(c2cc(-c3cccc([N+](=O)[O-])c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc([N+](=O)[O-])c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985699,CHEMBL899730,Inhibition of human recombinant DPP4,B,CC(=O)Nc1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,CHEMBL236719,nM,14,CHEMBL284,7.853871964,DPPIV,CC(=O)Nc1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,CC(=O)Nc1cccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985700,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(C(=O)O)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL236508,nM,5,CHEMBL284,8.301029996,DPPIV,N[C@H]1CN(c2cc(-c3cccc(C(=O)O)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(C(=O)O)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985701,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(CO)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL391252,nM,32,CHEMBL284,7.494850022,DPPIV,N[C@H]1CN(c2cc(-c3cccc(CO)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(CO)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985702,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(OC(F)(F)F)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL236085,nM,1300,CHEMBL284,5.886056648,DPPIV,N[C@H]1CN(c2cc(-c3cccc(OC(F)(F)F)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(OC(F)(F)F)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985703,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(C(F)(F)F)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL236084,nM,71,CHEMBL284,7.148741651,DPPIV,N[C@H]1CN(c2cc(-c3cccc(C(F)(F)F)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(C(F)(F)F)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985704,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cc1,CHEMBL391251,nM,120,CHEMBL284,6.920818754,DPPIV,COc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cc1,COc1ccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985705,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccc(F)cc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL236923,nM,51,CHEMBL284,7.292429824,DPPIV,N[C@H]1CN(c2cc(-c3ccc(F)cc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3ccc(F)cc3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985706,CHEMBL899730,Inhibition of human recombinant DPP4,B,CC(=O)c1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cc1,CHEMBL391837,nM,160,CHEMBL284,6.795880017,DPPIV,CC(=O)c1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cc1,CC(=O)c1ccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985707,CHEMBL899730,Inhibition of human recombinant DPP4,B,N#Cc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cc1,CHEMBL236922,nM,130,CHEMBL284,6.886056648,DPPIV,N#Cc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cc1,N#Cc1ccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985708,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccc(Cl)cc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL412585,nM,470,CHEMBL284,6.327902142,DPPIV,N[C@H]1CN(c2cc(-c3ccc(Cl)cc3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3ccc(Cl)cc3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985709,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,CHEMBL236714,nM,47,CHEMBL284,7.327902142,DPPIV,COc1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,COc1cccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985710,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(F)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL237343,nM,51,CHEMBL284,7.292429824,DPPIV,N[C@H]1CN(c2cc(-c3cccc(F)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(F)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985711,CHEMBL899730,Inhibition of human recombinant DPP4,B,CC(=O)c1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,CHEMBL393612,nM,19,CHEMBL284,7.721246399,DPPIV,CC(=O)c1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,CC(=O)c1cccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985712,CHEMBL899730,Inhibition of human recombinant DPP4,B,N#Cc1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,CHEMBL237342,nM,37,CHEMBL284,7.431798276,DPPIV,N#Cc1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1,N#Cc1cccc(-c2cc(N3CC(N)C(c4cc(F)c(F)cc4F)C3)ncn2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985713,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3cccc(Cl)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL237341,nM,190,CHEMBL284,6.721246399,DPPIV,N[C@H]1CN(c2cc(-c3cccc(Cl)c3)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3cccc(Cl)c3)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985714,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccccc1-c1cc(N2C[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)ncn1,CHEMBL393611,nM,180,CHEMBL284,6.744727495,DPPIV,COc1ccccc1-c1cc(N2C[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)ncn1,COc1ccccc1-c1cc(N2CC(N)C(c3cc(F)c(F)cc3F)C2)ncn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985715,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccccc3F)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL391048,nM,57,CHEMBL284,7.244125144,DPPIV,N[C@H]1CN(c2cc(-c3ccccc3F)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3ccccc3F)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985716,CHEMBL899730,Inhibition of human recombinant DPP4,B,CC(=O)c1ccccc1-c1cc(N2C[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)ncn1,CHEMBL236707,nM,230,CHEMBL284,6.638272164,DPPIV,CC(=O)c1ccccc1-c1cc(N2C[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)ncn1,CC(=O)c1ccccc1-c1cc(N2CC(N)C(c3cc(F)c(F)cc3F)C2)ncn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985717,CHEMBL899730,Inhibition of human recombinant DPP4,B,N#Cc1ccccc1-c1cc(N2C[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)ncn1,CHEMBL391047,nM,93,CHEMBL284,7.031517051,DPPIV,N#Cc1ccccc1-c1cc(N2C[C@H](c3cc(F)c(F)cc3F)[C@@H](N)C2)ncn1,N#Cc1ccccc1-c1cc(N2CC(N)C(c3cc(F)c(F)cc3F)C2)ncn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1985718,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccccc3Cl)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL236706,nM,260,CHEMBL284,6.585026652,DPPIV,N[C@H]1CN(c2cc(-c3ccccc3Cl)ncn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2cc(-c3ccccc3Cl)ncn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987758,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL237119,nM,12,CHEMBL284,7.920818754,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987759,CHEMBL898850,Inhibition of human DPP4,B,CC(=O)N[C@H]1CC[C@H]([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1,CHEMBL237547,nM,16,CHEMBL284,7.795880017,DPPIV,CC(=O)N[C@H]1CC[C@H](C(C)C(N)C(=O)N2CC[C@H](F)C2)CC1,CC(=O)NC1CCC(C(C)C(N)C(=O)N2CCC(F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987760,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL237337,nM,4,CHEMBL284,8.397940009,DPPIV,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(-c2ccc3ncnn3c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987761,CHEMBL898850,Inhibition of human DPP4,B,C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL237336,nM,64,CHEMBL284,7.193820026,DPPIV,CC(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987766,CHEMBL898850,Inhibition of human DPP4,B,C[C@@H](C1CCC(c2cccc3ncnn23)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL237152,nM,1.5,CHEMBL284,8.823908741,DPPIV,CC(C1CCC(c2cccc3ncnn23)CC1)C(N)C(=O)N1CCC(F)(F)C1,CC(C1CCC(c2cccc3ncnn23)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987767,CHEMBL898850,Inhibition of human DPP4,B,C[C@@H](C1CCC(c2cccnc2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL237151,nM,4.6,CHEMBL284,8.337242168,DPPIV,CC(C1CCC(c2cccnc2)CC1)C(N)C(=O)N1CCC(F)(F)C1,CC(C1CCC(c2cccnc2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987768,CHEMBL898850,Inhibition of human DPP4,B,C[C@@H](C1CCC(c2ccc(F)cc2)CC1)[C@H](N)C(=O)N1CC[C@](C)(F)C1,CHEMBL392524,nM,12,CHEMBL284,7.920818754,DPPIV,CC(C1CCC(c2ccc(F)cc2)CC1)C(N)C(=O)N1CC[C@](C)(F)C1,CC(C1CCC(c2ccc(F)cc2)CC1)C(N)C(=O)N1CCC(C)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987798,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2cccc3ncnn32)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL237997,nM,2.5,CHEMBL284,8.602059991,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](c2cccc3ncnn32)CC1,CN(C)C(=O)C(C1CCC(c2cccc3ncnn23)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987799,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@@H](c2cccc3ncnn32)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL237783,nM,260,CHEMBL284,6.585026652,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@@H](c2cccc3ncnn32)CC1,CN(C)C(=O)C(C1CCC(c2cccc3ncnn23)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987800,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2cccc3ncnn32)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL400841,nM,2.3,CHEMBL284,8.638272164,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](c2cccc3ncnn32)CC1,CN(C)C(=O)C(C1CCC(c2cccc3ncnn23)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987801,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@@H](c2cccc3ncnn32)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL237566,nM,310,CHEMBL284,6.508638306,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@@H](c2cccc3ncnn32)CC1,CN(C)C(=O)C(C1CCC(c2cccc3ncnn23)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987818,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@H](C2CCc3ncnn3C2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL235199,nM,38,CHEMBL284,7.420216403,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](C2CCc3ncnn3C2)CC1,CN(C)C(=O)C(C1CCC(C2CCc3ncnn3C2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987819,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@@H](C2CCc3ncnn3C2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL235198,nM,220,CHEMBL284,6.657577319,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@@H](C2CCc3ncnn3C2)CC1,CN(C)C(=O)C(C1CCC(C2CCc3ncnn3C2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987820,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2ccc3ncnn3c2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL437557,nM,4.8,CHEMBL284,8.318758763,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](c2ccc3ncnn3c2)CC1,CN(C)C(=O)C(C1CCC(c2ccc3ncnn3c2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987821,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@@H](c2ccc3ncnn3c2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL238191,nM,32,CHEMBL284,7.494850022,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@@H](c2ccc3ncnn3c2)CC1,CN(C)C(=O)C(C1CCC(c2ccc3ncnn3c2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987822,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2ccc(F)cc2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL238190,nM,11,CHEMBL284,7.958607315,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](c2ccc(F)cc2)CC1,CN(C)C(=O)C(C1CCC(c2ccc(F)cc2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987823,CHEMBL898850,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]([C@H]1CC[C@@H](c2ccc(F)cc2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1,CHEMBL237972,nM,150,CHEMBL284,6.823908741,DPPIV,CN(C)C(=O)C(C(N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@@H](c2ccc(F)cc2)CC1,CN(C)C(=O)C(C1CCC(c2ccc(F)cc2)CC1)C(N)C(=O)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987824,CHEMBL898850,Inhibition of human DPP4,B,COc1cc([C@H]2CC[C@H]([C@H](C(=O)N(C)C)[C@H](N)C(=O)N3CCC(F)(F)C3)CC2)nc(OC)n1,CHEMBL235223,nM,260,CHEMBL284,6.585026652,DPPIV,COc1cc(C2CCC(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)(F)C3)CC2)nc(OC)n1,COc1cc(C2CCC(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)(F)C3)CC2)nc(OC)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
1987825,CHEMBL898850,Inhibition of human DPP4,B,COc1cc([C@H]2CC[C@@H]([C@H](C(=O)N(C)C)[C@H](N)C(=O)N3CCC(F)(F)C3)CC2)nc(OC)n1,CHEMBL235004,nM,100,CHEMBL284,7,DPPIV,COc1cc(C2CCC(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)(F)C3)CC2)nc(OC)n1,COc1cc(C2CCC(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)(F)C3)CC2)nc(OC)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001133,CHEMBL901594,Inhibition of human DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2ccccc2C1,CHEMBL397070,nM,90000,CHEMBL284,4.045757491,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccccc2C1,CCC(C)C(N)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001164,CHEMBL901594,Inhibition of human DPP4,B,NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1Cc2ccccc2[C@H]1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL392162,nM,50000,CHEMBL284,4.301029996,DPPIV,NCCCCC(NC(=O)OCc1ccccc1)C(=O)N1Cc2ccccc2[C@H]1P(=O)(Oc1ccccc1)Oc1ccccc1,NCCCCC(NC(=O)OCc1ccccc1)C(=O)N1Cc2ccccc2C1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001166,CHEMBL901594,Inhibition of human DPP4,B,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)[C@H](CCCCN)NC(=O)OCc2ccccc2)cc1,CHEMBL238114,nM,4200,CHEMBL284,5.37675071,DPPIV,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C(CCCCN)NC(=O)OCc2ccccc2)cc1,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C(CCCCN)NC(=O)OCc2ccccc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001167,CHEMBL901594,Inhibition of human DPP4,B,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)[C@@H](N)CCCCN)cc1,CHEMBL236781,nM,8000,CHEMBL284,5.096910013,DPPIV,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C(N)CCCCN)cc1,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C(N)CCCCN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001171,CHEMBL901594,Inhibition of human DPP4,B,NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL439205,nM,4800,CHEMBL284,5.318758763,DPPIV,NCCCCC(NC(=O)OCc1ccccc1)C(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,NCCCCC(NC(=O)OCc1ccccc1)C(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001176,CHEMBL901594,Inhibition of human DPP4,B,CC(C)[C@H](N)C(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL236586,nM,89000,CHEMBL284,4.050609993,DPPIV,CC(C)C(N)C(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CC(C)C(N)C(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001177,CHEMBL901594,Inhibition of human DPP4,B,NCC(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,CHEMBL399189,nM,16000,CHEMBL284,4.795880017,DPPIV,NCC(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,NCC(=O)N1CCCC1P(=O)(Oc1ccccc1)Oc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001178,CHEMBL901594,Inhibition of human DPP4,B,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CHEMBL235766,nM,14,CHEMBL284,7.853871964,DPPIV,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2001179,CHEMBL901594,Inhibition of human DPP4,B,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CHEMBL439382,nM,5600,CHEMBL284,5.251811973,DPPIV,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008909,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL237500,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008910,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,Cn1c(=O)[nH]c(=O)c2c1nc(N1CCNCC1)n2Cc1ccccc1,CHEMBL235133,nM,3900,CHEMBL284,5.408935393,DPPIV,Cn1c(=O)[nH]c(=O)c2c1nc(N1CCNCC1)n2Cc1ccccc1,Cn1c(=O)[nH]c(=O)c2c1nc(N1CCNCC1)n2Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008911,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,CHEMBL237499,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008912,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,CHEMBL237289,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008913,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(OC)cc1)c(=O)n2C,CHEMBL391307,nM,8,CHEMBL284,8.096910013,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(OC)cc1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(OC)cc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008914,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL237288,nM,9,CHEMBL284,8.045757491,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008915,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL237287,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008916,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CHEMBL391089,nM,2,CHEMBL284,8.698970004,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008917,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CHEMBL429450,nM,4,CHEMBL284,8.397940009,DPPIV,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008918,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL237067,nM,3,CHEMBL284,8.522878745,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008919,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL237488,nM,6,CHEMBL284,8.22184875,DPPIV,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008921,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCc1ccccc1)c(=O)n2C,CHEMBL237281,nM,56,CHEMBL284,7.251811973,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCc1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCc1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008922,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1)c(=O)n2C,CHEMBL391634,nM,284,CHEMBL284,6.54668166,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008923,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL237280,nM,88,CHEMBL284,7.055517328,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008924,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL237279,nM,35,CHEMBL284,7.455931956,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008925,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2)n(C)c1=O,CHEMBL399216,nM,82,CHEMBL284,7.086186148,DPPIV,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2)n(C)c1=O,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008926,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL235792,nM,200,CHEMBL284,6.698970004,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(C)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008927,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,CC(C)=CCn1c(N2CCNCC2)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL235352,nM,580,CHEMBL284,6.236572006,DPPIV,CC(C)=CCn1c(N2CCNCC2)nc2c1c(=O)n(C)c(=O)n2C,CC(C)=CCn1c(N2CCNCC2)nc2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2008928,CHEMBL902716,Inhibition of human DPP4 in Caco-2 cells by fluorescene assay,B,Cn1c(=O)c2c(nc(N3CCNCC3)n2Cc2ccccc2)n(C)c1=O,CHEMBL235134,nM,2800,CHEMBL284,5.552841969,DPPIV,Cn1c(=O)c2c(nc(N3CCNCC3)n2Cc2ccccc2)n(C)c1=O,Cn1c(=O)c2c(nc(N3CCNCC3)n2Cc2ccccc2)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2012711,CHEMBL902269,Inhibition of human DPP4,B,NCC[C@H](N)C(=O)N1CC[C@H]2CCC[C@H]21,CHEMBL397057,nM,33000,CHEMBL284,4.48148606,DPPIV,NCCC(N)C(=O)N1CC[C@H]2CCC[C@H]21,NCCC(N)C(=O)N1CCC2CCCC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2012717,CHEMBL902269,Inhibition of human DPP4,B,CCCC[C@H](NC(=O)[C@@H](N)CCN)B(O)O,CHEMBL398076,nM,33000,CHEMBL284,4.48148606,DPPIV,CCCC[C@H](NC(=O)C(N)CCN)B(O)O,CCCCC(NC(=O)C(N)CCN)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023282,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1cccnc1N1CCN([C@@H]2CN[C@H](C(=O)N3CCSC3)C2)CC1,CHEMBL241464,nM,1.2,CHEMBL284,8.920818754,DPPIV,N#Cc1cccnc1N1CCN([C@@H]2CNC(C(=O)N3CCSC3)C2)CC1,N#Cc1cccnc1N1CCN(C2CNC(C(=O)N3CCSC3)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023283,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)nc1,CHEMBL241253,nM,1,CHEMBL284,9,DPPIV,N#Cc1ccc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)nc1,N#Cc1ccc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023284,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(C(F)(F)F)cn3)CC2)CN1)N1CCSC1,CHEMBL241252,nM,1.5,CHEMBL284,8.823908741,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(C(F)(F)F)cn3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(C(F)(F)F)cn3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023285,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc([N+](=O)[O-])cn3)CC2)CN1)N1CCSC1,CHEMBL399610,nM,0.92,CHEMBL284,9.036212173,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc([N+](=O)[O-])cn3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc([N+](=O)[O-])cn3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023286,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccnc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)c1,CHEMBL399405,nM,1.6,CHEMBL284,8.795880017,DPPIV,N#Cc1ccnc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)c1,N#Cc1ccnc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023287,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(Cl)cn3)CC2)CN1)N1CCSC1,CHEMBL239565,nM,2.5,CHEMBL284,8.602059991,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(Cl)cn3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(Cl)cn3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023288,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccncc3)CC2)CN1)N1CCSC1,CHEMBL239564,nM,3.1,CHEMBL284,8.508638306,DPPIV,O=C(C1C[C@H](N2CCN(c3ccncc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccncc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023289,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccccn3)CC2)CN1)N1CCSC1,CHEMBL395854,nM,2.7,CHEMBL284,8.568636236,DPPIV,O=C(C1C[C@H](N2CCN(c3ccccn3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccccn3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023290,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCCN(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,CHEMBL239356,nM,2.4,CHEMBL284,8.619788758,DPPIV,O=C(C1C[C@H](N2CCCN(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCCN(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023291,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCC(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,CHEMBL238516,nM,2.3,CHEMBL284,8.638272164,DPPIV,O=C(C1C[C@H](N2CCC(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCC(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023292,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCC(c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL395606,nM,5.6,CHEMBL284,8.251811973,DPPIV,O=C(C1C[C@H](N2CCC(c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCC(c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023293,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)cc1C#N,CHEMBL238515,nM,1.3,CHEMBL284,8.886056648,DPPIV,N#Cc1ccc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)cc1C#N,N#Cc1ccc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)cc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023294,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(Cl)c(Cl)c3)CC2)CN1)N1CCSC1,CHEMBL241246,nM,3,CHEMBL284,8.522878745,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(Cl)c(Cl)c3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(Cl)c(Cl)c3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023295,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(C(F)(F)F)cc3)CC2)CN1)N1CCSC1,CHEMBL241245,nM,6.8,CHEMBL284,8.167491087,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(C(F)(F)F)cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(C(F)(F)F)cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023296,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)cc1,CHEMBL391578,nM,4.3,CHEMBL284,8.366531544,DPPIV,N#Cc1ccc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)cc1,N#Cc1ccc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023297,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,CHEMBL391466,nM,1.6,CHEMBL284,8.795880017,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023298,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(Br)cc3)CC2)CN1)N1CCSC1,CHEMBL239984,nM,8.2,CHEMBL284,8.086186148,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(Br)cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(Br)cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023299,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccccc3Cl)CC2)CN1)N1CCSC1,CHEMBL239983,nM,10.8,CHEMBL284,7.966576245,DPPIV,O=C(C1C[C@H](N2CCN(c3ccccc3Cl)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccccc3Cl)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023300,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3cccc(Cl)c3)CC2)CN1)N1CCSC1,CHEMBL391577,nM,4.1,CHEMBL284,8.387216143,DPPIV,O=C(C1C[C@H](N2CCN(c3cccc(Cl)c3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3cccc(Cl)c3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023301,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(Cl)cc3)CC2)CN1)N1CCSC1,CHEMBL238507,nM,8.7,CHEMBL284,8.060480747,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(Cl)cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(Cl)cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023302,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(F)cc3)CC2)CN1)N1CCSC1,CHEMBL397893,nM,12.2,CHEMBL284,7.913640169,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(F)cc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc(F)cc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023303,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,COc1ccc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)cc1,CHEMBL238506,nM,13.5,CHEMBL284,7.869666232,DPPIV,COc1ccc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)cc1,COc1ccc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023304,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(C(c3ccccc3)c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL240602,nM,21,CHEMBL284,7.677780705,DPPIV,O=C(C1C[C@H](N2CCN(C(c3ccccc3)c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(C(c3ccccc3)c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023305,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(Cc3ccccc3)CC2)CN1)N1CCSC1,CHEMBL391433,nM,30.5,CHEMBL284,7.515700161,DPPIV,O=C(C1C[C@H](N2CCN(Cc3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(Cc3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023306,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL240601,nM,10.9,CHEMBL284,7.962573502,DPPIV,O=C(C1C[C@H](N2CCN(c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023307,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,CN1CCN([C@@H]2CN[C@H](C(=O)N3CCSC3)C2)CC1,CHEMBL391332,nM,57.5,CHEMBL284,7.240332155,DPPIV,CN1CCN([C@@H]2CNC(C(=O)N3CCSC3)C2)CC1,CN1CCN(C2CNC(C(=O)N3CCSC3)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023308,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCOCC2)CN1)N1CCSC1,CHEMBL241674,nM,13.9,CHEMBL284,7.8569852,DPPIV,O=C(C1C[C@H](N2CCOCC2)CN1)N1CCSC1,O=C(C1CC(N2CCOCC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023309,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCCCC2)CN1)N1CCSC1,CHEMBL391331,nM,47.6,CHEMBL284,7.322393047,DPPIV,O=C(C1C[C@H](N2CCCCC2)CN1)N1CCSC1,O=C(C1CC(N2CCCCC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2023310,CHEMBL886678,Inhibition of DPP4 in human plasma by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCCC2)CN1)N1CCSC1,CHEMBL241673,nM,127,CHEMBL284,6.896196279,DPPIV,O=C(C1C[C@H](N2CCCC2)CN1)N1CCSC1,O=C(C1CC(N2CCCC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024359,CHEMBL886790,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN1)Cc1cc(F)c(F)cc1F,CHEMBL534959,nM,3850,CHEMBL284,5.41453927,DPPIV,N[C@@H](CC(=O)N1CCCN1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024360,CHEMBL886790,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL539611,nM,70,CHEMBL284,7.15490196,DPPIV,N[C@@H](CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024361,CHEMBL886790,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL535180,nM,50,CHEMBL284,7.301029996,DPPIV,N[C@@H](CC(=O)N1CCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024362,CHEMBL886790,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL539610,nM,350,CHEMBL284,6.455931956,DPPIV,N[C@@H](CC(=O)N1CCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024363,CHEMBL886790,Inhibition of DPP4,B,Cc1ccc(S(=O)(=O)N2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL534960,nM,500,CHEMBL284,6.301029996,DPPIV,Cc1ccc(S(=O)(=O)N2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,Cc1ccc(S(=O)(=O)N2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024364,CHEMBL886790,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN1C(=O)Nc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL557776,nM,990,CHEMBL284,6.004364805,DPPIV,N[C@@H](CC(=O)N1CCCN1C(=O)Nc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN1C(=O)Nc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2024365,CHEMBL886790,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O=P(O)(O)O,CHEMBL393336,nM,50,CHEMBL284,7.301029996,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026068,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,C[C@@H](C1CCC(N(C)C(=O)C2CC2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL392825,nM,21,CHEMBL284,7.677780705,DPPIV,CC(C1CCC(N(C)C(=O)C2CC2)CC1)C(N)C(=O)N1CC[C@H](F)C1,CC(C1CCC(N(C)C(=O)C2CC2)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026069,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CC(=O)N(C)C1CCC([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1.Cl,CHEMBL245545,nM,16,CHEMBL284,7.795880017,DPPIV,CC(=O)N(C)C1CCC(C(C)C(N)C(=O)N2CC[C@H](F)C2)CC1,CC(=O)N(C)C1CCC(C(C)C(N)C(=O)N2CCC(F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026070,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CC(=O)N(C)C1CCC([C@H](C(=O)N(C)C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1.Cl,CHEMBL428747,nM,29,CHEMBL284,7.537602002,DPPIV,CC(=O)N(C)C1CCC(C(C(=O)N(C)C)C(N)C(=O)N2CC[C@H](F)C2)CC1,CC(=O)N(C)C1CCC(C(C(=O)N(C)C)C(N)C(=O)N2CCC(F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026071,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,COc1ccc(C(=O)N(C)C2CCC([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)CC2)cc1.Cl,CHEMBL395696,nM,27,CHEMBL284,7.568636236,DPPIV,COc1ccc(C(=O)N(C)C2CCC(C(C)C(N)C(=O)N3CC[C@H](F)C3)CC2)cc1,COc1ccc(C(=O)N(C)C2CCC(C(C)C(N)C(=O)N3CCC(F)C3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026072,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,COc1ccc(C(=O)NC2CCC([C@H](C)[C@H](N)C(=O)N3CC[C@H](F)C3)CC2)cc1.Cl,CHEMBL245380,nM,74,CHEMBL284,7.13076828,DPPIV,COc1ccc(C(=O)NC2CCC(C(C)C(N)C(=O)N3CC[C@H](F)C3)CC2)cc1,COc1ccc(C(=O)NC2CCC(C(C)C(N)C(=O)N3CCC(F)C3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026073,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,C[C@@H](C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL245379,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)C(N)C(=O)N1CC[C@H](F)C1,CC(C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026074,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CN(C)C(=O)[C@@H](C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL246374,nM,24,CHEMBL284,7.619788758,DPPIV,CN(C)C(=O)C(C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(C1CCC(N(C)C(=O)c2cccc(F)c2)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026075,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,C[C@@H](C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL246373,nM,440,CHEMBL284,6.356547324,DPPIV,CC(C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1)C(N)C(=O)N1CC[C@H](F)C1,CC(C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026076,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CN(C)C(=O)[C@@H](C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL397854,nM,360,CHEMBL284,6.443697499,DPPIV,CN(C)C(=O)C(C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(C1CCC(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026077,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,C[C@@H](C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL246372,nM,460,CHEMBL284,6.337242168,DPPIV,CC(C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1)C(N)C(=O)N1CC[C@H](F)C1,CC(C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026078,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CN(C)C(=O)[C@@H](C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1.Cl,CHEMBL246170,nM,330,CHEMBL284,6.48148606,DPPIV,CN(C)C(=O)C(C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026079,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,Cl.N[C@H](C(=O)N1CC[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,CHEMBL395213,nM,48,CHEMBL284,7.318758763,DPPIV,NC(C(=O)N1CC[C@H](F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,NC(C(=O)N1CCC(F)C1)C1CCC(NS(=O)(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026080,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CC(=O)N(C)c1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL246169,nM,210,CHEMBL284,6.677780705,DPPIV,CC(=O)N(C)c1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,CC(=O)N(C)c1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026081,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CC(=O)N(C)c1ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL246168,nM,150,CHEMBL284,6.823908741,DPPIV,CC(=O)N(C)c1ccc(C(C(=O)N(C)C)C(N)C(=O)N2CC[C@H](F)C2)cc1,CC(=O)N(C)c1ccc(C(C(=O)N(C)C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026082,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CC(=O)Nc1ccc([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL245971,nM,600,CHEMBL284,6.22184875,DPPIV,CC(=O)Nc1ccc(C(C)C(N)C(=O)N2CC[C@H](F)C2)cc1,CC(=O)Nc1ccc(C(C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026083,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CC(=O)Nc1ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N2CC[C@H](F)C2)cc1.O=C(O)C(F)(F)F,CHEMBL245970,nM,160,CHEMBL284,6.795880017,DPPIV,CC(=O)Nc1ccc(C(C(=O)N(C)C)C(N)C(=O)N2CC[C@H](F)C2)cc1,CC(=O)Nc1ccc(C(C(=O)N(C)C)C(N)C(=O)N2CCC(F)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026084,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,C[C@@H](c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL437379,nM,300,CHEMBL284,6.522878745,DPPIV,CC(c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026085,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CN(C)C(=O)[C@@H](c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL245969,nM,28,CHEMBL284,7.552841969,DPPIV,CN(C)C(=O)C(c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(N(C)C(=O)c2ccc(F)cc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026086,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,Cc1ccc(C(=O)N(C)c2ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL396168,nM,25,CHEMBL284,7.602059991,DPPIV,Cc1ccc(C(=O)N(C)c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cc1,Cc1ccc(C(=O)N(C)c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)C3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026087,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,Cc1ccc(S(=O)(=O)N(C)c2ccc([C@H](C(=O)N(C)C)[C@H](N)C(=O)N3CC[C@H](F)C3)cc2)cc1.O=C(O)C(F)(F)F,CHEMBL429653,nM,430,CHEMBL284,6.366531544,DPPIV,Cc1ccc(S(=O)(=O)N(C)c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CC[C@H](F)C3)cc2)cc1,Cc1ccc(S(=O)(=O)N(C)c2ccc(C(C(=O)N(C)C)C(N)C(=O)N3CCC(F)C3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2026088,CHEMBL887122,Inhibition of human recombinant DPP4 expressed in SF9 cells,B,CN(C)C(=O)[C@@H](c1ccc(NS(=O)(=O)c2ccccc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F,CHEMBL245772,nM,870,CHEMBL284,6.060480747,DPPIV,CN(C)C(=O)C(c1ccc(NS(=O)(=O)c2ccccc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(NS(=O)(=O)c2ccccc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045002,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1)Cc1cc(F)c(F)cc1F,CHEMBL399499,nM,59,CHEMBL284,7.229147988,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045006,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@H]1Cn1cncn1)Cc1cc(F)c(F)cc1F,CHEMBL400068,nM,2,CHEMBL284,8.698970004,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cncn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cncn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045007,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cncn1)Cc1cc(F)c(F)cc1F,CHEMBL250353,nM,5,CHEMBL284,8.301029996,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cncn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cncn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045008,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cccn1)Cc1cc(F)c(F)cc1F,CHEMBL250351,nM,4,CHEMBL284,8.397940009,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cccn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1cccn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045009,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1ccnc1)Cc1cc(F)c(F)cc1F,CHEMBL250147,nM,2,CHEMBL284,8.698970004,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1ccnc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cn1ccnc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045010,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@@H]1C(F)C1CC1)Cc1cc(F)c(F)cc1F,CHEMBL249945,nM,11,CHEMBL284,7.958607315,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1C(F)C1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1C(F)C1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045012,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@@H]1C(O)C1CC1)Cc1cc(F)c(F)cc1F,CHEMBL404210,nM,14,CHEMBL284,7.853871964,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1C(O)C1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1C(O)C1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045013,CHEMBL923806,Inhibition of DPP4,B,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@@H]1C(O)C1CC1)Cc1cc(F)c(F)cc1F,CHEMBL400722,nM,12,CHEMBL284,7.920818754,DPPIV,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1C(O)C1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1C(O)C1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045014,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@H]1CC1CC1)Cc1cc(F)c(F)cc1F,CHEMBL400752,nM,7,CHEMBL284,8.15490196,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1CC1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1CC1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045015,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@H]1Cc1ccc(C(F)(F)F)cc1)Cc1cc(F)c(F)cc1F,CHEMBL250999,nM,4,CHEMBL284,8.397940009,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cc1ccc(C(F)(F)F)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cc1ccc(C(F)(F)F)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045016,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2[C@H]1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,CHEMBL401304,nM,4,CHEMBL284,8.397940009,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045017,CHEMBL923806,Inhibition of DPP4,B,C[C@@H]1c2nc(C(F)(F)F)nn2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL250787,nM,25,CHEMBL284,7.602059991,DPPIV,CC1c2nc(C(F)(F)F)nn2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nc(C(F)(F)F)nn2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045018,CHEMBL923806,Inhibition of DPP4,B,C[C@H]1c2nc(C(F)(F)F)nn2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL251376,nM,274,CHEMBL284,6.562249437,DPPIV,CC1c2nc(C(F)(F)F)nn2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nc(C(F)(F)F)nn2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045019,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(-c3ccccc3)nc2C1)Cc1cc(F)c(F)cc1F,CHEMBL401057,nM,68,CHEMBL284,7.167491087,DPPIV,N[C@@H](CC(=O)N1CCn2nc(-c3ccccc3)nc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(-c3ccccc3)nc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045020,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2nc(C3CC3)nc2C1)Cc1cc(F)c(F)cc1F,CHEMBL248936,nM,71,CHEMBL284,7.148741651,DPPIV,N[C@@H](CC(=O)N1CCn2nc(C3CC3)nc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nc(C3CC3)nc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2045021,CHEMBL923806,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2ncnc2C1)Cc1cc(F)c(F)cc1F,CHEMBL248743,nM,100,CHEMBL284,7,DPPIV,N[C@@H](CC(=O)N1CCn2ncnc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2ncnc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047430,CHEMBL924146,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCc2[nH]c(C(F)(F)F)nc2C1)Cc1cc(F)ccc1F,CHEMBL402496,nM,140,CHEMBL284,6.853871964,DPPIV,N[C@@H](CC(=O)N1CCc2[nH]c(C(F)(F)F)nc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2[nH]c(C(F)(F)F)nc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047434,CHEMBL924146,Inhibition of DPP4,B,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2Cc1ccc(F)cc1,CHEMBL250285,nM,5.8,CHEMBL284,8.236572006,DPPIV,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2Cc1ccc(F)cc1,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047436,CHEMBL924146,Inhibition of DPP4,B,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2Cc1ccccc1,CHEMBL250284,nM,8.4,CHEMBL284,8.075720714,DPPIV,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2Cc1ccccc1,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047438,CHEMBL924146,Inhibition of DPP4,B,CC1c2nc(C(C)(C)C)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL250283,nM,370,CHEMBL284,6.431798276,DPPIV,CC1c2nc(C(C)(C)C)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nc(C(C)(C)C)n(C)c2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047440,CHEMBL924146,Inhibition of DPP4,B,CC1c2nc(C3CC3)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL1204389,nM,250,CHEMBL284,6.602059991,DPPIV,CC1c2nc(C3CC3)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nc(C3CC3)n(C)c2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047441,CHEMBL924146,Inhibition of DPP4,B,CC1c2nc(C3CC3)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL400911,nM,490,CHEMBL284,6.30980392,DPPIV,CC1c2nc(C3CC3)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nc(C3CC3)n(C)c2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047442,CHEMBL924146,Inhibition of DPP4,B,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2C1CC1,CHEMBL248810,nM,110,CHEMBL284,6.958607315,DPPIV,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2C1CC1,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2C1CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047444,CHEMBL924146,Inhibition of DPP4,B,Cn1cnc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2C(F)(F)F,CHEMBL400954,nM,50,CHEMBL284,7.301029996,DPPIV,Cn1cnc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2C(F)(F)F,Cn1cnc2c1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047446,CHEMBL924146,Inhibition of DPP4,B,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2(C)C,CHEMBL248615,nM,570,CHEMBL284,6.244125144,DPPIV,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C2(C)C,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)C2(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047447,CHEMBL924146,Inhibition of DPP4,B,CCC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL250204,nM,60,CHEMBL284,7.22184875,DPPIV,CCC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047449,CHEMBL924146,Inhibition of DPP4,B,CC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL250202,nM,45,CHEMBL284,7.346787486,DPPIV,CC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047450,CHEMBL924146,Inhibition of DPP4,B,CC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CHEMBL250006,nM,65,CHEMBL284,7.187086643,DPPIV,CC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)C[C@H](N)Cc1cc(F)ccc1F,CC1c2nc(C(F)(F)F)n(C)c2CCN1C(=O)CC(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047452,CHEMBL924146,Inhibition of DPP4,B,Cn1c(-c2ccc(F)cc2)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL398661,nM,280,CHEMBL284,6.552841969,DPPIV,Cn1c(-c2ccc(F)cc2)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cn1c(-c2ccc(F)cc2)nc2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047453,CHEMBL924146,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCc2[nH]c(-c3ccccc3)nc2C1)Cc1cc(F)ccc1F,CHEMBL248997,nM,130,CHEMBL284,6.886056648,DPPIV,N[C@@H](CC(=O)N1CCc2[nH]c(-c3ccccc3)nc2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2[nH]c(-c3ccccc3)nc2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047454,CHEMBL924146,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCc2nc(C(F)(F)F)n(Cc3ccc(F)cc3)c2C1)Cc1cc(F)ccc1F,CHEMBL400761,nM,250,CHEMBL284,6.602059991,DPPIV,N[C@@H](CC(=O)N1CCc2nc(C(F)(F)F)n(Cc3ccc(F)cc3)c2C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2nc(C(F)(F)F)n(Cc3ccc(F)cc3)c2C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047455,CHEMBL924146,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)n2Cc2ccc(F)cc2)C1)Cc1cc(F)ccc1F,CHEMBL248788,nM,250,CHEMBL284,6.602059991,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)n2Cc2ccc(F)cc2)C1)Cc1cc(F)ccc1F,NC(CC(=O)N1CCc2c(nc(C(F)(F)F)n2Cc2ccc(F)cc2)C1)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047456,CHEMBL924146,Inhibition of DPP4,B,CC(C)Cn1c(C(F)(F)F)nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL429829,nM,260,CHEMBL284,6.585026652,DPPIV,CC(C)Cn1c(C(F)(F)F)nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CC(C)Cn1c(C(F)(F)F)nc2c1CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047457,CHEMBL924146,Inhibition of DPP4,B,CC(C)Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL400278,nM,220,CHEMBL284,6.657577319,DPPIV,CC(C)Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CC(C)Cn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047458,CHEMBL924146,Inhibition of DPP4,B,CCn1c(C(F)(F)F)nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL398492,nM,230,CHEMBL284,6.638272164,DPPIV,CCn1c(C(F)(F)F)nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CCn1c(C(F)(F)F)nc2c1CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047459,CHEMBL924146,Inhibition of DPP4,B,CCn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL251405,nM,180,CHEMBL284,6.744727495,DPPIV,CCn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CCn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047460,CHEMBL924146,Inhibition of DPP4,B,Cn1c(C(F)(F)F)nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,CHEMBL251404,nM,130,CHEMBL284,6.886056648,DPPIV,Cn1c(C(F)(F)F)nc2c1CN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)CC2,Cn1c(C(F)(F)F)nc2c1CN(C(=O)CC(N)Cc1cc(F)ccc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2047461,CHEMBL924146,Inhibition of DPP4,B,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,CHEMBL251205,nM,150,CHEMBL284,6.823908741,DPPIV,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)C[C@H](N)Cc1cc(F)ccc1F)C2,Cn1c(C(F)(F)F)nc2c1CCN(C(=O)CC(N)Cc1cc(F)ccc1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053413,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2ccc(-n3cnnn3)cc2)C[C@H]1C(=O)N1CCCC1,CHEMBL249427,nM,30,CHEMBL284,7.522878745,DPPIV,N[C@H]1CN(C(=O)c2ccc(-n3cnnn3)cc2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2ccc(-n3cnnn3)cc2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053414,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2cc3cc(Cl)ccc3o2)C[C@H]1C(=O)N1CCCC1,CHEMBL401269,nM,86,CHEMBL284,7.065501549,DPPIV,N[C@H]1CN(C(=O)c2cc3cc(Cl)ccc3o2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2cc3cc(Cl)ccc3o2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053416,CHEMBL943037,Inhibition of human DPP4,B,Cc1cc(CN2C[C@H](N)[C@H](C(=O)C3CCC[C@H]3C#N)C2)ccc1-n1cncn1,CHEMBL401378,nM,46,CHEMBL284,7.337242168,DPPIV,Cc1cc(CN2CC(C(=O)C3CCC[C@H]3C#N)[C@@H](N)C2)ccc1-n1cncn1,Cc1cc(CN2CC(N)C(C(=O)C3CCCC3C#N)C2)ccc1-n1cncn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053418,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2cnc3ccccc3n2)C(=O)[C@H]1C(=O)N1CCCC1,CHEMBL428936,nM,65,CHEMBL284,7.187086643,DPPIV,N[C@H]1CN(C(=O)c2cnc3ccccc3n2)C(=O)C1C(=O)N1CCCC1,NC1CN(C(=O)c2cnc3ccccc3n2)C(=O)C1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053420,CHEMBL943037,Inhibition of human DPP4,B,N[C@@H]1CN(C(=O)c2cnc3ccccc3n2)C(=O)[C@@H]1C(=O)N1CCCC1,CHEMBL399348,nM,3,CHEMBL284,8.522878745,DPPIV,N[C@@H]1CN(C(=O)c2cnc3ccccc3n2)C(=O)C1C(=O)N1CCCC1,NC1CN(C(=O)c2cnc3ccccc3n2)C(=O)C1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053423,CHEMBL943037,Inhibition of human DPP4,B,Cc1cc(-n2cncn2)ccc1CN1C[C@H](N)[C@H](C(=O)C2CCC[C@H]2C#N)C1,CHEMBL250620,nM,3.8,CHEMBL284,8.420216403,DPPIV,Cc1cc(-n2cncn2)ccc1CN1CC(C(=O)C2CCC[C@H]2C#N)[C@@H](N)C1,Cc1cc(-n2cncn2)ccc1CN1CC(N)C(C(=O)C2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053424,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2ccc3ccccc3c2)C[C@H]1C(=O)N1CCCC1,CHEMBL248838,nM,79,CHEMBL284,7.102372909,DPPIV,N[C@H]1CN(C(=O)c2ccc3ccccc3c2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2ccc3ccccc3c2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053425,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2cc3ccccc3s2)C[C@H]1C(=O)N1CCCC1,CHEMBL248837,nM,62,CHEMBL284,7.207608311,DPPIV,N[C@H]1CN(C(=O)c2cc3ccccc3s2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2cc3ccccc3s2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053426,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2cnc3ccccc3c2)C[C@H]1C(=O)N1CCCC1,CHEMBL249826,nM,49,CHEMBL284,7.30980392,DPPIV,N[C@H]1CN(C(=O)c2cnc3ccccc3c2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2cnc3ccccc3c2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053427,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2cc3ccccc3cn2)C[C@H]1C(=O)N1CCCC1,CHEMBL249825,nM,47,CHEMBL284,7.327902142,DPPIV,N[C@H]1CN(C(=O)c2cc3ccccc3cn2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2cc3ccccc3cn2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053428,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2ccc3ncsc3c2)C[C@H]1C(=O)N1CCCC1,CHEMBL399247,nM,42,CHEMBL284,7.37675071,DPPIV,N[C@H]1CN(C(=O)c2ccc3ncsc3c2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2ccc3ncsc3c2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053429,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2ccc(-n3cncn3)cc2)C[C@H]1C(=O)N1CCCC1,CHEMBL401268,nM,40,CHEMBL284,7.397940009,DPPIV,N[C@H]1CN(C(=O)c2ccc(-n3cncn3)cc2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2ccc(-n3cncn3)cc2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053430,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(C(=O)c2ccc3ncccc3c2)C[C@H]1C(=O)N1CCCC1,CHEMBL249620,nM,38,CHEMBL284,7.420216403,DPPIV,N[C@H]1CN(C(=O)c2ccc3ncccc3c2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2ccc3ncccc3c2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053455,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(Cc2ccc(-c3csnn3)cc2)C[C@H]1C(=O)N1CCCC1,CHEMBL250611,nM,91,CHEMBL284,7.040958608,DPPIV,N[C@H]1CN(Cc2ccc(-c3csnn3)cc2)CC1C(=O)N1CCCC1,NC1CN(Cc2ccc(-c3csnn3)cc2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053456,CHEMBL943037,Inhibition of human DPP4,B,CC(c1ccc([N+](=O)[O-])cc1)N1C[C@H](N)[C@H](C(=O)N2CCCC2)C1,CHEMBL399693,nM,83,CHEMBL284,7.080921908,DPPIV,CC(c1ccc([N+](=O)[O-])cc1)N1CC(C(=O)N2CCCC2)[C@@H](N)C1,CC(c1ccc([N+](=O)[O-])cc1)N1CC(N)C(C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053457,CHEMBL943037,Inhibition of human DPP4,B,N#Cc1ccc(CN2C[C@H](N)[C@H](C(=O)N3CCCC3)C2)cc1,CHEMBL250400,nM,81,CHEMBL284,7.091514981,DPPIV,N#Cc1ccc(CN2CC(C(=O)N3CCCC3)[C@@H](N)C2)cc1,N#Cc1ccc(CN2CC(N)C(C(=O)N3CCCC3)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053458,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(Cc2ccc(F)c(F)c2)C[C@H]1C(=O)N1CCCC1,CHEMBL428937,nM,80,CHEMBL284,7.096910013,DPPIV,N[C@H]1CN(Cc2ccc(F)c(F)c2)CC1C(=O)N1CCCC1,NC1CN(Cc2ccc(F)c(F)c2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053459,CHEMBL943037,Inhibition of human DPP4,B,N#Cc1cc(CN2C[C@H](N)[C@H](C(=O)N3CCCC3)C2)ccc1F,CHEMBL250399,nM,78,CHEMBL284,7.107905397,DPPIV,N#Cc1cc(CN2CC(C(=O)N3CCCC3)[C@@H](N)C2)ccc1F,N#Cc1cc(CN2CC(N)C(C(=O)N3CCCC3)C2)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053460,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(Cc2ccc(-n3cncn3)cc2)C[C@H]1C(=O)N1CCCC1,CHEMBL249174,nM,69,CHEMBL284,7.161150909,DPPIV,N[C@H]1CN(Cc2ccc(-n3cncn3)cc2)CC1C(=O)N1CCCC1,NC1CN(Cc2ccc(-n3cncn3)cc2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053461,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(Cc2ccc(-n3cnnn3)cc2)C[C@H]1C(=O)N1CCCC1,CHEMBL250393,nM,50,CHEMBL284,7.301029996,DPPIV,N[C@H]1CN(Cc2ccc(-n3cnnn3)cc2)CC1C(=O)N1CCCC1,NC1CN(Cc2ccc(-n3cnnn3)cc2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053462,CHEMBL943037,Inhibition of human DPP4,B,N[C@H]1CN(Cc2cnc3ccccc3c2)C[C@H]1C(=O)N1CCCC1,CHEMBL250852,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@H]1CN(Cc2cnc3ccccc3c2)CC1C(=O)N1CCCC1,NC1CN(Cc2cnc3ccccc3c2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053471,CHEMBL943037,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CN(Cc2cnc3ccccc3c2)C[C@@H]1N,CHEMBL248795,nM,6.2,CHEMBL284,8.207608311,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CN(Cc2cnc3ccccc3c2)C[C@@H]1N,N#CC1CCCN1C(=O)C1CN(Cc2cnc3ccccc3c2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053472,CHEMBL943037,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CN(Cc2ccc(-n3nccn3)cc2)C[C@@H]1N,CHEMBL400338,nM,5.4,CHEMBL284,8.26760624,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CN(Cc2ccc(-n3nccn3)cc2)C[C@@H]1N,N#CC1CCCN1C(=O)C1CN(Cc2ccc(-n3nccn3)cc2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053473,CHEMBL943037,Inhibition of human DPP4,B,Cc1ncn(-c2ccc(CN3C[C@H](N)[C@H](C(=O)N4CCC[C@H]4C#N)C3)cc2)n1,CHEMBL248794,nM,5.3,CHEMBL284,8.27572413,DPPIV,Cc1ncn(-c2ccc(CN3CC(C(=O)N4CCC[C@H]4C#N)[C@@H](N)C3)cc2)n1,Cc1ncn(-c2ccc(CN3CC(N)C(C(=O)N4CCCC4C#N)C3)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053474,CHEMBL943037,Inhibition of human DPP4,B,N#Cc1cc(CN2C[C@H](N)[C@H](C(=O)N3CCC[C@H]3C#N)C2)ccc1F,CHEMBL438520,nM,3.6,CHEMBL284,8.443697499,DPPIV,N#Cc1cc(CN2CC(C(=O)N3CCC[C@H]3C#N)[C@@H](N)C2)ccc1F,N#Cc1cc(CN2CC(N)C(C(=O)N3CCCC3C#N)C2)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053475,CHEMBL943037,Inhibition of human DPP4,B,Cn1nccc1-c1ccc(CN2C[C@H](N)[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1,CHEMBL248793,nM,3.3,CHEMBL284,8.48148606,DPPIV,Cn1nccc1-c1ccc(CN2CC(C(=O)N3CCC[C@H]3C#N)[C@@H](N)C2)cc1,Cn1nccc1-c1ccc(CN2CC(N)C(C(=O)N3CCCC3C#N)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053476,CHEMBL943037,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CN(Cc2ccc(-n3cncn3)cc2)C[C@@H]1N,CHEMBL399525,nM,3.2,CHEMBL284,8.494850022,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CN(Cc2ccc(-n3cncn3)cc2)C[C@@H]1N,N#CC1CCCN1C(=O)C1CN(Cc2ccc(-n3cncn3)cc2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053477,CHEMBL943037,Inhibition of human DPP4,B,N#Cc1ccc(CN2C[C@H](N)[C@H](C(=O)N3CCC[C@H]3C#N)C2)cc1,CHEMBL248599,nM,2.4,CHEMBL284,8.619788758,DPPIV,N#Cc1ccc(CN2CC(C(=O)N3CCC[C@H]3C#N)[C@@H](N)C2)cc1,N#Cc1ccc(CN2CC(N)C(C(=O)N3CCCC3C#N)C2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053492,CHEMBL943037,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CN(Cc2ccc(-c3csnn3)cc2)C[C@@H]1N,CHEMBL249407,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CN(Cc2ccc(-c3csnn3)cc2)C[C@@H]1N,N#CC1CCCN1C(=O)C1CN(Cc2ccc(-c3csnn3)cc2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053493,CHEMBL943037,Inhibition of human DPP4,B,Cn1cc(-c2ccc(CN3C[C@H](N)[C@H](C(=O)N4CCC[C@H]4C#N)C3)cc2)cn1,CHEMBL249406,nM,10,CHEMBL284,8,DPPIV,Cn1cc(-c2ccc(CN3CC(C(=O)N4CCC[C@H]4C#N)[C@@H](N)C3)cc2)cn1,Cn1cc(-c2ccc(CN3CC(N)C(C(=O)N4CCCC4C#N)C3)cc2)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053494,CHEMBL943037,Inhibition of human DPP4,B,Cc1nnc(-c2ccc(CN3C[C@H](N)[C@H](C(=O)N4CCC[C@H]4C#N)C3)cc2)o1,CHEMBL399726,nM,8.5,CHEMBL284,8.070581074,DPPIV,Cc1nnc(-c2ccc(CN3CC(C(=O)N4CCC[C@H]4C#N)[C@@H](N)C3)cc2)o1,Cc1nnc(-c2ccc(CN3CC(N)C(C(=O)N4CCCC4C#N)C3)cc2)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053495,CHEMBL943037,Inhibition of human DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CN(Cc2ccc(-c3ccn[nH]3)cc2)C[C@@H]1N,CHEMBL249203,nM,6.7,CHEMBL284,8.173925197,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CN(Cc2ccc(-c3cc[nH]n3)cc2)C[C@@H]1N,N#CC1CCCN1C(=O)C1CN(Cc2ccc(-c3cc[nH]n3)cc2)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053504,CHEMBL943037,Inhibition of human DPP4,B,Cc1nnc(-c2ccc(CN3C[C@H](N)[C@H](C(=O)C4[C@H](C#N)CC[C@@H]4F)C3)cc2)o1,CHEMBL249602,nM,5.3,CHEMBL284,8.27572413,DPPIV,Cc1nnc(-c2ccc(CN3CC(C(=O)C4[C@H](C#N)CC[C@@H]4F)[C@@H](N)C3)cc2)o1,Cc1nnc(-c2ccc(CN3CC(N)C(C(=O)C4C(F)CCC4C#N)C3)cc2)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053505,CHEMBL943037,Inhibition of human DPP4,B,CC(c1ccc(C#N)cc1)N1C[C@H](N)[C@H](C(=O)N2CCC[C@H]2C#N)C1,CHEMBL249601,nM,5.5,CHEMBL284,8.259637311,DPPIV,CC(c1ccc(C#N)cc1)N1CC(C(=O)N2CCC[C@H]2C#N)[C@@H](N)C1,CC(c1ccc(C#N)cc1)N1CC(N)C(C(=O)N2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053506,CHEMBL943037,Inhibition of human DPP4,B,N#C[C@@H]1CCCC1C(=O)[C@@H]1CN(C2CCOc3ccccc32)C[C@@H]1N,CHEMBL400533,nM,3.5,CHEMBL284,8.455931956,DPPIV,N#C[C@@H]1CCCC1C(=O)C1CN(C2CCOc3ccccc32)C[C@@H]1N,N#CC1CCCC1C(=O)C1CN(C2CCOc3ccccc32)CC1N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053507,CHEMBL943037,Inhibition of human DPP4,B,N#Cc1ccc2c(c1)CCC2N1C[C@H](N)[C@H](C(=O)C2CCC[C@H]2C#N)C1,CHEMBL249408,nM,3.4,CHEMBL284,8.468521083,DPPIV,N#Cc1ccc2c(c1)CCC2N1CC(C(=O)C2CCC[C@H]2C#N)[C@@H](N)C1,N#Cc1ccc2c(c1)CCC2N1CC(N)C(C(=O)C2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053508,CHEMBL943037,Inhibition of human DPP4,B,CC(c1ccc(-n2cncn2)cc1)N1C[C@H](N)[C@H](C(=O)C2CCC[C@H]2C#N)C1,CHEMBL400532,nM,3,CHEMBL284,8.522878745,DPPIV,CC(c1ccc(-n2cncn2)cc1)N1CC(C(=O)C2CCC[C@H]2C#N)[C@@H](N)C1,CC(c1ccc(-n2cncn2)cc1)N1CC(N)C(C(=O)C2CCCC2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053519,CHEMBL943037,Inhibition of human DPP4,B,CCc1cc(CN2C[C@H](N)[C@H](C(=O)C3CCC[C@H]3C#N)C2)cc(CC)c1C#N,CHEMBL429482,nM,4.7,CHEMBL284,8.327902142,DPPIV,CCc1cc(CN2CC(C(=O)C3CCC[C@H]3C#N)[C@@H](N)C2)cc(CC)c1C#N,CCc1cc(CN2CC(N)C(C(=O)C3CCCC3C#N)C2)cc(CC)c1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053520,CHEMBL943037,Inhibition of human DPP4,B,Cc1cc(CN2C[C@H](N)[C@H](C(=O)C3CCC[C@H]3C#N)C2)cc(C)c1C#N,CHEMBL399791,nM,1.1,CHEMBL284,8.958607315,DPPIV,Cc1cc(CN2CC(C(=O)C3CCC[C@H]3C#N)[C@@H](N)C2)cc(C)c1C#N,Cc1cc(CN2CC(N)C(C(=O)C3CCCC3C#N)C2)cc(C)c1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2053521,CHEMBL943037,Inhibition of human DPP4,B,Cc1cc(CN2C[C@H](N)[C@H](C(=O)C3CCC[C@H]3C#N)C2)ccc1C#N,CHEMBL429115,nM,1.3,CHEMBL284,8.886056648,DPPIV,Cc1cc(CN2CC(C(=O)C3CCC[C@H]3C#N)[C@@H](N)C2)ccc1C#N,Cc1cc(CN2CC(N)C(C(=O)C3CCCC3C#N)C2)ccc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060331,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1ccc(C(CCc2ccc(O)cc2OC)c2c(OC)cc(/C=C/c3ccc(O)cc3)cc2OC)cc1,CHEMBL254229,nM,36900,CHEMBL284,4.432973634,DPPIV,COc1ccc(C(CCc2ccc(O)cc2OC)c2c(OC)cc(C=Cc3ccc(O)cc3)cc2OC)cc1,COc1ccc(C(CCc2ccc(O)cc2OC)c2c(OC)cc(C=Cc3ccc(O)cc3)cc2OC)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060339,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1cc(O)c(C(CCc2ccc(O)cc2OC)c2ccc(O)cc2)cc1CCC(=O)c1ccc(O)cc1,CHEMBL251977,nM,36900,CHEMBL284,4.432973634,DPPIV,COc1cc(O)c(C(CCc2ccc(O)cc2OC)c2ccc(O)cc2)cc1CCC(=O)c1ccc(O)cc1,COc1cc(O)c(C(CCc2ccc(O)cc2OC)c2ccc(O)cc2)cc1CCC(=O)c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060340,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1ccc(C(CCc2ccc(O)cc2OC)c2cc(CCC(=O)c3ccc(O)cc3)c(OC)cc2O)cc1,CHEMBL254649,nM,36900,CHEMBL284,4.432973634,DPPIV,COc1ccc(C(CCc2ccc(O)cc2OC)c2cc(CCC(=O)c3ccc(O)cc3)c(OC)cc2O)cc1,COc1ccc(C(CCc2ccc(O)cc2OC)c2cc(CCC(=O)c3ccc(O)cc3)c(OC)cc2O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060341,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1cc(OC)c(C(CCc2ccc(O)cc2OC)c2ccc(O)cc2)cc1CCC(=O)c1ccc(O)cc1,CHEMBL254648,nM,36900,CHEMBL284,4.432973634,DPPIV,COc1cc(OC)c(C(CCc2ccc(O)cc2OC)c2ccc(O)cc2)cc1CCC(=O)c1ccc(O)cc1,COc1cc(OC)c(C(CCc2ccc(O)cc2OC)c2ccc(O)cc2)cc1CCC(=O)c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060342,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1cc2c(c(C)c1O)O[C@@H](c1ccc(O)cc1)CC2,CHEMBL254647,nM,39100,CHEMBL284,4.407823243,DPPIV,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1cc2c(c(C)c1O)O[C@@H](c1ccc(O)cc1)CC2,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1cc2c(c(C)c1O)OC(c1ccc(O)cc1)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060343,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1c(O)cc(O)cc1/C=C/c1ccc(O)cc1,CHEMBL254440,nM,41300,CHEMBL284,4.384049948,DPPIV,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1c(O)cc(O)cc1C=Cc1ccc(O)cc1,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1c(O)cc(O)cc1C=Cc1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060344,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1c(/C=C/c2ccc(O)cc2)cc(O)cc1OC,CHEMBL254439,nM,40200,CHEMBL284,4.395773947,DPPIV,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1c(C=Cc2ccc(O)cc2)cc(O)cc1OC,COc1cc(O)ccc1CCC(c1ccc(O)cc1)c1c(C=Cc2ccc(O)cc2)cc(O)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2060345,CHEMBL925662,Inhibition of human recombinant DPP4,B,COc1ccc(C(CCc2ccc(O)cc2OC)c2c(O)cc(OC)cc2/C=C/c2ccc(O)cc2)cc1,CHEMBL399481,nM,39100,CHEMBL284,4.407823243,DPPIV,COc1ccc(C(CCc2ccc(O)cc2OC)c2c(O)cc(OC)cc2C=Cc2ccc(O)cc2)cc1,COc1ccc(C(CCc2ccc(O)cc2OC)c2c(O)cc(OC)cc2C=Cc2ccc(O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068764,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccn1)Cc1cc(F)c(F)cc1F,CHEMBL557176,nM,0.4,CHEMBL284,9.397940009,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068789,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Cc1cc(F)c(F)cc1F,CHEMBL536312,nM,6.3,CHEMBL284,8.200659451,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068791,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1C(O)c1ccc(F)cc1)Cc1cc(F)c(F)cc1F,CHEMBL536536,nM,0.5,CHEMBL284,9.301029996,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1C(O)c1ccc(F)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1C(O)c1ccc(F)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068795,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)[C@H]1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,CHEMBL1203953,nM,0.18,CHEMBL284,9.744727495,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068796,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)[C@@H]1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,CHEMBL559371,nM,116,CHEMBL284,6.935542011,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccc(F)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068797,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1F)Cc1cc(F)c(F)cc1F,CHEMBL540888,nM,0.46,CHEMBL284,9.337242168,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068799,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1C(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL536090,nM,0.31,CHEMBL284,9.508638306,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1C(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1C(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068801,CHEMBL944056,Inhibition of DPP4,B,COc1ccc(CC2c3nnc(C(F)(F)F)n3CCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL539352,nM,0.43,CHEMBL284,9.366531544,DPPIV,COc1ccc(CC2c3nnc(C(F)(F)F)n3CCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,COc1ccc(CC2c3nnc(C(F)(F)F)n3CCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068803,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL539350,nM,0.66,CHEMBL284,9.180456064,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1Cc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068805,CHEMBL944056,Inhibition of DPP4,B,CN(C)C(=O)CC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL556979,nM,2.8,CHEMBL284,8.552841969,DPPIV,CN(C)C(=O)CC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CN(C)C(=O)CC1c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068807,CHEMBL944056,Inhibition of DPP4,B,C=CCC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL537000,nM,32,CHEMBL284,7.494850022,DPPIV,C=CCC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,C=CCC1c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068809,CHEMBL944056,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL536999,nM,5.7,CHEMBL284,8.244125144,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068811,CHEMBL944056,Inhibition of DPP4,B,CCC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL556606,nM,5,CHEMBL284,8.301029996,DPPIV,CCC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCC1c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068813,CHEMBL944056,Inhibition of DPP4,B,CC1c2nnc(C(F)(F)F)n2C(C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL536089,nM,11,CHEMBL284,7.958607315,DPPIV,CC1c2nnc(C(F)(F)F)n2C(C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nnc(C(F)(F)F)n2C(C)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068814,CHEMBL944056,Inhibition of DPP4,B,C[C@@H]1c2nnc(C(F)(F)F)n2[C@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL536311,nM,12,CHEMBL284,7.920818754,DPPIV,CC1c2nnc(C(F)(F)F)n2[C@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nnc(C(F)(F)F)n2C(C)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068815,CHEMBL944056,Inhibition of DPP4,B,C[C@H]1c2nnc(C(F)(F)F)n2[C@@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL557219,nM,209,CHEMBL284,6.679853714,DPPIV,CC1c2nnc(C(F)(F)F)n2[C@@H](C)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nnc(C(F)(F)F)n2C(C)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068817,CHEMBL944056,Inhibition of DPP4,B,CC1(C)c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL536088,nM,175,CHEMBL284,6.756961951,DPPIV,CC1(C)c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1(C)c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068818,CHEMBL944056,Inhibition of DPP4,B,CC1(C)CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)Cc2nnc(C(F)(F)F)n21.Cl,CHEMBL536765,nM,92,CHEMBL284,7.036212173,DPPIV,CC1(C)CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)Cc2nnc(C(F)(F)F)n21,CC1(C)CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)Cc2nnc(C(F)(F)F)n21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068819,CHEMBL944056,Inhibition of DPP4,B,C[C@@H]1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL558779,nM,4.3,CHEMBL284,8.366531544,DPPIV,CC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068820,CHEMBL944056,Inhibition of DPP4,B,C[C@H]1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL557542,nM,88,CHEMBL284,7.055517328,DPPIV,CC1c2nnc(C(F)(F)F)n2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1c2nnc(C(F)(F)F)n2CCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068821,CHEMBL944056,Inhibition of DPP4,B,C[C@@H]1Cn2c(nnc2C(F)(F)F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL553787,nM,42,CHEMBL284,7.37675071,DPPIV,C[C@@H]1Cn2c(nnc2C(F)(F)F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1Cn2c(nnc2C(F)(F)F)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068822,CHEMBL944056,Inhibition of DPP4,B,C[C@H]1Cn2c(nnc2C(F)(F)F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL557990,nM,91,CHEMBL284,7.040958608,DPPIV,C[C@H]1Cn2c(nnc2C(F)(F)F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC1Cn2c(nnc2C(F)(F)F)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068823,CHEMBL944056,Inhibition of DPP4,B,C[C@@H]1CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)Cc2ccc(C(F)(F)F)n21.Cl,CHEMBL2021529,nM,14,CHEMBL284,7.853871964,DPPIV,C[C@@H]1CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)Cc2ccc(C(F)(F)F)n21,CC1CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)Cc2ccc(C(F)(F)F)n21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2068824,CHEMBL944056,Inhibition of DPP4,B,C[C@H]1CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)Cc2ccc(C(F)(F)F)n21.Cl,CHEMBL2021541,nM,23,CHEMBL284,7.638272164,DPPIV,C[C@H]1CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)Cc2ccc(C(F)(F)F)n21,CC1CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)Cc2ccc(C(F)(F)F)n21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2074598,CHEMBL927861,Inhibition of DPP4,B,CN(C)C(=N)NC(=N)N,CHEMBL1431,nM,29000,CHEMBL284,4.537602002,DPPIV,CN(C)C(N)=NC(=N)N,CN(C)C(N)=NC(=N)N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090790,CHEMBL932061,Inhibition of human DPP4,B,Cc1nsc(N2CCN(C(=O)[C@H]3C[C@@H](C(=O)N4CCSC4)N[C@H]3C)CC2)n1,CHEMBL269952,nM,14,CHEMBL284,7.853871964,DPPIV,Cc1nsc(N2CCN(C(=O)C3CC(C(=O)N4CCSC4)N[C@H]3C)CC2)n1,Cc1nsc(N2CCN(C(=O)C3CC(C(=O)N4CCSC4)NC3C)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090791,CHEMBL932061,Inhibition of human DPP4,B,Cc1nsc(N2CCN(C(=O)[C@H]3C[C@@H](C(=O)N4CCCC4)N[C@H]3C)CC2)n1,CHEMBL269953,nM,29,CHEMBL284,7.537602002,DPPIV,Cc1nsc(N2CCN(C(=O)C3CC(C(=O)N4CCCC4)N[C@H]3C)CC2)n1,Cc1nsc(N2CCN(C(=O)C3CC(C(=O)N4CCCC4)NC3C)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090792,CHEMBL932061,Inhibition of human DPP4,B,Cc1nsc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n1,CHEMBL403449,nM,18,CHEMBL284,7.744727495,DPPIV,Cc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCSC4)C3)CC2)n1,Cc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCSC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090793,CHEMBL932061,Inhibition of human DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1CCN(c2nc(C(F)(F)F)ns2)CC1,CHEMBL270163,nM,23,CHEMBL284,7.638272164,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1CCN(c2nc(C(F)(F)F)ns2)CC1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1CCN(c2nc(C(F)(F)F)ns2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090794,CHEMBL932061,Inhibition of human DPP4,B,COCc1nsc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL269965,nM,17,CHEMBL284,7.769551079,DPPIV,COCc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,COCc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090795,CHEMBL932061,Inhibition of human DPP4,B,CC(C)c1nsc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL402645,nM,52,CHEMBL284,7.283996656,DPPIV,CC(C)c1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,CC(C)c1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090796,CHEMBL932061,Inhibition of human DPP4,B,CCCc1nsc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL437592,nM,21,CHEMBL284,7.677780705,DPPIV,CCCc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,CCCc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090797,CHEMBL932061,Inhibition of human DPP4,B,CCc1nsc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL271444,nM,37,CHEMBL284,7.431798276,DPPIV,CCc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,CCc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090798,CHEMBL932061,Inhibition of human DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1CCN(c2ncns2)CC1,CHEMBL403969,nM,19,CHEMBL284,7.721246399,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1CCN(c2ncns2)CC1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1CCN(c2ncns2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090799,CHEMBL932061,Inhibition of human DPP4,B,Cc1nc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)no1,CHEMBL270395,nM,604,CHEMBL284,6.218963061,DPPIV,Cc1nc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)no1,Cc1nc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)no1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090800,CHEMBL932061,Inhibition of human DPP4,B,Cc1ncc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)s1,CHEMBL403970,nM,130,CHEMBL284,6.886056648,DPPIV,Cc1ncc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)s1,Cc1ncc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090801,CHEMBL932061,Inhibition of human DPP4,B,Cc1nc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)sc1C,CHEMBL271870,nM,410,CHEMBL284,6.387216143,DPPIV,Cc1nc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)sc1C,Cc1nc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)sc1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090802,CHEMBL932061,Inhibition of human DPP4,B,Cc1cnc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)s1,CHEMBL439067,nM,340,CHEMBL284,6.468521083,DPPIV,Cc1cnc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)s1,Cc1cnc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090803,CHEMBL932061,Inhibition of human DPP4,B,Cc1cc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)sn1,CHEMBL272079,nM,69,CHEMBL284,7.161150909,DPPIV,Cc1cc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)sn1,Cc1cc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)sn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090804,CHEMBL932061,Inhibition of human DPP4,B,Cc1csc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL273206,nM,52,CHEMBL284,7.283996656,DPPIV,Cc1csc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Cc1csc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090805,CHEMBL932061,Inhibition of human DPP4,B,Cc1nsc(C2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL404159,nM,350,CHEMBL284,6.455931956,DPPIV,Cc1nsc(C2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Cc1nsc(C2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090806,CHEMBL932061,Inhibition of human DPP4,B,Cc1nsc(N2CCCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL257742,nM,310,CHEMBL284,6.508638306,DPPIV,Cc1nsc(N2CCCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Cc1nsc(N2CCCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090807,CHEMBL932061,Inhibition of human DPP4,B,Cc1nsc(N2CCN(C(=O)[C@@H]3CN[C@H](C(=O)N4CCCC4)C3)CC2)n1,CHEMBL256691,nM,20,CHEMBL284,7.698970004,DPPIV,Cc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Cc1nsc(N2CCN(C(=O)C3CNC(C(=O)N4CCCC4)C3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090808,CHEMBL932061,Inhibition of human DPP4,B,O=C([C@@H]1CN[C@H](C(=O)N2CCCC2)C1)N1CCN(c2nc(-c3ccccc3)ns2)CC1,CHEMBL258101,nM,20,CHEMBL284,7.698970004,DPPIV,O=C(C1CNC(C(=O)N2CCCC2)C1)N1CCN(c2nc(-c3ccccc3)ns2)CC1,O=C(C1CNC(C(=O)N2CCCC2)C1)N1CCN(c2nc(-c3ccccc3)ns2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2090809,CHEMBL932061,Inhibition of human DPP4,B,CN(C)C(=O)[C@@H]1CN[C@H](C(=O)N2CCCC2)C1,CHEMBL271062,nM,670,CHEMBL284,6.173925197,DPPIV,CN(C)C(=O)C1CNC(C(=O)N2CCCC2)C1,CN(C)C(=O)C1CNC(C(=O)N2CCCC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091496,CHEMBL949931,Inhibition of human recombinant DPP4,B,O=C(c1nccs1)[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1,CHEMBL258288,nM,44,CHEMBL284,7.356547324,DPPIV,O=C(c1nccs1)C1CCCN1C(=O)C1C[C@@H]2CCCC[C@@H]2N1,O=C(c1nccs1)C1CCCN1C(=O)C1CC2CCCCC2N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091497,CHEMBL949931,Inhibition of human recombinant DPP4,B,N[C@H](C(=O)N1CC[C@H]1C(=O)c1nccs1)C1CCCCC1,CHEMBL402236,nM,30,CHEMBL284,7.522878745,DPPIV,NC(C(=O)N1CCC1C(=O)c1nccs1)C1CCCCC1,NC(C(=O)N1CCC1C(=O)c1nccs1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091498,CHEMBL949931,Inhibition of human recombinant DPP4,B,N[C@H](C(=O)N1CCC[C@H]1C(=O)c1nccs1)C1CCCCC1,CHEMBL256871,nM,42,CHEMBL284,7.37675071,DPPIV,NC(C(=O)N1CCCC1C(=O)c1nccs1)C1CCCCC1,NC(C(=O)N1CCCC1C(=O)c1nccs1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091499,CHEMBL949931,Inhibition of human recombinant DPP4,B,N[C@H](C(=O)N1CC[C@H]1C(=O)c1nc2ccccc2s1)C1CCCCC1,CHEMBL402151,nM,42,CHEMBL284,7.37675071,DPPIV,NC(C(=O)N1CCC1C(=O)c1nc2ccccc2s1)C1CCCCC1,NC(C(=O)N1CCC1C(=O)c1nc2ccccc2s1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091500,CHEMBL949931,Inhibition of human recombinant DPP4,B,N[C@H](C(=O)N1CCC[C@H]1C(=O)c1nc2ccccc2s1)C1CCCCC1,CHEMBL271694,nM,50,CHEMBL284,7.301029996,DPPIV,NC(C(=O)N1CCCC1C(=O)c1nc2ccccc2s1)C1CCCCC1,NC(C(=O)N1CCCC1C(=O)c1nc2ccccc2s1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091501,CHEMBL949931,Inhibition of human recombinant DPP4,B,O=C(c1cccs1)[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1,CHEMBL269926,nM,50000,CHEMBL284,4.301029996,DPPIV,O=C(c1cccs1)C1CCCN1C(=O)C1C[C@@H]2CCCC[C@@H]2N1,O=C(c1cccs1)C1CCCN1C(=O)C1CC2CCCCC2N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091502,CHEMBL949931,Inhibition of human recombinant DPP4,B,O=C(c1ccccn1)[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1,CHEMBL403160,nM,2000,CHEMBL284,5.698970004,DPPIV,O=C(c1ccccn1)C1CCCN1C(=O)C1C[C@@H]2CCCC[C@@H]2N1,O=C(c1ccccn1)C1CCCN1C(=O)C1CC2CCCCC2N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091503,CHEMBL949931,Inhibition of human recombinant DPP4,B,O=C(c1nc2ccccc2s1)[C@@H]1CCN1C(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1,CHEMBL365441,nM,80,CHEMBL284,7.096910013,DPPIV,O=C(c1nc2ccccc2s1)C1CCN1C(=O)C1C[C@@H]2CCCC[C@@H]2N1,O=C(c1nc2ccccc2s1)C1CCN1C(=O)C1CC2CCCCC2N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2091504,CHEMBL949931,Inhibition of human recombinant DPP4,B,O=C(c1nc2ccccc2s1)[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1,CHEMBL404030,nM,30,CHEMBL284,7.522878745,DPPIV,O=C(c1nc2ccccc2s1)C1CCCN1C(=O)C1C[C@@H]2CCCC[C@@H]2N1,O=C(c1nc2ccccc2s1)C1CCCN1C(=O)C1CC2CCCCC2N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121693,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CS(=O)(=O)c1ccc(-c2noc([C@H](CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL404079,nM,12,CHEMBL284,7.920818754,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(F)=C3CCCC3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121694,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL402163,nM,0.21,CHEMBL284,9.677780705,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(F)=C3CCCC3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121695,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CS(=O)(=O)c1ccc(-c2noc([C@H](CCO)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL255591,nM,93,CHEMBL284,7.031517051,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CCO)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CCO)C(N)C(F)=C3CCCC3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121696,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CCO)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL445674,nM,3.2,CHEMBL284,8.494850022,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CCO)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CCO)C(N)C(F)=C3CCCC3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121697,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(Cc1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL1162974,nM,21,CHEMBL284,7.677780705,DPPIV,CC(Cc1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(F)=C1CCCC1,CC(Cc1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121698,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CCS(=O)(=O)c1ccc(-c2noc(C(C)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1.O=C(O)C(F)(F)F,CHEMBL429757,nM,50,CHEMBL284,7.301029996,DPPIV,CCS(=O)(=O)c1ccc(-c2noc(C(C)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CCS(=O)(=O)c1ccc(-c2noc(C(C)C(N)C(F)=C3CCCC3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121699,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL257023,nM,7.5,CHEMBL284,8.124938737,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121700,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL256172,nM,57,CHEMBL284,7.244125144,DPPIV,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(NS(C)(=O)=O)cc2Cl)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121701,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL401932,nM,1490,CHEMBL284,5.826813732,DPPIV,CC(c1nc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121702,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL257709,nM,90,CHEMBL284,7.045757491,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121703,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(Br)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL256603,nM,645,CHEMBL284,6.190440285,DPPIV,CC(c1nc(-c2ccc(Br)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(Br)cc2Cl)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121704,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(C(F)(F)F)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL255351,nM,525,CHEMBL284,6.279840697,DPPIV,CC(c1nc(-c2ccc(C(F)(F)F)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(C(F)(F)F)cc2Cl)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121705,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1.O=C(O)C(F)(F)F,CHEMBL437026,nM,1165,CHEMBL284,5.933674075,DPPIV,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)C(F)=C1CCCC1,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)C(N)C(F)=C1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121709,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL437206,nM,17,CHEMBL284,7.769551079,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2121710,CHEMBL933456,Inhibition of human recombinant DPP4 expressed in insect cell,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)[C@H](N)C(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL403415,nM,122,CHEMBL284,6.913640169,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122451,CHEMBL951312,Inhibition of human DPP4,B,NCc1ccccc1-c1ccccc1,CHEMBL257036,nM,30000,CHEMBL284,4.522878745,DPPIV,NCc1ccccc1-c1ccccc1,NCc1ccccc1-c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122452,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2cc(C(N)=O)c(-c3ccccc3Cl)c(CN)c21,CHEMBL273209,nM,32,CHEMBL284,7.494850022,DPPIV,Cn1cnc2cc(C(N)=O)c(-c3ccccc3Cl)c(CN)c21,Cn1cnc2cc(C(N)=O)c(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122453,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2cc(C#N)c(-c3ccccc3Cl)c(CN)c21,CHEMBL272114,nM,8,CHEMBL284,8.096910013,DPPIV,Cn1cnc2cc(C#N)c(-c3ccccc3Cl)c(CN)c21,Cn1cnc2cc(C#N)c(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122454,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2cc(Br)c(-c3ccccc3Cl)c(CN)c21,CHEMBL257653,nM,50,CHEMBL284,7.301029996,DPPIV,Cn1cnc2cc(Br)c(-c3ccccc3Cl)c(CN)c21,Cn1cnc2cc(Br)c(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122455,CHEMBL951312,Inhibition of human DPP4,B,Cn1c(=O)[nH]c2ccc(-c3ccccc3Cl)c(CN)c21,CHEMBL257852,nM,52,CHEMBL284,7.283996656,DPPIV,Cn1c(=O)[nH]c2ccc(-c3ccccc3Cl)c(CN)c21,Cn1c(=O)[nH]c2ccc(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122456,CHEMBL951312,Inhibition of human DPP4,B,Cn1nnc2ccc(-c3ccccc3Cl)c(CN)c21,CHEMBL256266,nM,61,CHEMBL284,7.214670165,DPPIV,Cn1nnc2ccc(-c3ccccc3Cl)c(CN)c21,Cn1nnc2ccc(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122457,CHEMBL951312,Inhibition of human DPP4,B,Cn1c(-c2cccnc2)nc2ccc(-c3ccccc3Cl)c(CN)c21,CHEMBL261246,nM,11,CHEMBL284,7.958607315,DPPIV,Cn1c(-c2cccnc2)nc2ccc(-c3ccccc3Cl)c(CN)c21,Cn1c(-c2cccnc2)nc2ccc(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122458,CHEMBL951312,Inhibition of human DPP4,B,COCc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,CHEMBL263137,nM,66,CHEMBL284,7.180456064,DPPIV,COCc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,COCc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122459,CHEMBL951312,Inhibition of human DPP4,B,CCc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,CHEMBL263139,nM,97,CHEMBL284,7.013228266,DPPIV,CCc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,CCc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122460,CHEMBL951312,Inhibition of human DPP4,B,Cc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,CHEMBL257636,nM,160,CHEMBL284,6.795880017,DPPIV,Cc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,Cc1nc2ccc(-c3ccccc3Cl)c(CN)c2n1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122461,CHEMBL951312,Inhibition of human DPP4,B,NCc1c(-c2ccccc2Cl)ccc2ncn(Cc3ccccc3)c12,CHEMBL403156,nM,102,CHEMBL284,6.991399828,DPPIV,NCc1c(-c2ccccc2Cl)ccc2ncn(Cc3ccccc3)c12,NCc1c(-c2ccccc2Cl)ccc2ncn(Cc3ccccc3)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122462,CHEMBL951312,Inhibition of human DPP4,B,NCc1c(-c2ccccc2Cl)ccc2ncn(CCO)c12,CHEMBL401542,nM,96,CHEMBL284,7.017728767,DPPIV,NCc1c(-c2ccccc2Cl)ccc2ncn(CCO)c12,NCc1c(-c2ccccc2Cl)ccc2ncn(CCO)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122463,CHEMBL951312,Inhibition of human DPP4,B,CCn1cnc2ccc(-c3ccc(Cl)cc3Cl)c(CN)c21,CHEMBL257308,nM,66,CHEMBL284,7.180456064,DPPIV,CCn1cnc2ccc(-c3ccc(Cl)cc3Cl)c(CN)c21,CCn1cnc2ccc(-c3ccc(Cl)cc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122464,CHEMBL951312,Inhibition of human DPP4,B,NCc1c(-c2ccc(Cl)cc2Cl)ccc2nc[nH]c12,CHEMBL404544,nM,630,CHEMBL284,6.200659451,DPPIV,NCc1c(-c2ccc(Cl)cc2Cl)ccc2[nH]cnc12,NCc1c(-c2ccc(Cl)cc2Cl)ccc2[nH]cnc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122465,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccc(F)cc3F)c(CN)c21,CHEMBL406201,nM,790,CHEMBL284,6.102372909,DPPIV,Cn1cnc2ccc(-c3ccc(F)cc3F)c(CN)c21,Cn1cnc2ccc(-c3ccc(F)cc3F)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122466,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3cc(F)ccc3Cl)c(CN)c21,CHEMBL272771,nM,320,CHEMBL284,6.494850022,DPPIV,Cn1cnc2ccc(-c3cc(F)ccc3Cl)c(CN)c21,Cn1cnc2ccc(-c3cc(F)ccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122467,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccc(Cl)cc3Cl)c(CN)c21,CHEMBL255552,nM,62,CHEMBL284,7.207608311,DPPIV,Cn1cnc2ccc(-c3ccc(Cl)cc3Cl)c(CN)c21,Cn1cnc2ccc(-c3ccc(Cl)cc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122468,CHEMBL951312,Inhibition of human DPP4,B,Cc1ccccc1-c1ccc2ncn(C)c2c1CN,CHEMBL256625,nM,98,CHEMBL284,7.008773924,DPPIV,Cc1ccccc1-c1ccc2ncn(C)c2c1CN,Cc1ccccc1-c1ccc2ncn(C)c2c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122469,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccccc3O)c(CN)c21,CHEMBL256624,nM,1600,CHEMBL284,5.795880017,DPPIV,Cn1cnc2ccc(-c3ccccc3O)c(CN)c21,Cn1cnc2ccc(-c3ccccc3O)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122470,CHEMBL951312,Inhibition of human DPP4,B,COc1ccccc1-c1ccc2ncn(C)c2c1CN,CHEMBL428065,nM,2000,CHEMBL284,5.698970004,DPPIV,COc1ccccc1-c1ccc2ncn(C)c2c1CN,COc1ccccc1-c1ccc2ncn(C)c2c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122471,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccccc3C(N)=O)c(CN)c21,CHEMBL256826,nM,4000,CHEMBL284,5.397940009,DPPIV,Cn1cnc2ccc(-c3ccccc3C(N)=O)c(CN)c21,Cn1cnc2ccc(-c3ccccc3C(N)=O)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122472,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccccc3Cl)c(CN)c21,CHEMBL270365,nM,63,CHEMBL284,7.200659451,DPPIV,Cn1cnc2ccc(-c3ccccc3Cl)c(CN)c21,Cn1cnc2ccc(-c3ccccc3Cl)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122473,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccccc3CO)c(CN)c21,CHEMBL256252,nM,400,CHEMBL284,6.397940009,DPPIV,Cn1cnc2ccc(-c3ccccc3CO)c(CN)c21,Cn1cnc2ccc(-c3ccccc3CO)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122474,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2c(CN)c(-c3ccccc3)ccc21,CHEMBL403862,nM,40000,CHEMBL284,4.397940009,DPPIV,Cn1cnc2c(CN)c(-c3ccccc3)ccc21,Cn1cnc2c(CN)c(-c3ccccc3)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122475,CHEMBL951312,Inhibition of human DPP4,B,Cn1cnc2ccc(-c3ccccc3)c(CN)c21,CHEMBL255769,nM,1000,CHEMBL284,6,DPPIV,Cn1cnc2ccc(-c3ccccc3)c(CN)c21,Cn1cnc2ccc(-c3ccccc3)c(CN)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2122476,CHEMBL951312,Inhibition of human DPP4,B,NCc1c(-c2ccccc2)ccc2nc[nH]c12,CHEMBL255554,nM,12000,CHEMBL284,4.920818754,DPPIV,NCc1c(-c2ccccc2)ccc2[nH]cnc12,NCc1c(-c2ccccc2)ccc2[nH]cnc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130852,CHEMBL939125,Inhibition of human DPP4,B,CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)NCc2ccccc2)[C@H](C)N1,CHEMBL406219,nM,51,CHEMBL284,7.292429824,DPPIV,CCN(CC#N)C(=O)C1CC(C(=O)NCc2ccccc2)[C@H](C)N1,CCN(CC#N)C(=O)C1CC(C(=O)NCc2ccccc2)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130853,CHEMBL939125,Inhibition of human DPP4,B,CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N2Cc3ccccc3C2)[C@H](C)N1,CHEMBL438547,nM,11,CHEMBL284,7.958607315,DPPIV,CCN(CC#N)C(=O)C1CC(C(=O)N2Cc3ccccc3C2)[C@H](C)N1,CCN(CC#N)C(=O)C1CC(C(=O)N2Cc3ccccc3C2)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130854,CHEMBL939125,Inhibition of human DPP4,B,CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N2CCOCC2)[C@H](C)N1,CHEMBL402466,nM,24,CHEMBL284,7.619788758,DPPIV,CCN(CC#N)C(=O)C1CC(C(=O)N2CCOCC2)[C@H](C)N1,CCN(CC#N)C(=O)C1CC(C(=O)N2CCOCC2)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130855,CHEMBL939125,Inhibition of human DPP4,B,CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N2CCCCC2)[C@H](C)N1,CHEMBL260509,nM,17,CHEMBL284,7.769551079,DPPIV,CCN(CC#N)C(=O)C1CC(C(=O)N2CCCCC2)[C@H](C)N1,CCN(CC#N)C(=O)C1CC(C(=O)N2CCCCC2)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130856,CHEMBL939125,Inhibition of human DPP4,B,CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N2CCCC2)[C@H](C)N1,CHEMBL260702,nM,16,CHEMBL284,7.795880017,DPPIV,CCN(CC#N)C(=O)C1CC(C(=O)N2CCCC2)[C@H](C)N1,CCN(CC#N)C(=O)C1CC(C(=O)N2CCCC2)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130857,CHEMBL939125,Inhibition of human DPP4,B,C#CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N(C)C)[C@H](C)N1,CHEMBL260701,nM,60,CHEMBL284,7.22184875,DPPIV,C#CCN(CC#N)C(=O)C1CC(C(=O)N(C)C)[C@H](C)N1,C#CCN(CC#N)C(=O)C1CC(C(=O)N(C)C)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130858,CHEMBL939125,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N(CC#N)C2CC2)C[C@@H]1C(=O)N(C)C,CHEMBL261460,nM,56,CHEMBL284,7.251811973,DPPIV,C[C@@H]1NC(C(=O)N(CC#N)C2CC2)CC1C(=O)N(C)C,CC1NC(C(=O)N(CC#N)C2CC2)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130859,CHEMBL939125,Inhibition of human DPP4,B,C=CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N(C)C)[C@H](C)N1,CHEMBL261462,nM,41,CHEMBL284,7.387216143,DPPIV,C=CCN(CC#N)C(=O)C1CC(C(=O)N(C)C)[C@H](C)N1,C=CCN(CC#N)C(=O)C1CC(C(=O)N(C)C)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130860,CHEMBL939125,Inhibition of human DPP4,B,CCCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N(C)C)[C@H](C)N1,CHEMBL261463,nM,600,CHEMBL284,6.22184875,DPPIV,CCCN(CC#N)C(=O)C1CC(C(=O)N(C)C)[C@H](C)N1,CCCN(CC#N)C(=O)C1CC(C(=O)N(C)C)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130861,CHEMBL939125,Inhibition of human DPP4,B,CCN(CC#N)C(=O)[C@@H]1C[C@H](C(=O)N(C)C)[C@H](C)N1,CHEMBL407296,nM,24,CHEMBL284,7.619788758,DPPIV,CCN(CC#N)C(=O)C1CC(C(=O)N(C)C)[C@H](C)N1,CCN(CC#N)C(=O)C1CC(C(=O)N(C)C)C(C)N1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130862,CHEMBL939125,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N(C)CC#N)C[C@@H]1C(=O)N(C)C,CHEMBL259198,nM,25,CHEMBL284,7.602059991,DPPIV,C[C@@H]1NC(C(=O)N(C)CC#N)CC1C(=O)N(C)C,CC1NC(C(=O)N(C)CC#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130863,CHEMBL939125,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)NCC#N)C[C@@H]1C(=O)N(C)C,CHEMBL407293,nM,13000,CHEMBL284,4.886056648,DPPIV,C[C@@H]1NC(C(=O)NCC#N)CC1C(=O)N(C)C,CC1NC(C(=O)NCC#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130864,CHEMBL939125,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1CC(=O)N(C)C,CHEMBL430057,nM,5.6,CHEMBL284,8.251811973,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)C[C@@H]1CC(=O)N(C)C,CC1NC(C(=O)N2CCCC2C#N)CC1CC(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130865,CHEMBL939125,Inhibition of human DPP4,B,C[C@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@H]1C(=O)N(C)C,CHEMBL409010,nM,110,CHEMBL284,6.958607315,DPPIV,C[C@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N(C)C,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130866,CHEMBL939125,Inhibition of human DPP4,B,C[C@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N(C)C,CHEMBL260543,nM,70,CHEMBL284,7.15490196,DPPIV,C[C@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N(C)C,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130867,CHEMBL939125,Inhibition of human DPP4,B,C[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@H]1C(=O)N(C)C,CHEMBL260198,nM,1100,CHEMBL284,5.958607315,DPPIV,C[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N(C)C,CC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2130868,CHEMBL939125,Inhibition of human DPP4,B,CC[C@@H]1N[C@H](C(=O)N2CCC[C@H]2C#N)C[C@@H]1C(=O)N(C)C,CHEMBL260197,nM,16,CHEMBL284,7.795880017,DPPIV,CC[C@@H]1NC(C(=O)N2CCC[C@H]2C#N)CC1C(=O)N(C)C,CCC1NC(C(=O)N2CCCC2C#N)CC1C(=O)N(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171460,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL403553,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171463,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(NC[C@H](C)N)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL403408,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(=NC[C@H](C)N)[nH]c2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(=NCC(C)N)[nH]c2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171464,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(NCCN)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL257376,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(=NCCN)[nH]c2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(=NCCN)[nH]c2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171465,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCNCC2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL257999,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCCNCC2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(N2CCCNCC2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171466,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCNCC2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL401971,nM,5,CHEMBL284,8.301029996,DPPIV,CC#CCn1c(N2CCNCC2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(N2CCNCC2)nc2cnn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171467,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc4ccccc4o3)c(=O)c21,CHEMBL256969,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc4ccccc4o3)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc4ccccc4o3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171468,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3ccc(C#N)c4ccccc34)c(=O)c21,CHEMBL404220,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3ccc(C#N)c4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3ccc(C#N)c4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171469,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC(=O)c3ccccc3)c(=O)c21,CHEMBL256928,nM,26,CHEMBL284,7.585026652,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC(=O)c3ccccc3)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC(=O)c3ccccc3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171470,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,CHEMBL401502,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171471,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCC[C@H](N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,CHEMBL256929,nM,25,CHEMBL284,7.602059991,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171472,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,CHEMBL256729,nM,14,CHEMBL284,7.853871964,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(CC3=Nc4ccccc4Oc4ccccc43)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171473,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c(C)nn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL256121,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c(C)nn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2c(C)nn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171474,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(C(=O)NCc2nc(C)cc3ccccc23)nnc1N1CCCC(N)C1,CHEMBL255517,nM,24,CHEMBL284,7.619788758,DPPIV,CC#CCn1c(C(=O)NCc2nc(C)cc3ccccc23)nnc1N1CCCC(N)C1,CC#CCn1c(C(=O)NCc2nc(C)cc3ccccc23)nnc1N1CCCC(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171475,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc(Br)c1C(=O)NCc1cccc2ccccc12,CHEMBL402111,nM,559,CHEMBL284,6.252588192,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc(Br)c1C(=O)NCc1cccc2ccccc12,CC#CCn1c(N2CCCC(N)C2)nc(Br)c1C(=O)NCc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171476,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc(C#N)c1C(=O)NCc1cccc2ccccc12,CHEMBL402573,nM,582,CHEMBL284,6.235077015,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc(C#N)c1C(=O)NCc1cccc2ccccc12,CC#CCn1c(N2CCCC(N)C2)nc(C#N)c1C(=O)NCc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171477,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(C(=O)N(C)Cc2cccc3ccccc23)cnc1N1CCCC(N)C1,CHEMBL257589,nM,3059,CHEMBL284,5.514420523,DPPIV,CC#CCn1c(C(=O)N(C)Cc2cccc3ccccc23)cnc1N1CCCC(N)C1,CC#CCn1c(C(=O)N(C)Cc2cccc3ccccc23)cnc1N1CCCC(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171478,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(C(=O)NCc2nc(C)cc3ccccc23)cnc1N1CCCC(N)C1,CHEMBL257795,nM,99,CHEMBL284,7.004364805,DPPIV,CC#CCn1c(C(=O)NCc2nc(C)cc3ccccc23)cnc1N1CCCC(N)C1,CC#CCn1c(C(=O)NCc2nc(C)cc3ccccc23)cnc1N1CCCC(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171479,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(C(=O)NCc2cccc3ccccc23)cnc1N1CCCC(N)C1,CHEMBL401972,nM,107,CHEMBL284,6.970616222,DPPIV,CC#CCn1c(C(=O)NCc2cccc3ccccc23)cnc1N1CCCC(N)C1,CC#CCn1c(C(=O)NCc2cccc3ccccc23)cnc1N1CCCC(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171480,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2c(OC)nn(Cc3nc(C)cc4ccccc34)c(=O)c21,CHEMBL255862,nM,19,CHEMBL284,7.721246399,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c(OC)nn(Cc3nc(C)cc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2c(OC)nn(Cc3nc(C)cc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171481,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2c(OC)nn(Cc3cccc4ccccc34)c(=O)c21,CHEMBL255864,nM,52,CHEMBL284,7.283996656,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c(OC)nn(Cc3cccc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2c(OC)nn(Cc3cccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171482,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3nc(C)cc4ccccc34)c(=O)c21,CHEMBL255492,nM,21,CHEMBL284,7.677780705,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3nc(C)cc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3nc(C)cc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171483,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3cccc4ccccc34)c(=O)c21,CHEMBL255491,nM,89,CHEMBL284,7.050609993,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3cccc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3cccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171484,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2c(C)nn(Cc3nc(C)cc4ccccc34)c(=O)c21,CHEMBL255709,nM,7,CHEMBL284,8.15490196,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c(C)nn(Cc3nc(C)cc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2c(C)nn(Cc3nc(C)cc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171485,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc(C)cc4ccccc34)c(=O)c21,CHEMBL256521,nM,5,CHEMBL284,8.301029996,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc(C)cc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3nc(C)cc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171486,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3cccc4ccccc34)c(=O)c21,CHEMBL401709,nM,13,CHEMBL284,7.886056648,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3cccc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2cnn(Cc3cccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171487,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,CHEMBL402819,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2171488,CHEMBL925952,Inhibition of DPP4 in human Caco-2 cells after 1 hr,B,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cccc3ccccc13)c(=O)n2C,CHEMBL404326,nM,15,CHEMBL284,7.823908741,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cccc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190133,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1C2CC3CC1CC(O)(C3)C2,CHEMBL469660,nM,5.3,CHEMBL284,8.27572413,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1C2CC3CC1CC(O)(C3)C2,N#CC1CC(F)CN1C(=O)CNC1C2CC3CC1CC(O)(C3)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190134,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,COC12CC3CC(CC(NCC(=O)N4C[C@@H](F)C[C@H]4C#N)(C3)C1)C2,CHEMBL454193,nM,8.3,CHEMBL284,8.080921908,DPPIV,COC12CC3CC(CC(NCC(=O)N4C[C@@H](F)C[C@H]4C#N)(C3)C1)C2,COC12CC3CC(CC(NCC(=O)N4CC(F)CC4C#N)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190135,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,CHEMBL469659,nM,3.1,CHEMBL284,8.508638306,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,N#CC1CC(F)CN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190136,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1C2CC3CC(C2)CC1C3,CHEMBL451937,nM,3.1,CHEMBL284,8.508638306,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1C2CC3CC(C2)CC1C3,N#CC1CC(F)CN1C(=O)CNC1C2CC3CC(C2)CC1C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190137,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC12CC3CC(CC(C3)C1)C2,CHEMBL511785,nM,4.1,CHEMBL284,8.387216143,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC12CC3CC(CC(C3)C1)C2,N#CC1CC(F)CN1C(=O)CNC12CC3CC(CC(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190138,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CCCCCCC1,CHEMBL470681,nM,3.3,CHEMBL284,8.48148606,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CCCCCCC1,N#CC1CC(F)CN1C(=O)CNC1CCCCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190139,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1(CO)CCCC1,CHEMBL513725,nM,3.3,CHEMBL284,8.48148606,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1(CO)CCCC1,N#CC1CC(F)CN1C(=O)CNC1(CO)CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190140,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CCCC1,CHEMBL470477,nM,2.6,CHEMBL284,8.585026652,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CCCC1,N#CC1CC(F)CN1C(=O)CNC1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190141,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CCC1,CHEMBL470476,nM,3.1,CHEMBL284,8.508638306,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CCC1,N#CC1CC(F)CN1C(=O)CNC1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190142,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CC1,CHEMBL470330,nM,33,CHEMBL284,7.48148606,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC1CC1,N#CC1CC(F)CN1C(=O)CNC1CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190143,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,C#CC(CC)(CC)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL472097,nM,316,CHEMBL284,6.500312917,DPPIV,C#CC(CC)(CC)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,C#CC(CC)(CC)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190144,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CO)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL472096,nM,4.6,CHEMBL284,8.337242168,DPPIV,CC(C)(CO)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CO)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190145,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,COCC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N.Cl,CHEMBL1203962,nM,13,CHEMBL284,7.886056648,DPPIV,COCC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,COCC(C)(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190146,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)OCCCNCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL469452,nM,8.7,CHEMBL284,8.060480747,DPPIV,CC(C)OCCCNCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)OCCCNCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190147,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL472102,nM,7.8,CHEMBL284,8.107905397,DPPIV,CC(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190148,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL512726,nM,2.9,CHEMBL284,8.537602002,DPPIV,CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190149,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,COc1ccc(CCNCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1OC,CHEMBL472101,nM,27,CHEMBL284,7.568636236,DPPIV,COc1ccc(CCNCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1OC,COc1ccc(CCNCC(=O)N2CC(F)CC2C#N)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190150,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(/C=C/c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL508845,nM,16,CHEMBL284,7.795880017,DPPIV,CC(C)(/C=C/c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(C=Cc1ccccc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190151,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1cc2ccccc2o1,CHEMBL472100,nM,88,CHEMBL284,7.055517328,DPPIV,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1cc2ccccc2o1,CC(C)(NCC(=O)N1CC(F)CC1C#N)c1cc2ccccc2o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190152,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1cccs1,CHEMBL512890,nM,12,CHEMBL284,7.920818754,DPPIV,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1cccs1,CC(C)(NCC(=O)N1CC(F)CC1C#N)c1cccs1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190153,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1ccco1,CHEMBL471089,nM,8.6,CHEMBL284,8.065501549,DPPIV,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1ccco1,CC(C)(NCC(=O)N1CC(F)CC1C#N)c1ccco1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190154,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1ccccn1,CHEMBL512694,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)(NCC(=O)N1C[C@@H](F)C[C@H]1C#N)c1ccccn1,CC(C)(NCC(=O)N1CC(F)CC1C#N)c1ccccn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190155,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CN(Cc1ccc(C#N)cc1)C(=O)c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL471088,nM,6.2,CHEMBL284,8.207608311,DPPIV,CC(C)(CN(Cc1ccc(C#N)cc1)C(=O)c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CN(Cc1ccc(C#N)cc1)C(=O)c1ccccc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2190156,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)CN(CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N)C(=O)c1ccccc1,CHEMBL470893,nM,7.3,CHEMBL284,8.13667714,DPPIV,CC(C)CN(CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N)C(=O)c1ccccc1,CC(C)CN(CC(C)(C)NCC(=O)N1CC(F)CC1C#N)C(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191775,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CCN(CC)CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL511128,nM,252,CHEMBL284,6.598599459,DPPIV,CCN(CC)CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CCN(CC)CC(C)(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191776,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNCc1ccc(C#N)cc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL485828,nM,39,CHEMBL284,7.408935393,DPPIV,CC(C)(CNCc1ccc(C#N)cc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNCc1ccc(C#N)cc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191777,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)CNCC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL504237,nM,316,CHEMBL284,6.500312917,DPPIV,CC(C)CNCC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)CNCC(C)(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191778,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CN(CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N)S(=O)(=O)c1ccccc1,CHEMBL520854,nM,31,CHEMBL284,7.508638306,DPPIV,CN(CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N)S(=O)(=O)c1ccccc1,CN(CC(C)(C)NCC(=O)N1CC(F)CC1C#N)S(=O)(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191779,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNS(=O)(=O)c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL485827,nM,75,CHEMBL284,7.124938737,DPPIV,CC(C)(CNS(=O)(=O)c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNS(=O)(=O)c1ccccc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191780,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL488810,nM,109,CHEMBL284,6.962573502,DPPIV,CC(C)(CNC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191781,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)C1(C)CCCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL487862,nM,13,CHEMBL284,7.886056648,DPPIV,CC(C)(CNC(=O)C1(C)CCCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)C1(C)CCCCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191782,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)C(C)(C)C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL487861,nM,5.8,CHEMBL284,8.236572006,DPPIV,CC(C)(CNC(=O)C(C)(C)C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)C(C)(C)C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191783,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)c1ccc2[nH]nnc2c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL487860,nM,1.5,CHEMBL284,8.823908741,DPPIV,CC(C)(CNC(=O)c1ccc2[nH]nnc2c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)c1ccc2[nH]nnc2c1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191784,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)c1ccc2[nH]cnc2c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL519585,nM,5.7,CHEMBL284,8.244125144,DPPIV,CC(C)(CNC(=O)c1ccc2[nH]cnc2c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)c1ccc2[nH]cnc2c1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191785,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)c1ccc2c(c1)CCO2)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL488036,nM,2.9,CHEMBL284,8.537602002,DPPIV,CC(C)(CNC(=O)c1ccc2c(c1)CCO2)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)c1ccc2c(c1)CCO2)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191786,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)c1cccs1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL488419,nM,5.4,CHEMBL284,8.26760624,DPPIV,CC(C)(CNC(=O)c1cccs1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)c1cccs1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191787,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL488418,nM,4.5,CHEMBL284,8.346787486,DPPIV,CC(C)(CNC(=O)c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)c1ccccc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191788,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,CC(C)(CNC(=O)c1ccccn1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL487681,nM,8.2,CHEMBL284,8.086186148,DPPIV,CC(C)(CNC(=O)c1ccccn1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CNC(=O)c1ccccn1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191789,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNCCNc1ccc(C(N)=O)cn1,CHEMBL521224,nM,2.4,CHEMBL284,8.619788758,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNCCN=c1ccc(C(N)=O)c[nH]1,N#CC1CC(F)CN1C(=O)CNCCN=c1ccc(C(N)=O)c[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191790,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNCCNc1ccc(Cl)cn1,CHEMBL500008,nM,2.7,CHEMBL284,8.568636236,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNCCN=c1ccc(Cl)c[nH]1,N#CC1CC(F)CN1C(=O)CNCCN=c1ccc(Cl)c[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191791,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNCCNc1ccccn1,CHEMBL487680,nM,2.8,CHEMBL284,8.552841969,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNCCN=c1cccc[nH]1,N#CC1CC(F)CN1C(=O)CNCCN=c1cccc[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2191792,CHEMBL985439,Inhibition of DPP4 in human plasma by fluorescence assay,B,N#Cc1ccc(NCCNCC(=O)N2C[C@@H](F)C[C@H]2C#N)nc1.O=C(O)/C=C\C(=O)O,CHEMBL1744354,nM,1.1,CHEMBL284,8.958607315,DPPIV,N#Cc1ccc(=NCCNCC(=O)N2C[C@@H](F)C[C@H]2C#N)[nH]c1,N#Cc1ccc(=NCCNCC(=O)N2CC(F)CC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238086,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL488022,nM,510,CHEMBL284,6.292429824,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238087,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,CHEMBL488027,nM,4300,CHEMBL284,5.366531544,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238088,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccccc1OCC(=O)O)Cc1cc(F)c(F)cc1F,CHEMBL488713,nM,8500,CHEMBL284,5.070581074,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccccc1OCC(=O)O)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccccc1OCC(=O)O)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238089,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CC(C)[C@H](Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL488714,nM,2700,CHEMBL284,5.568636236,DPPIV,CC(C)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238090,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CC(C)[C@@H](Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL528328,nM,2200,CHEMBL284,5.657577319,DPPIV,CC(C)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238091,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)O)Cc1cc(F)c(F)cc1F,CHEMBL452836,nM,1400,CHEMBL284,5.853871964,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)O)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)O)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238092,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,CHEMBL488909,nM,2800,CHEMBL284,5.552841969,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)NCc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238093,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL488908,nM,2500,CHEMBL284,5.602059991,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238094,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL488056,nM,5900,CHEMBL284,5.229147988,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238095,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL470118,nM,1400,CHEMBL284,5.853871964,DPPIV,N[C@@H](CC(=O)n1nccc1C(=O)NCc1ccc(C(O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)n1nccc1C(=O)NCc1ccc(C(O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238097,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)[C@H](Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C.Cl,CHEMBL479536,nM,3600,CHEMBL284,5.443697499,DPPIV,CCOC(=O)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238098,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)[C@@H](Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C.Cl,CHEMBL516747,nM,2600,CHEMBL284,5.585026652,DPPIV,CCOC(=O)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Oc1ccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238099,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)COc1ccccc1NC(=O)C1CC=NN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL512013,nM,4800,CHEMBL284,5.318758763,DPPIV,CCOC(=O)COc1ccccc1NC(=O)C1CC=NN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCOC(=O)COc1ccccc1NC(=O)C1CC=NN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238100,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)COc1cccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1.Cl,CHEMBL472200,nM,1900,CHEMBL284,5.721246399,DPPIV,CCOC(=O)COc1cccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1,CCOC(=O)COc1cccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238101,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)COc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL472199,nM,690,CHEMBL284,6.161150909,DPPIV,CCOC(=O)COc1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)COc1ccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238102,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(S(=O)(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL472381,nM,8900,CHEMBL284,5.050609993,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(S(=O)(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccc(S(=O)(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238103,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(S(N)(=O)=O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL471515,nM,9100,CHEMBL284,5.040958608,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(S(N)(=O)=O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccc(S(N)(=O)=O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238104,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(N2CCOCC2)cc1)Cc1cc(F)c(F)cc1F,CHEMBL471343,nM,1600,CHEMBL284,5.795880017,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccc(N2CCOCC2)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccc(N2CCOCC2)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238105,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)COc1cccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1.Cl,CHEMBL518296,nM,2000,CHEMBL284,5.698970004,DPPIV,CCOC(=O)COc1cccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1,CCOC(=O)COc1cccc(CNC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238106,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)COc1ccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL456885,nM,2100,CHEMBL284,5.677780705,DPPIV,CCOC(=O)COc1ccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)COc1ccc(CNC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238107,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccc(S(N)(=O)=O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL459881,nM,3100,CHEMBL284,5.508638306,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccc(S(N)(=O)=O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)NCc1ccc(S(N)(=O)=O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238108,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.Nc1ccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CHEMBL518629,nM,1300,CHEMBL284,5.886056648,DPPIV,Nc1ccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,Nc1ccc(CNC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238109,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1nc2ccccc2[nH]1)Cc1cc(F)c(F)cc1F,CHEMBL462564,nM,3700,CHEMBL284,5.431798276,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1nc2ccccc2[nH]1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)NCc1nc2ccccc2[nH]1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238110,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccccn1)Cc1cc(F)c(F)cc1F,CHEMBL461112,nM,7400,CHEMBL284,5.13076828,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccccn1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)NCc1ccccn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238111,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)c1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL460951,nM,770,CHEMBL284,6.113509275,DPPIV,CCOC(=O)c1ccc(NC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)c1ccc(NC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238112,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL459883,nM,1600,CHEMBL284,5.795880017,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Nc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Nc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238113,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,COC(=O)c1ccc(CNC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL459882,nM,3000,CHEMBL284,5.522878745,DPPIV,COC(O)c1ccc(CNC(=O)c2ccnn2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,COC(O)c1ccc(CNC(=O)c2ccnn2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238114,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL461129,nM,1600,CHEMBL284,5.795880017,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)NCc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)NCc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238115,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.NC(=O)C1CC=NN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL511872,nM,5600,CHEMBL284,5.251811973,DPPIV,NC(=O)C1CC=NN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,NC(=O)C1CC=NN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238116,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,COC(=O)Cc1ccc(OC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL460950,nM,1900,CHEMBL284,5.721246399,DPPIV,COC(=O)Cc1ccc(OC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,COC(=O)Cc1ccc(OC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238117,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,CCOC(=O)c1ccc(OC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL460949,nM,1600,CHEMBL284,5.795880017,DPPIV,CCOC(=O)c1ccc(OC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)c1ccc(OC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238118,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)Oc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL452327,nM,2200,CHEMBL284,5.657577319,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)Oc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)Oc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238119,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,COC(=O)c1ccc(COC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL452326,nM,2700,CHEMBL284,5.568636236,DPPIV,COC(=O)c1ccc(COC(=O)C2CC=NN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,COC(=O)c1ccc(COC(=O)C2CC=NN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2238120,CHEMBL967900,Inhibition of DPP4 in human Caco-2 cells after 60 mins by fluorimetry assay,B,Cl.N[C@@H](CC(=O)N1N=CCC1C(=O)OCc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL510797,nM,710,CHEMBL284,6.148741651,DPPIV,N[C@@H](CC(=O)N1N=CCC1C(=O)OCc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1N=CCC1C(=O)OCc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252397,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,NCc1c(N)nc2ccccc2c1-c1ccc(Cl)cc1Cl,CHEMBL525183,nM,370,CHEMBL284,6.431798276,DPPIV,N=c1[nH]c2ccccc2c(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c2ccccc2c(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252399,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccccc2c1=O,CHEMBL498167,nM,250,CHEMBL284,6.602059991,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252400,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N[C@H](C(=O)N1CCC(F)C1)C1CCCCC1,CHEMBL443250,nM,170,CHEMBL284,6.769551079,DPPIV,NC(C(=O)N1CCC(F)C1)C1CCCCC1,NC(C(=O)N1CCC(F)C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252401,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N[C@H](C(=O)N1CC(F)(F)C(F)(F)C1)C1CCCCC1,CHEMBL380860,nM,110,CHEMBL284,6.958607315,DPPIV,NC(C(=O)N1CC(F)(F)C(F)(F)C1)C1CCCCC1,NC(C(=O)N1CC(F)(F)C(F)(F)C1)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252403,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,Cc1cc2ccccc2n1C[C@H](C)NCC(=O)N1CCC[C@H]1C#N,CHEMBL451319,nM,69,CHEMBL284,7.161150909,DPPIV,Cc1cc2ccccc2n1C[C@H](C)NCC(=O)N1CCC[C@H]1C#N,Cc1cc2ccccc2n1CC(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252404,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,Cc1nc2c(s1)CC([C@H](N)C(=O)N1CC[C@H](F)C1)CC2,CHEMBL496131,nM,43,CHEMBL284,7.366531544,DPPIV,Cc1nc2c(s1)CC(C(N)C(=O)N1CC[C@H](F)C1)CC2,Cc1nc2c(s1)CC(C(N)C(=O)N1CCC(F)C1)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252405,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N[C@H]1CCCCN(P(N)(=O)NS(=O)(=O)O)C1=O,CHEMBL495932,nM,25,CHEMBL284,7.602059991,DPPIV,NC1CCCCN(P(N)(=O)NS(=O)(=O)O)C1=O,NC1CCCCN(P(N)(=O)NS(=O)(=O)O)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252407,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N[C@H]1CCCN([P@@](N)(=O)NS(=O)(=O)O)C1=O,CHEMBL504823,nM,21,CHEMBL284,7.677780705,DPPIV,NC1CCCN([P@@](N)(=O)NS(=O)(=O)O)C1=O,NC1CCCN(P(N)(=O)NS(=O)(=O)O)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252409,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N#CC1CCCN1C(=O)C(N)C1CCCCC1,CHEMBL507254,nM,12,CHEMBL284,7.920818754,DPPIV,N#CC1CCCN1C(=O)C(N)C1CCCCC1,N#CC1CCCN1C(=O)C(N)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252410,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N[C@H]1CCN(P(N)(N)=O)C1=O,CHEMBL497993,nM,11,CHEMBL284,7.958607315,DPPIV,NC1CCN(P(N)(N)=O)C1=O,NC1CCN(P(N)(N)=O)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252411,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,COCCN(C)c1nc(N)c(CN)c(-c2ccc(Cl)cc2Cl)n1,CHEMBL324777,nM,9,CHEMBL284,8.045757491,DPPIV,COCCN(C)c1nc(-c2ccc(Cl)cc2Cl)c(CN)c(=N)[nH]1,COCCN(C)c1nc(-c2ccc(Cl)cc2Cl)c(CN)c(=N)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252416,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N[C@@H](COc1cc(F)cc(F)c1)Cc1cc2ccccc2[nH]1,CHEMBL496953,nM,50000,CHEMBL284,4.301029996,DPPIV,N[C@@H](COc1cc(F)cc(F)c1)Cc1cc2ccccc2[nH]1,NC(COc1cc(F)cc(F)c1)Cc1cc2ccccc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252417,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N#C[C@@H]1Cc2ccccc2CN1C(=O)[C@@H](N)Cc1cc2ccccc2[nH]1,CHEMBL497782,nM,13000,CHEMBL284,4.886056648,DPPIV,N#C[C@@H]1Cc2ccccc2CN1C(=O)C(N)Cc1cc2ccccc2[nH]1,N#CC1Cc2ccccc2CN1C(=O)C(N)Cc1cc2ccccc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252418,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N#C[C@@H]1CCCN1C(=O)N[C@H](CN)C1CCCCC1,CHEMBL522911,nM,12000,CHEMBL284,4.920818754,DPPIV,N#C[C@@H]1CCCN1C(=O)N[C@H](CN)C1CCCCC1,N#CC1CCCN1C(=O)NC(CN)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252420,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,N#C[C@@H]1CCCN1C(=O)/C(N)=C/C(=O)N1Cc2ccccc2C1,CHEMBL527015,nM,45,CHEMBL284,7.346787486,DPPIV,N#C[C@@H]1CCCN1C(=O)C(=N)CC(=O)N1Cc2ccccc2C1,N#CC1CCCN1C(=O)C(=N)CC(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2252421,CHEMBL999374,Inhibition of human DPP4 expressed in baculovirus system,B,C=CCN(CC=C)C(=O)n1cnc(S(=O)(=O)C2CC3CCC2C3)n1,CHEMBL522909,nM,21,CHEMBL284,7.677780705,DPPIV,C=CCN(CC=C)C(=O)n1cnc(S(=O)(=O)C2CC3CCC2C3)n1,C=CCN(CC=C)C(=O)n1cnc(S(=O)(=O)C2CC3CCC2C3)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258951,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,CC1(NC(=O)C[C@H](N)Cc2ccccc2F)CCN(Cc2ccccc2)CC1,CHEMBL513764,nM,7800,CHEMBL284,5.107905397,DPPIV,CC1(NC(=O)C[C@H](N)Cc2ccccc2F)CCN(Cc2ccccc2)CC1,CC1(NC(=O)CC(N)Cc2ccccc2F)CCN(Cc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258952,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2ccccc2)CCN(Cc2ccccc2)CC1)Cc1ccccc1F,CHEMBL471633,nM,1000,CHEMBL284,6,DPPIV,N[C@@H](CC(=O)NC1(c2ccccc2)CCN(Cc2ccccc2)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2ccccc2)CCN(Cc2ccccc2)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258953,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(Cc2ccccc2)CCN(Cc2ccccc2)CC1)Cc1ccccc1F,CHEMBL471841,nM,2200,CHEMBL284,5.657577319,DPPIV,N[C@@H](CC(=O)NC1(Cc2ccccc2)CCN(Cc2ccccc2)CC1)Cc1ccccc1F,NC(CC(=O)NC1(Cc2ccccc2)CCN(Cc2ccccc2)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258954,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,CN1CCC(NC(=O)C[C@H](N)Cc2ccccc2F)(c2ccccc2)CC1,CHEMBL471842,nM,870,CHEMBL284,6.060480747,DPPIV,CN1CCC(NC(=O)C[C@H](N)Cc2ccccc2F)(c2ccccc2)CC1,CN1CCC(NC(=O)CC(N)Cc2ccccc2F)(c2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258955,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2ccccc2)CCOCC1)Cc1ccccc1F,CHEMBL470170,nM,2500,CHEMBL284,5.602059991,DPPIV,N[C@@H](CC(=O)NC1(c2ccccc2)CCOCC1)Cc1ccccc1F,NC(CC(=O)NC1(c2ccccc2)CCOCC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258956,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2ccccc2)CCSCC1)Cc1ccccc1F,CHEMBL470171,nM,3300,CHEMBL284,5.48148606,DPPIV,N[C@@H](CC(=O)NC1(c2ccccc2)CCSCC1)Cc1ccccc1F,NC(CC(=O)NC1(c2ccccc2)CCSCC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258957,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2ccccc2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL512145,nM,570,CHEMBL284,6.244125144,DPPIV,N[C@@H](CC(=O)NC1(c2ccccc2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2ccccc2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258958,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2ccccn2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL469325,nM,470,CHEMBL284,6.327902142,DPPIV,N[C@@H](CC(=O)NC1(c2ccccn2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2ccccn2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258959,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2nccs2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL469538,nM,190,CHEMBL284,6.721246399,DPPIV,N[C@@H](CC(=O)NC1(c2nccs2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2nccs2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258960,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2nc3ccccc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL512718,nM,64,CHEMBL284,7.193820026,DPPIV,N[C@@H](CC(=O)NC1(c2nc3ccccc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2nc3ccccc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258961,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2nc3ccccc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL472027,nM,13,CHEMBL284,7.886056648,DPPIV,N[C@@H](CC(=O)NC1(c2nc3ccccc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nc3ccccc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258962,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)sc2c1,CHEMBL512709,nM,12,CHEMBL284,7.920818754,DPPIV,COc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)sc2c1,COc1ccc2nc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258963,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1,CHEMBL470356,nM,2.7,CHEMBL284,8.568636236,DPPIV,COc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1,COc1ccc2nc(C3(NC(=O)CC(N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258964,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COc1ccc2sc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)nc2c1,CHEMBL470357,nM,3.3,CHEMBL284,8.48148606,DPPIV,COc1ccc2sc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)nc2c1,COc1ccc2sc(C3(NC(=O)CC(N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)nc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258965,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COc1cccc2sc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)nc12,CHEMBL513543,nM,270,CHEMBL284,6.568636236,DPPIV,COc1cccc2sc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)nc12,COc1cccc2sc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258966,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2nc3ccc(Cl)cc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL469730,nM,35,CHEMBL284,7.455931956,DPPIV,N[C@@H](CC(=O)NC1(c2nc3ccc(Cl)cc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2nc3ccc(Cl)cc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258967,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2nc3c(Cl)cccc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL469521,nM,130,CHEMBL284,6.886056648,DPPIV,N[C@@H](CC(=O)NC1(c2nc3c(Cl)cccc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2nc3c(Cl)cccc3s2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258968,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,Cc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)sc2c1,CHEMBL469522,nM,70,CHEMBL284,7.15490196,DPPIV,Cc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)sc2c1,Cc1ccc2nc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258969,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,Cc1cccc2sc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)nc12,CHEMBL469740,nM,350,CHEMBL284,6.455931956,DPPIV,Cc1cccc2sc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)nc12,Cc1cccc2sc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258970,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1,CHEMBL471834,nM,1,CHEMBL284,9,DPPIV,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1,COCCOc1ccc2nc(C3(NC(=O)CC(N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258971,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCOCC3)sc2c1,CHEMBL470164,nM,3.6,CHEMBL284,8.443697499,DPPIV,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCOCC3)sc2c1,COCCOc1ccc2nc(C3(NC(=O)CC(N)Cc4cc(F)c(F)cc4F)CCOCC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258972,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(Cl)ccc4F)CCS(=O)(=O)CC3)sc2c1,CHEMBL512651,nM,0.64,CHEMBL284,9.193820026,DPPIV,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(Cl)ccc4F)CCS(=O)(=O)CC3)sc2c1,COCCOc1ccc2nc(C3(NC(=O)CC(N)Cc4cc(Cl)ccc4F)CCS(=O)(=O)CC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258973,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(Cl)ccc4F)CCOCC3)sc2c1,CHEMBL469317,nM,1.9,CHEMBL284,8.721246399,DPPIV,COCCOc1ccc2nc(C3(NC(=O)C[C@H](N)Cc4cc(Cl)ccc4F)CCOCC3)sc2c1,COCCOc1ccc2nc(C3(NC(=O)CC(N)Cc4cc(Cl)ccc4F)CCOCC3)sc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2258974,CHEMBL1002063,Inhibition of human Caco-2 cells-derived DPP4,B,N[C@@H](CC(=O)NC1(c2nc3ccc(OCCN4CCOCC4)cc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL504021,nM,0.79,CHEMBL284,9.102372909,DPPIV,N[C@@H](CC(=O)NC1(c2nc3ccc(OCCN4CCOCC4)cc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nc3ccc(OCCN4CCOCC4)cc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275011,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)N1Cc2ccccc2C1,CHEMBL522002,nM,298,CHEMBL284,6.525783736,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CC(=O)N1Cc2ccccc2C1,N#CC1CCCN1C(=O)C(N)CC(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275015,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCCC(=O)N1Cc2ccccc2C1,CHEMBL493544,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCCC(=O)N1Cc2ccccc2C1,N#CC1CCCN1C(=O)C(N)CCCC(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275019,CHEMBL1030770,Inhibition of DPP4,B,N[C@@H](CCC(=O)N1Cc2ccccc2C1)C(=O)N1CCSC1,CHEMBL493760,nM,1600,CHEMBL284,5.795880017,DPPIV,NC(CCC(=O)N1Cc2ccccc2C1)C(=O)N1CCSC1,NC(CCC(=O)N1Cc2ccccc2C1)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275023,CHEMBL1030770,Inhibition of DPP4,B,C[C@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL475662,nM,8,CHEMBL284,8.096910013,DPPIV,CC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)C(=O)N1CCC[C@H]1C#N,CC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275028,CHEMBL1030770,Inhibition of DPP4,B,CC[C@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL474002,nM,31,CHEMBL284,7.508638306,DPPIV,CCC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)C(=O)N1CCC[C@H]1C#N,CCC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275033,CHEMBL1030770,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL474003,nM,12,CHEMBL284,7.920818754,DPPIV,CC(C)(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275038,CHEMBL1030770,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL475169,nM,31,CHEMBL284,7.508638306,DPPIV,CC(C)(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCn2nc(C(F)(F)F)nc2C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275043,CHEMBL1030770,Inhibition of DPP4,B,CC(C)(CC(=O)N1Cc2ccccc2C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL475863,nM,12,CHEMBL284,7.920818754,DPPIV,CC(C)(CC(=O)N1Cc2ccccc2C1)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1Cc2ccccc2C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275048,CHEMBL1030770,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCc2ccccc2C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL474025,nM,16,CHEMBL284,7.795880017,DPPIV,CC(C)(CC(=O)N1CCc2ccccc2C1)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCc2ccccc2C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275053,CHEMBL1030770,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCc2ccsc2C1)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL514006,nM,25,CHEMBL284,7.602059991,DPPIV,CC(C)(CC(=O)N1CCc2ccsc2C1)C(N)C(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCc2ccsc2C1)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275058,CHEMBL1030770,Inhibition of DPP4,B,COC[C@@H]1CCCN1C(=O)CC(C)(C)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL475870,nM,14,CHEMBL284,7.853871964,DPPIV,COC[C@@H]1CCCN1C(=O)CC(C)(C)C(N)C(=O)N1CCC[C@H]1C#N,COCC1CCCN1C(=O)CC(C)(C)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275063,CHEMBL1030770,Inhibition of DPP4,B,C[C@@H]1CCCN1C(=O)CC(C)(C)[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL514317,nM,13,CHEMBL284,7.886056648,DPPIV,C[C@@H]1CCCN1C(=O)CC(C)(C)C(N)C(=O)N1CCC[C@H]1C#N,CC1CCCN1C(=O)CC(C)(C)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275068,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1Cc2ccccc2C1,CHEMBL493543,nM,2,CHEMBL284,8.698970004,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1Cc2ccccc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275069,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL2364733,nM,2,CHEMBL284,8.698970004,DPPIV,N#C[C@H]1CCCN1C(=O)C(N)CCC(=O)N1Cc2ccccc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275077,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL494146,nM,5,CHEMBL284,8.301029996,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCc2ccccc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275082,CHEMBL1030770,Inhibition of DPP4,B,COc1cc2c(cc1OC)C(C(C)C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C#N)CC2.O=C(O)C(F)(F)F,CHEMBL494147,nM,35,CHEMBL284,7.455931956,DPPIV,COc1cc2c(cc1OC)C(C(C)C)N(C(=O)CCC(N)C(=O)N1CCC[C@H]1C#N)CC2,COc1cc2c(cc1OC)C(C(C)C)N(C(=O)CCC(N)C(=O)N1CCCC1C#N)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275087,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCc2nc(-c3ccc(F)cc3)sc2C1.O=C(O)C(F)(F)F,CHEMBL494339,nM,40,CHEMBL284,7.397940009,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCc2nc(-c3ccc(F)cc3)sc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCc2nc(-c3ccc(F)cc3)sc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275092,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCc2ccsc2C1.O=C(O)C(F)(F)F,CHEMBL494340,nM,6,CHEMBL284,8.22184875,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCc2ccsc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCc2ccsc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275097,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCn2cnnc2C1.O=C(O)C(F)(F)F,CHEMBL492536,nM,7,CHEMBL284,8.15490196,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCn2cnnc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCn2cnnc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275102,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCn2c(nnc2C(F)(F)F)C1.O=C(O)C(F)(F)F,CHEMBL492733,nM,5,CHEMBL284,8.301029996,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCn2c(nnc2C(F)(F)F)C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCn2c(nnc2C(F)(F)F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275107,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCn2nc(C(F)(F)F)nc2C1.O=C(O)C(F)(F)F,CHEMBL474047,nM,9,CHEMBL284,8.045757491,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCn2nc(C(F)(F)F)nc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCn2nc(C(F)(F)F)nc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275112,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCn2cc(C(F)(F)F)nc2C1.O=C(O)C(F)(F)F,CHEMBL474048,nM,6,CHEMBL284,8.22184875,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCn2cc(C(F)(F)F)nc2C1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCn2cc(C(F)(F)F)nc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275117,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCCC1.O=C(O)C(F)(F)F,CHEMBL474049,nM,7,CHEMBL284,8.15490196,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCCC1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275122,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCSC1.O=C(O)C(F)(F)F,CHEMBL474211,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCSC1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275127,CHEMBL1030770,Inhibition of DPP4,B,COC[C@H]1CCCN1C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL474394,nM,22,CHEMBL284,7.657577319,DPPIV,COC[C@H]1CCCN1C(=O)CCC(N)C(=O)N1CCC[C@H]1C#N,COCC1CCCN1C(=O)CCC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275132,CHEMBL1030770,Inhibition of DPP4,B,COC[C@@H]1CCCN1C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL475465,nM,7,CHEMBL284,8.15490196,DPPIV,COC[C@@H]1CCCN1C(=O)CCC(N)C(=O)N1CCC[C@H]1C#N,COCC1CCCN1C(=O)CCC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275137,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCCCC1.O=C(O)C(F)(F)F,CHEMBL474800,nM,15,CHEMBL284,7.823908741,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCCCC1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275142,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCOCC1.O=C(O)C(F)(F)F,CHEMBL475634,nM,17,CHEMBL284,7.769551079,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCOCC1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCOCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275147,CHEMBL1030770,Inhibition of DPP4,B,CCOC(=O)N1CCN(C(=O)CC[C@H](N)C(=O)N2CCC[C@H]2C#N)CC1.O=C(O)C(F)(F)F,CHEMBL516080,nM,31,CHEMBL284,7.508638306,DPPIV,CCOC(=O)N1CCN(C(=O)CCC(N)C(=O)N2CCC[C@H]2C#N)CC1,CCOC(=O)N1CCN(C(=O)CCC(N)C(=O)N2CCCC2C#N)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275152,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCN(C(=O)C(F)(F)F)CC1.O=C(O)C(F)(F)F,CHEMBL474808,nM,8,CHEMBL284,8.096910013,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCN(C(=O)C(F)(F)F)CC1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCN(C(=O)C(F)(F)F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275157,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N1CCN(c2ccncc2)CC1.O=C(O)C(F)(F)F,CHEMBL474982,nM,19,CHEMBL284,7.721246399,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)N1CCN(c2ccncc2)CC1,N#CC1CCCN1C(=O)C(N)CCC(=O)N1CCN(c2ccncc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275162,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)Nc1ccccc1.O=C(O)C(F)(F)F,CHEMBL515435,nM,37,CHEMBL284,7.431798276,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)Nc1ccccc1,N#CC1CCCN1C(=O)C(N)CCC(=O)Nc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2275167,CHEMBL1030770,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)NC1CCCC1.O=C(O)C(F)(F)F,CHEMBL474983,nM,11,CHEMBL284,7.958607315,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCC(=O)NC1CCCC1,N#CC1CCCN1C(=O)C(N)CCC(=O)NC1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409792,CHEMBL975310,Inhibition of human DPP4,B,NCCc1cc(F)c(F)cc1F,CHEMBL470428,nM,30000,CHEMBL284,4.522878745,DPPIV,NCCc1cc(F)c(F)cc1F,NCCc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409793,CHEMBL975310,Inhibition of human DPP4,B,CC(C)[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL445544,nM,1930,CHEMBL284,5.714442691,DPPIV,CC(C)[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)C(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409794,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)C1CCCCC1,CHEMBL450211,nM,3580,CHEMBL284,5.446116973,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)C1CCCCC1,NC(Cc1cc(F)c(F)cc1F)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409795,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)CC1CCCCC1,CHEMBL510157,nM,30000,CHEMBL284,4.522878745,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)CC1CCCCC1,NC(Cc1cc(F)c(F)cc1F)CC1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409796,CHEMBL975310,Inhibition of human DPP4,B,CC(C)(C)[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL450091,nM,25900,CHEMBL284,4.586700236,DPPIV,CC(C)(C)[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)(C)C(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409797,CHEMBL975310,Inhibition of human DPP4,B,Fc1cc(F)c(C[C@@H]2CCCCN2)cc1F,CHEMBL469545,nM,30000,CHEMBL284,4.522878745,DPPIV,Fc1cc(F)c(C[C@@H]2CCCCN2)cc1F,Fc1cc(F)c(CC2CCCCN2)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409798,CHEMBL975310,Inhibition of human DPP4,B,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,CHEMBL501314,nM,3250,CHEMBL284,5.488116639,DPPIV,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409799,CHEMBL975310,Inhibition of human DPP4,B,COC(=O)c1ccc([C@H](N)Cc2cc(F)c(F)cc2F)cc1,CHEMBL509672,nM,1420,CHEMBL284,5.847711656,DPPIV,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2409800,CHEMBL975310,Inhibition of human DPP4,B,COC(=O)c1ccc([C@@H](N)Cc2cc(F)c(F)cc2F)cc1,CHEMBL471648,nM,30000,CHEMBL284,4.522878745,DPPIV,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,COC(=O)c1ccc(C(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410498,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)c1ccncc1,CHEMBL496691,nM,1970,CHEMBL284,5.705533774,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)c1ccncc1,NC(Cc1cc(F)c(F)cc1F)c1ccncc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410499,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)C1CCNCC1,CHEMBL451619,nM,272,CHEMBL284,6.565431096,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)C1CCNCC1,NC(Cc1cc(F)c(F)cc1F)C1CCNCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410500,CHEMBL975310,Inhibition of human DPP4,B,CC(C)(C)OC(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,CHEMBL496863,nM,270,CHEMBL284,6.568636236,DPPIV,CC(C)(C)OC(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,CC(C)(C)OC(=O)N1CCC(C(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410501,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2ccc(F)cc2F)CC1,CHEMBL497735,nM,35,CHEMBL284,7.455931956,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2ccc(F)cc2F)CC1,NC(Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2ccc(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410502,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cc3ccccc3cn2)CC1,CHEMBL498749,nM,26,CHEMBL284,7.585026652,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cc3ccccc3cn2)CC1,NC(Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cc3ccccc3cn2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410503,CHEMBL975310,Inhibition of human DPP4,B,Nc1nccnc1C(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,CHEMBL525011,nM,19,CHEMBL284,7.721246399,DPPIV,N=c1[nH]ccnc1C(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,N=c1[nH]ccnc1C(=O)N1CCC(C(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410504,CHEMBL975310,Inhibition of human DPP4,B,Cc1ncc(C)c(C(=O)N2CCC([C@H](N)Cc3cc(F)c(F)cc3F)CC2)n1,CHEMBL485123,nM,18,CHEMBL284,7.744727495,DPPIV,Cc1ncc(C)c(C(=O)N2CCC([C@H](N)Cc3cc(F)c(F)cc3F)CC2)n1,Cc1ncc(C)c(C(=O)N2CCC(C(N)Cc3cc(F)c(F)cc3F)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410505,CHEMBL975310,Inhibition of human DPP4,B,Cc1nccnc1C(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,CHEMBL485124,nM,22,CHEMBL284,7.657577319,DPPIV,Cc1nccnc1C(=O)N1CCC([C@H](N)Cc2cc(F)c(F)cc2F)CC1,Cc1nccnc1C(=O)N1CCC(C(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410506,CHEMBL975310,Inhibition of human DPP4,B,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cnc3ncccn23)CC1,CHEMBL485125,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@H](Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cnc3ncccn23)CC1,NC(Cc1cc(F)c(F)cc1F)C1CCN(C(=O)c2cnc3ncccn23)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2410507,CHEMBL975310,Inhibition of human DPP4,B,Cc1cc2ncc(C(=O)N3CCC([C@H](N)Cc4cc(F)c(F)cc4F)CC3)c(C)n2n1,CHEMBL484528,nM,4,CHEMBL284,8.397940009,DPPIV,Cc1cc2ncc(C(=O)N3CCC([C@H](N)Cc4cc(F)c(F)cc4F)CC3)c(C)n2n1,Cc1cc2ncc(C(=O)N3CCC(C(N)Cc4cc(F)c(F)cc4F)CC3)c(C)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450507,CHEMBL938682,Inhibition of DPP4,B,O=C([C@@H]1C[C@H](Nc2ccc3ccccc3c2)CN1)N1Cc2ccccc2C1,CHEMBL488493,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](Nc2ccc3ccccc3c2)CN1)N1Cc2ccccc2C1,O=C(C1CC(Nc2ccc3ccccc3c2)CN1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450509,CHEMBL938682,Inhibition of DPP4,B,O=C([C@@H]1C[C@H](Nc2cccc3ccccc23)CN1)N1Cc2ccccc2C1,CHEMBL527647,nM,4970,CHEMBL284,5.303643611,DPPIV,O=C(C1C[C@H](Nc2cccc3ccccc23)CN1)N1Cc2ccccc2C1,O=C(C1CC(Nc2cccc3ccccc23)CN1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450511,CHEMBL938682,Inhibition of DPP4,B,N[C@@H](CCCCN(c1ccc2ccccc2c1)c1ccc2ccccc2c1)C(=O)N1Cc2ccccc2C1,CHEMBL488047,nM,31250,CHEMBL284,4.505149978,DPPIV,NC(CCCCN(c1ccc2ccccc2c1)c1ccc2ccccc2c1)C(=O)N1Cc2ccccc2C1,NC(CCCCN(c1ccc2ccccc2c1)c1ccc2ccccc2c1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450513,CHEMBL938682,Inhibition of DPP4,B,N[C@@H](CCCCN(Cc1ccccc1)Cc1ccccc1)C(=O)N1Cc2ccccc2C1,CHEMBL487871,nM,62500,CHEMBL284,4.204119983,DPPIV,NC(CCCCN(Cc1ccccc1)Cc1ccccc1)C(=O)N1Cc2ccccc2C1,NC(CCCCN(Cc1ccccc1)Cc1ccccc1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450514,CHEMBL938682,Inhibition of DPP4,B,N[C@@H](CCCCNCc1ccccc1)C(=O)N1Cc2ccccc2C1,CHEMBL520200,nM,50000,CHEMBL284,4.301029996,DPPIV,NC(CCCCNCc1ccccc1)C(=O)N1Cc2ccccc2C1,NC(CCCCNCc1ccccc1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450517,CHEMBL938682,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1,CHEMBL488225,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450518,CHEMBL938682,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2ccc(C)cc2C1,CHEMBL506177,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(C)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(C)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450519,CHEMBL938682,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2ccc(F)cc2C1,CHEMBL502153,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(F)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450520,CHEMBL938682,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2cccc(F)c2C1,CHEMBL488105,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2cccc(F)c2C1,CCC(C)C(N)C(=O)N1Cc2cccc(F)c2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450521,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2cccnc2C1,CHEMBL453199,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2cccnc2C1,CCC(C)C(N)C(=O)N1Cc2cccnc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450522,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(N=[N+]=[N-])cc2C1,CHEMBL487432,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(N=[N+]=[N-])cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(N=[N+]=[N-])cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450523,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc([N+](=O)[O-])cc2C1,CHEMBL510322,nM,50000,CHEMBL284,4.301029996,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc([N+](=O)[O-])cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc([N+](=O)[O-])cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450524,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(I)cc2C1,CHEMBL508193,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(I)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(I)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450525,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(Br)cc2C1,CHEMBL469878,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(Br)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(Br)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450526,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1,CHEMBL469679,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450527,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(C(C)(C)C)cc2C1,CHEMBL469678,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(C(C)(C)C)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(C(C)(C)C)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450528,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(C)cc2C1,CHEMBL469669,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(C)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(C)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450529,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2ccc(F)cc2C1,CHEMBL466590,nM,80100,CHEMBL284,4.096367484,DPPIV,CCC(C)C(N)C(=O)N1Cc2ccc(F)cc2C1,CCC(C)C(N)C(=O)N1Cc2ccc(F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450530,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2cccc(C)c2C1,CHEMBL469892,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2cccc(C)c2C1,CCC(C)C(N)C(=O)N1Cc2cccc(C)c2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450531,CHEMBL938682,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1Cc2cccc(F)c2C1,CHEMBL469891,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2cccc(F)c2C1,CCC(C)C(N)C(=O)N1Cc2cccc(F)c2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450690,CHEMBL938686,Inhibition of DPP4,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)[C@@H](N)CCCCNc1ccc2ccccc2c1,CHEMBL472128,nM,560,CHEMBL284,6.251811973,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)C(N)CCCCNc1ccc2ccccc2c1,N#CC1CC(N=[N+]=[N-])CN1C(=O)C(N)CCCCNc1ccc2ccccc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450691,CHEMBL938686,Inhibition of DPP4,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)[C@@H](N)CCCCN(c1cccc2ccccc12)c1cccc2ccccc12,CHEMBL518144,nM,2500,CHEMBL284,5.602059991,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)C(N)CCCCN(c1cccc2ccccc12)c1cccc2ccccc12,N#CC1CC(N=[N+]=[N-])CN1C(=O)C(N)CCCCN(c1cccc2ccccc12)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450692,CHEMBL938686,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1C[C@H](N=[N+]=[N-])C[C@H]1C#N,CHEMBL511659,nM,52000,CHEMBL284,4.283996656,DPPIV,CCC(C)C(N)C(=O)N1C[C@H](N=[N+]=[N-])C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(N=[N+]=[N-])CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450693,CHEMBL938686,Inhibition of DPP4,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)[C@@H](N)CCCCNC(=O)OCc1ccccc1,CHEMBL471747,nM,530,CHEMBL284,6.27572413,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)C(N)CCCCNC(=O)OCc1ccccc1,N#CC1CC(N=[N+]=[N-])CN1C(=O)C(N)CCCCNC(=O)OCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450694,CHEMBL938686,Inhibition of DPP4,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)[C@@H](N)CCCCN,CHEMBL471731,nM,2200,CHEMBL284,5.657577319,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)C(N)CCCCN,N#CC1CC(N=[N+]=[N-])CN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450695,CHEMBL938686,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1C[C@@H](N=[N+]=[N-])C[C@H]1C#N,CHEMBL471547,nM,290,CHEMBL284,6.537602002,DPPIV,CCC(C)C(N)C(=O)N1C[C@@H](N=[N+]=[N-])C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(N=[N+]=[N-])CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2450696,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1C[C@@H](N=[N+]=[N-])C[C@H]1C#N,CHEMBL471546,nM,340,CHEMBL284,6.468521083,DPPIV,CCC(C)C(N)C(=O)N1C[C@@H](N=[N+]=[N-])C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(N=[N+]=[N-])CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451345,CHEMBL938686,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCCCNC(=O)OCc1ccccc1,CHEMBL471544,nM,35,CHEMBL284,7.455931956,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCCCNC(=O)OCc1ccccc1,N#CC1CCCN1C(=O)C(N)CCCCNC(=O)OCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451346,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)N1CCSC1,CHEMBL461092,nM,3700,CHEMBL284,5.431798276,DPPIV,NC(CCCCNC(=O)OCc1ccccc1)C(=O)N1CCSC1,NC(CCCCNC(=O)OCc1ccccc1)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451349,CHEMBL938686,Inhibition of DPP4,B,N#C[C@@H]1CCCCN1C(=O)[C@@H](N)CCCCN,CHEMBL461913,nM,51000,CHEMBL284,4.292429824,DPPIV,N#C[C@@H]1CCCCN1C(=O)C(N)CCCCN,N#CC1CCCCN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451353,CHEMBL938686,Inhibition of DPP4,B,NCCCC[C@H](N)C(=O)N1CCSC1,CHEMBL455298,nM,23000,CHEMBL284,4.638272164,DPPIV,NCCCCC(N)C(=O)N1CCSC1,NCCCCC(N)C(=O)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451357,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CCC(Cl)C1,CHEMBL460887,nM,94000,CHEMBL284,4.026872146,DPPIV,CCC(C)C(N)C(=O)N1CCC(Cl)C1,CCC(C)C(N)C(=O)N1CCC(Cl)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451358,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CCC(F)C1,CHEMBL460886,nM,3500,CHEMBL284,5.455931956,DPPIV,CCC(C)C(N)C(=O)N1CCC(F)C1,CCC(C)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451360,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CCC(O)C1,CHEMBL503809,nM,93000,CHEMBL284,4.031517051,DPPIV,CCC(C)C(N)C(=O)N1CCC(O)C1,CCC(C)C(N)C(=O)N1CCC(O)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451361,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CC=CCC1,CHEMBL452470,nM,52000,CHEMBL284,4.283996656,DPPIV,CCC(C)C(N)C(=O)N1CC=CCC1,CCC(C)C(N)C(=O)N1CC=CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451362,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CC=CC1,CHEMBL461291,nM,15000,CHEMBL284,4.823908741,DPPIV,CCC(C)C(N)C(=O)N1CC=CC1,CCC(C)C(N)C(=O)N1CC=CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451364,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CCCCC1,CHEMBL83418,nM,67000,CHEMBL284,4.173925197,DPPIV,CCC(C)C(N)C(=O)N1CCCCC1,CCC(C)C(N)C(=O)N1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451365,CHEMBL938686,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1CCC1,CHEMBL461496,nM,50400,CHEMBL284,4.297569464,DPPIV,CCC(C)C(N)C(=O)N1CCC1,CCC(C)C(N)C(=O)N1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451366,CHEMBL938686,Inhibition of DPP4,B,CCCC[C@H](N)C(=O)N1CCCC1,CHEMBL442952,nM,15000,CHEMBL284,4.823908741,DPPIV,CCCCC(N)C(=O)N1CCCC1,CCCCC(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451367,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](Cc1c[nH]cn1)C(=O)N1CCCC1,CHEMBL501521,nM,23100,CHEMBL284,4.63638802,DPPIV,NC(Cc1c[nH]cn1)C(=O)N1CCCC1,NC(Cc1c[nH]cn1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451368,CHEMBL938686,Inhibition of DPP4,B,N=C(NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCCC1)NC(=O)OCc1ccccc1,CHEMBL461290,nM,16800,CHEMBL284,4.774690718,DPPIV,N=C(NCCCC(NC(=O)OCc1ccccc1)C(=O)N1CCCC1)NC(=O)OCc1ccccc1,N=C(NCCCC(NC(=O)OCc1ccccc1)C(=O)N1CCCC1)NC(=O)OCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451369,CHEMBL938686,Inhibition of DPP4,B,N=C(N)NCCC[C@H](N)C(=O)N1CCCC1,CHEMBL461289,nM,12700,CHEMBL284,4.896196279,DPPIV,N=C(N)NCCCC(N)C(=O)N1CCCC1,N=C(N)NCCCC(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451370,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)N1CCCC1,CHEMBL460065,nM,9700,CHEMBL284,5.013228266,DPPIV,NC(CCCNC(=O)OCc1ccccc1)C(=O)N1CCCC1,NC(CCCNC(=O)OCc1ccccc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451372,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)N1CCCC1,CHEMBL459642,nM,15600,CHEMBL284,4.806875402,DPPIV,NC(CCCCNC(=O)OCc1ccccc1)C(=O)N1CCCC1,NC(CCCCNC(=O)OCc1ccccc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451373,CHEMBL938686,Inhibition of DPP4,B,NCCCC[C@H](N)C(=O)N1CCCC1,CHEMBL501126,nM,39000,CHEMBL284,4.408935393,DPPIV,NCCCCC(N)C(=O)N1CCCC1,NCCCCC(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451374,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCCC1,CHEMBL511346,nM,43500,CHEMBL284,4.361510743,DPPIV,NC(Cc1ccc(O)cc1)C(=O)N1CCCC1,NC(Cc1ccc(O)cc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451376,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](CS)C(=O)N1CCCC1,CHEMBL459159,nM,37000,CHEMBL284,4.431798276,DPPIV,NC(CS)C(=O)N1CCCC1,NC(CS)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451377,CHEMBL938686,Inhibition of DPP4,B,C[C@@H](O)[C@H](N)C(=O)N1CCCC1,CHEMBL459438,nM,98000,CHEMBL284,4.008773924,DPPIV,CC(=O)C(N)C(O)N1CCCC1,CC(=O)C(N)C(O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451381,CHEMBL938686,Inhibition of DPP4,B,N[C@@H](Cc1ccccc1)C(=O)N1CCCC1,CHEMBL453918,nM,21000,CHEMBL284,4.677780705,DPPIV,NC(Cc1ccccc1)C(=O)N1CCCC1,NC(Cc1ccccc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451384,CHEMBL938686,Inhibition of DPP4,B,CC(C)C[C@H](N)C(=O)N1CCCC1,CHEMBL453574,nM,24000,CHEMBL284,4.619788758,DPPIV,CC(C)CC(N)C(=O)N1CCCC1,CC(C)CC(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451385,CHEMBL938686,Inhibition of DPP4,B,CC[C@@H](C)[C@H](N)C(=O)N1CCCC1,CHEMBL453573,nM,3900,CHEMBL284,5.408935393,DPPIV,CCC(C)C(N)C(=O)N1CCCC1,CCC(C)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2451394,CHEMBL938686,Inhibition of DPP4,B,CC(C)[C@H](N)C(=O)N1CSC[C@H]1B(O)O,CHEMBL510594,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)C(N)C(=O)N1CSC[C@H]1B(O)O,CC(C)C(N)C(=O)N1CSCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462035,CHEMBL965322,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCSC1)C(=O)N1CC[C@H](F)C1,CHEMBL512887,nM,9800,CHEMBL284,5.008773924,DPPIV,NC(CC(=O)N1CCSC1)C(=O)N1CC[C@H](F)C1,NC(CC(=O)N1CCSC1)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462037,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2cccc(C(N)=O)c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL452290,nM,100,CHEMBL284,7,DPPIV,CC(c1ccc(-c2cccc(C(N)=O)c2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2cccc(C(N)=O)c2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462038,CHEMBL965322,Inhibition of DPP4,B,NC(=O)c1cccc(-c2ccc([C@H](N)Cc3cc(F)ccc3F)cc2)c1,CHEMBL452289,nM,32,CHEMBL284,7.494850022,DPPIV,NC(=O)c1cccc(-c2ccc([C@H](N)Cc3cc(F)ccc3F)cc2)c1,NC(=O)c1cccc(-c2ccc(C(N)Cc3cc(F)ccc3F)cc2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462039,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccncc2Cl)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL512895,nM,71,CHEMBL284,7.148741651,DPPIV,CC(c1ccc(-c2ccncc2Cl)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccncc2Cl)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462040,CHEMBL965322,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)c1ccc(-c2ccncc2Cl)cc1,CHEMBL472123,nM,107,CHEMBL284,6.970616222,DPPIV,N[C@H](Cc1cc(F)ccc1F)c1ccc(-c2ccncc2Cl)cc1,NC(Cc1cc(F)ccc1F)c1ccc(-c2ccncc2Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462041,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1ccc(-c2ccncc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL442673,nM,110,CHEMBL284,6.958607315,DPPIV,CC(c1ccc(-c2ccncc2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(-c2ccncc2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462042,CHEMBL965322,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)c1ccc(-c2ccncc2)cc1,CHEMBL471936,nM,253,CHEMBL284,6.596879479,DPPIV,N[C@H](Cc1cc(F)ccc1F)c1ccc(-c2ccncc2)cc1,NC(Cc1cc(F)ccc1F)c1ccc(-c2ccncc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462043,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1ccc(Br)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL472124,nM,245,CHEMBL284,6.610833916,DPPIV,CC(c1ccc(Br)cc1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1ccc(Br)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462044,CHEMBL965322,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)c1ccc(Br)cc1,CHEMBL504506,nM,1300,CHEMBL284,5.886056648,DPPIV,N[C@H](Cc1cc(F)ccc1F)c1ccc(Br)cc1,NC(Cc1cc(F)ccc1F)c1ccc(Br)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462046,CHEMBL965322,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)CN1CCCCC1=O,CHEMBL488678,nM,120,CHEMBL284,6.920818754,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)CN1CCCCC1=O,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)CN1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462047,CHEMBL965322,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCCNC(=O)[C@H]1CC(F)(F)F)Cc1ccccc1F,CHEMBL452297,nM,85,CHEMBL284,7.070581074,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1ccccc1F,NC(CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462048,CHEMBL965322,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCCNC(=O)[C@H]1CC(F)(F)F)CN1CCCCC1=O,CHEMBL510073,nM,120,CHEMBL284,6.920818754,DPPIV,N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)CN1CCCCC1=O,NC(CC(=O)N1CCCNC(=O)C1CC(F)(F)F)CN1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462049,CHEMBL965322,Inhibition of DPP4,B,C[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1ccccc1F,CHEMBL452805,nM,40,CHEMBL284,7.397940009,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)Cc1ccccc1F,CC1C(=O)NCCCN1C(=O)CC(N)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462050,CHEMBL965322,Inhibition of DPP4,B,C[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)CN1CCCCC1=O,CHEMBL507738,nM,20,CHEMBL284,7.698970004,DPPIV,CC1C(=O)NCCCN1C(=O)C[C@H](N)CN1CCCCC1=O,CC1C(=O)NCCCN1C(=O)CC(N)CN1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462051,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL527198,nM,46,CHEMBL284,7.337242168,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)Cc1cc(F)c(F)cc1F,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462052,CHEMBL965322,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL488469,nM,40,CHEMBL284,7.397940009,DPPIV,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1nc(-c2ccc(S(C)(=O)=O)cc2Cl)no1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462053,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL519591,nM,600,CHEMBL284,6.22184875,DPPIV,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)Cc1cc(F)c(F)cc1F,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)C(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462054,CHEMBL965322,Inhibition of DPP4,B,C[C@H](c1nc(-c2ccc(Cl)cc2Cl)no1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL487630,nM,615,CHEMBL284,6.211124884,DPPIV,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)C(N)C(=O)N1CC[C@H](F)C1,CC(c1nc(-c2ccc(Cl)cc2Cl)no1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462055,CHEMBL965322,Inhibition of DPP4,B,C[C@@H](c1nc(-c2ccc(OC(F)(F)F)cc2)no1)[C@H](N)Cc1cc(F)ccc1F,CHEMBL520067,nM,4400,CHEMBL284,5.356547324,DPPIV,CC(c1nc(-c2ccc(OC(F)(F)F)cc2)no1)[C@H](N)Cc1cc(F)ccc1F,CC(c1nc(-c2ccc(OC(F)(F)F)cc2)no1)C(N)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462057,CHEMBL965322,Inhibition of DPP4,B,Cc1noc(C(=O)C[C@H](N)Cc2cc(F)ccc2F)n1,CHEMBL507719,nM,55,CHEMBL284,7.259637311,DPPIV,Cc1noc(C(=O)C[C@H](N)Cc2cc(F)ccc2F)n1,Cc1noc(C(=O)CC(N)Cc2cc(F)ccc2F)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462058,CHEMBL965322,Inhibition of DPP4,B,Cc1noc(C(=O)C[C@H](N)C(=O)N2CC[C@H](F)C2)n1,CHEMBL488637,nM,8800,CHEMBL284,5.055517328,DPPIV,Cc1noc(C(=O)CC(N)C(=O)N2CC[C@H](F)C2)n1,Cc1noc(C(=O)CC(N)C(=O)N2CCC(F)C2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462059,CHEMBL965322,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CO)Cc1cc(F)ccc1F,CHEMBL488484,nM,200,CHEMBL284,6.698970004,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CO)Cc1cc(F)ccc1F,NC(CC(=O)N1CCCC1CO)Cc1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2462060,CHEMBL965322,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CO)C(=O)N1CC[C@H](F)C1,CHEMBL527424,nM,9200,CHEMBL284,5.036212173,DPPIV,NC(CC(=O)N1CCC[C@H]1CO)C(=O)N1CC[C@H](F)C1,NC(CC(=O)N1CCCC1CO)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507969,CHEMBL1034787,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL513425,nM,70,CHEMBL284,7.15490196,DPPIV,N[C@@H](CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507970,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCNCC1)Cc1cc(F)c(F)cc1F,CHEMBL519139,nM,1440,CHEMBL284,5.841637508,DPPIV,N[C@@H](CC(=O)N1CCCNCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCNCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507971,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL482338,nM,510,CHEMBL284,6.292429824,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507972,CHEMBL1034787,Inhibition of DPP4,B,CC(=O)N1CCCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1.Cl,CHEMBL480549,nM,3400,CHEMBL284,5.468521083,DPPIV,CC(=O)N1CCCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1,CC(=O)N1CCCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507973,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc3c(c2)OCO3)CC1)Cc1cc(F)c(F)cc1F,CHEMBL480550,nM,490,CHEMBL284,6.30980392,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc3c(c2)OCO3)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccc3c(c2)OCO3)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507974,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2cccnc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL481554,nM,410,CHEMBL284,6.387216143,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2cccnc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2cccnc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507975,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)OCc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL481714,nM,490,CHEMBL284,6.30980392,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)OCc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)OCc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507976,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)Nc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL521267,nM,1392,CHEMBL284,5.856360765,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)Nc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)Nc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507977,CHEMBL1034787,Inhibition of DPP4,B,CN1CCN(C(=O)N2CCCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)CC1.Cl,CHEMBL481725,nM,1500,CHEMBL284,5.823908741,DPPIV,CN1CCN(C(=O)N2CCCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)CC1,CN1CCN(C(=O)N2CCCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507978,CHEMBL1034787,Inhibition of DPP4,B,Cc1ccc(S(=O)(=O)N2CCCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1.Cl,CHEMBL481897,nM,350,CHEMBL284,6.455931956,DPPIV,Cc1ccc(S(=O)(=O)N2CCCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,Cc1ccc(S(=O)(=O)N2CCCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507979,CHEMBL1034787,Inhibition of DPP4,B,CS(=O)(=O)N1CCCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1.Cl,CHEMBL482070,nM,3100,CHEMBL284,5.508638306,DPPIV,CS(=O)(=O)N1CCCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1,CS(=O)(=O)N1CCCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507980,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL482071,nM,405,CHEMBL284,6.392544977,DPPIV,N[C@@H](CC(=O)N1CCCN(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507981,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(Cc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL520089,nM,387,CHEMBL284,6.412289035,DPPIV,N[C@@H](CC(=O)N1CCCN(Cc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(Cc2ccccc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507982,CHEMBL1034787,Inhibition of DPP4,B,CCN1CCCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1.Cl,CHEMBL481157,nM,6400,CHEMBL284,5.193820026,DPPIV,CCN1CCCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1,CCN1CCCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507983,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(c2ncccn2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL519773,nM,597,CHEMBL284,6.224025669,DPPIV,N[C@@H](CC(=O)N1CCCN(c2ncccn2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(c2ncccn2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507984,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(c2cnccn2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL481158,nM,423,CHEMBL284,6.373659633,DPPIV,N[C@@H](CC(=O)N1CCCN(c2cnccn2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(c2cnccn2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507986,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL482154,nM,223,CHEMBL284,6.651695137,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507987,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(S(=O)(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL474630,nM,239,CHEMBL284,6.621602099,DPPIV,N[C@@H](CC(=O)N1CCCN(S(=O)(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(S(=O)(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507988,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)Nc2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL474631,nM,788,CHEMBL284,6.103473783,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)Nc2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)Nc2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507989,CHEMBL1034787,Inhibition of DPP4,B,Cl.NC(=O)c1ccc(C(=O)N2CCCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,CHEMBL474794,nM,180,CHEMBL284,6.744727495,DPPIV,NC(=O)c1ccc(C(=O)N2CCCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,NC(=O)c1ccc(C(=O)N2CCCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507990,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL474812,nM,288,CHEMBL284,6.540607512,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507991,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)nc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL474813,nM,150,CHEMBL284,6.823908741,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)nc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)nc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507992,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2cccc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL475654,nM,50,CHEMBL284,7.301029996,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2cccc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2cccc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507993,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2cncc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL475655,nM,67,CHEMBL284,7.173925197,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2cncc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2cncc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2507994,CHEMBL1034787,Inhibition of DPP4,B,Cl.N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)o2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL473830,nM,260,CHEMBL284,6.585026652,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)o2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)o2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515605,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL515387,nM,12.9,CHEMBL284,7.88941029,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515606,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3noc4ccccc34)CC2)CN1)N1CCC(F)(F)C1,CHEMBL475246,nM,8.7,CHEMBL284,8.060480747,DPPIV,O=C(C1C[C@H](N2CCN(c3noc4ccccc34)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3noc4ccccc34)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515607,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4ccccc4o3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL515597,nM,8.2,CHEMBL284,8.086186148,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4ccccc4o3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3nc4ccccc4o3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515608,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4cnccc4o3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL475574,nM,5.8,CHEMBL284,8.236572006,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4cnccc4o3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3nc4cnccc4o3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515609,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4ccncc4o3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL475573,nM,7.4,CHEMBL284,8.13076828,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4ccncc4o3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3nc4ccncc4o3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515610,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3cnccn3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL474409,nM,5.6,CHEMBL284,8.251811973,DPPIV,O=C(C1C[C@H](N2CCN(c3cnccn3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3cnccn3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515611,CHEMBL1022016,Inhibition of human recombinant DPP4,B,N#Cc1cccnc1N1CCN([C@@H]2CN[C@H](C(=O)N3CCC(F)(F)C3)C2)CC1,CHEMBL514011,nM,4.8,CHEMBL284,8.318758763,DPPIV,N#Cc1cccnc1N1CCN([C@@H]2CNC(C(=O)N3CCC(F)(F)C3)C2)CC1,N#Cc1cccnc1N1CCN(C2CNC(C(=O)N3CCC(F)(F)C3)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515612,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc(C(F)(F)F)cn3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL474410,nM,5.2,CHEMBL284,8.283996656,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc(C(F)(F)F)cn3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3ccc(C(F)(F)F)cn3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515613,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4cccnc4o3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL475586,nM,5.2,CHEMBL284,8.283996656,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4cccnc4o3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3nc4cccnc4o3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515614,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC[C@@H](F)C1,CHEMBL473419,nM,51,CHEMBL284,7.292429824,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC[C@@H](F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515615,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCCC1,CHEMBL473418,nM,31,CHEMBL284,7.508638306,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCCC1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515616,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC[C@H](F)C1,CHEMBL514623,nM,31,CHEMBL284,7.508638306,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC[C@H](F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515617,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1C[C@@H](F)[C@@H](F)C1,CHEMBL474421,nM,13,CHEMBL284,7.886056648,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1C[C@@H](F)[C@@H](F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CC(F)C(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515618,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1C[C@@H](F)[C@H](F)C1,CHEMBL472992,nM,309,CHEMBL284,6.510041521,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1C[C@@H](F)[C@H](F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CC(F)C(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515619,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC(F)(F)C(F)(F)C1,CHEMBL515869,nM,25,CHEMBL284,7.602059991,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC(F)(F)C(F)(F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CC(F)(F)C(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515620,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC1,CHEMBL472993,nM,309,CHEMBL284,6.510041521,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515621,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC(F)C1,CHEMBL473188,nM,41,CHEMBL284,7.387216143,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC(F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515622,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC(F)(F)C1,CHEMBL514935,nM,134,CHEMBL284,6.872895202,DPPIV,O=C(C1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CC(F)(F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2515623,CHEMBL1022016,Inhibition of human recombinant DPP4,B,O=C([C@@H]1C[C@@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,CHEMBL472995,nM,338,CHEMBL284,6.4710833,DPPIV,O=C(C1C[C@@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,O=C(C1CC(N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2556632,CHEMBL981107,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL517072,nM,71,CHEMBL284,7.148741651,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2556634,CHEMBL981107,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCn2cnnc2C1)Cc1cc(F)c(F)cc1F,CHEMBL479370,nM,68,CHEMBL284,7.167491087,DPPIV,N[C@@H](CC(=O)N1CCn2cnnc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2cnnc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572462,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL479380,nM,165,CHEMBL284,6.782516056,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572472,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2CCSC2)nc1,CHEMBL480713,nM,10000,CHEMBL284,5,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2CCSC2)nc1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CCSC2)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572473,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2CC(F)(F)C[C@H]2C#N)nc1,CHEMBL480712,nM,93,CHEMBL284,7.031517051,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2CC(F)(F)C[C@H]2C#N)nc1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)(F)CC2C#N)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572474,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ncccc3Cl)C[C@@H]21,CHEMBL519272,nM,1300,CHEMBL284,5.886056648,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ncccc3Cl)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ncccc3Cl)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572475,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1cccnc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL452998,nM,91,CHEMBL284,7.040958608,DPPIV,N#Cc1cccnc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1cccnc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572476,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ncccc3[N+](=O)[O-])C[C@@H]21,CHEMBL480705,nM,78,CHEMBL284,7.107905397,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ncccc3[N+](=O)[O-])C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ncccc3[N+](=O)[O-])CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572477,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)nc1,CHEMBL519265,nM,147,CHEMBL284,6.832682665,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)nc1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572478,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(C(F)(F)F)cn3)C[C@@H]21,CHEMBL480324,nM,123,CHEMBL284,6.910094889,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(C(F)(F)F)cn3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ccc(C(F)(F)F)cn3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572479,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc([N+](=O)[O-])cn3)C[C@@H]21,CHEMBL479736,nM,85,CHEMBL284,7.070581074,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc([N+](=O)[O-])cn3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ccc([N+](=O)[O-])cn3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572480,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(Cl)cn3)C[C@@H]21,CHEMBL471956,nM,49,CHEMBL284,7.30980392,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(Cl)cn3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ccc(Cl)cn3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572481,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccccn3)C[C@@H]21,CHEMBL511125,nM,27,CHEMBL284,7.568636236,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccccn3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ccccn3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572482,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nccc4ccccc34)C[C@@H]21,CHEMBL509391,nM,3670,CHEMBL284,5.435333936,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nccc4ccccc34)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3nccc4ccccc34)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572483,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nc4ccccc4o3)C[C@@H]21,CHEMBL480537,nM,221,CHEMBL284,6.655607726,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nc4ccccc4o3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3nc4ccccc4o3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572484,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nc4ccccc4s3)C[C@@H]21,CHEMBL480536,nM,186,CHEMBL284,6.730487056,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nc4ccccc4s3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3nc4ccccc4s3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572485,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3cnc4ccccc4n3)C[C@@H]21,CHEMBL482104,nM,186,CHEMBL284,6.730487056,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3cnc4ccccc4n3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3cnc4ccccc4n3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572486,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nccs3)C[C@@H]21,CHEMBL479983,nM,146,CHEMBL284,6.835647144,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nccs3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3nccs3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572487,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nccc(C(F)(F)F)n3)C[C@@H]21,CHEMBL482262,nM,181,CHEMBL284,6.742321425,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3nccc(C(F)(F)F)n3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3nccc(C(F)(F)F)n3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572488,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ncccn3)C[C@@H]21,CHEMBL482261,nM,84,CHEMBL284,7.075720714,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ncccn3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ncccn3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572489,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c2ccccc12,CHEMBL480943,nM,1715,CHEMBL284,5.765735876,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c2ccccc12,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572490,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1cc(F)cc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c1,CHEMBL480942,nM,118,CHEMBL284,6.928117993,DPPIV,N#Cc1cc(F)cc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c1,N#Cc1cc(F)cc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572491,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1c(F)cc(F)cc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL520921,nM,630,CHEMBL284,6.200659451,DPPIV,N#Cc1c(F)cc(F)cc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1c(F)cc(F)cc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572492,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1cc(F)ccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL479803,nM,422,CHEMBL284,6.374687549,DPPIV,N#Cc1cc(F)ccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1cc(F)ccc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572493,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1cc(C(F)(F)F)ccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL480781,nM,141,CHEMBL284,6.850780887,DPPIV,N#Cc1cc(C(F)(F)F)ccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1cc(C(F)(F)F)ccc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572494,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1c(F)cccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL479794,nM,92,CHEMBL284,7.036212173,DPPIV,N#Cc1c(F)cccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1c(F)cccc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572495,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1cccc(F)c1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL481177,nM,63,CHEMBL284,7.200659451,DPPIV,N#Cc1cccc(F)c1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1cccc(F)c1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572496,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1c(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cccc1C(F)(F)F,CHEMBL520266,nM,42,CHEMBL284,7.37675071,DPPIV,N#Cc1c(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cccc1C(F)(F)F,N#Cc1c(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572497,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1c(Cl)cccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL479538,nM,31,CHEMBL284,7.508638306,DPPIV,N#Cc1c(Cl)cccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1c(Cl)cccc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572498,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL471960,nM,51,CHEMBL284,7.292429824,DPPIV,N#Cc1ccccc1N1C[C@@H]2[C@H](C1)[C@H]2NCC(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1ccccc1N1CC2C(C1)C2NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572499,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(C(=O)NC4CC4)cc3)C[C@@H]21,CHEMBL471785,nM,3740,CHEMBL284,5.427128398,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(C(=O)NC4CC4)cc3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ccc(C(=O)NC4CC4)cc3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572500,CHEMBL988353,Inhibition of human plasma DPP4,B,CNC(=O)c1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL471784,nM,3430,CHEMBL284,5.46470588,DPPIV,CNC(=O)c1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CNC(=O)c1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572501,CHEMBL988353,Inhibition of human plasma DPP4,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(C(N)=O)cc3)C[C@@H]21,CHEMBL480155,nM,95,CHEMBL284,7.022276395,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CN[C@H]1[C@@H]2CN(c3ccc(C(N)=O)cc3)C[C@@H]21,N#CC1CC(F)CN1C(=O)CNC1C2CN(c3ccc(C(N)=O)cc3)CC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572502,CHEMBL988353,Inhibition of human plasma DPP4,B,CCOC(=O)c1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL480154,nM,229,CHEMBL284,6.640164518,DPPIV,CCOC(=O)c1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CCOC(=O)c1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572503,CHEMBL988353,Inhibition of human plasma DPP4,B,CC(=O)c1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL480914,nM,109,CHEMBL284,6.962573502,DPPIV,CC(=O)c1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CC(=O)c1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572504,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1C(F)(F)F,CHEMBL480913,nM,2540,CHEMBL284,5.595166283,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1C(F)(F)F,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572505,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c(C(F)(F)F)c1,CHEMBL481288,nM,59,CHEMBL284,7.229147988,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c(C(F)(F)F)c1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)c(C(F)(F)F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572506,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1Cl,CHEMBL481290,nM,152,CHEMBL284,6.818156412,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1Cl,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572507,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c(Cl)c1,CHEMBL481669,nM,95,CHEMBL284,7.022276395,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c(Cl)c1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572508,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1c(F)cc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1F,CHEMBL520434,nM,38,CHEMBL284,7.420216403,DPPIV,N#Cc1c(F)cc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1F,N#Cc1c(F)cc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572509,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1F,CHEMBL479567,nM,110,CHEMBL284,6.958607315,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1F,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2572510,CHEMBL988353,Inhibition of human plasma DPP4,B,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c(F)c1,CHEMBL479381,nM,153,CHEMBL284,6.815308569,DPPIV,N#Cc1ccc(N2C[C@@H]3[C@H](C2)[C@H]3NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c(F)c1,N#Cc1ccc(N2CC3C(C2)C3NCC(=O)N2CC(F)CC2C#N)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2605864,CHEMBL1021164,Inhibition of DPP4,B,CC(C)(C)C(NC(=O)C[C@@H](N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CHEMBL515378,nM,251,CHEMBL284,6.600326279,DPPIV,CC(C)(C)C(NC(=O)CC(N)C(=O)N1CCC[C@H]1C#N)c1ccccc1,CC(C)(C)C(NC(=O)CC(N)C(=O)N1CCCC1C#N)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2605876,CHEMBL1021164,Inhibition of DPP4,B,CC[C@H](C)[C@H](N)C(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL461117,nM,0.6,CHEMBL284,9.22184875,DPPIV,CCC(C)C(N)C(=O)N1C[C@@H](F)C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2605879,CHEMBL1021164,Inhibition of DPP4,B,N#C[C@H]1C[C@@H](F)CN1C(=O)[C@@H](N)C(c1ccc(F)cc1)c1ccc(F)cc1,CHEMBL456413,nM,22,CHEMBL284,7.657577319,DPPIV,N#C[C@H]1C[C@@H](F)CN1C(=O)C(N)C(c1ccc(F)cc1)c1ccc(F)cc1,N#CC1CC(F)CN1C(=O)C(N)C(c1ccc(F)cc1)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2605882,CHEMBL1022259,Inhibition of human DPP4,B,CC1(NCC(=O)N2C[C@H](F)C[C@@H]2C#N)CCN(S(C)(=O)=O)CC1,CHEMBL456419,nM,6.2,CHEMBL284,8.207608311,DPPIV,CC1(NCC(=O)N2C[C@H](F)C[C@@H]2C#N)CCN(S(C)(=O)=O)CC1,CC1(NCC(=O)N2CC(F)CC2C#N)CCN(S(C)(=O)=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2605885,CHEMBL1022259,Inhibition of human DPP4,B,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1C#N,CHEMBL456420,nM,0.13,CHEMBL284,9.886056648,DPPIV,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1C#N,N#Cc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2605887,CHEMBL1022259,Inhibition of human DPP4,B,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1Cl,CHEMBL445437,nM,0.15,CHEMBL284,9.823908741,DPPIV,N#Cc1ccc(N[C@@H]2CNC(C(=O)N3CCC[C@H]3C#N)C2)cc1Cl,N#Cc1ccc(NC2CNC(C(=O)N3CCCC3C#N)C2)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606571,CHEMBL1021164,Inhibition of DPP4,B,CN(C)C(=O)[C@@H](c1ccc(C2=CN3N=CNC3C=C2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1,CHEMBL459357,nM,4.3,CHEMBL284,8.366531544,DPPIV,CN(C)C(=O)C(c1ccc(C2=CN3N=CNC3C=C2)cc1)C(N)C(=O)N1CC[C@H](F)C1,CN(C)C(=O)C(c1ccc(C2=CN3N=CNC3C=C2)cc1)C(N)C(=O)N1CCC(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606587,CHEMBL1021164,Inhibition of DPP4,B,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCC[C@H]1B(O)O,CHEMBL460842,nM,8,CHEMBL284,8.096910013,DPPIV,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCC[C@H]1B(O)O,O=C(CNC12CC3CC(CC(C3)C1)C2)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606590,CHEMBL1021164,Inhibition of DPP4,B,CC(C)[C@H](Oc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)ccc2F)cc1)C(=O)O.O=C(O)C(F)(F)F,CHEMBL445949,nM,0.48,CHEMBL284,9.318758763,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)C[C@H](N)Cc2cc(F)ccc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2CCCN2C(=O)CC(N)Cc2cc(F)ccc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606599,CHEMBL1021164,Inhibition of DPP4,B,CC(C)=CCN1C(C2CC[C@H]3NCC[C@@H]23)=NC2C1C(=O)N(CC(=O)c1ccccc1)C(=O)N2C,CHEMBL459591,nM,18,CHEMBL284,7.744727495,DPPIV,CC(C)=CCN1C(C2CC[C@H]3NCC[C@@H]23)=NC2C1C(=O)N(CC(=O)c1ccccc1)C(=O)N2C,CC(C)=CCN1C(C2CCC3NCCC32)=NC2C1C(=O)N(CC(=O)c1ccccc1)C(=O)N2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606603,CHEMBL1021164,Inhibition of DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)C(F)(F)F,CHEMBL459806,nM,10,CHEMBL284,8,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606606,CHEMBL1021164,Inhibition of DPP4,B,COc1ccccc1N1CCc2nc(C)c(CN)c(-c3ccc(Cl)cc3Cl)c2C1=O,CHEMBL459807,nM,2.28,CHEMBL284,8.642065153,DPPIV,COc1ccccc1N1CCc2nc(C)c(CN)c(-c3ccc(Cl)cc3Cl)c2C1=O,COc1ccccc1N1CCc2nc(C)c(CN)c(-c3ccc(Cl)cc3Cl)c2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2606609,CHEMBL1021164,Inhibition of DPP4,B,CC(N)/C(F)=C1\CCC[C@@H]1C#N.Cl,CHEMBL460013,nM,7690,CHEMBL284,5.11407366,DPPIV,CC(N)/C(F)=C1\CCC[C@@H]1C#N,CC(N)C(F)=C1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609323,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL473166,nM,85,CHEMBL284,7.070581074,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccccc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccccc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609324,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(F)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL514617,nM,54,CHEMBL284,7.26760624,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(F)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccc(F)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609325,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL473172,nM,64,CHEMBL284,7.193820026,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609326,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(F)cc1F)NCC(=O)N1CCC[C@H]1C#N,CHEMBL515552,nM,84,CHEMBL284,7.075720714,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(F)cc1F)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccc(F)cc1F)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609327,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cc(F)cc(F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL472976,nM,75,CHEMBL284,7.124938737,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cc(F)cc(F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cc(F)cc(F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609328,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(F)c(F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL472977,nM,62,CHEMBL284,7.207608311,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(F)c(F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccc(F)c(F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609329,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(C(F)(F)F)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL473176,nM,85,CHEMBL284,7.070581074,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(C(F)(F)F)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccc(C(F)(F)F)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609330,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(C(F)(F)F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL473973,nM,60,CHEMBL284,7.22184875,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(C(F)(F)F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(C(F)(F)F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609331,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(OC(F)(F)F)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL474559,nM,73,CHEMBL284,7.13667714,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(OC(F)(F)F)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(OC(F)(F)F)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609332,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(Cl)cc1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL474560,nM,86,CHEMBL284,7.065501549,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(Cl)cc1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccc(Cl)cc1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609333,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL463481,nM,42,CHEMBL284,7.37675071,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(Cl)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609334,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(Cl)c(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL474959,nM,68,CHEMBL284,7.167491087,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccc(Cl)c(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccc(Cl)c(Cl)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609335,CHEMBL1011679,Inhibition of human DPP4,B,COc1ccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1OC,CHEMBL474960,nM,101,CHEMBL284,6.995678626,DPPIV,COc1ccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cc1OC,COc1ccc(C2CC2NC(=O)CC(C)(C)NCC(=O)N2CCCC2C#N)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609336,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccnc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL472797,nM,24,CHEMBL284,7.619788758,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccnc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccnc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609337,CHEMBL1011679,Inhibition of human DPP4,B,Cc1ncsc1[C@H]1C[C@@H]1NC(=O)CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL474767,nM,16,CHEMBL284,7.795880017,DPPIV,Cc1ncsc1[C@H]1C[C@@H]1NC(=O)CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,Cc1ncsc1C1CC1NC(=O)CC(C)(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609338,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@@H]1C[C@H]1c1cccc(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL474768,nM,56,CHEMBL284,7.251811973,DPPIV,CC(C)(CC(=O)N[C@@H]1C[C@H]1c1cccc(Cl)c1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(Cl)c1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609340,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@@H]1C[C@H]1c1cccc(Cl)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL447393,nM,27,CHEMBL284,7.568636236,DPPIV,CC(C)(CC(=O)N[C@@H]1C[C@H]1c1cccc(Cl)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(Cl)c1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609341,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL464092,nM,19,CHEMBL284,7.721246399,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1ccccc1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1ccccc1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609342,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL517776,nM,15,CHEMBL284,7.823908741,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(Cl)c1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609343,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(F)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL464093,nM,21,CHEMBL284,7.677780705,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(F)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(F)c1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609344,CHEMBL1011679,Inhibition of human DPP4,B,COc1ccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL463277,nM,22,CHEMBL284,7.657577319,DPPIV,COc1ccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,COc1ccc(C2CC2NC(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609345,CHEMBL1011679,Inhibition of human DPP4,B,COc1cccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c1,CHEMBL518831,nM,26,CHEMBL284,7.585026652,DPPIV,COc1cccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c1,COc1cccc(C2CC2NC(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609346,CHEMBL1011679,Inhibition of human DPP4,B,CCOc1cccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c1,CHEMBL462839,nM,17,CHEMBL284,7.769551079,DPPIV,CCOc1cccc([C@H]2C[C@@H]2NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)c1,CCOc1cccc(C2CC2NC(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609347,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(OC(F)(F)F)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL463230,nM,20,CHEMBL284,7.698970004,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(OC(F)(F)F)c1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(OC(F)(F)F)c1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2609348,CHEMBL1011679,Inhibition of human DPP4,B,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1)NCC(=O)N1CC(F)(F)C[C@H]1C#N,CHEMBL463231,nM,26,CHEMBL284,7.585026652,DPPIV,CC(C)(CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1)NCC(=O)N1CC(F)(F)C[C@H]1C#N,CC(C)(CC(=O)NC1CC1c1cccc(Cl)c1)NCC(=O)N1CC(F)(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690353,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1)Cc1cccc(Cl)c1,CHEMBL562525,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1)Cc1cccc(Cl)c1,NC(CC(=O)N1CCCC1CNC(=O)c1ccccc1)Cc1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690354,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1F)Cc1ccccc1F,CHEMBL550862,nM,49,CHEMBL284,7.30980392,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1F)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1ccccc1F)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690355,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1cccc(F)c1)Cc1ccccc1F,CHEMBL552263,nM,92,CHEMBL284,7.036212173,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1cccc(F)c1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1cccc(F)c1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690356,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccc(F)cc1)Cc1ccccc1F,CHEMBL553936,nM,92,CHEMBL284,7.036212173,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccc(F)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1ccc(F)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690357,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccn1)Cc1ccccc1F,CHEMBL560123,nM,47,CHEMBL284,7.327902142,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccn1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1ccccn1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690358,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1cccnc1)Cc1ccccc1F,CHEMBL563911,nM,87,CHEMBL284,7.060480747,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1cccnc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1cccnc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690359,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccncc1)Cc1ccccc1F,CHEMBL562981,nM,66,CHEMBL284,7.180456064,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccncc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNC(=O)c1ccncc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690360,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,CS(=O)(=O)c1ccc(C(=O)NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2ccccc2F)cc1,CHEMBL557851,nM,77,CHEMBL284,7.113509275,DPPIV,CS(=O)(=O)c1ccc(C(=O)NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2ccccc2F)cc1,CS(=O)(=O)c1ccc(C(=O)NCC2CCCN2C(=O)CC(N)Cc2ccccc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690361,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,CS(=O)(=O)c1ccccc1C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1ccccc1F,CHEMBL563108,nM,27,CHEMBL284,7.568636236,DPPIV,CS(=O)(=O)c1ccccc1C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1ccccc1F,CS(=O)(=O)c1ccccc1C(=O)NCC1CCCN1C(=O)CC(N)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690362,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,CS(=O)(=O)c1ccccc1C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cccc(Cl)c1,CHEMBL564043,nM,14,CHEMBL284,7.853871964,DPPIV,CS(=O)(=O)c1ccccc1C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cccc(Cl)c1,CS(=O)(=O)c1ccccc1C(=O)NCC1CCCN1C(=O)CC(N)Cc1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690363,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,CS(=O)(=O)c1cccc(C(=O)NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cccc(Cl)c2)c1,CHEMBL564249,nM,0.38,CHEMBL284,9.420216403,DPPIV,CS(=O)(=O)c1cccc(C(=O)NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cccc(Cl)c2)c1,CS(=O)(=O)c1cccc(C(=O)NCC2CCCN2C(=O)CC(N)Cc2cccc(Cl)c2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690364,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CC1)Cc1cccc(Cl)c1,CHEMBL561120,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CC1)Cc1cccc(Cl)c1,NC(CC(=O)N1CCCC1CNC(=O)C1CC1)Cc1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690365,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CC1)Cc1cc(F)c(F)cc1F,CHEMBL563648,nM,9,CHEMBL284,8.045757491,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNC(=O)C1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690366,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccccc1)Cc1ccccc1F,CHEMBL539187,nM,34,CHEMBL284,7.468521083,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccccc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690367,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccccc1)Cc1cccc(Cl)c1,CHEMBL561322,nM,8,CHEMBL284,8.096910013,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccccc1)Cc1cccc(Cl)c1,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1ccccc1)Cc1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690368,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccccc1F)Cc1ccccc1F,CHEMBL549842,nM,53,CHEMBL284,7.27572413,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccccc1F)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1ccccc1F)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690369,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1cccc(F)c1)Cc1ccccc1F,CHEMBL562603,nM,94,CHEMBL284,7.026872146,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1cccc(F)c1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1cccc(F)c1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690370,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccc(F)cc1)Cc1ccccc1F,CHEMBL565056,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccc(F)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1ccc(F)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690371,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccc(Cl)cc1)Cc1ccccc1F,CHEMBL549432,nM,20,CHEMBL284,7.698970004,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1ccc(Cl)cc1)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1ccc(Cl)cc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690372,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1cc(Cl)ccc1Cl)Cc1ccccc1F,CHEMBL560183,nM,24,CHEMBL284,7.619788758,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)c1cc(Cl)ccc1Cl)Cc1ccccc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)c1cc(Cl)ccc1Cl)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690373,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)C1CC1)Cc1cccc(Cl)c1,CHEMBL560184,nM,30,CHEMBL284,7.522878745,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)C1CC1)Cc1cccc(Cl)c1,NC(CC(=O)N1CCCC1CNS(=O)(=O)C1CC1)Cc1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2690374,CHEMBL1058857,Inhibition of DPP4 by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)C1CC1)Cc1cc(F)c(F)cc1F,CHEMBL563272,nM,8,CHEMBL284,8.096910013,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)C1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)C1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697712,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,CHEMBL385517,nM,3,CHEMBL284,8.522878745,DPPIV,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2,N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697713,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@@H](N)C(=O)N12,CHEMBL539691,nM,105,CHEMBL284,6.978810701,DPPIV,N#C[C@@H]1CS[C@H]2CC(N)C(=O)N12,N#CC1CSC2CC(N)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697714,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(c3ccccc3)C(=O)N12,CHEMBL564670,nM,26,CHEMBL284,7.585026652,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(c3ccccc3)C(=O)N12,N#CC1CSC2CC(N)(c3ccccc3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697715,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,CC[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O.Cl,CHEMBL560583,nM,56,CHEMBL284,7.251811973,DPPIV,CC[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O,CCC1(N)CC2SCC(C#N)N2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697716,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,CC(C)[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O.Cl,CHEMBL564854,nM,33,CHEMBL284,7.48148606,DPPIV,CC(C)[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O,CC(C)C1(N)CC2SCC(C#N)N2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697717,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,CC(C)C[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O.Cl,CHEMBL561263,nM,63,CHEMBL284,7.200659451,DPPIV,CC(C)C[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O,CC(C)CC1(N)CC2SCC(C#N)N2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697718,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,CC[C@H](C)[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O.Cl,CHEMBL563772,nM,53,CHEMBL284,7.27572413,DPPIV,CC[C@H](C)[C@@]1(N)C[C@@H]2SC[C@@H](C#N)N2C1=O,CCC(C)C1(N)CC2SCC(C#N)N2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697719,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(Cc3ccccc3)C(=O)N12,CHEMBL561462,nM,109,CHEMBL284,6.962573502,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(Cc3ccccc3)C(=O)N12,N#CC1CSC2CC(N)(Cc3ccccc3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697720,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(C3CCCC3)C(=O)N12,CHEMBL558956,nM,89,CHEMBL284,7.050609993,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(C3CCCC3)C(=O)N12,N#CC1CSC2CC(N)(C3CCCC3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697721,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(C3CCCCC3)C(=O)N12,CHEMBL560985,nM,59,CHEMBL284,7.229147988,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(C3CCCCC3)C(=O)N12,N#CC1CSC2CC(N)(C3CCCCC3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697722,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(CCc3ccccc3)C(=O)N12,CHEMBL558313,nM,205,CHEMBL284,6.688246139,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(CCc3ccccc3)C(=O)N12,N#CC1CSC2CC(N)(CCc3ccccc3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697723,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(CC3CCCCC3)C(=O)N12,CHEMBL556219,nM,118,CHEMBL284,6.928117993,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(CC3CCCCC3)C(=O)N12,N#CC1CSC2CC(N)(CC3CCCCC3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697724,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,Cl.N#C[C@@H]1CS[C@H]2C[C@](N)(c3ccc(F)cc3)C(=O)N12,CHEMBL552403,nM,152,CHEMBL284,6.818156412,DPPIV,N#C[C@@H]1CS[C@H]2C[C@](N)(c3ccc(F)cc3)C(=O)N12,N#CC1CSC2CC(N)(c3ccc(F)cc3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697778,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,N#C[C@@H]1CS[C@H]2C[C@H](N)C(=O)N12,CHEMBL558509,nM,1600,CHEMBL284,5.795880017,DPPIV,N#C[C@@H]1CS[C@H]2CC(N)C(=O)N12,N#CC1CSC2CC(N)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697779,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,N#C[C@@H]1CS[C@H]2C[C@@H](NC3CCCC3)C(=O)N12,CHEMBL556220,nM,16000,CHEMBL284,4.795880017,DPPIV,N#C[C@@H]1CS[C@H]2CC(NC3CCCC3)C(=O)N12,N#CC1CSC2CC(NC3CCCC3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697780,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,N#C[C@@H]1CS[C@H]2C[C@@H](NCCc3ccccc3)C(=O)N12,CHEMBL552404,nM,16000,CHEMBL284,4.795880017,DPPIV,N#C[C@@H]1CS[C@H]2CC(NCCc3ccccc3)C(=O)N12,N#CC1CSC2CC(NCCc3ccccc3)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697781,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,N#C[C@@H]1CS[C@H]2CC[C@@H](N)C(=O)N12,CHEMBL551323,nM,1600,CHEMBL284,5.795880017,DPPIV,N#C[C@@H]1CS[C@H]2CCC(N)C(=O)N12,N#CC1CSC2CCC(N)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2697782,CHEMBL1061470,Inhibition of human recombinant DPP4 by fluorescence assay,B,N#C[C@@H]1CS[C@H]2CC[C@H](N)C(=O)N12,CHEMBL87265,nM,1600,CHEMBL284,5.795880017,DPPIV,N#C[C@@H]1CS[C@H]2CCC(N)C(=O)N12,N#CC1CSC2CCC(N)C(=O)N12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706890,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3ncccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL562388,nM,15,CHEMBL284,7.823908741,DPPIV,N[C@H]1Cn2c(nc3ncccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3ncccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706891,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cnc(C(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL541438,nM,11,CHEMBL284,7.958607315,DPPIV,N[C@H]1Cn2c(nc3cnc(C(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cnc(C(F)(F)F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706892,CHEMBL1054090,Inhibition of human recombinant DPP4,B,Cc1cc2c(cn1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL557514,nM,23,CHEMBL284,7.638272164,DPPIV,Cc1cc2c(cn1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,Cc1cc2c(cn1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706893,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cnc(Cl)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL557447,nM,15,CHEMBL284,7.823908741,DPPIV,N[C@H]1Cn2c(nc3cnc(Cl)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cnc(Cl)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706894,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cnc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL559477,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@H]1Cn2c(nc3cnc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cnc(F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706895,CHEMBL1054090,Inhibition of human recombinant DPP4,B,Cl.N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL552068,nM,8.3,CHEMBL284,8.080921908,DPPIV,N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cnccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706896,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL562188,nM,6.7,CHEMBL284,8.173925197,DPPIV,N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cnccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706897,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3ccncc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL549502,nM,51,CHEMBL284,7.292429824,DPPIV,N[C@H]1Cn2c(nc3ccncc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3ccncc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706898,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cccnc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL560926,nM,329,CHEMBL284,6.482804102,DPPIV,N[C@H]1Cn2c(nc3cccnc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cccnc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706899,CHEMBL1054090,Inhibition of human recombinant DPP4,B,CC(=O)Nc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL556494,nM,8.6,CHEMBL284,8.065501549,DPPIV,CC(=O)Nc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CC(=O)Nc1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706900,CHEMBL1054090,Inhibition of human recombinant DPP4,B,CS(=O)(=O)Nc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL561793,nM,7.1,CHEMBL284,8.148741651,DPPIV,CS(=O)(=O)Nc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CS(=O)(=O)Nc1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706901,CHEMBL1054090,Inhibition of human recombinant DPP4,B,CN(C)C(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL560729,nM,52,CHEMBL284,7.283996656,DPPIV,CN(C)C(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CN(C)C(=O)c1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706902,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cc(C(=O)O)ccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL563383,nM,13,CHEMBL284,7.886056648,DPPIV,N[C@H]1Cn2c(nc3cc(C(=O)O)ccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cc(C(=O)O)ccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706903,CHEMBL1054090,Inhibition of human recombinant DPP4,B,CS(=O)(=O)c1ccc2nc3n(c2c1)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)C3.O=C(O)C(F)(F)F,CHEMBL549645,nM,56,CHEMBL284,7.251811973,DPPIV,CS(=O)(=O)c1ccc2nc3n(c2c1)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)C3,CS(=O)(=O)c1ccc2nc3n(c2c1)CC(N)C(c1cc(F)c(F)cc1F)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706904,CHEMBL1054090,Inhibition of human recombinant DPP4,B,CCS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL560192,nM,8,CHEMBL284,8.096910013,DPPIV,CCS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CCS(=O)(=O)c1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706905,CHEMBL1054090,Inhibition of human recombinant DPP4,B,CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL559940,nM,4.2,CHEMBL284,8.37675071,DPPIV,CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CS(=O)(=O)c1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706906,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3ccc(C(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL550801,nM,47,CHEMBL284,7.327902142,DPPIV,N[C@H]1Cn2c(nc3ccc(C(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3ccc(C(F)(F)F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706907,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cc(C(F)(F)F)ccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL552479,nM,14,CHEMBL284,7.853871964,DPPIV,N[C@H]1Cn2c(nc3cc(C(F)(F)F)ccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cc(C(F)(F)F)ccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706908,CHEMBL1054090,Inhibition of human recombinant DPP4,B,Cc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL562953,nM,18,CHEMBL284,7.744727495,DPPIV,Cc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,Cc1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706909,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3ccc(OC(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL563155,nM,53,CHEMBL284,7.27572413,DPPIV,N[C@H]1Cn2c(nc3ccc(OC(F)(F)F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3ccc(OC(F)(F)F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706910,CHEMBL1054090,Inhibition of human recombinant DPP4,B,COc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1.O=C(O)C(F)(F)F,CHEMBL550598,nM,28,CHEMBL284,7.552841969,DPPIV,COc1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,COc1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706911,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3c(F)c(F)c(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL562530,nM,22,CHEMBL284,7.657577319,DPPIV,N[C@H]1Cn2c(nc3c(F)c(F)c(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3c(F)c(F)c(F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706912,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3c(F)cc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL558253,nM,47,CHEMBL284,7.327902142,DPPIV,N[C@H]1Cn2c(nc3c(F)cc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3c(F)cc(F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706913,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3ccc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL560669,nM,17,CHEMBL284,7.769551079,DPPIV,N[C@H]1Cn2c(nc3ccc(F)cc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3ccc(F)cc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706914,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3cc(F)ccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL552071,nM,77,CHEMBL284,7.113509275,DPPIV,N[C@H]1Cn2c(nc3cc(F)ccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cc(F)ccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706915,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3c(F)cccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL537962,nM,30,CHEMBL284,7.522878745,DPPIV,N[C@H]1Cn2c(nc3c(F)cccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3c(F)cccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2706916,CHEMBL1054090,Inhibition of human recombinant DPP4,B,N[C@H]1Cn2c(nc3ccccc32)C[C@@H]1c1cc(F)c(F)cc1F.O=C(O)C(F)(F)F,CHEMBL549913,nM,68,CHEMBL284,7.167491087,DPPIV,N[C@H]1Cn2c(nc3ccccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3ccccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712718,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CN(C1CC1)S(=O)(=O)C(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL558647,nM,2.7,CHEMBL284,8.568636236,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CN(C1CC1)S(=O)(=O)C(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CN(C1CC1)S(=O)(=O)C(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712719,CHEMBL1060835,Inhibition of DPP4,B,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)S(=O)(=O)C(F)(F)F,CHEMBL558452,nM,1.5,CHEMBL284,8.823908741,DPPIV,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)S(=O)(=O)C(F)(F)F,CN(CC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F)S(=O)(=O)C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712720,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)CC(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL559602,nM,5.6,CHEMBL284,8.251811973,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)CC(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)CC(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712721,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)C(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL564283,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNS(=O)(=O)C(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNS(=O)(=O)C(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712722,CHEMBL1060835,Inhibition of DPP4,B,CS(=O)(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL559543,nM,27,CHEMBL284,7.568636236,DPPIV,CS(=O)(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CS(=O)(=O)NCC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712723,CHEMBL1060835,Inhibition of DPP4,B,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(=O)C(C)(F)F,CHEMBL559601,nM,7.8,CHEMBL284,8.107905397,DPPIV,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(=O)C(C)(F)F,CN(CC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F)C(=O)C(C)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712724,CHEMBL1060835,Inhibition of DPP4,B,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(=O)C(C)(C)C,CHEMBL550321,nM,6.8,CHEMBL284,8.167491087,DPPIV,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(=O)C(C)(C)C,CN(CC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F)C(=O)C(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712725,CHEMBL1060835,Inhibition of DPP4,B,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(=O)C1CC1,CHEMBL564105,nM,1.1,CHEMBL284,8.958607315,DPPIV,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(=O)C1CC1,CN(CC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F)C(=O)C1CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712726,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)CC(F)(F)F)Cc1cc(F)c(F)cc1F,CHEMBL550114,nM,3.5,CHEMBL284,8.455931956,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)CC(F)(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNC(=O)CC(F)(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712727,CHEMBL1060835,Inhibition of DPP4,B,CC(F)(F)C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL557860,nM,5.9,CHEMBL284,8.229147988,DPPIV,CC(F)(F)C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(F)(F)C(=O)NCC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712728,CHEMBL1060835,Inhibition of DPP4,B,CC(C)(F)C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL558323,nM,6.3,CHEMBL284,8.200659451,DPPIV,CC(C)(F)C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)(F)C(=O)NCC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712729,CHEMBL1060835,Inhibition of DPP4,B,CC(C)(C)C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL558322,nM,3.7,CHEMBL284,8.431798276,DPPIV,CC(C)(C)C(=O)NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)(C)C(=O)NCC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712730,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CCCC1)Cc1cc(F)c(F)cc1F,CHEMBL557723,nM,4.8,CHEMBL284,8.318758763,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CCCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNC(=O)C1CCCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712731,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CCC1)Cc1cc(F)c(F)cc1F,CHEMBL563901,nM,2.2,CHEMBL284,8.657577319,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNC(=O)C1CCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712732,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CC1(F)F)Cc1cc(F)c(F)cc1F,CHEMBL554908,nM,1.3,CHEMBL284,8.886056648,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1CC1(F)F)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNC(=O)C1CC1(F)F)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712733,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1(C(F)(F)F)CC1)Cc1cc(F)c(F)cc1F,CHEMBL552069,nM,2.7,CHEMBL284,8.568636236,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)C1(C(F)(F)F)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNC(=O)C1(C(F)(F)F)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712734,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1COCC1CC1)Cc1cc(F)c(F)cc1F,CHEMBL549992,nM,10,CHEMBL284,8,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1COCC1CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1COCC1CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712735,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1COc1ccnc(C(F)(F)F)n1)Cc1cc(F)c(F)cc1F,CHEMBL557315,nM,6.1,CHEMBL284,8.214670165,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1COc1ccnc(C(F)(F)F)n1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1COc1ccnc(C(F)(F)F)n1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712736,CHEMBL1060835,Inhibition of DPP4,B,N#Cc1ccnc(OC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1,CHEMBL565101,nM,2.3,CHEMBL284,8.638272164,DPPIV,N#Cc1ccnc(OC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1,N#Cc1ccnc(OCC2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712737,CHEMBL1060835,Inhibition of DPP4,B,N#Cc1ccc(OC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)nc1,CHEMBL563849,nM,2,CHEMBL284,8.698970004,DPPIV,N#Cc1ccc(OC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)nc1,N#Cc1ccc(OCC2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712738,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNc1nccc(C(F)(F)F)n1)Cc1cc(F)c(F)cc1F,CHEMBL549296,nM,3.9,CHEMBL284,8.408935393,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CN=c1nc(C(F)(F)F)cc[nH]1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CN=c1nc(C(F)(F)F)cc[nH]1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712739,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNc1ncc(F)cn1)Cc1cc(F)c(F)cc1F,CHEMBL549581,nM,7.1,CHEMBL284,8.148741651,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CN=c1ncc(F)c[nH]1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CN=c1ncc(F)c[nH]1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712740,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNc1ncccn1)Cc1cc(F)c(F)cc1F,CHEMBL564488,nM,5.4,CHEMBL284,8.26760624,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CN=c1nccc[nH]1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CN=c1nccc[nH]1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712741,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNc1ccc(C(F)(F)F)nc1)Cc1cc(F)c(F)cc1F,CHEMBL562467,nM,15,CHEMBL284,7.823908741,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CNc1ccc(C(F)(F)F)nc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CNc1ccc(C(F)(F)F)nc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712742,CHEMBL1060835,Inhibition of DPP4,B,N[C@@H](CC(=O)N1CCC[C@H]1CNc1ccc(F)cn1)Cc1cc(F)c(F)cc1F,CHEMBL556708,nM,6.3,CHEMBL284,8.200659451,DPPIV,N[C@@H](CC(=O)N1CCC[C@H]1CN=c1ccc(F)c[nH]1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1CN=c1ccc(F)c[nH]1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712743,CHEMBL1060835,Inhibition of DPP4,B,N#Cc1cccnc1NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL562072,nM,3.2,CHEMBL284,8.494850022,DPPIV,N#Cc1ccc[nH]c1=NC[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,N#Cc1ccc[nH]c1=NCC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712744,CHEMBL1060835,Inhibition of DPP4,B,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)c1ccc(C#N)cn1,CHEMBL552127,nM,4,CHEMBL284,8.397940009,DPPIV,CN(C[C@@H]1CCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)c1ccc(C#N)cn1,CN(CC1CCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F)c1ccc(C#N)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2712745,CHEMBL1060835,Inhibition of DPP4,B,N#Cc1ccc(NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)nc1,CHEMBL563244,nM,3.5,CHEMBL284,8.455931956,DPPIV,N#Cc1ccc(=NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)[nH]c1,N#Cc1ccc(=NCC2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713676,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,CCCCN1CCN(CCNCC(=O)N2CCC[C@@H]2C#N)C1=O.O=C(O)C(=O)O,CHEMBL1202082,nM,53.5,CHEMBL284,7.271646218,DPPIV,CCCCN1CCN(CCNCC(=O)N2CCC[C@@H]2C#N)C1=O,CCCCN1CCN(CCNCC(=O)N2CCCC2C#N)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713677,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,CC(C)(C)N1CCN(CCNCC(=O)N2CCC[C@@H]2C#N)C1=O.O=C(O)C(=O)O,CHEMBL1202090,nM,68.1,CHEMBL284,7.166852888,DPPIV,CC(C)(C)N1CCN(CCNCC(=O)N2CCC[C@@H]2C#N)C1=O,CC(C)(C)N1CCN(CCNCC(=O)N2CCCC2C#N)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713678,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,CC(C)N1CCN(CCNCC(=O)N2CCC[C@@H]2C#N)C1=O.O=C(O)C(=O)O,CHEMBL1202091,nM,47.8,CHEMBL284,7.320572103,DPPIV,CC(C)N1CCN(CCNCC(=O)N2CCC[C@@H]2C#N)C1=O,CC(C)N1CCN(CCNCC(=O)N2CCCC2C#N)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713679,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(C2CCCCC2)C1=O.O=C(O)C(=O)O,CHEMBL1202092,nM,68.6,CHEMBL284,7.163675884,DPPIV,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(C2CCCCC2)C1=O,N#CC1CCCN1C(=O)CNCCN1CCN(C2CCCCC2)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713680,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccccc2)C1=O.O=C(O)C(=O)O,CHEMBL1202083,nM,34.8,CHEMBL284,7.458420756,DPPIV,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccccc2)C1=O,N#CC1CCCN1C(=O)CNCCN1CCN(c2ccccc2)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713681,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,Cc1ccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc1.O=C(O)C(=O)O,CHEMBL1202086,nM,29.3,CHEMBL284,7.53313238,DPPIV,Cc1ccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc1,Cc1ccc(N2CCN(CCNCC(=O)N3CCCC3C#N)C2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713682,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,COc1ccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc1.O=C(O)C(=O)O,CHEMBL1202093,nM,82.4,CHEMBL284,7.084072788,DPPIV,COc1ccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc1,COc1ccc(N2CCN(CCNCC(=O)N3CCCC3C#N)C2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713683,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,COc1cccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)c1.O=C(O)C(=O)O,CHEMBL1202081,nM,65.1,CHEMBL284,7.186419011,DPPIV,COc1cccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)c1,COc1cccc(N2CCN(CCNCC(=O)N3CCCC3C#N)C2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713684,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccc(Cl)cc2)C1=O.O=C(O)C(=O)O,CHEMBL1202089,nM,25.8,CHEMBL284,7.588380294,DPPIV,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccc(Cl)cc2)C1=O,N#CC1CCCN1C(=O)CNCCN1CCN(c2ccc(Cl)cc2)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713685,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccc(F)cc2)C1=O.O=C(O)C(=O)O,CHEMBL1202087,nM,44.5,CHEMBL284,7.351639989,DPPIV,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccc(F)cc2)C1=O,N#CC1CCCN1C(=O)CNCCN1CCN(c2ccc(F)cc2)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713686,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2cccc(F)c2)C1=O.O=C(O)C(=O)O,CHEMBL1202088,nM,60.1,CHEMBL284,7.221125528,DPPIV,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2cccc(F)c2)C1=O,N#CC1CCCN1C(=O)CNCCN1CCN(c2cccc(F)c2)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713687,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccccc2F)C1=O.O=C(O)C(=O)O,CHEMBL1202084,nM,133.6,CHEMBL284,6.874193542,DPPIV,N#C[C@H]1CCCN1C(=O)CNCCN1CCN(c2ccccc2F)C1=O,N#CC1CCCN1C(=O)CNCCN1CCN(c2ccccc2F)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713688,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,COc1cc(OC)cc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)c1.O=C(O)C(=O)O,CHEMBL1202094,nM,20.4,CHEMBL284,7.690369833,DPPIV,COc1cc(OC)cc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)c1,COc1cc(OC)cc(N2CCN(CCNCC(=O)N3CCCC3C#N)C2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713689,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,COc1ccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc1OC.O=C(O)C(=O)O,CHEMBL1202080,nM,2,CHEMBL284,8.698970004,DPPIV,COc1ccc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc1OC,COc1ccc(N2CCN(CCNCC(=O)N3CCCC3C#N)C2=O)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713690,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,COc1cc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc(OC)c1OC.O=C(O)C(=O)O,CHEMBL1202085,nM,165.6,CHEMBL284,6.780939668,DPPIV,COc1cc(N2CCN(CCNCC(=O)N3CCC[C@@H]3C#N)C2=O)cc(OC)c1OC,COc1cc(N2CCN(CCNCC(=O)N3CCCC3C#N)C2=O)cc(OC)c1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2713692,CHEMBL1057246,Inhibition of human DPP4 by fluorimetry,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL376359,nM,10,CHEMBL284,8,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993840,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1CNC(=O)c1ccccc1)Cc1ccccc1F,CHEMBL567263,nM,90,CHEMBL284,7.045757491,DPPIV,N[C@@H](CCN1CCC[C@H]1CNC(=O)c1ccccc1)Cc1ccccc1F,NC(CCN1CCCC1CNC(=O)c1ccccc1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993841,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1nc(-c2ccccc2)no1)Cc1ccccc1F,CHEMBL566460,nM,31,CHEMBL284,7.508638306,DPPIV,N[C@@H](CCN1CCCC1c1nc(-c2ccccc2)no1)Cc1ccccc1F,NC(CCN1CCCC1c1nc(-c2ccccc2)no1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993842,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1noc(-c2ccccc2)n1)Cc1ccccc1F,CHEMBL585663,nM,90,CHEMBL284,7.045757491,DPPIV,N[C@@H](CCN1CCCC1c1noc(-c2ccccc2)n1)Cc1ccccc1F,NC(CCN1CCCC1c1noc(-c2ccccc2)n1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993843,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1ncn(-c2ccccc2)n1)Cc1ccccc1F,CHEMBL565613,nM,62,CHEMBL284,7.207608311,DPPIV,N[C@@H](CCN1CCCC1c1ncn(-c2ccccc2)n1)Cc1ccccc1F,NC(CCN1CCCC1c1ncn(-c2ccccc2)n1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993844,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1nnc(-c2ccccc2)o1)Cc1ccccc1F,CHEMBL584276,nM,120,CHEMBL284,6.920818754,DPPIV,N[C@@H](CCN1CCCC1c1nnc(-c2ccccc2)o1)Cc1ccccc1F,NC(CCN1CCCC1c1nnc(-c2ccccc2)o1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993845,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1nc(-c2ccccc2)co1)Cc1ccccc1F,CHEMBL566617,nM,76,CHEMBL284,7.119186408,DPPIV,N[C@@H](CCN1CCCC1c1nc(-c2ccccc2)co1)Cc1ccccc1F,NC(CCN1CCCC1c1nc(-c2ccccc2)co1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993846,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1ccn(-c2ccccc2)n1)Cc1ccccc1F,CHEMBL565999,nM,180,CHEMBL284,6.744727495,DPPIV,N[C@@H](CCN1CCCC1c1ccn(-c2ccccc2)n1)Cc1ccccc1F,NC(CCN1CCCC1c1ccn(-c2ccccc2)n1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2993847,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CCN1CCC[C@H]1c1cn(-c2ccccc2)nn1)Cc1ccccc1F,CHEMBL566854,nM,130,CHEMBL284,6.886056648,DPPIV,N[C@@H](CCN1CCC[C@H]1c1cn(-c2ccccc2)nn1)Cc1ccccc1F,NC(CCN1CCCC1c1cn(-c2ccccc2)nn1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2994443,CHEMBL1045391,Inhibition of human DPP4 from human Caco-2 cells,B,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,CHEMBL1090,nM,62,CHEMBL284,7.207608311,DPPIV,N=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,N=c1[nH]cnc2c1ncn2C1OC(CO)C(O)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995124,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(C2CC2)no1)Cc1cc(F)c(F)cc1F,CHEMBL567278,nM,7,CHEMBL284,8.15490196,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(C2CC2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(C2CC2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995125,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,CC(C)(C)c1noc([C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)n1,CHEMBL565633,nM,2,CHEMBL284,8.698970004,DPPIV,CC(C)(C)c1noc(C2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)n1,CC(C)(C)c1noc(C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995126,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(CC2CC2)no1)Cc1cc(F)c(F)cc1F,CHEMBL566672,nM,3,CHEMBL284,8.522878745,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(CC2CC2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(CC2CC2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995127,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(C2(C(F)(F)F)CC2)no1)Cc1cc(F)c(F)cc1F,CHEMBL565813,nM,2,CHEMBL284,8.698970004,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(C2(C(F)(F)F)CC2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(C2(C(F)(F)F)CC2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995128,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(N2CCOCC2)no1)Cc1cc(F)c(F)cc1F,CHEMBL585129,nM,4,CHEMBL284,8.397940009,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(N2CCOCC2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(N2CCOCC2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995129,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(N2CCCC2)no1)Cc1cc(F)c(F)cc1F,CHEMBL566616,nM,4,CHEMBL284,8.397940009,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(N2CCCC2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(N2CCCC2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995130,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,CS(=O)(=O)N1CC(c2noc([C@@H]3CCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)n2)C1,CHEMBL566425,nM,1,CHEMBL284,9,DPPIV,CS(=O)(=O)N1CC(c2noc(C3CCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)n2)C1,CS(=O)(=O)N1CC(c2noc(C3CCCN3C(=O)CC(N)Cc3cc(F)c(F)cc3F)n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995131,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,CC(=O)N1CC(c2noc([C@@H]3CCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)n2)C1,CHEMBL567279,nM,5,CHEMBL284,8.301029996,DPPIV,CC(=O)N1CC(c2noc(C3CCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)n2)C1,CC(=O)N1CC(c2noc(C3CCCN3C(=O)CC(N)Cc3cc(F)c(F)cc3F)n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995132,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(-c2ccccn2)no1)Cc1cc(F)c(F)cc1F,CHEMBL584494,nM,10,CHEMBL284,8,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(-c2ccccn2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(-c2ccccn2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995133,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(-c2cnccn2)no1)Cc1cc(F)c(F)cc1F,CHEMBL566628,nM,2,CHEMBL284,8.698970004,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(-c2cnccn2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(-c2cnccn2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995134,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(-c2ncccn2)no1)Cc1cc(F)c(F)cc1F,CHEMBL567727,nM,4,CHEMBL284,8.397940009,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(-c2ncccn2)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(-c2ncccn2)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995135,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1nc(-c2ncc(F)cc2F)no1)Cc1cc(F)c(F)cc1F,CHEMBL566829,nM,3,CHEMBL284,8.522878745,DPPIV,N[C@@H](CC(=O)N1CCCC1c1nc(-c2ncc(F)cc2F)no1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1nc(-c2ncc(F)cc2F)no1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995136,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1noc(C2CC2)n1)Cc1cc(F)c(F)cc1F,CHEMBL566419,nM,17,CHEMBL284,7.769551079,DPPIV,N[C@@H](CC(=O)N1CCCC1c1noc(C2CC2)n1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1noc(C2CC2)n1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995137,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1noc(C2(C(F)(F)F)CC2)n1)Cc1cc(F)c(F)cc1F,CHEMBL584692,nM,11,CHEMBL284,7.958607315,DPPIV,N[C@@H](CC(=O)N1CCCC1c1noc(C2(C(F)(F)F)CC2)n1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1noc(C2(C(F)(F)F)CC2)n1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995138,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1noc(C2(O)CC2)n1)Cc1cc(F)c(F)cc1F,CHEMBL584698,nM,17,CHEMBL284,7.769551079,DPPIV,N[C@@H](CC(=O)N1CCCC1c1noc(C2(O)CC2)n1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1noc(C2(O)CC2)n1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995139,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1noc(C2(F)CC2)n1)Cc1cc(F)c(F)cc1F,CHEMBL585290,nM,22,CHEMBL284,7.657577319,DPPIV,N[C@@H](CC(=O)N1CCCC1c1noc(C2(F)CC2)n1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1noc(C2(F)CC2)n1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995140,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,CC(C)(F)c1nc([C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)no1,CHEMBL567728,nM,16,CHEMBL284,7.795880017,DPPIV,CC(C)(F)c1nc(C2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)no1,CC(C)(F)c1nc(C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)no1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995141,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,CC1(c2nc([C@@H]3CCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)no2)COC1,CHEMBL565600,nM,2,CHEMBL284,8.698970004,DPPIV,CC1(c2nc(C3CCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)no2)COC1,CC1(c2nc(C3CCCN3C(=O)CC(N)Cc3cc(F)c(F)cc3F)no2)COC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995142,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,N[C@@H](CC(=O)N1CCC[C@H]1c1ncn(-c2ccccn2)n1)Cc1cc(F)c(F)cc1F,CHEMBL567270,nM,28,CHEMBL284,7.552841969,DPPIV,N[C@@H](CC(=O)N1CCCC1c1ncn(-c2ccccn2)n1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCC1c1ncn(-c2ccccn2)n1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
2995143,CHEMBL1039009,Inhibition of human recombinant DPP4 transfected in Pichia methanolica expression system after 10 mins by continuous fluorimetric assay,B,CC(C)(C)c1nc([C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)no1,CHEMBL568111,nM,32,CHEMBL284,7.494850022,DPPIV,CC(C)(C)c1nc(C2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)no1,CC(C)(C)c1nc(C2CCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)no1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3003679,CHEMBL1039254,Inhibition of DPP4 after 10 to 15 mins by fluorescence assay,B,COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O,CHEMBL567893,nM,10000,CHEMBL284,5,DPPIV,COC(=O)C1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O,COC(=O)C1CCCN1C(=O)C(Cc1ccccc1)N(C)C(=O)C(C)NC(=O)C(NC(=O)CC(O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(OC(=O)C(OC(=O)C(C(C)C)N(C)C)C(C)C)C(C)C)C(C)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099269,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCCC3=O)CN1CC2,CHEMBL590326,nM,510,CHEMBL284,6.292429824,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCCC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099270,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCC3=O)CN1CC2,CHEMBL592779,nM,30,CHEMBL284,7.522878745,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099271,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3CCCCC3=O)CN1CC2,CHEMBL592778,nM,22,CHEMBL284,7.657577319,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3CCCCC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099272,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@H]1C[C@@H](N)[C@H](N3CCCCC3=O)CN1CC2,CHEMBL600440,nM,7800,CHEMBL284,5.107905397,DPPIV,COc1cc2c(cc1OC)[C@H]1C[C@@H](N)[C@H](N3CCCCC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099273,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCCC3=O)CN1CC2,CHEMBL592547,nM,430,CHEMBL284,6.366531544,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCCC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCCCC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099274,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCC[S+]3[O-])CN1CC2,CHEMBL605285,nM,1330,CHEMBL284,5.876148359,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCC[S+]3[O-])CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCC[S+]3[O-])CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099275,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCCC[S+]3[O-])CN1CC2,CHEMBL589598,nM,142,CHEMBL284,6.847711656,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCCC[S+]3[O-])CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCC[S+]3[O-])CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099276,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCOC3=O)CN1CC2,CHEMBL590330,nM,1150,CHEMBL284,5.93930216,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCOC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCOC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099277,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCCOC3=O)CN1CC2,CHEMBL600045,nM,142,CHEMBL284,6.847711656,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCCOC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCCOC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099278,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)CC3=O)CN1CC2,CHEMBL590086,nM,19,CHEMBL284,7.721246399,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)CC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)CC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099279,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CCC3=O)CN1CC2,CHEMBL590329,nM,3.7,CHEMBL284,8.431798276,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CCC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CCC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099280,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CC3=O)CN1CC2,CHEMBL590812,nM,9.3,CHEMBL284,8.031517051,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099281,CHEMBL1070385,Inhibition of human DPP4,B,CCC1CC(=O)N(C2CN3CCc4cc(OC)c(OC)cc4C3CC2N)C1,CHEMBL601074,nM,13,CHEMBL284,7.886056648,DPPIV,CCC1CC(=O)N(C2CN3CCc4cc(OC)c(OC)cc4C3CC2N)C1,CCC1CC(=O)N(C2CN3CCc4cc(OC)c(OC)cc4C3CC2N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099282,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)C3=O)CN1CC2,CHEMBL591060,nM,10000,CHEMBL284,5,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)C3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CCC(C)C3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099283,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)C1CC(N)C(N3C(=O)CCC3C)CN1CC2,CHEMBL591289,nM,2200,CHEMBL284,5.657577319,DPPIV,COc1cc2c(cc1OC)C1CC(N)C(N3C(=O)CCC3C)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3C(=O)CCC3C)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099284,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](C)CC3=O)CN1CC2,CHEMBL591290,nM,13,CHEMBL284,7.886056648,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](C)CC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099285,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@H](C)CC3=O)CN1CC2,CHEMBL591291,nM,2.6,CHEMBL284,8.585026652,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@H](C)CC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CC(C)CC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099286,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2,CHEMBL591118,nM,6.8,CHEMBL284,8.167491087,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CC(CF)CC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3099287,CHEMBL1070385,Inhibition of human DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@H](CF)CC3=O)CN1CC2,CHEMBL591117,nM,3.6,CHEMBL284,8.443697499,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@H](CF)CC3=O)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(N3CC(CF)CC3=O)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101902,CHEMBL1071791,Inhibition of DPP4,B,CCc1cccc([C@H]2CN3CCc4cc(OC)c(OC)cc4[C@@H]3CC2N)c1,CHEMBL591982,nM,61,CHEMBL284,7.214670165,DPPIV,CCc1cccc([C@H]2CN3CCc4cc(OC)c(OC)cc4[C@@H]3CC2N)c1,CCc1cccc(C2CN3CCc4cc(OC)c(OC)cc4C3CC2N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101905,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(C4CC4)c3)CN1CC2,CHEMBL591277,nM,38,CHEMBL284,7.420216403,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(C4CC4)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(C4CC4)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101908,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(C(C)C)c3)CN1CC2,CHEMBL591278,nM,5500,CHEMBL284,5.259637311,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(C(C)C)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(C(C)C)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101911,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(CF)c3)CN1CC2,CHEMBL591279,nM,0.5,CHEMBL284,9.301029996,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cccc(CF)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(CF)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101914,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cc(C)ccc3C)CN1CC2,CHEMBL601937,nM,1.7,CHEMBL284,8.769551079,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cc(C)ccc3C)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cc(C)ccc3C)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101919,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cc(CF)ccn3)CN1CC2,CHEMBL598470,nM,1.2,CHEMBL284,8.920818754,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cc(CF)ccn3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cc(CF)ccn3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101934,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cc(C)ccn3)CN1CC2,CHEMBL590557,nM,11,CHEMBL284,7.958607315,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cc(C)ccn3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cc(C)ccn3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101935,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@H]1C[C@@H](N)[C@H](c3cc(C)ccn3)CN1CC2,CHEMBL598754,nM,53000,CHEMBL284,4.27572413,DPPIV,COc1cc2c(cc1OC)[C@H]1C[C@@H](N)[C@H](c3cc(C)ccn3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cc(C)ccn3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3101936,CHEMBL1071791,Inhibition of DPP4,B,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cc(C)ccn3)CN1CC2,CHEMBL598755,nM,19,CHEMBL284,7.721246399,DPPIV,COc1cc2c(cc1OC)[C@@H]1CC(N)[C@@H](c3cc(C)ccn3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cc(C)ccn3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134828,CHEMBL899730,Inhibition of human recombinant DPP4,B,Nc1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CHEMBL401229,nM,3000,CHEMBL284,5.522878745,DPPIV,Nc1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,Nc1ccc(C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134829,CHEMBL899730,Inhibition of human recombinant DPP4,B,CC(C)c1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CHEMBL236934,nM,3000,CHEMBL284,5.522878745,DPPIV,CC(C)c1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CC(C)c1ccc(C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134830,CHEMBL899730,Inhibition of human recombinant DPP4,B,COC(=O)c1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CHEMBL236935,nM,3000,CHEMBL284,5.522878745,DPPIV,COC(=O)c1ccc(C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,COC(=O)c1ccc(C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134831,CHEMBL899730,Inhibition of human recombinant DPP4,B,COc1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CHEMBL237140,nM,3000,CHEMBL284,5.522878745,DPPIV,COc1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,COc1ccc(C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134832,CHEMBL899730,Inhibition of human recombinant DPP4,B,CN(C)c1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CHEMBL237141,nM,3000,CHEMBL284,5.522878745,DPPIV,CN(C)c1ccc([C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)C[C@@H]2N)cc1,CN(C)c1ccc(C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134833,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccc(O)cc1,CHEMBL237357,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C[C@H]1c1ccc(O)cc1,NC1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134834,CHEMBL899730,Inhibition of human recombinant DPP4,B,N#Cc1cccnc1N1C[C@H](c2ccccc2)[C@@H](N)C1,CHEMBL235202,nM,3000,CHEMBL284,5.522878745,DPPIV,N#Cc1cccnc1N1C[C@H](c2ccccc2)[C@@H](N)C1,N#Cc1cccnc1N1CC(N)C(c2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134835,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccccc3Cl)ncn2)C[C@@H]1c1ccccc1,CHEMBL235420,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2cc(-c3ccccc3Cl)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(-c3ccccc3Cl)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134836,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(Cl)nc(-c3ccccc3)n2)C[C@@H]1c1ccccc1,CHEMBL392698,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2cc(Cl)nc(-c3ccccc3)n2)C[C@@H]1c1ccccc1,NC1CN(c2cc(Cl)nc(-c3ccccc3)n2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134837,CHEMBL899730,Inhibition of human recombinant DPP4,B,Cn1cnc2c(N3C[C@H](c4ccccc4)[C@@H](N)C3)ncnc21,CHEMBL238201,nM,3000,CHEMBL284,5.522878745,DPPIV,Cn1cnc2c(N3C[C@H](c4ccccc4)[C@@H](N)C3)ncnc21,Cn1cnc2c(N3CC(N)C(c4ccccc4)C3)ncnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134838,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccc(O)cc3)ncn2)C[C@@H]1c1ccccc1,CHEMBL238202,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2cc(-c3ccc(O)cc3)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(-c3ccc(O)cc3)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134839,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cc(-c3ccc(Cl)cc3)ncn2)C[C@@H]1c1ccccc1,CHEMBL392907,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2cc(-c3ccc(Cl)cc3)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(-c3ccc(Cl)cc3)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134840,CHEMBL899730,Inhibition of human recombinant DPP4,B,CC(=O)c1ccc(N2C[C@H](c3ccccc3)[C@@H](N)C2)nc1,CHEMBL398101,nM,3000,CHEMBL284,5.522878745,DPPIV,CC(=O)c1ccc(N2C[C@H](c3ccccc3)[C@@H](N)C2)nc1,CC(=O)c1ccc(N2CC(N)C(c3ccccc3)C2)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134841,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2cnc3ccccc3n2)C[C@@H]1c1ccccc1,CHEMBL234986,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2cnc3ccccc3n2)C[C@@H]1c1ccccc1,NC1CN(c2cnc3ccccc3n2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3134842,CHEMBL899730,Inhibition of human recombinant DPP4,B,N[C@H]1CN(c2ccc3ccccc3n2)C[C@@H]1c1ccccc1,CHEMBL234987,nM,3000,CHEMBL284,5.522878745,DPPIV,N[C@H]1CN(c2ccc3ccccc3n2)C[C@@H]1c1ccccc1,NC1CN(c2ccc3ccccc3n2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3272085,CHEMBL1110128,Inhibition of DPP4,B,O=C(CO)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)NCc1ccccc1,CHEMBL76578,nM,100000,CHEMBL284,4,DPPIV,O=C(CO)C1CCCN1C(=O)C1CCCN1C(=O)NCc1ccccc1,O=C(CO)C1CCCN1C(=O)C1CCCN1C(=O)NCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302951,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,Cl.N#C[C@@H]1CCCN1C(=O)CN[C@H]1C[C@H]2C[C@@H](O)C[C@H]2C1,CHEMBL1083589,nM,12,CHEMBL284,7.920818754,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@H]1C[C@H]2C[C@@H](O)C[C@H]2C1,N#CC1CCCN1C(=O)CNC1CC2CC(O)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302952,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CO[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082653,nM,8,CHEMBL284,8.096910013,DPPIV,CO[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,COC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302953,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CCO[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082654,nM,59,CHEMBL284,7.229147988,DPPIV,CCO[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CCOC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302954,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CN(C)C(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082973,nM,65,CHEMBL284,7.187086643,DPPIV,CN(C)C(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CN(C)C(=O)OC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302955,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CCN(CC)C(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082974,nM,80,CHEMBL284,7.096910013,DPPIV,CCN(CC)C(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CCN(CC)C(=O)OC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302956,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CC(C)NC(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1083916,nM,204,CHEMBL284,6.690369833,DPPIV,CC(C)NC(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CC(C)NC(=O)OC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302957,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CC(C)(C)NC(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1084473,nM,326,CHEMBL284,6.4867824,DPPIV,CC(C)(C)NC(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CC(C)(C)NC(=O)OC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302958,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,Cl.N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2C[C@H](OC(=O)Nc3ccccc3)C[C@@H]2C1,CHEMBL1082345,nM,121,CHEMBL284,6.91721463,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2C[C@H](OC(=O)Nc3ccccc3)C[C@@H]2C1,N#CC1CCCN1C(=O)CNC1CC2CC(OC(=O)Nc3ccccc3)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302959,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CO[C@@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082346,nM,27,CHEMBL284,7.568636236,DPPIV,CO[C@@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,COC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302960,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CO[C@@H]1C[C@H]2C[C@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082347,nM,27,CHEMBL284,7.568636236,DPPIV,CO[C@@H]1C[C@H]2C[C@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,COC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302961,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CO[C@H]1C[C@H]2C[C@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082348,nM,47,CHEMBL284,7.327902142,DPPIV,CO[C@H]1C[C@H]2C[C@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,COC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3302991,CHEMBL1120123,Inhibition of DPP4 by chemical luminescent assay,B,CC(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1.Cl,CHEMBL1082350,nM,32,CHEMBL284,7.494850022,DPPIV,CC(=O)O[C@H]1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CC(=O)OC1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313828,CHEMBL1119677,Inhibition of DPP4,B,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)nc1,CHEMBL1085552,nM,19,CHEMBL284,7.721246399,DPPIV,COc1ccc(=NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)[nH]c1,COc1ccc(=NC(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313829,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)Nc1ccccn1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085306,nM,19,CHEMBL284,7.721246399,DPPIV,CC(C)(CC(=O)N=c1cccc[nH]1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N=c1cccc[nH]1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313830,CHEMBL1119677,Inhibition of DPP4,B,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1OC,CHEMBL1085305,nM,27,CHEMBL284,7.568636236,DPPIV,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1OC,COc1ccc(NC(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313831,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)NC1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1084972,nM,29,CHEMBL284,7.537602002,DPPIV,CC(C)(CC(=O)NC1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)NC1CCCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313832,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1C2CCC1CC2)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1084601,nM,66,CHEMBL284,7.180456064,DPPIV,CC(C)(CC(=O)N1C2CCC1CC2)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1C2CCC1CC2)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313833,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCCCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085598,nM,160,CHEMBL284,6.795880017,DPPIV,CC(C)(CC(=O)N1CCCCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCCCCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313834,CHEMBL1119677,Inhibition of DPP4,B,CCOC(=O)N1CCN(C(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)CC1,CHEMBL1085597,nM,63,CHEMBL284,7.200659451,DPPIV,CCOC(=O)N1CCN(C(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)CC1,CCOC(=O)N1CCN(C(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313835,CHEMBL1119677,Inhibition of DPP4,B,CN1CCN(C(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)CC1,CHEMBL1085596,nM,93,CHEMBL284,7.031517051,DPPIV,CN1CCN(C(=O)CC(C)(C)NCC(=O)N2C[C@@H](F)C[C@H]2C#N)CC1,CN1CCN(C(=O)CC(C)(C)NCC(=O)N2CC(F)CC2C#N)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313836,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCN(S(C)(=O)=O)CC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085595,nM,24,CHEMBL284,7.619788758,DPPIV,CC(C)(CC(=O)N1CCN(S(C)(=O)=O)CC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCN(S(C)(=O)=O)CC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313837,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCOCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085333,nM,20,CHEMBL284,7.698970004,DPPIV,CC(C)(CC(=O)N1CCOCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCOCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313838,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCC(=O)CC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085332,nM,26,CHEMBL284,7.585026652,DPPIV,CC(C)(CC(=O)N1CCC(=O)CC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCC(=O)CC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313839,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CC=CCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085075,nM,18,CHEMBL284,7.744727495,DPPIV,CC(C)(CC(=O)N1CC=CCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CC=CCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313840,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085074,nM,27,CHEMBL284,7.568636236,DPPIV,CC(C)(CC(=O)N1CCCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCCCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313841,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCSC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085580,nM,27,CHEMBL284,7.568636236,DPPIV,CC(C)(CC(=O)N1CCSC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCSC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313842,CHEMBL1119677,Inhibition of DPP4,B,C[C@@H]1CCCN1C(=O)CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1085579,nM,32,CHEMBL284,7.494850022,DPPIV,C[C@@H]1CCCN1C(=O)CC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC1CCCN1C(=O)CC(C)(C)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313843,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCC[C@H]1CO)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1086039,nM,24,CHEMBL284,7.619788758,DPPIV,CC(C)(CC(=O)N1CCC[C@H]1CO)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCCC1CO)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313844,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CC[C@@H](F)C1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1082465,nM,39,CHEMBL284,7.408935393,DPPIV,CC(C)(CC(=O)N1CC[C@@H](F)C1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCC(F)C1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313845,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CC[C@H](O)C1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1082464,nM,50,CHEMBL284,7.301029996,DPPIV,CC(C)(CC(=O)N1CC[C@H](O)C1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCC(O)C1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313846,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CC[C@@H](O)C1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1082463,nM,30,CHEMBL284,7.522878745,DPPIV,CC(C)(CC(=O)N1CC[C@@H](O)C1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCC(O)C1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313847,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL1082462,nM,15,CHEMBL284,7.823908741,DPPIV,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313848,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CC[C@@H](O)C1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL1086502,nM,180,CHEMBL284,6.744727495,DPPIV,CC(C)(CC(=O)N1CC[C@@H](O)C1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCC(O)C1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313849,CHEMBL1119677,Inhibition of DPP4,B,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1CCC[C@H]1C#N,CHEMBL1082997,nM,71,CHEMBL284,7.148741651,DPPIV,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1CCC[C@H]1C#N,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3313850,CHEMBL1119677,Inhibition of DPP4,B,C#C[C@@H]1C[C@H](F)CN1C(=O)CC(C)(C)CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1,CHEMBL1082996,nM,15,CHEMBL284,7.823908741,DPPIV,C#C[C@@H]1C[C@H](F)CN1C(=O)CC(C)(C)CC(=O)N[C@H]1C[C@@H]1c1cccc(Cl)c1,C#CC1CC(F)CN1C(=O)CC(C)(C)CC(=O)NC1CC1c1cccc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317308,CHEMBL1120109,Inhibition of DPP4,B,CN(C)C(=O)N1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CHEMBL1085269,nM,9,CHEMBL284,8.045757491,DPPIV,CN(C)C(=O)N1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CN(C)C(=O)N1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317311,CHEMBL1120109,Inhibition of DPP4,B,CC(C)NC(=O)N1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CHEMBL1085522,nM,120,CHEMBL284,6.920818754,DPPIV,CC(C)NC(=O)N1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CC(C)NC(=O)N1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317312,CHEMBL1120109,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)N3CCCC3)C[C@@H]2C1,CHEMBL1082707,nM,39,CHEMBL284,7.408935393,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)N3CCCC3)C[C@@H]2C1,N#CC1CCCN1C(=O)CNC1CC2CN(C(=O)N3CCCC3)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317313,CHEMBL1120109,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)N3CCCCC3)C[C@@H]2C1,CHEMBL1082708,nM,69,CHEMBL284,7.161150909,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)N3CCCCC3)C[C@@H]2C1,N#CC1CCCN1C(=O)CNC1CC2CN(C(=O)N3CCCCC3)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317314,CHEMBL1120109,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)N3CCOCC3)C[C@@H]2C1,CHEMBL1082716,nM,50,CHEMBL284,7.301029996,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)N3CCOCC3)C[C@@H]2C1,N#CC1CCCN1C(=O)CNC1CC2CN(C(=O)N3CCOCC3)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317315,CHEMBL1120109,Inhibition of DPP4,B,COC(=O)N1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CHEMBL1083031,nM,24,CHEMBL284,7.619788758,DPPIV,COC(=O)N1C[C@H]2C[C@@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,COC(=O)N1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317316,CHEMBL1120109,Inhibition of DPP4,B,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)CO)C[C@@H]2C1,CHEMBL1083032,nM,14,CHEMBL284,7.853871964,DPPIV,N#C[C@@H]1CCCN1C(=O)CN[C@@H]1C[C@@H]2CN(C(=O)CO)C[C@@H]2C1,N#CC1CCCN1C(=O)CNC1CC2CN(C(=O)CO)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317317,CHEMBL1120109,Inhibition of DPP4,B,CN(C)C(=O)N1C[C@H]2C[C@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CHEMBL1086466,nM,83,CHEMBL284,7.080921908,DPPIV,CN(C)C(=O)N1C[C@H]2C[C@H](NCC(=O)N3CCC[C@H]3C#N)C[C@H]2C1,CN(C)C(=O)N1CC2CC(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317318,CHEMBL1120109,Inhibition of DPP4,B,CN(C)C(=O)N1C[C@@H]2C[C@](C)(NCC(=O)N3CCC[C@H]3C#N)C[C@@H]2C1,CHEMBL1083287,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)N1C[C@@H]2C[C@](C)(NCC(=O)N3CCC[C@H]3C#N)C[C@@H]2C1,CN(C)C(=O)N1CC2CC(C)(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3317319,CHEMBL1120109,Inhibition of DPP4,B,CN(C)C(=O)N1C[C@@H]2C[C@@](C)(NCC(=O)N3CCC[C@H]3C#N)C[C@@H]2C1,CHEMBL1083588,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)N1C[C@@H]2C[C@@](C)(NCC(=O)N3CCC[C@H]3C#N)C[C@@H]2C1,CN(C)C(=O)N1CC2CC(C)(NCC(=O)N3CCCC3C#N)CC2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434572,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,O=C1c2ccccc2CN1CC(=O)N1CCC[C@H]1B(O)O,CHEMBL387050,nM,8000,CHEMBL284,5.096910013,DPPIV,O=C1c2ccccc2CN1CC(=O)N1CCC[C@H]1B(O)O,O=C1c2ccccc2CN1CC(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434573,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)CCCN1Cc2ccccc2C1=O,CHEMBL1243372,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)CCCN1Cc2ccccc2C1=O,N#CC1CCCN1C(=O)C(N)CCCN1Cc2ccccc2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434574,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1cccc2ccccc12,CHEMBL1243373,nM,20000,CHEMBL284,4.698970004,DPPIV,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1cccc2ccccc12,O=C(NCC(=O)N1CCCC1B(O)O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434575,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL1243374,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434576,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243402,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434577,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243403,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434578,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccc(Cl)cc3C2)C(=O)N1,CHEMBL1242939,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2Cc3ccc(Cl)cc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2Cc3ccc(Cl)cc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434579,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccc(F)cc3C2)C(=O)N1,CHEMBL1242940,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2Cc3ccc(F)cc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2Cc3ccc(F)cc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434580,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccc(C(F)(F)F)cc3C2)C(=O)N1,CHEMBL1242966,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2Cc3ccc(C(F)(F)F)cc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2Cc3ccc(C(F)(F)F)cc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434581,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCc3ccccc3C2)C(=O)N1,CHEMBL1242967,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCc3ccccc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434582,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCc3ccsc3C2)C(=O)N1,CHEMBL1242993,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCc3ccsc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCc3ccsc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434583,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCn3cc(C(F)(F)F)nc3C2)C(=O)N1,CHEMBL1242994,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCn3cc(C(F)(F)F)nc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCn3cc(C(F)(F)F)nc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434584,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)C(=O)N1,CHEMBL1243027,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCn3c(nnc3C(F)(F)F)C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCn3c(nnc3C(F)(F)F)C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434585,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCN(c3ccc(F)cc3)CC2)C(=O)N1,CHEMBL1243028,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCN(c3ccc(F)cc3)CC2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCN(c3ccc(F)cc3)CC2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434586,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCN(c3ccncc3)CC2)C(=O)N1,CHEMBL1243060,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCN(c3ccncc3)CC2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCN(c3ccncc3)CC2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434587,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CC=C(c3ccc(Cl)cc3)CC2)C(=O)N1,CHEMBL1243061,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CC=C(c3ccc(Cl)cc3)CC2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CC=C(c3ccc(Cl)cc3)CC2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434588,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCCC2)C(=O)N1,CHEMBL1243091,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCCC2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCCC2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434589,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2CCCCC2)C(=O)N1,CHEMBL1243092,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2CCCCC2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2CCCCC2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434590,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)Nc2ccccc2)C(=O)N1,CHEMBL1243093,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)Nc2ccccc2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)Nc2ccccc2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434591,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243126,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,N#CC1CC(F)CN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434592,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccc(Cl)cc3C2)C(=O)N1,CHEMBL1243127,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)c1cc(CC(O)N2Cc3ccc(Cl)cc3C2)c(O)[nH]1,N#CC1CC(F)CN1C(=O)c1cc(CC(O)N2Cc3ccc(Cl)cc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434593,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CC(F)(F)CN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243153,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,N#CC1CC(F)(F)CN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434594,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,O=C1N[C@H](C(=O)N2CCSC2)C[C@H]1CC(=O)N1Cc2ccccc2C1,CHEMBL1243154,nM,100000,CHEMBL284,4,DPPIV,O=C(Cc1cc(C(O)N2CCSC2)[nH]c1O)N1Cc2ccccc2C1,O=C(Cc1cc(C(O)N2CCSC2)[nH]c1O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434595,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,O=C1N[C@H](C(=O)N2CCCC2)C[C@H]1CC(=O)N1Cc2ccccc2C1,CHEMBL1243183,nM,100000,CHEMBL284,4,DPPIV,O=C(Cc1cc(C(O)N2CCCC2)[nH]c1O)N1Cc2ccccc2C1,O=C(Cc1cc(C(O)N2CCCC2)[nH]c1O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434596,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,O=C1N[C@H](C(=O)N2CCC[C@H]2B(O)O)C[C@H]1CC(=O)N1Cc2ccccc2C1,CHEMBL1243184,nM,570,CHEMBL284,6.244125144,DPPIV,O=C(Cc1cc(C(O)N2CCC[C@H]2B(O)O)[nH]c1O)N1Cc2ccccc2C1,O=C(Cc1cc(C(O)N2CCCC2B(O)O)[nH]c1O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434597,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,CC(C)(C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243215,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)NC(=O)C1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,CC(C)(C)NC(=O)C1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434598,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[C@@H](CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243216,nM,100000,CHEMBL284,4,DPPIV,NC(=O)C1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,NC(=O)C1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3434599,CHEMBL1246393,Inhibition of human recombinant His-tagged DPP4 expressed in insect cells,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CC(CC(=O)N2Cc3ccccc3C2)C(=O)N1,CHEMBL1243248,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,N#CC1CCCN1C(=O)c1cc(CC(O)N2Cc3ccccc3C2)c(O)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543707,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,N[C@@H](CC(=O)N1CCN2C(=O)OCC2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1276590,nM,2300,CHEMBL284,5.638272164,DPPIV,N[C@@H](CC(=O)N1CCN2C(=O)OCC2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN2C(=O)OCC2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543708,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,CN1CC2CN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCN2C1=O.O=C(O)/C=C/C(=O)O,CHEMBL1276619,nM,1240,CHEMBL284,5.906578315,DPPIV,CN1CC2CN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCN2C1=O,CN1CC2CN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CCN2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543709,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,N[C@@H](CC(=O)N1CCN2C(=O)N(Cc3ccc(F)cc3)CC2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1276682,nM,1236,CHEMBL284,5.907981529,DPPIV,N[C@@H](CC(=O)N1CCN2C(=O)N(Cc3ccc(F)cc3)CC2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN2C(=O)N(Cc3ccc(F)cc3)CC2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543710,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,N[C@@H](CC(=O)N1CCN2C(=O)NCC2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1276591,nM,1060,CHEMBL284,5.974694135,DPPIV,N[C@@H](CC(=O)N1CCN2C(=O)NCC2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN2C(=O)NCC2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543711,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,CCN1CC2CN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCN2C1=O.O=C(O)/C=C/C(=O)O,CHEMBL1276620,nM,460,CHEMBL284,6.337242168,DPPIV,CCN1CC2CN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCN2C1=O,CCN1CC2CN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CCN2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543712,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,COc1ccc(CN2CC3CN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCN3C2=O)cc1.O=C(O)/C=C/C(=O)O,CHEMBL1275851,nM,360,CHEMBL284,6.443697499,DPPIV,COc1ccc(CN2CC3CN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCN3C2=O)cc1,COc1ccc(CN2CC3CN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CCN3C2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543713,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,N[C@@H](CC(=O)N1CCN2C(=O)N(Cc3ccccc3)CC2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1276650,nM,300,CHEMBL284,6.522878745,DPPIV,N[C@@H](CC(=O)N1CCN2C(=O)N(Cc3ccccc3)CC2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN2C(=O)N(Cc3ccccc3)CC2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543714,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,COc1cccc(CN2CC3CN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCN3C2=O)c1.O=C(O)/C=C/C(=O)O,CHEMBL1275853,nM,124,CHEMBL284,6.906578315,DPPIV,COc1cccc(CN2CC3CN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCN3C2=O)c1,COc1cccc(CN2CC3CN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CCN3C2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543715,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,COc1cc(CN2CC3CN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCN3C2=O)cc(OC)c1.O=C(O)/C=C/C(=O)O,CHEMBL1275854,nM,114,CHEMBL284,6.943095149,DPPIV,COc1cc(CN2CC3CN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCN3C2=O)cc(OC)c1,COc1cc(CN2CC3CN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CCN3C2=O)cc(OC)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3543716,CHEMBL1285191,Inhibition of human seminal fluid DPP4,B,COc1ccccc1CN1CC2CN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCN2C1=O.O=C(O)/C=C/C(=O)O,CHEMBL1275852,nM,101,CHEMBL284,6.995678626,DPPIV,COc1ccccc1CN1CC2CN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCN2C1=O,COc1ccccc1CN1CC2CN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CCN2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603849,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1c(=O)[nH]c2cc(N3CCC[C@@](C)(N)C3)n(Cc3ccccc3)c2c1=O,CHEMBL1288231,nM,1.8,CHEMBL284,8.744727495,DPPIV,Cn1c(=O)[nH]c2cc(N3CCC[C@@](C)(N)C3)n(Cc3ccccc3)c2c1=O,Cn1c(=O)[nH]c2cc(N3CCCC(C)(N)C3)n(Cc3ccccc3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603850,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2ccccc2C#N)n(C)c1=O,CHEMBL1288232,nM,36,CHEMBL284,7.443697499,DPPIV,Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2ccccc2C#N)n(C)c1=O,Cn1c(=O)c2c(cc(N3CCCC(C)(N)C3)n2Cc2ccccc2C#N)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603851,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2Cl)n(C)c1=O,CHEMBL1288260,nM,28,CHEMBL284,7.552841969,DPPIV,Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2Cl)n(C)c1=O,Cn1c(=O)c2c(cc(N3CCCC(C)(N)C3)n2Cc2cc(F)ccc2Cl)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603852,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cc1ccc(F)cc1Cn1c(N2CCC[C@@](C)(N)C2)cc2c1c(=O)n(C)c(=O)n2C.Cl,CHEMBL1288261,nM,27,CHEMBL284,7.568636236,DPPIV,Cc1ccc(F)cc1Cn1c(N2CCC[C@@](C)(N)C2)cc2c1c(=O)n(C)c(=O)n2C,Cc1ccc(F)cc1Cn1c(N2CCCC(C)(N)C2)cc2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603853,CHEMBL1291739,Inhibition of human plasma DPP4,B,CCn1c(=O)n(C)c(=O)c2c1cc(N1CCC[C@@](C)(N)C1)n2Cc1cc(F)ccc1C#N.Cl,CHEMBL1288288,nM,12,CHEMBL284,7.920818754,DPPIV,CCn1c(=O)n(C)c(=O)c2c1cc(N1CCC[C@@](C)(N)C1)n2Cc1cc(F)ccc1C#N,CCn1c(=O)n(C)c(=O)c2c1cc(N1CCCC(C)(N)C1)n2Cc1cc(F)ccc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603854,CHEMBL1291739,Inhibition of human plasma DPP4,B,CN(C)C(=O)Cn1c(=O)n(C)c(=O)c2c1cc(N1CCC[C@@](C)(N)C1)n2Cc1cc(F)ccc1Cl.Cl,CHEMBL1288289,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)Cn1c(=O)n(C)c(=O)c2c1cc(N1CCC[C@@](C)(N)C1)n2Cc1cc(F)ccc1Cl,CN(C)C(=O)Cn1c(=O)n(C)c(=O)c2c1cc(N1CCCC(C)(N)C1)n2Cc1cc(F)ccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603855,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2Cl)n(CCCO)c1=O,CHEMBL1287844,nM,23,CHEMBL284,7.638272164,DPPIV,Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2Cl)n(CCCO)c1=O,Cn1c(=O)c2c(cc(N3CCCC(C)(N)C3)n2Cc2cc(F)ccc2Cl)n(CCCO)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603856,CHEMBL1291739,Inhibition of human plasma DPP4,B,CCOCCCn1c(=O)n(C)c(=O)c2c1cc(N1CCC[C@@](C)(N)C1)n2Cc1cc(F)ccc1Cl.Cl,CHEMBL1287845,nM,122,CHEMBL284,6.913640169,DPPIV,CCOCCCn1c(=O)n(C)c(=O)c2c1cc(N1CCC[C@@](C)(N)C1)n2Cc1cc(F)ccc1Cl,CCOCCCn1c(=O)n(C)c(=O)c2c1cc(N1CCCC(C)(N)C1)n2Cc1cc(F)ccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603857,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1cnc2cc(N3CCC[C@@](C)(N)C3)n(Cc3cc(F)ccc3Cl)c2c1=O,CHEMBL1287874,nM,103,CHEMBL284,6.987162775,DPPIV,Cn1cnc2cc(N3CCC[C@@](C)(N)C3)n(Cc3cc(F)ccc3Cl)c2c1=O,Cn1cnc2cc(N3CCCC(C)(N)C3)n(Cc3cc(F)ccc3Cl)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603858,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1cnc2cc(N3CCC[C@@](C)(N)C3)n(Cc3cc(F)ccc3C#N)c2c1=O,CHEMBL1287875,nM,87,CHEMBL284,7.060480747,DPPIV,Cn1cnc2cc(N3CCC[C@@](C)(N)C3)n(Cc3cc(F)ccc3C#N)c2c1=O,Cn1cnc2cc(N3CCCC(C)(N)C3)n(Cc3cc(F)ccc3C#N)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603859,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cc1ccc(F)cc1Cn1c(N2CCC[C@@](C)(N)C2)cc2ncn(C)c(=O)c21.Cl,CHEMBL1287901,nM,23,CHEMBL284,7.638272164,DPPIV,Cc1ccc(F)cc1Cn1c(N2CCC[C@@](C)(N)C2)cc2ncn(C)c(=O)c21,Cc1ccc(F)cc1Cn1c(N2CCCC(C)(N)C2)cc2ncn(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
3603860,CHEMBL1291739,Inhibition of human plasma DPP4,B,Cl.Cn1cnc2cc(N3CCC[C@@](C)(N)C3)n(Cc3ccccc3C#N)c2c1=O,CHEMBL1287902,nM,151,CHEMBL284,6.821023053,DPPIV,Cn1cnc2cc(N3CCC[C@@](C)(N)C3)n(Cc3ccccc3C#N)c2c1=O,Cn1cnc2cc(N3CCCC(C)(N)C3)n(Cc3ccccc3C#N)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131359,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)c1cccc(NC(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)c1.Cl.Cl,CHEMBL3216724,nM,3.7,CHEMBL284,8.431798276,DPPIV,COC(=O)c1cccc(NC(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)c1,COC(=O)c1cccc(NC(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131360,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)Nc3cccc(C(=O)O)c3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216940,nM,19,CHEMBL284,7.721246399,DPPIV,Cc1ccc(-c2c(CC(=O)Nc3cccc(C(=O)O)c3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)Nc3cccc(C(=O)O)c3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131361,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)Nc3cccc(C(N)=O)c3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216270,nM,8.1,CHEMBL284,8.091514981,DPPIV,Cc1ccc(-c2c(CC(=O)Nc3cccc(C(N)=O)c3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)Nc3cccc(C(N)=O)c3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131362,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,CC(=O)c1cccc(NC(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)c1.Cl.Cl,CHEMBL3215827,nM,1.8,CHEMBL284,8.744727495,DPPIV,CC(=O)c1cccc(NC(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)c1,CC(=O)c1cccc(NC(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131363,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)c1ccccc1NC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1.Cl.Cl,CHEMBL3216271,nM,19,CHEMBL284,7.721246399,DPPIV,COC(=O)c1ccccc1NC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,COC(=O)c1ccccc1NC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131364,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)c1cscc1NC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1.Cl.Cl,CHEMBL3216483,nM,23,CHEMBL284,7.638272164,DPPIV,COC(=O)c1cscc1NC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,COC(=O)c1cscc1NC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131365,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)Nc3cscc3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216272,nM,30,CHEMBL284,7.522878745,DPPIV,Cc1ccc(-c2c(CC(=O)Nc3cscc3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)Nc3cscc3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131366,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)Nc3cccc([S+](C)[O-])c3)c(C)nc(CC(C)C)c2CN)cc1.Cl,CHEMBL1644844,nM,2.8,CHEMBL284,8.552841969,DPPIV,Cc1ccc(-c2c(CC(=O)Nc3cccc([S+](C)[O-])c3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)Nc3cccc([S+](C)[O-])c3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131367,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)Nc3cccc(S(C)(=O)=O)c3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3217158,nM,8.2,CHEMBL284,8.086186148,DPPIV,Cc1ccc(-c2c(CC(=O)Nc3cccc(S(C)(=O)=O)c3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)Nc3cccc(S(C)(=O)=O)c3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131368,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)C1CCN(C(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)C1.Cl.Cl,CHEMBL3215828,nM,11,CHEMBL284,7.958607315,DPPIV,COC(=O)C1CCN(C(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)C1,COC(=O)C1CCN(C(=O)Cc2c(C)nc(CC(C)C)c(CN)c2-c2ccc(C)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131369,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)N3CCC(S(C)(=O)=O)C3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3215611,nM,53,CHEMBL284,7.27572413,DPPIV,Cc1ccc(-c2c(CC(=O)N3CCC(S(C)(=O)=O)C3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)N3CCC(S(C)(=O)=O)C3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131370,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)[C@@H]1CCCN1C(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1.Cl.Cl,CHEMBL3216064,nM,1.1,CHEMBL284,8.958607315,DPPIV,COC(=O)C1CCCN1C(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,COC(=O)C1CCCN1C(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131371,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)N3CCC[C@H]3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216485,nM,2.9,CHEMBL284,8.537602002,DPPIV,Cc1ccc(-c2c(CC(=O)N3CCCC3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)N3CCCC3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131372,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)N3CCC[C@H]3C(N)=O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216725,nM,1.1,CHEMBL284,8.958607315,DPPIV,Cc1ccc(-c2c(CC(=O)N3CCCC3C(N)=O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)N3CCCC3C(N)=O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131373,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)[C@H]1CCCN1C(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1.Cl.Cl,CHEMBL3216941,nM,23,CHEMBL284,7.638272164,DPPIV,COC(=O)C1CCCN1C(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,COC(=O)C1CCCN1C(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131374,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)N3CCC[C@@H]3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216726,nM,7.8,CHEMBL284,8.107905397,DPPIV,Cc1ccc(-c2c(CC(=O)N3CCCC3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)N3CCCC3C(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131375,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)N3CCC[C@@H]3C(N)=O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3217159,nM,12,CHEMBL284,7.920818754,DPPIV,Cc1ccc(-c2c(CC(=O)N3CCCC3C(N)=O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)N3CCCC3C(N)=O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131376,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,CNC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1.Cl.Cl,CHEMBL3216727,nM,69,CHEMBL284,7.161150909,DPPIV,CNC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,CNC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131377,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,COC(=O)CNC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1.Cl.Cl,CHEMBL3216942,nM,17,CHEMBL284,7.769551079,DPPIV,COC(=O)CNC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,COC(=O)CNC(=O)Cc1c(C)nc(CC(C)C)c(CN)c1-c1ccc(C)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131378,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CC(=O)NCC(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3217160,nM,73,CHEMBL284,7.13667714,DPPIV,Cc1ccc(-c2c(CC(=O)NCC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)NCC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5131379,CHEMBL1646015,Inhibition of DDP4 in human Caco2 cells after 60 mins by spectrophotometry,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)O)cc1,CHEMBL1614729,nM,18,CHEMBL284,7.744727495,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5177076,CHEMBL1663348,Inhibition of DPP4 after 20 mins by fluorescence assay,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2sccc2c1=O,CHEMBL1651763,nM,0.87,CHEMBL284,9.060480747,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2sccc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2sccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5177077,CHEMBL1663348,Inhibition of DPP4 after 20 mins by fluorescence assay,B,Cc1csc2nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c(=O)c12,CHEMBL1651764,nM,1.32,CHEMBL284,8.879426069,DPPIV,Cc1csc2nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c(=O)c12,Cc1csc2nc(N3CCCC(N)C3)n(Cc3ccccc3C#N)c(=O)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5177078,CHEMBL1663348,Inhibition of DPP4 after 20 mins by fluorescence assay,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2scc(C(F)(F)F)c2c1=O,CHEMBL1651765,nM,88.82,CHEMBL284,7.051489231,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2scc(C(F)(F)F)c2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2scc(C(F)(F)F)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5177079,CHEMBL1663348,Inhibition of DPP4 after 20 mins by fluorescence assay,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccsc2c1=O,CHEMBL1651766,nM,0.33,CHEMBL284,9.48148606,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccsc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2ccsc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5177080,CHEMBL1663348,Inhibition of DPP4 after 20 mins by fluorescence assay,B,Cc1csc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc12,CHEMBL1651767,nM,1.72,CHEMBL284,8.764471553,DPPIV,Cc1csc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc12,Cc1csc2c(=O)n(Cc3ccccc3C#N)c(N3CCCC(N)C3)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192902,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@](C)(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,CHEMBL1650449,nM,10,CHEMBL284,8,DPPIV,Cn1c(=O)cc(N2CCC[C@@](C)(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Cn1c(=O)cc(N2CCCC(C)(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192903,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCCCC(N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650448,nM,3800,CHEMBL284,5.420216403,DPPIV,Cn1c(=O)cc(N2CCCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Cn1c(=O)cc(N2CCCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192904,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(NC2CCCCNC2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650447,nM,590,CHEMBL284,6.229147988,DPPIV,Cn1c(=O)cc(NC2CCCCNC2)n(Cc2ccccc2C#N)c1=O,Cn1c(=O)cc(NC2CCCCNC2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192905,CHEMBL1664314,Inhibition of human DPP4,B,CCn1c(=O)cc(NCCN)n(Cc2ccccc2C#N)c1=O,CHEMBL1650446,nM,17000,CHEMBL284,4.769551079,DPPIV,CCn1c(=O)cc(NCCN)n(Cc2ccccc2C#N)c1=O,CCn1c(=O)cc(NCCN)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192906,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2c(F)ccc(F)c2Cl)c1=O,CHEMBL1650445,nM,830,CHEMBL284,6.080921908,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2c(F)ccc(F)c2Cl)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2c(F)ccc(F)c2Cl)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192907,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(Cl)ccc2Cl)c1=O,CHEMBL1650444,nM,27,CHEMBL284,7.568636236,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(Cl)ccc2Cl)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(Cl)ccc2Cl)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192908,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,CHEMBL1650443,nM,4,CHEMBL284,8.397940009,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192909,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccc(F)cc2Cl)c1=O,CHEMBL1650442,nM,890,CHEMBL284,6.050609993,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccc(F)cc2Cl)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccc(F)cc2Cl)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192910,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2Cl)c1=O,CHEMBL1650441,nM,14,CHEMBL284,7.853871964,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2Cl)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2Cl)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192911,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2Br)c1=O,CHEMBL1650440,nM,8,CHEMBL284,8.096910013,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2Br)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192912,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2Br)c1=O,CHEMBL1650439,nM,12,CHEMBL284,7.920818754,DPPIV,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2Br)c1=O,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192913,CHEMBL1664314,Inhibition of human DPP4,B,N[C@@H]1CCCN(c2cc(=O)[nH]c(=O)n2Cc2ccccc2Br)C1,CHEMBL1650438,nM,36,CHEMBL284,7.443697499,DPPIV,N[C@@H]1CCCN(c2cc(=O)[nH]c(=O)n2Cc2ccccc2Br)C1,NC1CCCN(c2cc(=O)[nH]c(=O)n2Cc2ccccc2Br)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192914,CHEMBL1664314,Inhibition of human DPP4,B,CCn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650437,nM,68,CHEMBL284,7.167491087,DPPIV,CCn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CCn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192915,CHEMBL1664314,Inhibition of human DPP4,B,Cn1c(=O)c(Cl)c(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650436,nM,57,CHEMBL284,7.244125144,DPPIV,Cn1c(=O)c(Cl)c(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,Cn1c(=O)c(Cl)c(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192917,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)[nH]c1=O,CHEMBL1650435,nM,4,CHEMBL284,8.397940009,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)[nH]c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)cc(=O)[nH]c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192918,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)ncc(Br)c1=O,CHEMBL1650434,nM,6,CHEMBL284,8.22184875,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)ncc(Br)c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)ncc(Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192919,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)ncc(Cl)c1=O,CHEMBL1650433,nM,8,CHEMBL284,8.096910013,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)ncc(Cl)c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)ncc(Cl)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192920,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)ncc(F)c1=O,CHEMBL1650432,nM,8,CHEMBL284,8.096910013,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)ncc(F)c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)ncc(F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192921,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1cc(F)ccc1Cn1c(N2CCC[C@@H](N)C2)ncc(F)c1=O,CHEMBL1650431,nM,430,CHEMBL284,6.366531544,DPPIV,N#Cc1cc(F)ccc1Cn1c(N2CCC[C@@H](N)C2)ncc(F)c1=O,N#Cc1cc(F)ccc1Cn1c(N2CCCC(N)C2)ncc(F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192922,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccsc1Cn1c(N2CCC[C@@H](N)C2)ncc(Br)c1=O,CHEMBL1650430,nM,3,CHEMBL284,8.522878745,DPPIV,N#Cc1ccsc1Cn1c(N2CCC[C@@H](N)C2)ncc(Br)c1=O,N#Cc1ccsc1Cn1c(N2CCCC(N)C2)ncc(Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192923,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(/C=C/c2cccnc2)c1=O,CHEMBL1650429,nM,6,CHEMBL284,8.22184875,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(/C=C/c2cccnc2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(C=Cc2cccnc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192924,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(/C=C/c2ccc(F)cc2)c1=O,CHEMBL1650428,nM,21,CHEMBL284,7.677780705,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(/C=C/c2ccc(F)cc2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(C=Cc2ccc(F)cc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192925,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(/C=C/c2ccccc2)c1=O,CHEMBL1650427,nM,22,CHEMBL284,7.657577319,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(/C=C/c2ccccc2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(C=Cc2ccccc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192926,CHEMBL1664314,Inhibition of human DPP4,B,C=Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650426,nM,8,CHEMBL284,8.096910013,DPPIV,C=Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,C=Cc1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192927,CHEMBL1664314,Inhibition of human DPP4,B,CC(C)(C)C#Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650425,nM,570,CHEMBL284,6.244125144,DPPIV,CC(C)(C)C#Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CC(C)(C)C#Cc1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192928,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(C#CCO)c1=O,CHEMBL1650424,nM,20,CHEMBL284,7.698970004,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(C#CCO)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(C#CCO)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192929,CHEMBL1664314,Inhibition of human DPP4,B,CC#Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650423,nM,5,CHEMBL284,8.301029996,DPPIV,CC#Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CC#Cc1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192930,CHEMBL1664314,Inhibition of human DPP4,B,C#Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650422,nM,5,CHEMBL284,8.301029996,DPPIV,C#Cc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,C#Cc1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192931,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(N2CCCC2)c1=O,CHEMBL1650421,nM,200,CHEMBL284,6.698970004,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(N2CCCC2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(N2CCCC2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192932,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2cc[nH]c2)c1=O,CHEMBL1650420,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2cc[nH]c2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(-c2cc[nH]c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192933,CHEMBL1664314,Inhibition of human DPP4,B,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1-c1ccoc1,CHEMBL1650419,nM,77,CHEMBL284,7.113509275,DPPIV,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1-c1ccoc1,Cc1nc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c(=O)c1-c1ccoc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192934,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2ccoc2)c1=O,CHEMBL1650418,nM,12,CHEMBL284,7.920818754,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2ccoc2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(-c2ccoc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192935,CHEMBL1664314,Inhibition of human DPP4,B,COc1ccccc1-c1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650417,nM,990,CHEMBL284,6.004364805,DPPIV,COc1ccccc1-c1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,COc1ccccc1-c1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192936,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2ccccc2F)c1=O,CHEMBL1650416,nM,240,CHEMBL284,6.619788758,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2ccccc2F)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(-c2ccccc2F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192937,CHEMBL1664314,Inhibition of human DPP4,B,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1-c1ccccc1,CHEMBL1650415,nM,540,CHEMBL284,6.26760624,DPPIV,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1-c1ccccc1,Cc1nc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c(=O)c1-c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192938,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2ccccc2)c1=O,CHEMBL1650414,nM,23,CHEMBL284,7.638272164,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(-c2ccccc2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(-c2ccccc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192939,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(c1=O)CCCC2,CHEMBL1650413,nM,13,CHEMBL284,7.886056648,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(c1=O)CCCC2,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c(c1=O)CCCC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192940,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc(-c2ccccc2)cc1=O,CHEMBL1650412,nM,23,CHEMBL284,7.638272164,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc(-c2ccccc2)cc1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc(-c2ccccc2)cc1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192941,CHEMBL1664314,Inhibition of human DPP4,B,COc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650411,nM,4,CHEMBL284,8.397940009,DPPIV,COc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,COc1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192942,CHEMBL1664314,Inhibition of human DPP4,B,CCc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL1650410,nM,17,CHEMBL284,7.769551079,DPPIV,CCc1cnc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CCc1cnc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192943,CHEMBL1664314,Inhibition of human DPP4,B,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1C,CHEMBL1650409,nM,10,CHEMBL284,8,DPPIV,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1C,Cc1nc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c(=O)c1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192944,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(I)c1=O,CHEMBL1650408,nM,6,CHEMBL284,8.22184875,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(I)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(I)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192945,CHEMBL1664314,Inhibition of human DPP4,B,CC(C)(C)c1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1Br,CHEMBL1650407,nM,7400,CHEMBL284,5.13076828,DPPIV,CC(C)(C)c1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1Br,CC(C)(C)c1nc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c(=O)c1Br,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192946,CHEMBL1664314,Inhibition of human DPP4,B,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1Br,CHEMBL1650406,nM,8,CHEMBL284,8.096910013,DPPIV,Cc1nc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c(=O)c1Br,Cc1nc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c(=O)c1Br,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192947,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(Br)c1=O,CHEMBL1235761,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(Br)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192948,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(Cl)c1=O,CHEMBL1650405,nM,7,CHEMBL284,8.15490196,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(Cl)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(Cl)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192949,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nccc1=O,CHEMBL1650403,nM,14,CHEMBL284,7.853871964,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nccc1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nccc1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5192950,CHEMBL1664314,Inhibition of human DPP4,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(F)c1=O,CHEMBL1650404,nM,6,CHEMBL284,8.22184875,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)ncc(F)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)ncc(F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208652,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL3216493,nM,23,CHEMBL284,7.638272164,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208653,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL3215844,nM,8.7,CHEMBL284,8.060480747,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208654,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL3216279,nM,9.6,CHEMBL284,8.017728767,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208655,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL3216495,nM,6.6,CHEMBL284,8.180456064,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCCCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208656,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CC(=O)NCC4=O)cc23)cc1.Cl.Cl,CHEMBL3142227,nM,1.1,CHEMBL284,8.958607315,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CC(=O)NCC4=O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CC(=O)NCC4=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208657,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)O)cc1.Cl.Cl,CHEMBL3215845,nM,18,CHEMBL284,7.744727495,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208658,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CC(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216734,nM,20,CHEMBL284,7.698970004,DPPIV,Cc1ccc(-c2c(CC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208659,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CCC(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216954,nM,39,CHEMBL284,7.408935393,DPPIV,Cc1ccc(-c2c(CCC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CCC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208660,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(/C=C/C(=O)O)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL3216718,nM,66,CHEMBL284,7.180456064,DPPIV,Cc1ccc(-c2c(C=CC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(C=CC(=O)O)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208661,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,CCCc1nc(C)c(C(=O)O)c(-c2ccc(C)cc2)c1CN.Cl.Cl,CHEMBL3216937,nM,57,CHEMBL284,7.244125144,DPPIV,CCCc1nc(C)c(C(=O)O)c(-c2ccc(C)cc2)c1CN,CCCc1nc(C)c(C(=O)O)c(-c2ccc(C)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208662,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,CCCCc1nc(C)c(C(=O)O)c(-c2ccc(C)cc2)c1CN.Cl.Cl,CHEMBL3216477,nM,58,CHEMBL284,7.236572006,DPPIV,CCCCc1nc(C)c(C(=O)O)c(-c2ccc(C)cc2)c1CN,CCCCc1nc(C)c(C(=O)O)c(-c2ccc(C)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208663,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(C)c2C(=O)O)cc1.Cl.Cl,CHEMBL3216938,nM,18,CHEMBL284,7.744727495,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(C)c2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(C)c2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208664,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,CCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1C(=O)O.Cl.Cl,CHEMBL3216719,nM,5.7,CHEMBL284,8.244125144,DPPIV,CCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1C(=O)O,CCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208665,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,CCCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1C(=O)O.Cl.Cl,CHEMBL3215820,nM,4.4,CHEMBL284,8.356547324,DPPIV,CCCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1C(=O)O,CCCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208666,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(C(C)C)c2C(=O)O)cc1.Cl.Cl,CHEMBL3215608,nM,19,CHEMBL284,7.721246399,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(C(C)C)c2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(C(C)C)c2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208667,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(CC(C)C)c2C(=O)O)cc1.Cl.Cl,CHEMBL3215606,nM,4.6,CHEMBL284,8.337242168,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(CC(C)C)c2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(CC(C)C)c2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208668,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(Cc3ccccc3)c2C(=O)O)cc1.Cl.Cl,CHEMBL3216060,nM,2.5,CHEMBL284,8.602059991,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(Cc3ccccc3)c2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)(C)C)nc(Cc3ccccc3)c2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208669,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,Cc1ccc(-c2c(CC(=O)O)c(C)nc(CC(C)(C)C)c2CN)cc1.Cl.Cl,CHEMBL3215607,nM,10,CHEMBL284,8,DPPIV,Cc1ccc(-c2c(CC(=O)O)c(C)nc(CC(C)(C)C)c2CN)cc1,Cc1ccc(-c2c(CC(=O)O)c(C)nc(CC(C)(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5208670,CHEMBL1680829,Inhibition of DPP4 in human Caco2 cells after 60 mins,B,CCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1CC(=O)O.O,CHEMBL1672127,nM,5.3,CHEMBL284,8.27572413,DPPIV,CCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1CC(=O)O,CCc1nc(CC(C)(C)C)c(CN)c(-c2ccc(C)cc2)c1CC(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236280,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)O)Cc1cc(F)c(F)cc1F,CHEMBL1683476,nM,601,CHEMBL284,6.221125528,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)O)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)O)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236281,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,COC(=O)C1SCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL1683477,nM,204,CHEMBL284,6.690369833,DPPIV,COC(=O)C1SCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,COC(=O)C1SCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236282,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCC(=O)O)Cc1cc(F)c(F)cc1F,CHEMBL1683478,nM,212,CHEMBL284,6.673664139,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCC(=O)O)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCC(=O)O)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236283,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)CNC(=O)C1SCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL1683479,nM,101,CHEMBL284,6.995678626,DPPIV,CCOC(=O)CNC(=O)C1SCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCOC(=O)CNC(=O)C1SCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236284,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CN(C)C(=O)C1SCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F.Cl,CHEMBL1683480,nM,1700,CHEMBL284,5.769551079,DPPIV,CN(C)C(=O)C1SCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CN(C)C(=O)C1SCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236285,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)N1CCOCC1)Cc1cc(F)c(F)cc1F,CHEMBL1683481,nM,807,CHEMBL284,6.093126465,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)N1CCOCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)N1CCOCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236286,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)N1CCNCC1)Cc1cc(F)c(F)cc1F,CHEMBL1683482,nM,680,CHEMBL284,6.167491087,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)N1CCNCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)N1CCNCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236287,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccoc1)Cc1cc(F)c(F)cc1F,CHEMBL1683483,nM,88,CHEMBL284,7.055517328,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccoc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccoc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236288,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccccc1)Cc1cc(F)c(F)cc1F,CHEMBL1681806,nM,77,CHEMBL284,7.113509275,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccccc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccccc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236289,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccncc1)Cc1cc(F)c(F)cc1F,CHEMBL1683484,nM,357,CHEMBL284,6.447331784,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccncc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccncc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236291,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL1683485,nM,328,CHEMBL284,6.484126156,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccc(O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236292,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL1683486,nM,229,CHEMBL284,6.640164518,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccc(C(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236293,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)COc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL1683487,nM,41,CHEMBL284,7.387216143,DPPIV,CCOC(=O)COc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)COc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236294,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL1683488,nM,51,CHEMBL284,7.292429824,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccc(OCC(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236295,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)COc1cccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1.Cl,CHEMBL1683489,nM,95,CHEMBL284,7.022276395,DPPIV,CCOC(=O)COc1cccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)c1,CCOC(=O)COc1cccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236296,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,CHEMBL1683490,nM,102,CHEMBL284,6.991399828,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1cccc(OCC(=O)O)c1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236297,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)C1COc2cc(CNC(=O)C3SCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)ccc2O1.Cl,CHEMBL1683491,nM,112,CHEMBL284,6.950781977,DPPIV,CCOC(=O)C1COc2cc(CNC(=O)C3SCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)ccc2O1,CCOC(=O)C1COc2cc(CNC(=O)C3SCCN3C(=O)CC(N)Cc3cc(F)c(F)cc3F)ccc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236298,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc2c(c1)OCC(C(=O)O)O2)Cc1cc(F)c(F)cc1F,CHEMBL1683492,nM,192,CHEMBL284,6.716698771,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc2c(c1)OCC(C(=O)O)O2)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccc2c(c1)OCC(C(=O)O)O2)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236299,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)C1Oc2ccc(CNC(=O)C3SCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)cc2O1.Cl,CHEMBL1683493,nM,64,CHEMBL284,7.193820026,DPPIV,CCOC(=O)C1Oc2ccc(CNC(=O)C3SCCN3C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)cc2O1,CCOC(=O)C1Oc2ccc(CNC(=O)C3SCCN3C(=O)CC(N)Cc3cc(F)c(F)cc3F)cc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236300,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc2c(c1)OC(C(=O)O)O2)Cc1cc(F)c(F)cc1F,CHEMBL1683494,nM,64,CHEMBL284,7.193820026,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc2c(c1)OC(C(=O)O)O2)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccc2c(c1)OC(C(=O)O)O2)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236301,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL1683495,nM,216,CHEMBL284,6.665546249,DPPIV,CC(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(Oc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236302,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL1683496,nM,56,CHEMBL284,7.251811973,DPPIV,CC(C)(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)(Oc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236303,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,Cl.N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(OC(Cc2ccccc2)C(=O)O)cc1)Cc1cc(F)c(F)cc1F,CHEMBL1683497,nM,28,CHEMBL284,7.552841969,DPPIV,N[C@@H](CC(=O)N1CCSC1C(=O)NCc1ccc(OC(Cc2ccccc2)C(=O)O)cc1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCSC1C(=O)NCc1ccc(OC(Cc2ccccc2)C(=O)O)cc1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236304,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)C(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL1683498,nM,6,CHEMBL284,8.22184875,DPPIV,CC(C)C(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Oc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236305,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)C(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C.Cl,CHEMBL1683499,nM,77,CHEMBL284,7.113509275,DPPIV,CCOC(=O)C(Oc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Oc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236306,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)C(C(=O)O)N(C)c1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL1683500,nM,80,CHEMBL284,7.096910013,DPPIV,CC(C)C(C(=O)O)N(C)c1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CC(C)C(C(=O)O)N(C)c1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236307,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)C(C(C)C)N(C)c1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL1683501,nM,80,CHEMBL284,7.096910013,DPPIV,CCOC(=O)C(C(C)C)N(C)c1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)C(C(C)C)N(C)c1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236308,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL1683502,nM,13,CHEMBL284,7.886056648,DPPIV,CC(C)(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236309,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)C(C)(C)Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1.Cl,CHEMBL1683503,nM,68,CHEMBL284,7.167491087,DPPIV,CCOC(=O)C(C)(C)Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CCOC(=O)C(C)(C)Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236310,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL1683504,nM,3,CHEMBL284,8.522878745,DPPIV,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236311,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C.Cl,CHEMBL1683505,nM,50,CHEMBL284,7.301029996,DPPIV,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236312,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)[C@@H](Nc1ccc(CNC(=O)[C@@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O.Cl,CHEMBL1683506,nM,1,CHEMBL284,9,DPPIV,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236313,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)[C@H](Nc1ccc(CNC(=O)[C@@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C.Cl,CHEMBL1683507,nM,17,CHEMBL284,7.769551079,DPPIV,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236314,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)[C@H](Nc1ccc(CNC(=O)[C@@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CHEMBL1683508,nM,1.2,CHEMBL284,8.920818754,DPPIV,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236315,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)[C@@H](Nc1ccc(CNC(=O)[C@@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CHEMBL1683641,nM,25,CHEMBL284,7.602059991,DPPIV,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236316,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)[C@@H](Nc1ccc(CNC(=O)[C@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CHEMBL1614845,nM,10,CHEMBL284,8,DPPIV,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236317,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)[C@H](Nc1ccc(CNC(=O)[C@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CHEMBL1683642,nM,175,CHEMBL284,6.756961951,DPPIV,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236318,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CC(C)[C@H](Nc1ccc(CNC(=O)[C@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CHEMBL1683643,nM,13,CHEMBL284,7.886056648,DPPIV,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,CC(C)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5236319,CHEMBL1686243,Inhibition of human recombinant DPP4 after 60 mins by fluorescence plate reader,B,CCOC(=O)[C@@H](Nc1ccc(CNC(=O)[C@H]2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CHEMBL1683644,nM,309,CHEMBL284,6.510041521,DPPIV,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,CCOC(=O)C(Nc1ccc(CNC(=O)C2SCCN2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237506,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccccc1,CHEMBL1682975,nM,140,CHEMBL284,6.853871964,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccccc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237507,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccccc1C(F)(F)F,CHEMBL1682976,nM,110,CHEMBL284,6.958607315,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccccc1C(F)(F)F,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237508,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccc(C#N)c1,CHEMBL1682977,nM,85,CHEMBL284,7.070581074,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccc(C#N)c1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccc(C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237509,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(C#N)cc1,CHEMBL1682978,nM,180,CHEMBL284,6.744727495,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(C#N)cc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237510,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(N)cc1,CHEMBL1682979,nM,140,CHEMBL284,6.853871964,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(N)cc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237511,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1,CHEMBL1682980,nM,400,CHEMBL284,6.397940009,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237512,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccc(C(N)=O)c1,CHEMBL1682981,nM,99,CHEMBL284,7.004364805,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccc(C(N)=O)c1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccc(C(N)=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237513,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(C(N)=O)cc1,CHEMBL1682982,nM,84,CHEMBL284,7.075720714,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(C(N)=O)cc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237514,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(F)cc1F,CHEMBL1682983,nM,150,CHEMBL284,6.823908741,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(F)cc1F,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237515,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(-c2cnco2)cc1,CHEMBL1682984,nM,130,CHEMBL284,6.886056648,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(-c2cnco2)cc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(-c2cnco2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237516,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(-c2csnn2)cc1,CHEMBL1682985,nM,94,CHEMBL284,7.026872146,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(-c2csnn2)cc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1ccc(-c2csnn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237517,CHEMBL1687449,Inhibition of DPP4,B,Cc1[nH]ncc1S(=O)(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683086,nM,280,CHEMBL284,6.552841969,DPPIV,Cc1[nH]ncc1S(=O)(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,Cc1[nH]ncc1S(=O)(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237518,CHEMBL1687449,Inhibition of DPP4,B,Cn1cnc(S(=O)(=O)N(C)[C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)c1,CHEMBL1683087,nM,500,CHEMBL284,6.301029996,DPPIV,Cn1cnc(S(=O)(=O)N(C)[C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)c1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cn(C)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237519,CHEMBL1687449,Inhibition of DPP4,B,Cc1oncc1S(=O)(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683088,nM,170,CHEMBL284,6.769551079,DPPIV,Cc1oncc1S(=O)(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,Cc1oncc1S(=O)(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237520,CHEMBL1687449,Inhibition of DPP4,B,CC(=O)Nc1nc(C)c(S(=O)(=O)N(C)[C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)s1,CHEMBL1683089,nM,100,CHEMBL284,7,DPPIV,CC(=O)N=c1[nH]c(C)c(S(=O)(=O)N(C)[C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)s1,CC(=O)N=c1[nH]c(C)c(S(=O)(=O)N(C)C2CCC(C(N)Cc3cc(F)ccc3F)CC2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237521,CHEMBL1687449,Inhibition of DPP4,B,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccnc1,CHEMBL1683090,nM,110,CHEMBL284,6.958607315,DPPIV,CN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccnc1,CN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1cccnc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237522,CHEMBL1687449,Inhibition of DPP4,B,Cc1noc(C)c1S(=O)(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683091,nM,55,CHEMBL284,7.259637311,DPPIV,Cc1noc(C)c1S(=O)(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,Cc1noc(C)c1S(=O)(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237523,CHEMBL1687449,Inhibition of DPP4,B,CCN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1c(C)noc1C,CHEMBL1683092,nM,38,CHEMBL284,7.420216403,DPPIV,CCN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1c(C)noc1C,CCN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(=O)(=O)c1c(C)noc1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237524,CHEMBL1687449,Inhibition of DPP4,B,Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683093,nM,670,CHEMBL284,6.173925197,DPPIV,Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,Cc1noc(C)c1S(=O)(=O)N(Cc1ccccc1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237525,CHEMBL1687449,Inhibition of DPP4,B,Cc1noc(C)c1S(=O)(=O)N(CCCC(F)(F)F)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683094,nM,570,CHEMBL284,6.244125144,DPPIV,Cc1noc(C)c1S(=O)(=O)N(CCCC(F)(F)F)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,Cc1noc(C)c1S(=O)(=O)N(CCCC(F)(F)F)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237526,CHEMBL1687449,Inhibition of DPP4,B,CCN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(C)(=O)=O,CHEMBL1683095,nM,260,CHEMBL284,6.585026652,DPPIV,CCN([C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1)S(C)(=O)=O,CCN(C1CCC(C(N)Cc2cc(F)ccc2F)CC1)S(C)(=O)=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237527,CHEMBL1687449,Inhibition of DPP4,B,CS(=O)(=O)N(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683096,nM,1300,CHEMBL284,5.886056648,DPPIV,CS(=O)(=O)N(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CS(=O)(=O)N(Cc1ccccc1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237528,CHEMBL1687449,Inhibition of DPP4,B,CS(=O)(=O)N(CCCC(F)(F)F)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683097,nM,2400,CHEMBL284,5.619788758,DPPIV,CS(=O)(=O)N(CCCC(F)(F)F)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CS(=O)(=O)N(CCCC(F)(F)F)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237529,CHEMBL1687449,Inhibition of DPP4,B,CC(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683098,nM,120,CHEMBL284,6.920818754,DPPIV,CC(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CC(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237530,CHEMBL1687449,Inhibition of DPP4,B,CC(=O)N(C)[C@H]1CC[C@@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683099,nM,990,CHEMBL284,6.004364805,DPPIV,CC(=O)N(C)[C@H]1CC[C@@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CC(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237531,CHEMBL1687449,Inhibition of DPP4,B,CC(C)C(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683100,nM,130,CHEMBL284,6.886056648,DPPIV,CC(C)C(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CC(C)C(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237532,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)C(C)(C)C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683101,nM,110,CHEMBL284,6.958607315,DPPIV,CN(C(=O)C(C)(C)C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)C(C)(C)C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237533,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)CCN)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683102,nM,730,CHEMBL284,6.13667714,DPPIV,CN(C(=O)CCN)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)CCN)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237534,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)CCC(=O)O)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683103,nM,140,CHEMBL284,6.853871964,DPPIV,CN(C(=O)CCC(=O)O)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)CCC(=O)O)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237535,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)c1cccnc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683104,nM,140,CHEMBL284,6.853871964,DPPIV,CN(C(=O)c1cccnc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)c1cccnc1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237536,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)c1csnn1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683105,nM,120,CHEMBL284,6.920818754,DPPIV,CN(C(=O)c1csnn1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)c1csnn1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237537,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)c1ccno1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683106,nM,120,CHEMBL284,6.920818754,DPPIV,CN(C(=O)c1ccno1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)c1ccno1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237538,CHEMBL1687449,Inhibition of DPP4,B,CN(C(=O)c1c[nH]c2ccccc12)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683107,nM,110,CHEMBL284,6.958607315,DPPIV,CN(C(=O)c1c[nH]c2ccccc12)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(C(=O)c1c[nH]c2ccccc12)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237539,CHEMBL1687449,Inhibition of DPP4,B,Cc1noc(C)c1C(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683108,nM,140,CHEMBL284,6.853871964,DPPIV,Cc1noc(C)c1C(=O)N(C)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,Cc1noc(C)c1C(=O)N(C)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237540,CHEMBL1687449,Inhibition of DPP4,B,Cn1ccc(C(=O)N(C)[C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)n1,CHEMBL1683109,nM,140,CHEMBL284,6.853871964,DPPIV,Cn1ccc(C(=O)N(C)[C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)n1,CN(C(=O)c1ccn(C)n1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237541,CHEMBL1687449,Inhibition of DPP4,B,CCN(C(C)=O)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683110,nM,260,CHEMBL284,6.585026652,DPPIV,CCN(C(C)=O)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CCN(C(C)=O)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237542,CHEMBL1687449,Inhibition of DPP4,B,CC(=O)N(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683111,nM,110,CHEMBL284,6.958607315,DPPIV,CC(=O)N(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CC(=O)N(Cc1ccccc1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237543,CHEMBL1687449,Inhibition of DPP4,B,CC(=O)N(CCCC(F)(F)F)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683112,nM,100,CHEMBL284,7,DPPIV,CC(=O)N(CCCC(F)(F)F)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CC(=O)N(CCCC(F)(F)F)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237544,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@@H](N2CCC(F)(F)C2)CC1,CHEMBL1683113,nM,1000,CHEMBL284,6,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@@H](N2CCC(F)(F)C2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCC(F)(F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237545,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCC(F)(F)C2)CC1,CHEMBL1683114,nM,850,CHEMBL284,6.070581074,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCC(F)(F)C2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCC(F)(F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237546,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CC1,CHEMBL1683115,nM,280,CHEMBL284,6.552841969,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCn3c(nnc3C(F)(F)F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237547,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2)CC1,CHEMBL1681802,nM,330,CHEMBL284,6.48148606,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCn3c(nnc3C(F)(F)F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237548,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@@H](N2CCCCC2)CC1,CHEMBL1683116,nM,1800,CHEMBL284,5.744727495,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@@H](N2CCCCC2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCCCC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237549,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCCCC2)CC1,CHEMBL1683117,nM,330,CHEMBL284,6.48148606,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCCCC2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCCCC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237550,CHEMBL1687449,Inhibition of DPP4,B,NC(=O)C1CCCN([C@H]2CC[C@@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683118,nM,1300,CHEMBL284,5.886056648,DPPIV,NC(=O)C1CCCN([C@H]2CC[C@@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,NC(=O)C1CCCN(C2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237551,CHEMBL1687449,Inhibition of DPP4,B,NC(=O)C1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683119,nM,57,CHEMBL284,7.244125144,DPPIV,NC(=O)C1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,NC(=O)C1CCCN(C2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237552,CHEMBL1687449,Inhibition of DPP4,B,NC(=O)[C@H]1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683120,nM,200,CHEMBL284,6.698970004,DPPIV,NC(=O)C1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,NC(=O)C1CCCN(C2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237553,CHEMBL1687449,Inhibition of DPP4,B,NC(=O)[C@@H]1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683121,nM,70,CHEMBL284,7.15490196,DPPIV,NC(=O)C1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,NC(=O)C1CCCN(C2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237554,CHEMBL1687449,Inhibition of DPP4,B,NC(=O)O[C@@H]1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683122,nM,310,CHEMBL284,6.508638306,DPPIV,NC(=O)O[C@@H]1CCCN([C@H]2CC[C@H]([C@H](N)Cc3cc(F)ccc3F)CC2)C1,NC(=O)OC1CCCN(C2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237555,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCC[C@@H](O)C2)CC1,CHEMBL1683123,nM,270,CHEMBL284,6.568636236,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N2CCC[C@@H](O)C2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N2CCCC(O)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237556,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](NCCCC(F)(F)F)CC1,CHEMBL1683124,nM,910,CHEMBL284,6.040958608,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](NCCCC(F)(F)F)CC1,NC(Cc1cc(F)ccc1F)C1CCC(NCCCC(F)(F)F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237557,CHEMBL1687449,Inhibition of DPP4,B,CN(Cc1ccc(C#N)cc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683125,nM,290,CHEMBL284,6.537602002,DPPIV,CN(Cc1ccc(C#N)cc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(Cc1ccc(C#N)cc1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237558,CHEMBL1687449,Inhibition of DPP4,B,CN(Cc1cccc(C#N)c1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683126,nM,220,CHEMBL284,6.657577319,DPPIV,CN(Cc1cccc(C#N)c1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CN(Cc1cccc(C#N)c1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237559,CHEMBL1687449,Inhibition of DPP4,B,CCN(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683127,nM,710,CHEMBL284,6.148741651,DPPIV,CCN(Cc1ccccc1)[C@H]1CC[C@H]([C@H](N)Cc2cc(F)ccc2F)CC1,CCN(Cc1ccccc1)C1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237560,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N(CCCC(F)(F)F)Cc2ccccc2)CC1,CHEMBL1683128,nM,690,CHEMBL284,6.161150909,DPPIV,N[C@H](Cc1cc(F)ccc1F)[C@H]1CC[C@H](N(CCCC(F)(F)F)Cc2ccccc2)CC1,NC(Cc1cc(F)ccc1F)C1CCC(N(CCCC(F)(F)F)Cc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237561,CHEMBL1687449,Inhibition of DPP4,B,CC(=O)N1CCC([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683129,nM,450,CHEMBL284,6.346787486,DPPIV,CC(=O)N1CCC([C@H](N)Cc2cc(F)ccc2F)CC1,CC(=O)N1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237562,CHEMBL1687449,Inhibition of DPP4,B,CS(=O)(=O)N1CCC([C@H](N)Cc2cc(F)ccc2F)CC1,CHEMBL1683130,nM,130,CHEMBL284,6.886056648,DPPIV,CS(=O)(=O)N1CCC([C@H](N)Cc2cc(F)ccc2F)CC1,CS(=O)(=O)N1CCC(C(N)Cc2cc(F)ccc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237563,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ccccn2)CC1,CHEMBL1683131,nM,450,CHEMBL284,6.346787486,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ccccn2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2ccccn2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237564,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2cccnc2)CC1,CHEMBL1683132,nM,110,CHEMBL284,6.958607315,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2cccnc2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2cccnc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237565,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ccncc2)CC1,CHEMBL1683133,nM,430,CHEMBL284,6.366531544,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ccncc2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2ccncc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237566,CHEMBL1687449,Inhibition of DPP4,B,N#Cc1cncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c1,CHEMBL1683134,nM,77,CHEMBL284,7.113509275,DPPIV,N#Cc1cncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c1,N#Cc1cncc(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237567,CHEMBL1687449,Inhibition of DPP4,B,Cc1ccc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c(C)n1,CHEMBL1683135,nM,71,CHEMBL284,7.148741651,DPPIV,Cc1ccc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c(C)n1,Cc1ccc(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)c(C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237568,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ccc(F)nc2)CC1,CHEMBL1683136,nM,110,CHEMBL284,6.958607315,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ccc(F)nc2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2ccc(F)nc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237569,CHEMBL1687449,Inhibition of DPP4,B,CCOC(=O)c1cncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c1,CHEMBL1683137,nM,82,CHEMBL284,7.086186148,DPPIV,CCOC(=O)c1cncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c1,CCOC(=O)c1cncc(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237570,CHEMBL1687449,Inhibition of DPP4,B,NOC(=O)c1cncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c1,CHEMBL1683138,nM,18,CHEMBL284,7.744727495,DPPIV,NOC(=O)c1cncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)c1,NOC(=O)c1cncc(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237571,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ncccn2)CC1,CHEMBL1683139,nM,670,CHEMBL284,6.173925197,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2ncccn2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2ncccn2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237572,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2cncnc2)CC1,CHEMBL1683140,nM,75,CHEMBL284,7.124938737,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2cncnc2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2cncnc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237573,CHEMBL1687449,Inhibition of DPP4,B,COc1ncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)cn1,CHEMBL1683141,nM,78,CHEMBL284,7.107905397,DPPIV,COc1ncc(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)cn1,COc1ncc(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237574,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2cnc(O)nc2)CC1,CHEMBL1683142,nM,72,CHEMBL284,7.142667504,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(c2cnc(=O)[nH]c2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(c2cnc(=O)[nH]c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237575,CHEMBL1687449,Inhibition of DPP4,B,COC(=O)C1CCCC(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683143,nM,54,CHEMBL284,7.26760624,DPPIV,COC(=O)C1CCCC(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)C1,COC(=O)C1CCCC(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237576,CHEMBL1687449,Inhibition of DPP4,B,N[C@H](Cc1cc(F)ccc1F)C1CCN(C2CCCC(C(=O)O)C2)CC1,CHEMBL1683144,nM,51,CHEMBL284,7.292429824,DPPIV,N[C@H](Cc1cc(F)ccc1F)C1CCN(C2CCCC(C(=O)O)C2)CC1,NC(Cc1cc(F)ccc1F)C1CCN(C2CCCC(C(=O)O)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5237577,CHEMBL1687449,Inhibition of DPP4,B,NC(=O)C1CCCC(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)C1,CHEMBL1683145,nM,21,CHEMBL284,7.677780705,DPPIV,NC(=O)C1CCCC(N2CCC([C@H](N)Cc3cc(F)ccc3F)CC2)C1,NC(=O)C1CCCC(N2CCC(C(N)Cc3cc(F)ccc3F)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240815,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(-c3cc(F)cc(F)c3F)ncn2)C[C@@H]1c1ccccc1,CHEMBL1683557,nM,13,CHEMBL284,7.886056648,DPPIV,N[C@H]1CN(c2cc(-c3cc(F)cc(F)c3F)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(-c3cc(F)cc(F)c3F)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240816,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(-c3cc(F)c(F)cc3F)ncn2)C[C@@H]1N1CCCC1=O,CHEMBL1683558,nM,488,CHEMBL284,6.311580178,DPPIV,N[C@H]1CN(c2cc(-c3cc(F)c(F)cc3F)ncn2)C[C@@H]1N1CCCC1=O,NC1CN(c2cc(-c3cc(F)c(F)cc3F)ncn2)CC1N1CCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240817,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(-c3cc(F)c(F)cc3F)ncn2)C[C@@H]1N1CCCCC1=O,CHEMBL1683559,nM,47,CHEMBL284,7.327902142,DPPIV,N[C@H]1CN(c2cc(-c3cc(F)c(F)cc3F)ncn2)C[C@@H]1N1CCCCC1=O,NC1CN(c2cc(-c3cc(F)c(F)cc3F)ncn2)CC1N1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240818,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(N3CCc4nocc4C3)ncn2)C[C@@H]1c1ccccc1,CHEMBL1683560,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1CN(c2cc(N3CCc4nocc4C3)ncn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(N3CCc4nocc4C3)ncn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240819,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(N3CCc4nocc4C3)ncn2)C[C@@H]1N1CCCC1=O,CHEMBL1683561,nM,153,CHEMBL284,6.815308569,DPPIV,N[C@H]1CN(c2cc(N3CCc4nocc4C3)ncn2)C[C@@H]1N1CCCC1=O,NC1CN(c2cc(N3CCc4nocc4C3)ncn2)CC1N1CCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240820,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(N3CCc4nocc4C3)ncn2)C[C@@H]1N1CCCCC1=O,CHEMBL1683562,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@H]1CN(c2cc(N3CCc4nocc4C3)ncn2)C[C@@H]1N1CCCCC1=O,NC1CN(c2cc(N3CCc4nocc4C3)ncn2)CC1N1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240821,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(NC3CC3)ncn2)C[C@@H]1c1ccccc1,CHEMBL1683563,nM,19,CHEMBL284,7.721246399,DPPIV,N[C@H]1CN(c2cc(=NC3CC3)[nH]cn2)C[C@@H]1c1ccccc1,NC1CN(c2cc(=NC3CC3)[nH]cn2)CC1c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240822,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(NC3CC3)ncn2)C[C@@H]1N1CCCC1=O,CHEMBL1683564,nM,1400,CHEMBL284,5.853871964,DPPIV,N[C@H]1CN(c2cc(=NC3CC3)[nH]cn2)C[C@@H]1N1CCCC1=O,NC1CN(c2cc(=NC3CC3)[nH]cn2)CC1N1CCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240823,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(NC3CC3)ncn2)C[C@@H]1N1CCCCC1=O,CHEMBL1683565,nM,74,CHEMBL284,7.13076828,DPPIV,N[C@H]1CN(c2cc(=NC3CC3)[nH]cn2)C[C@@H]1N1CCCCC1=O,NC1CN(c2cc(=NC3CC3)[nH]cn2)CC1N1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240824,CHEMBL1685334,Inhibition of human DPP4,B,COc1ccc(-c2cc(N3C[C@H](N)[C@@H](N4CCCCC4=O)C3)ncn2)cn1,CHEMBL1683566,nM,39,CHEMBL284,7.408935393,DPPIV,COc1ccc(-c2cc(N3C[C@H](N)[C@@H](N4CCCCC4=O)C3)ncn2)cn1,COc1ccc(-c2cc(N3CC(N)C(N4CCCCC4=O)C3)ncn2)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240825,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2ncnc(-c3ccccc3)n2)C[C@@H]1N1CCCCC1=O,CHEMBL1683567,nM,59,CHEMBL284,7.229147988,DPPIV,N[C@H]1CN(c2ncnc(-c3ccccc3)n2)C[C@@H]1N1CCCCC1=O,NC1CN(c2ncnc(-c3ccccc3)n2)CC1N1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240826,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(N3CCC(F)(F)C3)ncn2)C[C@@H]1N1CCCCC1=O,CHEMBL1683568,nM,26,CHEMBL284,7.585026652,DPPIV,N[C@H]1CN(c2cc(N3CCC(F)(F)C3)ncn2)C[C@@H]1N1CCCCC1=O,NC1CN(c2cc(N3CCC(F)(F)C3)ncn2)CC1N1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240827,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2ncnc(N3CCC(F)(F)C3)n2)C[C@@H]1N1CCCCC1=O,CHEMBL1683569,nM,37,CHEMBL284,7.431798276,DPPIV,N[C@H]1CN(c2ncnc(N3CCC(F)(F)C3)n2)C[C@@H]1N1CCCCC1=O,NC1CN(c2ncnc(N3CCC(F)(F)C3)n2)CC1N1CCCCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240828,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2cc(N3CCC(F)(F)C3)ncn2)C[C@@H]1N1CC(F)(F)CCC1=O,CHEMBL1683570,nM,8.4,CHEMBL284,8.075720714,DPPIV,N[C@H]1CN(c2cc(N3CCC(F)(F)C3)ncn2)C[C@@H]1N1CC(F)(F)CCC1=O,NC1CN(c2cc(N3CCC(F)(F)C3)ncn2)CC1N1CC(F)(F)CCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240829,CHEMBL1685334,Inhibition of human DPP4,B,N[C@H]1CN(c2ncnc(N3CCC(F)(F)C3)n2)C[C@@H]1N1CC(F)(F)CCC1=O,CHEMBL1683571,nM,23,CHEMBL284,7.638272164,DPPIV,N[C@H]1CN(c2ncnc(N3CCC(F)(F)C3)n2)C[C@@H]1N1CC(F)(F)CCC1=O,NC1CN(c2ncnc(N3CCC(F)(F)C3)n2)CC1N1CC(F)(F)CCC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5240830,CHEMBL1685334,Inhibition of human DPP4,B,Cc1nc(N2C[C@H](N)[C@@H](N3CC(F)(F)CCC3=O)C2)cc(N2CCC(F)(F)C2)n1,CHEMBL1683572,nM,13,CHEMBL284,7.886056648,DPPIV,Cc1nc(N2C[C@H](N)[C@@H](N3CC(F)(F)CCC3=O)C2)cc(N2CCC(F)(F)C2)n1,Cc1nc(N2CC(N)C(N3CC(F)(F)CCC3=O)C2)cc(N2CCC(F)(F)C2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244133,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(-c3cnco3)c2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1684000,nM,17.83,CHEMBL284,7.748848657,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3cnco3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3cnco3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244134,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(-c3ccsc3)c2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1683999,nM,47.27,CHEMBL284,7.325414398,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccsc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccsc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244135,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(-c3cccs3)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683998,nM,22.76,CHEMBL284,7.642827742,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3cccs3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3cccs3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244136,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(-c3ccoc3)c2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1683997,nM,26.17,CHEMBL284,7.582196277,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccoc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccoc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244137,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(-c3ccco3)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683996,nM,15.8,CHEMBL284,7.801342913,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccco3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccco3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244138,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(-c3ccccn3)c2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1683995,nM,33.25,CHEMBL284,7.47820835,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccccn3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccccn3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244139,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(-c3ccncc3)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683994,nM,28.6,CHEMBL284,7.543633967,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccncc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccncc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244140,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,CS(=O)(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1.Cl,CHEMBL1683993,nM,33.17,CHEMBL284,7.479254528,DPPIV,CS(=O)(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,CS(=O)(=O)c1ccc(-c2nnn3c2CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244141,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(C(=O)O)cc3)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683992,nM,33.78,CHEMBL284,7.471340355,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(C(=O)O)cc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccc(C(=O)O)cc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244142,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,COC(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1.O=P(O)(O)O,CHEMBL1683991,nM,12.4,CHEMBL284,7.906578315,DPPIV,COC(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,COC(=O)c1ccc(-c2nnn3c2CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244143,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,CN(C)C(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1.Cl,CHEMBL1683990,nM,26.64,CHEMBL284,7.57446578,DPPIV,CN(C)C(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,CN(C)C(=O)c1ccc(-c2nnn3c2CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244144,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.NC(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,CHEMBL1683989,nM,36.43,CHEMBL284,7.438540829,DPPIV,NC(=O)c1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,NC(=O)c1ccc(-c2nnn3c2CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244145,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,COC(=O)c1cccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)c1.Cl,CHEMBL1683988,nM,46.61,CHEMBL284,7.331520897,DPPIV,COC(=O)c1cccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)c1,COC(=O)c1cccc(-c2nnn3c2CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC3)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244146,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N#Cc1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,CHEMBL1683987,nM,30.03,CHEMBL284,7.522444668,DPPIV,N#Cc1ccc(-c2nnn3c2CN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC3)cc1,N#Cc1ccc(-c2nnn3c2CN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244147,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(C(F)(F)F)cc3)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683986,nM,75.35,CHEMBL284,7.122916743,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(C(F)(F)F)cc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccc(C(F)(F)F)cc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244148,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(Cl)cc3)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683985,nM,46.89,CHEMBL284,7.328919767,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(Cl)cc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccc(Cl)cc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244149,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(F)cc3)c2C1)Cc1cc(F)c(F)cc1F.O=P(O)(O)O,CHEMBL1683984,nM,45.2,CHEMBL284,7.344861565,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccc(F)cc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccc(F)cc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244150,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(-c3ccccc3)c2C1)Cc1cc(F)c(F)cc1F.O=P(O)(O)O,CHEMBL1683983,nM,37.54,CHEMBL284,7.425505732,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(-c3ccccc3)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(-c3ccccc3)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244151,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,CN(C)C(=O)c1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2.Cl,CHEMBL1683982,nM,52.34,CHEMBL284,7.281166282,DPPIV,CN(C)C(=O)c1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2,CN(C)C(=O)c1nnn2c1CN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244152,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.NC(=O)c1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2,CHEMBL1683981,nM,29.92,CHEMBL284,7.524038411,DPPIV,NC(=O)c1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2,NC(=O)c1nnn2c1CN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244153,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,COC(=O)c1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2.Cl,CHEMBL1683980,nM,15.09,CHEMBL284,7.82131076,DPPIV,COC(=O)c1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2,COC(=O)c1nnn2c1CN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244154,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nnc(C(F)(F)F)c2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1683979,nM,50.66,CHEMBL284,7.295334815,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(C(F)(F)F)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(C(F)(F)F)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244155,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cl.N[C@@H](CC(=O)N1CCn2nnc(C(F)F)c2C1)Cc1cc(F)c(F)cc1F,CHEMBL1683978,nM,22.53,CHEMBL284,7.647238808,DPPIV,N[C@@H](CC(=O)N1CCn2nnc(C(F)F)c2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nnc(C(F)F)c2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244156,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,Cc1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2.Cl,CHEMBL1681811,nM,77.06,CHEMBL284,7.113170995,DPPIV,Cc1nnn2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2,Cc1nnn2c1CN(C(=O)CC(N)Cc1cc(F)c(F)cc1F)CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5244157,CHEMBL1686148,Inhibition of human DPP4 assessed as hydrolytic reaction of Ala-Pro-AMC,B,N[C@@H](CC(=O)N1CCn2nncc2C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C/C(=O)O,CHEMBL1683977,nM,89.5,CHEMBL284,7.048176965,DPPIV,N[C@@H](CC(=O)N1CCn2nncc2C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2nncc2C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294379,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)O)cc(-c2ccc(F)cc2)c1CN,CHEMBL1688409,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)O)cc(-c2ccc(F)cc2)c1CN,Cc1nc(C(=O)O)cc(-c2ccc(F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294380,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)O)cc(-c2ccc(F)cc2F)c1CN,CHEMBL1688410,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)O)cc(-c2ccc(F)cc2F)c1CN,Cc1nc(C(=O)O)cc(-c2ccc(F)cc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294381,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(N)=O)cc(-c2ccc(Cl)cc2Cl)c1C#N,CHEMBL1688411,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(N)=O)cc(-c2ccc(Cl)cc2Cl)c1C#N,Cc1nc(C(N)=O)cc(-c2ccc(Cl)cc2Cl)c1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294382,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,CNC(=O)c1cc(-c2ccc(Cl)cc2Cl)c(C#N)c(C)n1,CHEMBL1688412,nM,50000,CHEMBL284,4.301029996,DPPIV,CNC(=O)c1cc(-c2ccc(Cl)cc2Cl)c(C#N)c(C)n1,CNC(=O)c1cc(-c2ccc(Cl)cc2Cl)c(C#N)c(C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294383,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(N)=O)cc(-c2ccccc2F)c1CN,CHEMBL1688413,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(N)=O)cc(-c2ccccc2F)c1CN,Cc1nc(C(N)=O)cc(-c2ccccc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294384,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)NC2CC2)cc(-c2ccccc2F)c1CN,CHEMBL1688414,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)NC2CC2)cc(-c2ccccc2F)c1CN,Cc1nc(C(=O)NC2CC2)cc(-c2ccccc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294385,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCCC2)cc(-c2ccccc2F)c1CN,CHEMBL1687950,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)N2CCCC2)cc(-c2ccccc2F)c1CN,Cc1nc(C(=O)N2CCCC2)cc(-c2ccccc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294386,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(F)cc2)c1CN,CHEMBL1688415,nM,80,CHEMBL284,7.096910013,DPPIV,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(F)cc2)c1CN,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294387,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(F)cc2)c1CN,CHEMBL1688416,nM,686,CHEMBL284,6.163675884,DPPIV,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(F)cc2)c1CN,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294388,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(F)cc2)c1CN,CHEMBL1688417,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(F)cc2)c1CN,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294389,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,CCOC(=O)C1CCN(C(=O)c2cc(-c3ccc(F)cc3)c(CN)c(C)n2)CC1,CHEMBL1688418,nM,937,CHEMBL284,6.028260409,DPPIV,CCOC(=O)C1CCN(C(=O)c2cc(-c3ccc(F)cc3)c(CN)c(C)n2)CC1,CCOC(=O)C1CCN(C(=O)c2cc(-c3ccc(F)cc3)c(CN)c(C)n2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294390,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(F)cc2F)c1CN,CHEMBL1688419,nM,674,CHEMBL284,6.171340103,DPPIV,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(F)cc2F)c1CN,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(F)cc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294391,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COC(=O)CNC(=O)c1cc(-c2ccc(F)cc2F)c(CN)c(C)n1,CHEMBL1688420,nM,50000,CHEMBL284,4.301029996,DPPIV,COC(=O)CNC(=O)c1cc(-c2ccc(F)cc2F)c(CN)c(C)n1,COC(=O)CNC(=O)c1cc(-c2ccc(F)cc2F)c(CN)c(C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294392,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(F)cc2F)c1CN,CHEMBL1688421,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(F)cc2F)c1CN,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(F)cc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294393,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(F)cc2F)c1CN,CHEMBL1688422,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(F)cc2F)c1CN,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(F)cc2F)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294394,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1cc(NC(=O)c2cc(-c3ccc(F)cc3F)c(CN)c(C)n2)no1,CHEMBL1688423,nM,674,CHEMBL284,6.171340103,DPPIV,Cc1cc(=NC(=O)c2cc(-c3ccc(F)cc3F)c(CN)c(C)n2)[nH]o1,Cc1cc(=NC(=O)c2cc(-c3ccc(F)cc3F)c(CN)c(C)n2)[nH]o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294395,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,CNC(=O)c1cc(-c2ccc(Cl)cc2)c(CN)c(C)n1,CHEMBL1688424,nM,50000,CHEMBL284,4.301029996,DPPIV,CNC(=O)c1cc(-c2ccc(Cl)cc2)c(CN)c(C)n1,CNC(=O)c1cc(-c2ccc(Cl)cc2)c(CN)c(C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294396,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(N)=O)cc(-c2ccc(Cl)cc2Cl)c1CN,CHEMBL1688425,nM,16,CHEMBL284,7.795880017,DPPIV,Cc1nc(C(N)=O)cc(-c2ccc(Cl)cc2Cl)c1CN,Cc1nc(C(N)=O)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294397,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,CNC(=O)c1cc(-c2ccc(Cl)cc2Cl)c(CN)c(C)n1,CHEMBL1688426,nM,11,CHEMBL284,7.958607315,DPPIV,CNC(=O)c1cc(-c2ccc(Cl)cc2Cl)c(CN)c(C)n1,CNC(=O)c1cc(-c2ccc(Cl)cc2Cl)c(CN)c(C)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294398,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(Cl)cc2Cl)c1CN,CHEMBL1688427,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(Cl)cc2Cl)c1CN,Cc1nc(C(=O)NC2CC2)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294399,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(Cl)cc2Cl)c1CN,CHEMBL1688428,nM,44,CHEMBL284,7.356547324,DPPIV,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(Cl)cc2Cl)c1CN,Cc1nc(C(=O)N2CCCC2)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294400,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(Cl)cc2Cl)c1CN,CHEMBL1688429,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(Cl)cc2Cl)c1CN,Cc1nc(C(=O)N2CCOCC2)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294401,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)NCC(N)=O)cc(-c2ccc(Cl)cc2Cl)c1CN,CHEMBL1688430,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(C(=O)NCC(N)=O)cc(-c2ccc(Cl)cc2Cl)c1CN,Cc1nc(C(=O)NCC(N)=O)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294402,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(C(=O)NCC#N)cc(-c2ccc(Cl)cc2Cl)c1CN,CHEMBL1688431,nM,10,CHEMBL284,8,DPPIV,Cc1nc(C(=O)NCC#N)cc(-c2ccc(Cl)cc2Cl)c1CN,Cc1nc(C(=O)NCC#N)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294403,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)NC3CC3)nc(C)c2CN)cc1,CHEMBL1688432,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)NC3CC3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)NC3CC3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294404,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)N3CCCC3)nc(C)c2CN)cc1,CHEMBL1688433,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N3CCCC3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)N3CCCC3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294405,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)N3CCOCC3)nc(C)c2CN)cc1,CHEMBL1688434,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N3CCOCC3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)N3CCOCC3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294406,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)NCc3ccc(Cl)c(Cl)c3)nc(C)c2CN)cc1,CHEMBL1688435,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)NCc3ccc(Cl)c(Cl)c3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)NCc3ccc(Cl)c(Cl)c3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294407,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)Nc3cc(C)on3)nc(C)c2CN)cc1,CHEMBL1688436,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N=c3cc(C)o[nH]3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)N=c3cc(C)o[nH]3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294408,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)N3CC[C@@H](N)C3)nc(C)c2CN)cc1,CHEMBL1688437,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N3CC[C@@H](N)C3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)N3CCC(N)C3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294409,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)N3CCC(N)CC3)nc(C)c2CN)cc1,CHEMBL1688438,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N3CCC(N)CC3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)N3CCC(N)CC3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294410,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)NCCN3CCNCC3)nc(C)c2CN)cc1,CHEMBL1688514,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)NCCN3CCNCC3)nc(C)c2CN)cc1,COc1ccc(-c2cc(C(=O)NCCN3CCNCC3)nc(C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294411,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(CN)cc(-c2ccccc2F)c1C(N)=O,CHEMBL1688515,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(CN)cc(-c2ccccc2F)c1C(N)=O,Cc1nc(CN)cc(-c2ccccc2F)c1C(N)=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294412,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(CN)cc(-c2ccc(Cl)cc2)c1C(N)=O,CHEMBL1688516,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(CN)cc(-c2ccc(Cl)cc2)c1C(N)=O,Cc1nc(CN)cc(-c2ccc(Cl)cc2)c1C(N)=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294413,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(CN)cc(-c2ccc(Cl)cc2Cl)c1C(N)=O,CHEMBL1688517,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(CN)cc(-c2ccc(Cl)cc2Cl)c1C(N)=O,Cc1nc(CN)cc(-c2ccc(Cl)cc2Cl)c1C(N)=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294414,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(CN)nc(C)c2C(N)=O)cc1,CHEMBL1688518,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(CN)nc(C)c2C(N)=O)cc1,COc1ccc(-c2cc(CN)nc(C)c2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294415,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(-c2ccc(F)cc2)cc(C(=O)N2CCCC2)c1CN,CHEMBL1688519,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(-c2ccc(F)cc2)cc(C(=O)N2CCCC2)c1CN,Cc1nc(-c2ccc(F)cc2)cc(C(=O)N2CCCC2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294416,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(-c2ccc(Cl)cc2)cc(C(=O)N2CCCC2)c1CN,CHEMBL1688520,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(-c2ccc(Cl)cc2)cc(C(=O)N2CCCC2)c1CN,Cc1nc(-c2ccc(Cl)cc2)cc(C(=O)N2CCCC2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294417,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(-c2ccc(Cl)cc2)cc(C(=O)N2CCOCC2)c1CN,CHEMBL1688521,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(-c2ccc(Cl)cc2)cc(C(=O)N2CCOCC2)c1CN,Cc1nc(-c2ccc(Cl)cc2)cc(C(=O)N2CCOCC2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294418,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,CCOC(=O)C1CCN(C(=O)c2cc(-c3ccc(Cl)cc3)nc(C)c2CN)CC1,CHEMBL1688522,nM,50000,CHEMBL284,4.301029996,DPPIV,CCOC(=O)C1CCN(C(=O)c2cc(-c3ccc(Cl)cc3)nc(C)c2CN)CC1,CCOC(=O)C1CCN(C(=O)c2cc(-c3ccc(Cl)cc3)nc(C)c2CN)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294419,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)NC2CC2)c1CN,CHEMBL1688523,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)NC2CC2)c1CN,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)NC2CC2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294420,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)N2CCCC2)c1CN,CHEMBL1688524,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)N2CCCC2)c1CN,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)N2CCCC2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294421,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)N2CCOCC2)c1CN,CHEMBL1688525,nM,50000,CHEMBL284,4.301029996,DPPIV,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)N2CCOCC2)c1CN,Cc1nc(-c2ccc(Cl)cc2Cl)cc(C(=O)N2CCOCC2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294422,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)NC3CC3)c(CN)c(C)n2)cc1,CHEMBL1688526,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)NC3CC3)c(CN)c(C)n2)cc1,COc1ccc(-c2cc(C(=O)NC3CC3)c(CN)c(C)n2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294423,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)N3CCCC3)c(CN)c(C)n2)cc1,CHEMBL1688527,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N3CCCC3)c(CN)c(C)n2)cc1,COc1ccc(-c2cc(C(=O)N3CCCC3)c(CN)c(C)n2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294424,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,COc1ccc(-c2cc(C(=O)N3CCOCC3)c(CN)c(C)n2)cc1,CHEMBL1688528,nM,50000,CHEMBL284,4.301029996,DPPIV,COc1ccc(-c2cc(C(=O)N3CCOCC3)c(CN)c(C)n2)cc1,COc1ccc(-c2cc(C(=O)N3CCOCC3)c(CN)c(C)n2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
5294425,CHEMBL1696535,Inhibition of human recombinant DPP4 assessed as Gly-Pro-pNA chromogenic substrate cleavage for 16 mins preincubated with compound for 10 mins before addition of chromogenic substrate,B,CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)CC,CHEMBL214381,nM,3000,CHEMBL284,5.522878745,DPPIV,CCC(C)C(N)C(=O)N1CCCC1C(=O)NC(C(=O)O)C(C)CC,CCC(C)C(N)C(=O)N1CCCC1C(=O)NC(C(=O)O)C(C)CC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6162115,CHEMBL1764296,Inhibition of human DPP-4 assessed as cleavage of substrate using H-Gly-Pro-AMC chromogenic substrate after 10 mins by double beam spectrophotometer,B,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(C(C)=O)=CC[C@@H]32)C1,CHEMBL1761683,nM,35600,CHEMBL284,4.448550002,DPPIV,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(C(C)=O)=CC[C@@H]32)C1,CC(=O)OC1CCC2(C)C(=CCC3C2CCC2(C)C(C(C)=O)=CCC32)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6162116,CHEMBL1764296,Inhibition of human DPP-4 assessed as cleavage of substrate using H-Gly-Pro-AMC chromogenic substrate after 10 mins by double beam spectrophotometer,B,CC(=O)[C@H]1C(NCc2ccccc2)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1761684,nM,21300,CHEMBL284,4.671620397,DPPIV,CC(=O)C1C(NCc2ccccc2)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CC(=O)C1C(NCc2ccccc2)CC2C3CC=C4CC(O)CCC4(C)C3CCC21C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6162117,CHEMBL1764296,Inhibition of human DPP-4 assessed as cleavage of substrate using H-Gly-Pro-AMC chromogenic substrate after 10 mins by double beam spectrophotometer,B,COc1ccc(/C=C/C(=O)C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)cc1OC,CHEMBL1761685,nM,26200,CHEMBL284,4.581698709,DPPIV,COc1ccc(/C=C/C(=O)C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)cc1OC,COc1ccc(C=CC(=O)C2=CCC3C4CC=C5CC(O)CCC5(C)C4CCC23C)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6162118,CHEMBL1764296,Inhibition of human DPP-4 assessed as cleavage of substrate using H-Gly-Pro-AMC chromogenic substrate after 10 mins by double beam spectrophotometer,B,CCCN1C(c2ccc(OC)cc2)CC(=O)[C@H]2C1C[C@H]1[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]21C,CHEMBL1761686,nM,32700,CHEMBL284,4.485452247,DPPIV,CCCN1C(c2ccc(OC)cc2)CC(=O)C2C1C[C@H]1[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]21C,CCCN1C(c2ccc(OC)cc2)CC(=O)C2C1CC1C3CC=C4CC(O)CCC4(C)C3CCC12C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6162119,CHEMBL1764296,Inhibition of human DPP-4 assessed as cleavage of substrate using H-Gly-Pro-AMC chromogenic substrate after 10 mins by double beam spectrophotometer,B,CCCN1C(c2ccc(C(C)C)cc2)CC(=O)[C@H]2C1C[C@H]1[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]21C,CHEMBL1761687,nM,29100,CHEMBL284,4.536107011,DPPIV,CCCN1C(c2ccc(C(C)C)cc2)CC(=O)C2C1C[C@H]1[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]21C,CCCN1C(c2ccc(C(C)C)cc2)CC(=O)C2C1CC1C3CC=C4CC(O)CCC4(C)C3CCC12C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6164131,CHEMBL1768627,Inhibition of DDP4 at pH 7.4 preincubated with alpha-chymotrypsin up to 8 hrs,B,C[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1B(O)O,CHEMBL1765236,nM,0.7,CHEMBL284,9.15490196,DPPIV,CC(NC(=O)C(Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CCC(=O)O)C(=O)N1CCC[C@H]1B(O)O,CC(NC(=O)CCC(=O)O)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(C)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6164145,CHEMBL1768626,Inhibition of DDP4 at pH 7.4 preincubated for 10 mins,B,C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL1765235,nM,7,CHEMBL284,8.15490196,DPPIV,CC(NC(=O)C1CCCN1C(=O)C(N)Cc1ccccc1)C(=O)N1CCC[C@H]1B(O)O,CC(NC(=O)C1CCCN1C(=O)C(N)Cc1ccccc1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6164146,CHEMBL1768626,Inhibition of DDP4 at pH 7.4 preincubated for 10 mins,B,CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C1CCCCC1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL1765234,nM,19,CHEMBL284,7.721246399,DPPIV,CC(C)C(NC(=O)C1CCCN1C(=O)C(N)C1CCCCC1)C(=O)N1CCC[C@H]1B(O)O,CC(C)C(NC(=O)C1CCCN1C(=O)C(N)C1CCCCC1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6181075,CHEMBL1772664,Inhibition of DPP4 assessed as p-nitrophenol release after 1 hr,B,O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1cccc(CCc2cccc(C(F)(F)F)c2)c1,CHEMBL1771583,nM,3100,CHEMBL284,5.508638306,DPPIV,O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1cccc(CCc2cccc(C(F)(F)F)c2)c1,O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1cccc(CCc2cccc(C(F)(F)F)c2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6181076,CHEMBL1772664,Inhibition of DPP4 assessed as p-nitrophenol release after 1 hr,B,O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1cccc(CCc2ccccc2C(F)(F)F)c1,CHEMBL1771584,nM,4000,CHEMBL284,5.397940009,DPPIV,O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1cccc(CCc2ccccc2C(F)(F)F)c1,O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1cccc(CCc2ccccc2C(F)(F)F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203094,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CN1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1=O,CHEMBL1779688,nM,92.6,CHEMBL284,7.033389013,DPPIV,CN1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1=O,CN1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203095,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(c2ccccn2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779689,nM,311,CHEMBL284,6.507239611,DPPIV,N[C@@H](CC(=O)N1CCN(c2ccccn2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(c2ccccn2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203096,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccc(-c3ccccc3)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779690,nM,44.8,CHEMBL284,7.348721986,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccc(-c3ccccc3)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccc(-c3ccccc3)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203097,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cn2nnc3ccccc32)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779691,nM,42.7,CHEMBL284,7.369572125,DPPIV,N[C@@H](CC(=O)N1CCN(Cn2nnc3ccccc32)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cn2nnc3ccccc32)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203098,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(CCN2CCOCC2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779692,nM,116,CHEMBL284,6.935542011,DPPIV,N[C@@H](CC(=O)N1CCN(CCN2CCOCC2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(CCN2CCOCC2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203099,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccccc2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779693,nM,54.1,CHEMBL284,7.266802735,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccccc2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccccc2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203100,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccc([N+](=O)[O-])cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779694,nM,38.5,CHEMBL284,7.41453927,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccc([N+](=O)[O-])cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccc([N+](=O)[O-])cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203101,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccccc2[N+](=O)[O-])C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779695,nM,13.7,CHEMBL284,7.863279433,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccccc2[N+](=O)[O-])C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccccc2[N+](=O)[O-])C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203102,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N#Cc1ccccc1CN1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1=O,CHEMBL1779696,nM,48.9,CHEMBL284,7.310691141,DPPIV,N#Cc1ccccc1CN1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1=O,N#Cc1ccccc1CN1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203103,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccccc2C(F)(F)F)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779697,nM,50.7,CHEMBL284,7.294992041,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccccc2C(F)(F)F)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccccc2C(F)(F)F)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203104,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CCc1ccc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2=O)cc1,CHEMBL1779698,nM,38.9,CHEMBL284,7.410050399,DPPIV,CCc1ccc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2=O)cc1,CCc1ccc(CN2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203105,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,COc1ccc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2=O)cc1,CHEMBL1779699,nM,33.9,CHEMBL284,7.469800302,DPPIV,COc1ccc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2=O)cc1,COc1ccc(CN2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203106,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccc(F)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779700,nM,33.8,CHEMBL284,7.4710833,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccc(F)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccc(F)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203107,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccc(I)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779701,nM,30.8,CHEMBL284,7.511449283,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccc(I)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccc(I)cc2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203108,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2cccc(Cl)c2)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779702,nM,26.7,CHEMBL284,7.573488739,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2cccc(Cl)c2)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2cccc(Cl)c2)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203109,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(Cc2ccccc2Cl)C(=O)C1)Cc1cc(F)c(F)cc1F,CHEMBL1779703,nM,29,CHEMBL284,7.537602002,DPPIV,N[C@@H](CC(=O)N1CCN(Cc2ccccc2Cl)C(=O)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(Cc2ccccc2Cl)C(=O)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203110,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,COc1cc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2=O)c([N+](=O)[O-])cc1OC,CHEMBL1779704,nM,7.4,CHEMBL284,8.13076828,DPPIV,COc1cc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2=O)c([N+](=O)[O-])cc1OC,COc1cc(CN2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2=O)c([N+](=O)[O-])cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203111,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCNC(=O)[C@H]1CO)Cc1cc(F)c(F)cc1F,CHEMBL1779705,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@@H](CC(=O)N1CCNC(=O)C1CO)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCNC(=O)C1CO)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203112,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,COC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779706,nM,7.4,CHEMBL284,8.13076828,DPPIV,COCC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,COCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203113,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CCOC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779707,nM,4.3,CHEMBL284,8.366531544,DPPIV,CCOCC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCOCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203114,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCNC(=O)[C@H]1COC1CCCC1)Cc1cc(F)c(F)cc1F,CHEMBL1779708,nM,1.7,CHEMBL284,8.769551079,DPPIV,N[C@@H](CC(=O)N1CCNC(=O)C1COC1CCCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCNC(=O)C1COC1CCCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203115,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CC(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779709,nM,2.2,CHEMBL284,8.657577319,DPPIV,CC(C)OCC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)OCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203116,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779710,nM,0.9,CHEMBL284,9.045757491,DPPIV,CC(C)(C)OCC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203117,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CCN(C)C[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779711,nM,17,CHEMBL284,7.769551079,DPPIV,CCN(C)CC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCN(C)CC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203118,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CCN(CC)C[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779712,nM,11,CHEMBL284,7.958607315,DPPIV,CCN(CC)CC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCN(CC)CC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203119,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCNC(=O)[C@H]1CN1CCOCC1)Cc1cc(F)c(F)cc1F,CHEMBL1779713,nM,5.2,CHEMBL284,8.283996656,DPPIV,N[C@@H](CC(=O)N1CCNC(=O)C1CN1CCOCC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCNC(=O)C1CN1CCOCC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6203120,CHEMBL1780909,Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay,B,CC(C)(C)SC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL1779714,nM,1.3,CHEMBL284,8.886056648,DPPIV,CC(C)(C)SCC1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(C)(C)SCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301104,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CHEMBL1809262,nM,34,CHEMBL284,7.468521083,DPPIV,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301105,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2cccc(F)c2)c1CN,CHEMBL1809263,nM,49,CHEMBL284,7.30980392,DPPIV,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2cccc(F)c2)c1CN,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2cccc(F)c2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301106,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1cccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(N)=O)cc23)c1,CHEMBL1809264,nM,57,CHEMBL284,7.244125144,DPPIV,Cc1cccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(N)=O)cc23)c1,Cc1cccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(N)=O)cc23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301107,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccc(F)cc2)c1CN,CHEMBL1808463,nM,26,CHEMBL284,7.585026652,DPPIV,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccc(F)cc2)c1CN,CC(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccc(F)cc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301108,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(N)=O)cc23)cc1,CHEMBL1808464,nM,4.2,CHEMBL284,8.37675071,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(N)=O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(N)=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301109,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,COC(=O)COc1ccc2nc(CC(C)C)c(CN)c(-c3ccc(C)cc3)c2c1.Cl.Cl,CHEMBL3216514,nM,84,CHEMBL284,7.075720714,DPPIV,COC(=O)COc1ccc2nc(CC(C)C)c(CN)c(-c3ccc(C)cc3)c2c1,COC(=O)COc1ccc2nc(CC(C)C)c(CN)c(-c3ccc(C)cc3)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301110,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,CNC(=O)COc1ccc2nc(CC(C)C)c(CN)c(-c3ccc(C)cc3)c2c1.Cl.Cl,CHEMBL3215633,nM,52,CHEMBL284,7.283996656,DPPIV,CNC(=O)COc1ccc2nc(CC(C)C)c(CN)c(-c3ccc(C)cc3)c2c1,CNC(=O)COc1ccc2nc(CC(C)C)c(CN)c(-c3ccc(C)cc3)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301111,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCC(N)=O)cc23)cc1.Cl.Cl,CHEMBL3216748,nM,7.5,CHEMBL284,8.124938737,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCC(N)=O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(CCC(N)=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301112,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(/C=C/C(N)=O)cc23)cc1,CHEMBL1808468,nM,1.8,CHEMBL284,8.744727495,DPPIV,Cc1ccc(-c2c(CN)c(=CC(C)C)nc3ccc(=CCC(N)=O)cc23)cc1,Cc1ccc(-c2c(CN)c(=CC(C)C)nc3ccc(=CCC(N)=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301113,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(C(N)=O)cc23)cc1.Cl.Cl,CHEMBL3216749,nM,55,CHEMBL284,7.259637311,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(C(N)=O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(C(N)=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301114,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(C(=O)O)cc23)cc1.Cl.Cl,CHEMBL3215858,nM,100,CHEMBL284,7,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(C(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(C(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301115,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nn[nH]n4)cc23)cc1.Cl.Cl,CHEMBL3215634,nM,9.2,CHEMBL284,8.036212173,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nn[nH]n4)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nn[nH]n4)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301116,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4noc(=O)[nH]4)cc23)cc1.Cl.Cl,CHEMBL3215859,nM,11,CHEMBL284,7.958607315,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nc(=O)o[nH]4)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nc(=O)o[nH]4)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301117,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CCNC(=O)C4)cc23)cc1,CHEMBL1808473,nM,2.2,CHEMBL284,8.657577319,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CCNC(=O)C4)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CCNC(=O)C4)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301118,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CCNC(=O)C4=O)cc23)cc1,CHEMBL1808474,nM,2.7,CHEMBL284,8.568636236,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CCNC(=O)C4=O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(N4CCNC(=O)C4=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6301140,CHEMBL1810495,Inhibition of human Dipeptidyl peptidase-4 expressed in Caco-2 cells using Gly-Pro-pNA.Tos as substrate after 60 mins by microplate reader analysis,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(OCC(N)=O)ccc2c1=O.Cl,CHEMBL1808475,nM,47,CHEMBL284,7.327902142,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(OCC(N)=O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(OCC(N)=O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310536,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.O=C([C@@H]1C[C@H](NCc2ccnc3ccccc23)CN1)N1Cc2ccccc2C1,CHEMBL1814760,nM,17700,CHEMBL284,4.752026734,DPPIV,O=C(C1C[C@H](NCc2ccnc3ccccc23)CN1)N1Cc2ccccc2C1,O=C(C1CC(NCc2ccnc3ccccc23)CN1)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310537,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,CHEMBL1814633,nM,50000,CHEMBL284,4.301029996,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310538,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CCC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814634,nM,100000,CHEMBL284,4,DPPIV,NC(CCC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CCC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310539,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814737,nM,100000,CHEMBL284,4,DPPIV,NC(CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310540,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C(CCC(=O)N1Cc2ccccc2C1)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F,CHEMBL1814738,nM,100000,CHEMBL284,4,DPPIV,O=C(CCC(=O)N1Cc2ccccc2C1)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,O=C(CCC(=O)N1Cc2ccccc2C1)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310541,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccc(F)cc2C1.O=C(O)C(F)(F)F,CHEMBL1814739,nM,50000,CHEMBL284,4.301029996,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccc(F)cc2C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccc(F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310542,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccc(F)cc2C1.O=C(O)C(F)(F)F,CHEMBL1814740,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccc(F)cc2C1,NC(CC(=O)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccc(F)cc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310543,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814741,nM,50000,CHEMBL284,4.301029996,DPPIV,NC(CC(=O)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310544,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.Cl.N[C@@H](CC(=O)N1CCN(Cc2ccc3ccccc3c2)CC1)C(=O)N1Cc2ccccc2C1,CHEMBL3216066,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(Cc2ccc3ccccc3c2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(Cc2ccc3ccccc3c2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310545,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#Cc1ccccc1-c1ccc(CN2CCN(C(=O)C[C@H](N)C(=O)N3Cc4ccccc4C3)CC2)cc1,CHEMBL1814743,nM,100000,CHEMBL284,4,DPPIV,N#Cc1ccccc1-c1ccc(CN2CCN(C(=O)CC(N)C(=O)N3Cc4ccccc4C3)CC2)cc1,N#Cc1ccccc1-c1ccc(CN2CCN(C(=O)CC(N)C(=O)N3Cc4ccccc4C3)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6310546,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(Cc2c(F)cccc2Cl)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814744,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(Cc2c(F)cccc2Cl)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(Cc2c(F)cccc2Cl)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311179,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814745,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311180,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.Cl.N[C@@H](CC(=O)N1C[C@H]2C[C@@H]1CN2C(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,CHEMBL3215830,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1C[C@H]2C[C@@H]1CN2C(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CC2CC1CN2C(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311181,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(Cc2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814747,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(Cc2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(Cc2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311182,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,C[C@H]1CN(C(=O)C[C@H](N)C(=O)N2Cc3ccccc3C2)CCN1C(c1ccc(F)cc1)c1ccc(F)cc1.O=C(O)C(F)(F)F,CHEMBL1814748,nM,100000,CHEMBL284,4,DPPIV,C[C@H]1CN(C(=O)CC(N)C(=O)N2Cc3ccccc3C2)CCN1C(c1ccc(F)cc1)c1ccc(F)cc1,CC1CN(C(=O)CC(N)C(=O)N2Cc3ccccc3C2)CCN1C(c1ccc(F)cc1)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311183,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,C[C@@H]1CN(C(=O)C[C@H](N)C(=O)N2Cc3ccccc3C2)CCN1C(c1ccc(F)cc1)c1ccc(F)cc1.O=C(O)C(F)(F)F,CHEMBL1814749,nM,50000,CHEMBL284,4.301029996,DPPIV,C[C@@H]1CN(C(=O)CC(N)C(=O)N2Cc3ccccc3C2)CCN1C(c1ccc(F)cc1)c1ccc(F)cc1,CC1CN(C(=O)CC(N)C(=O)N2Cc3ccccc3C2)CCN1C(c1ccc(F)cc1)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311184,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.Cl.N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)C(=O)C1)C(=O)N1Cc2ccccc2C1,CHEMBL3216276,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)C(=O)C1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)C(=O)C1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311185,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(C(=O)C2c3ccccc3-c3ccccc32)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814751,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(=O)C2c3ccccc3-c3ccccc32)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(=O)C2c3ccccc3-c3ccccc32)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311186,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814752,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(=O)C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311187,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(-c3ccccc3)c2)CC1)C(=O)N1Cc2ccccc2C1,CHEMBL1814753,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(=O)c2cccc(-c3ccccc3)c2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCN(C(=O)c2cccc(-c3ccccc3)c2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311188,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)c1cc(C(C)C)c(S(=O)(=O)N2CCN(C(=O)C[C@H](N)C(=O)N3Cc4ccccc4C3)CC2)c(C(C)C)c1.Cl,CHEMBL1811949,nM,100000,CHEMBL284,4,DPPIV,CC(C)c1cc(C(C)C)c(S(=O)(=O)N2CCN(C(=O)CC(N)C(=O)N3Cc4ccccc4C3)CC2)c(C(C)C)c1,CC(C)c1cc(C(C)C)c(S(=O)(=O)N2CCN(C(=O)CC(N)C(=O)N3Cc4ccccc4C3)CC2)c(C(C)C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311189,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.N[C@@H](CC(=O)N1CCC[C@H]1C(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,CHEMBL1814754,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCCC1C(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCCC1C(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311190,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.N[C@@H](CC(=O)N1CCC[C@H]1C(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,CHEMBL1814755,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCCC1C(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCCC1C(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311191,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.N[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)C(=O)N1Cc2ccccc2C1,CHEMBL1814756,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCC(N2CCCCC2)CC1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)N1CCC(N2CCCCC2)CC1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311192,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)NC(c1ccccc1)c1ccccc1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814757,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)NC(c1ccccc1)c1ccccc1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)NC(c1ccccc1)c1ccccc1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311193,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N[C@@H](CC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1.O=C(O)C(F)(F)F,CHEMBL1814758,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311194,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.N[C@@H](CC(=O)NC12CC3CC(CC(O)(C3)C1)C2)C(=O)N1Cc2ccccc2C1,CHEMBL1814632,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)NC12CC3CC(CC(O)(C3)C1)C2)C(=O)N1Cc2ccccc2C1,NC(CC(=O)NC12CC3CC(CC(O)(C3)C1)C2)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311195,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.N[C@@H](CC(=O)NC1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)C1)C(=O)N1Cc2ccccc2C1,CHEMBL1814759,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)NC1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)C1)C(=O)N1Cc2ccccc2C1,NC(CC(=O)NC1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)C1)C(=O)N1Cc2ccccc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6311196,CHEMBL1816905,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,COc1ccc2ccccc2c1CN[C@@H]1CN[C@H](C(=O)N2Cc3ccccc3C2)C1.Cl.Cl,CHEMBL3216065,nM,100000,CHEMBL284,4,DPPIV,COc1ccc2ccccc2c1CN[C@@H]1CNC(C(=O)N2Cc3ccccc3C2)C1,COc1ccc2ccccc2c1CNC1CNC(C(=O)N2Cc3ccccc3C2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321332,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,Cn1c(CO)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812727,nM,100000,CHEMBL284,4,DPPIV,Cn1c(CO)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Cn1c(CO)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321333,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812728,nM,16000,CHEMBL284,4.795880017,DPPIV,Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321334,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,Cl.Cn1c(CCN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812729,nM,87000,CHEMBL284,4.060480747,DPPIV,Cn1c(CCN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Cn1c(CCN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321335,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,Cn1c(N)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812730,nM,100000,CHEMBL284,4,DPPIV,Cn1c(N)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Cn1c(N)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321336,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CNCc1c(-c2ccccc2)c2cc(Cl)ccc2c(=O)n1CC(C)C,CHEMBL1812731,nM,100000,CHEMBL284,4,DPPIV,CNCc1c(-c2ccccc2)c2cc(Cl)ccc2c(=O)n1CC(C)C,CNCc1c(-c2ccccc2)c2cc(Cl)ccc2c(=O)n1CC(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321337,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN(C)C)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812732,nM,100000,CHEMBL284,4,DPPIV,CC(C)Cn1c(CN(C)C)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CC(C)Cn1c(CN(C)C)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321338,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812733,nM,8300,CHEMBL284,5.080921908,DPPIV,CCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321339,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812734,nM,2400,CHEMBL284,5.619788758,DPPIV,CCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321340,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CCCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812735,nM,2400,CHEMBL284,5.619788758,DPPIV,CCCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CCCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321341,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812736,nM,1600,CHEMBL284,5.795880017,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321342,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CCCCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812737,nM,3800,CHEMBL284,5.420216403,DPPIV,CCCCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CCCCCn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321343,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)(C)Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CHEMBL1812738,nM,1900,CHEMBL284,5.721246399,DPPIV,CC(C)(C)Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,CC(C)(C)Cn1c(CN)c(-c2ccccc2)c2cc(Cl)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321344,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(=O)O)ccc2c1=O.Cl,CHEMBL1812900,nM,980,CHEMBL284,6.008773924,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(=O)O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(=O)O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321345,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)ccc2c1=O.Cl,CHEMBL1812901,nM,360,CHEMBL284,6.443697499,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321346,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C#N)ccc2c1=O.Cl,CHEMBL1812902,nM,1100,CHEMBL284,5.958607315,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C#N)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C#N)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321347,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccc(C(N)=O)cc2c1=O.Cl,CHEMBL1812903,nM,2400,CHEMBL284,5.619788758,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccc(C(N)=O)cc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccc(C(N)=O)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321348,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CNC(=O)c1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1.Cl,CHEMBL1812904,nM,1900,CHEMBL284,5.721246399,DPPIV,CNC(=O)c1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,CNC(=O)c1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321349,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(=O)N(C)C)ccc2c1=O.Cl,CHEMBL1812905,nM,4000,CHEMBL284,5.397940009,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(=O)N(C)C)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(=O)N(C)C)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321350,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(O)ccc2c1=O.Cl,CHEMBL1812906,nM,790,CHEMBL284,6.102372909,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321351,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,COc1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,CHEMBL1812907,nM,870,CHEMBL284,6.060480747,DPPIV,COc1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,COc1ccc2c(=O)n(CC(C)C)c(CN)c(-c3ccccc3)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321353,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccc(OCC(N)=O)cc2c1=O.Cl,CHEMBL1812909,nM,1100,CHEMBL284,5.958607315,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccc(OCC(N)=O)cc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2ccc(OCC(N)=O)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321354,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(/C=C/C(N)=O)ccc2c1=O.Cl,CHEMBL1812910,nM,280,CHEMBL284,6.552841969,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(/C=C/C(N)=O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C=CC(N)=O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6321355,CHEMBL1816172,Inhibition of human DPP4 isolated from human CaCo2 cells incubated for 15 mins using Gly-Pro-pNA.Tos substrate,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(CCC(N)=O)ccc2c1=O.Cl,CHEMBL1812911,nM,1500,CHEMBL284,5.823908741,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(CCC(N)=O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(CCC(N)=O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6335423,CHEMBL1821018,Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence assay,B,Cl.Cn1c(=O)c2c(cc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,CHEMBL1819089,nM,0.34,CHEMBL284,9.468521083,DPPIV,Cn1c(=O)c2c(cc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,Cn1c(=O)c2c(cc(N3CCCC(N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6335424,CHEMBL1821018,Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence assay,B,CC[C@]1(N)CCCN(c2cc3c(c(=O)n(C)c(=O)n3C)n2Cc2cc(F)ccc2C#N)C1,CHEMBL1819092,nM,1000,CHEMBL284,6,DPPIV,CC[C@]1(N)CCCN(c2cc3c(c(=O)n(C)c(=O)n3C)n2Cc2cc(F)ccc2C#N)C1,CCC1(N)CCCN(c2cc3c(c(=O)n(C)c(=O)n3C)n2Cc2cc(F)ccc2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6335425,CHEMBL1821018,Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence assay,B,CC[C@@]1(N)CCCN(c2cc3c(c(=O)n(C)c(=O)n3C)n2Cc2cc(F)ccc2C#N)C1,CHEMBL1819091,nM,26,CHEMBL284,7.585026652,DPPIV,CC[C@@]1(N)CCCN(c2cc3c(c(=O)n(C)c(=O)n3C)n2Cc2cc(F)ccc2C#N)C1,CCC1(N)CCCN(c2cc3c(c(=O)n(C)c(=O)n3C)n2Cc2cc(F)ccc2C#N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
6335426,CHEMBL1821018,Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence assay,B,Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,CHEMBL1819090,nM,1.1,CHEMBL284,8.958607315,DPPIV,Cn1c(=O)c2c(cc(N3CCC[C@@](C)(N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,Cn1c(=O)c2c(cc(N3CCCC(C)(N)C3)n2Cc2cc(F)ccc2C#N)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7852224,CHEMBL1912790,Inhibition of DPP4,B,NCc1c(N)nc(-c2cc(F)cc(F)c2)nc1-c1ccc(Cl)cc1Cl,CHEMBL1909975,nM,3,CHEMBL284,8.522878745,DPPIV,N=c1[nH]c(-c2cc(F)cc(F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2cc(F)cc(F)c2)nc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7853086,CHEMBL1912807,Inhibition of DPP4,B,COc1cc2c(cc1OC)-c1nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)c1C2,CHEMBL122206,nM,7,CHEMBL284,8.15490196,DPPIV,COc1cc2c(cc1OC)-c1[nH]c(=N)c(CN)c(-c3ccc(Cl)cc3Cl)c1C2,COc1cc2c(cc1OC)-c1[nH]c(=N)c(CN)c(-c3ccc(Cl)cc3Cl)c1C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7853087,CHEMBL1912807,Inhibition of DPP4,B,NCc1c(-c2ccc(Cl)cc2Cl)cc(-c2ccccc2)nc1N,CHEMBL331950,nM,920,CHEMBL284,6.036212173,DPPIV,N=c1[nH]c(-c2ccccc2)cc(-c2ccc(Cl)cc2Cl)c1CN,N=c1[nH]c(-c2ccccc2)cc(-c2ccc(Cl)cc2Cl)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962678,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1.Cl,CHEMBL1929387,nM,3.8,CHEMBL284,8.420216403,DPPIV,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)cn2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962679,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(C)n2n1.Cl,CHEMBL1929388,nM,13,CHEMBL284,7.886056648,DPPIV,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(C)n2n1,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)c(C)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962680,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(C(F)(F)F)n2n1.Cl,CHEMBL1929389,nM,32,CHEMBL284,7.494850022,DPPIV,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(C(F)(F)F)n2n1,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)c(C(F)(F)F)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962681,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(O)n2n1.Cl,CHEMBL1929390,nM,1.8,CHEMBL284,8.744727495,DPPIV,Cc1cc2[nH]cc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(=O)n2n1,Cc1cc2[nH]cc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)c(=O)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962682,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1c(C(=O)NCC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cnc2cc(C(C)(C)C)nn12.Cl,CHEMBL1929391,nM,15,CHEMBL284,7.823908741,DPPIV,Cc1c(C(=O)NCC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cnc2cc(C(C)(C)C)nn12,Cc1c(C(=O)NCC(C)(C)NCC(=O)N2CCCC2C#N)cnc2cc(C(C)(C)C)nn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962683,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1c(C(=O)NCC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cnc2cc(-c3ccccc3)nn12.Cl,CHEMBL1929392,nM,11,CHEMBL284,7.958607315,DPPIV,Cc1c(C(=O)NCC(C)(C)NCC(=O)N2CCC[C@H]2C#N)cnc2cc(-c3ccccc3)nn12,Cc1c(C(=O)NCC(C)(C)NCC(=O)N2CCCC2C#N)cnc2cc(-c3ccccc3)nn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962684,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1nc2cc(C(C)(C)C)nn2c(C)c1C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N.Cl,CHEMBL1929393,nM,80,CHEMBL284,7.096910013,DPPIV,Cc1nc2cc(C(C)(C)C)nn2c(C)c1C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,Cc1nc2cc(C(C)(C)C)nn2c(C)c1C(=O)NCC(C)(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962685,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1nc2cc(-c3ccccc3)nn2c(C)c1C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N.Cl,CHEMBL1929394,nM,28,CHEMBL284,7.552841969,DPPIV,Cc1nc2cc(-c3ccccc3)nn2c(C)c1C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,Cc1nc2cc(-c3ccccc3)nn2c(C)c1C(=O)NCC(C)(C)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
7962686,CHEMBL1932590,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate preincubated for 30 mins before substrate addition measured after 20 mins by fluorescence assay,B,Cc1cc2nc(C)c(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(C)n2n1.Cl,CHEMBL1929395,nM,110,CHEMBL284,6.958607315,DPPIV,Cc1cc2nc(C)c(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)c(C)n2n1,Cc1cc2nc(C)c(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)c(C)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037767,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,Cn1cnc2c(C#N)c(N3CCNCC3)n(Cc3ccccc3)c2c1=O,CHEMBL1951417,nM,2100,CHEMBL284,5.677780705,DPPIV,Cn1cnc2c(C#N)c(N3CCNCC3)n(Cc3ccccc3)c2c1=O,Cn1cnc2c(C#N)c(N3CCNCC3)n(Cc3ccccc3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037768,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCNCC4)n(Cc4ccccc4)c3c2=O)c1,CHEMBL1951418,nM,400,CHEMBL284,6.397940009,DPPIV,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCNCC4)n(Cc4ccccc4)c3c2=O)c1,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCNCC4)n(Cc4ccccc4)c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037769,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCNCC2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,CHEMBL1951419,nM,23,CHEMBL284,7.638272164,DPPIV,CC#CCn1c(N2CCNCC2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,CC#CCn1c(N2CCNCC2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037770,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCNCC4)n(CC=C(C)C)c3c2=O)c1,CHEMBL1951420,nM,10,CHEMBL284,8,DPPIV,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCNCC4)n(CC=C(C)C)c3c2=O)c1,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCNCC4)n(CC=C(C)C)c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037771,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,Cn1cnc2c(C#N)c(N3CCC[C@H](N)C3)n(Cc3ccccc3)c2c1=O,CHEMBL1951421,nM,20,CHEMBL284,7.698970004,DPPIV,Cn1cnc2c(C#N)c(N3CCC[C@H](N)C3)n(Cc3ccccc3)c2c1=O,Cn1cnc2c(C#N)c(N3CCCC(N)C3)n(Cc3ccccc3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037772,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@@H](N)C4)n(Cc4ccccc4)c3c2=O)c1,CHEMBL1951422,nM,25,CHEMBL284,7.602059991,DPPIV,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@@H](N)C4)n(Cc4ccccc4)c3c2=O)c1,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCCC(N)C4)n(Cc4ccccc4)c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037773,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@H](N)C4)n(Cc4ccccc4)c3c2=O)c1,CHEMBL1951423,nM,4,CHEMBL284,8.397940009,DPPIV,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@H](N)C4)n(Cc4ccccc4)c3c2=O)c1,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCCC(N)C4)n(Cc4ccccc4)c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8037774,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,N#Cc1c(N2CCC[C@H](N)C2)n(Cc2ccccc2)c2c(=O)n(Cc3ccnc4ccccc34)cnc12,CHEMBL1951424,nM,17,CHEMBL284,7.769551079,DPPIV,N#Cc1c(N2CCC[C@H](N)C2)n(Cc2ccccc2)c2c(=O)n(Cc3ccnc4ccccc34)cnc12,N#Cc1c(N2CCCC(N)C2)n(Cc2ccccc2)c2c(=O)n(Cc3ccnc4ccccc34)cnc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038707,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@@H](N)C2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,CHEMBL1951425,nM,60,CHEMBL284,7.22184875,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038708,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,CHEMBL1951426,nM,15,CHEMBL284,7.823908741,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(CC(=O)c3cccc(OC)c3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038709,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,CHEMBL1951427,nM,10,CHEMBL284,8,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038710,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CHEMBL1951428,nM,5,CHEMBL284,8.301029996,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038711,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@@H](N)C4)n(CC=C(C)C)c3c2=O)c1,CHEMBL1951429,nM,4,CHEMBL284,8.397940009,DPPIV,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@@H](N)C4)n(CC=C(C)C)c3c2=O)c1,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCCC(N)C4)n(CC=C(C)C)c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038712,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@H](N)C4)n(CC=C(C)C)c3c2=O)c1,CHEMBL1951430,nM,1,CHEMBL284,9,DPPIV,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCC[C@H](N)C4)n(CC=C(C)C)c3c2=O)c1,COc1cccc(C(=O)Cn2cnc3c(C#N)c(N4CCCC(N)C4)n(CC=C(C)C)c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038713,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,CHEMBL1951431,nM,4,CHEMBL284,8.397940009,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(Cc3ccnc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038714,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CHEMBL1951432,nM,0.5,CHEMBL284,9.301029996,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038715,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL1951433,nM,3,CHEMBL284,8.522878745,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038716,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ncc4ccccc4n3)c(=O)c21,CHEMBL1951434,nM,8,CHEMBL284,8.096910013,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(Cc3ncc4ccccc4n3)c(=O)c21,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(Cc3ncc4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038717,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(C)c(=O)c21,CHEMBL1951435,nM,9,CHEMBL284,8.045757491,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2ncn(C)c(=O)c21,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2ncn(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038719,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,N#Cc1c(N2CCCNCC2)n(Cc2ccccc2)c2c(=O)n(Cc3nccc4ccccc34)cnc12,CHEMBL1951436,nM,60,CHEMBL284,7.22184875,DPPIV,N#Cc1c(N2CCCNCC2)n(Cc2ccccc2)c2c(=O)n(Cc3nccc4ccccc34)cnc12,N#Cc1c(N2CCCNCC2)n(Cc2ccccc2)c2c(=O)n(Cc3nccc4ccccc34)cnc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038720,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CHEMBL1951437,nM,7,CHEMBL284,8.15490196,DPPIV,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038721,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CHEMBL1951438,nM,6,CHEMBL284,8.22184875,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nccc4ccccc34)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038722,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CHEMBL1951439,nM,9,CHEMBL284,8.045757491,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nc(C)c4ccccc4n3)c(=O)c21,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3nc(C)c4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038723,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3ncc4ccccc4n3)c(=O)c21,CHEMBL1951440,nM,45,CHEMBL284,7.346787486,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3ncc4ccccc4n3)c(=O)c21,CC#CCn1c(N2CCCNCC2)c(C#N)c2ncn(Cc3ncc4ccccc4n3)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038724,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCC[C@H](N)C4)n3Cc3ccccc3)n(C)c2=O)c1,CHEMBL1951595,nM,1.5,CHEMBL284,8.823908741,DPPIV,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCC[C@H](N)C4)n3Cc3ccccc3)n(C)c2=O)c1,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCCC(N)C4)n3Cc3ccccc3)n(C)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038725,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,Cn1c(=O)n(Cc2nccc3ccccc23)c(=O)c2c1c(C#N)c(N1CCC[C@H](N)C1)n2Cc1ccccc1,CHEMBL1951596,nM,4,CHEMBL284,8.397940009,DPPIV,Cn1c(=O)n(Cc2nccc3ccccc23)c(=O)c2c1c(C#N)c(N1CCC[C@H](N)C1)n2Cc1ccccc1,Cn1c(=O)n(Cc2nccc3ccccc23)c(=O)c2c1c(C#N)c(N1CCCC(N)C1)n2Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038726,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,Cn1c(=O)c2c(c(C#N)c(N3CCC[C@H](N)C3)n2Cc2ccccc2)n(C)c1=O,CHEMBL1951597,nM,10,CHEMBL284,8,DPPIV,Cn1c(=O)c2c(c(C#N)c(N3CCC[C@H](N)C3)n2Cc2ccccc2)n(C)c1=O,Cn1c(=O)c2c(c(C#N)c(N3CCCC(N)C3)n2Cc2ccccc2)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038727,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCC[C@H](N)C4)n3CC=C(C)C)n(C)c2=O)c1,CHEMBL1951598,nM,0.5,CHEMBL284,9.301029996,DPPIV,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCC[C@H](N)C4)n3CC=C(C)C)n(C)c2=O)c1,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038728,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CHEMBL1951599,nM,1,CHEMBL284,9,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038729,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL1951600,nM,2,CHEMBL284,8.698970004,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038730,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1cnc3ccccc3n1)c(=O)n2C,CHEMBL1951601,nM,9,CHEMBL284,8.045757491,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1cnc3ccccc3n1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1cnc3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038731,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1ncccc1C#N)c(=O)n2C,CHEMBL1951602,nM,25,CHEMBL284,7.602059991,DPPIV,CC(C)=CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1ncccc1C#N)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1ncccc1C#N)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038732,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,CHEMBL1951603,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038733,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CHEMBL1951604,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038734,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL1951605,nM,20,CHEMBL284,7.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038735,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL1951606,nM,250,CHEMBL284,6.602059991,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038736,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCCNCC4)n3CC=C(C)C)n(C)c2=O)c1,CHEMBL1951607,nM,2,CHEMBL284,8.698970004,DPPIV,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCCNCC4)n3CC=C(C)C)n(C)c2=O)c1,COc1cccc(C(=O)Cn2c(=O)c3c(c(C#N)c(N4CCCNCC4)n3CC=C(C)C)n(C)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038737,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CHEMBL1951608,nM,3,CHEMBL284,8.522878745,DPPIV,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038738,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL1951609,nM,2,CHEMBL284,8.698970004,DPPIV,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038739,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1cn3ccccc3n1)c(=O)n2C,CHEMBL1951610,nM,10,CHEMBL284,8,DPPIV,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1cn3ccccc3n1)c(=O)n2C,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1cn3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038740,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,CHEMBL1951611,nM,1,CHEMBL284,9,DPPIV,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038741,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,CHEMBL1949693,nM,5.5,CHEMBL284,8.259637311,DPPIV,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,CC(C)=CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038742,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CHEMBL1951612,nM,5,CHEMBL284,8.301029996,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nccc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038743,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL1951613,nM,7.5,CHEMBL284,8.124938737,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038744,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,CHEMBL1951416,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1ncc3ccccc3c1C#N)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
8038745,CHEMBL1954392,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,B,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,CHEMBL1951614,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCNCC2)c(C#N)c2c1c(=O)n(Cc1c(C#N)cnc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10848040,CHEMBL2014319,Inhibition of human recombinant DPP4 using H-Gly-Pro-7-amino-4-methylcoumarin as substrate assessed as inhibition of 7-amino-4-methylcoumarin formation after 30 mins by fluorimetry,B,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C[C@@H]1c1cc(F)ccc1F,CHEMBL2011528,nM,1650,CHEMBL284,5.782516056,DPPIV,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C[C@@H]1c1cc(F)ccc1F,NC1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10848041,CHEMBL2014319,Inhibition of human recombinant DPP4 using H-Gly-Pro-7-amino-4-methylcoumarin as substrate assessed as inhibition of 7-amino-4-methylcoumarin formation after 30 mins by fluorimetry,B,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2011534,nM,1100,CHEMBL284,5.958607315,DPPIV,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10848042,CHEMBL2014319,Inhibition of human recombinant DPP4 using H-Gly-Pro-7-amino-4-methylcoumarin as substrate assessed as inhibition of 7-amino-4-methylcoumarin formation after 30 mins by fluorimetry,B,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2011535,nM,350,CHEMBL284,6.455931956,DPPIV,N[C@H]1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10848043,CHEMBL2014319,Inhibition of human recombinant DPP4 using H-Gly-Pro-7-amino-4-methylcoumarin as substrate assessed as inhibition of 7-amino-4-methylcoumarin formation after 30 mins by fluorimetry,B,N[C@@H]1CCN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C1,CHEMBL2011537,nM,100000,CHEMBL284,4,DPPIV,N[C@@H]1CCN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C1,NC1CCN(c2ccc(-n3ccc(OCc4ccccc4)cc3=O)cn2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865609,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(-c2cccs2)cc1,CHEMBL2022512,nM,13100,CHEMBL284,4.882728704,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(-c2cccs2)cc1,N#CC1CCCN1C(=O)CNC(=O)c1ccc(-c2cccs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865697,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)CCCc1ccccc1,CHEMBL2024671,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CCCN1C(=O)CCCc1ccccc1,N#CC1CCCN1C(=O)C1CCCN1C(=O)CCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865698,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccccc1,CHEMBL2024672,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccccc1,N#CC1CCCN1C(=O)CNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865699,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,COc1cccc(C(=O)NCC(=O)N2CCC[C@H]2C#N)c1,CHEMBL2024673,nM,100000,CHEMBL284,4,DPPIV,COc1cccc(C(=O)NCC(=O)N2CCC[C@H]2C#N)c1,COc1cccc(C(=O)NCC(=O)N2CCCC2C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865700,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)CC(=O)NCC(=O)N1CCC[C@H]1C#N,CHEMBL2024674,nM,100000,CHEMBL284,4,DPPIV,CC(C)CC(=O)NCC(=O)N1CCC[C@H]1C#N,CC(C)CC(=O)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865701,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCc1ccccc1,CHEMBL2022505,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCc1ccccc1,N#CC1CCCN1C(=O)CNC(=O)CCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865702,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1cccs1,CHEMBL2022506,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1cccs1,N#CC1CCCN1C(=O)CNC(=O)Cc1cccs1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865703,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1ccc(Cl)cc1,CHEMBL2022507,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1ccc(Cl)cc1,N#CC1CCCN1C(=O)CNC(=O)Cc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865704,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1,CHEMBL2022508,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1,N#CC1CCCN1C(=O)CNC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865705,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(OC(F)(F)F)cc1,CHEMBL2022509,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(OC(F)(F)F)cc1,N#CC1CCCN1C(=O)CNC(=O)c1ccc(OC(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865706,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,COc1ccc(C(=O)NCC(=O)N2CCC[C@H]2C#N)cc1OC1CCCC1,CHEMBL2022510,nM,100000,CHEMBL284,4,DPPIV,COc1ccc(C(=O)NCC(=O)N2CCC[C@H]2C#N)cc1OC1CCCC1,COc1ccc(C(=O)NCC(=O)N2CCCC2C#N)cc1OC1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865707,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c(Cl)cccc1Cl,CHEMBL2022511,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c(Cl)cccc1Cl,N#CC1CCCN1C(=O)CNC(=O)c1c(Cl)cccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865708,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc(-c2ccccc2)c1,CHEMBL2022513,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc(-c2ccccc2)c1,N#CC1CCCN1C(=O)CNC(=O)c1cccc(-c2ccccc2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865709,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc2ccccc2c1,CHEMBL2022514,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc2ccccc2c1,N#CC1CCCN1C(=O)CNC(=O)c1ccc2ccccc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865711,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,COc1cccc(S(=O)(=O)NCC(=O)N2CCC[C@H]2C#N)c1,CHEMBL2022515,nM,100000,CHEMBL284,4,DPPIV,COc1cccc(S(=O)(=O)NCC(=O)N2CCC[C@H]2C#N)c1,COc1cccc(S(=O)(=O)NCC(=O)N2CCCC2C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865712,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)CN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL2022516,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)CN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,N#CC1CCCN1C(=O)CNC(=O)CN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865713,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)NCc1ccc(F)cc1,CHEMBL2022517,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)NCc1ccc(F)cc1,N#CC1CCCN1C(=O)CNC(=O)CCC(=O)NCc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865714,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1,CHEMBL2022518,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1,N#CC1CCCN1C(=O)CNC(=O)CCC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865715,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1,CHEMBL2022519,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1,N#CC1CCCN1C(=O)CNC(=O)CCC(=O)N1CCN(Cc2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865716,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL2022520,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)CCC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,N#CC1CCCN1C(=O)CNC(=O)CCC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865717,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cn1cc(-c2ccc(F)c(F)c2)nn1,CHEMBL2022521,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cn1cc(-c2ccc(F)c(F)c2)nn1,N#CC1CCCN1C(=O)CNC(=O)Cn1cc(-c2ccc(F)c(F)c2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865718,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)OC(=O)N1CCN(c2cn(CC(=O)NCC(=O)N3CCC[C@H]3C#N)nn2)CC1,CHEMBL2022522,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)OC(=O)N1CCN(c2cn(CC(=O)NCC(=O)N3CCC[C@H]3C#N)nn2)CC1,CC(C)(C)OC(=O)N1CCN(c2cn(CC(=O)NCC(=O)N3CCCC3C#N)nn2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865719,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C(NCC(=O)N1CCCC1)c1ccccc1,CHEMBL2022523,nM,100000,CHEMBL284,4,DPPIV,O=C(NCC(=O)N1CCCC1)c1ccccc1,O=C(NCC(=O)N1CCCC1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865720,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccccc1,CHEMBL2022524,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)NC(=O)C1CCCN1C(=O)CNC(=O)c1ccccc1,CC(C)(C)NC(=O)C1CCCN1C(=O)CNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865721,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)CNC(=O)c1ccccc1,CHEMBL2022525,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)CNC(=O)c1ccccc1,N#CC1CC(N=[N+]=[N-])CN1C(=O)CNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865722,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL2022526,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CC(N=[N+]=[N-])CN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865723,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1C[C@@H](N=[N+]=[N-])CN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL2022527,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@@H](N=[N+]=[N-])CN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CC(N=[N+]=[N-])CN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865724,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL2022528,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CC(F)CN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865725,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccccc1,CHEMBL2022529,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccccc1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865726,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL2022530,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865727,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC1C[C@@H](C#N)N(C(=O)CNC(=O)c2ccccc2)C1,CHEMBL2021934,nM,100000,CHEMBL284,4,DPPIV,CC1C[C@@H](C#N)N(C(=O)CNC(=O)c2ccccc2)C1,CC1CC(C#N)N(C(=O)CNC(=O)c2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865728,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,C=C1C[C@@H](C#N)N(C(=O)CNC(=O)c2cccc3ccccc23)C1,CHEMBL2022531,nM,100000,CHEMBL284,4,DPPIV,C=C1C[C@@H](C#N)N(C(=O)CNC(=O)c2cccc3ccccc23)C1,C=C1CC(C#N)N(C(=O)CNC(=O)c2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865729,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CCC1C[C@@H](C#N)N(C(=O)CNC(=O)c2cccc3ccccc23)C1,CHEMBL2022532,nM,100000,CHEMBL284,4,DPPIV,CCC1C[C@@H](C#N)N(C(=O)CNC(=O)c2cccc3ccccc23)C1,CCC1CC(C#N)N(C(=O)CNC(=O)c2cccc3ccccc23)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865730,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1C[C@H](C(F)(F)F)CN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL2022533,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](C(F)(F)F)CN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CC(C(F)(F)F)CN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865731,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCCN1C(=O)CNC(=O)c1ccccc1,CHEMBL2022534,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCCN1C(=O)CNC(=O)c1ccccc1,N#CC1CCCCN1C(=O)CNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10865732,CHEMBL2026783,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCCN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL2022535,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCCN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CCCCN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10869443,CHEMBL2026010,Inhibition of human DPP4 after 10 mins,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,CHEMBL2023067,nM,1.4,CHEMBL284,8.853871964,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c(Br)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10869444,CHEMBL2026010,Inhibition of human DPP4 after 10 mins,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]c(-c3cccnc3)cc2c1=O,CHEMBL2023066,nM,2.34,CHEMBL284,8.630784143,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]c(-c3cccnc3)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2[nH]c(-c3cccnc3)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10869445,CHEMBL2026010,Inhibition of human DPP4 after 10 mins,B,Cc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc2[nH]1,CHEMBL2022464,nM,13.78,CHEMBL284,7.860750782,DPPIV,Cc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCC[C@@H](N)C3)nc2[nH]1,Cc1cc2c(=O)n(Cc3ccccc3C#N)c(N3CCCC(N)C3)nc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10869446,CHEMBL2026010,Inhibition of human DPP4 after 10 mins,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]c(Br)cc2c1=O,CHEMBL2022467,nM,2.64,CHEMBL284,8.578396073,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]c(Br)cc2c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2[nH]c(Br)cc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961279,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3nccc4ccccc34)CC2)CN1)N1CCSC1,CHEMBL2058973,nM,0.61,CHEMBL284,9.214670165,DPPIV,O=C(C1C[C@H](N2CCN(c3nccc4ccccc34)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nccc4ccccc34)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961280,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3ncc(Cl)c4ccccc34)CC2)CN1)N1CCSC1,CHEMBL2058974,nM,0.73,CHEMBL284,9.13667714,DPPIV,O=C(C1C[C@H](N2CCN(c3ncc(Cl)c4ccccc34)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ncc(Cl)c4ccccc34)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961281,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,N#Cc1cnc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)c2ccccc12,CHEMBL2058975,nM,0.51,CHEMBL284,9.292429824,DPPIV,N#Cc1cnc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)c2ccccc12,N#Cc1cnc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961282,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3ccc4ccccc4n3)CC2)CN1)N1CCSC1,CHEMBL2058968,nM,2.2,CHEMBL284,8.657577319,DPPIV,O=C(C1C[C@H](N2CCN(c3ccc4ccccc4n3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccc4ccccc4n3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961283,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3ccnc4ccccc34)CC2)CN1)N1CCSC1,CHEMBL2058969,nM,0.95,CHEMBL284,9.022276395,DPPIV,O=C(C1C[C@H](N2CCN(c3ccnc4ccccc34)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccnc4ccccc34)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961284,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)c2ccccc2n1,CHEMBL2058970,nM,0.56,CHEMBL284,9.251811973,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)c2ccccc2n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)c2ccccc2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961285,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3cc(C(F)(F)F)nc4ccccc34)CC2)CN1)N1CCSC1,CHEMBL2058971,nM,0.37,CHEMBL284,9.431798276,DPPIV,O=C(C1C[C@H](N2CCN(c3cc(C(F)(F)F)nc4ccccc34)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3cc(C(F)(F)F)nc4ccccc34)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961286,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3ccnc4cc(Cl)ccc34)CC2)CN1)N1CCSC1,CHEMBL2058972,nM,0.61,CHEMBL284,9.214670165,DPPIV,O=C(C1C[C@H](N2CCN(c3ccnc4cc(Cl)ccc34)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccnc4cc(Cl)ccc34)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961287,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3ccnc4cc(C(F)(F)F)ccc34)CC2)CN1)N1CCSC1,CHEMBL2058759,nM,1.6,CHEMBL284,8.795880017,DPPIV,O=C(C1C[C@H](N2CCN(c3ccnc4cc(C(F)(F)F)ccc34)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccnc4cc(C(F)(F)F)ccc34)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961288,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4ccccc4[nH]3)CC2)CN1)N1CCSC1,CHEMBL2058760,nM,0.8,CHEMBL284,9.096910013,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4ccccc4[nH]3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nc4ccccc4[nH]3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961289,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)CN1)N1CCSC1,CHEMBL2058761,nM,0.59,CHEMBL284,9.229147988,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961290,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,N#Cc1ccc2[nH]c(N3CCN([C@@H]4CN[C@H](C(=O)N5CCSC5)C4)CC3)nc2c1,CHEMBL2058762,nM,0.39,CHEMBL284,9.408935393,DPPIV,N#Cc1ccc2[nH]c(N3CCN([C@@H]4CNC(C(=O)N5CCSC5)C4)CC3)nc2c1,N#Cc1ccc2[nH]c(N3CCN(C4CNC(C(=O)N5CCSC5)C4)CC3)nc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961291,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4ccccc4o3)CC2)CN1)N1CCSC1,CHEMBL2058967,nM,1.2,CHEMBL284,8.920818754,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4ccccc4o3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nc4ccccc4o3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961292,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,N#Cc1ccc2oc(N3CCN([C@@H]4CN[C@H](C(=O)N5CCSC5)C4)CC3)nc2c1,CHEMBL2058756,nM,0.5,CHEMBL284,9.301029996,DPPIV,N#Cc1ccc2oc(N3CCN([C@@H]4CNC(C(=O)N5CCSC5)C4)CC3)nc2c1,N#Cc1ccc2oc(N3CCN(C4CNC(C(=O)N5CCSC5)C4)CC3)nc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961293,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,O=C([C@@H]1C[C@H](N2CCN(c3nc4ccccc4s3)CC2)CN1)N1CCSC1,CHEMBL2058757,nM,0.55,CHEMBL284,9.259637311,DPPIV,O=C(C1C[C@H](N2CCN(c3nc4ccccc4s3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nc4ccccc4s3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10961294,CHEMBL2060146,Inhibition of human DPP4 using Gly-Pro-MCA as substrate after 60 mins by fluorometry,B,N#Cc1ccc2sc(N3CCN([C@@H]4CN[C@H](C(=O)N5CCSC5)C4)CC3)nc2c1,CHEMBL2058758,nM,0.42,CHEMBL284,9.37675071,DPPIV,N#Cc1ccc2sc(N3CCN([C@@H]4CNC(C(=O)N5CCSC5)C4)CC3)nc2c1,N#Cc1ccc2sc(N3CCN(C4CNC(C(=O)N5CCSC5)C4)CC3)nc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982097,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,C[C@H](N)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063024,nM,2.3,CHEMBL284,8.638272164,DPPIV,CC(N)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,CC(N)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982098,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,C[C@H](N)C(=O)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063025,nM,23,CHEMBL284,7.638272164,DPPIV,CC(N)C(=O)N1C[C@H](O)C[C@H]1B(O)O,CC(N)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982099,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,C[C@H](N)C(=O)N1C[C@H](F)C[C@H]1B(O)O,CHEMBL2063026,nM,2.1,CHEMBL284,8.677780705,DPPIV,CC(N)C(=O)N1C[C@H](F)C[C@H]1B(O)O,CC(N)C(=O)N1CC(F)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982100,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,C[C@H](N)C(=O)N1CC(=O)C[C@H]1B(O)O,CHEMBL2063027,nM,200,CHEMBL284,6.698970004,DPPIV,CC(N)C(=O)N1CC(=O)C[C@H]1B(O)O,CC(N)C(=O)N1CC(=O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982101,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,C[C@H](N)C(=O)N1C[C@@H](Cl)C[C@H]1B(O)O,CHEMBL2063028,nM,18000,CHEMBL284,4.744727495,DPPIV,CC(N)C(=O)N1C[C@@H](Cl)C[C@H]1B(O)O,CC(N)C(=O)N1CC(Cl)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982102,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,N[C@@H](CCC(=O)O)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063029,nM,29,CHEMBL284,7.537602002,DPPIV,NC(CCC(=O)O)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,NC(CCC(=O)O)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982103,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,N[C@@H](CCC(=O)O)C(=O)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063030,nM,17,CHEMBL284,7.769551079,DPPIV,NC(CCC(=O)O)C(=O)N1C[C@H](O)C[C@H]1B(O)O,NC(CCC(=O)O)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982104,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,CC(C)(C)[C@H](N)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063031,nM,53,CHEMBL284,7.27572413,DPPIV,CC(C)(C)C(N)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,CC(C)(C)C(N)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982105,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,CC(C)(C)[C@H](N)C(=O)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063032,nM,59,CHEMBL284,7.229147988,DPPIV,CC(C)(C)C(N)C(=O)N1C[C@H](O)C[C@H]1B(O)O,CC(C)(C)C(N)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982106,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,O=C([C@@H]1CCCN1)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063033,nM,6.2,CHEMBL284,8.207608311,DPPIV,O=C(C1CCCN1)N1C[C@@H](O)C[C@H]1B(O)O,O=C(C1CCCN1)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982107,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,O=C([C@@H]1CCCN1)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063034,nM,6.5,CHEMBL284,8.187086643,DPPIV,O=C(C1CCCN1)N1C[C@H](O)C[C@H]1B(O)O,O=C(C1CCCN1)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982108,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,O=C([C@@H]1C[C@@H](O)CN1)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063035,nM,20,CHEMBL284,7.698970004,DPPIV,O=C(C1C[C@@H](O)CN1)N1C[C@@H](O)C[C@H]1B(O)O,O=C(C1CC(O)CN1)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982109,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,O=C([C@@H]1C[C@@H](O)CN1)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063036,nM,48,CHEMBL284,7.318758763,DPPIV,O=C(C1C[C@@H](O)CN1)N1C[C@H](O)C[C@H]1B(O)O,O=C(C1CC(O)CN1)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982110,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,O=C([C@@H]1C[C@H](O)CN1)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063037,nM,15,CHEMBL284,7.823908741,DPPIV,O=C(C1C[C@H](O)CN1)N1C[C@@H](O)C[C@H]1B(O)O,O=C(C1CC(O)CN1)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982111,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,O=C([C@@H]1C[C@H](O)CN1)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063038,nM,16,CHEMBL284,7.795880017,DPPIV,O=C(C1C[C@H](O)CN1)N1C[C@H](O)C[C@H]1B(O)O,O=C(C1CC(O)CN1)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982112,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,N[C@@H](CCCC(=O)O)C(=O)N1C[C@H](O)C[C@H]1B(O)O,CHEMBL2063039,nM,17,CHEMBL284,7.769551079,DPPIV,NC(CCCC(=O)O)C(=O)N1C[C@H](O)C[C@H]1B(O)O,NC(CCCC(=O)O)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10982113,CHEMBL2066843,Inhibition of human DPP4 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,B,N=C(N)NCCC[C@H](N)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,CHEMBL2063040,nM,0.3,CHEMBL284,9.522878745,DPPIV,N=C(N)NCCCC(N)C(=O)N1C[C@@H](O)C[C@H]1B(O)O,N=C(N)NCCCC(N)C(=O)N1CC(O)CC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991390,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069828,nM,85.7,CHEMBL284,7.067019178,DPPIV,N[C@@H](CC(=O)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991391,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(c2ccc([N+](=O)[O-])cc2F)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069829,nM,194,CHEMBL284,6.71219827,DPPIV,N[C@@H](CC(=O)N1CCN(c2ccc([N+](=O)[O-])cc2F)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(c2ccc([N+](=O)[O-])cc2F)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991392,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(c2ccc(F)cc2F)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069830,nM,291,CHEMBL284,6.536107011,DPPIV,N[C@@H](CC(=O)N1CCN(c2ccc(F)cc2F)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(c2ccc(F)cc2F)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991393,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,CC(O)c1ccc(N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,CHEMBL2069831,nM,264,CHEMBL284,6.578396073,DPPIV,CC(O)c1ccc(N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,CC(O)c1ccc(N2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991394,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,CC(=O)c1ccc(N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,CHEMBL2069832,nM,99.7,CHEMBL284,7.001304842,DPPIV,CC(=O)c1ccc(N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,CC(=O)c1ccc(N2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991395,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(c2ccccc2-c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069833,nM,569,CHEMBL284,6.244887734,DPPIV,N[C@@H](CC(=O)N1CCN(c2ccccc2-c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(c2ccccc2-c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991396,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N#Cc1ccccc1N1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1,CHEMBL2069834,nM,50.4,CHEMBL284,7.297569464,DPPIV,N#Cc1ccccc1N1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1,N#Cc1ccccc1N1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991397,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N#Cc1ccc(N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,CHEMBL2069835,nM,101,CHEMBL284,6.995678626,DPPIV,N#Cc1ccc(N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc1,N#Cc1ccc(N2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991398,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,COc1cc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc(OC)c1,CHEMBL2069836,nM,103,CHEMBL284,6.987162775,DPPIV,COc1cc(CN2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc(OC)c1,COc1cc(CN2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc(OC)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991399,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069837,nM,212,CHEMBL284,6.673664139,DPPIV,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991400,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069838,nM,52.6,CHEMBL284,7.279014256,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccccc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991401,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(F)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069839,nM,45.3,CHEMBL284,7.343901798,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(F)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(F)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991402,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069840,nM,39,CHEMBL284,7.408935393,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991403,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(OC(F)(F)F)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069841,nM,64.6,CHEMBL284,7.189767482,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(OC(F)(F)F)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(OC(F)(F)F)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991404,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(C(F)(F)F)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069842,nM,56.4,CHEMBL284,7.248720896,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(C(F)(F)F)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(C(F)(F)F)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991405,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069843,nM,45.3,CHEMBL284,7.343901798,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(S(N)(=O)=O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991406,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069844,nM,53.4,CHEMBL284,7.272458743,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991407,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069845,nM,56.9,CHEMBL284,7.244887734,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cccc(C(=O)O)c2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991408,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,CN1CCN(c2ccc(C(=O)N3CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CC3)cc2)CC1,CHEMBL2069846,nM,47.7,CHEMBL284,7.321481621,DPPIV,CN1CCN(c2ccc(C(=O)N3CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CC3)cc2)CC1,CN1CCN(c2ccc(C(=O)N3CCN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CC3)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991409,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccco2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069847,nM,67.7,CHEMBL284,7.169411331,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccco2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccco2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991410,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc3ccccc3n2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069848,nM,24.9,CHEMBL284,7.603800653,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc3ccccc3n2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc3ccccc3n2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991411,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,COc1cccc2cc(C(=O)N3CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CC3)oc12,CHEMBL2069849,nM,65.4,CHEMBL284,7.184422252,DPPIV,COc1cccc2cc(C(=O)N3CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CC3)oc12,COc1cccc2cc(C(=O)N3CCN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CC3)oc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991412,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccccn2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069850,nM,57.6,CHEMBL284,7.239577517,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccccn2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccccn2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991413,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cnccn2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069851,nM,74.4,CHEMBL284,7.128427064,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cnccn2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cnccn2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991414,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(O)nc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069852,nM,91.5,CHEMBL284,7.038578906,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc(=O)[nH]c2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc(=O)[nH]c2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991415,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cc(O)c3cccc(O)c3n2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069853,nM,31.2,CHEMBL284,7.505845406,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cc(=O)c3cccc(O)c3[nH]2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cc(=O)c3cccc(O)c3[nH]2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991416,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cc3ccccc3s2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069854,nM,50.6,CHEMBL284,7.295849483,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cc3ccccc3s2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cc3ccccc3s2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991417,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,Cn1c(C(=O)N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc2ccccc21,CHEMBL2069855,nM,33.9,CHEMBL284,7.469800302,DPPIV,Cn1c(C(=O)N2CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CC2)cc2ccccc21,Cn1c(C(=O)N2CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC2)cc2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991418,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cc3ccccc3o2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069856,nM,76.2,CHEMBL284,7.118045029,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cc3ccccc3o2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cc3ccccc3o2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991419,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc3cccnc3n2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069308,nM,36.7,CHEMBL284,7.435333936,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ccc3cccnc3n2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ccc3cccnc3n2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991420,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cc(Cl)ccn2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069857,nM,42.2,CHEMBL284,7.374687549,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cc(Cl)ccn2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cc(Cl)ccn2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991421,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(-c3ccc(F)cc3)n2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069858,nM,30.5,CHEMBL284,7.515700161,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(-c3ccc(F)cc3)n2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cccc(-c3ccc(F)cc3)n2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991422,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(F)n2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069859,nM,113.9,CHEMBL284,6.943476276,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2cccc(F)n2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2cccc(F)n2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
10991423,CHEMBL2072421,Inhibition of recombinant human DPP4 after 1 hr by fluorescence assay,B,N[C@@H](CC(=O)N1CCN(C(=O)c2ncc(F)cc2F)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2069860,nM,57.4,CHEMBL284,7.241088108,DPPIV,N[C@@H](CC(=O)N1CCN(C(=O)c2ncc(F)cc2F)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCN(C(=O)c2ncc(F)cc2F)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014676,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCNC(=O)c1ccccc1,CHEMBL2086587,nM,320,CHEMBL284,6.494850022,DPPIV,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccccc1,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014677,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,COc1ccc(C(=O)NCCC(=O)N2CCC[C@H]2C(N)=O)cc1,CHEMBL2086588,nM,890,CHEMBL284,6.050609993,DPPIV,COc1ccc(C(=O)NCCC(=O)N2CCCC2C(N)=O)cc1,COc1ccc(C(=O)NCCC(=O)N2CCCC2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014678,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCNC(=O)c1ccc(O)cc1,CHEMBL2086589,nM,863,CHEMBL284,6.063989204,DPPIV,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(O)cc1,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014679,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCNC(=O)c1ccc(F)cc1,CHEMBL2086590,nM,93,CHEMBL284,7.031517051,DPPIV,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(F)cc1,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014680,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#Cc1ccc(C(=O)NCCC(=O)N2CCC[C@H]2C(N)=O)cc1,CHEMBL2086591,nM,31,CHEMBL284,7.508638306,DPPIV,N#Cc1ccc(C(=O)NCCC(=O)N2CCCC2C(N)=O)cc1,N#Cc1ccc(C(=O)NCCC(=O)N2CCCC2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014681,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCNC(=O)c1ccc(C(F)(F)F)cc1,CHEMBL2086592,nM,28,CHEMBL284,7.552841969,DPPIV,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(C(F)(F)F)cc1,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014682,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,Cc1ccc(C(=O)NCCC(=O)N2CCC[C@H]2C(N)=O)cc1,CHEMBL2086593,nM,715,CHEMBL284,6.145693958,DPPIV,Cc1ccc(C(=O)NCCC(=O)N2CCCC2C(N)=O)cc1,Cc1ccc(C(=O)NCCC(=O)N2CCCC2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014683,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL2086594,nM,107,CHEMBL284,6.970616222,DPPIV,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(-c2ccccc2)cc1,NC(=O)C1CCCN1C(=O)CCNC(=O)c1ccc(-c2ccccc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014684,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccccc1,CHEMBL2086595,nM,298,CHEMBL284,6.525783736,DPPIV,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccccc1,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014685,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,COc1ccc(C(=O)NCCCC(=O)N2CCC[C@H]2C(N)=O)cc1,CHEMBL2086596,nM,869,CHEMBL284,6.060980224,DPPIV,COc1ccc(C(=O)NCCCC(=O)N2CCCC2C(N)=O)cc1,COc1ccc(C(=O)NCCCC(=O)N2CCCC2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014686,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccc(O)cc1,CHEMBL2086597,nM,843,CHEMBL284,6.074172425,DPPIV,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(O)cc1,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014687,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccc(F)cc1,CHEMBL2086598,nM,74,CHEMBL284,7.13076828,DPPIV,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(F)cc1,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014688,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#Cc1ccc(C(=O)NCCCC(=O)N2CCC[C@H]2C(N)=O)cc1,CHEMBL2086599,nM,26,CHEMBL284,7.585026652,DPPIV,N#Cc1ccc(C(=O)NCCCC(=O)N2CCCC2C(N)=O)cc1,N#Cc1ccc(C(=O)NCCCC(=O)N2CCCC2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014689,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccc(C(F)(F)F)cc1,CHEMBL2086600,nM,19,CHEMBL284,7.721246399,DPPIV,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(C(F)(F)F)cc1,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014690,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,Cc1ccc(C(=O)NCCCC(=O)N2CCC[C@H]2C(N)=O)cc1,CHEMBL2086601,nM,694,CHEMBL284,6.15864053,DPPIV,Cc1ccc(C(=O)NCCCC(=O)N2CCCC2C(N)=O)cc1,Cc1ccc(C(=O)NCCCC(=O)N2CCCC2C(N)=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014691,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL2086602,nM,104,CHEMBL284,6.982966661,DPPIV,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(-c2ccccc2)cc1,NC(=O)C1CCCN1C(=O)CCCNC(=O)c1ccc(-c2ccccc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014692,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccccc2)cc1,CHEMBL2086603,nM,311,CHEMBL284,6.507239611,DPPIV,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccccc2)cc1,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccccc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014693,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,COc1ccc(C(=O)Nc2ccc(C(=O)N3CCC[C@H]3C(N)=O)cc2)cc1,CHEMBL2086604,nM,879,CHEMBL284,6.056011125,DPPIV,COc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C(N)=O)cc2)cc1,COc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C(N)=O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014694,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccc(O)cc2)cc1,CHEMBL2086605,nM,863,CHEMBL284,6.063989204,DPPIV,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(O)cc2)cc1,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014695,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccc(F)cc2)cc1,CHEMBL2086606,nM,100,CHEMBL284,7,DPPIV,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(F)cc2)cc1,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014696,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC[C@H]3C(N)=O)cc2)cc1,CHEMBL2086607,nM,34,CHEMBL284,7.468521083,DPPIV,N#Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C(N)=O)cc2)cc1,N#Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C(N)=O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014697,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1,CHEMBL2086608,nM,31,CHEMBL284,7.508638306,DPPIV,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014698,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC[C@H]3C(N)=O)cc2)cc1,CHEMBL2086609,nM,723,CHEMBL284,6.140861703,DPPIV,Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C(N)=O)cc2)cc1,Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C(N)=O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014699,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,NC(=O)[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)cc1,CHEMBL2086610,nM,116,CHEMBL284,6.935542011,DPPIV,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)cc1,NC(=O)C1CCCN1C(=O)c1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014700,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#Cc1ccc(C(=O)NCCC(=O)N2CCC[C@H]2C#N)cc1,CHEMBL2086611,nM,10.3,CHEMBL284,7.987162775,DPPIV,N#Cc1ccc(C(=O)NCCC(=O)N2CCC[C@H]2C#N)cc1,N#Cc1ccc(C(=O)NCCC(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014701,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#C[C@@H]1CCCN1C(=O)CCNC(=O)c1ccc(C(F)(F)F)cc1,CHEMBL2086612,nM,13.2,CHEMBL284,7.879426069,DPPIV,N#C[C@@H]1CCCN1C(=O)CCNC(=O)c1ccc(C(F)(F)F)cc1,N#CC1CCCN1C(=O)CCNC(=O)c1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014702,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#Cc1ccc(C(=O)NCCCC(=O)N2CCC[C@H]2C#N)cc1,CHEMBL2086613,nM,2.3,CHEMBL284,8.638272164,DPPIV,N#Cc1ccc(C(=O)NCCCC(=O)N2CCC[C@H]2C#N)cc1,N#Cc1ccc(C(=O)NCCCC(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014703,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#C[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccc(C(F)(F)F)cc1,CHEMBL2086614,nM,3.8,CHEMBL284,8.420216403,DPPIV,N#C[C@@H]1CCCN1C(=O)CCCNC(=O)c1ccc(C(F)(F)F)cc1,N#CC1CCCN1C(=O)CCCNC(=O)c1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014704,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC[C@H]3C#N)cc2)cc1,CHEMBL2086615,nM,11.6,CHEMBL284,7.935542011,DPPIV,N#Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC[C@H]3C#N)cc2)cc1,N#Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC3C#N)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
11014705,CHEMBL2091655,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC substrate incubated or 30 mins by fluorescence based assay,B,N#C[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1,CHEMBL2086616,nM,14.3,CHEMBL284,7.844663963,DPPIV,N#C[C@@H]1CCCN1C(=O)c1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1,N#CC1CCCN1C(=O)c1ccc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034795,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3nc(-c4ccccc4)cs3)CC2)CN1)N1CCSC1,CHEMBL2147702,nM,4.5,CHEMBL284,8.346787486,DPPIV,O=C(C1C[C@H](N2CCN(c3nc(-c4ccccc4)cs3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nc(-c4ccccc4)cs3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034796,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3nccn3-c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL2147703,nM,0.26,CHEMBL284,9.585026652,DPPIV,O=C(C1C[C@H](N2CCN(c3nccn3-c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nccn3-c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034797,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3nnnn3-c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL2147704,nM,0.2,CHEMBL284,9.698970004,DPPIV,O=C(C1C[C@H](N2CCN(c3nnnn3-c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nnnn3-c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034798,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCC(c3nnnn3-c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL2147705,nM,4,CHEMBL284,8.397940009,DPPIV,O=C(C1C[C@H](N2CCC(c3nnnn3-c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCC(c3nnnn3-c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034799,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3nnnn3C3CCCCC3)CC2)CN1)N1CCSC1,CHEMBL2147706,nM,4.3,CHEMBL284,8.366531544,DPPIV,O=C(C1C[C@H](N2CCN(c3nnnn3C3CCCCC3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3nnnn3C3CCCCC3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034800,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3ccnn3-c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL2147707,nM,0.94,CHEMBL284,9.026872146,DPPIV,O=C(C1C[C@H](N2CCN(c3ccnn3-c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3ccnn3-c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034802,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCN(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL2147709,nM,0.32,CHEMBL284,9.494850022,DPPIV,O=C(C1C[C@H](N2CCN(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCN(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034803,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,O=C([C@@H]1C[C@H](N2CCC(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)CN1)N1CCSC1,CHEMBL2147710,nM,5.6,CHEMBL284,8.251811973,DPPIV,O=C(C1C[C@H](N2CCC(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)CN1)N1CCSC1,O=C(C1CC(N2CCC(c3cc(C(F)(F)F)nn3-c3ccccc3)CC2)CN1)N1CCSC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034804,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccc(F)cc2)n1,CHEMBL2147711,nM,2.9,CHEMBL284,8.537602002,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(F)cc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034805,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2cccc(F)c2)n1,CHEMBL2147712,nM,0.3,CHEMBL284,9.522878745,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2cccc(F)c2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2cccc(F)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034806,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2F)n1,CHEMBL2147713,nM,0.85,CHEMBL284,9.070581074,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2F)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2F)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034807,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccc(Cl)cc2)n1,CHEMBL2147714,nM,3.4,CHEMBL284,8.468521083,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(Cl)cc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(Cl)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034808,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccc(C#N)cc2)n1,CHEMBL2147715,nM,12,CHEMBL284,7.920818754,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(C#N)cc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(C#N)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034809,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccncc2)n1,CHEMBL2147772,nM,5,CHEMBL284,8.301029996,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccncc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccncc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034810,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2cccnc2)n1,CHEMBL2147773,nM,0.62,CHEMBL284,9.207608311,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2cccnc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2cccnc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034811,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccn2)n1,CHEMBL2147771,nM,0.63,CHEMBL284,9.200659451,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccn2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccn2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034812,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccc(C#N)cn2)n1,CHEMBL2147774,nM,15,CHEMBL284,7.823908741,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(C#N)cn2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccc(C#N)cn2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034813,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,CHEMBL2147775,nM,6.3,CHEMBL284,8.200659451,DPPIV,Cc1cc(N2CCN([C@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12034816,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@H]3CN[C@@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,CHEMBL2147776,nM,1000,CHEMBL284,6,DPPIV,Cc1cc(N2CCN([C@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12035240,CHEMBL2149800,Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,B,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,CHEMBL2147777,nM,0.37,CHEMBL284,9.431798276,DPPIV,Cc1cc(N2CCN([C@@H]3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044045,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2Cl)c2ccc(C(=O)O)cc21,CHEMBL2147070,nM,0.48,CHEMBL284,9.318758763,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2Cl)c2ccc(C(=O)O)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2cc(F)ccc2Cl)c2ccc(C(=O)O)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044073,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.N[C@@H]1CCCN(c2nc3c4ccccc4[nH]c(=O)c3n2Cc2ccccc2Cl)C1,CHEMBL2147057,nM,418,CHEMBL284,6.378823718,DPPIV,N[C@@H]1CCCN(c2nc3c4ccccc4[nH]c(=O)c3n2Cc2ccccc2Cl)C1,NC1CCCN(c2nc3c4ccccc4[nH]c(=O)c3n2Cc2ccccc2Cl)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044074,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccccc21,CHEMBL2147087,nM,103,CHEMBL284,6.987162775,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044075,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,CCn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccccc21.Cl,CHEMBL2147184,nM,400,CHEMBL284,6.397940009,DPPIV,CCn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccccc21,CCn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044076,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,CCCn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccccc21.Cl,CHEMBL2147185,nM,3400,CHEMBL284,5.468521083,DPPIV,CCCn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccccc21,CCCn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044077,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.N[C@@H]1CCCN(c2nc3c4ccccc4n(Cc4ccccc4)c(=O)c3n2Cc2ccccc2Cl)C1,CHEMBL2147186,nM,10000,CHEMBL284,5,DPPIV,N[C@@H]1CCCN(c2nc3c4ccccc4n(Cc4ccccc4)c(=O)c3n2Cc2ccccc2Cl)C1,NC1CCCN(c2nc3c4ccccc4n(Cc4ccccc4)c(=O)c3n2Cc2ccccc2Cl)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044078,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COc1cccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c12.Cl,CHEMBL2147187,nM,660,CHEMBL284,6.180456064,DPPIV,COc1cccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c12,COc1cccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044079,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COC(=O)c1cccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c12.Cl,CHEMBL2147188,nM,271,CHEMBL284,6.567030709,DPPIV,COC(=O)c1cccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c12,COC(=O)c1cccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044080,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cccc(C(=O)O)c21,CHEMBL2147189,nM,72,CHEMBL284,7.142667504,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cccc(C(=O)O)c21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2cccc(C(=O)O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044081,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(F)cc21,CHEMBL2147190,nM,66,CHEMBL284,7.180456064,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(F)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044082,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(-c3ccccc3)cc21,CHEMBL2147191,nM,72,CHEMBL284,7.142667504,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(-c3ccccc3)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(-c3ccccc3)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044083,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,CHEMBL2147192,nM,340,CHEMBL284,6.468521083,DPPIV,Cc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Cc1ccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044084,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1.Cl,CHEMBL2147193,nM,66,CHEMBL284,7.180456064,DPPIV,COc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,COc1ccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044085,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COCc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1.Cl,CHEMBL2147194,nM,17,CHEMBL284,7.769551079,DPPIV,COCc1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,COCc1ccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044086,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(CO)cc21,CHEMBL2147183,nM,22,CHEMBL284,7.657577319,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(CO)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(CO)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044087,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COC(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1.Cl,CHEMBL2147195,nM,16,CHEMBL284,7.795880017,DPPIV,COC(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,COC(=O)c1ccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044088,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C(N)=O)cc21,CHEMBL2147196,nM,12,CHEMBL284,7.920818754,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C(N)=O)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(C(N)=O)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044089,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,CN(C)C(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1.Cl,CHEMBL2147071,nM,10,CHEMBL284,8,DPPIV,CN(C)C(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,CN(C)C(=O)c1ccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044090,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C#N)cc21,CHEMBL2147072,nM,6.3,CHEMBL284,8.200659451,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C#N)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(C#N)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044091,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C(=O)O)cc21,CHEMBL2147073,nM,1.6,CHEMBL284,8.795880017,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(C(=O)O)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(C(=O)O)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044092,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(CC(=O)O)cc21,CHEMBL2147074,nM,3.8,CHEMBL284,8.420216403,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2ccc(CC(=O)O)cc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2ccc(CC(=O)O)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044093,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COc1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl,CHEMBL2147075,nM,90,CHEMBL284,7.045757491,DPPIV,COc1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,COc1ccc2c(c1)c1nc(N3CCCC(N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044094,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cc1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl,CHEMBL2147076,nM,94,CHEMBL284,7.026872146,DPPIV,Cc1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Cc1ccc2c(c1)c1nc(N3CCCC(N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044095,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(F)ccc21,CHEMBL2147077,nM,56,CHEMBL284,7.251811973,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(F)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2cc(F)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044096,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(OC(F)F)ccc21,CHEMBL2147078,nM,60,CHEMBL284,7.22184875,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(OC(F)F)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2cc(OC(F)F)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044097,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl,CHEMBL2147079,nM,21,CHEMBL284,7.677780705,DPPIV,COC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,COC(=O)c1ccc2c(c1)c1nc(N3CCCC(N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044098,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(C(N)=O)ccc21,CHEMBL2147080,nM,14,CHEMBL284,7.853871964,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(C(N)=O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2cc(C(N)=O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044099,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,CN(C)C(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl,CHEMBL2147081,nM,13,CHEMBL284,7.886056648,DPPIV,CN(C)C(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,CN(C)C(=O)c1ccc2c(c1)c1nc(N3CCCC(N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044100,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(C(=O)O)ccc21,CHEMBL2147082,nM,5.8,CHEMBL284,8.236572006,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044101,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(CC(=O)O)ccc21,CHEMBL2147083,nM,3.5,CHEMBL284,8.455931956,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2cc(CC(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2cc(CC(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044102,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2c(C(=O)O)cccc21,CHEMBL2147084,nM,54,CHEMBL284,7.26760624,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2c(C(=O)O)cccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2c(C(=O)O)cccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044103,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2c(CC(=O)O)cccc21,CHEMBL2147085,nM,17,CHEMBL284,7.769551079,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2Cl)c2c(CC(=O)O)cccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2Cl)c2c(CC(=O)O)cccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044104,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2)c2cc(C(=O)O)ccc21,CHEMBL2147086,nM,64,CHEMBL284,7.193820026,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044105,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21.Cl,CHEMBL2147058,nM,11,CHEMBL284,7.958607315,DPPIV,Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,Cc1ccccc1Cn1c(N2CCCC(N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044106,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21.Cl,CHEMBL2147059,nM,38,CHEMBL284,7.420216403,DPPIV,COc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,COc1ccccc1Cn1c(N2CCCC(N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044107,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2F)c2cc(C(=O)O)ccc21,CHEMBL2147060,nM,160,CHEMBL284,6.795880017,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccccc2F)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2F)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044108,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cccc(Cl)c2)c2cc(C(=O)O)ccc21,CHEMBL2147049,nM,110,CHEMBL284,6.958607315,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cccc(Cl)c2)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2cccc(Cl)c2)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044109,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccc(Cl)cc2)c2cc(C(=O)O)ccc21,CHEMBL2147061,nM,10000,CHEMBL284,5,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2ccc(Cl)cc2)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccc(Cl)cc2)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044110,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COc1cccc(Cn2c(N3CCC[C@@H](N)C3)nc3c4cc(C(=O)O)ccc4n(C)c(=O)c32)c1.Cl,CHEMBL2147062,nM,150,CHEMBL284,6.823908741,DPPIV,COc1cccc(Cn2c(N3CCC[C@@H](N)C3)nc3c4cc(C(=O)O)ccc4n(C)c(=O)c32)c1,COc1cccc(Cn2c(N3CCCC(N)C3)nc3c4cc(C(=O)O)ccc4n(C)c(=O)c32)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044111,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,COc1ccc(Cn2c(N3CCC[C@@H](N)C3)nc3c4cc(C(=O)O)ccc4n(C)c(=O)c32)cc1.Cl,CHEMBL2147063,nM,6900,CHEMBL284,5.161150909,DPPIV,COc1ccc(Cn2c(N3CCC[C@@H](N)C3)nc3c4cc(C(=O)O)ccc4n(C)c(=O)c32)cc1,COc1ccc(Cn2c(N3CCCC(N)C3)nc3c4cc(C(=O)O)ccc4n(C)c(=O)c32)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044112,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2CCc2ccccc2Cl)c2cc(C(=O)O)ccc21,CHEMBL2147064,nM,3500,CHEMBL284,5.455931956,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2CCc2ccccc2Cl)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2CCc2ccccc2Cl)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044113,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2CC2CCCCC2)c2cc(C(=O)O)ccc21,CHEMBL2147065,nM,8900,CHEMBL284,5.050609993,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2CC2CCCCC2)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2CC2CCCCC2)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044114,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21.Cl,CHEMBL2147066,nM,51,CHEMBL284,7.292429824,DPPIV,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,CC(C)=CCn1c(N2CCCC(N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044115,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21.Cl,CHEMBL2147067,nM,90,CHEMBL284,7.045757491,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2c3cc(C(=O)O)ccc3n(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044116,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(Cl)ccc2Cl)c2cc(C(=O)O)ccc21,CHEMBL2147068,nM,25,CHEMBL284,7.602059991,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(Cl)ccc2Cl)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2cc(Cl)ccc2Cl)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044117,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cl.Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2Cl)c2cc(C(=O)O)ccc21,CHEMBL2147069,nM,4.8,CHEMBL284,8.318758763,DPPIV,Cn1c(=O)c2c(nc(N3CCC[C@@H](N)C3)n2Cc2cc(F)ccc2Cl)c2cc(C(=O)O)ccc21,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2cc(F)ccc2Cl)c2cc(C(=O)O)ccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12044118,CHEMBL2149434,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,B,Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c3ccc(C(=O)O)cc3n(C)c(=O)c21.Cl,CHEMBL2147056,nM,0.55,CHEMBL284,9.259637311,DPPIV,Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c3ccc(C(=O)O)cc3n(C)c(=O)c21,Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c3ccc(C(=O)O)cc3n(C)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12049460,CHEMBL2155999,Inhibition of DPP4,B,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)[C@@H]2CCCN2)cc1,CHEMBL2153742,nM,400,CHEMBL284,6.397940009,DPPIV,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CC(=O)Nc1ccc(OP(=O)(Oc2ccc(NC(C)=O)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12049461,CHEMBL2155999,Inhibition of DPP4,B,COC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)OC)cc2)C2CCCN2C(=O)[C@@H]2CCCN2)cc1,CHEMBL2153743,nM,16,CHEMBL284,7.795880017,DPPIV,COC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,COC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)OC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12049462,CHEMBL2155999,Inhibition of DPP4,B,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)[C@@H]2CCCN2)cc1,CHEMBL2153744,nM,23,CHEMBL284,7.638272164,DPPIV,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,CCOC(=O)CNC(=O)c1ccc(OP(=O)(Oc2ccc(C(=O)NCC(=O)OCC)cc2)C2CCCN2C(=O)C2CCCN2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078476,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccccc3)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159175,nM,257,CHEMBL284,6.590066877,DPPIV,Cn1c(=O)c2c(-c3ccccc3)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccccc3)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078477,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccc(F)cc3)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159176,nM,1070,CHEMBL284,5.970616222,DPPIV,Cn1c(=O)c2c(-c3ccc(F)cc3)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccc(F)cc3)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078478,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccc(Br)cc3)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159177,nM,128,CHEMBL284,6.89279003,DPPIV,Cn1c(=O)c2c(-c3ccc(Br)cc3)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccc(Br)cc3)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078479,CHEMBL2162559,Inhibition of DPP4,B,COc1cccc(-c2c(CN)c(N)nc3c2c(=O)n(C)c(=O)n3C)c1,CHEMBL2159178,nM,2800,CHEMBL284,5.552841969,DPPIV,COc1cccc(-c2c(CN)c(=N)[nH]c3c2c(=O)n(C)c(=O)n3C)c1,COc1cccc(-c2c(CN)c(=N)[nH]c3c2c(=O)n(C)c(=O)n3C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078480,CHEMBL2162559,Inhibition of DPP4,B,COc1ccccc1-c1c(CN)c(N)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL2159179,nM,57,CHEMBL284,7.244125144,DPPIV,COc1ccccc1-c1c(CN)c(=N)[nH]c2c1c(=O)n(C)c(=O)n2C,COc1ccccc1-c1c(CN)c(=N)[nH]c2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078481,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccccc3C#N)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159180,nM,69,CHEMBL284,7.161150909,DPPIV,Cn1c(=O)c2c(-c3ccccc3C#N)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccccc3C#N)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078482,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccccc3Cl)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159181,nM,33,CHEMBL284,7.48148606,DPPIV,Cn1c(=O)c2c(-c3ccccc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccccc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078483,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccccc3Br)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159182,nM,17,CHEMBL284,7.769551079,DPPIV,Cn1c(=O)c2c(-c3ccccc3Br)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccccc3Br)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078484,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3cccc(Cl)c3Cl)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159183,nM,371,CHEMBL284,6.43062609,DPPIV,Cn1c(=O)c2c(-c3cccc(Cl)c3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3cccc(Cl)c3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078485,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3ccc(Cl)cc3Cl)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159184,nM,24,CHEMBL284,7.619788758,DPPIV,Cn1c(=O)c2c(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3ccc(Cl)cc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078486,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3cc(Cl)ccc3Cl)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159185,nM,29,CHEMBL284,7.537602002,DPPIV,Cn1c(=O)c2c(-c3cc(Cl)ccc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3cc(Cl)ccc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078487,CHEMBL2162559,Inhibition of DPP4,B,COc1ccc(F)cc1-c1c(CN)c(N)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL2159186,nM,20,CHEMBL284,7.698970004,DPPIV,COc1ccc(F)cc1-c1c(CN)c(=N)[nH]c2c1c(=O)n(C)c(=O)n2C,COc1ccc(F)cc1-c1c(CN)c(=N)[nH]c2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078488,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3cc(F)ccc3Cl)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159187,nM,7.6,CHEMBL284,8.119186408,DPPIV,Cn1c(=O)c2c(-c3cc(F)ccc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3cc(F)ccc3Cl)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078489,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(N)nc2n(C)c1=O,CHEMBL2159188,nM,4.8,CHEMBL284,8.318758763,DPPIV,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(=N)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(=N)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078490,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(O)nc2n(C)c1=O,CHEMBL2159189,nM,260,CHEMBL284,6.585026652,DPPIV,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(=O)[nH]c2n(C)c1=O,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(=O)[nH]c2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078491,CHEMBL2162559,Inhibition of DPP4,B,CNc1nc2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,CHEMBL2159190,nM,2.8,CHEMBL284,8.552841969,DPPIV,CN=c1[nH]c2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,CN=c1[nH]c2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078492,CHEMBL2162559,Inhibition of DPP4,B,CCNc1nc2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,CHEMBL2159191,nM,6.9,CHEMBL284,8.161150909,DPPIV,CCN=c1[nH]c2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,CCN=c1[nH]c2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078493,CHEMBL2162559,Inhibition of DPP4,B,CCN(CC)c1nc2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,CHEMBL2159192,nM,2.8,CHEMBL284,8.552841969,DPPIV,CCN(CC)c1nc2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,CCN(CC)c1nc2c(c(-c3cc(F)ccc3Br)c1CN)c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078494,CHEMBL2162559,Inhibition of DPP4,B,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(N3CCOCC3)nc2n(C)c1=O,CHEMBL2159193,nM,4.6,CHEMBL284,8.337242168,DPPIV,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(N3CCOCC3)nc2n(C)c1=O,Cn1c(=O)c2c(-c3cc(F)ccc3Br)c(CN)c(N3CCOCC3)nc2n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12078495,CHEMBL2162559,Inhibition of DPP4,B,CN1CCN(c2nc3c(c(-c4cc(F)ccc4Br)c2CN)c(=O)n(C)c(=O)n3C)CC1,CHEMBL2159194,nM,9.9,CHEMBL284,8.004364805,DPPIV,CN1CCN(c2nc3c(c(-c4cc(F)ccc4Br)c2CN)c(=O)n(C)c(=O)n3C)CC1,CN1CCN(c2nc3c(c(-c4cc(F)ccc4Br)c2CN)c(=O)n(C)c(=O)n3C)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152733,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)OC(=O)NCc1cn([C@H]2C[C@@H](C(=O)N3CCC[C@H]3C#N)N(C(=O)CCCc3ccccc3)C2)nn1,CHEMBL2178959,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)OC(=O)NCc1cn([C@H]2CC(C(=O)N3CCC[C@H]3C#N)N(C(=O)CCCc3ccccc3)C2)nn1,CC(C)(C)OC(=O)NCc1cn(C2CC(C(=O)N3CCCC3C#N)N(C(=O)CCCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152734,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)CCCc1ccccc1,CHEMBL2178958,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)C1C[C@H](N=[N+]=[N-])CN1C(=O)CCCc1ccccc1,N#CC1CCCN1C(=O)C1CC(N=[N+]=[N-])CN1C(=O)CCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152735,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,N#C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CCCc1ccccc1,CHEMBL189620,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)C1CCCN1C(=O)CCCc1ccccc1,N#CC1CCCN1C(=O)C1CCCN1C(=O)CCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152736,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)OC(=O)NCc1cn([C@@H]2C[C@@H](C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CHEMBL2178957,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)OC(=O)NCc1cn([C@@H]2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CC(C)(C)OC(=O)NCc1cn(C2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152737,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@@H](n2cc(-c3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178956,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@@H](n2cc(-c3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152738,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,[N-]=[N+]=N[C@@H]1C[C@@H](C(=O)N2CCCC2)N(C(=O)CCCc2ccccc2)C1,CHEMBL2178955,nM,100000,CHEMBL284,4,DPPIV,[N-]=[N+]=N[C@@H]1CC(C(=O)N2CCCC2)N(C(=O)CCCc2ccccc2)C1,[N-]=[N+]=NC1CC(C(=O)N2CCCC2)N(C(=O)CCCc2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152740,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(CN3CCNCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178975,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(CN3CCNCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(CN3CCNCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152741,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)OC(=O)N1CCN(Cc2cn([C@H]3C[C@@H](C(=O)N4CCCC4)N(C(=O)CCCc4ccccc4)C3)nn2)CC1,CHEMBL2178974,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)OC(=O)N1CCN(Cc2cn([C@H]3CC(C(=O)N4CCCC4)N(C(=O)CCCc4ccccc4)C3)nn2)CC1,CC(C)(C)OC(=O)N1CCN(Cc2cn(C3CC(C(=O)N4CCCC4)N(C(=O)CCCc4ccccc4)C3)nn2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152742,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(CN3CCOCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178973,nM,50000,CHEMBL284,4.301029996,DPPIV,O=C(C1C[C@H](n2cc(CN3CCOCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(CN3CCOCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152743,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CN(C)Cc1cn([C@H]2C[C@@H](C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CHEMBL2178972,nM,100000,CHEMBL284,4,DPPIV,CN(C)Cc1cn([C@H]2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CN(C)Cc1cn(C2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152744,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,Cl.NCc1cn([C@H]2C[C@@H](C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CHEMBL2178971,nM,100000,CHEMBL284,4,DPPIV,NCc1cn([C@H]2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,NCc1cn(C2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152745,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(COCc3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178970,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(COCc3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(COCc3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152746,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccccn3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178969,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccccn3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccccn3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152747,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccccn3)nn2)CN1C(=O)OCc1ccccc1)N1CCCC1,CHEMBL2178968,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccccn3)nn2)CN1C(=O)OCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccccn3)nn2)CN1C(=O)OCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152748,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccc(Br)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178967,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccc(Br)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccc(Br)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152749,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccccc3Cl)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178966,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccccc3Cl)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccccc3Cl)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152750,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccc(F)c(F)c3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178965,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccc(F)c(F)c3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccc(F)c(F)c3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152751,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccc(F)cc3F)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178964,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccc(F)cc3F)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccc(F)cc3F)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152752,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccc(F)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178963,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccc(F)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccc(F)cc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152753,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2178962,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccccc3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152754,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(-c3ccccc3)nn2)CN1C(=O)OCc1ccccc1)N1CCCC1,CHEMBL2178961,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(-c3ccccc3)nn2)CN1C(=O)OCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(-c3ccccc3)nn2)CN1C(=O)OCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152755,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)OC(=O)NCc1cn([C@H]2C[C@@H](C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CHEMBL2178960,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)OC(=O)NCc1cn([C@H]2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,CC(C)(C)OC(=O)NCc1cn(C2CC(C(=O)N3CCCC3)N(C(=O)CCCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152756,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,CC(C)(C)OC(=O)NCc1cn([C@H]2C[C@@H](C(=O)N3CCCC3)N(C(=O)OCc3ccccc3)C2)nn1,CHEMBL2179408,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)OC(=O)NCc1cn([C@H]2CC(C(=O)N3CCCC3)N(C(=O)OCc3ccccc3)C2)nn1,CC(C)(C)OC(=O)NCc1cn(C2CC(C(=O)N3CCCC3)N(C(=O)OCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152757,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(C3CCCCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2179407,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(C3CCCCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(C3CCCCC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152758,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2cc(C3CC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL2179406,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2cc(C3CC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CC(n2cc(C3CC3)nn2)CN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152759,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,C[Si](C)(C)c1cn([C@H]2C[C@@H](C(=O)N3CCCC3)N(C(=O)OCc3ccccc3)C2)nn1,CHEMBL2179405,nM,100000,CHEMBL284,4,DPPIV,C[Si](C)(C)c1cn([C@H]2CC(C(=O)N3CCCC3)N(C(=O)OCc3ccccc3)C2)nn1,C[Si](C)(C)c1cn(C2CC(C(=O)N3CCCC3)N(C(=O)OCc3ccccc3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152760,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1C[C@H](n2ccnn2)CN1C(=O)OCc1ccccc1)N1CCCC1,CHEMBL2178979,nM,100000,CHEMBL284,4,DPPIV,O=C(C1C[C@H](n2ccnn2)CN1C(=O)OCc1ccccc1)N1CCCC1,O=C(C1CC(n2ccnn2)CN1C(=O)OCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152761,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,[N-]=[N+]=N[C@H]1C[C@@H](C(=O)N2CCCC2)N(C(=O)CCCc2ccccc2)C1,CHEMBL2178978,nM,100000,CHEMBL284,4,DPPIV,[N-]=[N+]=N[C@H]1CC(C(=O)N2CCCC2)N(C(=O)CCCc2ccccc2)C1,[N-]=[N+]=NC1CC(C(=O)N2CCCC2)N(C(=O)CCCc2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152762,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,[N-]=[N+]=N[C@H]1C[C@@H](C(=O)N2CCCC2)N(C(=O)OCc2ccccc2)C1,CHEMBL2178977,nM,100000,CHEMBL284,4,DPPIV,[N-]=[N+]=N[C@H]1CC(C(=O)N2CCCC2)N(C(=O)OCc2ccccc2)C1,[N-]=[N+]=NC1CC(C(=O)N2CCCC2)N(C(=O)OCc2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152763,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1CCCN1C(=O)CCCc1ccccc1)N1CCCC1,CHEMBL289651,nM,100000,CHEMBL284,4,DPPIV,O=C(C1CCCN1C(=O)CCCc1ccccc1)N1CCCC1,O=C(C1CCCN1C(=O)CCCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12152764,CHEMBL2185387,Inhibition of human seminal plasma DPP4 assessed as pNA release from Gly-Pro-p-nitroanilide substrate pre-incubated with enzyme for 15 min prior to substrate addition by fluorescence technique,B,O=C([C@@H]1CCCN1C(=O)OCc1ccccc1)N1CCCC1,CHEMBL1088406,nM,100000,CHEMBL284,4,DPPIV,O=C(C1CCCN1C(=O)OCc1ccccc1)N1CCCC1,O=C(C1CCCN1C(=O)OCc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182788,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nc(-c3ccc(Cl)cc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206479,nM,1100,CHEMBL284,5.958607315,DPPIV,N[C@@H](CC(=O)NC1(c2nc(-c3ccc(Cl)cc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nc(-c3ccc(Cl)cc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182790,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,COc1ccc(-c2csc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)n2)cc1,CHEMBL2206477,nM,670,CHEMBL284,6.173925197,DPPIV,COc1ccc(-c2csc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)n2)cc1,COc1ccc(-c2csc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)n2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182792,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-c3ccncc3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206466,nM,490,CHEMBL284,6.30980392,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-c3ccncc3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2cccc(-c3ccncc3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182793,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-c3nccs3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206467,nM,390,CHEMBL284,6.408935393,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-c3nccs3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2cccc(-c3nccs3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182794,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-c3cn[nH]c3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206470,nM,330,CHEMBL284,6.48148606,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-c3cn[nH]c3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2cccc(-c3cn[nH]c3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182795,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,Cc1ncc(-c2cccc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)c2)s1,CHEMBL2206472,nM,280,CHEMBL284,6.552841969,DPPIV,Cc1ncc(-c2cccc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)c2)s1,Cc1ncc(-c2cccc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)c2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182796,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-c3cnc(C4CCCCN4)s3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206473,nM,250,CHEMBL284,6.602059991,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-c3cnc(C4CCCCN4)s3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2cccc(-c3cnc(C4CCCCN4)s3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182797,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nc(-c3cccc(C(F)(F)F)c3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206481,nM,190,CHEMBL284,6.721246399,DPPIV,N[C@@H](CC(=O)NC1(c2nc(-c3cccc(C(F)(F)F)c3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nc(-c3cccc(C(F)(F)F)c3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182799,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,Cn1cc(-c2ccccc2)nc1C1(NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CCS(=O)(=O)CC1,CHEMBL2206486,nM,160,CHEMBL284,6.795880017,DPPIV,Cn1cc(-c2ccccc2)nc1C1(NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CCS(=O)(=O)CC1,Cn1cc(-c2ccccc2)nc1C1(NC(=O)CC(N)Cc2cc(F)c(F)cc2F)CCS(=O)(=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182800,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nc(-c3ccc(C(F)(F)F)cc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206480,nM,110,CHEMBL284,6.958607315,DPPIV,N[C@@H](CC(=O)NC1(c2nc(-c3ccc(C(F)(F)F)cc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nc(-c3ccc(C(F)(F)F)cc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182801,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nc(-c3ccc(F)cc3)cs2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206482,nM,100,CHEMBL284,7,DPPIV,N[C@@H](CC(=O)NC1(c2nc(-c3ccc(F)cc3)cs2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2nc(-c3ccc(F)cc3)cs2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182802,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nnc(-c3ccccc3)o2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206483,nM,94,CHEMBL284,7.026872146,DPPIV,N[C@@H](CC(=O)NC1(c2nnc(-c3ccccc3)o2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nnc(-c3ccccc3)o2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182803,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,Cn1cncc1-c1cccc(C2(NC(=O)C[C@H](N)Cc3ccccc3F)CCS(=O)(=O)CC2)c1,CHEMBL2206471,nM,84,CHEMBL284,7.075720714,DPPIV,Cn1cncc1-c1cccc(C2(NC(=O)C[C@H](N)Cc3ccccc3F)CCS(=O)(=O)CC2)c1,Cn1cncc1-c1cccc(C2(NC(=O)CC(N)Cc3ccccc3F)CCS(=O)(=O)CC2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182804,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2ccccc2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206488,nM,83,CHEMBL284,7.080921908,DPPIV,N[C@@H](CC(=O)NC1(c2ccccc2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2ccccc2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182805,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,Cc1sc(C2(NC(=O)C[C@H](N)Cc3ccccc3F)CCS(=O)(=O)CC2)nc1-c1ccccc1,CHEMBL2206487,nM,72,CHEMBL284,7.142667504,DPPIV,Cc1sc(C2(NC(=O)C[C@H](N)Cc3ccccc3F)CCS(=O)(=O)CC2)nc1-c1ccccc1,Cc1sc(C2(NC(=O)CC(N)Cc3ccccc3F)CCS(=O)(=O)CC2)nc1-c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182806,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nc(-c3ccccc3)cs2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206474,nM,60,CHEMBL284,7.22184875,DPPIV,N[C@@H](CC(=O)NC1(c2nc(-c3ccccc3)cs2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2nc(-c3ccccc3)cs2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182807,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,COc1ccccc1-c1csc(C2(NC(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCS(=O)(=O)CC2)n1,CHEMBL2206478,nM,59,CHEMBL284,7.229147988,DPPIV,COc1ccccc1-c1csc(C2(NC(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)CCS(=O)(=O)CC2)n1,COc1ccccc1-c1csc(C2(NC(=O)CC(N)Cc3cc(F)c(F)cc3F)CCS(=O)(=O)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182808,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nnc(-c3cccc(F)c3)o2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206484,nM,55,CHEMBL284,7.259637311,DPPIV,N[C@@H](CC(=O)NC1(c2nnc(-c3cccc(F)c3)o2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nnc(-c3cccc(F)c3)o2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182809,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,COc1cccc(-c2nnc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)o2)c1,CHEMBL2206485,nM,50,CHEMBL284,7.301029996,DPPIV,COc1cccc(-c2nnc(C3(NC(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)o2)c1,COc1cccc(-c2nnc(C3(NC(=O)CC(N)Cc4cc(F)c(F)cc4F)CCS(=O)(=O)CC3)o2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182810,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-c3cncs3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,CHEMBL2206468,nM,41,CHEMBL284,7.387216143,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-c3cncs3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,NC(CC(=O)NC1(c2cccc(-c3cncs3)c2)CCS(=O)(=O)CC1)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182811,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,COc1cccc(-c2csc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)n2)c1,CHEMBL2206476,nM,24,CHEMBL284,7.619788758,DPPIV,COc1cccc(-c2csc(C3(NC(=O)C[C@H](N)Cc4ccccc4F)CCS(=O)(=O)CC3)n2)c1,COc1cccc(-c2csc(C3(NC(=O)CC(N)Cc4ccccc4F)CCS(=O)(=O)CC3)n2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182812,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2nc(-c3ccccc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206475,nM,16,CHEMBL284,7.795880017,DPPIV,N[C@@H](CC(=O)NC1(c2nc(-c3ccccc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2nc(-c3ccccc3)cs2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182813,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-n3ccnc3)c2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2203319,nM,12,CHEMBL284,7.920818754,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-n3ccnc3)c2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2cccc(-n3ccnc3)c2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12182814,CHEMBL2214974,Inhibition of DPP4 in human Caco2 cell extracts using Ala-Pro-AFC as substrate after 20 mins by fluorescence assay,B,N[C@@H](CC(=O)NC1(c2cccc(-c3cncs3)c2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,CHEMBL2206469,nM,7.8,CHEMBL284,8.107905397,DPPIV,N[C@@H](CC(=O)NC1(c2cccc(-c3cncs3)c2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)NC1(c2cccc(-c3cncs3)c2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588796,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,CC(=O)N(C)[C@H]1CC[C@H]([C@H](C)[C@H](N)C(=O)N2CC[C@H](F)C2)CC1,CHEMBL1229855,nM,16,CHEMBL284,7.795880017,DPPIV,CC(=O)N(C)[C@H]1CC[C@H](C(C)C(N)C(=O)N2CC[C@H](F)C2)CC1,CC(=O)N(C)C1CCC(C(C)C(N)C(=O)N2CCC(F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588806,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,CC(C)(CO)NCC(=O)N1C[C@@H](F)C[C@H]1[C@@H](O)c1nnc(C(C)(C)C)o1,CHEMBL1229644,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)(CO)NCC(=O)N1C[C@@H](F)CC1C(O)c1nnc(C(C)(C)C)o1,CC(C)(CO)NCC(=O)N1CC(F)CC1C(O)c1nnc(C(C)(C)C)o1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588807,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,N[C@H]1CN(C(=O)c2cnc3ccccc3n2)C[C@H]1C(=O)N1CCCC1,CHEMBL1230044,nM,65,CHEMBL284,7.187086643,DPPIV,N[C@H]1CN(C(=O)c2cnc3ccccc3n2)CC1C(=O)N1CCCC1,NC1CN(C(=O)c2cnc3ccccc3n2)CC1C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588808,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,CS(=O)(=O)c1ccc(-c2noc([C@@H](CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CHEMBL1185242,nM,12,CHEMBL284,7.920818754,DPPIV,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)[C@H](N)C(F)=C3CCCC3)n2)c(Cl)c1,CS(=O)(=O)c1ccc(-c2noc(C(CC3CC3)C(N)C(F)=C3CCCC3)n2)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588809,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,CS(=O)(=O)c1ccc([C@H]2NO[C@H]([C@@H](CC3CC3)[C@H](N)C(=O)N3CC[C@H](F)C3)N2)c(F)c1,CHEMBL1230015,nM,19,CHEMBL284,7.721246399,DPPIV,CS(=O)(=O)c1ccc([C@H]2NO[C@H](C(CC3CC3)C(N)C(=O)N3CC[C@H](F)C3)N2)c(F)c1,CS(=O)(=O)c1ccc(C2NOC(C(CC3CC3)C(N)C(=O)N3CCC(F)C3)N2)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588810,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12C[C@H]3C[C@@H](C1)C[C@](O)(C3)C2,CHEMBL2298396,nM,23,CHEMBL284,7.638272164,DPPIV,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C(N)C12C[C@H]3C[C@@H](C1)C[C@](O)(C3)C2,N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588814,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,CHEMBL1186902,nM,223,CHEMBL284,6.651695137,DPPIV,N[C@@H](CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCCN(C(=O)c2ccc(C(=O)O)cc2)CC1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588816,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL1194345,nM,67,CHEMBL284,7.173925197,DPPIV,N[C@H]1Cn2c(nc3cnccc32)C[C@@H]1c1cc(F)c(F)cc1F,NC1Cn2c(nc3cnccc32)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588817,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CHEMBL1197118,nM,42,CHEMBL284,7.37675071,DPPIV,CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1,CS(=O)(=O)c1ccc2c(c1)nc1n2CC(N)C(c2cc(F)c(F)cc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588820,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cccc(CF)c3)CN1CC2,CHEMBL1229820,nM,0.5,CHEMBL284,9.301029996,DPPIV,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](c3cccc(CF)c3)CN1CC2,COc1cc2c(cc1OC)C1CC(N)C(c3cccc(CF)c3)CN1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588821,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,Nc1nc(Cl)c2nc[nH]c2n1,CHEMBL226396,nM,5,CHEMBL284,8.301029996,DPPIV,N=c1nc(Cl)c2[nH]cnc2[nH]1,N=c1nc(Cl)c2[nH]cnc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588822,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,OCCC(CCO)C(CO)(CO)CO,CHEMBL1236897,nM,2000,CHEMBL284,5.698970004,DPPIV,OCCC(CCO)C(CO)(CO)CO,OCCC(CCO)C(CO)(CO)CO,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12588823,CHEMBL3074800,Inhibition of dipeptidyl peptidase 4 (unknown origin),B,O=C(O)c1c(Cl)ccc(Cl)c1O,CHEMBL1233461,nM,7,CHEMBL284,8.15490196,DPPIV,O=C(O)c1c(Cl)ccc(Cl)c1O,O=C(O)c1c(Cl)ccc(Cl)c1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12667692,CHEMBL2346132,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay,B,CC(C)[C@H](NC(=O)c1cccnc1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL2333024,nM,100000,CHEMBL284,4,DPPIV,CC(C)C(NC(=O)c1cccnc1)C(=O)N1CCC[C@H]1B(O)O,CC(C)C(NC(=O)c1cccnc1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12667693,CHEMBL2346132,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay,B,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1cccnc1,CHEMBL2333023,nM,1800,CHEMBL284,5.744727495,DPPIV,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1cccnc1,O=C(NCC(=O)N1CCCC1B(O)O)c1cccnc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12667695,CHEMBL2346132,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay,B,C[C@@H](NC(=O)c1ccncc1)C(=O)N1CCC[C@H]1B(O)O,CHEMBL2333026,nM,100000,CHEMBL284,4,DPPIV,CC(NC(=O)c1ccncc1)C(=O)N1CCC[C@H]1B(O)O,CC(NC(=O)c1ccncc1)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12667696,CHEMBL2346132,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 10 mins prior to substrate addition by fluorescence assay,B,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1ccncc1,CHEMBL2333025,nM,2800,CHEMBL284,5.552841969,DPPIV,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1ccncc1,O=C(NCC(=O)N1CCCC1B(O)O)c1ccncc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718706,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(C)c2c1=O,CHEMBL2346919,nM,211.9,CHEMBL284,6.673869043,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(C)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(C)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718718,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3nc(C)c4ccccc4n3)c2c1=O,CHEMBL2347039,nM,1.55,CHEMBL284,8.809668302,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3nc(C)c4ccccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3nc(C)c4ccccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718719,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3nc4ccccc4nc3C)c2c1=O,CHEMBL2347038,nM,15.5,CHEMBL284,7.809668302,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3nc4ccccc4nc3C)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3nc4ccccc4nc3C)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718720,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3cnc4ccccc4n3)c2c1=O,CHEMBL2347037,nM,5.93,CHEMBL284,8.226945307,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3cnc4ccccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3cnc4ccccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718721,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4ccc(F)cc4n3)c2c1=O,CHEMBL2347036,nM,4.67,CHEMBL284,8.330683119,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4ccc(F)cc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4ccc(F)cc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718722,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4ccc(Cl)cc4n3)c2c1=O,CHEMBL2347035,nM,11.4,CHEMBL284,7.943095149,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4ccc(Cl)cc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4ccc(Cl)cc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718723,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(C)ccc4n3)c2c1=O,CHEMBL2346930,nM,52.6,CHEMBL284,7.279014256,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(C)ccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4cc(C)ccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718724,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(F)ccc4n3)c2c1=O,CHEMBL2346929,nM,14.5,CHEMBL284,7.838631998,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(F)ccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4cc(F)ccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718725,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(Cl)ccc4n3)c2c1=O,CHEMBL2346928,nM,60.1,CHEMBL284,7.221125528,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(Cl)ccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4cc(Cl)ccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718726,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(Br)ccc4n3)c2c1=O,CHEMBL2346927,nM,139.2,CHEMBL284,6.856360765,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4cc(Br)ccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4cc(Br)ccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718727,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4ccccc4n3)c2c1=O,CHEMBL2346926,nM,7.05,CHEMBL284,8.151810883,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccc4ccccc4n3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccc4ccccc4n3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718728,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccnc4ccccc34)c2c1=O,CHEMBL2346925,nM,48.2,CHEMBL284,7.316952962,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ccnc4ccccc34)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ccnc4ccccc34)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718729,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3nc4ccccc4[nH]3)c2c1=O,CHEMBL2346924,nM,27.6,CHEMBL284,7.559090918,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3nc4ccccc4[nH]3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3nc4ccccc4[nH]3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718730,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3c[nH]c4ccccc34)c2c1=O,CHEMBL2346923,nM,44.1,CHEMBL284,7.355561411,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3c[nH]c4ccccc34)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3c[nH]c4ccccc34)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718731,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ncccn3)c2c1=O,CHEMBL2346922,nM,44,CHEMBL284,7.356547324,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3ncccn3)c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2ccn(Cc3ncccn3)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718732,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2cc[nH]c2c1=O,CHEMBL2346921,nM,460,CHEMBL284,6.337242168,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2cc[nH]c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2cc[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
12718733,CHEMBL2353262,Inhibition of human DPP4 using Gly-Pro-AMC as substrate treated with enzyme 10 mins prior to substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,CHEMBL2346920,nM,860,CHEMBL284,6.065501549,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,CC#CCn1c(N2CCCC(N)C2)nc2c(Br)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322354,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2cccnc12,CHEMBL2385280,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2cccnc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2cccnc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322355,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2ccncc12,CHEMBL2385279,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2ccncc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2ccncc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322356,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2cnccc12,CHEMBL2385278,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2cnccc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2cnccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322357,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2ncccc12,CHEMBL2385277,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cccc2ncccc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2ncccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322358,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cncc2ccccc12,CHEMBL2385276,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cncc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1cncc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322359,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2c(Br)cccc12,CHEMBL2385275,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2c(Br)cccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2c(Br)cccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322360,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2c(Cl)cccc12,CHEMBL2385274,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2c(Cl)cccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2c(Cl)cccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322361,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(Br)ccc12,CHEMBL2385273,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(Br)ccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cc(Br)ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322362,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(Cl)ccc12,CHEMBL2385272,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(Cl)ccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cc(Cl)ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322363,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,COc1ccc2nccc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c2c1,CHEMBL2385271,nM,100000,CHEMBL284,4,DPPIV,COc1ccc2nccc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c2c1,COc1ccc2nccc(C(=O)NCC(=O)N3CCCC3C#N)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322364,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccc(F)cc12,CHEMBL2385270,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccc(F)cc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccc(F)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322365,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccc(OC(F)(F)F)cc12,CHEMBL2385302,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccc(OC(F)(F)F)cc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccc(OC(F)(F)F)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322366,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccc(Cl)cc12,CHEMBL2385301,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccc(Cl)cc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccc(Cl)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322367,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cccc(Br)c12,CHEMBL2385300,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cccc(Br)c12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cccc(Br)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322368,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cccc(Cl)c12,CHEMBL2385299,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cccc(Cl)c12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cccc(Cl)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322369,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c(O)cnc2ccccc12,CHEMBL2385298,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c(O)cnc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1c(O)cnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322370,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c2c(nc3ccccc13)CCCC2,CHEMBL2385297,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c2c(nc3ccccc13)CCCC2,N#CC1CCCN1C(=O)CNC(=O)c1c2c(nc3ccccc13)CCCC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322371,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,COc1ccc(-c2cc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c3ccccc3n2)cc1,CHEMBL2385296,nM,100000,CHEMBL284,4,DPPIV,COc1ccc(-c2cc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c3ccccc3n2)cc1,COc1ccc(-c2cc(C(=O)NCC(=O)N3CCCC3C#N)c3ccccc3n2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322372,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cc(O)nc2ccccc12,CHEMBL2385295,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cc(=O)[nH]c2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1cc(=O)[nH]c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322373,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,Cc1nc2ccccc2c(C(=O)NCC(=O)N2CCC[C@H]2C#N)c1O,CHEMBL2385294,nM,100000,CHEMBL284,4,DPPIV,Cc1nc2ccccc2c(C(=O)NCC(=O)N2CCC[C@H]2C#N)c1O,Cc1nc2ccccc2c(C(=O)NCC(=O)N2CCCC2C#N)c1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322374,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,Cc1cc(C(=O)NCC(=O)N2CCC[C@H]2C#N)c2ccccc2n1,CHEMBL2385293,nM,100000,CHEMBL284,4,DPPIV,Cc1cc(C(=O)NCC(=O)N2CCC[C@H]2C#N)c2ccccc2n1,Cc1cc(C(=O)NCC(=O)N2CCCC2C#N)c2ccccc2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322375,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CN1Cc2ccccc2C1=O,CHEMBL2385292,nM,10000,CHEMBL284,5,DPPIV,N#C[C@@H]1CCCN1C(=O)CN1Cc2ccccc2C1=O,N#CC1CCCN1C(=O)CN1Cc2ccccc2C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322376,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)C12CC3CC(CC(O)(C3)C1)C2,CHEMBL2385291,nM,10000,CHEMBL284,5,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)C12CC3CC(CC(O)(C3)C1)C2,N#CC1CCCN1C(=O)CNC(=O)C12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322377,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#Cc1ccc(NCC(=O)NCC(=O)N2CCC[C@H]2C#N)nc1,CHEMBL2385290,nM,100000,CHEMBL284,4,DPPIV,N#Cc1ccc(=NCC(=O)NCC(=O)N2CCC[C@H]2C#N)[nH]c1,N#Cc1ccc(=NCC(=O)NCC(=O)N2CCCC2C#N)[nH]c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322378,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNS(=O)(=O)c1cccc2ccccc12,CHEMBL2385289,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNS(=O)(=O)c1cccc2ccccc12,N#CC1CCCN1C(=O)CNS(=O)(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322379,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)COc1ccc2ccccc2c1,CHEMBL2385288,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)COc1ccc2ccccc2c1,N#CC1CCCN1C(=O)COc1ccc2ccccc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322380,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)COc1cccc2ccccc12,CHEMBL2385287,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)COc1cccc2ccccc12,N#CC1CCCN1C(=O)COc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322381,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1cccc2ccccc12,CHEMBL2385286,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1cccc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)Cc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322382,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)COc1cccc2ccccc12,CHEMBL2385285,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)COc1cccc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)COc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322383,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)COc1ccc2ccccc2c1,CHEMBL2385284,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)COc1ccc2ccccc2c1,N#CC1CCCN1C(=O)CNC(=O)COc1ccc2ccccc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322384,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cc2ccccc2[nH]1,CHEMBL2385283,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cc2ccccc2[nH]1,N#CC1CCCN1C(=O)CNC(=O)c1cc2ccccc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322385,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c[nH]c2ccccc12,CHEMBL2385282,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c[nH]c2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1c[nH]c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13322386,CHEMBL2389862,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL2385281,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394513,CHEMBL2410616,Inhibition of human DPP4,B,CC(C)=CCn1c(OCC(C)(C)CN)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408638,nM,120,CHEMBL284,6.920818754,DPPIV,CC(C)=CCn1c(OCC(C)(C)CN)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OCC(C)(C)CN)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394515,CHEMBL2410616,Inhibition of human DPP4,B,CC(C)=CCn1c(N2CCC3CNCC32)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408655,nM,9,CHEMBL284,8.045757491,DPPIV,CC(C)=CCn1c(N2CCC3CNCC32)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCC3CNCC32)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394528,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(OCC(C)(C)N)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408639,nM,2500,CHEMBL284,5.602059991,DPPIV,CC(C)=CCn1c(OCC(C)(C)N)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OCC(C)(C)N)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394530,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(OC[C@@H]2CCCN2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408651,nM,290,CHEMBL284,6.537602002,DPPIV,CC(C)=CCn1c(OC[C@@H]2CCCN2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OCC2CCCN2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394531,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(OC[C@H]2CCCN2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408649,nM,5000,CHEMBL284,5.301029996,DPPIV,CC(C)=CCn1c(OC[C@H]2CCCN2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OCC2CCCN2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394532,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(O[C@@H]2CCNC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408646,nM,910,CHEMBL284,6.040958608,DPPIV,CC(C)=CCn1c(O[C@@H]2CCNC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OC2CCNC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394533,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(O[C@H]2CCNC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408644,nM,715,CHEMBL284,6.145693958,DPPIV,CC(C)=CCn1c(O[C@H]2CCNC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OC2CCNC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394534,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(OC2CCNCC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408643,nM,1000,CHEMBL284,6,DPPIV,CC(C)=CCn1c(OC2CCNCC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(OC2CCNCC2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394535,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(N2CCC3CNCC32)nc2c1c(=O)n(C)c(=O)n2C,CHEMBL2408642,nM,100,CHEMBL284,7,DPPIV,CC(C)=CCn1c(N2CCC3CNCC32)nc2c1c(=O)n(C)c(=O)n2C,CC(C)=CCn1c(N2CCC3CNCC32)nc2c1c(=O)n(C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394536,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(N2CC3CCNC3C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408774,nM,645,CHEMBL284,6.190440285,DPPIV,CC(C)=CCn1c(N2CC3CCNC3C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CC3CCNC3C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13394537,CHEMBL2410618,Inhibition of human DPP4 using H-Gly-Pro-AMC as substrate by fluorescence assay,B,CC(C)=CCn1c(N2CC3CCCNC3C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL2408771,nM,1.6,CHEMBL284,8.795880017,DPPIV,CC(C)=CCn1c(N2CC3CCCNC3C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CC3CCCNC3C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421613,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,COc1ccc(Cn2cc(-c3ccc(C[C@H](N)C(=O)N4CCC[C@H]4C#N)cc3)nn2)cc1OC.Cl,CHEMBL2418634,nM,15.7,CHEMBL284,7.804100348,DPPIV,COc1ccc(Cn2cc(-c3ccc(CC(N)C(=O)N4CCC[C@H]4C#N)cc3)nn2)cc1OC,COc1ccc(Cn2cc(-c3ccc(CC(N)C(=O)N4CCCC4C#N)cc3)nn2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421614,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccc(Cl)c(Cl)c3)nn2)cc1,CHEMBL2418633,nM,10.02,CHEMBL284,7.999132278,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(Cl)c(Cl)c3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(Cl)c(Cl)c3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421615,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccc(F)c(F)c3)nn2)cc1,CHEMBL2418632,nM,8.57,CHEMBL284,8.067019178,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(F)c(F)c3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(F)c(F)c3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421616,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,COc1ccc(Cn2cc(-c3ccc(C[C@H](N)C(=O)N4CCC[C@H]4C#N)cc3)nn2)cc1.Cl,CHEMBL2418631,nM,4.35,CHEMBL284,8.361510743,DPPIV,COc1ccc(Cn2cc(-c3ccc(CC(N)C(=O)N4CCC[C@H]4C#N)cc3)nn2)cc1,COc1ccc(Cn2cc(-c3ccc(CC(N)C(=O)N4CCCC4C#N)cc3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421617,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,COc1cccc(Cn2cc(-c3ccc(C[C@H](N)C(=O)N4CCC[C@H]4C#N)cc3)nn2)c1.Cl,CHEMBL2418630,nM,7.5,CHEMBL284,8.124938737,DPPIV,COc1cccc(Cn2cc(-c3ccc(CC(N)C(=O)N4CCC[C@H]4C#N)cc3)nn2)c1,COc1cccc(Cn2cc(-c3ccc(CC(N)C(=O)N4CCCC4C#N)cc3)nn2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421618,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,COc1ccccc1Cn1cc(-c2ccc(C[C@H](N)C(=O)N3CCC[C@H]3C#N)cc2)nn1.Cl,CHEMBL2418629,nM,20.84,CHEMBL284,7.681102285,DPPIV,COc1ccccc1Cn1cc(-c2ccc(CC(N)C(=O)N3CCC[C@H]3C#N)cc2)nn1,COc1ccccc1Cn1cc(-c2ccc(CC(N)C(=O)N3CCCC3C#N)cc2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421619,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccc(Cl)cc3)nn2)cc1,CHEMBL2418628,nM,6.05,CHEMBL284,8.218244625,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(Cl)cc3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(Cl)cc3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421620,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3cccc(Cl)c3)nn2)cc1,CHEMBL2417563,nM,10.45,CHEMBL284,7.98088371,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3cccc(Cl)c3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3cccc(Cl)c3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421621,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccccc3Cl)nn2)cc1,CHEMBL2418627,nM,15.24,CHEMBL284,7.817015033,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccccc3Cl)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccccc3Cl)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421622,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccc(F)cc3)nn2)cc1,CHEMBL2418626,nM,3.79,CHEMBL284,8.42136079,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(F)cc3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccc(F)cc3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421623,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3cccc(F)c3)nn2)cc1,CHEMBL2418625,nM,7.56,CHEMBL284,8.121478204,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3cccc(F)c3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3cccc(F)c3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421624,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccccc3F)nn2)cc1,CHEMBL2418624,nM,19.54,CHEMBL284,7.709075441,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccccc3F)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccccc3F)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421625,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3cccs3)nn2)cc1,CHEMBL2418639,nM,8.28,CHEMBL284,8.081969663,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3cccs3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3cccs3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421626,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccncc3)nn2)cc1,CHEMBL2418638,nM,17.61,CHEMBL284,7.754240644,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccncc3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccncc3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421627,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(CCc3ccccc3)nn2)cc1,CHEMBL2418637,nM,25.5,CHEMBL284,7.59345982,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(CCc3ccccc3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(CCc3ccccc3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421628,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(Cc3ccccc3)nn2)cc1,CHEMBL2418636,nM,9.39,CHEMBL284,8.027334408,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccccc3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(Cc3ccccc3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13421629,CHEMBL2424445,Inhibition of human purified His-tagged DPP-4 assessed as cleavage of substrate using Gly-Pro-AMC chromogenic substrate after 60 mins by fluorescence spectrophotometry,B,Cl.Cn1cc(-c2ccc(C[C@H](N)C(=O)N3CCC[C@H]3C#N)cc2)nn1,CHEMBL2418635,nM,265,CHEMBL284,6.576754126,DPPIV,Cn1cc(-c2ccc(CC(N)C(=O)N3CCC[C@H]3C#N)cc2)nn1,Cn1cc(-c2ccc(CC(N)C(=O)N3CCCC3C#N)cc2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441650,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2)c1=O,CHEMBL2425883,nM,10000,CHEMBL284,5,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccccc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441651,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(CC#CC)c1=O,CHEMBL2425882,nM,2177.5,CHEMBL284,5.662041836,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(CC#CC)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(CC#CC)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441652,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(C)c1=O,CHEMBL2424672,nM,198,CHEMBL284,6.70333481,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(C)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441696,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3c(ccc4ccccc43)n2)c1=O,CHEMBL2425887,nM,31.3,CHEMBL284,7.504455662,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3c(ccc4ccccc43)n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3c(ccc4ccccc43)n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441698,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2nc3ccccc3[nH]2)c1=O,CHEMBL2425885,nM,22,CHEMBL284,7.657577319,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2nc3ccccc3[nH]2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2nc3ccccc3[nH]2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441701,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(Br)ccc3n2)c1=O,CHEMBL2425888,nM,10.8,CHEMBL284,7.966576245,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(Br)ccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3cc(Br)ccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441702,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(C)ccc3n2)c1=O,CHEMBL2425891,nM,9.1,CHEMBL284,8.040958608,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(C)ccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3cc(C)ccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441704,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(Cl)ccc3n2)c1=O,CHEMBL2425889,nM,6.6,CHEMBL284,8.180456064,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(Cl)ccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3cc(Cl)ccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441708,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ncccn2)c1=O,CHEMBL2425884,nM,3.4,CHEMBL284,8.468521083,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ncccn2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ncccn2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441709,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccccc3n2)c1=O,CHEMBL2425886,nM,3.1,CHEMBL284,8.508638306,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3ccccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441711,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(F)ccc3n2)c1=O,CHEMBL2425890,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(F)ccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3cc(F)ccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441712,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(OC)ccc3n2)c1=O,CHEMBL2425892,nM,1.9,CHEMBL284,8.721246399,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3cc(OC)ccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3cc(OC)ccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441714,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Cl)c3ccccc3n2)c1=O,CHEMBL2425895,nM,1.2,CHEMBL284,8.920818754,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Cl)c3ccccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(Cl)c3ccccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441717,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccc(F)cc3n2)c1=O,CHEMBL2425894,nM,0.7,CHEMBL284,9.15490196,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccc(F)cc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3ccc(F)cc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13441719,CHEMBL2429190,Inhibition of human DPP-4 using Gly-pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccc(Cl)cc3n2)c1=O,CHEMBL2425893,nM,0.4,CHEMBL284,9.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc3ccc(Cl)cc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc3ccc(Cl)cc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452829,CHEMBL2429421,Inhibition of human DPP4,B,N[C@@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425082,nM,100000,CHEMBL284,4,DPPIV,N[C@@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452838,CHEMBL2429421,Inhibition of human DPP4,B,N[C@@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@H]1c1cc(F)ccc1F,CHEMBL2425078,nM,38000,CHEMBL284,4.420216403,DPPIV,N[C@@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452841,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@H](N2Cc3cn[nH]c3C2)CO[C@H]1c1cc(F)ccc1F,CHEMBL2425080,nM,26600,CHEMBL284,4.575118363,DPPIV,N[C@H]1C[C@H](N2Cc3c[nH]nc3C2)CO[C@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452842,CHEMBL2429421,Inhibition of human DPP4,B,N[C@@H]1C[C@H](N2Cc3cn[nH]c3C2)CO[C@H]1c1cc(F)ccc1F,CHEMBL2425077,nM,24400,CHEMBL284,4.612610174,DPPIV,N[C@@H]1C[C@H](N2Cc3c[nH]nc3C2)CO[C@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452847,CHEMBL2429421,Inhibition of human DPP4,B,N[C@@H]1C[C@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425081,nM,13100,CHEMBL284,4.882728704,DPPIV,N[C@@H]1C[C@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452848,CHEMBL2429421,Inhibition of human DPP4,B,CC1(C)c2cnc(C3CC3)nc2CN1[C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CHEMBL2425065,nM,12600,CHEMBL284,4.899629455,DPPIV,CC1(C)c2cnc(C3CC3)nc2CN1[C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CC1(C)c2cnc(C3CC3)nc2CN1C1COC(c2cc(F)ccc2F)C(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452852,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@H]1c1cc(F)ccc1F,CHEMBL2425079,nM,2800,CHEMBL284,5.552841969,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452853,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3ccccc3C2=O)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425066,nM,720,CHEMBL284,6.142667504,DPPIV,N[C@H]1C[C@@H](N2Cc3ccccc3C2=O)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3ccccc3C2=O)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452857,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](n2cc3cnc(C4CC4)nc3c2)CO[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2425062,nM,140,CHEMBL284,6.853871964,DPPIV,N[C@H]1C[C@@H](n2cc3cnc(C4CC4)nc3c2)CO[C@@H]1c1cc(F)c(F)cc1F,NC1CC(n2cc3cnc(C4CC4)nc3c2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452858,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3ccccc3O2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425067,nM,125,CHEMBL284,6.903089987,DPPIV,N[C@H]1C[C@@H](N2Cc3ccccc3O2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3ccccc3O2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452863,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1ccccc1Cl,CHEMBL2425071,nM,64,CHEMBL284,7.193820026,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1ccccc1Cl,NC1CC(N2Cc3c[nH]nc3C2)COC1c1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452864,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425076,nM,56,CHEMBL284,7.251811973,DPPIV,N[C@H]1C[C@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452867,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)c(Cl)cc1F,CHEMBL2425073,nM,48,CHEMBL284,7.318758763,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)c(Cl)cc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)c(Cl)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452869,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)ccc1Cl,CHEMBL2425074,nM,37,CHEMBL284,7.431798276,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)ccc1Cl,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452870,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425063,nM,37,CHEMBL284,7.431798276,DPPIV,N[C@H]1C[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2CCn3c(nnc3C(F)(F)F)C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452874,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1ccc(F)cc1F,CHEMBL2425072,nM,27,CHEMBL284,7.568636236,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1ccc(F)cc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1ccc(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452875,CHEMBL2429421,Inhibition of human DPP4,B,CC1(C)c2nc(C3CC3)ncc2CN1[C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CHEMBL2425064,nM,27,CHEMBL284,7.568636236,DPPIV,CC1(C)c2nc(C3CC3)ncc2CN1[C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CC1(C)c2nc(C3CC3)ncc2CN1C1COC(c2cc(F)ccc2F)C(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452879,CHEMBL2429421,Inhibition of human DPP4,B,Cc1nc2c(o1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL2425068,nM,11,CHEMBL284,7.958607315,DPPIV,Cc1nc2c(o1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,Cc1nc2c(o1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452896,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nc(C(F)(F)F)[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425069,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](N2Cc3nc(C(F)(F)F)[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3nc(C(F)(F)F)[nH]c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452898,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL2425070,nM,1.4,CHEMBL284,8.853871964,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452899,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2425060,nM,1.3,CHEMBL284,8.886056648,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnc(C(F)(F)F)nc3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452901,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CO[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2425075,nM,1,CHEMBL284,9,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3c[nH]nc3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452903,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2425061,nM,0.66,CHEMBL284,9.180456064,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CO[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnc(C4CC4)nc3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13452905,CHEMBL2429421,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL2425059,nM,0.5,CHEMBL284,9.301029996,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnc(C(F)(F)F)nc3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856207,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1cccc(C(F)(F)F)c1,CHEMBL3093901,nM,209,CHEMBL284,6.679853714,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1cccc(C(F)(F)F)c1,N#CC1CCCN1C(=O)C(N)Cc1cccc(C(F)(F)F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856215,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#Cc1cccc(C[C@H](N)C(=O)N2CCC[C@H]2C#N)c1,CHEMBL3093900,nM,63,CHEMBL284,7.200659451,DPPIV,N#Cc1cccc(CC(N)C(=O)N2CCC[C@H]2C#N)c1,N#Cc1cccc(CC(N)C(=O)N2CCCC2C#N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856222,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1C(F)(F)F,CHEMBL3093899,nM,46,CHEMBL284,7.337242168,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccccc1C(F)(F)F,N#CC1CCCN1C(=O)C(N)Cc1ccccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856229,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#Cc1ccccc1C[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL3093898,nM,27,CHEMBL284,7.568636236,DPPIV,N#Cc1ccccc1CC(N)C(=O)N1CCC[C@H]1C#N,N#Cc1ccccc1CC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856236,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,Cc1ccccc1C[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL3093897,nM,42,CHEMBL284,7.37675071,DPPIV,Cc1ccccc1CC(N)C(=O)N1CCC[C@H]1C#N,Cc1ccccc1CC(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856244,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2ccccc2)cc1,CHEMBL200347,nM,145,CHEMBL284,6.838631998,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2ccccc2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2ccccc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856251,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(Br)cc1,CHEMBL3093896,nM,4,CHEMBL284,8.397940009,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(Br)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(Br)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856258,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(Cl)cc1,CHEMBL3093925,nM,4,CHEMBL284,8.397940009,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(Cl)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856265,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(C(F)(F)F)cc1,CHEMBL3093924,nM,31,CHEMBL284,7.508638306,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(C(F)(F)F)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856273,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#Cc1ccc(C[C@H](N)C(=O)N2CCC[C@H]2C#N)cc1,CHEMBL3093923,nM,21,CHEMBL284,7.677780705,DPPIV,N#Cc1ccc(CC(N)C(=O)N2CCC[C@H]2C#N)cc1,N#Cc1ccc(CC(N)C(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856279,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1,CHEMBL3093922,nM,20,CHEMBL284,7.698970004,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc([N+](=O)[O-])cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc([N+](=O)[O-])cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856285,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(N)cc1,CHEMBL3093921,nM,75,CHEMBL284,7.124938737,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(N)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856292,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,COc1ccc(C[C@H](N)C(=O)N2CCC[C@H]2C#N)cc1,CHEMBL3093920,nM,29,CHEMBL284,7.537602002,DPPIV,COc1ccc(CC(N)C(=O)N2CCC[C@H]2C#N)cc1,COc1ccc(CC(N)C(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856299,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,Cc1ccc(C[C@H](N)C(=O)N2CCC[C@H]2C#N)cc1,CHEMBL3093919,nM,17,CHEMBL284,7.769551079,DPPIV,Cc1ccc(CC(N)C(=O)N2CCC[C@H]2C#N)cc1,Cc1ccc(CC(N)C(=O)N2CCCC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856306,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(F)cc1,CHEMBL3093918,nM,11,CHEMBL284,7.958607315,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(F)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856312,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1cccc(F)c1,CHEMBL3093917,nM,248,CHEMBL284,6.605548319,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1cccc(F)c1,N#CC1CCCN1C(=O)C(N)Cc1cccc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856319,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1F,CHEMBL3093916,nM,18,CHEMBL284,7.744727495,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccccc1F,N#CC1CCCN1C(=O)C(N)Cc1ccccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856325,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1,CHEMBL201268,nM,27,CHEMBL284,7.568636236,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccccc1,N#CC1CCCN1C(=O)C(N)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856332,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cc(F)cc(F)c1F,CHEMBL3093915,nM,60,CHEMBL284,7.22184875,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1cc(F)cc(F)c1F,N#CC1CC(F)CN1C(=O)C(N)Cc1cc(F)cc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856339,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccc(F)c(F)c1F,CHEMBL3091488,nM,23,CHEMBL284,7.638272164,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccc(F)c(F)c1F,N#CC1CC(F)CN1C(=O)C(N)Cc1ccc(F)c(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856346,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3093914,nM,17,CHEMBL284,7.769551079,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1cc(F)c(F)cc1F,N#CC1CC(F)CN1C(=O)C(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856353,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccc(F)cc1F,CHEMBL3093913,nM,6,CHEMBL284,8.22184875,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccc(F)cc1F,N#CC1CC(F)CN1C(=O)C(N)Cc1ccc(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856360,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccccc1C(F)(F)F,CHEMBL3093912,nM,20,CHEMBL284,7.698970004,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccccc1C(F)(F)F,N#CC1CC(F)CN1C(=O)C(N)Cc1ccccc1C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856367,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#Cc1ccccc1C[C@H](N)C(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL3093911,nM,22,CHEMBL284,7.657577319,DPPIV,N#Cc1ccccc1CC(N)C(=O)N1C[C@@H](F)C[C@H]1C#N,N#Cc1ccccc1CC(N)C(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856374,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccc(OCc2ccccc2)cc1,CHEMBL3093910,nM,94,CHEMBL284,7.026872146,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccc(OCc2ccccc2)cc1,N#CC1CC(F)CN1C(=O)C(N)Cc1ccc(OCc2ccccc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856381,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,CC(C)(C)c1ccc(C[C@H](N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL3093909,nM,125,CHEMBL284,6.903089987,DPPIV,CC(C)(C)c1ccc(CC(N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CC(C)(C)c1ccc(CC(N)C(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856387,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccc(C(F)(F)F)cc1,CHEMBL3093908,nM,6,CHEMBL284,8.22184875,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccc(C(F)(F)F)cc1,N#CC1CC(F)CN1C(=O)C(N)Cc1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856394,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#Cc1ccc(C[C@H](N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL3093907,nM,5,CHEMBL284,8.301029996,DPPIV,N#Cc1ccc(CC(N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,N#Cc1ccc(CC(N)C(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856401,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1,CHEMBL3093906,nM,292,CHEMBL284,6.534617149,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccc([N+](=O)[O-])cc1,N#CC1CC(F)CN1C(=O)C(N)Cc1ccc([N+](=O)[O-])cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856408,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,COc1ccc(C[C@H](N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL3093905,nM,15,CHEMBL284,7.823908741,DPPIV,COc1ccc(CC(N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,COc1ccc(CC(N)C(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856415,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,Cc1ccc(C[C@H](N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL3093904,nM,4,CHEMBL284,8.397940009,DPPIV,Cc1ccc(CC(N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,Cc1ccc(CC(N)C(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856422,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccc(F)cc1,CHEMBL3093903,nM,3,CHEMBL284,8.522878745,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccc(F)cc1,N#CC1CC(F)CN1C(=O)C(N)Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13856471,CHEMBL3096171,Inhibition of 6xHis-tagged recombinant human DPP4 expressed in baculovirus expression system assessed as hydrolysis of Ala-Pro-aminomethylcoumarin by fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1ccccc1,CHEMBL3093902,nM,17,CHEMBL284,7.769551079,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1ccccc1,N#CC1CC(F)CN1C(=O)C(N)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903876,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,CO[C@H]1CC[C@](CN)(c2ccccc2)CC1,CHEMBL3112963,nM,60000,CHEMBL284,4.22184875,DPPIV,CO[C@H]1CC[C@](CN)(c2ccccc2)CC1,COC1CCC(CN)(c2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903888,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2ccccc2)CC[C@H](OCc2ccccc2)CC1,CHEMBL3112962,nM,19900,CHEMBL284,4.701146924,DPPIV,NC[C@]1(c2ccccc2)CC[C@H](OCc2ccccc2)CC1,NCC1(c2ccccc2)CCC(OCc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903892,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,CO[C@H]1CC[C@](CN)(c2cc(F)c(F)cc2F)CC1,CHEMBL3112965,nM,15700,CHEMBL284,4.804100348,DPPIV,CO[C@H]1CC[C@](CN)(c2cc(F)c(F)cc2F)CC1,COC1CCC(CN)(c2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903897,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2ccccc2)CC[C@H](OC/C=C/c2ccccc2)CC1,CHEMBL3112961,nM,11900,CHEMBL284,4.924453039,DPPIV,NC[C@]1(c2ccccc2)CC[C@H](OC/C=C/c2ccccc2)CC1,NCC1(c2ccccc2)CCC(OCC=Cc2ccccc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903910,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,CO[C@H]1CC[C@](CN)(c2cccc(Cl)c2)CC1,CHEMBL3112964,nM,4200,CHEMBL284,5.37675071,DPPIV,CO[C@H]1CC[C@](CN)(c2cccc(Cl)c2)CC1,COC1CCC(CN)(c2cccc(Cl)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903922,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCCCC2)CC1,CHEMBL3112969,nM,250,CHEMBL284,6.602059991,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCCCC2)CC1,NCC1(c2cccc(Cl)c2)CCC(N2CCCCC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903923,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2ncccc2=O)CC1,CHEMBL3112957,nM,200,CHEMBL284,6.698970004,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2ncccc2=O)CC1,NCC1(c2cccc(Cl)c2)CCC(n2ncccc2=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903924,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,Cc1ccc(=O)n([C@H]2CC[C@](CN)(c3cccc(Cl)c3)CC2)n1,CHEMBL3112958,nM,40,CHEMBL284,7.397940009,DPPIV,Cc1ccc(=O)n([C@H]2CC[C@](CN)(c3cccc(Cl)c3)CC2)n1,Cc1ccc(=O)n(C2CCC(CN)(c3cccc(Cl)c3)CC2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903925,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2)CC1,CHEMBL3112970,nM,40,CHEMBL284,7.397940009,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2)CC1,NCC1(c2cccc(Cl)c2)CCC(N2CCn3c(nnc3C(F)(F)F)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903926,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCCCC2=O)CC1,CHEMBL3112966,nM,20,CHEMBL284,7.698970004,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCCCC2=O)CC1,NCC1(c2cccc(Cl)c2)CCC(N2CCCCC2=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903929,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCc3c(nc(C(F)(F)F)nc3C3CC3)C2)CC1,CHEMBL3112971,nM,9,CHEMBL284,8.045757491,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCc3c(nc(C(F)(F)F)nc3C3CC3)C2)CC1,NCC1(c2cccc(Cl)c2)CCC(N2CCc3c(nc(C(F)(F)F)nc3C3CC3)C2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903930,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2=O)CC1,CHEMBL3112967,nM,7,CHEMBL284,8.15490196,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCn3c(nnc3C(F)(F)F)C2=O)CC1,NCC1(c2cccc(Cl)c2)CCC(N2CCn3c(nnc3C(F)(F)F)C2=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903932,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2nc(-c3cccnc3)ccc2=O)CC1,CHEMBL3112960,nM,4,CHEMBL284,8.397940009,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2nc(-c3cccnc3)ccc2=O)CC1,NCC1(c2cccc(Cl)c2)CCC(n2nc(-c3cccnc3)ccc2=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903933,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2nc(-c3ccccc3)ccc2=O)CC1,CHEMBL3112959,nM,3,CHEMBL284,8.522878745,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2nc(-c3ccccc3)ccc2=O)CC1,NCC1(c2cccc(Cl)c2)CCC(n2nc(-c3ccccc3)ccc2=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13903934,CHEMBL3118377,Inhibition of human recombinant DPP4 (39 to 766),B,NC[C@]1(c2cccc(Cl)c2)CC[C@H](N2CCc3c(nc(C(F)(F)F)nc3C3CC3)C2=O)CC1,CHEMBL3112968,nM,2,CHEMBL284,8.698970004,DPPIV,NC[C@]1(c2cccc(Cl)c2)CC[C@H](n2ccc3c(c2=O)=NC(C(F)(F)F)NC=3C2CC2)CC1,NCC1(c2cccc(Cl)c2)CCC(n2ccc3c(c2=O)=NC(C(F)(F)F)NC=3C2CC2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13910923,CHEMBL3118414,Inhibition of human recombinant DPP-4 using H-Gly-Pro-AMC as substrate after 10 mins by fluorescence assay,B,N#C[C@@H]1C[C@H]2C[C@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,CHEMBL3114069,nM,4364,CHEMBL284,5.360115258,DPPIV,N#C[C@@H]1C[C@H]2C[C@H]2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2,N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960730,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccn1,CHEMBL3127983,nM,520,CHEMBL284,6.283996656,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccccn1,N#CC1CCCN1C(=O)C(N)Cc1ccccn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960731,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1csc(-c2ccccc2)n1,CHEMBL3127988,nM,390,CHEMBL284,6.408935393,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1csc(-c2ccccc2)n1,N#CC1CC(F)CN1C(=O)C(N)Cc1csc(-c2ccccc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960732,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1cscn1,CHEMBL3127982,nM,330,CHEMBL284,6.48148606,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1cscn1,N#CC1CCCN1C(=O)C(N)Cc1cscn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960737,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccsc1,CHEMBL3127980,nM,170,CHEMBL284,6.769551079,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccsc1,N#CC1CCCN1C(=O)C(N)Cc1ccsc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960738,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1csc(-c2cccs2)n1,CHEMBL3127991,nM,120,CHEMBL284,6.920818754,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1csc(-c2cccs2)n1,N#CC1CC(F)CN1C(=O)C(N)Cc1csc(-c2cccs2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960739,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1csc(-c2ccc(C(F)(F)F)cc2)n1,CHEMBL3127990,nM,50,CHEMBL284,7.301029996,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1csc(-c2ccc(C(F)(F)F)cc2)n1,N#CC1CC(F)CN1C(=O)C(N)Cc1csc(-c2ccc(C(F)(F)F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960740,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1csc(-c2ccc(Cl)cc2)n1,CHEMBL3127989,nM,50,CHEMBL284,7.301029996,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1csc(-c2ccc(Cl)cc2)n1,N#CC1CC(F)CN1C(=O)C(N)Cc1csc(-c2ccc(Cl)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960741,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1csc2ccccc12,CHEMBL3127985,nM,50,CHEMBL284,7.301029996,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1csc2ccccc12,N#CC1CC(F)CN1C(=O)C(N)Cc1csc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960742,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,Cc1nc(C[C@H](N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cs1,CHEMBL3127987,nM,40,CHEMBL284,7.397940009,DPPIV,Cc1nc(CC(N)C(=O)N2C[C@@H](F)C[C@H]2C#N)cs1,Cc1nc(CC(N)C(=O)N2CC(F)CC2C#N)cs1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960743,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1csc2ccccc12,CHEMBL3127981,nM,30,CHEMBL284,7.522878745,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1csc2ccccc12,N#CC1CCCN1C(=O)C(N)Cc1csc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960745,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cc2c(cc1Br)OCO2,CHEMBL3127992,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1cc2c(cc1Br)OCO2,N#CC1CC(F)CN1C(=O)C(N)Cc1cc2c(cc1Br)OCO2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960747,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cccs1,CHEMBL3127984,nM,5,CHEMBL284,8.301029996,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1cccs1,N#CC1CC(F)CN1C(=O)C(N)Cc1cccs1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
13960748,CHEMBL3128756,Inhibition of recombinant his6-tagged DPP4 (unknown origin) expressed in baculovirus expression system using Ala-pro-AMC as substrate by fluorometric analysis,B,N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)Cc1cscn1,CHEMBL3127986,nM,4,CHEMBL284,8.397940009,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C(N)Cc1cscn1,N#CC1CC(F)CN1C(=O)C(N)Cc1cscn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528200,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1cc(O)c(C(=O)/C=C/c2ccc(O)cc2)c(OC)c1,CHEMBL251958,nM,33110,CHEMBL284,4.480040819,DPPIV,COc1cc(O)c(C(=O)C=Cc2ccc(O)cc2)c(OC)c1,COc1cc(O)c(C(=O)C=Cc2ccc(O)cc2)c(OC)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528201,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,O=C(/C=C/c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)c1ccc(O)cc1O,CHEMBL599763,nM,26920,CHEMBL284,4.569924944,DPPIV,O=C(/C=C/c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)c1ccc(O)cc1O,O=C(C=Cc1ccc(OC2OC(CO)C(O)C(O)C2O)cc1)c1ccc(O)cc1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528203,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1cc(O)c2c(=O)c(O)c(-c3ccc(OC)c(O)c3)oc2c1,CHEMBL75589,nM,41690,CHEMBL284,4.379968105,DPPIV,COc1cc(O)c2c(=O)c(O)c(-c3ccc(OC)c(O)c3)oc2c1,COc1cc(O)c2c(=O)c(O)c(-c3ccc(OC)c(O)c3)oc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528204,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL164,nM,37150,CHEMBL284,4.430041182,DPPIV,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528205,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,O=C(CC(O)CCc1ccccc1)c1ccc(O)cc1,CHEMBL1724888,nM,38430,CHEMBL284,4.415329616,DPPIV,O=C(CC(O)CCc1ccccc1)c1ccc(O)cc1,O=C(CC(O)CCc1ccccc1)c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528206,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COC(=O)C1(O)CC(O)C(O)C(OC(=O)/C=C/c2ccc(O)c(O)c2)C1,CHEMBL2048503,nM,41400,CHEMBL284,4.382999659,DPPIV,COC(=O)C1(O)CC(O)C(O)C(OC(=O)C=Cc2ccc(O)c(O)c2)C1,COC(=O)C1(O)CC(O)C(O)C(OC(=O)C=Cc2ccc(O)c(O)c2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528207,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,O=C(CCCCc1ccccc1)c1ccc(O)cc1,CHEMBL3220151,nM,22390,CHEMBL284,4.649945906,DPPIV,O=C(CCCCc1ccccc1)c1ccc(O)cc1,O=C(CCCCc1ccccc1)c1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528208,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,CCOC(=O)/C=C/c1ccc(O)c(O)c1,CHEMBL17347,nM,87720,CHEMBL284,4.056901377,DPPIV,CCOC(=O)C=Cc1ccc(O)c(O)c1,CCOC(=O)C=Cc1ccc(O)c(O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528209,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,O=C(O)/C=C/c1ccc(O)cc1,CHEMBL66879,nM,83180,CHEMBL284,4.079981084,DPPIV,O=C(O)C=Cc1ccc(O)cc1,O=C(O)C=Cc1ccc(O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528210,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1cc2cc(Oc3ccc4ccc(=O)oc4c3)c(=O)oc2cc1O,CHEMBL508494,nM,87100,CHEMBL284,4.059981845,DPPIV,COc1cc2cc(Oc3ccc4ccc(=O)oc4c3)c(=O)oc2cc1O,COc1cc2cc(Oc3ccc4ccc(=O)oc4c3)c(=O)oc2cc1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528211,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,CHEMBL269277,nM,55820,CHEMBL284,4.253210168,DPPIV,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528212,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,CHEMBL400359,nM,56230,CHEMBL284,4.250031916,DPPIV,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528213,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1ccc2c(c1OC)C(O)N(C)c1c-2ccc2cc3c(cc12)OCO3,CHEMBL3220152,nM,32360,CHEMBL284,4.489991487,DPPIV,COc1ccc2c(c1OC)C(O)N(C)c1c-2ccc2cc3c(cc12)OCO3,COc1ccc2c(c1OC)C(O)N(C)c1c-2ccc2cc3c(cc12)OCO3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528214,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,CCCCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]5(C)CC[C@@H]43)C2)[C@H](O)[C@@H](O)[C@@H]1O,CHEMBL3220153,nM,16580,CHEMBL284,4.780415474,DPPIV,CCCCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]5(C)CC[C@@H]43)C2)[C@H](O)[C@@H](O)[C@@H]1O,CCCCCCCCCCCCCCCCC(=O)OCC1OC(OC2CCC3(C)C(=CCC4C3CCC3(C)C(C(C)C=CC(CC)C(C)C)CCC43)C2)C(O)C(O)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528215,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,CHEMBL221542,nM,28840,CHEMBL284,4.540004744,DPPIV,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14528216,CHEMBL3224678,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1cc([C@@H]2Oc3ccc4ccc(=O)oc4c3O[C@H]2CO)ccc1O,CHEMBL574038,nM,14130,CHEMBL284,4.849857838,DPPIV,COc1cc([C@@H]2Oc3ccc4ccc(=O)oc4c3O[C@H]2CO)ccc1O,COc1cc(C2Oc3ccc4ccc(=O)oc4c3OC2CO)ccc1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579385,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccccc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236100,nM,1436,CHEMBL284,5.84284556,DPPIV,NC[C@H]1CN(c2ccccc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccccc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579386,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,N#Cc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cc1,CHEMBL3236101,nM,378,CHEMBL284,6.4225082,DPPIV,N#Cc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cc1,N#Cc1ccc(N2CC(CN)C(c3cc(F)ccc3F)CC2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579387,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc(F)cc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236102,nM,382,CHEMBL284,6.417936637,DPPIV,NC[C@H]1CN(c2ccc(F)cc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccc(F)cc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579388,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc(C(F)(F)F)cc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236103,nM,342,CHEMBL284,6.465973894,DPPIV,NC[C@H]1CN(c2ccc(C(F)(F)F)cc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccc(C(F)(F)F)cc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579389,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,COc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cc1,CHEMBL3236104,nM,217,CHEMBL284,6.663540266,DPPIV,COc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cc1,COc1ccc(N2CC(CN)C(c3cc(F)ccc3F)CC2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579390,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,CS(=O)(=O)c1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cc1,CHEMBL3236105,nM,193,CHEMBL284,6.714442691,DPPIV,CS(=O)(=O)c1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cc1,CS(=O)(=O)c1ccc(N2CC(CN)C(c3cc(F)ccc3F)CC2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579391,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2cccnc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236106,nM,1388,CHEMBL284,5.857610534,DPPIV,NC[C@H]1CN(c2cccnc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2cccnc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579392,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,COc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cn1,CHEMBL3236107,nM,452,CHEMBL284,6.344861565,DPPIV,COc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cn1,COc1ccc(N2CC(CN)C(c3cc(F)ccc3F)CC2=O)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579393,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc(C(F)(F)F)nc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236108,nM,443,CHEMBL284,6.353596274,DPPIV,NC[C@H]1CN(c2ccc(C(F)(F)F)nc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccc(C(F)(F)F)nc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579394,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,N#Cc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cn1,CHEMBL3236109,nM,404,CHEMBL284,6.393618635,DPPIV,N#Cc1ccc(N2C[C@H](CN)[C@@H](c3cc(F)ccc3F)CC2=O)cn1,N#Cc1ccc(N2CC(CN)C(c3cc(F)ccc3F)CC2=O)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579395,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(Cc2ccccc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236110,nM,885,CHEMBL284,6.053056729,DPPIV,NC[C@H]1CN(Cc2ccccc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(Cc2ccccc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579396,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(Cc2ccc(C(F)(F)F)cc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236111,nM,910,CHEMBL284,6.040958608,DPPIV,NC[C@H]1CN(Cc2ccc(C(F)(F)F)cc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(Cc2ccc(C(F)(F)F)cc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579397,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3ccccc3n2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236112,nM,1034,CHEMBL284,5.985479461,DPPIV,NC[C@H]1CN(c2ccc3ccccc3n2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccc3ccccc3n2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579398,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2nccn3cnnc23)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236113,nM,1023,CHEMBL284,5.990124366,DPPIV,NC[C@H]1CN(c2nccn3cnnc23)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2nccn3cnnc23)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579399,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,Cc1cc(=O)n2nc(N3C[C@H](CN)[C@@H](c4cc(F)ccc4F)CC3=O)ccc2n1,CHEMBL3236114,nM,997,CHEMBL284,6.001304842,DPPIV,Cc1cc(=O)n2nc(N3C[C@H](CN)[C@@H](c4cc(F)ccc4F)CC3=O)ccc2n1,Cc1cc(=O)n2nc(N3CC(CN)C(c4cc(F)ccc4F)CC3=O)ccc2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579400,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccccc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236115,nM,119,CHEMBL284,6.924453039,DPPIV,NC[C@H]1CN(CCc2ccccc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(CCc2ccccc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579401,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccncc2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236116,nM,84,CHEMBL284,7.075720714,DPPIV,NC[C@H]1CN(CCc2ccncc2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(CCc2ccncc2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579402,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,Cc1cc2ncc(N3C[C@H](CN)[C@@H](c4cc(F)ccc4F)CC3=O)c(C)n2n1,CHEMBL3236117,nM,77.6,CHEMBL284,7.110138279,DPPIV,Cc1cc2ncc(N3C[C@H](CN)[C@@H](c4cc(F)ccc4F)CC3=O)c(C)n2n1,Cc1cc2ncc(N3CC(CN)C(c4cc(F)ccc4F)CC3=O)c(C)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579403,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,Cc1nnc2ccc(N3C[C@H](CN)[C@@H](c4cc(F)ccc4F)CC3=O)nn12,CHEMBL3236118,nM,122,CHEMBL284,6.913640169,DPPIV,Cc1nnc2ccc(N3C[C@H](CN)[C@@H](c4cc(F)ccc4F)CC3=O)nn12,Cc1nnc2ccc(N3CC(CN)C(c4cc(F)ccc4F)CC3=O)nn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579404,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236119,nM,79,CHEMBL284,7.102372909,DPPIV,NC[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579405,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236120,nM,74,CHEMBL284,7.13076828,DPPIV,NC[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579406,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1cc(F)ccc1F,CHEMBL3236121,nM,8.5,CHEMBL284,8.070581074,DPPIV,NC[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1cc(F)ccc1F,NCC1CN(CCc2ccc3c(c2)OCO3)C(=O)CC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579407,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccncc2)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3236122,nM,157,CHEMBL284,6.804100348,DPPIV,NC[C@H]1CN(CCc2ccncc2)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,NCC1CN(CCc2ccncc2)C(=O)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579408,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,Cc1cc2ncc(N3C[C@H](CN)[C@@H](c4cc(F)c(F)cc4F)CC3=O)c(C)n2n1,CHEMBL3236123,nM,119,CHEMBL284,6.924453039,DPPIV,Cc1cc2ncc(N3C[C@H](CN)[C@@H](c4cc(F)c(F)cc4F)CC3=O)c(C)n2n1,Cc1cc2ncc(N3CC(CN)C(c4cc(F)c(F)cc4F)CC3=O)c(C)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579409,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3236124,nM,125,CHEMBL284,6.903089987,DPPIV,NC[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,NCC1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579410,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3236125,nM,111,CHEMBL284,6.954677021,DPPIV,NC[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,NCC1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579411,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3236126,nM,19,CHEMBL284,7.721246399,DPPIV,NC[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1cc(F)c(F)cc1F,NCC1CN(CCc2ccc3c(c2)OCO3)C(=O)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579412,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccncc2)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,CHEMBL3236127,nM,197,CHEMBL284,6.705533774,DPPIV,NC[C@H]1CN(CCc2ccncc2)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,NCC1CN(CCc2ccncc2)C(=O)CC1c1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579413,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,Cc1cc2ncc(N3C[C@H](CN)[C@@H](c4ccc(Cl)cc4Cl)CC3=O)c(C)n2n1,CHEMBL3236128,nM,148,CHEMBL284,6.829738285,DPPIV,Cc1cc2ncc(N3C[C@H](CN)[C@@H](c4ccc(Cl)cc4Cl)CC3=O)c(C)n2n1,Cc1cc2ncc(N3CC(CN)C(c4ccc(Cl)cc4Cl)CC3=O)c(C)n2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579414,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,CHEMBL3236129,nM,134,CHEMBL284,6.872895202,DPPIV,NC[C@H]1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,NCC1CN(c2ccc3nnc(C(F)(F)F)n3n2)C(=O)CC1c1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579415,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,CHEMBL3236130,nM,137,CHEMBL284,6.863279433,DPPIV,NC[C@H]1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,NCC1CN(c2ccc3nc(C(F)(F)F)nn3n2)C(=O)CC1c1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14579416,CHEMBL3241352,Inhibition of human DPP-4 expressed in baculovirus expression system using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,NC[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,CHEMBL3236131,nM,43,CHEMBL284,7.366531544,DPPIV,NC[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1ccc(Cl)cc1Cl,NCC1CN(CCc2ccc3c(c2)OCO3)C(=O)CC1c1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14592990,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,COc1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c2c1,CHEMBL3233843,nM,19000,CHEMBL284,4.721246399,DPPIV,COc1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c2c1,COc1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593013,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1ccnc2ccccc12,CHEMBL3233847,nM,50000,CHEMBL284,4.301029996,DPPIV,O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1ccnc2ccccc12,O=C(NCC(=O)N1CCCC1B(O)O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593040,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)[C@@H](CO)NC(=O)c1ccnc2ccccc12,CHEMBL3233538,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)C(CO)NC(=O)c1ccnc2ccccc12,N#CC1CCCN1C(=O)C(CO)NC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593041,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,C[C@@H](NC(=O)c1ccnc2ccccc12)C(=O)N1CCC[C@H]1C#N,CHEMBL3233539,nM,100000,CHEMBL284,4,DPPIV,CC(NC(=O)c1ccnc2ccccc12)C(=O)N1CCC[C@H]1C#N,CC(NC(=O)c1ccnc2ccccc12)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593042,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,C[C@H](NC(=O)c1ccnc2ccccc12)C(=O)N1CCC[C@H]1C#N,CHEMBL3233540,nM,100000,CHEMBL284,4,DPPIV,CC(NC(=O)c1ccnc2ccccc12)C(=O)N1CCC[C@H]1C#N,CC(NC(=O)c1ccnc2ccccc12)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593043,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)C1(NC(=O)c2ccnc3ccccc23)CC1,CHEMBL3233541,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)C1(NC(=O)c2ccnc3ccccc23)CC1,N#CC1CCCN1C(=O)C1(NC(=O)c2ccnc3ccccc23)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593044,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,CN(CC(=O)N1CCC[C@H]1C#N)C(=O)c1ccnc2ccccc12,CHEMBL3233542,nM,100000,CHEMBL284,4,DPPIV,CN(CC(=O)N1CCC[C@H]1C#N)C(=O)c1ccnc2ccccc12,CN(CC(=O)N1CCCC1C#N)C(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593045,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CN(C(=O)c1ccnc2ccccc12)C1CC1,CHEMBL3233543,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CN(C(=O)c1ccnc2ccccc12)C1CC1,N#CC1CCCN1C(=O)CN(C(=O)c1ccnc2ccccc12)C1CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593046,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CN(Cc1ccc(Cl)cc1)C(=O)c1ccnc2ccccc12,CHEMBL3233544,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CN(Cc1ccc(Cl)cc1)C(=O)c1ccnc2ccccc12,N#CC1CCCN1C(=O)CN(Cc1ccc(Cl)cc1)C(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593047,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,COCCN(CC(=O)N1CCC[C@H]1C#N)C(=O)c1ccnc2ccccc12,CHEMBL3233545,nM,100000,CHEMBL284,4,DPPIV,COCCN(CC(=O)N1CCC[C@H]1C#N)C(=O)c1ccnc2ccccc12,COCCN(CC(=O)N1CCCC1C#N)C(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593048,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,CC(C)CCN(CC(=O)N1CCC[C@H]1C#N)C(=O)c1ccnc2ccccc12,CHEMBL3233546,nM,100000,CHEMBL284,4,DPPIV,CC(C)CCN(CC(=O)N1CCC[C@H]1C#N)C(=O)c1ccnc2ccccc12,CC(C)CCN(CC(=O)N1CCCC1C#N)C(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593049,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,COCCN(CC(=O)N1CCC[C@H]1C#N)Cc1ccnc2ccccc12,CHEMBL3233547,nM,100000,CHEMBL284,4,DPPIV,COCCN(CC(=O)N1CCC[C@H]1C#N)Cc1ccnc2ccccc12,COCCN(CC(=O)N1CCCC1C#N)Cc1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593050,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,CN(CC(=O)N1CCC[C@H]1C#N)Cc1ccnc2ccccc12,CHEMBL3233548,nM,100000,CHEMBL284,4,DPPIV,CN(CC(=O)N1CCC[C@H]1C#N)Cc1ccnc2ccccc12,CN(CC(=O)N1CCCC1C#N)Cc1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593051,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,CN(CC(=O)N1CCC[C@H]1C#N)CC(=O)N1CCC[C@H]1C#N,CHEMBL3233549,nM,100000,CHEMBL284,4,DPPIV,CN(CC(=O)N1CCC[C@H]1C#N)CC(=O)N1CCC[C@H]1C#N,CN(CC(=O)N1CCCC1C#N)CC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593052,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)Cn1cc(-c2ccccc2)nn1,CHEMBL3233550,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)Cn1cc(-c2ccccc2)nn1,N#CC1CCCN1C(=O)Cn1cc(-c2ccccc2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593053,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)Cn1cc(-c2ccc(F)cc2)nn1,CHEMBL3233551,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)Cn1cc(-c2ccc(F)cc2)nn1,N#CC1CCCN1C(=O)Cn1cc(-c2ccc(F)cc2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593054,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)Cn1cc(CCC(=O)N2Cc3ccccc3C2)nn1,CHEMBL3233552,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)Cn1cc(CCC(=O)N2Cc3ccccc3C2)nn1,N#CC1CCCN1C(=O)Cn1cc(CCC(=O)N2Cc3ccccc3C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593055,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)Cn1cc(-c2cccc3ccccc23)nn1,CHEMBL3233553,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)Cn1cc(-c2cccc3ccccc23)nn1,N#CC1CCCN1C(=O)Cn1cc(-c2cccc3ccccc23)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593056,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccncc1,CHEMBL3233554,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccncc1,N#CC1CCCN1C(=O)CNC(=O)c1ccncc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593057,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(Cl)c1,CHEMBL3233555,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(Cl)c1,N#CC1CCCN1C(=O)CNC(=O)c1ccnc(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593058,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(Br)c1,CHEMBL3233556,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(Br)c1,N#CC1CCCN1C(=O)CNC(=O)c1ccnc(Br)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593059,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(N)c1,CHEMBL3233557,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cc[nH]c(=N)c1,N#CC1CCCN1C(=O)CNC(=O)c1cc[nH]c(=N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593060,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(-c2ccccc2)c1,CHEMBL3233558,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc(-c2ccccc2)c1,N#CC1CCCN1C(=O)CNC(=O)c1ccnc(-c2ccccc2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593061,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,COc1ccc(-c2cc(C(=O)NCC(=O)N3CCC[C@H]3C#N)ccn2)cc1OC,CHEMBL3233559,nM,100000,CHEMBL284,4,DPPIV,COc1ccc(-c2cc(C(=O)NCC(=O)N3CCC[C@H]3C#N)ccn2)cc1OC,COc1ccc(-c2cc(C(=O)NCC(=O)N3CCCC3C#N)ccn2)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593062,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#Cc1ccc(-c2cc(C(=O)NCC(=O)N3CCC[C@H]3C#N)ccn2)cc1,CHEMBL3233560,nM,100000,CHEMBL284,4,DPPIV,N#Cc1ccc(-c2cc(C(=O)NCC(=O)N3CCC[C@H]3C#N)ccn2)cc1,N#Cc1ccc(-c2cc(C(=O)NCC(=O)N3CCCC3C#N)ccn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593063,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1ccncc1,CHEMBL3233561,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1ccncc1,N#CC1CCCN1C(=O)CNC(=O)Cc1ccncc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593064,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)C1CCNCC1,CHEMBL3233562,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)C1CCNCC1,N#CC1CCCN1C(=O)CNC(=O)C1CCNCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593065,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnnc1,CHEMBL3233563,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnnc1,N#CC1CCCN1C(=O)CNC(=O)c1ccnnc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593066,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,Cn1cncc1C(=O)NCC(=O)N1CCC[C@H]1C#N,CHEMBL3233564,nM,100000,CHEMBL284,4,DPPIV,Cn1cncc1C(=O)NCC(=O)N1CCC[C@H]1C#N,Cn1cncc1C(=O)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593067,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cnn[nH]1,CHEMBL3233565,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1c[nH]nn1,N#CC1CCCN1C(=O)CNC(=O)c1c[nH]nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593068,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1nc[nH]n1,CHEMBL3233566,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1nc[nH]n1,N#CC1CCCN1C(=O)CNC(=O)c1nc[nH]n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593069,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1c[nH]cn1,CHEMBL3233567,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)Cc1c[nH]cn1,N#CC1CCCN1C(=O)CNC(=O)Cc1c[nH]cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593070,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,Cc1ncsc1C(=O)NCC(=O)N1CCC[C@H]1C#N,CHEMBL3233568,nM,100000,CHEMBL284,4,DPPIV,Cc1ncsc1C(=O)NCC(=O)N1CCC[C@H]1C#N,Cc1ncsc1C(=O)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593071,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,Cc1ncoc1C(=O)NCC(=O)N1CCC[C@H]1C#N,CHEMBL3233569,nM,100000,CHEMBL284,4,DPPIV,Cc1ncoc1C(=O)NCC(=O)N1CCC[C@H]1C#N,Cc1ncoc1C(=O)NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593072,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(N)cc1,CHEMBL3233570,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(N)cc1,N#CC1CCCN1C(=O)CNC(=O)c1ccc(N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593073,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(NC(=O)C(F)(F)F)cc1,CHEMBL3233571,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccc(NC(=O)C(F)(F)F)cc1,N#CC1CCCN1C(=O)CNC(=O)c1ccc(NC(=O)C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593074,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2[nH]ccc12,CHEMBL3233572,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2[nH]ccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2[nH]ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593075,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12,CHEMBL3233573,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593076,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,COc1ccc(-c2nc3c(C(=O)NCC(=O)N4CCC[C@H]4C#N)ccnc3[nH]2)cc1,CHEMBL3233574,nM,100000,CHEMBL284,4,DPPIV,COc1ccc(-c2nc3c(C(=O)NCC(=O)N4CCC[C@H]4C#N)ccnc3[nH]2)cc1,COc1ccc(-c2nc3c(C(=O)NCC(=O)N4CCCC4C#N)ccnc3[nH]2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593077,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ncnn12,CHEMBL3233575,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ncnn12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ncnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593078,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cnccc12,CHEMBL3233833,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cnccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cnccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593079,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,Cc1ccc2c(C(=O)NCC(=O)N3CCC[C@H]3C#N)ccnc2c1,CHEMBL3233834,nM,100000,CHEMBL284,4,DPPIV,Cc1ccc2c(C(=O)NCC(=O)N3CCC[C@H]3C#N)ccnc2c1,Cc1ccc2c(C(=O)NCC(=O)N3CCCC3C#N)ccnc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593080,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,Cc1cccc2nccc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c12,CHEMBL3233835,nM,100000,CHEMBL284,4,DPPIV,Cc1cccc2nccc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c12,Cc1cccc2nccc(C(=O)NCC(=O)N3CCCC3C#N)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593081,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(-c3ccccc3)ccc12,CHEMBL3233836,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(-c3ccccc3)ccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cc(-c3ccccc3)ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593082,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(Nc3ccccc3)ccc12,CHEMBL3233837,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(Nc3ccccc3)ccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cc(Nc3ccccc3)ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593083,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cccc(-c3ccccc3)c12,CHEMBL3233838,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cccc(-c3ccccc3)c12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2cccc(-c3ccccc3)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593084,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,COc1cccc2nccc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c12,CHEMBL3233839,nM,100000,CHEMBL284,4,DPPIV,COc1cccc2nccc(C(=O)NCC(=O)N3CCC[C@H]3C#N)c12,COc1cccc2nccc(C(=O)NCC(=O)N3CCCC3C#N)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593085,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL3233840,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,N#CC1CC(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593086,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1C[C@@H](F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL3233841,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@@H](F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,N#CC1CC(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593087,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL3233842,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593088,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2cccc(Br)c12,CHEMBL3233844,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2cccc(Br)c12,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2cccc(Br)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593089,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,N#Cc1cccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c12,CHEMBL3233845,nM,100000,CHEMBL284,4,DPPIV,N#Cc1cccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c12,N#Cc1cccc2nccc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593090,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,O=C(NCC(=O)N1CCCC1)c1ccnc2ccccc12,CHEMBL3233846,nM,100000,CHEMBL284,4,DPPIV,O=C(NCC(=O)N1CCCC1)c1ccnc2ccccc12,O=C(NCC(=O)N1CCCC1)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14593091,CHEMBL3239281,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,B,O=C(NCC(=O)N1CCC[C@H]1C(=O)CCl)c1ccnc2ccccc12,CHEMBL3233848,nM,100000,CHEMBL284,4,DPPIV,O=C(NCC(=O)N1CCCC1C(=O)CCl)c1ccnc2ccccc12,O=C(NCC(=O)N1CCCC1C(=O)CCl)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14597077,CHEMBL3243518,Competitive reversible inhibition of DPP4 (unknown origin),B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL2105762,nM,1.6,CHEMBL284,8.795880017,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979493,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,C=CC(O)C(/C=C/C#CC#CC#CC)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,CHEMBL3343905,nM,100000,CHEMBL284,4,DPPIV,C=CC(O)C(/C=C/C#CC#CC#CC)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,C=CC(O)C(C=CC#CC#CC#CC)OC1OC(CO)C(O)C(O)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979494,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,CC#CC#CC#C/C=C/C=C/C(CCO)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,CHEMBL3343904,nM,100000,CHEMBL284,4,DPPIV,CC#CC#CC#C/C=C/C=C/C(CCO)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,CC#CC#CC#CC=CC=CC(CCO)OC1OC(CO)C(O)C(O)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979496,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,O=Cc1ccc(-c2ccc(-c3cccs3)s2)s1,CHEMBL91933,nM,890,CHEMBL284,6.050609993,DPPIV,O=Cc1ccc(-c2ccc(-c3cccs3)s2)s1,O=Cc1ccc(-c2ccc(-c3cccs3)s2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979497,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,CCOCc1ccc(-c2ccc(-c3cccs3)s2)s1,CHEMBL3343903,nM,510,CHEMBL284,6.292429824,DPPIV,CCOCc1ccc(-c2ccc(-c3cccs3)s2)s1,CCOCc1ccc(-c2ccc(-c3cccs3)s2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979498,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,COCc1ccc(-c2ccc(-c3cccs3)s2)s1,CHEMBL3343902,nM,2390,CHEMBL284,5.621602099,DPPIV,COCc1ccc(-c2ccc(-c3cccs3)s2)s1,COCc1ccc(-c2ccc(-c3cccs3)s2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979499,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,OCc1ccc(-c2ccc(-c3cccs3)s2)s1,CHEMBL90170,nM,3350,CHEMBL284,5.474955193,DPPIV,OCc1ccc(-c2ccc(-c3cccs3)s2)s1,OCc1ccc(-c2ccc(-c3cccs3)s2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979500,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,CC(C)CC(=O)OCCC#Cc1ccc(-c2ccc(COC(=O)CC(C)C)s2)s1,CHEMBL3343901,nM,750,CHEMBL284,6.124938737,DPPIV,CC(C)CC(=O)OCCC#Cc1ccc(-c2ccc(COC(=O)CC(C)C)s2)s1,CC(C)CC(=O)OCCC#Cc1ccc(-c2ccc(COC(=O)CC(C)C)s2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979501,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,OCc1ccc(-c2ccc(C#CC(O)CO)s2)s1,CHEMBL3343900,nM,2810,CHEMBL284,5.55129368,DPPIV,OCc1ccc(-c2ccc(C#CC(O)CO)s2)s1,OCc1ccc(-c2ccc(C#CC(O)CO)s2)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14979502,CHEMBL3382310,Inhibition of DPP4 in human plasma using Gly-Pro-AMC substrate incubated for 20 mins by fluorometry,B,CC#CC#Cc1ccc(C#CC(O)CO)s1,CHEMBL3343899,nM,2740,CHEMBL284,5.562249437,DPPIV,CC#CC#Cc1ccc(C#CC(O)CO)s1,CC#CC#Cc1ccc(C#CC(O)CO)s1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989317,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](CNS(=O)(=O)C(F)(F)F)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357782,nM,170,CHEMBL284,6.769551079,DPPIV,N[C@@H](CC(=O)N1[C@H](CNS(=O)(=O)C(F)(F)F)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(CNS(=O)(=O)C(F)(F)F)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989318,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,CS(=O)(=O)NC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3357781,nM,430,CHEMBL284,6.366531544,DPPIV,CS(=O)(=O)NC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CS(=O)(=O)NCC1CC2CCCCC2N1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989319,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,Cc1ccc(S(=O)(=O)NC[C@@H]2C[C@@H]3CCCC[C@@H]3N2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,CHEMBL3357780,nM,140,CHEMBL284,6.853871964,DPPIV,Cc1ccc(S(=O)(=O)NC[C@@H]2C[C@@H]3CCCC[C@@H]3N2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)cc1,Cc1ccc(S(=O)(=O)NCC2CC3CCCCC3N2C(=O)CC(N)Cc2cc(F)c(F)cc2F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989320,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](CNC(=O)c2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357779,nM,610,CHEMBL284,6.214670165,DPPIV,N[C@@H](CC(=O)N1[C@H](CNC(=O)c2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(CNC(=O)c2ccccc2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989321,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](CNC(=O)C2CCCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357778,nM,430,CHEMBL284,6.366531544,DPPIV,N[C@@H](CC(=O)N1[C@H](CNC(=O)C2CCCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(CNC(=O)C2CCCC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989322,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](CNC(=O)C2CCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357777,nM,330,CHEMBL284,6.48148606,DPPIV,N[C@@H](CC(=O)N1[C@H](CNC(=O)C2CCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(CNC(=O)C2CCC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989323,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](CNC(=O)C2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357776,nM,540,CHEMBL284,6.26760624,DPPIV,N[C@@H](CC(=O)N1[C@H](CNC(=O)C2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(CNC(=O)C2CC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989324,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,CC(=O)NC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3357775,nM,290,CHEMBL284,6.537602002,DPPIV,CC(=O)NC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(=O)NCC1CC2CCCCC2N1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989325,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](CO)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357774,nM,510,CHEMBL284,6.292429824,DPPIV,N[C@@H](CC(=O)N1[C@H](CO)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(CO)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989326,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](COC(=O)c2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357773,nM,320,CHEMBL284,6.494850022,DPPIV,N[C@@H](CC(=O)N1[C@H](COC(=O)c2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(COC(=O)c2ccccc2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989327,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](COC(=O)C2CCCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357772,nM,180,CHEMBL284,6.744727495,DPPIV,N[C@@H](CC(=O)N1[C@H](COC(=O)C2CCCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(COC(=O)C2CCCC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989328,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](COC(=O)C2CCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357771,nM,70,CHEMBL284,7.15490196,DPPIV,N[C@@H](CC(=O)N1[C@H](COC(=O)C2CCC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(COC(=O)C2CCC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989329,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](COC(=O)C2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357770,nM,80,CHEMBL284,7.096910013,DPPIV,N[C@@H](CC(=O)N1[C@H](COC(=O)C2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(COC(=O)C2CC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989330,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,CC(=O)OC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3357769,nM,70,CHEMBL284,7.15490196,DPPIV,CC(=O)OC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CC(=O)OCC1CC2CCCCC2N1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989332,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357768,nM,3660,CHEMBL284,5.436518915,DPPIV,N[C@@H](CC(=O)N1C(C(=O)O)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(C(=O)O)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989333,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,CCOC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3357767,nM,70,CHEMBL284,7.15490196,DPPIV,CCOC(=O)C1C[C@@H]2CCCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CCOC(=O)C1CC2CCCCC2N1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989334,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](C(=O)NCC2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357766,nM,760,CHEMBL284,6.119186408,DPPIV,N[C@@H](CC(=O)N1C(C(=O)NCC2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(C(=O)NCC2CC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989335,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](C(=O)NC2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357765,nM,380,CHEMBL284,6.420216403,DPPIV,N[C@@H](CC(=O)N1C(C(=O)NC2CC2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(C(=O)NC2CC2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989336,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](C(=O)NCc2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357764,nM,340,CHEMBL284,6.468521083,DPPIV,N[C@@H](CC(=O)N1C(C(=O)NCc2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(C(=O)NCc2ccccc2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
14989337,CHEMBL3389736,Inhibition of human recombinant his6-tagged DPP4 using Ala-Pro-AMC as substrate by continuous fluorometric method,B,N[C@@H](CC(=O)N1[C@H](C(=O)Nc2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,CHEMBL3357763,nM,5810,CHEMBL284,5.235823868,DPPIV,N[C@@H](CC(=O)N1C(C(=O)Nc2ccccc2)C[C@@H]2CCCC[C@@H]21)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1C(C(=O)Nc2ccccc2)CC2CCCCC21)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15010450,CHEMBL3373767,Inhibition of human DPP-4 using H-Gly-Pro-para-Nitroanilide as substrate incubated for 20 mins prior to substrate addition measured after 30 mins by spectrophotometry,B,Cn1c(=O)c(C(C)(NN)Nc2ccccc2)c(O)c2ccccc21,CHEMBL3310986,nM,730,CHEMBL284,6.13667714,DPPIV,Cn1c(=O)c(C(C)(NN)Nc2ccccc2)c(O)c2ccccc21,Cn1c(=O)c(C(C)(NN)Nc2ccccc2)c(O)c2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15010451,CHEMBL3373767,Inhibition of human DPP-4 using H-Gly-Pro-para-Nitroanilide as substrate incubated for 20 mins prior to substrate addition measured after 30 mins by spectrophotometry,B,CCn1c(=O)c(C(C)(NN)Nc2ccc(C)cc2)c(O)c2ccccc21,CHEMBL3310987,nM,2950,CHEMBL284,5.530177984,DPPIV,CCn1c(=O)c(C(C)(NN)Nc2ccc(C)cc2)c(O)c2ccccc21,CCn1c(=O)c(C(C)(NN)Nc2ccc(C)cc2)c(O)c2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15010452,CHEMBL3373767,Inhibition of human DPP-4 using H-Gly-Pro-para-Nitroanilide as substrate incubated for 20 mins prior to substrate addition measured after 30 mins by spectrophotometry,B,Br.Cc1ccc(=N)n(Cc2cccc(F)c2)c1,CHEMBL3310988,nM,34650,CHEMBL284,4.460296761,DPPIV,Cc1ccc(=N)n(Cc2cccc(F)c2)c1,Cc1ccc(=N)n(Cc2cccc(F)c2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15010459,CHEMBL3373767,Inhibition of human DPP-4 using H-Gly-Pro-para-Nitroanilide as substrate incubated for 20 mins prior to substrate addition measured after 30 mins by spectrophotometry,B,N=CC(C(=O)c1ccccc1)c1ccccc1,CHEMBL3310990,nM,100000,CHEMBL284,4,DPPIV,N=CC(C(=O)c1ccccc1)c1ccccc1,N=CC(C(=O)c1ccccc1)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065858,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(N3CCOCC3)nc21,CHEMBL3329703,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(N3CCOCC3)nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cc(N3CCOCC3)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065859,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(N3CCCC3)nc21,CHEMBL3329702,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(N3CCCC3)nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cc(N3CCCC3)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065860,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(C(=O)O)nc21,CHEMBL3329701,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(C(=O)O)nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cc(C(=O)O)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065861,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(C(N)=O)nc21,CHEMBL3329700,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(C(N)=O)nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cc(C(N)=O)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065862,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(CO)nc21,CHEMBL3329699,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(CO)nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cc(CO)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065863,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(C(F)(F)F)nc21,CHEMBL3329698,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cc(C(F)(F)F)nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cc(C(F)(F)F)nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065864,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,CCc1cc(N2CCC[C@@H](N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,CHEMBL3329697,nM,100000,CHEMBL284,4,DPPIV,CCc1cc(N2CCC[C@@H](N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,CCc1cc(N2CCCC(N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065865,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cc1cc(N2CCC[C@@H](N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,CHEMBL3329696,nM,100000,CHEMBL284,4,DPPIV,Cc1cc(N2CCC[C@@H](N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,Cc1cc(N2CCCC(N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065866,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,COc1cc(N2CCC[C@@H](N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,CHEMBL3329695,nM,100000,CHEMBL284,4,DPPIV,COc1cc(N2CCC[C@@H](N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,COc1cc(N2CCCC(N)C2)c2c(n1)n(C)c(=O)n2Cc1ccccc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065867,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@H](N)C3)ccnc21,CHEMBL3329694,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065868,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,CC(=O)N[C@@H]1CCCN(c2ccnc3c2n(Cc2ccccc2C#N)c(=O)n3C)C1,CHEMBL3329693,nM,100000,CHEMBL284,4,DPPIV,CC(=O)N[C@@H]1CCCN(c2ccnc3c2n(Cc2ccccc2C#N)c(=O)n3C)C1,CC(=O)NC1CCCN(c2ccnc3c2n(Cc2ccccc2C#N)c(=O)n3C)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065869,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,CN[C@@H]1CCCN(c2ccnc3c2n(Cc2ccccc2C#N)c(=O)n3C)C1,CHEMBL3329692,nM,430,CHEMBL284,6.366531544,DPPIV,CN[C@@H]1CCCN(c2ccnc3c2n(Cc2ccccc2C#N)c(=O)n3C)C1,CNC1CCCN(c2ccnc3c2n(Cc2ccccc2C#N)c(=O)n3C)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065870,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCNCC3)ccnc21,CHEMBL3329691,nM,5200,CHEMBL284,5.283996656,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCNCC3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCNCC3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065871,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(NC3CCNCC3)ccnc21,CHEMBL3329690,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(=NC3CCNCC3)cc[nH]c21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(=NC3CCNCC3)cc[nH]c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065874,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,N#Cc1ccccc1Cn1c(=O)oc2nccc(N3CCC[C@@H](N)C3)c21,CHEMBL3329624,nM,100,CHEMBL284,7,DPPIV,N#Cc1ccccc1Cn1c(=O)oc2nccc(N3CCC[C@@H](N)C3)c21,N#Cc1ccccc1Cn1c(=O)oc2nccc(N3CCCC(N)C3)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065875,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,CC1(C)C(=O)N(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329625,nM,3400,CHEMBL284,5.468521083,DPPIV,CC1(C)C(=O)N(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CC1(C)C(=O)N(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065876,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,N#Cc1ccccc1Cn1c(=O)[nH]c2nccc(N3CCC[C@@H](N)C3)c21,CHEMBL3329626,nM,45,CHEMBL284,7.346787486,DPPIV,N#Cc1ccccc1Cn1c(=O)[nH]c2nccc(N3CCC[C@@H](N)C3)c21,N#Cc1ccccc1Cn1c(=O)[nH]c2nccc(N3CCCC(N)C3)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065877,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329627,nM,13,CHEMBL284,7.886056648,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065878,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,CC(C)n1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329628,nM,480,CHEMBL284,6.318758763,DPPIV,CC(C)n1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CC(C)n1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065879,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=S)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329629,nM,38000,CHEMBL284,4.420216403,DPPIV,Cn1c(=S)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=S)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065880,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329630,nM,55000,CHEMBL284,4.259637311,DPPIV,Cn1c(=O)c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065881,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)c3ccccc3nc21,CHEMBL3329631,nM,1100,CHEMBL284,5.958607315,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)c3ccccc3nc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)c3ccccc3nc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065882,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ncnc21,CHEMBL3329632,nM,10,CHEMBL284,8,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)ncnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)ncnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065883,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cccc21,CHEMBL3329633,nM,45,CHEMBL284,7.346787486,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC[C@@H](N)C3)cccc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCC(N)C3)cccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065884,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2cccc(C#N)c2)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329634,nM,88000,CHEMBL284,4.055517328,DPPIV,Cn1c(=O)n(Cc2cccc(C#N)c2)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2cccc(C#N)c2)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065885,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccc(C#N)cc2)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329635,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccc(C#N)cc2)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccc(C#N)cc2)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065886,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2Cl)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329636,nM,110,CHEMBL284,6.958607315,DPPIV,Cn1c(=O)n(Cc2ccccc2Cl)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2Cl)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065887,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2F)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329637,nM,2500,CHEMBL284,5.602059991,DPPIV,Cn1c(=O)n(Cc2ccccc2F)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2F)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065888,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccc(Cl)cc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329638,nM,16000,CHEMBL284,4.795880017,DPPIV,Cn1c(=O)n(Cc2ccc(Cl)cc2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccc(Cl)cc2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065889,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccc3ccccc3c2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,CHEMBL3329639,nM,20000,CHEMBL284,4.698970004,DPPIV,Cn1c(=O)n(Cc2ccc3ccccc3c2C#N)c2c(N3CCC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccc3ccccc3c2C#N)c2c(N3CCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065890,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CC(N)C3)ccnc21,CHEMBL3329640,nM,100000,CHEMBL284,4,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CC(N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065891,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CC[C@@H](N)C3)ccnc21,CHEMBL3329641,nM,22,CHEMBL284,7.657577319,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CC[C@@H](N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065892,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCCC(N)C3)ccnc21,CHEMBL3329688,nM,530,CHEMBL284,6.27572413,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCCC(N)C3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCCCC(N)C3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15065893,CHEMBL3365706,Inhibition of human recombinant DPP4 pre-incubated with compound for 15 mins before substrate addition by luminescence assay,B,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCNCC3)ccnc21,CHEMBL3329689,nM,23000,CHEMBL284,4.638272164,DPPIV,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCNCC3)ccnc21,Cn1c(=O)n(Cc2ccccc2C#N)c2c(N3CCNCC3)ccnc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094916,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(C(F)(F)F)cc1,CHEMBL3330055,nM,640,CHEMBL284,6.193820026,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(C(F)(F)F)cc1,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094917,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(I)cc1,CHEMBL3330054,nM,430,CHEMBL284,6.366531544,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(I)cc1,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccc(I)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094918,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(F)cc1,CHEMBL3330053,nM,320,CHEMBL284,6.494850022,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(F)cc1,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094919,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cccc(F)c1,CHEMBL3330052,nM,220,CHEMBL284,6.657577319,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cccc(F)c1,N#CC1CC(F)CN1C(=O)CC(N)Cc1cccc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094920,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,Cc1ccccc1C[C@@H](N)CC(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL3330051,nM,160,CHEMBL284,6.795880017,DPPIV,Cc1ccccc1C[C@@H](N)CC(=O)N1C[C@@H](F)C[C@H]1C#N,Cc1ccccc1CC(N)CC(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094921,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccccc1Cl,CHEMBL3330050,nM,220,CHEMBL284,6.657577319,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccccc1Cl,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094922,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccccc1,CHEMBL3330049,nM,450,CHEMBL284,6.346787486,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccccc1,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094976,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3330073,nM,10,CHEMBL284,8,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094977,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)cc(F)c1,CHEMBL3330072,nM,9650,CHEMBL284,5.015472687,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cc(F)cc(F)c1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1cc(F)cc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094978,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(Cl)c(Cl)c1,CHEMBL3330071,nM,47440,CHEMBL284,4.32385532,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(Cl)c(Cl)c1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccc(Cl)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094979,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(Cl)cc1Cl,CHEMBL3330070,nM,70,CHEMBL284,7.15490196,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(Cl)cc1Cl,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094981,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(C(F)(F)F)cc1,CHEMBL3330068,nM,1980,CHEMBL284,5.70333481,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(C(F)(F)F)cc1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccc(C(F)(F)F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094982,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(I)cc1,CHEMBL3330067,nM,8800,CHEMBL284,5.055517328,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(I)cc1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccc(I)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094983,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(F)cc1,CHEMBL3330066,nM,270,CHEMBL284,6.568636236,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccc(F)cc1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccc(F)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094984,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cccc(F)c1,CHEMBL3330065,nM,130,CHEMBL284,6.886056648,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1cccc(F)c1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1cccc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094985,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,Cc1ccccc1C[C@@H](N)CC(=O)N1[C@H](C#N)C[C@@H]2CCC[C@@H]21,CHEMBL3330064,nM,360,CHEMBL284,6.443697499,DPPIV,Cc1ccccc1C[C@@H](N)CC(=O)N1[C@H](C#N)C[C@@H]2CCC[C@@H]21,Cc1ccccc1CC(N)CC(=O)N1C(C#N)CC2CCCC21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094986,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccccc1Cl,CHEMBL3330063,nM,70,CHEMBL284,7.15490196,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccccc1Cl,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094987,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccccc1,CHEMBL3330062,nM,440,CHEMBL284,6.356547324,DPPIV,N#C[C@@H]1C[C@@H]2CCC[C@@H]2N1C(=O)C[C@H](N)Cc1ccccc1,N#CC1CC2CCCC2N1C(=O)CC(N)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094990,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@@H](N)Cc1ccccc1,CHEMBL3330061,nM,1940,CHEMBL284,5.71219827,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@@H](N)Cc1ccccc1,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094991,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,CHEMBL3330060,nM,50,CHEMBL284,7.301029996,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,N#CC1CC(F)CN1C(=O)CC(N)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094992,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cc(F)cc(F)c1,CHEMBL3330059,nM,1580,CHEMBL284,5.801342913,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1cc(F)cc(F)c1,N#CC1CC(F)CN1C(=O)CC(N)Cc1cc(F)cc(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094993,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(Cl)c(Cl)c1,CHEMBL3330058,nM,530,CHEMBL284,6.27572413,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(Cl)c(Cl)c1,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccc(Cl)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094994,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(Cl)cc1Cl,CHEMBL3330057,nM,40,CHEMBL284,7.397940009,DPPIV,N#C[C@@H]1C[C@H](F)CN1C(=O)C[C@H](N)Cc1ccc(Cl)cc1Cl,N#CC1CC(F)CN1C(=O)CC(N)Cc1ccc(Cl)cc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15094995,CHEMBL3370155,Inhibition of human recombinant DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by continuous fluorometric assay,B,COc1ccc(C[C@@H](N)CC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,CHEMBL3330056,nM,770,CHEMBL284,6.113509275,DPPIV,COc1ccc(C[C@@H](N)CC(=O)N2C[C@@H](F)C[C@H]2C#N)cc1,COc1ccc(CC(N)CC(=O)N2CC(F)CC2C#N)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15163470,CHEMBL3405177,Inhibition of human DPP4,B,Cc1oc(=O)oc1COC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl,CHEMBL3400963,nM,6,CHEMBL284,8.22184875,DPPIV,Cc1oc(=O)oc1COC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Cc1oc(=O)oc1COC(=O)c1ccc2c(c1)c1nc(N3CCCC(N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15163471,CHEMBL3405177,Inhibition of human DPP4,B,Cc1oc(=O)oc1COC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3Cl)c1c(=O)n2C.Cl,CHEMBL3400964,nM,4.7,CHEMBL284,8.327902142,DPPIV,Cc1oc(=O)oc1COC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3Cl)c1c(=O)n2C,Cc1oc(=O)oc1COC(=O)c1ccc2c(c1)c1nc(N3CCCC(N)C3)n(Cc3cc(F)ccc3Cl)c1c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15163472,CHEMBL3405177,Inhibition of human DPP4,B,Cc1oc(=O)oc1COC(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1.Cl,CHEMBL3400965,nM,1.4,CHEMBL284,8.853871964,DPPIV,Cc1oc(=O)oc1COC(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Cc1oc(=O)oc1COC(=O)c1ccc2c3nc(N4CCCC(N)C4)n(Cc4ccccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15163473,CHEMBL3405177,Inhibition of human DPP4,B,Cc1oc(=O)oc1COC(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4cc(F)ccc4Cl)c3c(=O)n(C)c2c1.Cl,CHEMBL3400966,nM,3.4,CHEMBL284,8.468521083,DPPIV,Cc1oc(=O)oc1COC(=O)c1ccc2c3nc(N4CCC[C@@H](N)C4)n(Cc4cc(F)ccc4Cl)c3c(=O)n(C)c2c1,Cc1oc(=O)oc1COC(=O)c1ccc2c3nc(N4CCCC(N)C4)n(Cc4cc(F)ccc4Cl)c3c(=O)n(C)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15178621,CHEMBL3405279,Inhibition of DPP4 (unknown origin) pre-incubated for 1 hr before Gly-Pro-pNA substrate addition and measured 2 hrs post substrate addition,B,Cn1c(=O)n(Cc2cc(C(=O)O)cc(C(=O)O)c2)c(=O)c2c1nc(N1CCC[C@@H](N)C1)n2Cc1ccccc1Cl,CHEMBL3402118,nM,500,CHEMBL284,6.301029996,DPPIV,Cn1c(=O)n(Cc2cc(C(=O)O)cc(C(=O)O)c2)c(=O)c2c1nc(N1CCC[C@@H](N)C1)n2Cc1ccccc1Cl,Cn1c(=O)n(Cc2cc(C(=O)O)cc(C(=O)O)c2)c(=O)c2c1nc(N1CCCC(N)C1)n2Cc1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15178623,CHEMBL3405279,Inhibition of DPP4 (unknown origin) pre-incubated for 1 hr before Gly-Pro-pNA substrate addition and measured 2 hrs post substrate addition,B,Cn1c(=O)n(Cc2cccc(C(=O)O)c2)c(=O)c2c1nc(N1CCC[C@@H](N)C1)n2Cc1ccccc1Cl,CHEMBL3402120,nM,230,CHEMBL284,6.638272164,DPPIV,Cn1c(=O)n(Cc2cccc(C(=O)O)c2)c(=O)c2c1nc(N1CCC[C@@H](N)C1)n2Cc1ccccc1Cl,Cn1c(=O)n(Cc2cccc(C(=O)O)c2)c(=O)c2c1nc(N1CCCC(N)C1)n2Cc1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15178628,CHEMBL3405279,Inhibition of DPP4 (unknown origin) pre-incubated for 1 hr before Gly-Pro-pNA substrate addition and measured 2 hrs post substrate addition,B,Cn1c(=O)n(Cc2ccc(F)c(C(=O)O)c2)c(=O)c2c1nc(N1CCC[C@@H](N)C1)n2Cc1ccccc1Cl,CHEMBL3402125,nM,640,CHEMBL284,6.193820026,DPPIV,Cn1c(=O)n(Cc2ccc(F)c(C(=O)O)c2)c(=O)c2c1nc(N1CCC[C@@H](N)C1)n2Cc1ccccc1Cl,Cn1c(=O)n(Cc2ccc(F)c(C(=O)O)c2)c(=O)c2c1nc(N1CCCC(N)C1)n2Cc1ccccc1Cl,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15178632,CHEMBL3405279,Inhibition of DPP4 (unknown origin) pre-incubated for 1 hr before Gly-Pro-pNA substrate addition and measured 2 hrs post substrate addition,B,COc1ccc(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3Cl)n(C)c2=O)cc1C(=O)O,CHEMBL3402129,nM,36,CHEMBL284,7.443697499,DPPIV,COc1ccc(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3Cl)n(C)c2=O)cc1C(=O)O,COc1ccc(Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3ccccc3Cl)n(C)c2=O)cc1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249313,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1ccccc1,CHEMBL3425745,nM,695,CHEMBL284,6.158015195,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1ccccc1,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)F)n32)C1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249314,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,N[C@@H](CC(=O)N1CC[C@@H]2[C@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1ccccc1,CHEMBL3425746,nM,2801,CHEMBL284,5.552686891,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1ccccc1,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)F)n32)C1)Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249315,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL3425747,nM,28,CHEMBL284,7.552841969,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249317,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,N[C@@H](CC(=O)N1CC[C@@H]2[C@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL3425748,nM,145,CHEMBL284,6.838631998,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249319,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,CCc1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@@H]1CC2,CHEMBL3425749,nM,85,CHEMBL284,7.070581074,DPPIV,CCc1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@@H]1CC2,CCc1nnc2n1C1CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249320,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,CCc1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@H]1CC2,CHEMBL3425750,nM,108,CHEMBL284,6.966576245,DPPIV,CCc1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@H]1CC2,CCc1nnc2n1C1CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249321,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(C(F)(F)C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL3425751,nM,67,CHEMBL284,7.173925197,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(C(F)(F)C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249322,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,N[C@@H](CC(=O)N1CC[C@@H]2[C@H](CCc3nnc(C(F)(F)C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL3425752,nM,258,CHEMBL284,6.588380294,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@H](CCc3nnc(C(F)(F)C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249324,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,Cc1nnc(C(F)(F)F)n1C1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1.Cl,CHEMBL3425753,nM,100,CHEMBL284,7,DPPIV,Cc1nnc(C(F)(F)F)n1C1CCN(C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1,Cc1nnc(C(F)(F)F)n1C1CCN(C(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15249325,CHEMBL3429510,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC substrate incubated for 15 mins by fluorescent AMC release assay,B,Cl.N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](Cc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL3425754,nM,94,CHEMBL284,7.026872146,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](Cc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(Cc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617499,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2cc(C(F)(F)F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580781,nM,19.2,CHEMBL284,7.716698771,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2cc(C(F)(F)F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2cc(C(F)(F)F)ccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617500,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,COc1ccc2c(c1)NC(=O)CN(C(=O)C[C@H](N)[C@H]1CCc3cc(F)c(F)cc31)C2,CHEMBL3580780,nM,20,CHEMBL284,7.698970004,DPPIV,COc1ccc2c(c1)NC(=O)CN(C(=O)C[C@H](N)[C@H]1CCc3cc(F)c(F)cc31)C2,COc1ccc2c(c1)NC(=O)CN(C(=O)CC(N)C1CCc3cc(F)c(F)cc31)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617501,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2cc(F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580779,nM,3.8,CHEMBL284,8.420216403,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2cc(F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2cc(F)ccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617502,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2nccnc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580778,nM,89.6,CHEMBL284,7.04769199,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2nccnc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2nccnc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617503,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2cccnc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580777,nM,148,CHEMBL284,6.829738285,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2cccnc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2cccnc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617504,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2cc(Br)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580782,nM,15.4,CHEMBL284,7.812479279,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2cc(Br)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2cc(Br)ccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617505,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2ccccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580776,nM,4.9,CHEMBL284,8.30980392,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2ccccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2ccccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617506,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580775,nM,10.8,CHEMBL284,7.966576245,DPPIV,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617507,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N#Cc1ccc2c(c1)NC(=O)CN(C(=O)C[C@H](N)[C@H]1CCc3cc(F)c(F)cc31)C2,CHEMBL3580783,nM,18.6,CHEMBL284,7.730487056,DPPIV,N#Cc1ccc2c(c1)NC(=O)CN(C(=O)C[C@H](N)[C@H]1CCc3cc(F)c(F)cc31)C2,N#Cc1ccc2c(c1)NC(=O)CN(C(=O)CC(N)C1CCc3cc(F)c(F)cc31)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617508,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CC(=O)Nc2cc(F)c(F)cc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580784,nM,19.8,CHEMBL284,7.70333481,DPPIV,N[C@@H](CC(=O)N1CC(=O)Nc2cc(F)c(F)cc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CC(=O)Nc2cc(F)c(F)cc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617509,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CCNc2ccccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580785,nM,299,CHEMBL284,6.524328812,DPPIV,N[C@@H](CC(=O)N1CCNc2ccccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CCNc2ccccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617510,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CCNc2cc(F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580786,nM,346,CHEMBL284,6.460923901,DPPIV,N[C@@H](CC(=O)N1CCNc2cc(F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CCNc2cc(F)ccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617511,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,N[C@@H](CC(=O)N1CCNc2cc(C(F)(F)F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,CHEMBL3580787,nM,2290,CHEMBL284,5.640164518,DPPIV,N[C@@H](CC(=O)N1CCNc2cc(C(F)(F)F)ccc2C1)[C@H]1CCc2cc(F)c(F)cc21,NC(CC(=O)N1CCNc2cc(C(F)(F)F)ccc2C1)C1CCc2cc(F)c(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617512,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CHEMBL3580788,nM,3,CHEMBL284,8.522878745,DPPIV,CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CN1C(=O)CN(C(=O)CC(N)C2CCc3cc(F)c(F)cc32)Cc2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617513,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccc(F)cc21,CHEMBL3580789,nM,3.4,CHEMBL284,8.468521083,DPPIV,CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccc(F)cc21,CN1C(=O)CN(C(=O)CC(N)C2CCc3cc(F)c(F)cc32)Cc2ccc(F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617514,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,CCN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CHEMBL3580790,nM,2.9,CHEMBL284,8.537602002,DPPIV,CCN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CCN1C(=O)CN(C(=O)CC(N)C2CCc3cc(F)c(F)cc32)Cc2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617515,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,CC(C)N1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CHEMBL3580791,nM,6.4,CHEMBL284,8.193820026,DPPIV,CC(C)N1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CC(C)N1C(=O)CN(C(=O)CC(N)C2CCc3cc(F)c(F)cc32)Cc2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15617516,CHEMBL3582591,Inhibition of DPP4 extracted from human Caco2 cells using H-Gly-Pro-AMC substrate after 10 mins by fluorescence assay,B,CCOC(=O)CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CHEMBL3580792,nM,3.4,CHEMBL284,8.468521083,DPPIV,CCOC(=O)CN1C(=O)CN(C(=O)C[C@H](N)[C@H]2CCc3cc(F)c(F)cc32)Cc2ccccc21,CCOC(=O)CN1C(=O)CN(C(=O)CC(N)C2CCc3cc(F)c(F)cc32)Cc2ccccc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15685981,CHEMBL3606470,Inhibition of DPP4 (unknown origin),B,CC(C)N(C)C(=O)n1cnc(S(=O)(=O)C2CC3CCC2C3)n1,CHEMBL537586,nM,9,CHEMBL284,8.045757491,DPPIV,CC(C)N(C)C(=O)n1cnc(S(=O)(=O)C2CC3CCC2C3)n1,CC(C)N(C)C(=O)n1cnc(S(=O)(=O)C2CC3CCC2C3)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714185,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616890,nM,19.4,CHEMBL284,7.71219827,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714186,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCN3CCC[C@H]3C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616891,nM,13900,CHEMBL284,4.8569852,DPPIV,CC#CCn1c(N2CCN3CCC[C@H]3C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCN3CCCC3C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714187,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCCCC2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616892,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(N2CCCCC2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCCC2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714188,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(OCC)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616893,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(OCC)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(OCC)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714189,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCC[C@@H](NC(C)=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616894,nM,12200,CHEMBL284,4.913640169,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(C)=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(C)=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714190,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616895,nM,50000,CHEMBL284,4.301029996,DPPIV,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714191,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CC(=O)N[C@H](CO)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616896,nM,18100,CHEMBL284,4.742321425,DPPIV,CC#CCn1c(N2CC(=O)N[C@H](CO)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CC(=O)NC(CO)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714192,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(NCC(N)=O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616897,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(=NCC(N)=O)[nH]c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(=NCC(N)=O)[nH]c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714193,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(NCCNC(C)=O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616898,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(=NCCNC(C)=O)[nH]c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(=NCCNC(C)=O)[nH]c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714194,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(NCCNC(=O)c2ccncc2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CHEMBL3616899,nM,50000,CHEMBL284,4.301029996,DPPIV,CC#CCn1c(=NCCNC(=O)c2ccncc2)[nH]c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC#CCn1c(=NCCNC(=O)c2ccncc2)[nH]c2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714195,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ncc3ccccc3n1)c(=O)n2C,CHEMBL3616900,nM,5.8,CHEMBL284,8.236572006,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ncc3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ncc3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714196,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nc(OC)c3ccccc3n1)c(=O)n2C,CHEMBL3616901,nM,25,CHEMBL284,7.602059991,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nc(OC)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nc(OC)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714197,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc3ccccc3n1)c(=O)n2C,CHEMBL3616902,nM,29,CHEMBL284,7.537602002,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714198,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc3ccccc3c1)c(=O)n2C,CHEMBL3616903,nM,180,CHEMBL284,6.744727495,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc3ccccc3c1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc3ccccc3c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714199,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1csc(CO)n1)c(=O)n2C,CHEMBL3616888,nM,650,CHEMBL284,6.187086643,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1csc(CO)n1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1csc(CO)n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714200,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccccc1)c(=O)n2C,CHEMBL3616904,nM,1230,CHEMBL284,5.910094889,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccccc1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714201,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1cccc(C#N)c1)c(=O)n2C,CHEMBL3616905,nM,340,CHEMBL284,6.468521083,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1cccc(C#N)c1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1cccc(C#N)c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714202,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-c3ccccc3C#N)cc1)c(=O)n2C,CHEMBL3616906,nM,1800,CHEMBL284,5.744727495,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-c3ccccc3C#N)cc1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-c3ccccc3C#N)cc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714203,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nn(-c3ccccc3)nc1C)c(=O)n2C,CHEMBL3616907,nM,180,CHEMBL284,6.744727495,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nn(-c3ccccc3)nc1C)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1nn(-c3ccccc3)nc1C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714204,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-n3cccn3)cc1)c(=O)n2C,CHEMBL3616908,nM,1440,CHEMBL284,5.841637508,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-n3cccn3)cc1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-n3cccn3)cc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714205,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-n3cncn3)cc1)c(=O)n2C,CHEMBL3616909,nM,220,CHEMBL284,6.657577319,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-n3cncn3)cc1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(Cc1ccc(-n3cncn3)cc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714206,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1ccccn1)c(=O)n2C,CHEMBL3616910,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1ccccn1)c(=O)n2C,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1ccccn1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714207,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1cccnc1)c(=O)n2C,CHEMBL3616911,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1cccnc1)c(=O)n2C,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1cccnc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714208,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1ccncc1)c(=O)n2C,CHEMBL3616912,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1ccncc1)c(=O)n2C,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1ccncc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714209,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(C(C)C)c(=O)n2C,CHEMBL3616913,nM,980,CHEMBL284,6.008773924,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(C(C)C)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C(C)C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714210,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,Cn1c(N2CCNC(=O)C2)nc2c1c(=O)[nH]c(=O)n2C,CHEMBL3616914,nM,100000,CHEMBL284,4,DPPIV,Cn1c(N2CCNC(=O)C2)nc2c1c(=O)[nH]c(=O)n2C,Cn1c(N2CCNC(=O)C2)nc2c1c(=O)[nH]c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714211,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)[nH]c(=O)n2C,CHEMBL3616915,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)[nH]c(=O)n2C,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)[nH]c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714212,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,COc1nc(Cn2c(=O)c3c(nc(N4CCNC(=O)C4)n3C)n(C)c2=O)nc2ccccc12,CHEMBL3616916,nM,100000,CHEMBL284,4,DPPIV,COc1nc(Cn2c(=O)c3c(nc(N4CCNC(=O)C4)n3C)n(C)c2=O)nc2ccccc12,COc1nc(Cn2c(=O)c3c(nc(N4CCNC(=O)C4)n3C)n(C)c2=O)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714213,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1nc(OC)c3ccccc3n1)c(=O)n2C,CHEMBL3616917,nM,100000,CHEMBL284,4,DPPIV,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1nc(OC)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCNC(=O)C2)nc2c1c(=O)n(Cc1nc(OC)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714215,CHEMBL3620564,Binding affinity to DPP4 (unknown origin),B,COc1nc(Cn2c(=O)c3c(nc(N4CCNC(=O)C4)n3CCC=C(C)C)n(C)c2=O)nc2ccccc12,CHEMBL3616919,nM,100000,CHEMBL284,4,DPPIV,COc1nc(Cn2c(=O)c3c(nc(N4CCNC(=O)C4)n3CCC=C(C)C)n(C)c2=O)nc2ccccc12,COc1nc(Cn2c(=O)c3c(nc(N4CCNC(=O)C4)n3CCC=C(C)C)n(C)c2=O)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15714350,CHEMBL3620574,Inhibition of DPP4 (unknown origin),B,O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O,CHEMBL4296719,nM,23,CHEMBL284,7.638272164,DPPIV,O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O,O=C(CNC1CCNC1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722570,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,O=C(Nc1ccc(F)cc1)c1cnn(-c2ccccc2)c1NC(=O)C(F)(F)F,CHEMBL3618140,nM,1250,CHEMBL284,5.903089987,DPPIV,O=C(Nc1ccc(F)cc1)c1c[nH]n(-c2ccccc2)c1=NC(=O)C(F)(F)F,O=C(Nc1ccc(F)cc1)c1c[nH]n(-c2ccccc2)c1=NC(=O)C(F)(F)F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722573,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,COc1ccc(-n2ncc3c(=O)n(-c4nc(-c5ccc(Cl)cc5)cs4)c(C)nc32)cc1,CHEMBL3618137,nM,100000,CHEMBL284,4,DPPIV,COc1ccc(-n2ncc3c(=O)n(-c4nc(-c5ccc(Cl)cc5)cs4)c(C)nc32)cc1,COc1ccc(-n2ncc3c(=O)n(-c4nc(-c5ccc(Cl)cc5)cs4)c(C)nc32)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722576,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,COc1ccc(-n2ncc3c(=O)n(-c4cc(C)ccn4)c(C)nc32)cc1,CHEMBL3618134,nM,2230,CHEMBL284,5.651695137,DPPIV,COc1ccc(-n2ncc3c(=O)n(-c4cc(C)ccn4)c(C)nc32)cc1,COc1ccc(-n2ncc3c(=O)n(-c4cc(C)ccn4)c(C)nc32)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722579,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccc(Br)cn1,CHEMBL3618039,nM,11000,CHEMBL284,4.958607315,DPPIV,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccc(Br)cn1,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccc(Br)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722580,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,Cc1ccnc(-n2c(C)nc3c(cnn3-c3ccccc3)c2=O)c1,CHEMBL3618038,nM,1060,CHEMBL284,5.974694135,DPPIV,Cc1ccnc(-n2c(C)nc3c(cnn3-c3ccccc3)c2=O)c1,Cc1ccnc(-n2c(C)nc3c(cnn3-c3ccccc3)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722581,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ncccn1,CHEMBL3618037,nM,24000,CHEMBL284,4.619788758,DPPIV,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ncccn1,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ncccn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722582,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccn1,CHEMBL3618036,nM,4000,CHEMBL284,5.397940009,DPPIV,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccn1,Cc1nc2c(cnn2-c2ccccc2)c(=O)n1-c1ccccn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15722586,CHEMBL3618876,Inhibition of human recombinant DPP-4 using Gly-pro-p-nitroanilide as substrate assessed as formation of p-nitroaniline after 30 mins by colorimetric assay,B,Cc1cc(C)c(-n2c(C)nc3c(cnn3-c3ccccc3)c2=O)c(C)c1,CHEMBL3618032,nM,1320,CHEMBL284,5.879426069,DPPIV,Cc1cc(C)c(-n2c(C)nc3c(cnn3-c3ccccc3)c2=O)c(C)c1,Cc1cc(C)c(-n2c(C)nc3c(cnn3-c3ccccc3)c2=O)c(C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15762431,CHEMBL3635485,Inhibition of human plasma DPP-4 using Gly-Pro-4-methylcoumaryl-7-amide as substrate assessed as formation of 7-amino-4-methylcoumarin after 2 hrs by fluorescence plate reader analysis,B,CC[C@@H](C)[C@H](N)C(=O)N1CC(F)(F)C[C@H]1C#N,CHEMBL3632867,nM,0.8,CHEMBL284,9.096910013,DPPIV,CCC(C)C(N)C(=O)N1CC(F)(F)C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(F)(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15762432,CHEMBL3635485,Inhibition of human plasma DPP-4 using Gly-Pro-4-methylcoumaryl-7-amide as substrate assessed as formation of 7-amino-4-methylcoumarin after 2 hrs by fluorescence plate reader analysis,B,CC[C@@H](C)[C@H](N)C(=O)N1C[C@H](F)C[C@H]1C#N,CHEMBL3632866,nM,290,CHEMBL284,6.537602002,DPPIV,CCC(C)C(N)C(=O)N1C[C@H](F)C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15762433,CHEMBL3635485,Inhibition of human plasma DPP-4 using Gly-Pro-4-methylcoumaryl-7-amide as substrate assessed as formation of 7-amino-4-methylcoumarin after 2 hrs by fluorescence plate reader analysis,B,CC[C@@H](C)[C@H](N)C(=O)N1C[C@@H](F)C[C@H]1C#N,CHEMBL3632865,nM,0.6,CHEMBL284,9.22184875,DPPIV,CCC(C)C(N)C(=O)N1C[C@@H](F)C[C@H]1C#N,CCC(C)C(N)C(=O)N1CC(F)CC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
15762434,CHEMBL3635485,Inhibition of human plasma DPP-4 using Gly-Pro-4-methylcoumaryl-7-amide as substrate assessed as formation of 7-amino-4-methylcoumarin after 2 hrs by fluorescence plate reader analysis,B,CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C#N,CHEMBL3632864,nM,1.5,CHEMBL284,8.823908741,DPPIV,CCC(C)C(N)C(=O)N1CCC[C@H]1C#N,CCC(C)C(N)C(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16265262,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,CHEMBL3644788,nM,6,CHEMBL284,8.22184875,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,NC(CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16269984,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,COCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)[C@@H]1O)C2,CHEMBL3644790,nM,14,CHEMBL284,7.853871964,DPPIV,COCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)[C@@H]1O)C2,COCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)CC(N)CN1C(=O)CCC(F)(F)C1O)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16272442,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,CHEMBL3644783,nM,5,CHEMBL284,8.301029996,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,NC(CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16275670,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,CC1CC(=O)N(C[C@@H](N)CC(=O)N2CCc3c(nc(C(C)(C)C)nc3C(F)(F)F)C2)C1=O,CHEMBL3644802,nM,2500,CHEMBL284,5.602059991,DPPIV,Cc1cc(O)n(C[C@@H](N)CC(=O)N2CCc3c(nc(C(C)(C)C)nc3C(F)(F)F)C2)c1O,Cc1cc(O)n(CC(N)CC(=O)N2CCc3c(nc(C(C)(C)C)nc3C(F)(F)F)C2)c1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16278124,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,CHEMBL3644787,nM,10,CHEMBL284,8,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,NC(CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16278421,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,CCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)C1O)C2,CHEMBL3644799,nM,409,CHEMBL284,6.388276692,DPPIV,CCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)C1O)C2,CCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)CC(N)CN1C(=O)CCC(F)C1O)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16283750,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,CHEMBL3644782,nM,36,CHEMBL284,7.443697499,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,NC(CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16285074,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,CC(C)(C)c1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)C1O)C2,CHEMBL3644785,nM,39,CHEMBL284,7.408935393,DPPIV,CC(C)(C)c1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)C1O)C2,CC(C)(C)c1nc2c(c(C(F)(F)F)n1)CCN(C(=O)CC(N)CN1C(=O)CCC(F)(F)C1O)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16289231,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,CC1CCC(=O)N(C[C@@H](N)CC(=O)N2CCc3c(nc(-c4cccs4)nc3C(F)(F)F)C2)C1=O,CHEMBL3644801,nM,2500,CHEMBL284,5.602059991,DPPIV,CC1CCC(=O)N(C[C@@H](N)CC(=O)N2CCc3c(nc(-c4cccs4)nc3C(F)(F)F)C2)C1=O,CC1CCC(=O)N(CC(N)CC(=O)N2CCc3c(nc(-c4cccs4)nc3C(F)(F)F)C2)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16292595,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,CHEMBL3644793,nM,195,CHEMBL284,6.709965389,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,NC(CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16292839,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(C3CCC3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,CHEMBL3644786,nM,17,CHEMBL284,7.769551079,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(C3CCC3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,NC(CC(=O)N1CCc2c(nc(C3CCC3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16296253,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,COCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)[C@H]1O)C2,CHEMBL3644791,nM,160,CHEMBL284,6.795880017,DPPIV,COCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)[C@H]1O)C2,COCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)CC(N)CN1C(=O)CCC(F)(F)C1O)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16306966,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccc(F)cc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,CHEMBL3644794,nM,57,CHEMBL284,7.244125144,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccc(F)cc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,NC(CC(=O)N1CCc2c(nc(-c3ccc(F)cc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16307977,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,CHEMBL3644798,nM,159,CHEMBL284,6.798602876,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,NC(CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16312550,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,CHEMBL3644803,nM,63,CHEMBL284,7.200659451,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,NC(CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16313091,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,CHEMBL3644789,nM,93,CHEMBL284,7.031517051,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@H]1O,NC(CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16317545,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,CHEMBL3644792,nM,10,CHEMBL284,8,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)[C@@H]1O,NC(CC(=O)N1CCc2c(nc(-c3cccs3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16326371,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,CC(C)(C)c1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)C1O)C2,CHEMBL3644796,nM,197,CHEMBL284,6.705533774,DPPIV,CC(C)(C)c1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)C1O)C2,CC(C)(C)c1nc2c(c(C(F)(F)F)n1)CCN(C(=O)CC(N)CN1C(=O)CCC(F)C1O)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16329140,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,CCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)C1O)C2,CHEMBL3644784,nM,20,CHEMBL284,7.698970004,DPPIV,CCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)C[C@H](N)CN1C(=O)CCC(F)(F)C1O)C2,CCCc1nc2c(c(C(F)(F)F)n1)CCN(C(=O)CC(N)CN1C(=O)CCC(F)(F)C1O)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16336488,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,CHEMBL3644797,nM,81,CHEMBL284,7.091514981,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,NC(CC(=O)N1CCc2c(nc(-c3ccco3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16350569,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,CHEMBL3644800,nM,206,CHEMBL284,6.68613278,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,NC(CC(=O)N1CCc2c(nc(-c3ccncc3)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16352886,CHEMBL3705245,"DPP-IV Assay: Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution containing 50 mM HEPES (pH 7.4), with the concentration of DPP-IV being 7.1 nM. IC50 values of the inhibitors were determined by measuring the amount of fluorescence so emitted in a fluorescence spectrometer after allowing an enzymatic reaction for 1 hour, and then calculating the concentration of inhibitors exhibiting 50% inhibition of the total enzymatic reaction. Spectra MAX GeminiXS fluorescence spectrometer (Molecular Device Co.) was used as the fluorescence spectrometer and the excitation and emission wavelengths were set to 400 nm and 505 nm, respectively.",B,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1=O,CHEMBL3644795,nM,2500,CHEMBL284,5.602059991,DPPIV,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1=O,NC(CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1C(=O)CCC(F)(F)C1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378634,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NC(=O)C4CC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3734964,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](n2cc3[nH][nH]c(=NC(O)C4CC4)c3c2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(n2cc3[nH][nH]c(=NC(O)C4CC4)c3c2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378635,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NC(=O)c4nccs4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3735129,nM,4.3,CHEMBL284,8.366531544,DPPIV,N[C@H]1C[C@@H](n2cc3[nH][nH]c(=NC(O)c4nccs4)c3c2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(n2cc3[nH][nH]c(=NC(O)c4nccs4)c3c2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378636,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NC(=O)c4ccncc4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3735925,nM,3.7,CHEMBL284,8.431798276,DPPIV,N[C@H]1C[C@@H](n2cc3[nH][nH]c(=NC(O)c4ccncc4)c3c2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(n2cc3[nH][nH]c(=NC(O)c4ccncc4)c3c2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378637,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CS(=O)(=O)Nc1n[nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3734769,nM,3.2,CHEMBL284,8.494850022,DPPIV,CS(=O)(=O)N=c1[nH][nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)N=c1[nH][nH]c2c1CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378638,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CCS(=O)(=O)Nc1n[nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3734828,nM,1.1,CHEMBL284,8.958607315,DPPIV,CCS(=O)(=O)N=c1[nH][nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CCS(=O)(=O)N=c1[nH][nH]c2c1CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378639,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NS(=O)(=O)CC(F)(F)F)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3735461,nM,1.3,CHEMBL284,8.886056648,DPPIV,N[C@H]1C[C@@H](N2Cc3[nH][nH]c(=NS(=O)(=O)CC(F)(F)F)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3[nH][nH]c(=NS(=O)(=O)CC(F)(F)F)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378640,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NS(=O)(=O)C4CC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3734999,nM,1.8,CHEMBL284,8.744727495,DPPIV,N[C@H]1C[C@@H](N2Cc3[nH][nH]c(=NS(=O)(=O)C4CC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3[nH][nH]c(=NS(=O)(=O)C4CC4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378641,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NS(=O)(=O)Cc4ccncc4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3735433,nM,1.8,CHEMBL284,8.744727495,DPPIV,N[C@H]1C[C@@H](N2Cc3[nH][nH]c(=NS(=O)(=O)Cc4ccncc4)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3[nH][nH]c(=NS(=O)(=O)Cc4ccncc4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378642,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(NS(=O)(=O)c4c[nH]cn4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3736137,nM,0.3,CHEMBL284,9.522878745,DPPIV,N[C@H]1C[C@@H](N2Cc3[nH][nH]c(=NS(=O)(=O)c4c[nH]cn4)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3[nH][nH]c(=NS(=O)(=O)c4c[nH]cn4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378643,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CS(=O)(=O)c1n[nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3735917,nM,1.7,CHEMBL284,8.769551079,DPPIV,CS(=O)(=O)c1[nH]nc2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)c1[nH]nc2c1CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378644,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CC(C)S(=O)(=O)c1n[nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3735694,nM,1.7,CHEMBL284,8.769551079,DPPIV,CC(C)S(=O)(=O)c1[nH]nc2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CC(C)S(=O)(=O)c1[nH]nc2c1CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16378645,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3[nH]nc(S(=O)(=O)c4ccccc4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3735843,nM,0.4,CHEMBL284,9.397940009,DPPIV,N[C@H]1C[C@@H](N2Cc3[nH]nc(S(=O)(=O)c4ccccc4)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3[nH]nc(S(=O)(=O)c4ccccc4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394166,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C(F)(F)F)nc3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3736188,nM,2.3,CHEMBL284,8.638272164,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C(F)(F)F)nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C(F)(F)F)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394167,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CCS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3735281,nM,1.8,CHEMBL284,8.744727495,DPPIV,CCS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CCS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394168,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CCCS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3734912,nM,5.7,CHEMBL284,8.244125144,DPPIV,CCCS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CCCS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394169,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CC(C)S(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3735865,nM,0.7,CHEMBL284,9.15490196,DPPIV,CC(C)S(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CC(C)S(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394170,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3736190,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cnn(S(=O)(=O)C4CC4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394171,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3735329,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394172,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CCCC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3645492,nM,2.6,CHEMBL284,8.585026652,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CCCC4)c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cnn(S(=O)(=O)C4CCCC4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394173,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3736085,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394174,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,Cn1cnc(S(=O)(=O)n2ncc3c2CN([C@H]2CO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)c1,CHEMBL3735852,nM,4.9,CHEMBL284,8.30980392,DPPIV,Cn1cnc(S(=O)(=O)n2ncc3c2CN([C@H]2CO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)c1,Cn1cnc(S(=O)(=O)n2ncc3c2CN(C2COC(c4cc(F)ccc4F)C(N)C2)C3)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394175,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,Cn1cnc(S(=O)(=O)n2cc3c(n2)CN([C@H]2CO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)c1,CHEMBL3736423,nM,1.9,CHEMBL284,8.721246399,DPPIV,Cn1cnc(S(=O)(=O)n2cc3c(n2)CN([C@H]2CO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)c1,Cn1cnc(S(=O)(=O)n2cc3c(n2)CN(C2COC(c4cc(F)ccc4F)C(N)C2)C3)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394176,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)c4ccccc4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3736511,nM,2.3,CHEMBL284,8.638272164,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)c4ccccc4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)c4ccccc4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394177,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)c4cccc(C(F)(F)F)c4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3736067,nM,1.9,CHEMBL284,8.721246399,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)c4cccc(C(F)(F)F)c4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)c4cccc(C(F)(F)F)c4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16394178,CHEMBL3737789,Inhibition of recombinant human DPP4 expressed in Sf9 cells using Gly-Pro-AMC substrate after 30 mins by plate reader analysis,B,CCC(=O)Nc1n[nH]c2c1CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3736135,nM,1.4,CHEMBL284,8.853871964,DPPIV,CCC(O)N=c1[nH][nH]c2cn([C@H]3CO[C@H](c4cc(F)ccc4F)[C@@H](N)C3)cc12,CCC(O)N=c1[nH][nH]c2cn(C3COC(c4cc(F)ccc4F)C(N)C3)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565491,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)[C@@H](N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL3797441,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1C[C@H](N=[N+]=[N-])CN1C(=O)C(N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,N#CC1CC(N=[N+]=[N-])CN1C(=O)C(N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565492,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,C[C@H]1C[C@@H](C#N)N(C(=O)[C@@H](N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL3798441,nM,2600,CHEMBL284,5.585026652,DPPIV,C[C@H]1C[C@@H](C#N)N(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,CC1CC(C#N)N(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565493,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CC1CCN(C(=O)[C@@H](N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1.O=C(O)C(F)(F)F,CHEMBL3799388,nM,19400,CHEMBL284,4.71219827,DPPIV,CC1CCN(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,CC1CCN(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565494,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CC[C@@H](C)[C@H](N)C(=O)N1CCC(C)C1.O=C(O)C(F)(F)F,CHEMBL3798777,nM,16200,CHEMBL284,4.790484985,DPPIV,CCC(C)C(N)C(=O)N1CCC(C)C1,CCC(C)C(N)C(=O)N1CCC(C)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565495,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,C=C1C[C@@H](C#N)N(C(=O)[C@@H](N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL3797842,nM,680,CHEMBL284,6.167491087,DPPIV,C=C1C[C@@H](C#N)N(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,C=C1CC(C#N)N(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565496,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,C=C1CCN(C(=O)[C@@H](N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL3800113,nM,34000,CHEMBL284,4.468521083,DPPIV,C=C1CCN(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,C=C1CCN(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565497,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,C=C1CCN(C(=O)[C@@H](N)[C@H](C)CC)C1.O=C(O)C(F)(F)F,CHEMBL3798975,nM,50000,CHEMBL284,4.301029996,DPPIV,C=C1CCN(C(=O)C(N)C(C)CC)C1,C=C1CCN(C(=O)C(N)C(C)CC)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565498,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CCC1CCN(C(=O)[C@@H](N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,CHEMBL3797358,nM,100000,CHEMBL284,4,DPPIV,CCC1CCN(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,CCC1CCN(C(=O)C(N)CC(=O)N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565499,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CCC1CCN(C(=O)[C@@H](N)[C@H](C)CC)C1.O=C(O)C(F)(F)F,CHEMBL3797398,nM,100000,CHEMBL284,4,DPPIV,CCC1CCN(C(=O)C(N)C(C)CC)C1,CCC1CCN(C(=O)C(N)C(C)CC)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565500,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1CCC(C(F)(F)F)C1,CHEMBL3798691,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1CCC(C(F)(F)F)C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1CCC(C(F)(F)F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565501,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2cn[nH]c2C1.O=C(O)C(F)(F)F,CHEMBL3800436,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2c[nH]nc2C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2c[nH]nc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565502,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2cn[nH]c2C1.O=C(O)C(F)(F)F,CHEMBL3800132,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2c[nH]nc2C1,CCC(C)C(N)C(=O)N1Cc2c[nH]nc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565503,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2conc2C1.O=C(O)C(F)(F)F,CHEMBL3798277,nM,100000,CHEMBL284,4,DPPIV,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2conc2C1,NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2conc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565504,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2conc2C1.O=C(O)C(F)(F)F,CHEMBL3800380,nM,56000,CHEMBL284,4.251811973,DPPIV,CCC(C)C(N)C(=O)N1Cc2conc2C1,CCC(C)C(N)C(=O)N1Cc2conc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565505,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,Cc1nc2c(s1)CN(C(=O)[C@@H](N)CC(=O)N1CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC1)C2.O=C(O)C(F)(F)F,CHEMBL3797355,nM,100000,CHEMBL284,4,DPPIV,Cc1nc2c(s1)CN(C(=O)C(N)CC(=O)N1CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC1)C2,Cc1nc2c(s1)CN(C(=O)C(N)CC(=O)N1CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565506,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CC[C@@H](C)[C@H](N)C(=O)N1Cc2nc(C)sc2C1.O=C(O)C(F)(F)F,CHEMBL3797536,nM,100000,CHEMBL284,4,DPPIV,CCC(C)C(N)C(=O)N1Cc2nc(C)sc2C1,CCC(C)C(N)C(=O)N1Cc2nc(C)sc2C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565507,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,N#C[C@@H]1[C@@H]2C[C@@H]2CN1C(=O)[C@@H](N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F,CHEMBL3797299,nM,790,CHEMBL284,6.102372909,DPPIV,N#C[C@@H]1[C@@H]2C[C@@H]2CN1C(=O)C(N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,N#CC1C2CC2CN1C(=O)C(N)CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16565508,CHEMBL3802984,Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate preincubated for 15 mins followed by substrate addition measured for 10 mins by spectrofluorimetry,B,CC[C@@H](C)[C@H](N)C(=O)N1C[C@H]2C[C@H]2[C@H]1C#N.O=C(O)C(F)(F)F,CHEMBL3799074,nM,4000,CHEMBL284,5.397940009,DPPIV,CCC(C)C(N)C(=O)N1C[C@H]2C[C@H]2[C@H]1C#N,CCC(C)C(N)C(=O)N1CC2CC2C1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584366,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccn2nc3c(c2n1)CN([C@@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3804940,nM,8.6,CHEMBL284,8.065501549,DPPIV,Cc1ccn2nc3c(c2n1)CN([C@@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccn2nc3c(c2n1)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584367,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccnc2c3c(nn12)CN([C@@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3805696,nM,289,CHEMBL284,6.539102157,DPPIV,Cc1ccnc2c3c(nn12)CN([C@@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccnc2c3c(nn12)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584368,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccnc2c3c(nn12)CN([C@@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3805235,nM,44,CHEMBL284,7.356547324,DPPIV,Cc1ccnc2c3c(nn12)CN([C@@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccnc2c3c(nn12)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584392,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccn2nc3c(c2n1)CN([C@@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3804854,nM,699,CHEMBL284,6.155522824,DPPIV,Cc1ccn2nc3c(c2n1)CN([C@@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccn2nc3c(c2n1)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584393,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)ccc1F,CHEMBL3806164,nM,1170,CHEMBL284,5.931814138,DPPIV,N[C@H]1C[C@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3nn4cccnc4c3C2)CCC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584394,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4nccnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3806052,nM,0.12,CHEMBL284,9.920818754,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4nccnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3nn4nccnc4c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584395,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4cncnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3805353,nM,3.5,CHEMBL284,8.455931956,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4cncnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3nn4cncnc4c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584396,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc(O)nc2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3806310,nM,0.6,CHEMBL284,9.22184875,DPPIV,Cc1cc(=O)[nH]c2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1cc(=O)[nH]c2c3c(nn12)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584397,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc(O)n2nc3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3805154,nM,0.5,CHEMBL284,9.301029996,DPPIV,Cc1cc(=O)n2[nH]c3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1cc(=O)n2[nH]c3c(c2n1)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584398,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc(C(F)(F)F)nc2c3c(nn12)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3804996,nM,1.9,CHEMBL284,8.721246399,DPPIV,Cc1cc(C(F)(F)F)nc2c3c(nn12)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1cc(C(F)(F)F)nc2c3c(nn12)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584399,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4c(C(F)(F)F)ccnc4c3C2)CO[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3805937,nM,1.4,CHEMBL284,8.853871964,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4c(C(F)(F)F)ccnc4c3C2)CO[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3nn4c(C(F)(F)F)ccnc4c3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584400,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4c(C(F)(F)F)ccnc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3805179,nM,1.1,CHEMBL284,8.958607315,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4c(C(F)(F)F)ccnc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3nn4c(C(F)(F)F)ccnc4c3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584401,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccnc2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3804950,nM,2.9,CHEMBL284,8.537602002,DPPIV,Cc1ccnc2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1ccnc2c3c(nn12)CN(C1COC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584402,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccnc2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3806021,nM,0.6,CHEMBL284,9.22184875,DPPIV,Cc1ccnc2c3c(nn12)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccnc2c3c(nn12)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584403,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccnc2c3c(nn12)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3804994,nM,54,CHEMBL284,7.26760624,DPPIV,Cc1ccnc2c3c(nn12)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccnc2c3c(nn12)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584404,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4ccc(C(F)(F)F)nc4c3C2)CO[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3805502,nM,1.5,CHEMBL284,8.823908741,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4ccc(C(F)(F)F)nc4c3C2)CO[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3nn4ccc(C(F)(F)F)nc4c3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584405,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4ccc(C(F)(F)F)nc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3805871,nM,1.1,CHEMBL284,8.958607315,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4ccc(C(F)(F)F)nc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3nn4ccc(C(F)(F)F)nc4c3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584406,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccn2nc3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3805400,nM,1.5,CHEMBL284,8.823908741,DPPIV,Cc1ccn2nc3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1ccn2nc3c(c2n1)CN(C1COC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584407,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccn2nc3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3805751,nM,0.5,CHEMBL284,9.301029996,DPPIV,Cc1ccn2nc3c(c2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccn2nc3c(c2n1)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584408,CHEMBL3807661,Inhibition of human DPP4,B,Cc1ccn2nc3c(c2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3806239,nM,155,CHEMBL284,6.809668302,DPPIV,Cc1ccn2nc3c(c2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1ccn2nc3c(c2n1)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584409,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL3806216,nM,0.7,CHEMBL284,9.15490196,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3nn4cccnc4c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584410,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3806003,nM,3.7,CHEMBL284,8.431798276,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3nn4cccnc4c3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584411,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)ccc1F,CHEMBL3806026,nM,7.3,CHEMBL284,8.13667714,DPPIV,N[C@H]1C[C@@H](N2Cc3nn4cccnc4c3C2)CC[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3nn4cccnc4c3C2)CCC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584412,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cnc4nc(C5CC5)nn4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3805346,nM,1.7,CHEMBL284,8.769551079,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc4nc(C5CC5)nn4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnc4nc(C5CC5)nn4c3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584413,CHEMBL3807661,Inhibition of human DPP4,B,N[C@H]1C[C@@H](N2Cc3cnc4nnc(C5CC5)n4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3806041,nM,0.24,CHEMBL284,9.619788758,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc4nnc(C5CC5)n4c3C2)CC[C@@H]1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnc4nnc(C5CC5)n4c3C2)CCC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584414,CHEMBL3807661,Inhibition of human DPP4,B,Cc1nc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3805629,nM,0.23,CHEMBL284,9.638272164,DPPIV,Cc1nc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1nc2ncc3c(n2n1)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584415,CHEMBL3807661,Inhibition of human DPP4,B,Cc1nnc2ncc3c(n12)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3806023,nM,0.56,CHEMBL284,9.251811973,DPPIV,Cc1nnc2ncc3c(n12)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1nnc2ncc3c(n12)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584416,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2ncc3c(n2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3806029,nM,0.7,CHEMBL284,9.15490196,DPPIV,Cc1cc2ncc3c(n2n1)CN([C@H]1CO[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1cc2ncc3c(n2n1)CN(C1COC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584417,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,CHEMBL3805966,nM,0.14,CHEMBL284,9.853871964,DPPIV,Cc1cc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)c(F)cc2F)[C@@H](N)C1)C3,Cc1cc2ncc3c(n2n1)CN(C1CCC(c2cc(F)c(F)cc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584418,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2ncc3c(n2n1)CN([C@@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3806179,nM,16,CHEMBL284,7.795880017,DPPIV,Cc1cc2ncc3c(n2n1)CN([C@@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1cc2ncc3c(n2n1)CN(C1CCC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584419,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2ncc3c(n2n1)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3805294,nM,0.7,CHEMBL284,9.15490196,DPPIV,Cc1cc2ncc3c(n2n1)CN([C@H]1CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1cc2ncc3c(n2n1)CN(C1COC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584420,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3806157,nM,0.6,CHEMBL284,9.22184875,DPPIV,Cc1cc2ncc3c(n2n1)CN([C@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1cc2ncc3c(n2n1)CN(C1CCC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584421,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2nc3c(cn2n1)CN([C@@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3804982,nM,26,CHEMBL284,7.585026652,DPPIV,Cc1cc2nc3c(cn2n1)CN([C@@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1cc2nc3c(cn2n1)CN(C1CCC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16584422,CHEMBL3807661,Inhibition of human DPP4,B,Cc1cc2nc3c(cn2n1)CN([C@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,CHEMBL3805226,nM,1.1,CHEMBL284,8.958607315,DPPIV,Cc1cc2nc3c(cn2n1)CN([C@H]1CC[C@H](c2cc(F)ccc2F)[C@@H](N)C1)C3,Cc1cc2nc3c(cn2n1)CN(C1CCC(c2cc(F)ccc2F)C(N)C1)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609224,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CCN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3F)c1c2=O,CHEMBL3687982,nM,625,CHEMBL284,6.204119983,DPPIV,CCn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3F)nc12,CCn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3F)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609225,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CCN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C(F)(F)F)c1c2=O,CHEMBL3687983,nM,11.2,CHEMBL284,7.950781977,DPPIV,CCn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3C(F)(F)F)nc12,CCn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3C(F)(F)F)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609226,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CCN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c1c2=O,CHEMBL3813856,nM,13.5,CHEMBL284,7.869666232,DPPIV,CCn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3C#N)nc12,CCn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3C#N)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609227,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3F)c1c2=O,CHEMBL3687979,nM,156.1,CHEMBL284,6.806597097,DPPIV,Cn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3F)nc12,Cn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3F)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609228,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C(F)(F)F)c1c2=O,CHEMBL3687977,nM,27.4,CHEMBL284,7.562249437,DPPIV,Cn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3C(F)(F)F)nc12,Cn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3C(F)(F)F)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609229,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c1c2=O,CHEMBL3687984,nM,1.7,CHEMBL284,8.769551079,DPPIV,Cn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3C#N)nc12,Cn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3C#N)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609230,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c1c2=O,CHEMBL3687978,nM,10.6,CHEMBL284,7.974694135,DPPIV,Cn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3C#N)nc12,Cn1c(O)cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3ccccc3C#N)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16609231,CHEMBL3816312,Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2nc3n(c(=O)c21)CC(=O)N3C,CHEMBL3687980,nM,123,CHEMBL284,6.910094889,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2nc3n(C)c(O)cn3c(=O)c21,CC#CCn1c(N2CCCC(N)C2)nc2nc3n(C)c(O)cn3c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763211,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,COc1cc([C@H]2Oc3ccc4ccc(=O)oc4c3O[C@@H]2CO)cc(OC)c1O,CHEMBL584162,nM,14130,CHEMBL284,4.849857838,DPPIV,COc1cc([C@H]2Oc3ccc4ccc(=O)oc4c3O[C@@H]2CO)cc(OC)c1O,COc1cc(C2Oc3ccc4ccc(=O)oc4c3OC2CO)cc(OC)c1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763212,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,N[C@@H]1Cc2c(ccc3ccc(=O)oc23)O[C@H]1c1cc(F)c(F)cc1F,CHEMBL3952716,nM,206.71,CHEMBL284,6.684638513,DPPIV,N[C@@H]1Cc2c(ccc3ccc(=O)oc23)O[C@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3ccc(=O)oc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763213,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,N[C@@H]1Cc2c(ccc3ccccc23)O[C@H]1c1cc(F)c(F)cc1F,CHEMBL3926320,nM,110.1,CHEMBL284,6.958212681,DPPIV,N[C@@H]1Cc2c(ccc3ccccc23)O[C@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3ccccc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763215,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)O3,CHEMBL3928073,nM,60.61,CHEMBL284,7.217455716,DPPIV,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1cc(F)c(F)cc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763216,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N[C@@H]1Cc2c(ccc3ccc(Br)cc23)O[C@H]1c1cc(F)c(F)cc1F,CHEMBL3919178,nM,216.2,CHEMBL284,6.66514431,DPPIV,N[C@@H]1Cc2c(ccc3ccc(Br)cc23)O[C@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3ccc(Br)cc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763217,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N#Cc1ccc2ccc3c(c2c1)C[C@@H](N)[C@H](c1cc(F)c(F)cc1F)O3,CHEMBL3942715,nM,205.2,CHEMBL284,6.687822644,DPPIV,N#Cc1ccc2ccc3c(c2c1)C[C@@H](N)[C@H](c1cc(F)c(F)cc1F)O3,N#Cc1ccc2ccc3c(c2c1)CC(N)C(c1cc(F)c(F)cc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763218,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,CS(=O)(=O)c1cccc(-c2ccc3ccc4c(c3c2)C[C@@H](N)[C@H](c2cc(F)c(F)cc2F)O4)c1,CHEMBL3910262,nM,14.6,CHEMBL284,7.835647144,DPPIV,CS(=O)(=O)c1cccc(-c2ccc3ccc4c(c3c2)C[C@@H](N)[C@H](c2cc(F)c(F)cc2F)O4)c1,CS(=O)(=O)c1cccc(-c2ccc3ccc4c(c3c2)CC(N)C(c2cc(F)c(F)cc2F)O4)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763219,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2c3c(ccc2c1)O[C@@H](c1cc(F)c(F)cc1F)[C@H](N)C3,CHEMBL3929146,nM,49.73,CHEMBL284,7.303381541,DPPIV,COc1ccc2c3c(ccc2c1)O[C@@H](c1cc(F)c(F)cc1F)[C@H](N)C3,COc1ccc2c3c(ccc2c1)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763220,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N[C@@H]1Cc2c(ccc3cc(Br)ccc23)O[C@H]1c1cc(F)c(F)cc1F,CHEMBL3892233,nM,39.2,CHEMBL284,7.406713933,DPPIV,N[C@@H]1Cc2c(ccc3cc(Br)ccc23)O[C@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3cc(Br)ccc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763221,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N#Cc1ccc2c3c(ccc2c1)O[C@@H](c1cc(F)c(F)cc1F)[C@H](N)C3,CHEMBL3920234,nM,8.42,CHEMBL284,8.074687909,DPPIV,N#Cc1ccc2c3c(ccc2c1)O[C@@H](c1cc(F)c(F)cc1F)[C@H](N)C3,N#Cc1ccc2c3c(ccc2c1)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763222,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N[C@H]1Cc2c(ccc3cc(C(=O)O)ccc23)O[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3950517,nM,17.65,CHEMBL284,7.75325529,DPPIV,N[C@H]1Cc2c(ccc3cc(C(=O)O)ccc23)O[C@@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3cc(C(=O)O)ccc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763223,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N[C@H]1Cc2c(ccc3cc(N4CCOCC4)ccc23)O[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3890161,nM,70.42,CHEMBL284,7.152303979,DPPIV,N[C@H]1Cc2c(ccc3cc(N4CCOCC4)ccc23)O[C@@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3cc(N4CCOCC4)ccc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763224,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,CS(=O)(=O)Nc1ccc2c3c(ccc2c1)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3959221,nM,10.9,CHEMBL284,7.962573502,DPPIV,CS(=O)(=O)Nc1ccc2c3c(ccc2c1)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CS(=O)(=O)Nc1ccc2c3c(ccc2c1)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763225,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,CS(=O)(=O)c1ccc2c3c(ccc2c1)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3932825,nM,10.71,CHEMBL284,7.970210529,DPPIV,CS(=O)(=O)c1ccc2c3c(ccc2c1)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CS(=O)(=O)c1ccc2c3c(ccc2c1)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763226,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1ccc(F)cc1F)O3,CHEMBL3952691,nM,78.33,CHEMBL284,7.106071873,DPPIV,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1ccc(F)cc1F)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1ccc(F)cc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763227,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1ccccc1F)O3,CHEMBL3981442,nM,563.9,CHEMBL284,6.248797905,DPPIV,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1ccccc1F)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1ccccc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763228,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1cc(F)ccc1F)O3,CHEMBL3934008,nM,32.64,CHEMBL284,7.48624985,DPPIV,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1cc(F)ccc1F)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1cc(F)ccc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763229,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1cccc(F)c1)O3,CHEMBL3892398,nM,121.56,CHEMBL284,6.915209309,DPPIV,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1cccc(F)c1)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1cccc(F)c1)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763230,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1ccccc1Cl)O3,CHEMBL3972474,nM,337.8,CHEMBL284,6.471340355,DPPIV,COc1ccc2ccc3c(c2c1)C[C@H](N)[C@@H](c1ccccc1Cl)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1ccccc1Cl)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763232,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2ccc3c(c2c1)C[C@@H](N)[C@H](c1cc(F)c(F)cc1F)O3,CHEMBL3955701,nM,2930,CHEMBL284,5.53313238,DPPIV,COc1ccc2ccc3c(c2c1)C[C@@H](N)[C@H](c1cc(F)c(F)cc1F)O3,COc1ccc2ccc3c(c2c1)CC(N)C(c1cc(F)c(F)cc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763233,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1ccc2c3c(ccc2c1)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3901191,nM,19.64,CHEMBL284,7.706858517,DPPIV,COc1ccc2c3c(ccc2c1)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,COc1ccc2c3c(ccc2c1)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763235,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,N[C@H]1Cc2c(ccc3cc(Br)ccc23)O[C@@H]1c1cc(F)c(F)cc1F,CHEMBL3979508,nM,5.17,CHEMBL284,8.286509457,DPPIV,N[C@H]1Cc2c(ccc3cc(Br)ccc23)O[C@@H]1c1cc(F)c(F)cc1F,NC1Cc2c(ccc3cc(Br)ccc23)OC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763238,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1cc2ccc3c(c2cc1OC)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)O3,CHEMBL3941804,nM,2.06,CHEMBL284,8.68613278,DPPIV,COc1cc2ccc3c(c2cc1OC)C[C@H](N)[C@@H](c1cc(F)c(F)cc1F)O3,COc1cc2ccc3c(c2cc1OC)CC(N)C(c1cc(F)c(F)cc1F)O3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763265,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1cc2c3c(ccc2cc1NS(C)(=O)=O)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3942843,nM,6.13,CHEMBL284,8.212539525,DPPIV,COc1cc2c3c(ccc2cc1NS(C)(=O)=O)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,COc1cc2c3c(ccc2cc1NS(C)(=O)=O)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763266,CHEMBL3862754,Inhibition of DPP4 (unknown origin) expressed in Sf9 cells using Gly-Pro-AMC substrate,B,COc1cc2c3c(ccc2cc1S(C)(=O)=O)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3944427,nM,1.9,CHEMBL284,8.721246399,DPPIV,COc1cc2c3c(ccc2cc1S(C)(=O)=O)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,COc1cc2c3c(ccc2cc1S(C)(=O)=O)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763291,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,Cc1cc(=O)oc2c3c(ccc12)O[C@@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3968332,nM,50860,CHEMBL284,4.293623644,DPPIV,Cc1cc(=O)oc2c3c(ccc12)O[C@@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,Cc1cc(=O)oc2c3c(ccc12)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763292,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,Cc1cc(=O)oc2c3c(ccc12)O[C@H](c1cc(F)c(F)cc1F)[C@H](N)C3,CHEMBL3929764,nM,21520,CHEMBL284,4.667157733,DPPIV,Cc1cc(=O)oc2c3c(ccc12)O[C@H](c1cc(F)c(F)cc1F)[C@H](N)C3,Cc1cc(=O)oc2c3c(ccc12)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763293,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,Cc1cc(=O)oc2c3c(ccc12)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,CHEMBL3959577,nM,154.67,CHEMBL284,6.810593914,DPPIV,Cc1cc(=O)oc2c3c(ccc12)O[C@H](c1cc(F)c(F)cc1F)[C@@H](N)C3,Cc1cc(=O)oc2c3c(ccc12)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16763296,CHEMBL3862753,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,B,Cc1cc(=O)oc2c3c(ccc12)O[C@@H](c1cc(F)c(F)cc1F)[C@H](N)C3,CHEMBL3971196,nM,13070,CHEMBL284,4.883724412,DPPIV,Cc1cc(=O)oc2c3c(ccc12)O[C@@H](c1cc(F)c(F)cc1F)[C@H](N)C3,Cc1cc(=O)oc2c3c(ccc12)OC(c1cc(F)c(F)cc1F)C(N)C3,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823197,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(C#N)cc3)CC1)c(=O)n2C,CHEMBL3945617,nM,800,CHEMBL284,6.096910013,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(C#N)cc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(C#N)cc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823198,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(Br)cc3)CC1)c(=O)n2C,CHEMBL3924059,nM,770,CHEMBL284,6.113509275,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(Br)cc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(Br)cc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823199,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(Cl)cc3)CC1)c(=O)n2C,CHEMBL3896047,nM,360,CHEMBL284,6.443697499,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(Cl)cc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(Cl)cc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823200,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(F)cc3)CC1)c(=O)n2C,CHEMBL3915044,nM,510,CHEMBL284,6.292429824,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(F)cc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(F)cc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823201,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(OC)cc3)CC1)c(=O)n2C,CHEMBL3984849,nM,120,CHEMBL284,6.920818754,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(OC)cc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(OC)cc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823202,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(C)cc3)CC1)c(=O)n2C,CHEMBL3898220,nM,300,CHEMBL284,6.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(C)cc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccc(C)cc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823203,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccccc3)CC1)c(=O)n2C,CHEMBL3976778,nM,220,CHEMBL284,6.657577319,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccccc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Nc3ccccc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823204,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)N(C)C)CC1)c(=O)n2C,CHEMBL3897118,nM,260,CHEMBL284,6.585026652,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)N(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)N(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823205,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Oc3ccccc3)CC1)c(=O)n2C,CHEMBL3968249,nM,280,CHEMBL284,6.552841969,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Oc3ccccc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)Oc3ccccc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823206,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCCCC3)CC1)c(=O)n2C,CHEMBL3979866,nM,360,CHEMBL284,6.443697499,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCCCC3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCCCC3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823207,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCCC3)CC1)c(=O)n2C,CHEMBL3899590,nM,890,CHEMBL284,6.050609993,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCCC3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCCC3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823208,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCC3)CC1)c(=O)n2C,CHEMBL3972227,nM,610,CHEMBL284,6.214670165,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCC3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC3CCC3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823209,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OCCC)CC1)c(=O)n2C,CHEMBL3933623,nM,500,CHEMBL284,6.301029996,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OCCC)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OCCC)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823210,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OCC)CC1)c(=O)n2C,CHEMBL3980269,nM,140,CHEMBL284,6.853871964,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OCC)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OCC)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823211,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC)CC1)c(=O)n2C,CHEMBL3910158,nM,250,CHEMBL284,6.602059991,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823212,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCCNCC2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3927979,nM,2600,CHEMBL284,5.585026652,DPPIV,CC#CCn1c(N2CCCNCC2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCNCC2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823213,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3909049,nM,5400,CHEMBL284,5.26760624,DPPIV,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCNCC2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823215,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3920718,nM,400,CHEMBL284,6.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823216,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3892718,nM,140,CHEMBL284,6.853871964,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823217,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3929627,nM,760,CHEMBL284,6.119186408,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCN1CCC(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823218,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3901674,nM,250,CHEMBL284,6.602059991,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823219,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3902771,nM,73,CHEMBL284,7.13667714,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823220,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3973741,nM,950,CHEMBL284,6.022276395,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
16823221,CHEMBL3873292,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CHEMBL3911786,nM,5000,CHEMBL284,5.301029996,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC1CCN(C(=O)OC(C)C)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17611004,CHEMBL3706171,"In Vitro Enzyme Assay: The proteolytic enzyme, Dipeptidyle Peptidase IV (DppIV) was monitored in vitro by the substrate Gly-Pro 4-methoxy-β-naphthylamide while in the presence of compound 7. 20 ul of 1.3 mM DppIV was pipetted into twenty-four micro centrifuge tubes containing various concentrations of compound 7 in a total volume of 100 uL. The samples were thoroughly vortexed and centrifuged at 5,000 RPM for 30 seconds. The micro centrifuge tube were then placed in a 37° C. water bath and incubated for 30 minutes. After incubation, 0.625 uM of substrate was added and the volume was adjusted to 130 uM with incubation buffer. Samples were thoroughly mixed and centrifuged at 5,000 RPM for 30 seconds before placed in a 37° C. water bath for an additional 30 minutes. The reaction was terminated by adding 1 ml of 100 mM Citrate buffer pH 4.0 and vortexing thoroughly for 1 minute. The excitation and emission spectrum of each sample was measured at 340 nm and 425 nm respectfully on a Fluoromax-II Fluorometer.",B,N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1,CHEMBL3704833,nM,1,CHEMBL284,9,DPPIV,N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1,N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614739,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1COC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3645490,nM,2.5,CHEMBL284,8.602059991,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1COC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614740,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1COC(c3cc(F)c(F)cc3F)[C@@H](N)C1)C2,CHEMBL3645491,nM,2.2,CHEMBL284,8.657577319,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1COC(c3cc(F)c(F)cc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)c(F)cc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614741,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)c(F)cc1F,CHEMBL3645496,nM,1.9,CHEMBL284,8.721246399,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614742,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)ccc1F,CHEMBL3645493,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614743,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)ccc1F,CHEMBL3645497,nM,1,CHEMBL284,9,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614744,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)c(F)cc1F,CHEMBL3645494,nM,1.3,CHEMBL284,8.886056648,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17614745,CHEMBL3705151,Enzyme Assay: Enzyme assay using dipeptidyl peptidase-IV.,B,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CC4)c3C2)COC1c1cc(F)ccc1F,CHEMBL3645495,nM,1.6,CHEMBL284,8.795880017,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CC4)c3C2)COC1c1cc(F)ccc1F,NC1CC(N2Cc3cnn(S(=O)(=O)C4CC4)c3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630250,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCN12,CHEMBL3675618,nM,0.38,CHEMBL284,9.420216403,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630251,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,[C-]#[N+]c1ccc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC#CC)N3CCN=C23)cc1,CHEMBL3675619,nM,10,CHEMBL284,8,DPPIV,[C-]#[N+]c1ccc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC#CC)N3CCN=C23)cc1,[C-]#[N+]c1ccc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3CC#CC)N3CCN=C23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630252,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3F)N3CCN=C23)nc2ccccc12,CHEMBL3675620,nM,43,CHEMBL284,7.366531544,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3F)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3F)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630253,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3C#N)N3CCCN=C23)nc2ccccc12,CHEMBL3675621,nM,99,CHEMBL284,7.004364805,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)ccc3C#N)N3CCCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)ccc3C#N)N3CCCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630254,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCCN12,CHEMBL3675622,nM,1.3,CHEMBL284,8.886056648,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630255,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3C)N3CCN=C23)nc2ccccc12,CHEMBL3675623,nM,539,CHEMBL284,6.268411235,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3C)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3C)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630256,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCN12,CHEMBL3675624,nM,1.6,CHEMBL284,8.795880017,DPPIV,CC(C)=CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCN12,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630257,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cccc(F)c3)N3CCN=C23)nc2ccccc12,CHEMBL3675625,nM,19,CHEMBL284,7.721246399,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cccc(F)c3)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cccc(F)c3)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630258,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3)N3CCN=C23)nc2ccccc12,CHEMBL3675626,nM,32,CHEMBL284,7.494850022,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3ccccc3)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630259,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC3CC3)N3CCN=C23)nc2ccccc12,CHEMBL3675627,nM,8,CHEMBL284,8.096910013,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC3CC3)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3CC3CC3)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630260,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1ccc(OC)cc1)C1=NCCCN12,CHEMBL3675628,nM,39,CHEMBL284,7.408935393,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1ccc(OC)cc1)C1=NCCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1ccc(OC)cc1)C1=NCCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630261,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)NC1=NCCCN12,CHEMBL3675629,nM,6113,CHEMBL284,5.213745604,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)nc1n2CCCN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630262,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1cccc3ccccc13)C1=NCCCN12,CHEMBL3675630,nM,44,CHEMBL284,7.356547324,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1cccc3ccccc13)C1=NCCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1cccc3ccccc13)C1=NCCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630263,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nccc(C#N)n1)C1=NCCN12,CHEMBL3675631,nM,11,CHEMBL284,7.958607315,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nccc(C#N)n1)C1=NCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1nccc(C#N)n1)C1=NCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630264,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1ccccc1C#N)C1=NCCN12,CHEMBL3675632,nM,9,CHEMBL284,8.045757491,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1ccccc1C#N)C1=NCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1ccccc1C#N)C1=NCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630265,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3sccc3F)N3CCN=C23)nc2ccccc12,CHEMBL3675633,nM,29,CHEMBL284,7.537602002,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3sccc3F)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3sccc3F)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630266,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC3CC3(F)F)N3CCN=C23)nc2ccccc12,CHEMBL3675634,nM,14,CHEMBL284,7.853871964,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC3CC3(F)F)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3CC3CC3(F)F)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630267,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC3CCC3)N3CCN=C23)nc2ccccc12,CHEMBL3675635,nM,29,CHEMBL284,7.537602002,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC3CCC3)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3CC3CCC3)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630268,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3C#N)N3CCN=C23)nc2ccccc12,CHEMBL3675636,nM,82,CHEMBL284,7.086186148,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3C#N)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3ccccc3C#N)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630269,CHEMBL3705186,"Enzyme Inhibition Assay : DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37° C. The 30 μl assay solution contained 20 pM recombinant human DPP4 and 50 μM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37° C. prior to start of the experiment.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=N[C@@H](C)CN12,CHEMBL3675637,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=N[C@@H](C)CN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1nc(C)c3ccccc3n1)C1=NC(C)CN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630579,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc(NCc3ccccc3)c3ccccc3n1)c(=O)n2C,CHEMBL3680628,nM,6,CHEMBL284,8.22184875,DPPIV,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc(=NCc3ccccc3)c3ccccc3[nH]1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc(=NCc3ccccc3)c3ccccc3[nH]1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630580,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1cc(C#N)cc3ccccc13)c(=O)n2C,CHEMBL3680629,nM,6,CHEMBL284,8.22184875,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1cc(C#N)cc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1cc(C#N)cc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630581,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc(-c3ccccc3)nc3ccccc13)c(=O)n2C,CHEMBL3680630,nM,9,CHEMBL284,8.045757491,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc(-c3ccccc3)nc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc(-c3ccccc3)nc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630582,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1cc(C#N)c3ccccc3n1)c(=O)n2C,CHEMBL3680631,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1cc(C#N)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1cc(C#N)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630583,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1cccc(OC3CC3)c1)c(=O)n2C,CHEMBL3680632,nM,5,CHEMBL284,8.301029996,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1cccc(OC3CC3)c1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1cccc(OC3CC3)c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630584,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1ccc3nc(C)c(C)nc3c1)c(=O)n2C,CHEMBL3680633,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1ccc3nc(C)c(C)nc3c1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1ccc3nc(C)c(C)nc3c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630585,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1ccccc1Br)c(=O)n2C,CHEMBL3680634,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1ccccc1Br)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1ccccc1Br)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630586,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc3ccccc3c(C)c1C#N)c(=O)n2C,CHEMBL3680635,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc3ccccc3c(C)c1C#N)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nc3ccccc3c(C)c1C#N)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630587,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nccc(-c3ccccc3)n1)c(=O)n2C,CHEMBL3680636,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nccc(-c3ccccc3)n1)c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(Cc1nccc(-c3ccccc3)n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17630588,CHEMBL3705209,"Biological Assay: 50 μl of substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, was placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted therein. The reaction was started by the addition of 30 μl of solubilized Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances under investigation were typically added prediluted to 20 μl, while the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, the incubation period was 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, with the excitation wavelength at 405 nm and the emission wavelength at 535 nm.",B,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1ccccc1[N+](=O)[O-])c(=O)n2C,CHEMBL3680637,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1ccccc1[N+](=O)[O-])c(=O)n2C,CC#CCn1c(N2CCCC(NC(=O)OC(C)(C)C)C2)nc2c1c(=O)n(CC(=O)c1ccccc1[N+](=O)[O-])c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632174,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CNC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3694421,nM,6.8,CHEMBL284,8.167491087,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CNC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CNC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632175,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CNC1c1cc(F)c(F)cc1F,CHEMBL3694422,nM,0.7,CHEMBL284,9.15490196,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CNC1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CNC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632176,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(CC(N)=O)C1)C2,CHEMBL3694423,nM,4.3,CHEMBL284,8.366531544,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(CC(N)=O)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(CC(N)=O)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632177,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CN(CC(=O)N2CC[C@@H](F)C2)C1c1cc(F)ccc1F,CHEMBL3694424,nM,1,CHEMBL284,9,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CN(CC(=O)N2CC[C@@H](F)C2)C1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)CN(CC(=O)N2CCC(F)C2)C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632178,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CN1C[C@H](N2Cc3cn(S(C)(=O)=O)nc3C2)C[C@H](N)C1c1cc(F)c(F)cc1F,CHEMBL3697938,nM,0.9,CHEMBL284,9.045757491,DPPIV,CN1C[C@H](N2Cc3cn(S(C)(=O)=O)nc3C2)C[C@H](N)C1c1cc(F)c(F)cc1F,CN1CC(N2Cc3cn(S(C)(=O)=O)nc3C2)CC(N)C1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632179,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(C(=O)C(F)(F)F)C1)C2,CHEMBL3697939,nM,14.5,CHEMBL284,7.838631998,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(C(=O)C(F)(F)F)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(C(=O)C(F)(F)F)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632180,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(CCO)C1)C2,CHEMBL3697940,nM,1.7,CHEMBL284,8.769551079,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(CCO)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(CCO)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632181,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(CC3CC3)C1)C2,CHEMBL3697941,nM,1.6,CHEMBL284,8.795880017,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(CC3CC3)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(CC3CC3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632182,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,C[C@H](F)CN1C[C@H](N2Cc3cn(S(C)(=O)=O)nc3C2)C[C@H](N)C1c1cc(F)ccc1F,CHEMBL3697942,nM,0.4,CHEMBL284,9.397940009,DPPIV,C[C@H](F)CN1C[C@H](N2Cc3cn(S(C)(=O)=O)nc3C2)C[C@H](N)C1c1cc(F)ccc1F,CC(F)CN1CC(N2Cc3cn(S(C)(=O)=O)nc3C2)CC(N)C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632183,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CN(CCN2CCC(F)(F)C2)C1c1cc(F)ccc1F,CHEMBL3697943,nM,25.4,CHEMBL284,7.595166283,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CN(CCN2CCC(F)(F)C2)C1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)CN(CCN2CCC(F)(F)C2)C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632184,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,Cn1cc(CCN2C[C@H](N3Cc4cn[nH]c4C3)C[C@H](N)C2c2cc(F)ccc2F)cn1,CHEMBL3697944,nM,7.1,CHEMBL284,8.148741651,DPPIV,Cn1cc(CCN2C[C@H](N3Cc4c[nH]nc4C3)C[C@H](N)C2c2cc(F)ccc2F)cn1,Cn1cc(CCN2CC(N3Cc4c[nH]nc4C3)CC(N)C2c2cc(F)ccc2F)cn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632185,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CN(Cc2cnccn2)C1c1cc(F)ccc1F,CHEMBL3697945,nM,12.9,CHEMBL284,7.88941029,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CN(Cc2cnccn2)C1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)CN(Cc2cnccn2)C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632186,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(Cc3cncnc3)C1)C2,CHEMBL3697946,nM,3,CHEMBL284,8.522878745,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)C(c3cc(F)ccc3F)N(Cc3cncnc3)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(Cc3cncnc3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632187,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,N[C@H]1C[C@@H](N2Cc3cn[nH]c3C2)CN(Cc2cn[nH]c2)C1c1cc(F)ccc1F,CHEMBL3697947,nM,2.9,CHEMBL284,8.537602002,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CN(Cc2cn[nH]c2)C1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)CN(Cc2cn[nH]c2)C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632188,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)N1C[C@@H](N2Cc3cn(S(C)(=O)=O)nc3C2)C[C@H](N)C1c1cc(F)ccc1F,CHEMBL3697948,nM,53.3,CHEMBL284,7.273272791,DPPIV,CS(=O)(=O)N1C[C@@H](N2Cc3cn(S(C)(=O)=O)nc3C2)C[C@H](N)C1c1cc(F)ccc1F,CS(=O)(=O)N1CC(N2Cc3cn(S(C)(=O)=O)nc3C2)CC(N)C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632189,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)C(c3cc(F)ccc3F)N(Cc3cn[nH]c3)C1)C2,CHEMBL3697949,nM,3.9,CHEMBL284,8.408935393,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)C(c3cc(F)ccc3F)N(Cc3cn[nH]c3)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(Cc3cn[nH]c3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17632190,CHEMBL3705360,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s−1; kcat/Km=1.5×106 M−1s−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL).",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)C(c3cc(F)ccc3F)N(Cc3cncc4cccnc34)C1)C2,CHEMBL3697950,nM,24.6,CHEMBL284,7.609064893,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)C(c3cc(F)ccc3F)N(Cc3cncc4cccnc34)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)N(Cc3cncc4cccnc34)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652370,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CSC1c1cc(F)ccc1F,CHEMBL3644451,nM,2.3,CHEMBL284,8.638272164,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CSC1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)CSC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652371,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CSC1c1cc(F)cc(F)c1F,CHEMBL3644452,nM,3.4,CHEMBL284,8.468521083,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CSC1c1cc(F)cc(F)c1F,NC1CC(N2Cc3c[nH]nc3C2)CSC1c1cc(F)cc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652372,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)C[S+]([O-])C1c1cc(F)cc(F)c1F,CHEMBL3644453,nM,40,CHEMBL284,7.397940009,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)C[S+]([O-])C1c1cc(F)cc(F)c1F,NC1CC(N2Cc3c[nH]nc3C2)C[S+]([O-])C1c1cc(F)cc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652374,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CS(=O)(=O)C1c1cc(F)cc(F)c1F,CHEMBL3644454,nM,119,CHEMBL284,6.924453039,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)CS(=O)(=O)C1c1cc(F)cc(F)c1F,NC1CC(N2Cc3c[nH]nc3C2)CS(=O)(=O)C1c1cc(F)cc(F)c1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652375,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CC(C)(O)Cn1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CHEMBL3644455,nM,2.6,CHEMBL284,8.585026652,DPPIV,CC(C)(O)Cn1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CC(C)(O)Cn1cc2c(n1)CN(C1CSC(c3cc(F)cc(F)c3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652376,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CHEMBL3644456,nM,0.5,CHEMBL284,9.301029996,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CSC(c3cc(F)cc(F)c3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652377,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CC(C)(F)Cn1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CHEMBL3644457,nM,1.6,CHEMBL284,8.795880017,DPPIV,CC(C)(F)Cn1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CC(C)(F)Cn1cc2c(n1)CN(C1CSC(c3cc(F)cc(F)c3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652378,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3644458,nM,0.6,CHEMBL284,9.22184875,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CSC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652379,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,NC(=O)c1[nH]nc2c1CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3644459,nM,0.17,CHEMBL284,9.769551079,DPPIV,NC(O)c1n[nH]c2cn([C@H]3CSC(c4cc(F)ccc4F)[C@@H](N)C3)cc12,NC(O)c1n[nH]c2cn(C3CSC(c4cc(F)ccc4F)C(N)C3)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652380,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N#Cc1[nH]nc2c1CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3644460,nM,0.46,CHEMBL284,9.337242168,DPPIV,N#Cc1[nH]nc2c1CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,N#Cc1[nH]nc2c1CN(C1CSC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652381,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3nc(C(F)(F)F)[nH]c3C2)CSC1c1cc(F)ccc1F,CHEMBL3644461,nM,1.1,CHEMBL284,8.958607315,DPPIV,N[C@H]1C[C@@H](N2Cc3nc(C(F)(F)F)[nH]c3C2)CSC1c1cc(F)ccc1F,NC1CC(N2Cc3nc(C(F)(F)F)[nH]c3C2)CSC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652382,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CSC1c1cc(F)ccc1F,CHEMBL3639433,nM,0.7,CHEMBL284,9.15490196,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc(C(F)(F)F)nc3C2)CSC1c1cc(F)ccc1F,NC1CC(N2Cc3cnc(C(F)(F)F)nc3C2)CSC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652383,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3nc(-c4ccccc4)[nH]c3C2)CSC1c1cc(F)ccc1F,CHEMBL3644462,nM,0.7,CHEMBL284,9.15490196,DPPIV,N[C@H]1C[C@@H](N2Cc3nc(-c4ccccc4)[nH]c3C2)CSC1c1cc(F)ccc1F,NC1CC(N2Cc3nc(-c4ccccc4)[nH]c3C2)CSC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652384,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,NC(=O)Cn1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,CHEMBL3644463,nM,1.7,CHEMBL284,8.769551079,DPPIV,NC(=O)Cn1cc2c(n1)CN([C@H]1CSC(c3cc(F)cc(F)c3F)[C@@H](N)C1)C2,NC(=O)Cn1cc2c(n1)CN(C1CSC(c3cc(F)cc(F)c3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652385,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,Cc1nc2c([nH]1)CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3644464,nM,1.5,CHEMBL284,8.823908741,DPPIV,Cc1nc2c([nH]1)CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,Cc1nc2c([nH]1)CN(C1CSC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17652386,CHEMBL3705729,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x10E+6 M-1 s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,Cc1nc2c(o1)CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3644465,nM,8.1,CHEMBL284,8.091514981,DPPIV,Cc1nc2c(o1)CN([C@H]1CSC(c3cc(F)ccc3F)[C@@H](N)C1)C2,Cc1nc2c(o1)CN(C1CSC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657787,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,CHEMBL3650433,nM,5.7,CHEMBL284,8.244125144,DPPIV,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Cn1c2nccc-2c(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657788,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL3650440,nM,34,CHEMBL284,7.468521083,DPPIV,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,Cn1c2nccc-2c(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657789,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2F)c1=O,CHEMBL3650435,nM,1343,CHEMBL284,5.871923987,DPPIV,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2F)c1=O,Cn1c2nccc-2c(N2CCCC(N)C2)n(Cc2cc(F)ccc2F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657790,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2cccc(F)c2)c1=O,CHEMBL3650436,nM,1590,CHEMBL284,5.798602876,DPPIV,Cn1c2nccc-2c(N2CCC[C@@H](N)C2)n(Cc2cccc(F)c2)c1=O,Cn1c2nccc-2c(N2CCCC(N)C2)n(Cc2cccc(F)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657791,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2nc(Cl)cc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,CHEMBL3650439,nM,5.6,CHEMBL284,8.251811973,DPPIV,Cn1c2nc(Cl)cc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Cn1c2nc(Cl)cc-2c(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657792,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2ncnc-2c(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,CHEMBL3650434,nM,106,CHEMBL284,6.974694135,DPPIV,Cn1c2ncnc-2c(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,Cn1c2ncnc-2c(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657793,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cn1c2nc(C#N)cc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,CHEMBL3650437,nM,14,CHEMBL284,7.853871964,DPPIV,Cn1c2nc(C#N)cc-2c(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Cn1c2nc(C#N)cc-2c(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17657794,CHEMBL3706123,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 uM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 101 each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,Cc1nc(Cn2c3nccc-3c(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c2=O)nc2ccccc12,CHEMBL3650438,nM,104,CHEMBL284,6.982966661,DPPIV,Cc1nc(Cn2c3nccc-3c(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c2=O)nc2ccccc12,Cc1nc(Cn2c3nccc-3c(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c2=O)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660154,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,C[C@H](N)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686733,nM,0.35,CHEMBL284,9.455931956,DPPIV,CC(N)C(=S)N1CCC[C@H]1B(O)O,CC(N)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660156,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,CC(C)[C@H](N)C(=S)N[C@@H](C)B(O)O,CHEMBL3686734,nM,73,CHEMBL284,7.13667714,DPPIV,CC(C)C(N)C(=S)N[C@@H](C)B(O)O,CC(NC(=S)C(N)C(C)C)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660157,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,C[C@H](NC(=O)[C@H](C)N)B(O)O,CHEMBL3639856,nM,63,CHEMBL284,7.200659451,DPPIV,CC(N)C(=O)N[C@@H](C)B(O)O,CC(NC(=O)C(C)N)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660158,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,C[C@H](NC(=S)[C@H](C)N)B(O)O,CHEMBL3686735,nM,6500,CHEMBL284,5.187086643,DPPIV,CC(N)C(=S)N[C@@H](C)B(O)O,CC(NC(=S)C(C)N)B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660160,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,CC(C)[C@H](N)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686736,nM,44,CHEMBL284,7.356547324,DPPIV,CC(C)C(N)C(=S)N1CCC[C@H]1B(O)O,CC(C)C(N)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660161,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@H](C(=O)N1CCC[C@H]1B(O)O)C1CCCCC1,CHEMBL3686737,nM,1,CHEMBL284,9,DPPIV,NC(C(=O)N1CCC[C@H]1B(O)O)C1CCCCC1,NC(C(=O)N1CCCC1B(O)O)C1CCCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660164,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,NCC(=S)N1CCC[C@H]1B(O)O,CHEMBL3686738,nM,3,CHEMBL284,8.522878745,DPPIV,NCC(=S)N1CCC[C@H]1B(O)O,NCC(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660165,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,O=C(CNC12CC3CC(CC(O)(C3)C1)C2)N1CCC[C@H]1B(O)O,CHEMBL3686739,nM,42,CHEMBL284,7.37675071,DPPIV,O=C(CNC12CC3CC(CC(O)(C3)C1)C2)N1CCC[C@H]1B(O)O,O=C(CNC12CC3CC(CC(O)(C3)C1)C2)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660166,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,OB(O)[C@@H]1CCCN1C(=S)CNC12CC3CC(CC(O)(C3)C1)C2,CHEMBL3686740,nM,160,CHEMBL284,6.795880017,DPPIV,OB(O)[C@@H]1CCCN1C(=S)CNC12CC3CC(CC(O)(C3)C1)C2,OB(O)C1CCCN1C(=S)CNC12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660167,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,O=C(CNCc1ccccc1)N1CCC[C@H]1B(O)O,CHEMBL3686741,nM,9.5,CHEMBL284,8.022276395,DPPIV,O=C(CNCc1ccccc1)N1CCC[C@H]1B(O)O,O=C(CNCc1ccccc1)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660168,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,OB(O)[C@@H]1CCCN1C(=S)CNCc1ccccc1,CHEMBL3686742,nM,24,CHEMBL284,7.619788758,DPPIV,OB(O)[C@@H]1CCCN1C(=S)CNCc1ccccc1,OB(O)C1CCCN1C(=S)CNCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660169,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1B(O)O,CHEMBL3686752,nM,200,CHEMBL284,6.698970004,DPPIV,NC(CC(=O)O)C(=O)N1CCC[C@H]1B(O)O,NC(CC(=O)O)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660170,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@@H](CC(=O)O)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686743,nM,17,CHEMBL284,7.769551079,DPPIV,NC(CC(=O)O)C(=S)N1CCC[C@H]1B(O)O,NC(CC(=O)O)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660171,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1B(O)O,CHEMBL494497,nM,6,CHEMBL284,8.22184875,DPPIV,NC(CCC(=O)O)C(=O)N1CCC[C@H]1B(O)O,NC(CCC(=O)O)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660172,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@@H](CCC(=O)O)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686744,nM,4.6,CHEMBL284,8.337242168,DPPIV,NC(CCC(=O)O)C(=S)N1CCC[C@H]1B(O)O,NC(CCC(=O)O)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660173,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,CCC[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL3686745,nM,4.5,CHEMBL284,8.346787486,DPPIV,CCCC(N)C(=O)N1CCC[C@H]1B(O)O,CCCC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660174,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,CCC[C@H](N)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686746,nM,1.6,CHEMBL284,8.795880017,DPPIV,CCCC(N)C(=S)N1CCC[C@H]1B(O)O,CCCC(N)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660175,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1B(O)O,CHEMBL3686747,nM,2,CHEMBL284,8.698970004,DPPIV,NC(Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1B(O)O,NC(Cc1c[nH]c2ccccc12)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660176,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N[C@@H](Cc1c[nH]c2ccccc12)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686748,nM,1.6,CHEMBL284,8.795880017,DPPIV,NC(Cc1c[nH]c2ccccc12)C(=S)N1CCC[C@H]1B(O)O,NC(Cc1c[nH]c2ccccc12)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660177,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N=C(N)NCCC[C@H](N)C(=O)N1CCC[C@H]1B(O)O,CHEMBL3686749,nM,1.8,CHEMBL284,8.744727495,DPPIV,N=C(N)NCCCC(N)C(=O)N1CCC[C@H]1B(O)O,N=C(N)NCCCC(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660178,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,N=C(N)NCCC[C@H](N)C(=S)N1CCC[C@H]1B(O)O,CHEMBL3686750,nM,1.2,CHEMBL284,8.920818754,DPPIV,N=C(N)NCCCC(N)C(=S)N1CCC[C@H]1B(O)O,N=C(N)NCCCC(N)C(=S)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17660180,CHEMBL3706075,"Inhibition Assay: The inhibitor solution is prepared by dissolving 3-5 mg of inhibitor in pH 2 solution (0.01 N HCl), such that the concentration of the solution is equal to 1 mg/10 mL. A 10 μL sample of this solution is then added to 990 μL of pH 8 buffer (0.1 M HEPES, 0.14 M NaCl), and the solution is allowed to stand at room temperature overnight.The enzyme solution is prepared by diluting 20 μL of DPIV (concentration 2.5 nM) into 40 mL of pH 8 buffer.The substrate solution is prepared by dissolving 2.0 mg of L-alanyl-L-proline-para-nitroanilide into 20 mL of pH 8 buffer.250 μL of enzyme solution is added to well #B1 to #H1, #A2 to #H2, and #A3 to #H3 of a 96 well plate, while well #A1 receives 250 μL of pH 8 buffer instead of enzyme solution. 904 of pH 8 buffer is then added to column 5 (from well #A5 to #H5).",B,OB(O)[C@@H]1CCCN1C(=S)[C@@H]1CCCN1,CHEMBL3686751,nM,6.4,CHEMBL284,8.193820026,DPPIV,OB(O)[C@@H]1CCCN1C(=S)C1CCCN1,OB(O)C1CCCN1C(=S)C1CCCN1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672029,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3654418,nM,2.3,CHEMBL284,8.638272164,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CCOC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672030,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3cnn(-c4ncccn4)c3C2)CCO[C@@H]1c1cc(F)ccc1F,CHEMBL3654419,nM,2.2,CHEMBL284,8.657577319,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(-c4ncccn4)c3C2)CCO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cnn(-c4ncccn4)c3C2)CCOC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672031,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3cnn(-c4ccccc4)c3C2)CCO[C@@H]1c1cc(F)ccc1F,CHEMBL3654420,nM,3,CHEMBL284,8.522878745,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(-c4ccccc4)c3C2)CCO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cnn(-c4ccccc4)c3C2)CCOC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672032,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N#Cc1n[nH]c2c1CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3654421,nM,8.5,CHEMBL284,8.070581074,DPPIV,N#Cc1[nH]nc2c1CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,N#Cc1[nH]nc2c1CN(C1CCOC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672033,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,NC(=O)c1n[nH]c2c1CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3654422,nM,2.6,CHEMBL284,8.585026652,DPPIV,NC(O)c1n[nH]c2cn([C@H]3CCO[C@H](c4cc(F)ccc4F)[C@@H](N)C3)cc12,NC(O)c1n[nH]c2cn(C3CCOC(c4cc(F)ccc4F)C(N)C3)cc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672034,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CCO[C@@H]1c1cc(F)ccc1F,CHEMBL3654423,nM,5.8,CHEMBL284,8.236572006,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CCO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)CCOC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672035,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,Cc1c2c(nn1S(=O)(=O)C1(C)CC1)CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3654424,nM,0.5,CHEMBL284,9.301029996,DPPIV,Cc1c2c(nn1S(=O)(=O)C1(C)CC1)CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,Cc1c2c(nn1S(=O)(=O)C1(C)CC1)CN(C1CCOC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672036,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CC1(S(=O)(=O)n2cc3c(n2)CN([C@H]2CCO[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C2)C3)CC1,CHEMBL3654425,nM,4,CHEMBL284,8.397940009,DPPIV,CC1(S(=O)(=O)n2cc3c(n2)CN([C@H]2CCO[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C2)C3)CC1,CC1(S(=O)(=O)n2cc3c(n2)CN(C2CCOC(c4cc(F)c(F)cc4F)C(N)C2)C3)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672037,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CCO[C@@H]1c1cc(F)ccc1F,CHEMBL3654426,nM,4.1,CHEMBL284,8.387216143,DPPIV,N[C@H]1C[C@@H](N2Cc3cnc(C4CC4)nc3C2)CCO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cnc(C4CC4)nc3C2)CCOC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672038,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CCS[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3654427,nM,14.3,CHEMBL284,7.844663963,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CCS[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CCSC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672039,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CC(C)(O)Cn1cc2c(n1)CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL3654428,nM,21.1,CHEMBL284,7.675717545,DPPIV,CC(C)(O)Cn1cc2c(n1)CN([C@H]1CCO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CC(C)(O)Cn1cc2c(n1)CN(C1CCOC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672040,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,N[C@H]1C[C@@H](N2Cc3cnn(-c4ccc(C(F)(F)F)cn4)c3C2)CCO[C@@H]1c1cc(F)ccc1F,CHEMBL3654429,nM,5.9,CHEMBL284,8.229147988,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(-c4ccc(C(F)(F)F)cn4)c3C2)CCO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cnn(-c4ccc(C(F)(F)F)cn4)c3C2)CCOC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17672041,CHEMBL3706292,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature.",B,CC1(S(=O)(=O)n2cc3c(n2)CN([C@H]2CCO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)CC1,CHEMBL3654430,nM,8.1,CHEMBL284,8.091514981,DPPIV,CC1(S(=O)(=O)n2cc3c(n2)CN([C@H]2CCO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)CC1,CC1(S(=O)(=O)n2cc3c(n2)CN(C2CCOC(c4cc(F)ccc4F)C(N)C2)C3)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17686216,CHEMBL3705816,"Enzyme Inhibition Assay: DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 pM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 10 ul each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",B,CCN1C(=O)Cn2c1nc1nc(N3CCC[C@@H](NC(=O)OC(C)(C)C)C3)n(Cc3cc(F)ccc3C#N)c1c2=O,CHEMBL3687981,nM,13.5,CHEMBL284,7.869666232,DPPIV,CCn1c(O)cn2c(=O)c3c(nc(N4CCC[C@@H](NC(=O)OC(C)(C)C)C4)n3Cc3cc(F)ccc3C#N)nc12,CCn1c(O)cn2c(=O)c3c(nc(N4CCCC(NC(=O)OC(C)(C)C)C4)n3Cc3cc(F)ccc3C#N)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17701080,CHEMBL3706171,"In Vitro Enzyme Assay: The proteolytic enzyme, Dipeptidyle Peptidase IV (DppIV) was monitored in vitro by the substrate Gly-Pro 4-methoxy-β-naphthylamide while in the presence of compound 7. 20 ul of 1.3 mM DppIV was pipetted into twenty-four micro centrifuge tubes containing various concentrations of compound 7 in a total volume of 100 uL. The samples were thoroughly vortexed and centrifuged at 5,000 RPM for 30 seconds. The micro centrifuge tube were then placed in a 37° C. water bath and incubated for 30 minutes. After incubation, 0.625 uM of substrate was added and the volume was adjusted to 130 uM with incubation buffer. Samples were thoroughly mixed and centrifuged at 5,000 RPM for 30 seconds before placed in a 37° C. water bath for an additional 30 minutes. The reaction was terminated by adding 1 ml of 100 mM Citrate buffer pH 4.0 and vortexing thoroughly for 1 minute. The excitation and emission spectrum of each sample was measured at 340 nm and 425 nm respectfully on a Fluoromax-II Fluorometer.",B,CC(C)C(N)C(=O)N1CCCC1,CHEMBL16709,nM,548,CHEMBL284,6.261219442,DPPIV,CC(C)C(N)C(=O)N1CCCC1,CC(C)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17701081,CHEMBL3706171,"In Vitro Enzyme Assay: The proteolytic enzyme, Dipeptidyle Peptidase IV (DppIV) was monitored in vitro by the substrate Gly-Pro 4-methoxy-β-naphthylamide while in the presence of compound 7. 20 ul of 1.3 mM DppIV was pipetted into twenty-four micro centrifuge tubes containing various concentrations of compound 7 in a total volume of 100 uL. The samples were thoroughly vortexed and centrifuged at 5,000 RPM for 30 seconds. The micro centrifuge tube were then placed in a 37° C. water bath and incubated for 30 minutes. After incubation, 0.625 uM of substrate was added and the volume was adjusted to 130 uM with incubation buffer. Samples were thoroughly mixed and centrifuged at 5,000 RPM for 30 seconds before placed in a 37° C. water bath for an additional 30 minutes. The reaction was terminated by adding 1 ml of 100 mM Citrate buffer pH 4.0 and vortexing thoroughly for 1 minute. The excitation and emission spectrum of each sample was measured at 340 nm and 425 nm respectfully on a Fluoromax-II Fluorometer.",B,CCC(C)C(N)C(=O)N1CCCC1,CHEMBL17041,nM,2000,CHEMBL284,5.698970004,DPPIV,CCC(C)C(N)C(=O)N1CCCC1,CCC(C)C(N)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17701082,CHEMBL3706171,"In Vitro Enzyme Assay: The proteolytic enzyme, Dipeptidyle Peptidase IV (DppIV) was monitored in vitro by the substrate Gly-Pro 4-methoxy-β-naphthylamide while in the presence of compound 7. 20 ul of 1.3 mM DppIV was pipetted into twenty-four micro centrifuge tubes containing various concentrations of compound 7 in a total volume of 100 uL. The samples were thoroughly vortexed and centrifuged at 5,000 RPM for 30 seconds. The micro centrifuge tube were then placed in a 37° C. water bath and incubated for 30 minutes. After incubation, 0.625 uM of substrate was added and the volume was adjusted to 130 uM with incubation buffer. Samples were thoroughly mixed and centrifuged at 5,000 RPM for 30 seconds before placed in a 37° C. water bath for an additional 30 minutes. The reaction was terminated by adding 1 ml of 100 mM Citrate buffer pH 4.0 and vortexing thoroughly for 1 minute. The excitation and emission spectrum of each sample was measured at 340 nm and 425 nm respectfully on a Fluoromax-II Fluorometer.",B,O=C(CNCC(O)COc1ccccc1)N1CCCC1,CHEMBL3704834,nM,12000,CHEMBL284,4.920818754,DPPIV,O=C(CNCC(O)COc1ccccc1)N1CCCC1,O=C(CNCC(O)COc1ccccc1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17701083,CHEMBL3706171,"In Vitro Enzyme Assay: The proteolytic enzyme, Dipeptidyle Peptidase IV (DppIV) was monitored in vitro by the substrate Gly-Pro 4-methoxy-β-naphthylamide while in the presence of compound 7. 20 ul of 1.3 mM DppIV was pipetted into twenty-four micro centrifuge tubes containing various concentrations of compound 7 in a total volume of 100 uL. The samples were thoroughly vortexed and centrifuged at 5,000 RPM for 30 seconds. The micro centrifuge tube were then placed in a 37° C. water bath and incubated for 30 minutes. After incubation, 0.625 uM of substrate was added and the volume was adjusted to 130 uM with incubation buffer. Samples were thoroughly mixed and centrifuged at 5,000 RPM for 30 seconds before placed in a 37° C. water bath for an additional 30 minutes. The reaction was terminated by adding 1 ml of 100 mM Citrate buffer pH 4.0 and vortexing thoroughly for 1 minute. The excitation and emission spectrum of each sample was measured at 340 nm and 425 nm respectfully on a Fluoromax-II Fluorometer.",B,CC(C)C(NCC(O)COc1ccccc1)C(=O)N1CCCC1,CHEMBL3704835,nM,8500,CHEMBL284,5.070581074,DPPIV,CC(C)C(NCC(O)COc1ccccc1)C(=O)N1CCCC1,CC(C)C(NCC(O)COc1ccccc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17701084,CHEMBL3706171,"In Vitro Enzyme Assay: The proteolytic enzyme, Dipeptidyle Peptidase IV (DppIV) was monitored in vitro by the substrate Gly-Pro 4-methoxy-β-naphthylamide while in the presence of compound 7. 20 ul of 1.3 mM DppIV was pipetted into twenty-four micro centrifuge tubes containing various concentrations of compound 7 in a total volume of 100 uL. The samples were thoroughly vortexed and centrifuged at 5,000 RPM for 30 seconds. The micro centrifuge tube were then placed in a 37° C. water bath and incubated for 30 minutes. After incubation, 0.625 uM of substrate was added and the volume was adjusted to 130 uM with incubation buffer. Samples were thoroughly mixed and centrifuged at 5,000 RPM for 30 seconds before placed in a 37° C. water bath for an additional 30 minutes. The reaction was terminated by adding 1 ml of 100 mM Citrate buffer pH 4.0 and vortexing thoroughly for 1 minute. The excitation and emission spectrum of each sample was measured at 340 nm and 425 nm respectfully on a Fluoromax-II Fluorometer.",B,CCC(C)C(NCC(O)COc1ccccc1)C(=O)N1CCCC1,CHEMBL3704836,nM,33000,CHEMBL284,4.48148606,DPPIV,CCC(C)C(NCC(O)COc1ccccc1)C(=O)N1CCCC1,CCC(C)C(NCC(O)COc1ccccc1)C(=O)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17712984,CHEMBL3887347,"Fluorometric Assay: The utility of the compounds in accordance with the present invention as inhibitors of dipeptidyl peptidase-IV enzyme activity may be demonstrated by methodology known in the art. Inhibition constants are determined as follows. A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C.",B,Cc1ccc(S(=O)(=O)N=S(C)(=O)n2cc3c(n2)CN([C@H]2CO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)cc1,CHEMBL4106669,nM,18.5,CHEMBL284,7.732828272,DPPIV,Cc1ccc(S(=O)(=O)N=S(C)(=O)n2cc3c(n2)CN([C@H]2CO[C@H](c4cc(F)ccc4F)[C@@H](N)C2)C3)cc1,Cc1ccc(S(=O)(=O)N=S(C)(=O)n2cc3c(n2)CN(C2COC(c4cc(F)ccc4F)C(N)C2)C3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17712985,CHEMBL3887347,"Fluorometric Assay: The utility of the compounds in accordance with the present invention as inhibitors of dipeptidyl peptidase-IV enzyme activity may be demonstrated by methodology known in the art. Inhibition constants are determined as follows. A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C.",B,C[C@]1(N2Cc3c[nH]nc3C2)CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CHEMBL3931183,nM,34.5,CHEMBL284,7.462180905,DPPIV,C[C@]1(N2Cc3c[nH]nc3C2)CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CC1(N2Cc3c[nH]nc3C2)COC(c2cc(F)ccc2F)C(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17712986,CHEMBL3887347,"Fluorometric Assay: The utility of the compounds in accordance with the present invention as inhibitors of dipeptidyl peptidase-IV enzyme activity may be demonstrated by methodology known in the art. Inhibition constants are determined as follows. A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C.",B,C[C@]1(N2Cc3cn(S(C)(=O)=O)nc3C2)CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CHEMBL3940772,nM,37,CHEMBL284,7.431798276,DPPIV,C[C@]1(N2Cc3cn(S(C)(=O)=O)nc3C2)CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CC1(N2Cc3cn(S(C)(=O)=O)nc3C2)COC(c2cc(F)ccc2F)C(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17712987,CHEMBL3887347,"Fluorometric Assay: The utility of the compounds in accordance with the present invention as inhibitors of dipeptidyl peptidase-IV enzyme activity may be demonstrated by methodology known in the art. Inhibition constants are determined as follows. A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C.",B,C[C@]1(N2Cc3cn(S(=O)(=O)NC(=O)OCc4ccccc4)nc3C2)CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CHEMBL3970322,nM,8.8,CHEMBL284,8.055517328,DPPIV,C[C@]1(N2Cc3cn(S(=O)(=O)NC(=O)OCc4ccccc4)nc3C2)CO[C@H](c2cc(F)ccc2F)[C@@H](N)C1,CC1(N2Cc3cn(S(=O)(=O)NC(=O)OCc4ccccc4)nc3C2)COC(c2cc(F)ccc2F)C(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17739783,CHEMBL3887953,"DPP-IV Activity InhibitoryAssay: Gly-Pro-7-amido-4-methylcoumarin can be hydrolyzed by dipeptidyl peptidase IV (DPP-IV) at room temperature, to generate 7-amido-4-methyl coumarin, which can emit fluorescence with wavelength of 460 nm at excitation wavelength of 355 nm. The variation of the product amount can be determined by the variation of fluorescence intensity, so as to reflect the activity level of the enzyme. The dipeptidyl peptidase IV (DPP-IV), DPP-IV buffer and test samples were used to construct the reaction system of 200 uL, while the blank control (without enzyme and samples) and negative control (without samples) having the same volume were set up. The reaction system and the controls were reacted at room temperature for 10 min, and then dipeptidyl peptidase IV substrate was added thereto respectively, then reacted at room temperature for 30 min. The fluorescence intensity F (excitation wavelength of 355 nm, emission wavelength of 460 nm) was determined.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc3cc(F)ccc3s1)c(=O)n2C,CHEMBL4113723,nM,0.05,CHEMBL284,10.30103,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc3cc(F)ccc3s1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc3cc(F)ccc3s1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17739784,CHEMBL3887953,"DPP-IV Activity InhibitoryAssay: Gly-Pro-7-amido-4-methylcoumarin can be hydrolyzed by dipeptidyl peptidase IV (DPP-IV) at room temperature, to generate 7-amido-4-methyl coumarin, which can emit fluorescence with wavelength of 460 nm at excitation wavelength of 355 nm. The variation of the product amount can be determined by the variation of fluorescence intensity, so as to reflect the activity level of the enzyme. The dipeptidyl peptidase IV (DPP-IV), DPP-IV buffer and test samples were used to construct the reaction system of 200 uL, while the blank control (without enzyme and samples) and negative control (without samples) having the same volume were set up. The reaction system and the controls were reacted at room temperature for 10 min, and then dipeptidyl peptidase IV substrate was added thereto respectively, then reacted at room temperature for 30 min. The fluorescence intensity F (excitation wavelength of 355 nm, emission wavelength of 460 nm) was determined.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc3ccccc3s1)c(=O)n2C,CHEMBL4111229,nM,0.1,CHEMBL284,10,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc3ccccc3s1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc3ccccc3s1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17739785,CHEMBL3887953,"DPP-IV Activity InhibitoryAssay: Gly-Pro-7-amido-4-methylcoumarin can be hydrolyzed by dipeptidyl peptidase IV (DPP-IV) at room temperature, to generate 7-amido-4-methyl coumarin, which can emit fluorescence with wavelength of 460 nm at excitation wavelength of 355 nm. The variation of the product amount can be determined by the variation of fluorescence intensity, so as to reflect the activity level of the enzyme. The dipeptidyl peptidase IV (DPP-IV), DPP-IV buffer and test samples were used to construct the reaction system of 200 uL, while the blank control (without enzyme and samples) and negative control (without samples) having the same volume were set up. The reaction system and the controls were reacted at room temperature for 10 min, and then dipeptidyl peptidase IV substrate was added thereto respectively, then reacted at room temperature for 30 min. The fluorescence intensity F (excitation wavelength of 355 nm, emission wavelength of 460 nm) was determined.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc3cc(Cl)ccc3s1)c(=O)n2C,CHEMBL4109453,nM,0.2,CHEMBL284,9.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc3cc(Cl)ccc3s1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc3cc(Cl)ccc3s1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17749374,CHEMBL3888129,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 uM; kcat=75 s-1; kcat/Km=1.5x106 M-1s-1. A typical reaction contains approximately 50 pM enzyme, 50 uM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 uL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 uM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature values for the native enzyme. To measure the dissociation constants for compounds, solutions of inhibitor in DMSO were added to reactions containing enzyme and substrate (final DMSO concentration is 1%). All experiments were conducted at room temperature using the standard reaction conditions described above.",B,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CCCC4)c3C2)COC1c1cc(F)c(F)cc1F,CHEMBL3935335,nM,2.6,CHEMBL284,8.585026652,DPPIV,N[C@H]1C[C@@H](N2Cc3cnn(S(=O)(=O)C4CCCC4)c3C2)COC1c1cc(F)c(F)cc1F,NC1CC(N2Cc3cnn(S(=O)(=O)C4CCCC4)c3C2)COC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17762283,CHEMBL3888316,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s^−1; kcat/Km=1.5×10^6 M^−1s^−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature values for the native enzyme. To measure the dissociation constants for compounds, solutions of inhibitor in DMSO were added to reactions containing enzyme and substrate (final DMSO concentration is 1%). All experiments were conducted at room temperature using the standard reaction conditions described above.",B,N[C@H]1CC(N2Cc3c[nH]nc3C2)c2ccccc2[C@@H]1c1cc(F)ccc1F,CHEMBL3924307,nM,1000,CHEMBL284,6,DPPIV,N[C@H]1CC(N2Cc3c[nH]nc3C2)c2ccccc2[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)c2ccccc2C1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17762284,CHEMBL3888316,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s^−1; kcat/Km=1.5×10^6 M^−1s^−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature values for the native enzyme. To measure the dissociation constants for compounds, solutions of inhibitor in DMSO were added to reactions containing enzyme and substrate (final DMSO concentration is 1%). All experiments were conducted at room temperature using the standard reaction conditions described above.",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)[C@H]3CC13)C2,CHEMBL3896302,nM,9,CHEMBL284,8.045757491,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)[C@H]3CC13)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)C3CC31)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17762285,CHEMBL3888316,"Fluorometric Assay: A continuous fluorometric assay is employed with the substrate Gly-Pro-AMC, which is cleaved by DPP-4 to release the fluorescent AMC leaving group. The kinetic parameters that describe this reaction are as follows: Km=50 μM; kcat=75 s^−1; kcat/Km=1.5×10^6 M^−1s^−1. A typical reaction contains approximately 50 μM enzyme, 50 μM Gly-Pro-AMC, and buffer (100 mM HEPES, pH 7.5, 0.1 mg/ml BSA) in a total reaction volume of 100 μL. Liberation of AMC is monitored continuously in a 96-well plate fluorometer using an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Under these conditions, approximately 0.8 μM AMC is produced in 30 minutes at 25 degrees C. The enzyme used in these studies was soluble (transmembrane domain and cytoplasmic extension excluded) human protein produced in a baculovirus expression system (Bac-To-Bac, Gibco BRL). The kinetic constants for hydrolysis of Gly-Pro-AMC and GLP-1 were found to be in accord with literature values for the native enzyme. To measure the dissociation constants for compounds, solutions of inhibitor in DMSO were added to reactions containing enzyme and substrate (final DMSO concentration is 1%). All experiments were conducted at room temperature using the standard reaction conditions described above.",B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)[C@@H]3C[C@@H]31)C2,CHEMBL3926627,nM,5.4,CHEMBL284,8.26760624,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)[C@@H]3C[C@@H]31)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)C3CC31)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763448,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C(C)C(=O)c1ccccc1)c(=O)n2C,CHEMBL3922613,nM,2160,CHEMBL284,5.665546249,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C(C)C(=O)c1ccccc1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(C(C)C(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763449,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,COCCn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2C#N)n(C)c1=O,CHEMBL3945052,nM,264,CHEMBL284,6.578396073,DPPIV,COCCn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2C#N)n(C)c1=O,COCCn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2C#N)n(C)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763450,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C#CCn1c(=O)n(C)c(=O)c2c1nc(N1CCCC(N)C1)n2Cc1ccccc1C#N,CHEMBL3913618,nM,16,CHEMBL284,7.795880017,DPPIV,C#CCn1c(=O)n(C)c(=O)c2c1nc(N1CCCC(N)C1)n2Cc1ccccc1C#N,C#CCn1c(=O)n(C)c(=O)c2c1nc(N1CCCC(N)C1)n2Cc1ccccc1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763451,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2C#N)n(-c2ccccc2)c1=O,CHEMBL3913689,nM,32,CHEMBL284,7.494850022,DPPIV,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2C#N)n(-c2ccccc2)c1=O,Cn1c(=O)c2c(nc(N3CCCC(N)C3)n2Cc2ccccc2C#N)n(-c2ccccc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763452,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc3ccccc3n1)c(=O)n2C,CHEMBL3904065,nM,12,CHEMBL284,7.920818754,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc3ccccc3n1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763453,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ncnc3ccccc13)c(=O)n2C,CHEMBL3934913,nM,4,CHEMBL284,8.397940009,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ncnc3ccccc13)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ncnc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763454,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc3ccccc3cn1)c(=O)n2C,CHEMBL3942798,nM,9,CHEMBL284,8.045757491,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc3ccccc3cn1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc3ccccc3cn1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763455,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1cccc(C(=O)O)c1)c(=O)n2C,CHEMBL3965610,nM,5,CHEMBL284,8.301029996,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1cccc(C(=O)O)c1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1cccc(C(=O)O)c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763456,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CNC(=O)c1cccc(C(=O)Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1,CHEMBL3897624,nM,5,CHEMBL284,8.301029996,DPPIV,CNC(=O)c1cccc(C(=O)Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1,CNC(=O)c1cccc(C(=O)Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763457,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1C(=O)N1CCOCC1)c(=O)n2C,CHEMBL3957746,nM,6,CHEMBL284,8.22184875,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1C(=O)N1CCOCC1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1C(=O)N1CCOCC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763458,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(=O)n(C)c3ccccc13)c(=O)n2C,CHEMBL3986470,nM,6,CHEMBL284,8.22184875,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(=O)n(C)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(=O)n(C)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763459,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccnc3ccccc13)c(=O)n2C,CHEMBL3985360,nM,9,CHEMBL284,8.045757491,DPPIV,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccnc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccnc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763460,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)N1CCCCC1)c(=O)n2C,CHEMBL3912125,nM,250,CHEMBL284,6.602059991,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)N1CCCCC1)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)N1CCCCC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763461,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,COc1cccc(C(=O)Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1OC,CHEMBL3974068,nM,22,CHEMBL284,7.657577319,DPPIV,COc1cccc(C(=O)Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1OC,COc1cccc(C(=O)Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3CC=C(C)C)n(C)c2=O)c1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763462,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ncc3ccccc3n1)c(=O)n2C,CHEMBL3903110,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ncc3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ncc3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763463,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NCC)c(=O)n2C,CHEMBL3955534,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NCC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NCC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763464,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(C)=O)c(=O)n2C,CHEMBL3889902,nM,2,CHEMBL284,8.698970004,DPPIV,C/C=C/Cn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(C)=O)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(C)=O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763466,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CHEMBL3987141,nM,3,CHEMBL284,8.522878745,DPPIV,C/C=C/Cn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763467,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CHEMBL3958450,nM,3,CHEMBL284,8.522878745,DPPIV,C/C=C/Cn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763468,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,CHEMBL3898310,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763470,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1ncc(C)c3ccccc13)c(=O)n2C,CHEMBL3966199,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1ncc(C)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ncc(C)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763471,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ncc(C)c3ccccc13)c(=O)n2C,CHEMBL3903787,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ncc(C)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ncc(C)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763472,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1cccc3c1OCCO3)c(=O)n2C,CHEMBL3974699,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1cccc3c1OCCO3)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1cccc3c1OCCO3)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763473,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1ccc(OC)c3ccccc13)c(=O)n2C,CHEMBL3912809,nM,13,CHEMBL284,7.886056648,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(Cc1ccc(OC)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(OC)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763474,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(OC)c3ccccc13)c(=O)n2C,CHEMBL3986074,nM,8,CHEMBL284,8.096910013,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(OC)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(OC)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763475,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1cccc3c1OCO3)c(=O)n2C,CHEMBL3979864,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1cccc3c1OCO3)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1cccc3c1OCO3)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763477,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CHEMBL3950914,nM,4,CHEMBL284,8.397940009,DPPIV,C/C=C/Cn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763478,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,CHEMBL3965981,nM,1,CHEMBL284,9,DPPIV,C/C=C/Cn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763479,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,CHEMBL3893759,nM,1,CHEMBL284,9,DPPIV,C/C=C/Cn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1OCC(=O)NC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763480,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CHEMBL3903674,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763481,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,C/C=C/Cn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CHEMBL3926493,nM,4,CHEMBL284,8.397940009,DPPIV,C/C=C/Cn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,CC=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1NC(=O)C(C)C)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763482,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(C#N)c3ccccc13)c(=O)n2C,CHEMBL3981831,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(C#N)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(C#N)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763483,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(-c3ccccc3)c3ccccc3n1)c(=O)n2C,CHEMBL3953094,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(-c3ccccc3)c3ccccc3n1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(-c3ccccc3)c3ccccc3n1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763484,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(C)c3nccnc3c1)c(=O)n2C,CHEMBL3938646,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(C)c3nccnc3c1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(C)c3nccnc3c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763485,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(F)c3ccccc13)c(=O)n2C,CHEMBL3957200,nM,12,CHEMBL284,7.920818754,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(F)c3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(F)c3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763486,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(C/C=C/c1c(F)c(F)c(F)c(F)c1F)c(=O)n2C,CHEMBL3958670,nM,8,CHEMBL284,8.096910013,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(C/C=C/c1c(F)c(F)c(F)c(F)c1F)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC=Cc1c(F)c(F)c(F)c(F)c1F)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763487,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C(F)(F)F)cc3ccccc13)c(=O)n2C,CHEMBL3931178,nM,13,CHEMBL284,7.886056648,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C(F)(F)F)cc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C(F)(F)F)cc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763488,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C(F)F)cc3ccccc13)c(=O)n2C,CHEMBL3917354,nM,6,CHEMBL284,8.22184875,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C(F)F)cc3ccccc13)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C(F)F)cc3ccccc13)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763489,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1-c1ccccc1)c(=O)n2C,CHEMBL3948679,nM,6,CHEMBL284,8.22184875,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1-c1ccccc1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1-c1ccccc1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763490,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C1CC1,CHEMBL3911930,nM,5,CHEMBL284,8.301029996,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C1CC1,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)cc3ccccc13)c(=O)n2C1CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763491,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,CHEMBL3939916,nM,3,CHEMBL284,8.522878745,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC(=O)c1cccc(OC)c1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763492,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,Cc1cc2ccccc2c(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3Cl)n(C)c2=O)n1,CHEMBL3938789,nM,11,CHEMBL284,7.958607315,DPPIV,Cc1cc2ccccc2c(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3Cl)n(C)c2=O)n1,Cc1cc2ccccc2c(Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3ccccc3Cl)n(C)c2=O)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17763493,CHEMBL3888356,"DPP-IV Assay: 50 μl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 μM, were placed in black microtitre plates. 20 μl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 μl of solubilised Caco-2 protein (final concentration 0.14 μg of protein per well). The test substances to be investigated were typically added prediluted in 20 μl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added.",B,Cc1cc2ccccc2c(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3Br)n(C)c2=O)n1,CHEMBL3962719,nM,14,CHEMBL284,7.853871964,DPPIV,Cc1cc2ccccc2c(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3ccccc3Br)n(C)c2=O)n1,Cc1cc2ccccc2c(Cn2c(=O)c3c(nc(N4CCCC(N)C4)n3Cc3ccccc3Br)n(C)c2=O)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772827,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#CC1CCCN1C(=O)CNC(=O)c1cccc2ccccc12,CHEMBL3913191,nM,100000,CHEMBL284,4,DPPIV,N#CC1CCCN1C(=O)CNC(=O)c1cccc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772828,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cnc2ccccc2c1,CHEMBL3937692,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1cnc2ccccc2c1,N#CC1CCCN1C(=O)CNC(=O)c1cnc2ccccc2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772829,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#CC1CCCN1C(=O)CNC(=O)c1cc2ccccc2[nH]1,CHEMBL3896942,nM,100000,CHEMBL284,4,DPPIV,N#CC1CCCN1C(=O)CNC(=O)c1cc2ccccc2[nH]1,N#CC1CCCN1C(=O)CNC(=O)c1cc2ccccc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772830,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#CC1CCCN1C(=O)CNC(=O)c1c[nH]c2ccccc12,CHEMBL3984057,nM,100000,CHEMBL284,4,DPPIV,N#CC1CCCN1C(=O)CNC(=O)c1c[nH]c2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1c[nH]c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772833,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#CC1CCCN1C(=O)CNC(=O)c1cncc2ccccc12,CHEMBL3914236,nM,100000,CHEMBL284,4,DPPIV,N#CC1CCCN1C(=O)CNC(=O)c1cncc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1cncc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772835,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL3920977,nM,100000,CHEMBL284,4,DPPIV,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772836,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#CC1CCCN1C(=O)CNC(=O)c1cccc2cnccc12,CHEMBL3934376,nM,100000,CHEMBL284,4,DPPIV,N#CC1CCCN1C(=O)CNC(=O)c1cccc2cnccc12,N#CC1CCCN1C(=O)CNC(=O)c1cccc2cnccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772864,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,[C-]#[N+][C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(C)ccc12,CHEMBL3900683,nM,100000,CHEMBL284,4,DPPIV,[C-]#[N+][C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2cc(C)ccc12,[C-]#[N+]C1CCCN1C(=O)CNC(=O)c1ccnc2cc(C)ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
17772866,CHEMBL3888520,"Enzymatic Assay: Enzyme activities were determined kinetically in a final volume of 200 μl for 10 minutes at 37° C. by measuring the initial velocities of pNA release (405 nm) from the substrate using a Spectramax plus microtiterplate reader (Molecular devices). One unit of enzyme activity was defined as the amount of enzyme that catalyzes the release of 1 μmol pNA from the substrate per minute under assay conditions. The chromogenic substrate Gly-Pro-p-nitroanilide (100 μmol/l) was used at pH 8.3 for DPP IV, Lys-Ala-p-nitroanilide (1 mmol/l) at pH 5.5 for DPP II, Ala-Pro-p-nitroanilide (300 μmol/l) at pH 7.4 for DPP9 and Ala-Pro-p-nitroanilide (2 mmol/l) at pH 7.4 for FAP activity measurement. To evaluate the endopeptidase activity of FAP and the influence of inhibitors thereon, Z-Gly-Pro-AMC and Z-Gly-Pro-p-nitroanilide were used at a final concentration of 300 and 100 μmol/l, respectively. The substrate concentrations were chosen around the Km value obtained under the assay conditions used. Buffer compositions for the DPP assays were reported before in the purification articles−vide supra. The FAP assay buffer consisted of 50 mM Tris pH7.4 containing 100 mmol/l NaCl and 0.1 mg/ml bovine serum albumin. The PREP activity was measured as described by Brandt et al. using the chromogenic substrate Z-Gly-Pro-p-nitroanilide (0.25 mmol/l) at pH 7.5 in the presence of 10 mmol/l DTT. Test compounds were dissolved and diluted in DMSO (final concentration DMSO during assay 5% v/v) except for FAP where dilution of the inhibitor was done in water. Inhibitors are pre-incubated with the enzyme for 15 min at 37° C. before starting the assay by the addition of substrate. The concentration of enzyme and of inhibitor during the preincubation is double of the final concentration during activity measurement.",B,N#C[C@@H]1CCCN1C(=O)CNC(=O)C1=CC=NC2=NC=CC12,CHEMBL3929674,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2[nH]ccc12,N#CC1CCCN1C(=O)CNC(=O)c1ccnc2[nH]ccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18097714,CHEMBL4021430,Inhibition of human plasma DPP4,B,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,CHEMBL577,nM,100000,CHEMBL284,4,DPPIV,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18097716,CHEMBL4021430,Inhibition of human plasma DPP4,B,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C[C@H]1C(=O)O,CHEMBL4067185,nM,255,CHEMBL284,6.59345982,DPPIV,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CC(NC(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18097717,CHEMBL4021430,Inhibition of human plasma DPP4,B,CC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C[C@H]1C(=O)O,CHEMBL4086264,nM,57,CHEMBL284,7.244125144,DPPIV,CCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,CCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CC(NC(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18097718,CHEMBL4021430,Inhibition of human plasma DPP4,B,CCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C[C@H]1C(=O)O,CHEMBL4078112,nM,67,CHEMBL284,7.173925197,DPPIV,CCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,CCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CC(NC(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18097719,CHEMBL4021430,Inhibition of human plasma DPP4,B,CCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)C[C@H]1C(=O)O,CHEMBL4090635,nM,102,CHEMBL284,6.991399828,DPPIV,CCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1C[C@@H](NC(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,CCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CC(NC(=O)CC(N)Cc2cc(F)c(F)cc2F)CC1C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164868,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2ccccc2C(=O)O)cc1.Cl.Cl,CHEMBL4081713,nM,29,CHEMBL284,7.537602002,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2ccccc2C(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2ccccc2C(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164869,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OC[C@H]2CC[C@H](C(=O)O)CC2)cc1.Cl.Cl,CHEMBL4059789,nM,80,CHEMBL284,7.096910013,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCC2CCC(C(=O)O)CC2)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCC2CCC(C(=O)O)CC2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164870,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCCCC(=O)O)cc1.Cl.Cl,CHEMBL4071166,nM,470,CHEMBL284,6.327902142,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCCCC(=O)O)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCCCC(=O)O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164871,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CCc3nc(C(=O)O)cs3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL4098218,nM,2.6,CHEMBL284,8.585026652,DPPIV,Cc1ccc(-c2c(CCc3nc(C(=O)O)cs3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CCc3nc(C(=O)O)cs3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164872,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(/C=C/c3nc(C(=O)O)cs3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL4097306,nM,5.5,CHEMBL284,8.259637311,DPPIV,Cc1ccc(-c2c(C=Cc3nc(C(=O)O)cs3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(C=Cc3nc(C(=O)O)cs3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164874,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)n(CC(C)C)c(=O)c3ccc(OCC(N)=O)cc23)cc1,CHEMBL4089584,nM,220,CHEMBL284,6.657577319,DPPIV,Cc1ccc(-c2c(CN)n(CC(C)C)c(=O)c3ccc(OCC(N)=O)cc23)cc1,Cc1ccc(-c2c(CN)n(CC(C)C)c(=O)c3ccc(OCC(N)=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164875,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nc(C(=O)O)cs4)cc23)cc1.Cl.Cl,CHEMBL4068446,nM,0.38,CHEMBL284,9.420216403,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nc(C(=O)O)cs4)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4nc(C(=O)O)cs4)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164876,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4ccc(C(=O)O)o4)cc23)cc1.Cl.Cl,CHEMBL4085490,nM,28,CHEMBL284,7.552841969,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4ccc(C(=O)O)o4)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(-c4ccc(C(=O)O)o4)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164877,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL4078049,nM,6.8,CHEMBL284,8.167491087,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164878,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL4098936,nM,4.6,CHEMBL284,8.337242168,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164879,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL4071958,nM,17,CHEMBL284,7.769551079,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164880,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL4075351,nM,29,CHEMBL284,7.537602002,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164881,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(=O)O)cc23)cc1.Cl.Cl,CHEMBL4082445,nM,140,CHEMBL284,6.853871964,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(=O)O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCC(=O)O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164888,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,NCc1c(Cc2ccccc2)nc2ccc(OCC(N)=O)cc2c1-c1ccccc1,CHEMBL4064424,nM,720,CHEMBL284,6.142667504,DPPIV,NCc1c(Cc2ccccc2)nc2ccc(OCC(N)=O)cc2c1-c1ccccc1,NCc1c(Cc2ccccc2)nc2ccc(OCC(N)=O)cc2c1-c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164889,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CHEMBL4085958,nM,250,CHEMBL284,6.602059991,DPPIV,CC(C)(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CC(C)(C)Cc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164891,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CCCCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CHEMBL4072939,nM,540,CHEMBL284,6.26760624,DPPIV,CCCCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CCCCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164892,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CCCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CHEMBL4083433,nM,620,CHEMBL284,6.207608311,DPPIV,CCCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CCCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164893,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CHEMBL4101425,nM,510,CHEMBL284,6.292429824,DPPIV,CCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,CCCc1nc2ccc(OCC(N)=O)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164894,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)Cc1nc2ccc(C(N)=O)cc2c(-c2ccccc2)c1CN,CHEMBL4092983,nM,170,CHEMBL284,6.769551079,DPPIV,CC(C)Cc1nc2ccc(C(N)=O)cc2c(-c2ccccc2)c1CN,CC(C)Cc1nc2ccc(C(N)=O)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164895,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)Cc1nc2ccc(Br)cc2c(-c2ccccc2)c1CN,CHEMBL4072218,nM,630,CHEMBL284,6.200659451,DPPIV,CC(C)Cc1nc2ccc(Br)cc2c(-c2ccccc2)c1CN,CC(C)Cc1nc2ccc(Br)cc2c(-c2ccccc2)c1CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164896,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)cnc2c1=O.Cl.Cl,CHEMBL4105034,nM,470,CHEMBL284,6.327902142,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)cnc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)cnc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164897,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Br)cnc2c1=O,CHEMBL4087191,nM,1200,CHEMBL284,5.920818754,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Br)cnc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Br)cnc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164898,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)ccc2c1=O,CHEMBL1852708,nM,360,CHEMBL284,6.443697499,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(C(N)=O)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164899,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Br)ccc2c1=O,CHEMBL4079304,nM,1200,CHEMBL284,5.920818754,DPPIV,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Br)ccc2c1=O,CC(C)Cn1c(CN)c(-c2ccccc2)c2cc(Br)ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164900,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CCc3nc(C(N)=O)cs3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL4089615,nM,8.5,CHEMBL284,8.070581074,DPPIV,Cc1ccc(-c2c(CCc3nc(C(N)=O)cs3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(CCc3nc(C(N)=O)cs3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164901,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(-c3nc(C(N)=O)cs3)cnc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL4068477,nM,2.1,CHEMBL284,8.677780705,DPPIV,Cc1ccc(-c2c(-c3nc(C(N)=O)cs3)cnc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(-c3nc(C(N)=O)cs3)cnc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164902,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCC(N)=O)cc23)cc1,CHEMBL4081741,nM,13,CHEMBL284,7.886056648,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCC(N)=O)cc23)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc3ccc(OCCCCC(N)=O)cc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164903,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(COCc3ccc(C(=O)O)cc3)c(C)nc(CC(C)C)c2CN)cc1.Cl.Cl,CHEMBL4059815,nM,7.2,CHEMBL284,8.142667504,DPPIV,Cc1ccc(-c2c(COCc3ccc(C(=O)O)cc3)c(C)nc(CC(C)C)c2CN)cc1,Cc1ccc(-c2c(COCc3ccc(C(=O)O)cc3)c(C)nc(CC(C)C)c2CN)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164904,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2ccc(C(=O)O)cc2)cc1.Cl.Cl,CHEMBL4100667,nM,17,CHEMBL284,7.769551079,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2ccc(C(=O)O)cc2)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2ccc(C(=O)O)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164905,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2cccc(C(=O)O)c2)cc1.Cl.Cl,CHEMBL4082680,nM,87,CHEMBL284,7.060480747,DPPIV,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2cccc(C(=O)O)c2)cc1,Cc1ccc(-c2c(CN)c(CC(C)C)nc(C)c2C(=O)OCc2cccc(C(=O)O)c2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18164906,CHEMBL4036397,Inhibition of human DPP4 purified from Caco2 cells pre-incubated for 15 mins before Gly-Pro-pNA substrate addition and measured after 60 mins,B,CC(=O)c1csc(-c2cnc(CC(C)C)c(CN)c2-c2ccc(C)cc2)n1.Cl.Cl,CHEMBL4096274,nM,8.7,CHEMBL284,8.060480747,DPPIV,CC(=O)c1csc(-c2cnc(CC(C)C)c(CN)c2-c2ccc(C)cc2)n1,CC(=O)c1csc(-c2cnc(CC(C)C)c(CN)c2-c2ccc(C)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245800,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,N[C@@H](CC(=O)N1CC[C@H]2[C@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL4066703,nM,70,CHEMBL284,7.15490196,DPPIV,N[C@@H](CC(=O)N1CC[C@H]2[C@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245801,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,N[C@@H](CC(=O)N1CC[C@H]2[C@@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL4077696,nM,537,CHEMBL284,6.270025714,DPPIV,N[C@@H](CC(=O)N1CC[C@H]2[C@@H](CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(C(F)(F)F)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245802,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,Cc1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@@H]1CC2.Cl,CHEMBL4063983,nM,28,CHEMBL284,7.552841969,DPPIV,Cc1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@@H]1CC2,Cc1nnc2n1C1CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245803,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,CC(C)c1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@@H]1CC2.Cl,CHEMBL4085550,nM,31.8,CHEMBL284,7.49757288,DPPIV,CC(C)c1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@@H]1CC2,CC(C)c1nnc2n1C1CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245804,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,Cl.N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(Cc4ccccc4)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL4077174,nM,123.3,CHEMBL284,6.909036923,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(Cc4ccccc4)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(Cc4ccccc4)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245805,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,CCOc1cccc(-c2nnc3n2[C@@H]2CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)C[C@@H]2CC3)n1.Cl,CHEMBL4093298,nM,139,CHEMBL284,6.8569852,DPPIV,CCOc1cccc(-c2nnc3n2[C@@H]2CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)C[C@@H]2CC3)n1,CCOc1cccc(-c2nnc3n2C2CCN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CC2CC3)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245806,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,Cl.N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(-c4ccccn4)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL4062977,nM,43.4,CHEMBL284,7.36251027,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(-c4ccccn4)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(-c4ccccn4)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245807,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,Cl.N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(-c4cnccn4)n32)C1)Cc1cc(F)c(F)cc1F,CHEMBL4090906,nM,60,CHEMBL284,7.22184875,DPPIV,N[C@@H](CC(=O)N1CC[C@@H]2[C@@H](CCc3nnc(-c4cnccn4)n32)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCC2C(CCc3nnc(-c4cnccn4)n32)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245808,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,Cc1nc(-c2nnc3n2[C@@H]2CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)C[C@@H]2CC3)cs1.Cl,CHEMBL4071607,nM,50.2,CHEMBL284,7.299296283,DPPIV,Cc1nc(-c2nnc3n2[C@@H]2CCN(C(=O)C[C@H](N)Cc4cc(F)c(F)cc4F)C[C@@H]2CC3)cs1,Cc1nc(-c2nnc3n2C2CCN(C(=O)CC(N)Cc4cc(F)c(F)cc4F)CC2CC3)cs1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18245809,CHEMBL4053403,Inhibition of recombinant human DPP-4 expressed in HEK293 cells using H-Gly-Pro-AMC as substrate measured over 15 mins by fluorescence analysis,B,CC(C)c1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@H]1CC2.Cl,CHEMBL4098632,nM,151.7,CHEMBL284,6.819014419,DPPIV,CC(C)c1nnc2n1[C@@H]1CCN(C(=O)C[C@H](N)Cc3cc(F)c(F)cc3F)C[C@H]1CC2,CC(C)c1nnc2n1C1CCN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CC1CC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18293683,CHEMBL4123027,Inhibition of human recombinant C-terminal 6His-tagged DPP-4 expressed in insect cells incubated for 30 mins by TPE-KFPE fluorescent probe-based assay,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(F)cc(F)c2)c1=O,CHEMBL4128601,nM,65.36,CHEMBL284,7.184687956,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(F)cc(F)c2)c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(F)cc(F)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18293684,CHEMBL4123027,Inhibition of human recombinant C-terminal 6His-tagged DPP-4 expressed in insect cells incubated for 30 mins by TPE-KFPE fluorescent probe-based assay,B,Cc1cc(C)cc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c2=O)c1,CHEMBL4129968,nM,188.7,CHEMBL284,6.7242281,DPPIV,Cc1cc(C)cc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c2=O)c1,Cc1cc(C)cc(Cn2c(=O)cc(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18293685,CHEMBL4123027,Inhibition of human recombinant C-terminal 6His-tagged DPP-4 expressed in insect cells incubated for 30 mins by TPE-KFPE fluorescent probe-based assay,B,COc1ccc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c2=O)cc1OC,CHEMBL4128052,nM,64.47,CHEMBL284,7.19064233,DPPIV,COc1ccc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c2=O)cc1OC,COc1ccc(Cn2c(=O)cc(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c2=O)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18314053,CHEMBL4132759,Inhibition of human DPP4,B,CC(C)[C@H](N)C(=O)N1CCCC1B(O)O,CHEMBL4176189,nM,22,CHEMBL284,7.657577319,DPPIV,CC(C)C(N)C(=O)N1CCCC1B(O)O,CC(C)C(N)C(=O)N1CCCC1B(O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357658,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(N2CCOCC2)cc1Cn1c(N2CCC[C@@H](N)C2)nc2cc[nH]c2c1=O,CHEMBL4165788,nM,100,CHEMBL284,7,DPPIV,N#Cc1ccc(N2CCOCC2)cc1Cn1c(N2CCC[C@@H](N)C2)nc2cc[nH]c2c1=O,N#Cc1ccc(N2CCOCC2)cc1Cn1c(N2CCCC(N)C2)nc2cc[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357659,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CN(C)c1ccc(C#N)c(Cn2c(N3CCC[C@@H](N)C3)nc3cc[nH]c3c2=O)c1,CHEMBL4173013,nM,100,CHEMBL284,7,DPPIV,CN(C)c1ccc(C#N)c(Cn2c(N3CCC[C@@H](N)C3)nc3cc[nH]c3c2=O)c1,CN(C)c1ccc(C#N)c(Cn2c(N3CCCC(N)C3)nc3cc[nH]c3c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357660,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2cc[nH]c2c1=O,CHEMBL4162340,nM,2.3,CHEMBL284,8.638272164,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2cc[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2cc[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357661,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]ccc2c1=O,CHEMBL4169618,nM,2.4,CHEMBL284,8.619788758,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2[nH]ccc2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2[nH]ccc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357662,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2scnc2c1=O,CHEMBL4177478,nM,6.8,CHEMBL284,8.167491087,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2scnc2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2scnc2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357663,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,Cn1cnc2nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c(=O)c21,CHEMBL4174924,nM,15.3,CHEMBL284,7.815308569,DPPIV,Cn1cnc2nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c(=O)c21,Cn1cnc2nc(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357665,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,CHEMBL4169403,nM,0.79,CHEMBL284,9.102372909,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(Br)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357666,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c(Br)[nH]c2c1=O,CHEMBL4161474,nM,1.67,CHEMBL284,8.777283529,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(Br)c(Br)[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(Br)c(Br)[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357667,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(F)c[nH]c2c1=O,CHEMBL4172793,nM,0.77,CHEMBL284,9.113509275,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(F)c[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(F)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357668,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(F)c(F)[nH]c2c1=O,CHEMBL4164893,nM,1.25,CHEMBL284,8.903089987,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(F)c(F)[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(F)c(F)[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357669,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CS(=O)(=O)n1ccc2nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c(=O)c21,CHEMBL4162532,nM,18,CHEMBL284,7.744727495,DPPIV,CS(=O)(=O)n1ccc2nc(N3CCC[C@@H](N)C3)n(Cc3cc(F)ccc3C#N)c(=O)c21,CS(=O)(=O)n1ccc2nc(N3CCCC(N)C3)n(Cc3cc(F)ccc3C#N)c(=O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357670,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3cc(F)ccc3C#N)c2c1=O,CHEMBL4173215,nM,26.6,CHEMBL284,7.575118363,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2ccn(Cc3cc(F)ccc3C#N)c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2ccn(Cc3cc(F)ccc3C#N)c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357671,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3ccsc3)c[nH]c2c1=O,CHEMBL4165967,nM,0.76,CHEMBL284,9.119186408,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3ccsc3)c[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(-c3ccsc3)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357672,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3cccs3)c[nH]c2c1=O,CHEMBL4176578,nM,0.54,CHEMBL284,9.26760624,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3cccs3)c[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(-c3cccs3)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357673,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3ccc(F)cc3)c[nH]c2c1=O,CHEMBL4164470,nM,0.54,CHEMBL284,9.26760624,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3ccc(F)cc3)c[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(-c3ccc(F)cc3)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357674,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)cc1,CHEMBL4175111,nM,0.72,CHEMBL284,9.142667504,DPPIV,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)cc1,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCCC(N)C4)nc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357675,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CS(=O)(=O)c1ccccc1-c1c[nH]c2c(=O)n(Cc3cc(F)ccc3C#N)c(N3CCC[C@@H](N)C3)nc12,CHEMBL4161924,nM,1.58,CHEMBL284,8.801342913,DPPIV,CS(=O)(=O)c1ccccc1-c1c[nH]c2c(=O)n(Cc3cc(F)ccc3C#N)c(N3CCC[C@@H](N)C3)nc12,CS(=O)(=O)c1ccccc1-c1c[nH]c2c(=O)n(Cc3cc(F)ccc3C#N)c(N3CCCC(N)C3)nc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357676,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CS(=O)(=O)c1cccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)c1,CHEMBL4169845,nM,0.61,CHEMBL284,9.214670165,DPPIV,CS(=O)(=O)c1cccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)c1,CS(=O)(=O)c1cccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCCC(N)C4)nc23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357677,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CC(C)S(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)cc1,CHEMBL4165359,nM,1.69,CHEMBL284,8.772113295,DPPIV,CC(C)S(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)cc1,CC(C)S(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCCC(N)C4)nc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357678,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3ccc(S(N)(=O)=O)cc3)c[nH]c2c1=O,CHEMBL4173272,nM,1.61,CHEMBL284,8.793174124,DPPIV,N#Cc1ccc(F)cc1Cn1c(N2CCC[C@@H](N)C2)nc2c(-c3ccc(S(N)(=O)=O)cc3)c[nH]c2c1=O,N#Cc1ccc(F)cc1Cn1c(N2CCCC(N)C2)nc2c(-c3ccc(S(N)(=O)=O)cc3)c[nH]c2c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357679,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)cc1F,CHEMBL4173673,nM,1.45,CHEMBL284,8.838631998,DPPIV,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)cc1F,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCCC(N)C4)nc23)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18357680,CHEMBL4140929,Inhibition of human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition measured for 5 to 10 mins,B,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)c(F)c1,CHEMBL4162971,nM,0.77,CHEMBL284,9.113509275,DPPIV,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCC[C@@H](N)C4)nc23)c(F)c1,CS(=O)(=O)c1ccc(-c2c[nH]c3c(=O)n(Cc4cc(F)ccc4C#N)c(N4CCCC(N)C4)nc23)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493689,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N#Cc1ccccc1Cc1c(Cl)nc2ccnn2c1N1CCC[C@@H](N)C1,CHEMBL4205581,nM,49,CHEMBL284,7.30980392,DPPIV,N#Cc1ccccc1Cc1c(Cl)nc2ccnn2c1N1CCC[C@@H](N)C1,N#Cc1ccccc1Cc1c(Cl)nc2ccnn2c1N1CCCC(N)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493690,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,CCOC(=O)c1ccc(Cn2c(N3CCC[C@@H](N)C3)cc(=O)n3nccc23)cc1,CHEMBL4216792,nM,10400,CHEMBL284,4.982966661,DPPIV,CCOC(=O)c1ccc(Cn2c(N3CCC[C@@H](N)C3)cc(=O)n3nccc23)cc1,CCOC(=O)c1ccc(Cn2c(N3CCCC(N)C3)cc(=O)n3nccc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493691,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,O=c1cc(N2CCNCC2)n(Cc2ccc([N+](=O)[O-])cc2)c2ccnn12,CHEMBL4217326,nM,17200,CHEMBL284,4.764471553,DPPIV,O=c1cc(N2CCNCC2)n(Cc2ccc([N+](=O)[O-])cc2)c2ccnn12,O=c1cc(N2CCNCC2)n(Cc2ccc([N+](=O)[O-])cc2)c2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493692,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccc([N+](=O)[O-])cc2)C1,CHEMBL4212367,nM,11500,CHEMBL284,4.93930216,DPPIV,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccc([N+](=O)[O-])cc2)C1,NC1CCCN(c2cc(=O)n3nccc3n2Cc2ccc([N+](=O)[O-])cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493693,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,Cc1ccc(Cn2c(N3CCNCC3)cc(=O)n3nccc23)cc1,CHEMBL4212894,nM,400,CHEMBL284,6.397940009,DPPIV,Cc1ccc(Cn2c(N3CCNCC3)cc(=O)n3nccc23)cc1,Cc1ccc(Cn2c(N3CCNCC3)cc(=O)n3nccc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493694,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,Cc1ccc(Cn2c(N3CCC[C@@H](N)C3)cc(=O)n3nccc23)cc1,CHEMBL4207996,nM,2000,CHEMBL284,5.698970004,DPPIV,Cc1ccc(Cn2c(N3CCC[C@@H](N)C3)cc(=O)n3nccc23)cc1,Cc1ccc(Cn2c(N3CCCC(N)C3)cc(=O)n3nccc23)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493695,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,O=c1cc(N2CCNCC2)n(Cc2ccccc2)c2ccnn12,CHEMBL4208513,nM,2500,CHEMBL284,5.602059991,DPPIV,O=c1cc(N2CCNCC2)n(Cc2ccccc2)c2ccnn12,O=c1cc(N2CCNCC2)n(Cc2ccccc2)c2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493696,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccccc2)C1,CHEMBL4203639,nM,46500,CHEMBL284,4.332547047,DPPIV,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccccc2)C1,NC1CCCN(c2cc(=O)n3nccc3n2Cc2ccccc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493697,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N#Cc1ccccc1Cn1c(N2CCNCC2)cc(=O)n2nccc12,CHEMBL4204176,nM,80,CHEMBL284,7.096910013,DPPIV,N#Cc1ccccc1Cn1c(N2CCNCC2)cc(=O)n2nccc12,N#Cc1ccccc1Cn1c(N2CCNCC2)cc(=O)n2nccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493698,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,O=c1cc(N2CCNCC2)n(Cc2ccccc2[N+](=O)[O-])c2ccnn12,CHEMBL4213950,nM,1200,CHEMBL284,5.920818754,DPPIV,O=c1cc(N2CCNCC2)n(Cc2ccccc2[N+](=O)[O-])c2ccnn12,O=c1cc(N2CCNCC2)n(Cc2ccccc2[N+](=O)[O-])c2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493699,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccccc2F)C1,CHEMBL4210635,nM,21500,CHEMBL284,4.66756154,DPPIV,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccccc2F)C1,NC1CCCN(c2cc(=O)n3nccc3n2Cc2ccccc2F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493700,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccc(C(=O)O)cc2)C1,CHEMBL4205100,nM,59900,CHEMBL284,4.222573178,DPPIV,N[C@@H]1CCCN(c2cc(=O)n3nccc3n2Cc2ccc(C(=O)O)cc2)C1,NC1CCCN(c2cc(=O)n3nccc3n2Cc2ccc(C(=O)O)cc2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18493701,CHEMBL4187777,Inhibition of human DPP4 using A-P-7-amido-4-trifluoromethylcoumarin as substrate pretreated for 10 mins followed by substrate addition measured after 10 mins,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)n2nccc12,CHEMBL4215849,nM,1300,CHEMBL284,5.886056648,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)n2nccc12,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)cc(=O)n2nccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662254,CHEMBL4232376,Inhibition of DPP4 (unknown origin) using Gly-Pro-pNA as substrate after 60 mins,B,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,CHEMBL91777,nM,65690,CHEMBL284,4.182500738,DPPIV,CC(C)C(N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O,CC(C)C(N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662261,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=C(O)c1cc(O)c(O)c(O)c1,CHEMBL288114,nM,4650,CHEMBL284,5.332547047,DPPIV,O=C(O)c1cc(O)c(O)c(O)c1,O=C(O)c1cc(O)c(O)c(O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662262,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,CHEMBL297453,nM,10210,CHEMBL284,4.990974258,DPPIV,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662263,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O,CHEMBL257839,nM,420,CHEMBL284,6.37675071,DPPIV,OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O,OCC1OC(Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)C(O)C(O)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662264,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)c(O)c3)CC4=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,CHEMBL2165586,nM,10360,CHEMBL284,4.984640245,DPPIV,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)c(O)c3)CC4=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,CC1OC(OCC2OC(Oc3cc(O)c4c(c3)OC(c3ccc(O)c(O)c3)CC4=O)C(O)C(O)C2O)C(O)C(O)C1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662265,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O.[Cl-],CHEMBL592005,nM,1410,CHEMBL284,5.850780887,DPPIV,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662266,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=C(O)/C=C/c1ccc(O)c(O)c1,CHEMBL145,nM,3370,CHEMBL284,5.472370099,DPPIV,O=C(O)C=Cc1ccc(O)c(O)c1,O=C(O)C=Cc1ccc(O)c(O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662267,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,Oc1cc(O)c2cc(O)c(-c3ccc(O)c(O)c3)[o+]c2c1.[Cl-],CHEMBL511367,nM,1410,CHEMBL284,5.850780887,DPPIV,Oc1cc(O)c2cc(O)c(-c3ccc(O)c(O)c3)[o+]c2c1,Oc1cc(O)c2cc(O)c(-c3ccc(O)c(O)c3)[o+]c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662268,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,CHEMBL165,nM,0.6,CHEMBL284,9.22184875,DPPIV,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662269,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,CHEMBL44,nM,480,CHEMBL284,6.318758763,DPPIV,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662271,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,CHEMBL9352,nM,240,CHEMBL284,6.619788758,DPPIV,O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21,O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662272,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O,CHEMBL399121,nM,280,CHEMBL284,6.552841969,DPPIV,COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O,COc1ccc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662273,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=c1cc(-c2ccccc2)oc2ccccc12,CHEMBL275638,nM,170,CHEMBL284,6.769551079,DPPIV,O=c1cc(-c2ccccc2)oc2ccccc12,O=c1cc(-c2ccccc2)oc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662275,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,CHEMBL28,nM,140,CHEMBL284,6.853871964,DPPIV,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662276,CHEMBL4232373,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay,B,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL151,nM,120,CHEMBL284,6.920818754,DPPIV,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662278,CHEMBL4232372,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate after 30 mins by fluorescence assay,B,Brc1nc2n(n1)CC(c1cc3ccccc3o1)=NN2,CHEMBL4246951,nM,28050,CHEMBL284,4.552067134,DPPIV,Brc1nc2n(n1)CC(c1cc3ccccc3o1)=NN2,Brc1nc2n(n1)CC(c1cc3ccccc3o1)=NN2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662279,CHEMBL4232371,Inhibition of DPP4 (unknown origin) using H-Gly-Pro-AMC as substrate,B,Cc1ccc2nc(CNc3nc(C)cs3)n(/N=C/c3ccc(O)cc3)c(=O)c2c1,CHEMBL4247480,nM,1.12,CHEMBL284,8.950781977,DPPIV,Cc1ccc2nc(CN=c3[nH]c(C)cs3)n(N=Cc3ccc(O)cc3)c(=O)c2c1,Cc1ccc2nc(CN=c3[nH]c(C)cs3)n(N=Cc3ccc(O)cc3)c(=O)c2c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662280,CHEMBL4232371,Inhibition of DPP4 (unknown origin) using H-Gly-Pro-AMC as substrate,B,Cc1csc(NC2c3cc(I)ccc3N=C(c3ccccc3)N2/N=C/c2cccc([N+](=O)[O-])c2)n1,CHEMBL4238698,nM,1.22,CHEMBL284,8.913640169,DPPIV,Cc1csc(=NC2c3cc(I)ccc3N=C(c3ccccc3)N2/N=C/c2cccc([N+](=O)[O-])c2)[nH]1,Cc1csc(=NC2c3cc(I)ccc3N=C(c3ccccc3)N2N=Cc2cccc([N+](=O)[O-])c2)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662281,CHEMBL4232371,Inhibition of DPP4 (unknown origin) using H-Gly-Pro-AMC as substrate,B,COc1ccc(/C=N/N2C(c3ccccc3)=Nc3ccc(I)cc3C2Nc2nccs2)cc1,CHEMBL4242883,nM,1.62,CHEMBL284,8.790484985,DPPIV,COc1ccc(/C=N/N2C(c3ccccc3)=Nc3ccc(I)cc3C2N=c2[nH]ccs2)cc1,COc1ccc(C=NN2C(c3ccccc3)=Nc3ccc(I)cc3C2N=c2[nH]ccs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662282,CHEMBL4232371,Inhibition of DPP4 (unknown origin) using H-Gly-Pro-AMC as substrate,B,O=[N+]([O-])c1cccc(/C=N/N2C(c3ccccc3)=Nc3ccccc3C2Nc2nccs2)c1,CHEMBL4249193,nM,1.33,CHEMBL284,8.876148359,DPPIV,O=[N+]([O-])c1cccc(/C=N/N2C(c3ccccc3)=Nc3ccccc3C2N=c2[nH]ccs2)c1,O=[N+]([O-])c1cccc(C=NN2C(c3ccccc3)=Nc3ccccc3C2N=c2[nH]ccs2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662283,CHEMBL4232371,Inhibition of DPP4 (unknown origin) using H-Gly-Pro-AMC as substrate,B,O=[N+]([O-])c1cccc(/C=N/N2C(c3ccccc3)=Nc3ccc(I)cc3C2Nc2nccs2)c1,CHEMBL4239107,nM,0.76,CHEMBL284,9.119186408,DPPIV,O=[N+]([O-])c1cccc(/C=N/N2C(c3ccccc3)=Nc3ccc(I)cc3C2N=c2[nH]ccs2)c1,O=[N+]([O-])c1cccc(C=NN2C(c3ccccc3)=Nc3ccc(I)cc3C2N=c2[nH]ccs2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662284,CHEMBL4232370,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate after 1 hr by fluorescence assay,B,N[C@@H](CCn1cc(-c2ccncc2)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4250492,nM,14,CHEMBL284,7.853871964,DPPIV,N[C@@H](CCn1cc(-c2ccncc2)nn1)Cc1cc(F)c(F)cc1F,NC(CCn1cc(-c2ccncc2)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662286,CHEMBL4232369,Inhibition of recombinant human DPP4 pre-incubated for 30 mins before Gly-Pro-Aminomethylcoumarin substrate addition,B,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1C#N)c(=O)n2C,CHEMBL4246674,nM,19.6,CHEMBL284,7.707743929,DPPIV,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1C#N)c(=O)n2C,CC(C)=CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1C#N)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662287,CHEMBL4232368,Inhibition of DPP4 (unknown origin),B,NCc1c(-c2ccc(Cl)cc2Cl)n(C[SH](=O)=O)c2ccccc12,CHEMBL4246222,nM,232.8,CHEMBL284,6.633017024,DPPIV,NCc1c(-c2ccc(Cl)cc2Cl)n(C[SH](=O)=O)c2ccccc12,NCc1c(-c2ccc(Cl)cc2Cl)n(C[SH](=O)=O)c2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662289,CHEMBL4232368,Inhibition of DPP4 (unknown origin),B,CC(C)(C)[C@H](N)C(=O)N1CCSCC1,CHEMBL4241283,nM,3.4,CHEMBL284,8.468521083,DPPIV,CC(C)(C)C(N)C(=O)N1CCSCC1,CC(C)(C)C(N)C(=O)N1CCSCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662290,CHEMBL4232368,Inhibition of DPP4 (unknown origin),B,CC(C)C[C@H](N)C(=O)N1CCSCC1,CHEMBL4250956,nM,6.29,CHEMBL284,8.201349355,DPPIV,CC(C)CC(N)C(=O)N1CCSCC1,CC(C)CC(N)C(=O)N1CCSCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662291,CHEMBL4232368,Inhibition of DPP4 (unknown origin),B,CCC(C)[C@H](N)C(=O)N1CCSCC1,CHEMBL4241366,nM,6.93,CHEMBL284,8.159266765,DPPIV,CCC(C)C(N)C(=O)N1CCSCC1,CCC(C)C(N)C(=O)N1CCSCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662292,CHEMBL4232367,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured for 20 mins with 1 min interval,B,O=C(N/N=C/c1cccc2ccccc12)c1[nH]nc2c1CCCC2,CHEMBL1976036,nM,3440,CHEMBL284,5.463441557,DPPIV,O=C(N/N=C/c1cccc2ccccc12)c1[nH]nc2c1CCCC2,O=C(NN=Cc1cccc2ccccc12)c1[nH]nc2c1CCCC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662293,CHEMBL4232367,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured for 20 mins with 1 min interval,B,O=C(N/N=C/c1c(O)ccc2ccccc12)c1n[nH]c2c1CCCC2,CHEMBL4247286,nM,2120,CHEMBL284,5.673664139,DPPIV,O=C(NN=Cc1c(O)ccc2ccccc12)c1[nH]nc2c1CCCC2,O=C(NN=Cc1c(O)ccc2ccccc12)c1[nH]nc2c1CCCC2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662294,CHEMBL4232366,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate after 30 mins by fluorometric analysis,B,O=C(CNC(=O)C1CCCN(S(=O)(=O)c2ccccc2)C1)Nc1ccc(Cl)cc1,CHEMBL4250558,nM,94.82,CHEMBL284,7.023100049,DPPIV,O=C(CNC(=O)C1CCCN(S(=O)(=O)c2ccccc2)C1)Nc1ccc(Cl)cc1,O=C(CNC(=O)C1CCCN(S(=O)(=O)c2ccccc2)C1)Nc1ccc(Cl)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662295,CHEMBL4232365,Inhibition of recombinant human DPP4 assessed as hydrolyzing H-Gly-Pro-pNA hydrolysis by measuring p-nitroaniline release after 10 mins by double beam spectrophotometric analysis,B,O=C(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)N1CCCC1,CHEMBL4245414,nM,3730,CHEMBL284,5.428291168,DPPIV,O=C(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)N1CCCC1,O=C(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)N1CCCC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662296,CHEMBL4232364,Inhibition of recombinant human DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by fluorometric analysis,B,COC(=O)c1cn([C@@H]2CN[C@H](C(=O)N3CCC(F)(F)C3)C2)nn1,CHEMBL4241199,nM,720,CHEMBL284,6.142667504,DPPIV,COC(=O)c1cn([C@@H]2CNC(C(=O)N3CCC(F)(F)C3)C2)nn1,COC(=O)c1cn(C2CNC(C(=O)N3CCC(F)(F)C3)C2)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662297,CHEMBL4232364,Inhibition of recombinant human DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by fluorometric analysis,B,O=C([C@@H]1C[C@H](n2cc(-c3ccccc3)nn2)CN1)N1CCC(F)(F)C1,CHEMBL4249750,nM,660,CHEMBL284,6.180456064,DPPIV,O=C(C1C[C@H](n2cc(-c3ccccc3)nn2)CN1)N1CCC(F)(F)C1,O=C(C1CC(n2cc(-c3ccccc3)nn2)CN1)N1CCC(F)(F)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18662298,CHEMBL4232364,Inhibition of recombinant human DPP4 expressed in baculovirus expression system using Ala-Pro-AMC as substrate by fluorometric analysis,B,Cc1cc(-c2cn([C@@H]3CN[C@H](C(=O)N4CCC(F)(F)C4)C3)nn2)ccc1F,CHEMBL4240687,nM,1320,CHEMBL284,5.879426069,DPPIV,Cc1cc(-c2cn([C@@H]3CNC(C(=O)N4CCC(F)(F)C4)C3)nn2)ccc1F,Cc1cc(-c2cn(C3CNC(C(=O)N4CCC(F)(F)C4)C3)nn2)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18672851,CHEMBL4235009,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate measured after 10 mins,B,CC1(C)[C@@H]2CC[C@@]1(C)[C@H](NCC(=O)N1CCC[C@H]1C#N)C2,CHEMBL4247814,nM,1270,CHEMBL284,5.896196279,DPPIV,CC1(C)[C@@H]2CC[C@@]1(C)[C@H](NCC(=O)N1CCC[C@H]1C#N)C2,CC1(C)C2CCC1(C)C(NCC(=O)N1CCCC1C#N)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18672852,CHEMBL4235009,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate measured after 10 mins,B,CC1(C)[C@H]2CC[C@]1(C)[C@@H](NCC(=O)N1CCC[C@H]1C#N)C2,CHEMBL4242321,nM,1780,CHEMBL284,5.749579998,DPPIV,CC1(C)[C@H]2CC[C@]1(C)[C@@H](NCC(=O)N1CCC[C@H]1C#N)C2,CC1(C)C2CCC1(C)C(NCC(=O)N1CCCC1C#N)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18672853,CHEMBL4235009,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate measured after 10 mins,B,CC1(C)[C@H]2CC[C@]1(C)C(=O)[C@H]2NCC(=O)N1CCC[C@H]1C#N,CHEMBL4238169,nM,15780,CHEMBL284,4.801893001,DPPIV,CC1(C)C2CC[C@]1(C)C(=O)C2NCC(=O)N1CCC[C@H]1C#N,CC12CCC(C(NCC(=O)N3CCCC3C#N)C1=O)C2(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18672854,CHEMBL4235009,Inhibition of recombinant human DPP4 using H-Gly-Pro-AMC as substrate measured after 10 mins,B,CC1(C)[C@H]2CC[C@]1(C)[C@@H](O)[C@H]2NCC(=O)N1CCC[C@H]1C#N,CHEMBL4238607,nM,7580,CHEMBL284,5.120330794,DPPIV,CC1(C)[C@H]2CC[C@]1(C)[C@@H](O)[C@H]2NCC(=O)N1CCC[C@H]1C#N,CC1(C)C2CCC1(C)C(O)C2NCC(=O)N1CCCC1C#N,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896723,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4555157,nM,100000,CHEMBL284,4,DPPIV,CCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896724,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC(C)CNc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4554062,nM,68510,CHEMBL284,4.164246032,DPPIV,CC(C)CNc1nc2scnn2c(=O)c1[N+](=O)[O-],CC(C)CNc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896725,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC(C)(C)Nc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4540237,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)Nc1nc2scnn2c(=O)c1[N+](=O)[O-],CC(C)(C)Nc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896726,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4582763,nM,100000,CHEMBL284,4,DPPIV,CCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896727,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC(C)Nc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4535561,nM,76170,CHEMBL284,4.118216044,DPPIV,CC(C)Nc1nc2scnn2c(=O)c1[N+](=O)[O-],CC(C)Nc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896728,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC(=O)OCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4557028,nM,100000,CHEMBL284,4,DPPIV,CC(=O)OCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CC(=O)OCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896729,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC(=O)OCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4471409,nM,100000,CHEMBL284,4,DPPIV,CC(=O)OCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CC(=O)OCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896730,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC(=O)OCCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CHEMBL4448038,nM,100000,CHEMBL284,4,DPPIV,CC(=O)OCCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],CC(=O)OCCCCNc1nc2scnn2c(=O)c1[N+](=O)[O-],Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896732,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,O=c1c([N+](=O)[O-])c(NCCCO)nc2scnn12,CHEMBL4435578,nM,100000,CHEMBL284,4,DPPIV,O=c1c([N+](=O)[O-])c(NCCCO)nc2scnn12,O=c1c([N+](=O)[O-])c(NCCCO)nc2scnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896733,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,O=c1c([N+](=O)[O-])c(NCCCCO)nc2scnn12,CHEMBL4567960,nM,100000,CHEMBL284,4,DPPIV,O=c1c([N+](=O)[O-])c(NCCCCO)nc2scnn12,O=c1c([N+](=O)[O-])c(NCCCCO)nc2scnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896734,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,O=c1c([N+](=O)[O-])c(NCCc2ccc(Cl)cc2)nc2scnn12,CHEMBL4571225,nM,55870,CHEMBL284,4.252821329,DPPIV,O=c1c([N+](=O)[O-])c(NCCc2ccc(Cl)cc2)nc2scnn12,O=c1c([N+](=O)[O-])c(NCCc2ccc(Cl)cc2)nc2scnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896735,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,O=c1c([N+](=O)[O-])c(NCCc2ccc(O)cc2)nc2scnn12,CHEMBL4463269,nM,100000,CHEMBL284,4,DPPIV,O=c1c([N+](=O)[O-])c(NCCc2ccc(O)cc2)nc2scnn12,O=c1c([N+](=O)[O-])c(NCCc2ccc(O)cc2)nc2scnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896736,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,O=c1c([N+](=O)[O-])c(NCC(O)CO)nc2scnn12,CHEMBL4466627,nM,100000,CHEMBL284,4,DPPIV,O=c1c([N+](=O)[O-])c(NCC(O)CO)nc2scnn12,O=c1c([N+](=O)[O-])c(NCC(O)CO)nc2scnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18896737,CHEMBL4315807,Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis,B,CC1(C)OCC(CNc2nc3scnn3c(=O)c2[N+](=O)[O-])O1,CHEMBL4563602,nM,100000,CHEMBL284,4,DPPIV,CC1(C)OCC(CNc2nc3scnn3c(=O)c2[N+](=O)[O-])O1,CC1(C)OCC(CNc2nc3scnn3c(=O)c2[N+](=O)[O-])O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934793,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CCCCCO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4516388,nM,223,CHEMBL284,6.651695137,DPPIV,O=C(CCCCCO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CCCCCO)NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934794,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CCCCO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4464592,nM,226,CHEMBL284,6.645891561,DPPIV,O=C(CCCCO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CCCCO)NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934795,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CCCO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4458307,nM,208,CHEMBL284,6.681936665,DPPIV,O=C(CCCO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CCCO)NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934796,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4537702,nM,217,CHEMBL284,6.663540266,DPPIV,O=C(CO)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CO)NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934797,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CCCCCO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4524414,nM,60,CHEMBL284,7.22184875,DPPIV,O=C(CCCCCO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CCCCCO[N+](=O)[O-])NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934798,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CCCCO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4577865,nM,170,CHEMBL284,6.769551079,DPPIV,O=C(CCCCO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CCCCO[N+](=O)[O-])NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934799,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CCCO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4437841,nM,197,CHEMBL284,6.705533774,DPPIV,O=C(CCCO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CCCO[N+](=O)[O-])NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
18934800,CHEMBL4326781,Inhibition of human DPP-4 using Ala-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 5 to 10 mins by fluorescence assay,B,O=C(CO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL4434648,nM,190,CHEMBL284,6.721246399,DPPIV,O=C(CO[N+](=O)[O-])N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,O=C(CO[N+](=O)[O-])NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099006,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(F)c2C(=O)O)c1=O,CHEMBL4446618,nM,2.19,CHEMBL284,8.659555885,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(F)c2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(F)c2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099007,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccccc1C(=O)O)c(=O)n2C,CHEMBL4452518,nM,1.98,CHEMBL284,8.70333481,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099008,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cccc(F)c1C(=O)O)c(=O)n2C,CHEMBL4441220,nM,10.21,CHEMBL284,7.990974258,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cccc(F)c1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cccc(F)c1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099009,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(F)cc1C(=O)O)c(=O)n2C,CHEMBL4528994,nM,2.35,CHEMBL284,8.628932138,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(F)cc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(F)cc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099010,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(Cl)cccc1C(=O)O)c(=O)n2C,CHEMBL4458949,nM,3.9,CHEMBL284,8.408935393,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(Cl)cccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1c(Cl)cccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099011,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(Cl)ccc1C(=O)O)c(=O)n2C,CHEMBL4465482,nM,0.18,CHEMBL284,9.744727495,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(Cl)ccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(Cl)ccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099012,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)O)c(=O)n2C,CHEMBL4448186,nM,0.1,CHEMBL284,10,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099013,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(Br)cccc1C(=O)O)c(=O)n2C,CHEMBL4544024,nM,1.05,CHEMBL284,8.978810701,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(Br)cccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1c(Br)cccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099014,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(Br)ccc1C(=O)O)c(=O)n2C,CHEMBL4536341,nM,0.72,CHEMBL284,9.142667504,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(Br)ccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(Br)ccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099015,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)O)c(=O)n2C,CHEMBL4461587,nM,0.22,CHEMBL284,9.657577319,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099016,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(OC)cccc1C(=O)O)c(=O)n2C,CHEMBL4458832,nM,5.99,CHEMBL284,8.222573178,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(OC)cccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1c(OC)cccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099017,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(OC)ccc1C(=O)O)c(=O)n2C,CHEMBL4588692,nM,0.44,CHEMBL284,9.356547324,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(OC)ccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(OC)ccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099018,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(C#N)ccc1C(=O)O)c(=O)n2C,CHEMBL4464069,nM,2.43,CHEMBL284,8.614393726,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(C#N)ccc1C(=O)O)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(C#N)ccc1C(=O)O)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099019,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccccc1C(=O)OC)c(=O)n2C,CHEMBL4435383,nM,2.91,CHEMBL284,8.536107011,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccccc1C(=O)OC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccccc1C(=O)OC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099020,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cccc(F)c1C(=O)OC)c(=O)n2C,CHEMBL4590999,nM,5.06,CHEMBL284,8.295849483,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cccc(F)c1C(=O)OC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cccc(F)c1C(=O)OC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099021,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(Cl)cccc1C(=O)OC)c(=O)n2C,CHEMBL4465448,nM,50.9,CHEMBL284,7.293282218,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1c(Cl)cccc1C(=O)OC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1c(Cl)cccc1C(=O)OC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099022,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(Cl)ccc1C(=O)OC)c(=O)n2C,CHEMBL4458152,nM,5.61,CHEMBL284,8.251037139,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1cc(Cl)ccc1C(=O)OC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1cc(Cl)ccc1C(=O)OC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099023,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)OC)c(=O)n2C,CHEMBL4567320,nM,20.48,CHEMBL284,7.688670048,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)OC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)OC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099024,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)OCC)c(=O)n2C,CHEMBL4468590,nM,74.43,CHEMBL284,7.128251981,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)OCC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Cl)cc1C(=O)OCC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099025,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OC)c(=O)n2C,CHEMBL4465374,nM,22.09,CHEMBL284,7.655804284,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19099026,CHEMBL4368093,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition measured at 60 secs interval for 20 mins by fluorometic method,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OCC)c(=O)n2C,CHEMBL4528149,nM,85.48,CHEMBL284,7.068135487,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OCC)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OCC)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19149784,CHEMBL4379983,Inhibition of human DPP4 in pH 7.4 Tris buffer using AP-7-ATFMC as substrate preincubated for 15 mins followed by substrate addition by microplate reader analysis,B,CCOC(=O)N1CCN(c2ccc3nnc(-c4cccc(C)c4)n3n2)CC1,CHEMBL4454091,nM,0.75,CHEMBL284,9.124938737,DPPIV,CCOC(=O)N1CCN(c2ccc3nnc(-c4cccc(C)c4)n3n2)CC1,CCOC(=O)N1CCN(c2ccc3nnc(-c4cccc(C)c4)n3n2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19149785,CHEMBL4379983,Inhibition of human DPP4 in pH 7.4 Tris buffer using AP-7-ATFMC as substrate preincubated for 15 mins followed by substrate addition by microplate reader analysis,B,Cc1cccc(-c2nnc3ccc(N4CCN(C(=O)c5ccccc5)CC4)nn23)c1,CHEMBL4529301,nM,2.25,CHEMBL284,8.647817482,DPPIV,Cc1cccc(-c2nnc3ccc(N4CCN(C(=O)c5ccccc5)CC4)nn23)c1,Cc1cccc(-c2nnc3ccc(N4CCN(C(=O)c5ccccc5)CC4)nn23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19149786,CHEMBL4379983,Inhibition of human DPP4 in pH 7.4 Tris buffer using AP-7-ATFMC as substrate preincubated for 15 mins followed by substrate addition by microplate reader analysis,B,Cc1cccc(-c2nnc3ccc(N4CCN(Cc5ccc(F)cc5)CC4)nn23)c1,CHEMBL4547171,nM,2,CHEMBL284,8.698970004,DPPIV,Cc1cccc(-c2nnc3ccc(N4CCN(Cc5ccc(F)cc5)CC4)nn23)c1,Cc1cccc(-c2nnc3ccc(N4CCN(Cc5ccc(F)cc5)CC4)nn23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19149787,CHEMBL4379983,Inhibition of human DPP4 in pH 7.4 Tris buffer using AP-7-ATFMC as substrate preincubated for 15 mins followed by substrate addition by microplate reader analysis,B,Cc1cccc(-c2nnc3ccc(N4CCN(C(c5ccccc5)c5ccccc5)CC4)nn23)c1,CHEMBL4460852,nM,1.75,CHEMBL284,8.756961951,DPPIV,Cc1cccc(-c2nnc3ccc(N4CCN(C(c5ccccc5)c5ccccc5)CC4)nn23)c1,Cc1cccc(-c2nnc3ccc(N4CCN(C(c5ccccc5)c5ccccc5)CC4)nn23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301460,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2C(=O)OC)c1=O,CHEMBL4436620,nM,74.6,CHEMBL284,7.127261173,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2C(=O)OC)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccccc2C(=O)OC)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301461,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2CC(=O)OC)c1=O,CHEMBL4530011,nM,56.6,CHEMBL284,7.247183569,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2CC(=O)OC)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccccc2CC(=O)OC)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301462,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2C(=O)O)c1=O,CHEMBL4538597,nM,7.5,CHEMBL284,8.124938737,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccccc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301463,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2CC(=O)O)c1=O,CHEMBL4468423,nM,89.8,CHEMBL284,7.046723663,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2CC(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccccc2CC(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301474,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(F)cc2C(=O)O)c1=O,CHEMBL4438210,nM,7.6,CHEMBL284,8.119186408,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(F)cc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(F)cc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301476,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Cl)cc2C(=O)O)c1=O,CHEMBL4562685,nM,3.9,CHEMBL284,8.408935393,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Cl)cc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(Cl)cc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301477,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Br)cc2C(=O)O)c1=O,CHEMBL4527363,nM,4.6,CHEMBL284,8.337242168,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Br)cc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(Br)cc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301478,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)ccc2C(=O)O)c1=O,CHEMBL4558007,nM,2.5,CHEMBL284,8.602059991,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)ccc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(Br)ccc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301479,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(OC)ccc2C(=O)O)c1=O,CHEMBL4581959,nM,4,CHEMBL284,8.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(OC)ccc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(OC)ccc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301480,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C#N)ccc2C(=O)O)c1=O,CHEMBL4516959,nM,3.5,CHEMBL284,8.455931956,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C#N)ccc2C(=O)O)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(C#N)ccc2C(=O)O)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301481,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(F)c2C(=O)OC)c1=O,CHEMBL4453917,nM,93.2,CHEMBL284,7.030584088,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(F)c2C(=O)OC)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(F)c2C(=O)OC)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19301482,CHEMBL4413686,Inhibition of recombinant human DPP4 expressed in baculovirus infected Sf9 insect cells using Gly-Pro-AMC as substrate measured at 60 secs interval for 20 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)ccc2C(=O)OC)c1=O,CHEMBL4445783,nM,395,CHEMBL284,6.403402904,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)ccc2C(=O)OC)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(Br)ccc2C(=O)OC)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439488,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1Cc1nc(C)c2ccccc2n1,CHEMBL4557196,nM,4376,CHEMBL284,5.358922687,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1Cc1nc(C)c2ccccc2n1,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)nc1n2CCCN1Cc1nc(C)c2ccccc2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439489,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1Cc1ccc(OC)cc1,CHEMBL4465057,nM,790,CHEMBL284,6.102372909,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1Cc1ccc(OC)cc1,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)nc1n2CCCN1Cc1ccc(OC)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439490,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1Cc1cccc2ccccc12,CHEMBL4537708,nM,483,CHEMBL284,6.316052869,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1Cc1cccc2ccccc12,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)nc1n2CCCN1Cc1cccc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439491,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1CCCc1ccccc1,CHEMBL4443493,nM,10000,CHEMBL284,5,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1CCCc1ccccc1,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)nc1n2CCCN1CCCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439492,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1CC(=O)c1ccccc1,CHEMBL4591675,nM,421,CHEMBL284,6.375717904,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)nc1n2CCCN1CC(=O)c1ccccc1,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)nc1n2CCCN1CC(=O)c1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439496,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(CCCc1ccccc1)C1=NCCCN12,CHEMBL4549857,nM,10000,CHEMBL284,5,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(CCCc1ccccc1)C1=NCCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(CCCc1ccccc1)C1=NCCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439500,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC#N)N3CCN=C23)nc2ccccc12,CHEMBL4443070,nM,538,CHEMBL284,6.269217724,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC#N)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3CC#N)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439505,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC(=O)C3CC3)N3CCN=C23)nc2ccccc12,CHEMBL4464819,nM,4.41,CHEMBL284,8.355561411,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC(=O)C3CC3)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3CC(=O)C3CC3)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439510,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)cs3)N3CCN=C23)nc2ccccc12,CHEMBL4563476,nM,28.7,CHEMBL284,7.542118103,DPPIV,Cc1nc(CN2C(=O)c3c(nc(N4CCC[C@@H](N)C4)n3Cc3cc(F)cs3)N3CCN=C23)nc2ccccc12,Cc1nc(CN2C(=O)c3c(nc(N4CCCC(N)C4)n3Cc3cc(F)cs3)N3CCN=C23)nc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439512,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1cccc(C#N)c1)C1=NCCN12,CHEMBL4516443,nM,11.2,CHEMBL284,7.950781977,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1cccc(C#N)c1)C1=NCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1cccc(C#N)c1)C1=NCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19439513,CHEMBL4431128,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 50 mins by fluorescence assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1ccc(C#N)cc1)C1=NCCN12,CHEMBL4568895,nM,10,CHEMBL284,8,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1C(=O)N(Cc1ccc(C#N)cc1)C1=NCCN12,CC#CCn1c(N2CCCC(N)C2)nc2c1C(=O)N(Cc1ccc(C#N)cc1)C1=NCCN12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
19442623,CHEMBL4432067,Inhibition of human recombinant DPP4 (39 to 766 residues) using Ala-Pro-AFC as substrate incubated for 1 hr by fluorescence assay,B,O=c1[nH]c(=O)c2c(nc(N3CCNCC3)n2Cc2ccccc2)[nH]1,CHEMBL4456228,nM,3900,CHEMBL284,5.408935393,DPPIV,O=c1[nH]c(=O)c2c(nc(N3CCNCC3)n2Cc2ccccc2)[nH]1,O=c1[nH]c(=O)c2c(nc(N3CCNCC3)n2Cc2ccccc2)[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653408,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CHEMBL4635648,nM,1000,CHEMBL284,6,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)OC1C(F)(F)F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653409,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@H]1C(F)(F)F)C2,CHEMBL4633377,nM,1000,CHEMBL284,6,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@H]1C(F)(F)F)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)OC1C(F)(F)F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653410,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@H]1C(F)(F)F)C2,CHEMBL4643841,nM,1000,CHEMBL284,6,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@H]1C(F)(F)F)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)OC1C(F)(F)F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653411,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,N[C@H]1C[C@@H](N2CCC(F)(F)C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,CHEMBL4635433,nM,48.9,CHEMBL284,7.310691141,DPPIV,N[C@H]1C[C@@H](N2CCC(F)(F)C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,NC1CC(N2CCC(F)(F)C2)C(C(F)(F)F)OC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653412,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,CHEMBL4640183,nM,18.2,CHEMBL284,7.739928612,DPPIV,N[C@H]1C[C@@H](N2Cc3c[nH]nc3C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3c[nH]nc3C2)C(C(F)(F)F)OC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653413,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CCOC(=O)c1nc2c(n1C)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CHEMBL4634272,nM,20.6,CHEMBL284,7.68613278,DPPIV,CCOC(O)c1nc2cn([C@@H]3C[C@H](N)[C@@H](c4cc(F)ccc4F)O[C@@H]3C(F)(F)F)cc2n1C,CCOC(O)c1nc2cn(C3CC(N)C(c4cc(F)ccc4F)OC3C(F)(F)F)cc2n1C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653414,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,Cn1c(C(N)=O)nc2c1CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CHEMBL4644314,nM,7.1,CHEMBL284,8.148741651,DPPIV,Cn1c(C(N)O)nc2cn([C@@H]3C[C@H](N)[C@@H](c4cc(F)ccc4F)O[C@@H]3C(F)(F)F)cc21,Cn1c(C(N)O)nc2cn(C3CC(N)C(c4cc(F)ccc4F)OC3C(F)(F)F)cc21,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653415,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)c(F)cc3F)O[C@@H]1C(F)(F)F)C2,CHEMBL4641763,nM,3.9,CHEMBL284,8.408935393,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)c(F)cc3F)O[C@@H]1C(F)(F)F)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)c(F)cc3F)OC1C(F)(F)F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653416,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,CHEMBL4634474,nM,26.5,CHEMBL284,7.576754126,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CCCC4)nc3C2)C(C(F)(F)F)OC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653417,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,CHEMBL4636223,nM,11.7,CHEMBL284,7.931814138,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)[C@@H](C(F)(F)F)O[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)C4CC4)nc3C2)C(C(F)(F)F)OC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653418,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CCS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CHEMBL4649110,nM,60,CHEMBL284,7.22184875,DPPIV,CCS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CCS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)OC1C(F)(F)F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653419,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CHEMBL4646510,nM,4.2,CHEMBL284,8.37675071,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@@H]1C[C@H](N)[C@@H](c3cc(F)ccc3F)O[C@@H]1C(F)(F)F)C2,CS(=O)(=O)n1cc2c(n1)CN(C1CC(N)C(c3cc(F)ccc3F)OC1C(F)(F)F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20653420,CHEMBL4616383,Inhibition of human recombinant DPP4 incubated for 15 mins using Gly-Pro-7-AMC substrate,B,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)[C@H]1F)C2,CHEMBL4640418,nM,22.1,CHEMBL284,7.655607726,DPPIV,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)[C@H]1F)C2,CS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1F)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680783,CHEMBL4623016,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition by florescence assay,B,Cc1ccc(NS(=O)(=O)c2ccc3c(c2)CCCC3)cc1,CHEMBL4641140,nM,2.8,CHEMBL284,8.552841969,DPPIV,Cc1ccc(NS(=O)(=O)c2ccc3c(c2)CCCC3)cc1,Cc1ccc(NS(=O)(=O)c2ccc3c(c2)CCCC3)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680787,CHEMBL4623041,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate preincubated for 10 mins followed by substrate addition,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cn(CC(=O)N(C)C)nn2)c1=O,CHEMBL4636081,nM,28.62,CHEMBL284,7.543330371,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cn(CC(=O)N(C)C)nn2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cn(CC(=O)N(C)C)nn2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680791,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,CC#CCn1c(N2CCC[C@H](N)C2)cc(=O)n(Cc2nc(C)c3cc(C)ccc3n2)c1=O,CHEMBL4647761,nM,5.78,CHEMBL284,8.238072162,DPPIV,CC#CCn1c(N2CCC[C@H](N)C2)cc(=O)n(Cc2nc(C)c3cc(C)ccc3n2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2nc(C)c3cc(C)ccc3n2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680793,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,N[C@@H]1CN(c2ncc(Oc3c[nH]nc3C3=CCC(F)(F)CC3)cn2)C[C@@H]1c1cc(F)c(F)cc1F,CHEMBL4642801,nM,6,CHEMBL284,8.22184875,DPPIV,N[C@@H]1CN(c2ncc(Oc3c[nH]nc3C3=CCC(F)(F)CC3)cn2)C[C@@H]1c1cc(F)c(F)cc1F,NC1CN(c2ncc(Oc3c[nH]nc3C3=CCC(F)(F)CC3)cn2)CC1c1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680794,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,CC#CCN1C(N2CCC[C@H](N)C2)=NC2C1C(=O)N(C(C)c1nc(C)c3ccccc3n1)C(=O)N2C,CHEMBL4649180,nM,2.07,CHEMBL284,8.684029655,DPPIV,CC#CCN1C(N2CCC[C@H](N)C2)=NC2C1C(=O)N(C(C)c1nc(C)c3ccccc3n1)C(=O)N2C,CC#CCN1C(N2CCCC(N)C2)=NC2C1C(=O)N(C(C)c1nc(C)c3ccccc3n1)C(=O)N2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680795,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,CCOC(=O)c1c(C(C)C)cc(C(C)C)c(C(=O)OCC)c1-c1cc2ccc(-c3ccc4c(C)cccc4c3)cc2[nH]1,CHEMBL4632896,nM,2.72,CHEMBL284,8.565431096,DPPIV,CCOC(=O)c1c(C(C)C)cc(C(C)C)c(C(=O)OCC)c1-c1cc2ccc(-c3ccc4c(C)cccc4c3)cc2[nH]1,CCOC(=O)c1c(C(C)C)cc(C(C)C)c(C(=O)OCC)c1-c1cc2ccc(-c3ccc4c(C)cccc4c3)cc2[nH]1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680796,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,O=[N+]([O-])c1cccc(/C=N/N2C(c3ccccc3)=Nc3ccc(I)cc3C2NC2NC=CS2)c1,CHEMBL4638480,nM,0.76,CHEMBL284,9.119186408,DPPIV,O=[N+]([O-])c1cccc(/C=N/N2C(c3ccccc3)=Nc3ccc(I)cc3C2NC2N=CCS2)c1,O=[N+]([O-])c1cccc(C=NN2C(c3ccccc3)=Nc3ccc(I)cc3C2NC2N=CCS2)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680798,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,Cl.N#C[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(-c2cn(C3CC3)nn2)cc1,CHEMBL4647956,nM,247,CHEMBL284,6.607303047,DPPIV,N#C[C@@H]1CCCN1C(=O)C(N)Cc1ccc(-c2cn(C3CC3)nn2)cc1,N#CC1CCCN1C(=O)C(N)Cc1ccc(-c2cn(C3CC3)nn2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
20680799,CHEMBL4623044,Inhibition of DPP4 (unknown origin),B,N#C[C@@H]1CCCN1C(=O)CN(C(=O)CCCCCl)C12CC3CC(CC(O)(C3)C1)C2,CHEMBL4638352,nM,12,CHEMBL284,7.920818754,DPPIV,N#C[C@@H]1CCCN1C(=O)CN(C(=O)CCCCCl)C12CC3CC(CC(O)(C3)C1)C2,N#CC1CCCN1C(=O)CN(C(=O)CCCCCl)C12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463724,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)no3)CC1)c(=O)n2C,CHEMBL4761281,nM,230,CHEMBL284,6.638272164,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)no3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)no3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463725,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(n3cc(-c4ccccc4)nn3)CC1)c(=O)n2C,CHEMBL4762199,nM,47,CHEMBL284,7.327902142,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(n3cc(-c4ccccc4)nn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(n3cc(-c4ccccc4)nn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463726,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)cs3)CC1)c(=O)n2C,CHEMBL4743350,nM,190,CHEMBL284,6.721246399,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)cs3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)cs3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463727,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)c[nH]3)CC1)c(=O)n2C,CHEMBL4744389,nM,44,CHEMBL284,7.356547324,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)c[nH]3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(c3nc(-c4ccccc4)c[nH]3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463728,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3ncc(-c4ccccc4)o3)CC1)c(=O)n2C,CHEMBL4750433,nM,120,CHEMBL284,6.920818754,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3ncc(-c4ccccc4)o3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(c3ncc(-c4ccccc4)o3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463729,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3cc(-c4ccccc4)on3)CC1)c(=O)n2C,CHEMBL4783756,nM,190,CHEMBL284,6.721246399,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3cc(-c4ccccc4)on3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(c3cc(-c4ccccc4)on3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463730,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nnnn3-c3ccccc3)CC1)c(=O)n2C,CHEMBL4796411,nM,270,CHEMBL284,6.568636236,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCC(c3nnnn3-c3ccccc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCC(c3nnnn3-c3ccccc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463731,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)no3)CC1)c(=O)n2C,CHEMBL4784857,nM,40,CHEMBL284,7.397940009,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)no3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)no3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463732,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)ns3)CC1)c(=O)n2C,CHEMBL4795875,nM,360,CHEMBL284,6.443697499,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)ns3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)ns3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463733,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nnc(-c4ccccc4)[nH]3)CC1)c(=O)n2C,CHEMBL4742337,nM,76,CHEMBL284,7.119186408,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3n[nH]c(-c4ccccc4)n3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3n[nH]c(-c4ccccc4)n3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463734,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3cc(C)nn3-c3ccccc3)CC1)c(=O)n2C,CHEMBL4799779,nM,83,CHEMBL284,7.080921908,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3cc(C)nn3-c3ccccc3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3cc(C)nn3-c3ccccc3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463735,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)cs3)CC1)c(=O)n2C,CHEMBL4740282,nM,59,CHEMBL284,7.229147988,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)cs3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3nc(-c4ccccc4)cs3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463736,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3noc(-c4ccccc4)n3)CC1)c(=O)n2C,CHEMBL4782382,nM,680,CHEMBL284,6.167491087,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3noc(-c4ccccc4)n3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3noc(-c4ccccc4)n3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463738,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(C)cn3)CC1)c(=O)n2C,CHEMBL4785060,nM,660,CHEMBL284,6.180456064,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(C)cn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(C)cn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463739,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(CC)cn3)CC1)c(=O)n2C,CHEMBL4745258,nM,610,CHEMBL284,6.214670165,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(CC)cn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(CC)cn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463740,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(CCC)cn3)CC1)c(=O)n2C,CHEMBL4776485,nM,590,CHEMBL284,6.229147988,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(CCC)cn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(CCC)cn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463741,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(OC)cn3)CC1)c(=O)n2C,CHEMBL4764779,nM,430,CHEMBL284,6.366531544,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(OC)cn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(OC)cn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463742,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(F)cn3)CC1)c(=O)n2C,CHEMBL4749117,nM,350,CHEMBL284,6.455931956,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(F)cn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(F)cn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22463743,CHEMBL4683606,Inhibition of DPP4 (unknown origin) using Gly-Pro-p-nitroanilide as substrate incubated for 1 hr,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(C(F)(F)F)cn3)CC1)c(=O)n2C,CHEMBL4751384,nM,740,CHEMBL284,6.13076828,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(C(F)(F)F)cn3)CC1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CCCN1CCN(c3ncc(C(F)(F)F)cn3)CC1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483370,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](CCn1cc(-c2ccccn2)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4750352,nM,143,CHEMBL284,6.844663963,DPPIV,N[C@@H](CCn1cc(-c2ccccn2)nn1)Cc1cc(F)c(F)cc1F,NC(CCn1cc(-c2ccccn2)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483371,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](CCn1cc(-c2cccnc2)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4790735,nM,28,CHEMBL284,7.552841969,DPPIV,N[C@@H](CCn1cc(-c2cccnc2)nn1)Cc1cc(F)c(F)cc1F,NC(CCn1cc(-c2cccnc2)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483373,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](CCn1ccnn1)Cc1cc(F)c(F)cc1F,CHEMBL4792546,nM,254,CHEMBL284,6.595166283,DPPIV,N[C@@H](CCn1ccnn1)Cc1cc(F)c(F)cc1F,NC(CCn1ccnn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483374,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,Cc1cn(CC[C@H](N)Cc2cc(F)c(F)cc2F)nn1,CHEMBL4747721,nM,133,CHEMBL284,6.876148359,DPPIV,Cc1cn(CC[C@H](N)Cc2cc(F)c(F)cc2F)nn1,Cc1cn(CCC(N)Cc2cc(F)c(F)cc2F)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483375,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,CC(C)(C)c1cn(CC[C@H](N)Cc2cc(F)c(F)cc2F)nn1,CHEMBL4789426,nM,121,CHEMBL284,6.91721463,DPPIV,CC(C)(C)c1cn(CC[C@H](N)Cc2cc(F)c(F)cc2F)nn1,CC(C)(C)c1cn(CCC(N)Cc2cc(F)c(F)cc2F)nn1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483376,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](Cc1cn(-c2cccnc2)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4790799,nM,305,CHEMBL284,6.515700161,DPPIV,N[C@@H](Cc1cn(-c2cccnc2)nn1)Cc1cc(F)c(F)cc1F,NC(Cc1cn(-c2cccnc2)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483377,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](Cc1cn(-c2ccncc2)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4763110,nM,427,CHEMBL284,6.369572125,DPPIV,N[C@@H](Cc1cn(-c2ccncc2)nn1)Cc1cc(F)c(F)cc1F,NC(Cc1cn(-c2ccncc2)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483378,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](Cc1cn(-c2cccc3ncccc23)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4745231,nM,265,CHEMBL284,6.576754126,DPPIV,N[C@@H](Cc1cn(-c2cccc3ncccc23)nn1)Cc1cc(F)c(F)cc1F,NC(Cc1cn(-c2cccc3ncccc23)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22483379,CHEMBL4688063,Inhibition of recombinant human DPP4 using Gly-Pro-AMC as substrate incubated for 1 hr by fluorogenic assay,B,N[C@@H](Cc1cn(-c2ccc3ncccc3c2)nn1)Cc1cc(F)c(F)cc1F,CHEMBL4798357,nM,780,CHEMBL284,6.107905397,DPPIV,N[C@@H](Cc1cn(-c2ccc3ncccc3c2)nn1)Cc1cc(F)c(F)cc1F,NC(Cc1cn(-c2ccc3ncccc3c2)nn1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22791977,CHEMBL4709761,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC as substrate by fluorometric assay,B,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)NC(=O)c4ccccc4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,CHEMBL4746458,nM,8.8,CHEMBL284,8.055517328,DPPIV,N[C@H]1C[C@@H](N2Cc3cn(S(=O)(=O)NC(=O)c4ccccc4)nc3C2)CO[C@@H]1c1cc(F)ccc1F,NC1CC(N2Cc3cn(S(=O)(=O)NC(=O)c4ccccc4)nc3C2)COC1c1cc(F)ccc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22791978,CHEMBL4709761,Inhibition of human DPP4 expressed in baculovirus expression system using Gly-Pro-AMC as substrate by fluorometric assay,B,CS(=O)(=NS(=O)(=O)c1ccccc1)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CHEMBL4776573,nM,18,CHEMBL284,7.744727495,DPPIV,CS(=O)(=NS(=O)(=O)c1ccccc1)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2,CS(=O)(=NS(=O)(=O)c1ccccc1)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800175,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Cc1ccc(Nc2cc(N3CCC[C@@H](N)C3)nc3ccnn23)c(N)c1,CHEMBL4798053,nM,1200,CHEMBL284,5.920818754,DPPIV,Cc1ccc(N=c2cc(N3CCC[C@@H](N)C3)[nH]c3ccnn23)c(N)c1,Cc1ccc(N=c2cc(N3CCCC(N)C3)[nH]c3ccnn23)c(N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800176,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Cc1ccc(Nc2cc(N3CCC[C@@H](N)C3)nc3ccnn23)c(C)c1,CHEMBL4787437,nM,9100,CHEMBL284,5.040958608,DPPIV,Cc1ccc(N=c2cc(N3CCC[C@@H](N)C3)[nH]c3ccnn23)c(C)c1,Cc1ccc(N=c2cc(N3CCCC(N)C3)[nH]c3ccnn23)c(C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800177,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3ccccc3Cl)n3nccc3n2)C1,CHEMBL4751895,nM,25300,CHEMBL284,4.596879479,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3ccccc3Cl)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3ccccc3Cl)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800178,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3ccc(F)cc3F)n3nccc3n2)C1,CHEMBL4760965,nM,17700,CHEMBL284,4.752026734,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3ccc(F)cc3F)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3ccc(F)cc3F)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800179,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3ccc(Cl)cc3Cl)n3nccc3n2)C1,CHEMBL4753503,nM,22200,CHEMBL284,4.653647026,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3ccc(Cl)cc3Cl)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3ccc(Cl)cc3Cl)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800180,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3ccccc3[N+](=O)[O-])n3nccc3n2)C1,CHEMBL4745889,nM,11700,CHEMBL284,4.931814138,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3ccccc3[N+](=O)[O-])n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3ccccc3[N+](=O)[O-])n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800181,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,CN(c1ccccc1)c1cc(N2CCC[C@@H](N)C2)nc2ccnn12,CHEMBL4794198,nM,100000,CHEMBL284,4,DPPIV,CN(c1ccccc1)c1cc(N2CCC[C@@H](N)C2)nc2ccnn12,CN(c1ccccc1)c1cc(N2CCCC(N)C2)nc2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800182,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(NCc3ccccc3)n3nccc3n2)C1,CHEMBL4743490,nM,300,CHEMBL284,6.522878745,DPPIV,N[C@@H]1CCCN(c2cc(=NCc3ccccc3)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=NCc3ccccc3)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800183,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(NCc3ccc(O)cc3)n3nccc3n2)C1,CHEMBL4763718,nM,7900,CHEMBL284,5.102372909,DPPIV,N[C@@H]1CCCN(c2cc(=NCc3ccc(O)cc3)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=NCc3ccc(O)cc3)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800184,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(NCc3ccc(Cl)cc3Cl)n3nccc3n2)C1,CHEMBL4791597,nM,5700,CHEMBL284,5.244125144,DPPIV,N[C@@H]1CCCN(c2cc(=NCc3ccc(Cl)cc3Cl)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=NCc3ccc(Cl)cc3Cl)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800185,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(NCCc3ccc(Cl)cc3Cl)n3nccc3n2)C1,CHEMBL4754343,nM,1100,CHEMBL284,5.958607315,DPPIV,N[C@@H]1CCCN(c2cc(=NCCc3ccc(Cl)cc3Cl)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=NCCc3ccc(Cl)cc3Cl)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800186,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Cc1ccnc(Nc2cc(N3CCC[C@@H](N)C3)nc3ccnn23)c1,CHEMBL4743516,nM,8100,CHEMBL284,5.091514981,DPPIV,Cc1cc[nH]c(=Nc2cc(N3CCC[C@@H](N)C3)nc3ccnn23)c1,Cc1cc[nH]c(=Nc2cc(N3CCCC(N)C3)nc3ccnn23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800187,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3cc(F)ccn3)n3nccc3n2)C1,CHEMBL4786137,nM,14400,CHEMBL284,4.841637508,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3cc(F)ccn3)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3cc(F)ccn3)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800188,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3cc(Cl)ccn3)n3nccc3n2)C1,CHEMBL4794801,nM,2400,CHEMBL284,5.619788758,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3cc(Cl)ccn3)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3cc(Cl)ccn3)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800189,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,N[C@@H]1CCCN(c2cc(Nc3cc[nH]n3)n3nccc3n2)C1,CHEMBL4779718,nM,31800,CHEMBL284,4.49757288,DPPIV,N[C@@H]1CCCN(c2cc(=Nc3cc[nH]n3)n3[nH]ccc3n2)C1,NC1CCCN(c2cc(=Nc3cc[nH]n3)n3[nH]ccc3n2)C1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800190,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Cc1ccc(Nc2cc(N3CCNCC3)nc3ccnn23)c(N)c1,CHEMBL4764894,nM,800,CHEMBL284,6.096910013,DPPIV,Cc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(N)c1,Cc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(N)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800191,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Cc1ccc(Nc2cc(N3CCNCC3)nc3ccnn23)c(C)c1,CHEMBL4752835,nM,1600,CHEMBL284,5.795880017,DPPIV,Cc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(C)c1,Cc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800192,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Clc1ccccc1Nc1cc(N2CCNCC2)nc2ccnn12,CHEMBL4782865,nM,23600,CHEMBL284,4.627087997,DPPIV,Clc1ccccc1N=c1cc(N2CCNCC2)[nH]c2ccnn12,Clc1ccccc1N=c1cc(N2CCNCC2)[nH]c2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800193,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Fc1ccc(Nc2cc(N3CCNCC3)nc3ccnn23)c(F)c1,CHEMBL4798418,nM,400,CHEMBL284,6.397940009,DPPIV,Fc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(F)c1,Fc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800194,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,O=[N+]([O-])c1ccccc1Nc1cc(N2CCNCC2)nc2ccnn12,CHEMBL4749086,nM,3500,CHEMBL284,5.455931956,DPPIV,O=[N+]([O-])c1ccccc1N=c1cc(N2CCNCC2)[nH]c2ccnn12,O=[N+]([O-])c1ccccc1N=c1cc(N2CCNCC2)[nH]c2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800195,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,CN(c1ccccc1)c1cc(N2CCNCC2)nc2ccnn12,CHEMBL4776878,nM,80500,CHEMBL284,4.09420412,DPPIV,CN(c1ccccc1)c1cc(N2CCNCC2)nc2ccnn12,CN(c1ccccc1)c1cc(N2CCNCC2)nc2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800196,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Clc1ccc(Nc2cc(N3CCNCC3)nc3ccnn23)c(Cl)c1,CHEMBL4765147,nM,470,CHEMBL284,6.327902142,DPPIV,Clc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(Cl)c1,Clc1ccc(N=c2cc(N3CCNCC3)[nH]c3ccnn23)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800197,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Clc1ccc(CCNc2cc(N3CCNCC3)nc3ccnn23)c(Cl)c1,CHEMBL4764120,nM,89,CHEMBL284,7.050609993,DPPIV,Clc1ccc(CCN=c2cc(N3CCNCC3)[nH]c3ccnn23)c(Cl)c1,Clc1ccc(CCN=c2cc(N3CCNCC3)[nH]c3ccnn23)c(Cl)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800198,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Fc1ccc(CNc2cc(N3CCNCC3)nc3ccnn23)c(F)c1,CHEMBL4784434,nM,2,CHEMBL284,8.698970004,DPPIV,Fc1ccc(CN=c2cc(N3CCNCC3)[nH]c3ccnn23)c(F)c1,Fc1ccc(CN=c2cc(N3CCNCC3)[nH]c3ccnn23)c(F)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800199,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,Cc1ccnc(Nc2cc(N3CCNCC3)nc3ccnn23)c1,CHEMBL4754461,nM,2800,CHEMBL284,5.552841969,DPPIV,Cc1cc[nH]c(=Nc2cc(N3CCNCC3)nc3ccnn23)c1,Cc1cc[nH]c(=Nc2cc(N3CCNCC3)nc3ccnn23)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800200,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,c1cc2nc(N3CCOCC3)cc(Nc3cc[nH]n3)n2n1,CHEMBL4751103,nM,100000,CHEMBL284,4,DPPIV,c1cc(N=c2cc(N3CCOCC3)[nH]c3ccnn23)[nH]n1,c1cc(N=c2cc(N3CCOCC3)[nH]c3ccnn23)[nH]n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22800201,CHEMBL4711280,Inhibition of DPP4 in human Caco-2 cells using AP-AFC as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by fluorescence based analysis,B,CC(C)(C)Nc1cc(NC(C)(C)C)n2nccc2n1,CHEMBL4799877,nM,100000,CHEMBL284,4,DPPIV,CC(C)(C)N=c1cc(NC(C)(C)C)[nH]c2ccnn12,CC(C)(C)N=c1cc(NC(C)(C)C)[nH]c2ccnn12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812737,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC1=NC3C=CC=CC3C(C)=N1)c(=O)n2C,CHEMBL4747683,nM,2,CHEMBL284,8.698970004,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC1=NC3C=CC=CC3C(C)=N1)c(=O)n2C,CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(CC1=NC3C=CC=CC3C(C)=N1)c(=O)n2C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812740,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(-c2ccc(C(F)(F)F)cc2)n1,CHEMBL4740030,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(-c2ccc(C(F)(F)F)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(-c2ccc(C(F)(F)F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812741,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(-c2ccc(Cl)cc2C(F)(F)F)n1,CHEMBL4762435,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(-c2ccc(Cl)cc2C(F)(F)F)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(-c2ccc(Cl)cc2C(F)(F)F)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812742,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)cc2)n1,CHEMBL4789754,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812743,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2Br)n1,CHEMBL4751873,nM,200,CHEMBL284,6.698970004,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2Br)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2Br)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812744,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2cccc(Br)c2)n1,CHEMBL4755802,nM,52020,CHEMBL284,4.283829652,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2cccc(Br)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2cccc(Br)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812745,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Br)cc2)n1,CHEMBL4746868,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Br)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Br)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812746,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2I)n1,CHEMBL4758377,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2I)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2I)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812747,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,COc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4748328,nM,100000,CHEMBL284,4,DPPIV,COc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,COc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812748,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2-c2ccc3ccccc3c2)n1,CHEMBL4750058,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2-c2ccc3ccccc3c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccccc2-c2ccc3ccccc3c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812749,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)c(Cl)c2)n1,CHEMBL4786982,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)c(Cl)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)c(Cl)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812750,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)cc2Cl)n1,CHEMBL4762591,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)cc2Cl)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(Cl)cc2Cl)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812751,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2cc(Cl)ccc2Cl)n1,CHEMBL4792518,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2cc(Cl)ccc2Cl)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2cc(Cl)ccc2Cl)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812752,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(F)c(F)c2)n1,CHEMBL4748332,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(F)c(F)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(F)c(F)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812753,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(F)cc2Cl)n1,CHEMBL4785892,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(F)cc2Cl)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(F)cc2Cl)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812754,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,Cc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4779526,nM,68850,CHEMBL284,4.162096055,DPPIV,Cc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,Cc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812755,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(OC(F)(F)F)cc2)n1,CHEMBL4744633,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(OC(F)(F)F)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(OC(F)(F)F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812756,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#Cc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4799823,nM,100000,CHEMBL284,4,DPPIV,N#Cc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,N#Cc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812757,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#Cc1ccc(-c2ccc(Cc3nc(C(=O)NCC(=O)N4CC(F)(F)C[C@H]4C#N)cs3)cc2)cc1,CHEMBL4753316,nM,100000,CHEMBL284,4,DPPIV,N#Cc1ccc(-c2ccc(Cc3nc(C(=O)NCC(=O)N4CC(F)(F)C[C@H]4C#N)cs3)cc2)cc1,N#Cc1ccc(-c2ccc(Cc3nc(C(=O)NCC(=O)N4CC(F)(F)CC4C#N)cs3)cc2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812758,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-c3ccc(Cl)cc3)cc2)n1,CHEMBL4743815,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-c3ccc(Cl)cc3)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-c3ccc(Cl)cc3)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812759,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,CSc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4762306,nM,100000,CHEMBL284,4,DPPIV,CSc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CSc1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812760,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,C[S+]([O-])c1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4748662,nM,4120,CHEMBL284,5.385102784,DPPIV,C[S+]([O-])c1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,C[S+]([O-])c1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812761,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,CS(=O)(=O)c1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4797479,nM,10110,CHEMBL284,4.995248844,DPPIV,CS(=O)(=O)c1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CS(=O)(=O)c1ccc(Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812762,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-n3cccn3)cc2)n1,CHEMBL4742308,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-n3cccn3)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-n3cccn3)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812763,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-n3cncn3)cc2)n1,CHEMBL4761499,nM,18710,CHEMBL284,4.727926212,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-n3cncn3)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(Cc2ccc(-n3cncn3)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812764,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CCCc2ccc(Cl)c(Cl)c2)n1,CHEMBL4743736,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CCCc2ccc(Cl)c(Cl)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CCCc2ccc(Cl)c(Cl)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812765,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#Cc1ccc(CCCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4781018,nM,82530,CHEMBL284,4.083388155,DPPIV,N#Cc1ccc(CCCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,N#Cc1ccc(CCCc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812766,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CSc2ccc(Cl)c(Cl)c2)n1,CHEMBL4746891,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CSc2ccc(Cl)c(Cl)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CSc2ccc(Cl)c(Cl)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812767,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,Cc1ccc(SCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4780357,nM,100000,CHEMBL284,4,DPPIV,Cc1ccc(SCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,Cc1ccc(SCc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812768,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#Cc1ccc(SCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4748680,nM,44560,CHEMBL284,4.351054818,DPPIV,N#Cc1ccc(SCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,N#Cc1ccc(SCc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812769,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CSc2ccc(C(F)(F)F)cc2)n1,CHEMBL4776967,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CSc2ccc(C(F)(F)F)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CSc2ccc(C(F)(F)F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812770,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CS(=O)(=O)c2ccc(Cl)c(Cl)c2)n1,CHEMBL4791505,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CS(=O)(=O)c2ccc(Cl)c(Cl)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CS(=O)(=O)c2ccc(Cl)c(Cl)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812771,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#Cc1ccc(S(=O)(=O)Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4789965,nM,76790,CHEMBL284,4.114695332,DPPIV,N#Cc1ccc(S(=O)(=O)Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,N#Cc1ccc(S(=O)(=O)Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812772,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1,CHEMBL4758299,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(CS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812773,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,Cc1ccc(S(=O)(=O)Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4759201,nM,100000,CHEMBL284,4,DPPIV,Cc1ccc(S(=O)(=O)Cc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,Cc1ccc(S(=O)(=O)Cc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812774,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(COc2ccc(Cl)c(Cl)c2)n1,CHEMBL4754490,nM,100000,CHEMBL284,4,DPPIV,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1csc(COc2ccc(Cl)c(Cl)c2)n1,N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1csc(COc2ccc(Cl)c(Cl)c2)n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
22812775,CHEMBL4714147,Inhibition of DPP4 (unknown origin) using AMC substrate by fluorometric assay,B,N#Cc1ccc(OCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,CHEMBL4747575,nM,100000,CHEMBL284,4,DPPIV,N#Cc1ccc(OCc2nc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)cs2)cc1,N#Cc1ccc(OCc2nc(C(=O)NCC(=O)N3CC(F)(F)CC3C#N)cs2)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23270331,CHEMBL4835183,Inhibition of DPP-IV (unknown origin),B,Cc1ccc(Cl)cc1N1CCN(C(=O)CCC2(C3CC3)NC(=O)NC2=O)CC1,CHEMBL4854306,nM,30000,CHEMBL284,4.522878745,DPPIV,Cc1ccc(Cl)cc1N1CCN(C(=O)CCC2(C3CC3)NC(=O)NC2=O)CC1,Cc1ccc(Cl)cc1N1CCN(C(=O)CCC2(C3CC3)NC(=O)NC2=O)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23270332,CHEMBL4835183,Inhibition of DPP-IV (unknown origin),B,O=C1NC(=O)[C@@H](CCC(=O)N2CCN(c3cc(Cl)cc(Cl)c3)CC2)N1,CHEMBL4873384,nM,30000,CHEMBL284,4.522878745,DPPIV,O=C(CCc1[nH]c(=O)[nH]c1O)N1CCN(c2cc(Cl)cc(Cl)c2)CC1,O=C(CCc1[nH]c(=O)[nH]c1O)N1CCN(c2cc(Cl)cc(Cl)c2)CC1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297202,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2)c1=O,CHEMBL4853464,nM,18.2,CHEMBL284,7.739928612,DPPIV,N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2)c1=O,N#Cc1ccccc1Cn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccccc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297203,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(C(=O)OC)cc2)c1=O,CHEMBL4862579,nM,9.2,CHEMBL284,8.036212173,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(C(=O)OC)cc2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(C(=O)OC)cc2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297205,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,COC(=O)c1cccc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c2=O)c1,CHEMBL4856604,nM,15,CHEMBL284,7.823908741,DPPIV,COC(=O)c1cccc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c2=O)c1,COC(=O)c1cccc(Cn2c(=O)cc(N3CCCC(N)C3)n(Cc3ccccc3C#N)c2=O)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297206,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,COC(=O)c1ccc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c2=O)cc1,CHEMBL4864734,nM,20.2,CHEMBL284,7.694648631,DPPIV,COC(=O)c1ccc(Cn2c(=O)cc(N3CCC[C@@H](N)C3)n(Cc3ccccc3C#N)c2=O)cc1,COC(=O)c1ccc(Cn2c(=O)cc(N3CCCC(N)C3)n(Cc3ccccc3C#N)c2=O)cc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297212,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)NCC(=O)OC)c2)c1=O,CHEMBL4874467,nM,9.1,CHEMBL284,8.040958608,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)NCC(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)NCC(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297214,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCC[C@@H]3C(=O)OC)c2)c1=O,CHEMBL4867117,nM,47.6,CHEMBL284,7.322393047,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCCC3C(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCCC3C(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297215,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N[C@@H](C)C(=O)OC)c2)c1=O,CHEMBL4858093,nM,23.7,CHEMBL284,7.625251654,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)NC(C)C(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)NC(C)C(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297216,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)NCC(=O)O)c2)c1=O,CHEMBL4869930,nM,6.9,CHEMBL284,8.161150909,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)NCC(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)NCC(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297217,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCC[C@H]3C(=O)O)c2)c1=O,CHEMBL4859630,nM,34.6,CHEMBL284,7.460923901,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCCC3C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCCC3C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297218,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCC[C@@H]3C(=O)O)c2)c1=O,CHEMBL4871197,nM,19.1,CHEMBL284,7.718966633,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCCC3C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)N3CCCC3C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297219,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)N[C@@H](C)C(=O)O)c2)c1=O,CHEMBL4858682,nM,9.1,CHEMBL284,8.040958608,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)NC(C)C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)NC(C)C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297220,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)O)c2F)c1=O,CHEMBL4876933,nM,1000,CHEMBL284,6,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)O)c2F)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)O)c2F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297221,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(F)c(C(=O)O)c2)c1=O,CHEMBL4863102,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(F)c(C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(F)c(C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297222,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)O)ccc2F)c1=O,CHEMBL4857729,nM,2.8,CHEMBL284,8.552841969,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)O)ccc2F)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(C(=O)O)ccc2F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297223,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)O)c2Br)c1=O,CHEMBL4875769,nM,1000,CHEMBL284,6,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)O)c2Br)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)O)c2Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297224,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Br)c(C(=O)O)c2)c1=O,CHEMBL4856337,nM,0.8,CHEMBL284,9.096910013,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Br)c(C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(Br)c(C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297225,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)cc(C(=O)O)c2)c1=O,CHEMBL4860737,nM,4.9,CHEMBL284,8.30980392,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)cc(C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(Br)cc(C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297226,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)O)ccc2Br)c1=O,CHEMBL4873862,nM,13,CHEMBL284,7.886056648,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)O)ccc2Br)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(C(=O)O)ccc2Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297227,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Cl)c(C(=O)O)c2)c1=O,CHEMBL4865204,nM,1,CHEMBL284,9,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Cl)c(C(=O)O)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(Cl)c(C(=O)O)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297228,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)OC)c2F)c1=O,CHEMBL4871141,nM,7,CHEMBL284,8.15490196,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)OC)c2F)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)OC)c2F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297229,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(F)c(C(=O)OC)c2)c1=O,CHEMBL4846335,nM,1.6,CHEMBL284,8.795880017,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(F)c(C(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(F)c(C(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297230,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)OC)ccc2F)c1=O,CHEMBL4876894,nM,4.3,CHEMBL284,8.366531544,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)OC)ccc2F)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(C(=O)OC)ccc2F)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297231,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)OC)c2Br)c1=O,CHEMBL4852700,nM,4.5,CHEMBL284,8.346787486,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cccc(C(=O)OC)c2Br)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cccc(C(=O)OC)c2Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297232,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Br)c(C(=O)OC)c2)c1=O,CHEMBL4851477,nM,1.3,CHEMBL284,8.886056648,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Br)c(C(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(Br)c(C(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297233,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)cc(C(=O)OC)c2)c1=O,CHEMBL4863369,nM,1.3,CHEMBL284,8.886056648,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(Br)cc(C(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(Br)cc(C(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297234,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)OC)ccc2Br)c1=O,CHEMBL4856255,nM,2.6,CHEMBL284,8.585026652,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2cc(C(=O)OC)ccc2Br)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2cc(C(=O)OC)ccc2Br)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23297235,CHEMBL4841116,Inhibition of human recombinant DPP4 using Gly-Pro-AMC as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by fluorescence based microplate reader assay,B,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Cl)c(C(=O)OC)c2)c1=O,CHEMBL4845890,nM,1.1,CHEMBL284,8.958607315,DPPIV,CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccc(Cl)c(C(=O)OC)c2)c1=O,CC#CCn1c(N2CCCC(N)C2)cc(=O)n(Cc2ccc(Cl)c(C(=O)OC)c2)c1=O,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308664,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,COc1ccc(CNC(=O)C(=O)[C@@H]2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)cc1OC,CHEMBL4877950,nM,4000,CHEMBL284,5.397940009,DPPIV,COc1ccc(CNC(=O)C(=O)C2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)cc1OC,COc1ccc(CNC(=O)C(=O)C2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308665,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,O=C(NCc1ccc(F)cc1)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4864133,nM,3000,CHEMBL284,5.522878745,DPPIV,O=C(NCc1ccc(F)cc1)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,O=C(NCc1ccc(F)cc1)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308666,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,Cc1ccc(CNC(=O)C(=O)[C@@H]2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)c(C)c1,CHEMBL4859756,nM,4000,CHEMBL284,5.397940009,DPPIV,Cc1ccc(CNC(=O)C(=O)C2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)c(C)c1,Cc1ccc(CNC(=O)C(=O)C2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)c(C)c1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308667,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,COc1ccc(CCNC(=O)C(=O)[C@@H]2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)cc1OC,CHEMBL4853661,nM,4000,CHEMBL284,5.397940009,DPPIV,COc1ccc(CCNC(=O)C(=O)C2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)cc1OC,COc1ccc(CCNC(=O)C(=O)C2CCCN2C(=O)CNC(=O)c2ccnc3ccccc23)cc1OC,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308668,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,CCCCCNC(=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4855449,nM,4000,CHEMBL284,5.397940009,DPPIV,CCCCCNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CCCCCNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308669,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,CC(C)(C)OC(=O)CNC(=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4878759,nM,3000,CHEMBL284,5.522878745,DPPIV,CC(C)(C)OC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CC(C)(C)OC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308670,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,O=C(NCC(=O)N1CCOCC1)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4868869,nM,4000,CHEMBL284,5.397940009,DPPIV,O=C(NCC(=O)N1CCOCC1)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,O=C(NCC(=O)N1CCOCC1)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308671,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,CC(C)(C)NC(=O)CNC(=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4871602,nM,4000,CHEMBL284,5.397940009,DPPIV,CC(C)(C)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CC(C)(C)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308672,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,COC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4854865,nM,4000,CHEMBL284,5.397940009,DPPIV,COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308673,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,COC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4864489,nM,4000,CHEMBL284,5.397940009,DPPIV,COC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,COC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
23308674,CHEMBL4843583,Inhibition of SF-tagged DPP4 (unknown origin) expressed in Drosophila S2 cells using fluorogenic substrate by spectrometric analysis,B,COC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)CNC(=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,CHEMBL4876026,nM,4000,CHEMBL284,5.397940009,DPPIV,COC(=O)C(CCCCNC(=O)OCc1ccccc1)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,COC(=O)C(CCCCNC(=O)OCc1ccccc1)NC(=O)CNC(=O)C(=O)C1CCCN1C(=O)CNC(=O)c1ccnc2ccccc12,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24719107,CHEMBL5112289,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based microplate reader assay,B,COc1cc(S(N)(=O)=O)cc(OC)c1OCCC(N=[N+]=[N-])C1COc2ccccc2O1,CHEMBL5198237,nM,33.2,CHEMBL284,7.478861916,DPPIV,COc1cc(S(N)(=O)=O)cc(OC)c1OCCC(N=[N+]=[N-])C1COc2ccccc2O1,COc1cc(S(N)(=O)=O)cc(OC)c1OCCC(N=[N+]=[N-])C1COc2ccccc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24719108,CHEMBL5112289,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based microplate reader assay,B,NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1,CHEMBL5177166,nM,49,CHEMBL284,7.30980392,DPPIV,NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1,NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24719109,CHEMBL5112289,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based microplate reader assay,B,COc1cc(S(N)(=O)=O)ccc1OCCC(N)C1COc2ccccc2O1,CHEMBL5193531,nM,57440,CHEMBL284,4.240785569,DPPIV,COc1cc(S(N)(=O)=O)ccc1OCCC(N)C1COc2ccccc2O1,COc1cc(S(N)(=O)=O)ccc1OCCC(N)C1COc2ccccc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24719110,CHEMBL5112289,Inhibition of human recombinant DPP4 using H-Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based microplate reader assay,B,COc1cc(S(N)(=O)=O)cc(OC)c1OCCC(N)C1COc2ccccc2O1,CHEMBL5205289,nM,28.3,CHEMBL284,7.548213564,DPPIV,COc1cc(S(N)(=O)=O)cc(OC)c1OCCC(N)C1COc2ccccc2O1,COc1cc(S(N)(=O)=O)cc(OC)c1OCCC(N)C1COc2ccccc2O1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24872437,CHEMBL5153403,Inhibition of human DPP4 expressed in Silkworm baculovirus system preincubated for 30 mins followed by substrate addition and measured after 20 mins using Gly-Pro-4-methylcoumarin-7-amide as substrate by fluorescence assay,B,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,CHEMBL1929396,nM,3.3,CHEMBL284,8.48148606,DPPIV,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)cn2n1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24956783,CHEMBL5213844,Selectivity interaction (Serine protease panel) EUB0000735a DPP4,B,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,CHEMBL3617968,nM,30000,CHEMBL284,4.522878745,DPPIV,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)NC1c1ccc(C#N)nc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967450,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,C=COC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CHEMBL5220594,nM,0.16,CHEMBL284,9.795880017,DPPIV,C=COC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,C=COC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967451,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O/C=C/c1ccccc1,CHEMBL5219996,nM,171,CHEMBL284,6.76700389,DPPIV,CC(C)(C)OC(=O)NCCCCC(NC(=O)OC(C)(C)C)C(=O)N1CCCC1C(=O)O/C=C/c1ccccc1,CC(C)(C)OC(=O)NCCCCC(NC(=O)OC(C)(C)C)C(=O)N1CCCC1C(=O)OC=Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967452,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CC(C)=CCC/C(C)=C/OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CHEMBL5219532,nM,0.37,CHEMBL284,9.431798276,DPPIV,CC(C)=CCC/C(C)=C/OC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CC(C)=CCCC(C)=COC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967453,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,C/C=C/OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CHEMBL5219761,nM,6.39,CHEMBL284,8.194499142,DPPIV,C/C=C/OC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CC=COC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967454,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CCOC(=O)/C=C/OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CHEMBL5220613,nM,0.14,CHEMBL284,9.853871964,DPPIV,CCOC(=O)/C=C/OC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,CCOC(=O)C=COC(=O)C1CCCN1C(=O)C(CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967455,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,C=COC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN,CHEMBL5220657,nM,0.13,CHEMBL284,9.886056648,DPPIV,C=COC(=O)C1CCCN1C(=O)C(N)CCCCN,C=COC(=O)C1CCCN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967456,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O/C=C/c1ccccc1,CHEMBL5220750,nM,0.27,CHEMBL284,9.568636236,DPPIV,NCCCCC(N)C(=O)N1CCCC1C(=O)O/C=C/c1ccccc1,NCCCCC(N)C(=O)N1CCCC1C(=O)OC=Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967457,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CC(C)=CCC/C(C)=C/OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN,CHEMBL5220348,nM,15.3,CHEMBL284,7.815308569,DPPIV,CC(C)=CCC/C(C)=C/OC(=O)C1CCCN1C(=O)C(N)CCCCN,CC(C)=CCCC(C)=COC(=O)C1CCCN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967458,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,C/C=C/OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN,CHEMBL5218500,nM,0.75,CHEMBL284,9.124938737,DPPIV,C/C=C/OC(=O)C1CCCN1C(=O)C(N)CCCCN,CC=COC(=O)C1CCCN1C(=O)C(N)CCCCN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967459,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,C=COC(=O)[C@@H]1CCCN1C(=O)CNC(=O)OC(C)(C)C,CHEMBL5220053,nM,24.7,CHEMBL284,7.607303047,DPPIV,C=COC(=O)C1CCCN1C(=O)CNC(=O)OC(C)(C)C,C=COC(=O)C1CCCN1C(=O)CNC(=O)OC(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967460,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CC(C)(C)OC(=O)NCC(=O)N1CCC[C@H]1C(=O)O/C=C/c1ccccc1,CHEMBL5219939,nM,0.26,CHEMBL284,9.585026652,DPPIV,CC(C)(C)OC(=O)NCC(=O)N1CCCC1C(=O)O/C=C/c1ccccc1,CC(C)(C)OC(=O)NCC(=O)N1CCCC1C(=O)OC=Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967461,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CCOC(=O)/C=C/OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)OC(C)(C)C,CHEMBL5220415,nM,5.9,CHEMBL284,8.229147988,DPPIV,CCOC(=O)/C=C/OC(=O)C1CCCN1C(=O)CNC(=O)OC(C)(C)C,CCOC(=O)C=COC(=O)C1CCCN1C(=O)CNC(=O)OC(C)(C)C,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967462,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,C=COC(=O)[C@@H]1CCCN1C(=O)CN,CHEMBL5219299,nM,0.28,CHEMBL284,9.552841969,DPPIV,C=COC(=O)C1CCCN1C(=O)CN,C=COC(=O)C1CCCN1C(=O)CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967463,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,NCC(=O)N1CCC[C@H]1C(=O)O/C=C/c1ccccc1,CHEMBL5219451,nM,0.28,CHEMBL284,9.552841969,DPPIV,NCC(=O)N1CCCC1C(=O)O/C=C/c1ccccc1,NCC(=O)N1CCCC1C(=O)OC=Cc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967464,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,CCOC(=O)/C=C/OC(=O)[C@@H]1CCCN1C(=O)CN,CHEMBL5219735,nM,1.17,CHEMBL284,8.931814138,DPPIV,CCOC(=O)/C=C/OC(=O)C1CCCN1C(=O)CN,CCOC(=O)C=COC(=O)C1CCCN1C(=O)CN,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967465,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,COC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1,CHEMBL5220474,nM,0.46,CHEMBL284,9.337242168,DPPIV,COC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1,COC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967466,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,COC(=O)C(Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1,CHEMBL5219966,nM,10.2,CHEMBL284,7.991399828,DPPIV,COC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1,COC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
24967467,CHEMBL5217459,Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate incubated for 30 mins by fluorescence based enzyme immunoassay,B,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,CHEMBL3185489,nM,18.5,CHEMBL284,7.732828272,DPPIV,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,Dipeptidyl Peptidase IV (DPP-IV),Dipeptidyl Peptidase IV (DPP-IV)
222967,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,CHEMBL7917,nM,1300,CHEMBL3975,5.886056648,FBPase,COc1cc2[nH]cnc(=Nc3cccc(Cl)c3)c2cc1OC,COc1cc2[nH]cnc(=Nc3cccc(Cl)c3)c2cc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
222971,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1Cl,CHEMBL63469,nM,11900,CHEMBL3975,4.924453039,FBPase,Nc1cc2c(=Nc3cccc(Br)c3)[nH]cnc2cc1Cl,Nc1cc2c(=Nc3cccc(Br)c3)[nH]cnc2cc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
222972,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,O=[N+]([O-])c1cc2c(Nc3cccc(Br)c3)ncnc2cc1Cl,CHEMBL66409,nM,10000,CHEMBL3975,5,FBPase,O=[N+]([O-])c1cc2c(=Nc3cccc(Br)c3)[nH]cnc2cc1Cl,O=[N+]([O-])c1cc2c(=Nc3cccc(Br)c3)[nH]cnc2cc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
225609,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3cccc(F)c3)c2cc1OCC,CHEMBL294126,nM,9200,CHEMBL3975,5.036212173,FBPase,CCOc1cc2[nH]cnc(=Nc3cccc(F)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3cccc(F)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
228199,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(-c3ccccc3)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL63152,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(-c3ccccc3)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(-c3ccccc3)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
229399,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CC(C)Oc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,CHEMBL303996,nM,10000,CHEMBL3975,5,FBPase,CC(C)Oc1ccc2[nH]cnc(=Nc3cccc(Br)c3)c2c1,CC(C)Oc1ccc2[nH]cnc(=Nc3cccc(Br)c3)c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
230679,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COCCOc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,CHEMBL65275,nM,2900,CHEMBL3975,5.537602002,FBPase,COCCOc1ccc2[nH]cnc(=Nc3cccc(Br)c3)c2c1,COCCOc1ccc2[nH]cnc(=Nc3cccc(Br)c3)c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
232040,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3ccccc3)c2cc1OCC,CHEMBL65055,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]cnc(=Nc3ccccc3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3ccccc3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
233262,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(CN3CCOCC3)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL307526,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(CN3CCOCC3)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(CN3CCOCC3)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
235821,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COc1cc2nc(C)nc(Nc3cccc(Br)c3)c2cc1OC,CHEMBL294769,nM,4500,CHEMBL3975,5.346787486,FBPase,COc1cc2[nH]c(C)nc(=Nc3cccc(Br)c3)c2cc1OC,COc1cc2[nH]c(C)nc(=Nc3cccc(Br)c3)c2cc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
237069,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,C#Cc1cccc(Nc2ncnc3cc(OCC)c(OCC)cc23)c1,CHEMBL63244,nM,2400,CHEMBL3975,5.619788758,FBPase,C#Cc1cccc(N=c2[nH]cnc3cc(OCC)c(OCC)cc23)c1,C#Cc1cccc(N=c2[nH]cnc3cc(OCC)c(OCC)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
237070,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(CN(CC)CC)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL306005,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(CN(CC)CC)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(CN(CC)CC)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
238315,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCCCOc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,CHEMBL63450,nM,10000,CHEMBL3975,5,FBPase,CCCCOc1ccc2[nH]cnc(=Nc3cccc(Br)c3)c2c1,CCCCOc1ccc2[nH]cnc(=Nc3cccc(Br)c3)c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
239815,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],CHEMBL67008,nM,3600,CHEMBL3975,5.443697499,FBPase,CCOc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],CCOc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
241170,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL35820,nM,1700,CHEMBL3975,5.769551079,FBPase,CCOc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
241174,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,C#Cc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1F,CHEMBL65250,nM,250,CHEMBL3975,6.602059991,FBPase,C#Cc1cc(N=c2[nH]cnc3cc(OC)c(OC)cc23)ccc1F,C#Cc1cc(N=c2[nH]cnc3cc(OC)c(OC)cc23)ccc1F,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
242441,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(CS(C)(=O)=O)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL63451,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(CS(C)(=O)=O)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(CS(C)(=O)=O)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
243823,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,C#Cc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1,CHEMBL304929,nM,900,CHEMBL3975,6.045757491,FBPase,C#Cc1cccc(N=c2[nH]cnc3cc(OC)c(OC)cc23)c1,C#Cc1cccc(N=c2[nH]cnc3cc(OC)c(OC)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
245188,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,O=C(O)c1ccc2c(Nc3cccc(Br)c3)ncnc2c1,CHEMBL303318,nM,10000,CHEMBL3975,5,FBPase,O=C(O)c1ccc2c(=Nc3cccc(Br)c3)[nH]cnc2c1,O=C(O)c1ccc2c(=Nc3cccc(Br)c3)[nH]cnc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
245189,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(Cc3ccccc3)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL63203,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(Cc3ccccc3)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(Cc3ccccc3)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
247829,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCN(CC)c1nc(Nc2cccc(Br)c2)c2cc(OC)c(OC)cc2n1,CHEMBL433251,nM,10000,CHEMBL3975,5,FBPase,CCN(CC)c1nc(=Nc2cccc(Br)c2)c2cc(OC)c(OC)cc2[nH]1,CCN(CC)c1nc(=Nc2cccc(Br)c2)c2cc(OC)c(OC)cc2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
247830,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(CCl)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL67906,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(CCl)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(CCl)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
250670,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COCCOc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC,CHEMBL63906,nM,5500,CHEMBL3975,5.259637311,FBPase,COCCOc1cc2c(=Nc3cccc(Br)c3)[nH]cnc2cc1OC,COCCOc1cc2c(=Nc3cccc(Br)c3)[nH]cnc2cc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
252030,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3cccc(C#N)c3)c2cc1OCC,CHEMBL68020,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]cnc(=Nc3cccc(C#N)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3cccc(C#N)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
252031,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3ccc(C)c(Cl)c3)c2cc1OCC,CHEMBL303292,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]cnc(=Nc3ccc(C)c(Cl)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3ccc(C)c(Cl)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
252032,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OCC,CHEMBL63605,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]cnc(=Nc3ccc(Cl)c(Cl)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3ccc(Cl)c(Cl)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
252033,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2nc(CC(C)C)nc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL63787,nM,10000,CHEMBL3975,5,FBPase,CCOc1cc2[nH]c(CC(C)C)nc(=Nc3cccc(Br)c3)c2cc1OCC,CCOc1cc2[nH]c(CC(C)C)nc(=Nc3cccc(Br)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
252034,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,Brc1cccc(Nc2ncnc3cc4ccccc4cc23)c1,CHEMBL63786,nM,7500,CHEMBL3975,5.124938737,FBPase,Brc1cccc(N=c2[nH]cnc3cc4ccccc4cc23)c1,Brc1cccc(N=c2[nH]cnc3cc4ccccc4cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
257528,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC,CHEMBL63676,nM,530,CHEMBL3975,6.27572413,FBPase,CCOc1cc2[nH]cnc(=Nc3ccc(F)c(Cl)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3ccc(F)c(Cl)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
257532,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC,CHEMBL301018,nM,290,CHEMBL3975,6.537602002,FBPase,COc1cc2[nH]cnc(=Nc3ccc(F)c(Cl)c3)c2cc1OC,COc1cc2[nH]cnc(=Nc3ccc(F)c(Cl)c3)c2cc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
258838,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCOC,CHEMBL63917,nM,10000,CHEMBL3975,5,FBPase,COCCOc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1OCCOC,COCCOc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1OCCOC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
260160,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],CHEMBL65038,nM,10000,CHEMBL3975,5,FBPase,COc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],COc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
261476,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OCC,CHEMBL64950,nM,1600,CHEMBL3975,5.795880017,FBPase,CCOc1cc2[nH]cnc(=Nc3cccc(Cl)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3cccc(Cl)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
261480,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,CHEMBL29197,nM,1000,CHEMBL3975,6,FBPase,COc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1OC,COc1cc2[nH]cnc(=Nc3cccc(Br)c3)c2cc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
262809,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O,CHEMBL752,nM,800,CHEMBL3975,6.096910013,FBPase,N=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO[PH](=O)(=O)O)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1ncn2C1OC(CO[PH](=O)(=O)O)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
264132,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,CCOc1cc2ncnc(Nc3cccc(I)c3)c2cc1OCC,CHEMBL65704,nM,2100,CHEMBL3975,5.677780705,FBPase,CCOc1cc2[nH]cnc(=Nc3cccc(I)c3)c2cc1OCC,CCOc1cc2[nH]cnc(=Nc3cccc(I)c3)c2cc1OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
264133,CHEMBL694959,"Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase.",B,Brc1cccc(Nc2ncnc3cc4[nH]cnc4cc23)c1,CHEMBL66031,nM,4000,CHEMBL3975,5.397940009,FBPase,Brc1cccc(N=c2[nH]cnc3cc4[nH]cnc4cc23)c1,Brc1cccc(N=c2[nH]cnc3cc4[nH]cnc4cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703227,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,CHEMBL207095,nM,3400,CHEMBL3975,5.468521083,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703228,CHEMBL861116,Inhibition of human FBPase1,B,COc1cc(-c2cccc(N)c2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL205792,nM,570,CHEMBL3975,6.244125144,FBPase,COc1cc(-c2cccc(N)c2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,COc1cc(-c2cccc(N)c2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703229,CHEMBL861116,Inhibition of human FBPase1,B,COc1cc(-c2ccc(N)cc2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL205712,nM,1300,CHEMBL3975,5.886056648,FBPase,COc1cc(-c2ccc(N)cc2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,COc1cc(-c2ccc(N)cc2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703230,CHEMBL861116,Inhibition of human FBPase1,B,COc1cc(-c2cccc(CN)c2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL382008,nM,2600,CHEMBL3975,5.585026652,FBPase,COc1cc(-c2cccc(CN)c2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,COc1cc(-c2cccc(CN)c2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703231,CHEMBL861116,Inhibition of human FBPase1,B,COc1cc(-c2ccc(O)cc2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL380170,nM,1800,CHEMBL3975,5.744727495,FBPase,COc1cc(-c2ccc(O)cc2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,COc1cc(-c2ccc(O)cc2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703232,CHEMBL861116,Inhibition of human FBPase1,B,COc1cc(-c2cccc(O)c2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL205039,nM,1700,CHEMBL3975,5.769551079,FBPase,COc1cc(-c2cccc(O)c2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,COc1cc(-c2cccc(O)c2)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703233,CHEMBL861116,Inhibition of human FBPase1,B,COc1cc(-c2cnccc2OC)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL381536,nM,3500,CHEMBL3975,5.455931956,FBPase,COc1cc(-c2cnccc2OC)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,COc1cc(-c2cnccc2OC)c2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703234,CHEMBL861116,Inhibition of human FBPase1,B,COc1ccc2nc(NS(=O)(=O)c3cc(Cl)ccc3Cl)oc2c1,CHEMBL206824,nM,8000,CHEMBL3975,5.096910013,FBPase,COc1ccc2[nH]c(=NS(=O)(=O)c3cc(Cl)ccc3Cl)oc2c1,COc1ccc2[nH]c(=NS(=O)(=O)c3cc(Cl)ccc3Cl)oc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703235,CHEMBL861116,Inhibition of human FBPase1,B,Cc1ccc2nc(NS(=O)(=O)c3cc(Cl)ccc3Cl)oc2c1,CHEMBL205656,nM,10000,CHEMBL3975,5,FBPase,Cc1ccc2[nH]c(=NS(=O)(=O)c3cc(Cl)ccc3Cl)oc2c1,Cc1ccc2[nH]c(=NS(=O)(=O)c3cc(Cl)ccc3Cl)oc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703236,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2ccc(Cl)cc2o1)c1cc(Cl)ccc1Cl,CHEMBL205295,nM,8100,CHEMBL3975,5.091514981,FBPase,O=S(=O)(N=c1[nH]c2ccc(Cl)cc2o1)c1cc(Cl)ccc1Cl,O=S(=O)(N=c1[nH]c2ccc(Cl)cc2o1)c1cc(Cl)ccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703237,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(-c3ccoc3)ccc2o1)c1cc(Cl)ccc1Cl,CHEMBL377365,nM,4000,CHEMBL3975,5.397940009,FBPase,O=S(=O)(N=c1[nH]c2cc(-c3ccoc3)ccc2o1)c1cc(Cl)ccc1Cl,O=S(=O)(N=c1[nH]c2cc(-c3ccoc3)ccc2o1)c1cc(Cl)ccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703238,CHEMBL861116,Inhibition of human FBPase1,B,CC(C)(C)c1ccc2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL381757,nM,32000,CHEMBL3975,4.494850022,FBPase,CC(C)(C)c1ccc2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,CC(C)(C)c1ccc2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703239,CHEMBL861116,Inhibition of human FBPase1,B,Cc1ccc2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1,CHEMBL205185,nM,6400,CHEMBL3975,5.193820026,FBPase,Cc1ccc2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,Cc1ccc2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703240,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Br)ccc2o1)c1cc(Cl)ccc1Cl,CHEMBL203011,nM,1900,CHEMBL3975,5.721246399,FBPase,O=S(=O)(N=c1[nH]c2cc(Br)ccc2o1)c1cc(Cl)ccc1Cl,O=S(=O)(N=c1[nH]c2cc(Br)ccc2o1)c1cc(Cl)ccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703241,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2c(C3=CCNC=C3)cccc2o1)c1cc(Cl)ccc1Cl,CHEMBL204931,nM,50000,CHEMBL3975,4.301029996,FBPase,O=S(=O)(N=c1[nH]c2c(C3=CC=NCC3)cccc2o1)c1cc(Cl)ccc1Cl,O=S(=O)(N=c1[nH]c2c(C3=CC=NCC3)cccc2o1)c1cc(Cl)ccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703242,CHEMBL861116,Inhibition of human FBPase1,B,Cc1cccc2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc12,CHEMBL204894,nM,55000,CHEMBL3975,4.259637311,FBPase,Cc1cccc2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c12,Cc1cccc2oc(=NS(=O)(=O)c3cc(Cl)ccc3Cl)[nH]c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703243,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2c(I)cccc2o1)c1cc(Cl)ccc1Cl,CHEMBL203628,nM,50000,CHEMBL3975,4.301029996,FBPase,O=S(=O)(N=c1[nH]c2c(I)cccc2o1)c1cc(Cl)ccc1Cl,O=S(=O)(N=c1[nH]c2c(I)cccc2o1)c1cc(Cl)ccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703244,CHEMBL861116,Inhibition of human FBPase1,B,Cc1cccc(Cl)c1S(=O)(=O)Nc1nc2cc(Cl)ccc2o1,CHEMBL382861,nM,50000,CHEMBL3975,4.301029996,FBPase,Cc1cccc(Cl)c1S(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,Cc1cccc(Cl)c1S(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703245,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1c(Cl)cccc1Cl,CHEMBL380739,nM,50000,CHEMBL3975,4.301029996,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1c(Cl)cccc1Cl,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1c(Cl)cccc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703246,CHEMBL861116,Inhibition of human FBPase1,B,CCCC(=O)Nc1ccc(S(=O)(=O)Nc2nc3cc(Cl)ccc3o2)cc1,CHEMBL205624,nM,12000,CHEMBL3975,4.920818754,FBPase,CCCC(=O)Nc1ccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)cc1,CCCC(=O)Nc1ccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703247,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccc(-c2ccoc2)cc1,CHEMBL381082,nM,6700,CHEMBL3975,5.173925197,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(-c2ccoc2)cc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(-c2ccoc2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703248,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccc(-c2ccccc2)cc1,CHEMBL203397,nM,4000,CHEMBL3975,5.397940009,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(-c2ccccc2)cc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(-c2ccccc2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703249,CHEMBL861116,Inhibition of human FBPase1,B,CC(C)(C)c1ccc(S(=O)(=O)Nc2nc3cc(Cl)ccc3o2)cc1,CHEMBL382856,nM,24000,CHEMBL3975,4.619788758,FBPase,CC(C)(C)c1ccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)cc1,CC(C)(C)c1ccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703250,CHEMBL861116,Inhibition of human FBPase1,B,Cc1ccc(S(=O)(=O)Nc2nc3cc(Cl)ccc3o2)cc1,CHEMBL204842,nM,6200,CHEMBL3975,5.207608311,FBPase,Cc1ccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)cc1,Cc1ccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703251,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccc(OC(F)(F)F)cc1,CHEMBL205184,nM,7800,CHEMBL3975,5.107905397,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(OC(F)(F)F)cc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(OC(F)(F)F)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703252,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccc(F)cc1,CHEMBL381567,nM,2800,CHEMBL3975,5.552841969,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(F)cc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc(F)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703253,CHEMBL861116,Inhibition of human FBPase1,B,CC(C)(C)c1ccc(COc2cccc(S(=O)(=O)Nc3nc4cc(Cl)ccc4o3)c2)cc1,CHEMBL382691,nM,50000,CHEMBL3975,4.301029996,FBPase,CC(C)(C)c1ccc(COc2cccc(S(=O)(=O)N=c3[nH]c4cc(Cl)ccc4o3)c2)cc1,CC(C)(C)c1ccc(COc2cccc(S(=O)(=O)N=c3[nH]c4cc(Cl)ccc4o3)c2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703254,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cccc(-c2ccccc2)c1,CHEMBL203398,nM,9800,CHEMBL3975,5.008773924,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cccc(-c2ccccc2)c1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cccc(-c2ccccc2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703255,CHEMBL861116,Inhibition of human FBPase1,B,O=[N+]([O-])c1cccc(S(=O)(=O)Nc2nc3cc(Cl)ccc3o2)c1,CHEMBL207984,nM,1800,CHEMBL3975,5.744727495,FBPase,O=[N+]([O-])c1cccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)c1,O=[N+]([O-])c1cccc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703256,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cccc(Cl)c1,CHEMBL379604,nM,1300,CHEMBL3975,5.886056648,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cccc(Cl)c1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703257,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccccc1-n1ccnc1,CHEMBL207851,nM,23000,CHEMBL3975,4.638272164,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1-n1ccnc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1-n1ccnc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703258,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccccc1-c1ccccc1,CHEMBL203073,nM,3800,CHEMBL3975,5.420216403,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1-c1ccccc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1-c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703259,CHEMBL861116,Inhibition of human FBPase1,B,N#Cc1ccccc1S(=O)(=O)Nc1nc2cc(Cl)ccc2o1,CHEMBL381827,nM,6000,CHEMBL3975,5.22184875,FBPase,N#Cc1ccccc1S(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,N#Cc1ccccc1S(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703260,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccccc1Br,CHEMBL381535,nM,6500,CHEMBL3975,5.187086643,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1Br,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1Br,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703261,CHEMBL861116,Inhibition of human FBPase1,B,CCCCS(=O)(=O)Nc1nc2cc(Cl)ccc2o1,CHEMBL205376,nM,50000,CHEMBL3975,4.301029996,FBPase,CCCCS(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,CCCCS(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703262,CHEMBL861116,Inhibition of human FBPase1,B,CS(=O)(=O)Nc1nc2cc(Cl)ccc2o1,CHEMBL205392,nM,50000,CHEMBL3975,4.301029996,FBPase,CS(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,CS(=O)(=O)N=c1[nH]c2cc(Cl)ccc2o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703263,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccc2cc3ccccc3cc2c1,CHEMBL206012,nM,3400,CHEMBL3975,5.468521083,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc2cc3ccccc3cc2c1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc2cc3ccccc3cc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703264,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccc2ccccc2c1,CHEMBL381594,nM,2500,CHEMBL3975,5.602059991,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc2ccccc2c1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccc2ccccc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703265,CHEMBL861116,Inhibition of human FBPase1,B,Cn1cnc(S(=O)(=O)Nc2nc3cc(Cl)ccc3o2)c1,CHEMBL381803,nM,9400,CHEMBL3975,5.026872146,FBPase,Cn1cnc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)c1,Cn1cnc(S(=O)(=O)N=c2[nH]c3cc(Cl)ccc3o2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703266,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cccs1,CHEMBL380326,nM,13000,CHEMBL3975,4.886056648,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cccs1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1cccs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
1703267,CHEMBL861116,Inhibition of human FBPase1,B,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1ccccc1,CHEMBL207096,nM,7700,CHEMBL3975,5.113509275,FBPase,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1,O=S(=O)(N=c1[nH]c2cc(Cl)ccc2o1)c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508939,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCCP(=O)(O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL483163,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508941,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,C[C@H]1O[C@@H](n2c(NCCP(=O)(O)O)nc3c(N)ncnc32)[C@H](O)[C@@H]1O,CHEMBL519323,nM,100000,CHEMBL3975,4,FBPase,C[C@H]1O[C@@H](n2c(=NCC[PH](=O)(=O)O)[nH]c3c(=N)[nH]cnc32)[C@H](O)[C@@H]1O,CC1OC(n2c(=NCC[PH](=O)(=O)O)[nH]c3c(=N)[nH]cnc32)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508942,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCCP(=O)(O)O)n2Cc1ccccc1,CHEMBL484136,nM,91000,CHEMBL3975,4.040958608,FBPase,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2Cc1ccccc1,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2Cc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508943,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCCP(=O)(O)O)n2CCc1ccccc1,CHEMBL521165,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2CCc1ccccc1,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508944,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCCP(=O)(O)O)n2Cc1ccc2ccccc2c1,CHEMBL519845,nM,35000,CHEMBL3975,4.455931956,FBPase,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2Cc1ccc2ccccc2c1,N=c1[nH]cnc2c1[nH]c(=NCC[PH](=O)(=O)O)n2Cc1ccc2ccccc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508945,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(C(=O)NCP(=O)(O)O)n2CCc1ccccc1,CHEMBL484782,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1nc(C(=O)NC[PH](=O)(=O)O)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(C(=O)NC[PH](=O)(=O)O)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508946,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(CCCP(=O)(O)O)n2CCc1ccccc1,CHEMBL520009,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1nc(CCC[PH](=O)(=O)O)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(CCC[PH](=O)(=O)O)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508947,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(/C=C/CP(=O)(O)O)n2CCc1ccccc1,CHEMBL519996,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1nc(C=CC[PH](=O)(=O)O)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(C=CC[PH](=O)(=O)O)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508949,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(COCP(=O)(O)O)n2CCc1ccccc1,CHEMBL483999,nM,23000,CHEMBL3975,4.638272164,FBPase,N=c1[nH]cnc2c1nc(COC[PH](=O)(=O)O)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(COC[PH](=O)(=O)O)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508950,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CCc1ccccc1,CHEMBL519503,nM,5000,CHEMBL3975,5.301029996,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508951,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)s1)n2CCc1ccccc1,CHEMBL485361,nM,48000,CHEMBL3975,4.318758763,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)s1)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)s1)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508952,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(CCOP(=O)(O)O)n2CCc1ccccc1,CHEMBL482992,nM,40000,CHEMBL3975,4.397940009,FBPase,N=c1[nH]cnc2c1nc(CCO[PH](=O)(=O)O)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(CCO[PH](=O)(=O)O)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508955,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CNc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CCc1ccccc1,CHEMBL515243,nM,50000,CHEMBL3975,4.301029996,FBPase,CN=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CCc1ccccc1,CN=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508956,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,O=P(O)(O)c1ccc(-c2nc3c(Cl)ncnc3n2CCc2ccccc2)o1,CHEMBL515436,nM,50000,CHEMBL3975,4.301029996,FBPase,O=[PH](=O)(O)c1ccc(-c2nc3c(Cl)ncnc3n2CCc2ccccc2)o1,O=[PH](=O)(O)c1ccc(-c2nc3c(Cl)ncnc3n2CCc2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508957,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC(c1ccccc1)c1ccccc1,CHEMBL475304,nM,70000,CHEMBL3975,4.15490196,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC(c1ccccc1)c1ccccc1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC(c1ccccc1)c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508958,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CCC1CCCCC1,CHEMBL514660,nM,1400,CHEMBL3975,5.853871964,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CCC1CCCCC1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CCC1CCCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508959,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1ccc2ccccc2c1,CHEMBL475305,nM,3300,CHEMBL3975,5.48148606,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccc2ccccc2c1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccc2ccccc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508960,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2C1CC1,CHEMBL514803,nM,1500,CHEMBL3975,5.823908741,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2C1CC1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2C1CC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508961,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2C1CCCC1,CHEMBL519477,nM,2000,CHEMBL3975,5.698970004,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2C1CCCC1,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2C1CCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508962,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CCn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL510249,nM,1800,CHEMBL3975,5.744727495,FBPase,CCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508963,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL482734,nM,1500,CHEMBL3975,5.823908741,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508964,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL482735,nM,800,CHEMBL3975,6.096910013,FBPase,CC(C)(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CC(C)(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508965,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CSc1nc(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)C)c2n1,CHEMBL507312,nM,700,CHEMBL3975,6.15490196,FBPase,CSc1nc(=N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c2[nH]1,CSc1nc(=N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508966,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)nc(S(C)(=O)=O)nc21,CHEMBL484331,nM,28000,CHEMBL3975,4.552841969,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]c(S(C)(=O)=O)nc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]c(S(C)(=O)=O)nc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508967,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(CO)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL520490,nM,4500,CHEMBL3975,5.346787486,FBPase,CC(C)(CO)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CC(C)(CO)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508968,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(CCl)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL484332,nM,900,CHEMBL3975,6.045757491,FBPase,CC(C)(CCl)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CC(C)(CCl)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508969,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(C)CCn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL447259,nM,1600,CHEMBL3975,5.795880017,FBPase,CC(C)(C)CCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CC(C)(C)CCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508970,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(n1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21)C(C)(C)C,CHEMBL482561,nM,5000,CHEMBL3975,5.301029996,FBPase,CC(n1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21)C(C)(C)C,CC(n1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21)C(C)(C)C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508971,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)nc(N)nc21,CHEMBL483556,nM,5500,CHEMBL3975,5.259637311,FBPase,CC(C)(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]c(=N)[nH]c21,CC(C)(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]c(=N)[nH]c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508972,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CSc1nc(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)(C)C)c2n1,CHEMBL483354,nM,1100,CHEMBL3975,5.958607315,FBPase,CSc1nc(=N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)(C)C)c2[nH]1,CSc1nc(=N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)(C)C)c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508973,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(C)Cn1c(-c2oc(P(=O)(O)O)c(Cl)c2Cl)nc2c(N)ncnc21,CHEMBL519692,nM,13000,CHEMBL3975,4.886056648,FBPase,CC(C)(C)Cn1c(-c2oc([PH](=O)(=O)O)c(Cl)c2Cl)nc2c(=N)[nH]cnc21,CC(C)(C)Cn1c(-c2oc([PH](=O)(=O)O)c(Cl)c2Cl)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508984,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(/C=C/C(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL519202,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1nc(C=CC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1nc(C=CC(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508985,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(CCC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL485129,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1nc(CCC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1nc(CCC(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508986,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL485130,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1[nH]c(=NCC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1[nH]c(=NCC(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508987,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCCC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL519361,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1[nH]c(=NCCC(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1[nH]c(=NCCC(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508988,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCP(=O)(O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL482951,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1[nH]c(=NC[PH](=O)(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1[nH]c(=NC[PH](=O)(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508989,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(NCCCP(=O)(O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL520307,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1[nH]c(=NCCC[PH](=O)(=O)O)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,N=c1[nH]cnc2c1[nH]c(=NCCC[PH](=O)(=O)O)n2C1OC(CO)C(O)C1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508990,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2[nH]c(NCCP(=O)(O)O)nc12,CHEMBL483356,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2[nH]c(=NCC[PH](=O)(=O)O)[nH]c12,N=c1[nH]cnc2[nH]c(=NCC[PH](=O)(=O)O)[nH]c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508996,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(C(=O)O)o1)n2CCc1ccccc1,CHEMBL520175,nM,100000,CHEMBL3975,4,FBPase,N=c1[nH]cnc2c1nc(-c1ccc(C(=O)O)o1)n2CCc1ccccc1,N=c1[nH]cnc2c1nc(-c1ccc(C(=O)O)o1)n2CCc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508997,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CCOP(=O)(O)c1ccc(-c2nc3c(N)ncnc3n2CCc2ccccc2)o1,CHEMBL484923,nM,100000,CHEMBL3975,4,FBPase,CCO[PH](=O)(=O)c1ccc(-c2nc3c(=N)[nH]cnc3n2CCc2ccccc2)o1,CCO[PH](=O)(=O)c1ccc(-c2nc3c(=N)[nH]cnc3n2CCc2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508998,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CCOP(=O)(OCC)c1ccc(-c2nc3c(N)ncnc3n2CCc2ccccc2)o1,CHEMBL520176,nM,100000,CHEMBL3975,4,FBPase,CCOP(=O)(OCC)c1ccc(-c2nc3c(=N)[nH]cnc3n2CCc2ccccc2)o1,CCOP(=O)(OCC)c1ccc(-c2nc3c(=N)[nH]cnc3n2CCc2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2508999,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2C12CC3CC(CC(C3)C1)C2,CHEMBL519641,nM,10000,CHEMBL3975,5,FBPase,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2C12CC3CC(CC(C3)C1)C2,N=c1[nH]cnc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2C12CC3CC(CC(C3)C1)C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2509000,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CN(C)CC(C)(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21,CHEMBL484135,nM,10000,CHEMBL3975,5,FBPase,CN(C)CC(C)(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,CN(C)CC(C)(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2509001,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Cn1c(-c2nc3c(N)ncnc3n2CC(C)(C)C)ccc1P(=O)(O)O,CHEMBL483555,nM,10000,CHEMBL3975,5,FBPase,Cn1c(-c2nc3c(=N)[nH]cnc3n2CC(C)(C)C)ccc1[PH](=O)(=O)O,Cn1c(-c2nc3c(=N)[nH]cnc3n2CC(C)(C)C)ccc1[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2509002,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,Cn1c(P(=O)(O)O)cnc1-c1nc2c(N)ncnc2n1CC(C)(C)C,CHEMBL484592,nM,10000,CHEMBL3975,5,FBPase,Cn1c([PH](=O)(=O)O)cnc1-c1nc2c(=N)[nH]cnc2n1CC(C)(C)C,Cn1c([PH](=O)(=O)O)cnc1-c1nc2c(=N)[nH]cnc2n1CC(C)(C)C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2509003,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(C)Cn1c(-c2coc(P(=O)(O)O)c2)nc2c(N)ncnc21,CHEMBL520998,nM,10000,CHEMBL3975,5,FBPase,CC(C)(C)Cn1c(-c2coc([PH](=O)(=O)O)c2)nc2c(=N)[nH]cnc21,CC(C)(C)Cn1c(-c2coc([PH](=O)(=O)O)c2)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2509004,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,CC(C)(C)Cn1c(Cn2ccnc2P(=O)(O)O)nc2c(N)ncnc21,CHEMBL485144,nM,100000,CHEMBL3975,4,FBPase,CC(C)(C)Cn1c(Cn2ccnc2[PH](=O)(=O)O)nc2c(=N)[nH]cnc21,CC(C)(C)Cn1c(Cn2ccnc2[PH](=O)(=O)O)nc2c(=N)[nH]cnc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2509049,CHEMBL981259,Inhibition of human liver FBPase expressed in Escherichia coli by spectrophotometry,B,NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1N,CHEMBL483849,nM,12000,CHEMBL3975,4.920818754,FBPase,NC(=O)c1ncn([C@@H]2O[C@H](CO[PH](=O)(=O)O)[C@@H](O)[C@H]2O)c1N,NC(=O)c1ncn(C2OC(CO[PH](=O)(=O)O)C(O)C2O)c1N,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562709,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL456319,nM,2755,CHEMBL3975,5.559878397,FBPase,O=C(NCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562712,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCS)c1,CHEMBL459135,nM,20481,CHEMBL3975,4.688648842,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCS)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCS)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562717,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCNCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL457849,nM,43809,CHEMBL3975,4.35843666,FBPase,O=C(NCCCNCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCNCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562718,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCOCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL458276,nM,125,CHEMBL3975,6.903089987,FBPase,O=C(NCCCOCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCOCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562719,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCSSCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL458056,nM,29,CHEMBL3975,7.537602002,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCSSCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCSSCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562720,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCSSCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL515524,nM,55,CHEMBL3975,7.259637311,FBPase,O=C(NCCSSCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCSSCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562721,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCNCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL458055,nM,100000,CHEMBL3975,4,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCNCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCNCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562722,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCOCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL456543,nM,827,CHEMBL3975,6.08249449,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCOCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCOCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562723,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCSCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL514722,nM,70,CHEMBL3975,7.15490196,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCSCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCSCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562724,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCc2cccc(CNC(=O)NS(=O)(=O)c3cccc(C)c3)c2)c1,CHEMBL463183,nM,12,CHEMBL3975,7.920818754,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCc2cccc(CNC(=O)NS(=O)(=O)c3cccc(C)c3)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCc2cccc(CNC(=O)NS(=O)(=O)c3cccc(C)c3)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562725,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCc2ccc(CNC(=O)NS(=O)(=O)c3cccc(C)c3)cc2)c1,CHEMBL462979,nM,3,CHEMBL3975,8.522878745,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCc2ccc(CNC(=O)NS(=O)(=O)c3cccc(C)c3)cc2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCc2ccc(CNC(=O)NS(=O)(=O)c3cccc(C)c3)cc2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562726,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCc1ccc(CNC(=O)NS(=O)(=O)c2cccc(Cl)c2)cc1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL462978,nM,6,CHEMBL3975,8.22184875,FBPase,O=C(NCc1ccc(CNC(=O)NS(=O)(=O)c2cccc(Cl)c2)cc1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCc1ccc(CNC(=O)NS(=O)(=O)c2cccc(Cl)c2)cc1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562727,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NC[C@H]1CC[C@H](CNC(=O)NS(=O)(=O)c2cccc(Cl)c2)CC1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL456155,nM,28,CHEMBL3975,7.552841969,FBPase,O=C(NC[C@H]1CC[C@H](CNC(=O)NS(=O)(=O)c2cccc(Cl)c2)CC1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCC1CCC(CNC(=O)NS(=O)(=O)c2cccc(Cl)c2)CC1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562728,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCC#CCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL456154,nM,95,CHEMBL3975,7.022276395,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCC#CCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCC#CCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562729,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCC/C=C/CCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL455930,nM,68,CHEMBL3975,7.167491087,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCC/C=C/CCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCC=CCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562730,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCC/C=C/CCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL456564,nM,40,CHEMBL3975,7.397940009,FBPase,O=C(NCC/C=C/CCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCC=CCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562731,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL515042,nM,35,CHEMBL3975,7.455931956,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562732,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL456563,nM,45,CHEMBL3975,7.346787486,FBPase,O=C(NCCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562733,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL457400,nM,12,CHEMBL3975,7.920818754,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562734,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL457189,nM,9,CHEMBL3975,8.045757491,FBPase,O=C(NCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562735,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL456978,nM,24,CHEMBL3975,7.619788758,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562736,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL456977,nM,17,CHEMBL3975,7.769551079,FBPase,O=C(NCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562737,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL456321,nM,72,CHEMBL3975,7.142667504,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562738,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(NCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL456320,nM,50,CHEMBL3975,7.301029996,FBPase,O=C(NCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(NCCCCCNC(=O)NS(=O)(=O)c1cccc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562739,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL516135,nM,3396,CHEMBL3975,5.469032318,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562740,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL498538,nM,100000,CHEMBL3975,4,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562741,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)NCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,CHEMBL496654,nM,100000,CHEMBL3975,4,FBPase,Cc1cccc(S(=O)(=O)NC(=O)NCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,Cc1cccc(S(=O)(=O)NC(=O)NCCNC(=O)NS(=O)(=O)c2cccc(C)c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2562781,CHEMBL974537,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Nc1ccc(S(=O)(=O)NC(=O)NCCS)cc1,CHEMBL497689,nM,1600,CHEMBL3975,5.795880017,FBPase,Nc1ccc(S(=O)(=O)NC(=O)NCCS)cc1,Nc1ccc(S(=O)(=O)NC(=O)NCCS)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987502,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)cccc21,CHEMBL572295,nM,6000,CHEMBL3975,5.22184875,FBPase,Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987503,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)cccc21,CHEMBL576114,nM,2250,CHEMBL3975,5.647817482,FBPase,CCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,CCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987504,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCCn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)cccc21,CHEMBL570965,nM,1100,CHEMBL3975,5.958607315,FBPase,CCCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,CCCn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987505,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)cccc21,CHEMBL571182,nM,1500,CHEMBL3975,5.823908741,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)cccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987506,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC1CC1,CHEMBL583908,nM,800,CHEMBL3975,6.096910013,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CC1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987507,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC1CCC1,CHEMBL571844,nM,800,CHEMBL3975,6.096910013,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCC1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987508,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC1CCCC1,CHEMBL571879,nM,1500,CHEMBL3975,5.823908741,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCCC1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987509,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC1CCCCC1,CHEMBL571435,nM,2500,CHEMBL3975,5.602059991,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCCCC1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987510,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC1CCCCCC1,CHEMBL570964,nM,3250,CHEMBL3975,5.488116639,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCCCCC1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CCCCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987511,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC12CCC(CC1)C2,CHEMBL571839,nM,1000,CHEMBL3975,6,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC12CCC(CC1)C2,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC12CCC(CC1)C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987512,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1ccccc1,CHEMBL584749,nM,5000,CHEMBL3975,5.301029996,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccccc1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987513,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)(C)c1ccc(Cn2c(-c3ccc(P(=O)(O)O)o3)nc3c(N)cccc32)cc1,CHEMBL585947,nM,9500,CHEMBL3975,5.022276395,FBPase,CC(C)(C)c1ccc(Cn2c(-c3ccc([PH](=O)(=O)O)o3)nc3c(N)cccc32)cc1,CC(C)(C)c1ccc(Cn2c(-c3ccc([PH](=O)(=O)O)o3)nc3c(N)cccc32)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987514,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1ccc(C(F)(F)F)cc1,CHEMBL572057,nM,7000,CHEMBL3975,5.15490196,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccc(C(F)(F)F)cc1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccc(C(F)(F)F)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987515,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1ccc(-c2ccccc2)cc1,CHEMBL571847,nM,2500,CHEMBL3975,5.602059991,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccc(-c2ccccc2)cc1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccc(-c2ccccc2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987516,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1ccoc1,CHEMBL570325,nM,4200,CHEMBL3975,5.37675071,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccoc1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccoc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987517,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1cccc(O)c1,CHEMBL585727,nM,1850,CHEMBL3975,5.732828272,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1cccc(O)c1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1cccc(O)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987518,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1cccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2Cc1ccsc1,CHEMBL583038,nM,4000,CHEMBL3975,5.397940009,FBPase,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccsc1,Nc1cccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2Cc1ccsc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987519,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCc1ccc2c(nc(-c3ccc(P(=O)(O)O)o3)n2CC(C)C)c1N,CHEMBL570991,nM,2500,CHEMBL3975,5.602059991,FBPase,CCc1ccc2c(nc(-c3ccc([PH](=O)(=O)O)o3)n2CC(C)C)c1N,CCc1ccc2c(nc(-c3ccc([PH](=O)(=O)O)o3)n2CC(C)C)c1N,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987520,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCCc1ccc2c(nc(-c3ccc(P(=O)(O)O)o3)n2CC(C)C)c1N,CHEMBL577114,nM,3000,CHEMBL3975,5.522878745,FBPase,CCCc1ccc2c(nc(-c3ccc([PH](=O)(=O)O)o3)n2CC(C)C)c1N,CCCc1ccc2c(nc(-c3ccc([PH](=O)(=O)O)o3)n2CC(C)C)c1N,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2987521,CHEMBL1037322,Inhibition of human liver FBPase 1,B,COc1ccc2c(nc(-c3ccc(P(=O)(O)O)o3)n2CC(C)C)c1N,CHEMBL583139,nM,700,CHEMBL3975,6.15490196,FBPase,COc1ccc2c(nc(-c3ccc([PH](=O)(=O)O)o3)n2CC(C)C)c1N,COc1ccc2c(nc(-c3ccc([PH](=O)(=O)O)o3)n2CC(C)C)c1N,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988205,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(O)ccc21,CHEMBL576128,nM,500,CHEMBL3975,6.301029996,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(O)ccc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(O)ccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988206,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(Cl)ccc21,CHEMBL583346,nM,200,CHEMBL3975,6.698970004,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Cl)ccc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Cl)ccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988207,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ccc(Cl)c21,CHEMBL572062,nM,900,CHEMBL3975,6.045757491,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)ccc(Cl)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)ccc(Cl)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988208,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(Br)ccc21,CHEMBL570088,nM,400,CHEMBL3975,6.397940009,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Br)ccc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Br)ccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988209,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ccc(Br)c21,CHEMBL576291,nM,400,CHEMBL3975,6.397940009,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)ccc(Br)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)ccc(Br)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988210,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)ccc21,CHEMBL585945,nM,100,CHEMBL3975,7,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)ccc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)ccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988211,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCC(CC)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)ccc21,CHEMBL585946,nM,150,CHEMBL3975,6.823908741,FBPase,CCC(CC)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)ccc21,CCC(CC)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)ccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988212,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCC(CC)n1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)ccc21,CHEMBL571840,nM,850,CHEMBL3975,6.070581074,FBPase,CCC(CC)n1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)ccc21,CCC(CC)n1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)ccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988213,CHEMBL1037322,Inhibition of human liver FBPase 1,B,Nc1c(F)ccc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CC1CC1,CHEMBL578622,nM,55,CHEMBL3975,7.259637311,FBPase,Nc1c(F)ccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CC1,Nc1c(F)ccc2c1nc(-c1ccc([PH](=O)(=O)O)o1)n2CC1CC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988214,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(Br)cc(Br)c21,CHEMBL572202,nM,1000,CHEMBL3975,6,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Br)cc(Br)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Br)cc(Br)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988215,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(Cl)cc(Cl)c21,CHEMBL578624,nM,450,CHEMBL3975,6.346787486,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Cl)cc(Cl)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Cl)cc(Cl)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988216,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(Cl)c21,CHEMBL570796,nM,100,CHEMBL3975,7,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(Cl)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(Cl)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988217,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(Br)c21,CHEMBL577117,nM,130,CHEMBL3975,6.886056648,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(Br)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(Br)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988218,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)c(Cl)cc21,CHEMBL571183,nM,225,CHEMBL3975,6.647817482,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)c(Cl)cc21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)c(Cl)cc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988219,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(Br)c(Cl)c(Cl)c21,CHEMBL584097,nM,10000,CHEMBL3975,5,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Br)c(Cl)c(Cl)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(Br)c(Cl)c(Cl)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988220,CHEMBL1037322,Inhibition of human liver FBPase 1,B,C=Cc1cc(F)c(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)C)c12,CHEMBL570089,nM,280,CHEMBL3975,6.552841969,FBPase,C=Cc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,C=Cc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988221,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(C3CC3)c21,CHEMBL571017,nM,60,CHEMBL3975,7.22184875,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(C3CC3)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(C3CC3)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988222,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(-c3ccccc3)c21,CHEMBL571018,nM,90,CHEMBL3975,7.045757491,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(-c3ccccc3)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(-c3ccccc3)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988223,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(-c3ccc(F)cc3)c21,CHEMBL571426,nM,180,CHEMBL3975,6.744727495,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(-c3ccc(F)cc3)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(-c3ccc(F)cc3)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988224,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(-c3ccc(Cl)cc3)c21,CHEMBL585541,nM,90,CHEMBL3975,7.045757491,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(-c3ccc(Cl)cc3)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(-c3ccc(Cl)cc3)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988225,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCc1cc(F)c(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)C)c12,CHEMBL570790,nM,55,CHEMBL3975,7.259637311,FBPase,CCc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,CCc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988226,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CCCc1cc(F)c(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)C)c12,CHEMBL572055,nM,100,CHEMBL3975,7,FBPase,CCCc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,CCCc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988227,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(CCC(C)(C)C)c21,CHEMBL585915,nM,210,CHEMBL3975,6.677780705,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCC(C)(C)C)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCC(C)(C)C)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988228,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)CCCc1cc(F)c(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)C)c12,CHEMBL571654,nM,100,CHEMBL3975,7,FBPase,CC(C)CCCc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,CC(C)CCCc1cc(F)c(N)c2nc(-c3ccc([PH](=O)(=O)O)o3)n(CC(C)C)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988229,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(CCCO)c21,CHEMBL571207,nM,80,CHEMBL3975,7.096910013,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCCO)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCCO)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988230,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(CCCN(C)C)c21,CHEMBL570326,nM,55,CHEMBL3975,7.259637311,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCCN(C)C)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCCN(C)C)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988231,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)c(F)cc(CCCCCl)c21,CHEMBL571872,nM,70,CHEMBL3975,7.15490196,FBPase,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCCCCl)c21,CC(C)Cn1c(-c2ccc([PH](=O)(=O)O)o2)nc2c(N)c(F)cc(CCCCCl)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
2988352,CHEMBL1037322,Inhibition of human liver FBPase 1,B,CC(C)Cc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL495498,nM,16,CHEMBL3975,7.795880017,FBPase,CC(C)Cc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017720,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)Cc1cc(P(=O)(O)O)ccc1-2,CHEMBL568552,nM,91900,CHEMBL3975,4.036684489,FBPase,N=c1[nH]c2c(s1)Cc1cc([PH](=O)(=O)O)ccc1-2,N=c1[nH]c2c(s1)Cc1cc([PH](=O)(=O)O)ccc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017721,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)Cc1ccc(P(=O)(O)O)cc1-2,CHEMBL565407,nM,18700,CHEMBL3975,4.728158393,FBPase,N=c1[nH]c2c(s1)Cc1ccc([PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)Cc1ccc([PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017722,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)Cc1cccc(P(=O)(O)O)c1-2,CHEMBL576045,nM,28400,CHEMBL3975,4.54668166,FBPase,N=c1[nH]c2c(s1)Cc1cccc([PH](=O)(=O)O)c1-2,N=c1[nH]c2c(s1)Cc1cccc([PH](=O)(=O)O)c1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017724,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1ccc(P(=O)(O)O)cc1-2,CHEMBL567512,nM,9320,CHEMBL3975,5.030584088,FBPase,N=c1[nH]c2c(s1)CCc1ccc([PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCc1ccc([PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017726,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCCc1ccc(P(=O)(O)O)cc1-2,CHEMBL566669,nM,169,CHEMBL3975,6.772113295,FBPase,N=c1[nH]c2c(s1)CCCc1ccc([PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCCc1ccc([PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017729,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)Cc1cccc(OP(=O)(O)O)c1-2,CHEMBL578134,nM,70,CHEMBL3975,7.15490196,FBPase,N=c1[nH]c2c(s1)Cc1cccc(O[PH](=O)(=O)O)c1-2,N=c1[nH]c2c(s1)Cc1cccc(O[PH](=O)(=O)O)c1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017731,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1ccc(OP(=O)(O)O)cc1-2,CHEMBL565809,nM,13,CHEMBL3975,7.886056648,FBPase,N=c1[nH]c2c(s1)CCc1ccc(O[PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCc1ccc(O[PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017733,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCCc1ccc(OP(=O)(O)O)cc1-2,CHEMBL572208,nM,22,CHEMBL3975,7.657577319,FBPase,N=c1[nH]c2c(s1)CCCc1ccc(O[PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCCc1ccc(O[PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017736,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)Cc1cccc(OCP(=O)(O)O)c1-2,CHEMBL567704,nM,124,CHEMBL3975,6.906578315,FBPase,N=c1[nH]c2c(s1)Cc1cccc(OC[PH](=O)(=O)O)c1-2,N=c1[nH]c2c(s1)Cc1cccc(OC[PH](=O)(=O)O)c1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017737,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1cc(OCP(=O)(O)O)ccc1-2,CHEMBL567705,nM,16400,CHEMBL3975,4.785156152,FBPase,N=c1[nH]c2c(s1)CCc1cc(OC[PH](=O)(=O)O)ccc1-2,N=c1[nH]c2c(s1)CCc1cc(OC[PH](=O)(=O)O)ccc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017738,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1ccc(OCP(=O)(O)O)cc1-2,CHEMBL577270,nM,19100,CHEMBL3975,4.718966633,FBPase,N=c1[nH]c2c(s1)CCc1ccc(OC[PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCc1ccc(OC[PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017739,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1cccc(OCP(=O)(O)O)c1-2,CHEMBL567501,nM,21500,CHEMBL3975,4.66756154,FBPase,N=c1[nH]c2c(s1)CCc1cccc(OC[PH](=O)(=O)O)c1-2,N=c1[nH]c2c(s1)CCc1cccc(OC[PH](=O)(=O)O)c1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017740,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCCc1ccc(OCP(=O)(O)O)cc1-2,CHEMBL579216,nM,41700,CHEMBL3975,4.379863945,FBPase,N=c1[nH]c2c(s1)CCCc1ccc(OC[PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCCc1ccc(OC[PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017741,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1ccc(CP(=O)(O)O)cc1-2,CHEMBL567030,nM,840,CHEMBL3975,6.075720714,FBPase,N=c1[nH]c2c(s1)CCc1ccc(C[PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCc1ccc(C[PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3017742,CHEMBL1039077,Inhibition of human liver FBPase,B,Nc1nc2c(s1)CCc1ccc(C(F)(F)P(=O)(O)O)cc1-2,CHEMBL568686,nM,47,CHEMBL3975,7.327902142,FBPase,N=c1[nH]c2c(s1)CCc1ccc(C(F)(F)[PH](=O)(=O)O)cc1-2,N=c1[nH]c2c(s1)CCc1ccc(C(F)(F)[PH](=O)(=O)O)cc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081752,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1ccc(S(=O)(=O)NC(=O)/N=c2/[nH]cc(Br)s2)cc1,CHEMBL595067,nM,920,CHEMBL3975,6.036212173,FBPase,Cc1ccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1,Cc1ccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081755,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cccc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c1,CHEMBL589861,nM,310,CHEMBL3975,6.508638306,FBPase,Cc1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,Cc1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081758,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cc(C)cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c1,CHEMBL589862,nM,350,CHEMBL3975,6.455931956,FBPase,Cc1cc(C)cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,Cc1cc(C)cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081761,CHEMBL1074684,Inhibition of FBPase in human liver,B,CCc1cccc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c1,CHEMBL589137,nM,230,CHEMBL3975,6.638272164,FBPase,CCc1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,CCc1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081764,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1ccccc1S(=O)(=O)NC(=O)Nc1ncc(Br)s1,CHEMBL607540,nM,6400,CHEMBL3975,5.193820026,FBPase,Cc1ccccc1S(=O)(=O)NC(=O)N=c1[nH]cc(Br)s1,Cc1ccccc1S(=O)(=O)NC(=O)N=c1[nH]cc(Br)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081767,CHEMBL1074684,Inhibition of FBPase in human liver,B,O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL595149,nM,330,CHEMBL3975,6.48148606,FBPase,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cccc(Cl)c1,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081770,CHEMBL1074684,Inhibition of FBPase in human liver,B,O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1cccc(OC(F)F)c1,CHEMBL595150,nM,210,CHEMBL3975,6.677780705,FBPase,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cccc(OC(F)F)c1,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cccc(OC(F)F)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081773,CHEMBL1074684,Inhibition of FBPase in human liver,B,O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1cccc(OC(F)(F)F)c1,CHEMBL594668,nM,1000,CHEMBL3975,6,FBPase,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cccc(OC(F)(F)F)c1,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cccc(OC(F)(F)F)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081776,CHEMBL1074684,Inhibition of FBPase in human liver,B,CC(C)c1cccc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c1,CHEMBL608398,nM,690,CHEMBL3975,6.161150909,FBPase,CC(C)c1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,CC(C)c1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081779,CHEMBL1074684,Inhibition of FBPase in human liver,B,Nc1cccc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c1,CHEMBL595304,nM,2100,CHEMBL3975,5.677780705,FBPase,Nc1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,Nc1cccc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081782,CHEMBL1074684,Inhibition of FBPase in human liver,B,CCc1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)ccc1-c1ccccc1,CHEMBL595529,nM,150,CHEMBL3975,6.823908741,FBPase,CCc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)ccc1-c1ccccc1,CCc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)ccc1-c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081785,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)ccc1-c1ccc(F)nc1,CHEMBL611631,nM,130,CHEMBL3975,6.886056648,FBPase,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)ccc1-c1ccc(F)nc1,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)ccc1-c1ccc(F)nc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081788,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1nc(-c2ccc(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cc2C)cs1,CHEMBL594444,nM,320,CHEMBL3975,6.494850022,FBPase,COc1nc(-c2ccc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)cs1,COc1nc(-c2ccc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)cs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081791,CHEMBL1074684,Inhibition of FBPase in human liver,B,O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1ccc(Cl)s1,CHEMBL594445,nM,440,CHEMBL3975,6.356547324,FBPase,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1ccc(Cl)s1,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1ccc(Cl)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081794,CHEMBL1074684,Inhibition of FBPase in human liver,B,O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1cc(Br)c(Cl)s1,CHEMBL610462,nM,230,CHEMBL3975,6.638272164,FBPase,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cc(Br)c(Cl)s1,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cc(Br)c(Cl)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081797,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1sc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)cc1C,CHEMBL593282,nM,150,CHEMBL3975,6.823908741,FBPase,COc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,COc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081800,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)sc1CC(C)C,CHEMBL590359,nM,40,CHEMBL3975,7.397940009,FBPase,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)sc1CC(C)C,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)sc1CC(C)C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081803,CHEMBL1074684,Inhibition of FBPase in human liver,B,COCc1sc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)cc1C,CHEMBL590360,nM,220,CHEMBL3975,6.657577319,FBPase,COCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,COCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081806,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)sc1CO,CHEMBL600653,nM,310,CHEMBL3975,6.508638306,FBPase,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)sc1CO,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)sc1CO,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081808,CHEMBL1074684,Inhibition of FBPase in human liver,B,COCCc1sc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)cc1C,CHEMBL590361,nM,90,CHEMBL3975,7.045757491,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081811,CHEMBL1074684,Inhibition of FBPase in human liver,B,O=C(Nc1ncc(Br)s1)NS(=O)(=O)c1cc2c(s1)CCOC2,CHEMBL585961,nM,530,CHEMBL3975,6.27572413,FBPase,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cc2c(s1)CCOC2,O=C(N=c1[nH]cc(Br)s1)NS(=O)(=O)c1cc2c(s1)CCOC2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081814,CHEMBL1074684,Inhibition of FBPase in human liver,B,COCCCc1sc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)cc1C,CHEMBL589863,nM,90,CHEMBL3975,7.045757491,FBPase,COCCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,COCCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081817,CHEMBL1074684,Inhibition of FBPase in human liver,B,COCCOc1sc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)cc1C,CHEMBL585620,nM,310,CHEMBL3975,6.508638306,FBPase,COCCOc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,COCCOc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081820,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1ccc(-c2sc(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cc2C)c(C)c1,CHEMBL590597,nM,70,CHEMBL3975,7.15490196,FBPase,COc1ccc(-c2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)c(C)c1,COc1ccc(-c2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)c(C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081823,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1ccc(-c2sc(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cc2C)cn1,CHEMBL589865,nM,150,CHEMBL3975,6.823908741,FBPase,COc1ccc(-c2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)cn1,COc1ccc(-c2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)cn1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081826,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1cc(C)c(-c2sc(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cc2C)cn1,CHEMBL601691,nM,60,CHEMBL3975,7.22184875,FBPase,COc1cc(C)c(-c2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)cn1,COc1cc(C)c(-c2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2C)cn1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081829,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)sc1-c1ccc(F)nc1,CHEMBL590111,nM,60,CHEMBL3975,7.22184875,FBPase,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)sc1-c1ccc(F)nc1,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)sc1-c1ccc(F)nc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081832,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1ccc2sc(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cc2c1,CHEMBL590839,nM,90,CHEMBL3975,7.045757491,FBPase,Cc1ccc2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2c1,Cc1ccc2sc(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081835,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cn1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c2ccccc21,CHEMBL590840,nM,390,CHEMBL3975,6.408935393,FBPase,Cn1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c2ccccc21,Cn1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c2ccccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081838,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1cccc2c(S(=O)(=O)NC(=O)Nc3ncc(Br)s3)cn(C)c12,CHEMBL590113,nM,70,CHEMBL3975,7.15490196,FBPase,COc1cccc2c(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cn(C)c12,COc1cccc2c(S(=O)(=O)NC(=O)N=c3[nH]cc(Br)s3)cn(C)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081840,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cn1cc(S(=O)(=O)NC(=O)Nc2ncc(Br)s2)c2cccc(OCCO)c21,CHEMBL601267,nM,100,CHEMBL3975,7,FBPase,Cn1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c2cccc(OCCO)c21,Cn1cc(S(=O)(=O)NC(=O)N=c2[nH]cc(Br)s2)c2cccc(OCCO)c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081842,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1nc(NC(=O)NS(=O)(=O)c2cccc(OC(F)F)c2)sc1Br,CHEMBL590362,nM,170,CHEMBL3975,6.769551079,FBPase,Cc1[nH]c(=NC(=O)NS(=O)(=O)c2cccc(OC(F)F)c2)sc1Br,Cc1[nH]c(=NC(=O)NS(=O)(=O)c2cccc(OC(F)F)c2)sc1Br,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081844,CHEMBL1074684,Inhibition of FBPase in human liver,B,COCCc1sc(S(=O)(=O)NC(=O)Nc2ncc(SC)s2)cc1C,CHEMBL573056,nM,180,CHEMBL3975,6.744727495,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(SC)s2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]cc(SC)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081846,CHEMBL1074684,Inhibition of FBPase in human liver,B,COCCc1sc(S(=O)(=O)NC(=O)Nc2nc(C)c(SC)s2)cc1C,CHEMBL591083,nM,180,CHEMBL3975,6.744727495,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]c(C)c(SC)s2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2[nH]c(C)c(SC)s2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081848,CHEMBL1074684,Inhibition of FBPase in human liver,B,CSc1sc(NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)nc1C,CHEMBL605615,nM,70,CHEMBL3975,7.15490196,FBPase,CSc1sc(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)[nH]c1C,CSc1sc(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)[nH]c1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081850,CHEMBL1074684,Inhibition of FBPase in human liver,B,CCc1nc(NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)sc1SC,CHEMBL590363,nM,80,CHEMBL3975,7.096910013,FBPase,CCc1[nH]c(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)sc1SC,CCc1[nH]c(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)sc1SC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081852,CHEMBL1074684,Inhibition of FBPase in human liver,B,CCc1nc(NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)sc1OC,CHEMBL602789,nM,260,CHEMBL3975,6.585026652,FBPase,CCc1[nH]c(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)sc1OC,CCc1[nH]c(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)sc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081854,CHEMBL1074684,Inhibition of FBPase in human liver,B,CCc1sc(NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)nc1C,CHEMBL600654,nM,410,CHEMBL3975,6.387216143,FBPase,CCc1sc(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)[nH]c1C,CCc1sc(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)[nH]c1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081856,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cc(S(=O)(=O)NC(=O)Nc2nc(C)c(C(F)(F)F)s2)sc1CCO,CHEMBL591316,nM,300,CHEMBL3975,6.522878745,FBPase,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]c(C)c(C(F)(F)F)s2)sc1CCO,Cc1cc(S(=O)(=O)NC(=O)N=c2[nH]c(C)c(C(F)(F)F)s2)sc1CCO,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081858,CHEMBL1074684,Inhibition of FBPase in human liver,B,COc1ccc(Cl)c2sc(NC(=O)NS(=O)(=O)c3cc(C)c(CCO)s3)nc12,CHEMBL591317,nM,40,CHEMBL3975,7.397940009,FBPase,COc1ccc(Cl)c2sc(=NC(=O)NS(=O)(=O)c3cc(C)c(CCO)s3)[nH]c12,COc1ccc(Cl)c2sc(=NC(=O)NS(=O)(=O)c3cc(C)c(CCO)s3)[nH]c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081860,CHEMBL1074684,Inhibition of FBPase in human liver,B,Cc1cccc(S(=O)(=O)NC(N)=O)c1,CHEMBL593391,nM,100000,CHEMBL3975,4,FBPase,Cc1cccc(S(=O)(=O)NC(N)=O)c1,Cc1cccc(S(=O)(=O)NC(N)=O)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3081861,CHEMBL1074684,Inhibition of FBPase in human liver,B,COS(=O)(=O)NC(=O)CCCCCCNC(=O)NS(C)(=O)=O,CHEMBL591318,nM,100000,CHEMBL3975,4,FBPase,COS(=O)(=O)NC(=O)CCCCCCNC(=O)NS(C)(=O)=O,COS(=O)(=O)NC(=O)CCCCCCNC(=O)NS(C)(=O)=O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096646,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,Cc1nc2c(s1)Cc1cccc(OCP(=O)(O)O)c1-2,CHEMBL603409,nM,995,CHEMBL3975,6.002176919,FBPase,Cc1nc2c(s1)Cc1cccc(OC[PH](=O)(=O)O)c1-2,Cc1nc2c(s1)Cc1cccc(OC[PH](=O)(=O)O)c1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096647,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1cccc2c1-c1nc(Cl)sc1C2,CHEMBL596870,nM,908,CHEMBL3975,6.041914151,FBPase,O=[PH](=O)(O)COc1cccc2c1-c1nc(Cl)sc1C2,O=[PH](=O)(O)COc1cccc2c1-c1nc(Cl)sc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096648,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1cccc2c1-c1nc(Br)sc1C2,CHEMBL597068,nM,772,CHEMBL3975,6.1123827,FBPase,O=[PH](=O)(O)COc1cccc2c1-c1nc(Br)sc1C2,O=[PH](=O)(O)COc1cccc2c1-c1nc(Br)sc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096649,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1cccc2c1-c1ncsc1C2,CHEMBL592390,nM,12,CHEMBL3975,7.920818754,FBPase,O=[PH](=O)(O)COc1cccc2c1-c1ncsc1C2,O=[PH](=O)(O)COc1cccc2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096650,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,Cc1ccc(OCP(=O)(O)O)c2c1Cc1scnc1-2,CHEMBL597282,nM,8,CHEMBL3975,8.096910013,FBPase,Cc1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,Cc1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096651,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,CCc1ccc(OCP(=O)(O)O)c2c1Cc1scnc1-2,CHEMBL592391,nM,11,CHEMBL3975,7.958607315,FBPase,CCc1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,CCc1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096652,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(F)c2c1-c1ncsc1C2,CHEMBL597483,nM,15,CHEMBL3975,7.823908741,FBPase,O=[PH](=O)(O)COc1ccc(F)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(F)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096653,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(Cl)c2c1-c1ncsc1C2,CHEMBL597484,nM,8,CHEMBL3975,8.096910013,FBPase,O=[PH](=O)(O)COc1ccc(Cl)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(Cl)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096654,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,Cc1cc(OCP(=O)(O)O)c2c(c1C)Cc1scnc1-2,CHEMBL609616,nM,10,CHEMBL3975,8,FBPase,Cc1cc(OC[PH](=O)(=O)O)c2c(c1C)Cc1scnc1-2,Cc1cc(OC[PH](=O)(=O)O)c2c(c1C)Cc1scnc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096655,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1cc(F)c(F)c2c1-c1ncsc1C2,CHEMBL592639,nM,9,CHEMBL3975,8.045757491,FBPase,O=[PH](=O)(O)COc1cc(F)c(F)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1cc(F)c(F)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096656,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(-c2ccccc2)c2c1-c1ncsc1C2,CHEMBL606385,nM,28,CHEMBL3975,7.552841969,FBPase,O=[PH](=O)(O)COc1ccc(-c2ccccc2)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(-c2ccccc2)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096657,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(-c2ccccn2)c2c1-c1ncsc1C2,CHEMBL603871,nM,40,CHEMBL3975,7.397940009,FBPase,O=[PH](=O)(O)COc1ccc(-c2ccccn2)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(-c2ccccn2)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096658,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(-c2cccnc2)c2c1-c1ncsc1C2,CHEMBL597691,nM,9,CHEMBL3975,8.045757491,FBPase,O=[PH](=O)(O)COc1ccc(-c2cccnc2)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(-c2cccnc2)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096659,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(-c2ccncc2)c2c1-c1ncsc1C2,CHEMBL605956,nM,9,CHEMBL3975,8.045757491,FBPase,O=[PH](=O)(O)COc1ccc(-c2ccncc2)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(-c2ccncc2)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096660,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,O=P(O)(O)COc1ccc(-c2cncnc2)c2c1-c1ncsc1C2,CHEMBL597692,nM,3,CHEMBL3975,8.522878745,FBPase,O=[PH](=O)(O)COc1ccc(-c2cncnc2)c2c1-c1ncsc1C2,O=[PH](=O)(O)COc1ccc(-c2cncnc2)c2c1-c1ncsc1C2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096661,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,NC(=O)c1ccc(OCP(=O)(O)O)c2c1Cc1scnc1-2,CHEMBL589266,nM,1,CHEMBL3975,9,FBPase,NC(=O)c1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,NC(=O)c1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3096662,CHEMBL1074153,Inhibition of human liver recombinant FBPase,B,CNC(=O)c1ccc(OCP(=O)(O)O)c2c1Cc1scnc1-2,CHEMBL597891,nM,2,CHEMBL3975,8.698970004,FBPase,CNC(=O)c1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,CNC(=O)c1ccc(OC[PH](=O)(=O)O)c2c1Cc1scnc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3268100,CHEMBL1106396,"Inhibition of human liver fructose-1,6-bisphosphatase expressed in Escherichia coli BL21 (DE3) assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase/glucose-6-phosphate dehydrogenase coupled assay",B,CC(C)CC(=O)c1c(O)cc2oc3c(C(=O)CC(C)C)c(O)cc(O)c3c2c1O,CHEMBL1097226,nM,8100,CHEMBL3975,5.091514981,FBPase,CC(C)CC(=O)c1c(O)cc2oc3c(C(=O)CC(C)C)c(O)cc(O)c3c2c1O,CC(C)CC(=O)c1c(O)cc2oc3c(C(=O)CC(C)C)c(O)cc(O)c3c2c1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3268102,CHEMBL1106396,"Inhibition of human liver fructose-1,6-bisphosphatase expressed in Escherichia coli BL21 (DE3) assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase/glucose-6-phosphate dehydrogenase coupled assay",B,CCC(C)C(=O)c1c(O)cc2oc3c(C(=O)C(C)CC)c(O)cc(O)c3c2c1O,CHEMBL1097227,nM,6000,CHEMBL3975,5.22184875,FBPase,CCC(C)C(=O)c1c(O)cc2oc3c(C(=O)C(C)CC)c(O)cc(O)c3c2c1O,CCC(C)C(=O)c1c(O)cc2oc3c(C(=O)C(C)CC)c(O)cc(O)c3c2c1O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360477,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(COc1ccc(C(N)=O)c2c1-c1ncsc1C2)N[C@@H](C)C(=O)OCC,CHEMBL1173125,nM,1,CHEMBL3975,9,FBPase,CCOC(=O)C(C)NP(=O)(COc1ccc(C(N)=O)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,CCOC(=O)C(C)NP(=O)(COc1ccc(C(N)=O)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360478,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(COc1ccc(C(=O)NC)c2c1-c1ncsc1C2)N[C@@H](C)C(=O)OCC,CHEMBL1173126,nM,2,CHEMBL3975,8.698970004,FBPase,CCOC(=O)C(C)NP(=O)(COc1ccc(C(=O)NC)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,CCOC(=O)C(C)NP(=O)(COc1ccc(C(=O)NC)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360479,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(COc1ccc(C(=O)NCC(C)(C)C)c2c1-c1ncsc1C2)N[C@@H](C)C(=O)OCC,CHEMBL1173571,nM,11,CHEMBL3975,7.958607315,FBPase,CCOC(=O)C(C)NP(=O)(COc1ccc(C(=O)NCC(C)(C)C)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,CCOC(=O)C(C)NP(=O)(COc1ccc(C(=O)NCC(C)(C)C)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360480,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(COc1ccc(C)c2c1-c1ncsc1C2)N[C@@H](C)C(=O)OCC,CHEMBL1173572,nM,8,CHEMBL3975,8.096910013,FBPase,CCOC(=O)C(C)NP(=O)(COc1ccc(C)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,CCOC(=O)C(C)NP(=O)(COc1ccc(C)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360481,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(COc1ccc(CC)c2c1-c1ncsc1C2)N[C@@H](C)C(=O)OCC,CHEMBL1173636,nM,11,CHEMBL3975,7.958607315,FBPase,CCOC(=O)C(C)NP(=O)(COc1ccc(CC)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,CCOC(=O)C(C)NP(=O)(COc1ccc(CC)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360482,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(COc1cc(C)c(C)c2c1-c1ncsc1C2)N[C@@H](C)C(=O)OCC,CHEMBL1096789,nM,10,CHEMBL3975,8,FBPase,CCOC(=O)C(C)NP(=O)(COc1cc(C)c(C)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,CCOC(=O)C(C)NP(=O)(COc1cc(C)c(C)c2c1-c1ncsc1C2)NC(C)C(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360483,CHEMBL1175836,Inhibition of human FBase,B,Cc1cc(OCP(=O)(N[C@@H](C)C(=O)OC(C)C)N[C@@H](C)C(=O)OC(C)C)c2c(c1C)Cc1scnc1-2,CHEMBL1172935,nM,10,CHEMBL3975,8,FBPase,Cc1cc(OCP(=O)(NC(C)C(=O)OC(C)C)NC(C)C(=O)OC(C)C)c2c(c1C)Cc1scnc1-2,Cc1cc(OCP(=O)(NC(C)C(=O)OC(C)C)NC(C)C(=O)OC(C)C)c2c(c1C)Cc1scnc1-2,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360484,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)CNP(=O)(COc1cc(C)c(C)c2c1-c1ncsc1C2)NCC(=O)OCC,CHEMBL1172936,nM,10,CHEMBL3975,8,FBPase,CCOC(=O)CNP(=O)(COc1cc(C)c(C)c2c1-c1ncsc1C2)NCC(=O)OCC,CCOC(=O)CNP(=O)(COc1cc(C)c(C)c2c1-c1ncsc1C2)NCC(=O)OCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3360485,CHEMBL1175836,Inhibition of human FBase,B,CCOC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OCC)c1ccc(-c2nc(N)sc2CC(C)C)o1,CHEMBL259771,nM,10,CHEMBL3975,8,FBPase,CCOC(=O)C(C)NP(=O)(NC(C)C(=O)OCC)c1ccc(-c2[nH]c(=N)sc2CC(C)C)o1,CCOC(=O)C(C)NP(=O)(NC(C)C(=O)OCC)c1ccc(-c2[nH]c(=N)sc2CC(C)C)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140921,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(-c2ccccc2)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649990,nM,13500,CHEMBL3975,4.869666232,FBPase,CC(C)Cc1sc(-c2ccccc2)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(-c2ccccc2)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140922,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(-c2cccs2)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649991,nM,8000,CHEMBL3975,5.096910013,FBPase,CC(C)Cc1sc(-c2cccs2)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(-c2cccs2)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140923,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(-c2cccnc2)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649992,nM,5000,CHEMBL3975,5.301029996,FBPase,CC(C)Cc1sc(-c2cccnc2)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(-c2cccnc2)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140924,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)cs1,CHEMBL1649993,nM,450,CHEMBL3975,6.346787486,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)cs1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)cs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140925,CHEMBL1657811,Inhibition of human liver FBP,B,Cc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649994,nM,120,CHEMBL3975,6.920818754,FBPase,Cc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,Cc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140926,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CO)s1,CHEMBL1649995,nM,500,CHEMBL3975,6.301029996,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CO)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CO)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140927,CHEMBL1657811,Inhibition of human liver FBP,B,CCCc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649996,nM,30,CHEMBL3975,7.522878745,FBPase,CCCc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCCc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140928,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)c1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649997,nM,28,CHEMBL3975,7.552841969,FBPase,CC(C)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140929,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(F)(F)F)s1,CHEMBL1650180,nM,57,CHEMBL3975,7.244125144,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(F)(F)F)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(F)(F)F)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140930,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)(C)Cc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650181,nM,12,CHEMBL3975,7.920818754,FBPase,CC(C)(C)Cc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)(C)Cc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140931,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(C2CCC2)s1,CHEMBL1650182,nM,19,CHEMBL3975,7.721246399,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C2CCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C2CCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140932,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(C2CCCC2)s1,CHEMBL1650183,nM,21,CHEMBL3975,7.677780705,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C2CCCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C2CCCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140933,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(C2CCCCC2)s1,CHEMBL1650184,nM,10,CHEMBL3975,8,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C2CCCCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C2CCCCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140934,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CC2CC2)s1,CHEMBL1650185,nM,20,CHEMBL3975,7.698970004,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140935,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CC2CCCC2)s1,CHEMBL1650186,nM,18,CHEMBL3975,7.744727495,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CCCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CCCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140936,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CC2CCCCC2)s1,CHEMBL1650187,nM,59,CHEMBL3975,7.229147988,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CCCCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CCCCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140937,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Cc2ccccc2)s1,CHEMBL1650188,nM,150,CHEMBL3975,6.823908741,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cc2ccccc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cc2ccccc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140938,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CN2CCOCC2)s1,CHEMBL1650189,nM,560,CHEMBL3975,6.251811973,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CN2CCOCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CN2CCOCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140939,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Cl)s1,CHEMBL1650190,nM,70,CHEMBL3975,7.15490196,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cl)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cl)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140940,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Br)s1,CHEMBL1650191,nM,50,CHEMBL3975,7.301029996,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Br)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Br)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140941,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(I)s1,CHEMBL1650192,nM,100,CHEMBL3975,7,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(I)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(I)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140942,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(N2CCOCC2)s1,CHEMBL1649590,nM,16,CHEMBL3975,7.795880017,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(N2CCOCC2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(N2CCOCC2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140943,CHEMBL1657811,Inhibition of human liver FBP,B,CCSc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650193,nM,33,CHEMBL3975,7.48148606,FBPase,CCSc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCSc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140944,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Sc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650194,nM,24,CHEMBL3975,7.619788758,FBPase,CC(C)Sc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)Sc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140945,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)(C)Sc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650195,nM,24,CHEMBL3975,7.619788758,FBPase,CC(C)(C)Sc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)(C)Sc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140946,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Sc2ccccc2)s1,CHEMBL1650196,nM,300,CHEMBL3975,6.522878745,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Sc2ccccc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Sc2ccccc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140947,CHEMBL1657811,Inhibition of human liver FBP,B,CN(C)C(=O)c1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650197,nM,1700,CHEMBL3975,5.769551079,FBPase,CN(C)C(=O)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CN(C)C(=O)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140948,CHEMBL1657811,Inhibition of human liver FBP,B,CCOC(=O)c1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL501816,nM,14,CHEMBL3975,7.853871964,FBPase,CCOC(=O)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCOC(=O)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140949,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(C(=O)OCc2ccccc2)s1,CHEMBL1650198,nM,15,CHEMBL3975,7.823908741,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C(=O)OCc2ccccc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C(=O)OCc2ccccc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140950,CHEMBL1657811,Inhibition of human liver FBP,B,CCC[S+]([O-])c1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650199,nM,858,CHEMBL3975,6.066512712,FBPase,CCC[S+]([O-])c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCC[S+]([O-])c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140951,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccccc2)s1,CHEMBL504104,nM,14,CHEMBL3975,7.853871964,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccccc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccccc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140952,CHEMBL1657811,Inhibition of human liver FBP,B,COc1ccccc1-c1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1650200,nM,43,CHEMBL3975,7.366531544,FBPase,COc1ccccc1-c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,COc1ccccc1-c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140953,CHEMBL1657811,Inhibition of human liver FBP,B,COc1cccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)c1,CHEMBL1650201,nM,21,CHEMBL3975,7.677780705,FBPase,COc1cccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)c1,COc1cccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140954,CHEMBL1657811,Inhibition of human liver FBP,B,COc1ccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)cc1,CHEMBL1650178,nM,22,CHEMBL3975,7.657577319,FBPase,COc1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,COc1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140955,CHEMBL1657811,Inhibition of human liver FBP,B,CSc1ccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)cc1,CHEMBL1650179,nM,21,CHEMBL3975,7.677780705,FBPase,CSc1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,CSc1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140956,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)(C)c1ccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)cc1,CHEMBL1650202,nM,88,CHEMBL3975,7.055517328,FBPase,CC(C)(C)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,CC(C)(C)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140957,CHEMBL1657811,Inhibition of human liver FBP,B,COC(=O)c1ccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)cc1,CHEMBL1650203,nM,14,CHEMBL3975,7.853871964,FBPase,COC(=O)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,COC(=O)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140958,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccc(F)cc2)s1,CHEMBL1650204,nM,16,CHEMBL3975,7.795880017,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc(F)cc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc(F)cc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140959,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccc(Cl)cc2)s1,CHEMBL1650205,nM,13,CHEMBL3975,7.886056648,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc(Cl)cc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc(Cl)cc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140960,CHEMBL1657811,Inhibition of human liver FBP,B,CC(=O)c1ccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)cc1,CHEMBL1650206,nM,32,CHEMBL3975,7.494850022,FBPase,CC(=O)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,CC(=O)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140961,CHEMBL1657811,Inhibition of human liver FBP,B,CS(=O)(=O)c1ccc(-c2sc(N)nc2-c2ccc(P(=O)(O)O)o2)cc1,CHEMBL1650207,nM,41,CHEMBL3975,7.387216143,FBPase,CS(=O)(=O)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,CS(=O)(=O)c1ccc(-c2sc(=N)[nH]c2-c2ccc([PH](=O)(=O)O)o2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140962,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccc(-c3ccccc3)cc2)s1,CHEMBL1650208,nM,34,CHEMBL3975,7.468521083,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc(-c3ccccc3)cc2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc(-c3ccccc3)cc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140963,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccc3ccccc3c2)s1,CHEMBL1650209,nM,12,CHEMBL3975,7.920818754,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc3ccccc3c2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccc3ccccc3c2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140964,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccco2)s1,CHEMBL1650210,nM,40,CHEMBL3975,7.397940009,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccco2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccco2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140965,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2cccs2)s1,CHEMBL1650211,nM,44,CHEMBL3975,7.356547324,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2cccs2)s1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2cccs2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140966,CHEMBL1657811,Inhibition of human liver FBP,B,CCCc1sc(N)nc1-c1ccc(P(=O)(O)O)s1,CHEMBL1650212,nM,10000,CHEMBL3975,5,FBPase,CCCc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)s1,CCCc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140967,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-n2ccc(P(=O)(O)O)c2)c(-c2ccccc2)s1,CHEMBL1650213,nM,10000,CHEMBL3975,5,FBPase,N=c1[nH]c(-n2ccc([PH](=O)(=O)O)c2)c(-c2ccccc2)s1,N=c1[nH]c(-n2ccc([PH](=O)(=O)O)c2)c(-c2ccccc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140968,CHEMBL1657811,Inhibition of human liver FBP,B,Cc1oc(-c2nc(N)sc2-c2ccccc2)nc1P(=O)(O)O,CHEMBL1650214,nM,10000,CHEMBL3975,5,FBPase,Cc1oc(-c2[nH]c(=N)sc2-c2ccccc2)nc1[PH](=O)(=O)O,Cc1oc(-c2[nH]c(=N)sc2-c2ccccc2)nc1[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140969,CHEMBL1657811,Inhibition of human liver FBP,B,CCCc1sc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL1650215,nM,50,CHEMBL3975,7.301029996,FBPase,CCCc1sc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,CCCc1sc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140970,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(C(=O)NCP(=O)(O)O)c(-c2cccs2)s1,CHEMBL1650216,nM,950,CHEMBL3975,6.022276395,FBPase,N=c1[nH]c(C(=O)NC[PH](=O)(=O)O)c(-c2cccs2)s1,N=c1[nH]c(C(=O)NC[PH](=O)(=O)O)c(-c2cccs2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140971,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2cccc(P(=O)(O)O)n2)cs1,CHEMBL1650217,nM,2000,CHEMBL3975,5.698970004,FBPase,N=c1[nH]c(-c2cccc([PH](=O)(=O)O)n2)cs1,N=c1[nH]c(-c2cccc([PH](=O)(=O)O)n2)cs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140972,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2cccc(P(=O)(O)O)c2)cs1,CHEMBL1650218,nM,1300,CHEMBL3975,5.886056648,FBPase,N=c1[nH]c(-c2cccc([PH](=O)(=O)O)c2)cs1,N=c1[nH]c(-c2cccc([PH](=O)(=O)O)c2)cs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140973,CHEMBL1657811,Inhibition of human liver FBP,B,CCCc1sc(N)nc1-c1cccc(P(=O)(O)O)c1,CHEMBL1650219,nM,250,CHEMBL3975,6.602059991,FBPase,CCCc1sc(=N)[nH]c1-c1cccc([PH](=O)(=O)O)c1,CCCc1sc(=N)[nH]c1-c1cccc([PH](=O)(=O)O)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140974,CHEMBL1657811,Inhibition of human liver FBP,B,CCCc1sc(N)nc1-c1cc(P(=O)(O)O)ccc1C,CHEMBL1650220,nM,135,CHEMBL3975,6.869666232,FBPase,CCCc1sc(=N)[nH]c1-c1cc([PH](=O)(=O)O)ccc1C,CCCc1sc(=N)[nH]c1-c1cc([PH](=O)(=O)O)ccc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140975,CHEMBL1657811,Inhibition of human liver FBP,B,COc1ccc(P(=O)(O)O)cc1-c1nc(N)sc1C(C)C,CHEMBL1650221,nM,210,CHEMBL3975,6.677780705,FBPase,COc1ccc([PH](=O)(=O)O)cc1-c1[nH]c(=N)sc1C(C)C,COc1ccc([PH](=O)(=O)O)cc1-c1[nH]c(=N)sc1C(C)C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5140976,CHEMBL1657811,Inhibition of human liver FBP,B,Nc1nc(-c2cc(P(=O)(O)O)ccc2F)c(-c2ccccc2)s1,CHEMBL1650222,nM,80,CHEMBL3975,7.096910013,FBPase,N=c1[nH]c(-c2cc([PH](=O)(=O)O)ccc2F)c(-c2ccccc2)s1,N=c1[nH]c(-c2cc([PH](=O)(=O)O)ccc2F)c(-c2ccccc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5141078,CHEMBL1657811,Inhibition of human liver FBP,B,CCCSc1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL509861,nM,16,CHEMBL3975,7.795880017,FBPase,CCCSc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCCSc1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161987,CHEMBL1657811,Inhibition of human liver FBP,B,Cc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)s1,CHEMBL1649977,nM,100,CHEMBL3975,7,FBPase,Cc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,Cc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161988,CHEMBL1657811,Inhibition of human liver FBP,B,CCc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)s1,CHEMBL1649978,nM,400,CHEMBL3975,6.397940009,FBPase,CCc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,CCc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161989,CHEMBL1657811,Inhibition of human liver FBP,B,C=Cc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)s1,CHEMBL1649979,nM,1200,CHEMBL3975,5.920818754,FBPase,C=Cc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,C=Cc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161990,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(CO)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649980,nM,220,CHEMBL3975,6.657577319,FBPase,CC(C)Cc1sc(CO)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(CO)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161991,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1scnc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649981,nM,500,CHEMBL3975,6.301029996,FBPase,CC(C)Cc1scnc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1scnc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161992,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(Cl)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649982,nM,180,CHEMBL3975,6.744727495,FBPase,CC(C)Cc1sc(Cl)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(Cl)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161993,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(Br)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649983,nM,80,CHEMBL3975,7.096910013,FBPase,CC(C)Cc1sc(Br)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(Br)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161994,CHEMBL1657811,Inhibition of human liver FBP,B,CSc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)s1,CHEMBL1649984,nM,890,CHEMBL3975,6.050609993,FBPase,CSc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,CSc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161995,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(C#N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649985,nM,2000,CHEMBL3975,5.698970004,FBPase,CC(C)Cc1sc(C#N)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(C#N)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161996,CHEMBL1657811,Inhibition of human liver FBP,B,CNc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)s1,CHEMBL1649986,nM,1000,CHEMBL3975,6,FBPase,CN=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,CN=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161997,CHEMBL1657811,Inhibition of human liver FBP,B,CC(=O)Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)s1,CHEMBL1649987,nM,10000,CHEMBL3975,5,FBPase,CC(=O)N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,CC(=O)N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161998,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(C(N)=O)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649988,nM,2750,CHEMBL3975,5.560667306,FBPase,CC(C)Cc1sc(C(N)=O)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(C(N)=O)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
5161999,CHEMBL1657811,Inhibition of human liver FBP,B,CC(C)Cc1sc(C(N)=S)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL1649989,nM,500,CHEMBL3975,6.301029996,FBPase,CC(C)Cc1sc(C(N)=S)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1sc(C(N)=S)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200646,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(Nc1cc(Cl)cc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL1778441,nM,640,CHEMBL3975,6.193820026,FBPase,O=C(Nc1cc(Cl)cc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,O=C(Nc1cc(Cl)cc(Cl)c1)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200647,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(Nc1cc(Br)cc2[nH]ccc12)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL1778442,nM,350,CHEMBL3975,6.455931956,FBPase,O=C(Nc1cc(Br)cc2[nH]ccc12)NS(=O)(=O)c1cccc(Cl)c1,O=C(Nc1cc(Br)cc2[nH]ccc12)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200648,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,O=C(Nc1cc(Br)cc2[nH]ncc12)NS(=O)(=O)c1cccc(Cl)c1,CHEMBL1778443,nM,330,CHEMBL3975,6.48148606,FBPase,O=C(Nc1cc(Br)cc2[nH]ncc12)NS(=O)(=O)c1cccc(Cl)c1,O=C(Nc1cc(Br)cc2[nH]ncc12)NS(=O)(=O)c1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200649,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cccc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3[nH]ncc23)c1,CHEMBL1778444,nM,290,CHEMBL3975,6.537602002,FBPase,Cc1cccc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3[nH]ncc23)c1,Cc1cccc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3[nH]ncc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200650,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3[nH]ncc23)cc1C,CHEMBL1778445,nM,140,CHEMBL3975,6.853871964,FBPase,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3[nH]ncc23)cc1C,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3[nH]ncc23)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200651,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(Br)cc3nccn23)cc1C,CHEMBL1778446,nM,820,CHEMBL3975,6.086186148,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(Br)cc3[nH]ccn23)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(Br)cc3[nH]ccn23)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200652,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,CNC(=O)Nc1cc(Br)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)n1,CHEMBL1778447,nM,80,CHEMBL3975,7.096910013,FBPase,CNC(=O)N=c1cc(Br)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)[nH]1,CNC(=O)N=c1cc(Br)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200653,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,CNC(=O)Nc1cc(SC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)n1,CHEMBL1778448,nM,170,CHEMBL3975,6.769551079,FBPase,CNC(=O)N=c1cc(SC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)[nH]1,CNC(=O)N=c1cc(SC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200654,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,CNC(=O)Nc1cc(OC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)n1,CHEMBL1738935,nM,220,CHEMBL3975,6.657577319,FBPase,CNC(=O)N=c1cc(OC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)[nH]1,CNC(=O)N=c1cc(OC)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCOC)s2)[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200655,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(Br)cc(N)n2)cc1C,CHEMBL1778449,nM,130,CHEMBL3975,6.886056648,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(Br)cc(N)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(Br)cc(N)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200656,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(Br)cc(NCC(F)(F)F)n2)cc1C,CHEMBL1778450,nM,200,CHEMBL3975,6.698970004,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(Br)cc(NCC(F)(F)F)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(Br)cc(NCC(F)(F)F)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200657,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(SC)cc(N)n2)cc1C,CHEMBL1778451,nM,1800,CHEMBL3975,5.744727495,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(SC)cc(N)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(SC)cc(N)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200658,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(OC)cc(N)n2)cc1C,CHEMBL1778452,nM,400,CHEMBL3975,6.397940009,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(OC)cc(N)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(OC)cc(N)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200659,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)cc(N)n2)cc1C,CHEMBL1778453,nM,760,CHEMBL3975,6.119186408,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc(N)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc(N)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200660,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)c(F)c(N)n2)cc1C,CHEMBL1778454,nM,600,CHEMBL3975,6.22184875,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)c(F)c(N)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)c(F)c(N)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200661,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)c(F)c(N)n2)sc1CCO,CHEMBL1778555,nM,420,CHEMBL3975,6.37675071,FBPase,Cc1cc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)c(F)c(N)[nH]2)sc1CCO,Cc1cc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)c(F)c(N)[nH]2)sc1CCO,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200662,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,CC(=O)OCCc1sc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)c(F)c(N)n2)cc1C,CHEMBL1778556,nM,670,CHEMBL3975,6.173925197,FBPase,CC(=O)OCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)c(F)c(N)[nH]2)cc1C,CC(=O)OCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)c(F)c(N)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200663,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)cc(C)n2)cc1C,CHEMBL1778557,nM,530,CHEMBL3975,6.27572413,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc(C)[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc(C)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200664,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,Cc1cc(C(F)(F)F)cc(NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)n1,CHEMBL1778558,nM,350,CHEMBL3975,6.455931956,FBPase,Cc1cc(C(F)(F)F)cc(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)[nH]1,Cc1cc(C(F)(F)F)cc(=NC(=O)NS(=O)(=O)c2cc(C)c(CCO)s2)[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200665,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,CC(=O)OCCc1sc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)cc(C)n2)cc1C,CHEMBL1778559,nM,520,CHEMBL3975,6.283996656,FBPase,CC(=O)OCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc(C)[nH]2)cc1C,CC(=O)OCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc(C)[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
6200666,CHEMBL1781851,"Inhibition of human liver fructose-1,6-bisphosphatase",B,COCCc1sc(S(=O)(=O)NC(=O)Nc2cc(C(F)(F)F)ccn2)cc1C,CHEMBL1778560,nM,1700,CHEMBL3975,5.769551079,FBPase,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc[nH]2)cc1C,COCCc1sc(S(=O)(=O)NC(=O)N=c2cc(C(F)(F)F)cc[nH]2)cc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955147,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12,CHEMBL31344,nM,2000,CHEMBL3975,5.698970004,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12,O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955148,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(CC(C)C)cc12,CHEMBL3127628,nM,990,CHEMBL3975,6.004364805,FBPase,CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(CC(C)C)cc12,CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(CC(C)C)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955149,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1cccc(Nc2cc([N+](=O)[O-])c3[nH]c(C(=O)O)cc3c2)c1,CHEMBL3127749,nM,4060,CHEMBL3975,5.391473966,FBPase,COc1cccc(Nc2cc([N+](=O)[O-])c3[nH]c(C(=O)O)cc3c2)c1,COc1cccc(Nc2cc([N+](=O)[O-])c3[nH]c(C(=O)O)cc3c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955150,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(=O)Nc1cccc(-c2cc([N+](=O)[O-])c3[nH]c(C(=O)O)cc3c2)c1,CHEMBL3127748,nM,3700,CHEMBL3975,5.431798276,FBPase,CC(=O)Nc1cccc(-c2cc([N+](=O)[O-])c3[nH]c(C(=O)O)cc3c2)c1,CC(=O)Nc1cccc(-c2cc([N+](=O)[O-])c3[nH]c(C(=O)O)cc3c2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955151,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(C)Cc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)cc2c1,CHEMBL3127747,nM,5400,CHEMBL3975,5.26760624,FBPase,CC(C)Cc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)cc2c1,CC(C)Cc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)cc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955152,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(C)Cc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,CHEMBL3127746,nM,9700,CHEMBL3975,5.013228266,FBPase,CC(C)Cc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,CC(C)Cc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13955153,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(=O)Nc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127744,nM,18500,CHEMBL3975,4.732828272,FBPase,CC(=O)Nc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CC(=O)Nc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956324,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,Cc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127641,nM,25900,CHEMBL3975,4.586700236,FBPase,Cc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,Cc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956325,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,Cc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,CHEMBL3127630,nM,33900,CHEMBL3975,4.469800302,FBPase,Cc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,Cc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956326,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,Cc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127629,nM,4300,CHEMBL3975,5.366531544,FBPase,Cc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,Cc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956327,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3ccc([N+](=O)[O-])cc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127767,nM,3400,CHEMBL3975,5.468521083,FBPase,O=C(O)c1cc2c(Nc3ccc([N+](=O)[O-])cc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3ccc([N+](=O)[O-])cc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956328,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3ccc(C(F)(F)F)cc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127763,nM,12200,CHEMBL3975,4.913640169,FBPase,O=C(O)c1cc2c(Nc3ccc(C(F)(F)F)cc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3ccc(C(F)(F)F)cc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956329,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3cccc(C(F)(F)F)c3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127762,nM,29100,CHEMBL3975,4.536107011,FBPase,O=C(O)c1cc2c(Nc3cccc(C(F)(F)F)c3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3cccc(C(F)(F)F)c3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956330,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1OC,CHEMBL3127760,nM,7700,CHEMBL3975,5.113509275,FBPase,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1OC,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956331,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127758,nM,25600,CHEMBL3975,4.591760035,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956332,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,Nc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127745,nM,50000,CHEMBL3975,4.301029996,FBPase,Nc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,Nc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956333,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(-c3ccc(C(F)(F)F)cc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127743,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(-c3ccc(C(F)(F)F)cc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(-c3ccc(C(F)(F)F)cc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956334,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(-c3cccc(C(F)(F)F)c3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127642,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(-c3cccc(C(F)(F)F)c3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(-c3cccc(C(F)(F)F)c3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956335,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,N#Cc1ccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,CHEMBL3127640,nM,50000,CHEMBL3975,4.301029996,FBPase,N#Cc1ccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,N#Cc1ccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956336,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,N#Cc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127639,nM,50000,CHEMBL3975,4.301029996,FBPase,N#Cc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,N#Cc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956337,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(-c3ccc(Cl)cc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127638,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(-c3ccc(Cl)cc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(-c3ccc(Cl)cc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956338,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(-c3cccc(Cl)c3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127637,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(-c3cccc(Cl)c3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(-c3cccc(Cl)c3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956339,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127636,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,COc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956340,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(-c3ccccc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127635,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(-c3ccccc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(-c3ccccc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956341,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CCCN(c1cccc(OC)c1)c1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,CHEMBL3127634,nM,50000,CHEMBL3975,4.301029996,FBPase,CCCN(c1cccc(OC)c1)c1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,CCCN(c1cccc(OC)c1)c1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956342,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1cccc(N(C)c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127633,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1cccc(N(C)c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,COc1cccc(N(C)c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956343,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,Nc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127632,nM,50000,CHEMBL3975,4.301029996,FBPase,Nc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,Nc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956344,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(=O)Nc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CHEMBL3127631,nM,50000,CHEMBL3975,4.301029996,FBPase,CC(=O)Nc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,CC(=O)Nc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956345,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3cccc([N+](=O)[O-])c3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127766,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(Nc3cccc([N+](=O)[O-])c3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3cccc([N+](=O)[O-])c3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956346,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3ccc(Cl)cc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127765,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(Nc3ccc(Cl)cc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3ccc(Cl)cc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956347,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3cccc(Cl)c3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127764,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(Nc3cccc(Cl)c3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3cccc(Cl)c3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956348,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1cc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc(OC)c1OC,CHEMBL3127761,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1cc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc(OC)c1OC,COc1cc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc(OC)c1OC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956349,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,CHEMBL3127759,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)cc23)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956350,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1ccccc1Nc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,CHEMBL3127757,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1ccccc1Nc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,COc1ccccc1Nc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956351,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1cc2c(Nc3ccccc3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL3127756,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)c1cc2c(Nc3ccccc3)ccc([N+](=O)[O-])c2[nH]1,O=C(O)c1cc2c(Nc3ccccc3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956352,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1[nH]c2c([N+](=O)[O-])cccc2c1-c1cccc(F)c1,CHEMBL3127755,nM,4500,CHEMBL3975,5.346787486,FBPase,O=C(O)c1[nH]c2c([N+](=O)[O-])cccc2c1-c1cccc(F)c1,O=C(O)c1[nH]c2c([N+](=O)[O-])cccc2c1-c1cccc(F)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956353,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(=O)Nc1cccc(-c2c(C(=O)O)[nH]c3c([N+](=O)[O-])cccc23)c1,CHEMBL3127754,nM,7400,CHEMBL3975,5.13076828,FBPase,CC(=O)Nc1cccc(-c2c(C(=O)O)[nH]c3c([N+](=O)[O-])cccc23)c1,CC(=O)Nc1cccc(-c2c(C(=O)O)[nH]c3c([N+](=O)[O-])cccc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956354,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,COc1cccc(-c2c(C(=O)O)[nH]c3c([N+](=O)[O-])cccc23)c1,CHEMBL3127753,nM,35600,CHEMBL3975,4.448550002,FBPase,COc1cccc(-c2c(C(=O)O)[nH]c3c([N+](=O)[O-])cccc23)c1,COc1cccc(-c2c(C(=O)O)[nH]c3c([N+](=O)[O-])cccc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956355,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,O=C(O)c1[nH]c2c([N+](=O)[O-])cccc2c1-c1ccccc1,CHEMBL3127752,nM,12700,CHEMBL3975,4.896196279,FBPase,O=C(O)c1[nH]c2c([N+](=O)[O-])cccc2c1-c1ccccc1,O=C(O)c1[nH]c2c([N+](=O)[O-])cccc2c1-c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956356,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CC(C)Cc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,CHEMBL3127751,nM,10300,CHEMBL3975,4.987162775,FBPase,CC(C)Cc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,CC(C)Cc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
13956357,CHEMBL3131191,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,B,CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,CHEMBL3127750,nM,6200,CHEMBL3975,5.207608311,FBPase,CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537902,CHEMBL3225162,Inhibition of human liver FBPase,B,CCc1oc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL3218449,nM,380,CHEMBL3975,6.420216403,FBPase,CCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,CCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537903,CHEMBL3225162,Inhibition of human liver FBPase,B,Cc1oc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL3218448,nM,420,CHEMBL3975,6.37675071,FBPase,Cc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,Cc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537904,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)c1oc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL3218451,nM,580,CHEMBL3975,6.236572006,FBPase,CC(C)c1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,CC(C)c1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537905,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(C(=O)OCc2ccccc2)o1,CHEMBL3218437,nM,85,CHEMBL3975,7.070581074,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C(=O)OCc2ccccc2)o1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(C(=O)OCc2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537906,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)Sc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218220,nM,110,CHEMBL3975,6.958607315,FBPase,CC(C)Sc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)Sc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537907,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)Cc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218216,nM,120,CHEMBL3975,6.920818754,FBPase,CC(C)Cc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537908,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)(C)Sc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218221,nM,120,CHEMBL3975,6.920818754,FBPase,CC(C)(C)Sc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)(C)Sc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537909,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)Cc1oc(C(C)C)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218442,nM,2200,CHEMBL3975,5.657577319,FBPase,CC(C)Cc1oc(C(C)C)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1oc(C(C)C)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537910,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)Cc1ocnc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218440,nM,1900,CHEMBL3975,5.721246399,FBPase,CC(C)Cc1ocnc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1ocnc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537912,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)(C)C(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218209,nM,855,CHEMBL3975,6.068033885,FBPase,CC(C)(C)C(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)(C)C(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537914,CHEMBL3225162,Inhibition of human liver FBPase,B,CCCc1oc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL3218450,nM,280,CHEMBL3975,6.552841969,FBPase,CCCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,CCCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537915,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(CC2CCCCC2)o1,CHEMBL3218212,nM,320,CHEMBL3975,6.494850022,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CCCCC2)o1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC2CCCCC2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537916,CHEMBL3225162,Inhibition of human liver FBPase,B,CCCCCc1oc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL3218453,nM,350,CHEMBL3975,6.455931956,FBPase,CCCCCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,CCCCCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537917,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)Cc1oc(N(C)C)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218441,nM,2100,CHEMBL3975,5.677780705,FBPase,CC(C)Cc1oc(N(C)C)nc1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1oc(N(C)C)nc1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537921,CHEMBL3225162,Inhibition of human liver FBPase,B,CNC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218208,nM,1000,CHEMBL3975,6,FBPase,CNC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CNC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537923,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)OC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218436,nM,40,CHEMBL3975,7.397940009,FBPase,CC(C)OC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)OC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537924,CHEMBL3225162,Inhibition of human liver FBPase,B,COC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218223,nM,67,CHEMBL3975,7.173925197,FBPase,COC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,COC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537925,CHEMBL3225162,Inhibition of human liver FBPase,B,CCCSc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218222,nM,70,CHEMBL3975,7.15490196,FBPase,CCCSc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCCSc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537927,CHEMBL3225162,Inhibition of human liver FBPase,B,C=CCc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218218,nM,140,CHEMBL3975,6.853871964,FBPase,C=CCc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,C=CCc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537928,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(-c2ccccc2)o1,CHEMBL3218213,nM,160,CHEMBL3975,6.795880017,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccccc2)o1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(-c2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537929,CHEMBL3225162,Inhibition of human liver FBPase,B,CCCCc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218219,nM,170,CHEMBL3975,6.769551079,FBPase,CCCCc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCCCc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537930,CHEMBL3225162,Inhibition of human liver FBPase,B,CCCCCc1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218211,nM,210,CHEMBL3975,6.677780705,FBPase,CCCCCc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCCCCc1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537931,CHEMBL3225162,Inhibition of human liver FBPase,B,CCCCc1oc(N)nc1C(=O)OCP(=O)(O)O,CHEMBL3218452,nM,250,CHEMBL3975,6.602059991,FBPase,CCCCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,CCCCc1oc(=N)[nH]c1C(=O)OC[PH](=O)(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537932,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Cc2cccs2)o1,CHEMBL3218215,nM,260,CHEMBL3975,6.585026652,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cc2cccs2)o1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cc2cccs2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537933,CHEMBL3225162,Inhibition of human liver FBPase,B,CCc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)o1,CHEMBL3218444,nM,950,CHEMBL3975,6.022276395,FBPase,CCc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,CCc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537934,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Cc2ccccc2)o1,CHEMBL3218214,nM,900,CHEMBL3975,6.045757491,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cc2ccccc2)o1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Cc2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537935,CHEMBL3225162,Inhibition of human liver FBPase,B,Cc1nc(CC(C)C)c(-c2ccc(P(=O)(O)O)o2)o1,CHEMBL3218438,nM,600,CHEMBL3975,6.22184875,FBPase,Cc1nc(CC(C)C)c(-c2ccc([PH](=O)(=O)O)o2)o1,Cc1nc(CC(C)C)c(-c2ccc([PH](=O)(=O)O)o2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537938,CHEMBL3225162,Inhibition of human liver FBPase,B,CCSC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218207,nM,30,CHEMBL3975,7.522878745,FBPase,CCSC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCSC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537939,CHEMBL3225162,Inhibition of human liver FBPase,B,CCOC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218224,nM,38,CHEMBL3975,7.420216403,FBPase,CCOC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CCOC(=O)c1oc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537947,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Sc2ccccc2)o1,CHEMBL3217761,nM,4000,CHEMBL3975,5.397940009,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Sc2ccccc2)o1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(Sc2ccccc2)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537948,CHEMBL3225162,Inhibition of human liver FBPase,B,CNc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)o1,CHEMBL3218443,nM,4300,CHEMBL3975,5.366531544,FBPase,CN=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,CN=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537950,CHEMBL3225162,Inhibition of human liver FBPase,B,Cc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)o1,CHEMBL3218210,nM,6000,CHEMBL3975,5.22184875,FBPase,Cc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,Cc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537951,CHEMBL3225162,Inhibition of human liver FBPase,B,C=CNc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)o1,CHEMBL3218446,nM,6700,CHEMBL3975,5.173925197,FBPase,CC=Nc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,CC=Nc1nc(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537952,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(C(=O)OCP(=O)(O)O)co1,CHEMBL3218447,nM,7000,CHEMBL3975,5.15490196,FBPase,N=c1[nH]c(C(=O)OC[PH](=O)(=O)O)co1,N=c1[nH]c(C(=O)OC[PH](=O)(=O)O)co1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537956,CHEMBL3225162,Inhibition of human liver FBPase,B,Nc1nc(-c2ccc(P(=O)(O)O)o2)co1,CHEMBL3218217,nM,10000,CHEMBL3975,5,FBPase,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)co1,N=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)co1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537957,CHEMBL3225162,Inhibition of human liver FBPase,B,CC(C)Cc1oc(O)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL3218439,nM,10000,CHEMBL3975,5,FBPase,CC(C)Cc1oc(=O)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)Cc1oc(=O)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537958,CHEMBL3225162,Inhibition of human liver FBPase,B,CCNc1nc(-c2ccc(P(=O)(O)O)o2)c(CC(C)C)o1,CHEMBL3218445,nM,10000,CHEMBL3975,5,FBPase,CCN=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,CCN=c1[nH]c(-c2ccc([PH](=O)(=O)O)o2)c(CC(C)C)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537959,CHEMBL3225162,Inhibition of human liver FBPase,B,Cc1nc(C(=O)OCP(=O)(O)O)c(C(F)(F)F)o1,CHEMBL3218454,nM,10000,CHEMBL3975,5,FBPase,Cc1nc(C(=O)OC[PH](=O)(=O)O)c(C(F)(F)F)o1,Cc1nc(C(=O)OC[PH](=O)(=O)O)c(C(F)(F)F)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
14537960,CHEMBL3225162,Inhibition of human liver FBPase,B,O=C(OCP(=O)(O)O)c1ncoc1-c1ccccc1,CHEMBL3218455,nM,10000,CHEMBL3975,5,FBPase,O=C(OC[PH](=O)(=O)O)c1ncoc1-c1ccccc1,O=C(OC[PH](=O)(=O)O)c1ncoc1-c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148226,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Nc3ccccc3)cc12,CHEMBL3393957,nM,1600,CHEMBL3975,5.795880017,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Nc3ccccc3)cc12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Nc3ccccc3)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148227,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,CCc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c2c1,CHEMBL3393956,nM,100,CHEMBL3975,7,FBPase,CCc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c2c1,CCc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148228,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,CC(C)Cc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c2c1,CHEMBL3393955,nM,450,CHEMBL3975,6.346787486,FBPase,CC(C)Cc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c2c1,CC(C)Cc1cc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148229,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(-c3ccccc3)cc12,CHEMBL3393954,nM,6430,CHEMBL3975,5.191789027,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(-c3ccccc3)cc12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(-c3ccccc3)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148230,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)cc1,CHEMBL3393953,nM,1700,CHEMBL3975,5.769551079,FBPase,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)cc1,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148231,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)c1,CHEMBL3393952,nM,1310,CHEMBL3975,5.882728704,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148232,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(Nc3ccccc3)c12,CHEMBL3393951,nM,690,CHEMBL3975,6.161150909,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(Nc3ccccc3)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(Nc3ccccc3)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148233,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,CC(C)Cc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c12,CHEMBL3393950,nM,690,CHEMBL3975,6.161150909,FBPase,CC(C)Cc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c12,CC(C)Cc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148234,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,CCc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c12,CHEMBL3393949,nM,2760,CHEMBL3975,5.559090918,FBPase,CCc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c12,CCc1ccc([N+](=O)[O-])c2[nH]c(C(=O)O)c(CCC(=O)O)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148235,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccc([N+](=O)[O-])cc3)c12,CHEMBL3393948,nM,2000,CHEMBL3975,5.698970004,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccc([N+](=O)[O-])cc3)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccc([N+](=O)[O-])cc3)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148236,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3cccc([N+](=O)[O-])c3)c12,CHEMBL3393947,nM,1100,CHEMBL3975,5.958607315,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3cccc([N+](=O)[O-])c3)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3cccc([N+](=O)[O-])c3)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148237,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,COc1ccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)cc1,CHEMBL3393946,nM,1800,CHEMBL3975,5.744727495,FBPase,COc1ccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)cc1,COc1ccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148238,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,COc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)c1,CHEMBL3393945,nM,5220,CHEMBL3975,5.282329497,FBPase,COc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)c1,COc1cccc(-c2ccc([N+](=O)[O-])c3[nH]c(C(=O)O)c(CCC(=O)O)c23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148239,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccc(F)cc3)c12,CHEMBL3393944,nM,2400,CHEMBL3975,5.619788758,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccc(F)cc3)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccc(F)cc3)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148240,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3cccc(F)c3)c12,CHEMBL3393943,nM,5270,CHEMBL3975,5.278189385,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3cccc(F)c3)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3cccc(F)c3)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148241,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccccc3F)c12,CHEMBL3393942,nM,2400,CHEMBL3975,5.619788758,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccccc3F)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccccc3F)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148242,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccccc3)c12,CHEMBL3393941,nM,1400,CHEMBL3975,5.853871964,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccccc3)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(-c3ccccc3)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148243,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)n(Cc2ccccc2)c2c([N+](=O)[O-])cccc12,CHEMBL3393940,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)CCc1c(C(=O)O)n(Cc2ccccc2)c2c([N+](=O)[O-])cccc12,O=C(O)CCc1c(C(=O)O)n(Cc2ccccc2)c2c([N+](=O)[O-])cccc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148244,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)n(CC2CC2)c2c([N+](=O)[O-])cccc12,CHEMBL3393939,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)CCc1c(C(=O)O)n(CC2CC2)c2c([N+](=O)[O-])cccc12,O=C(O)CCc1c(C(=O)O)n(CC2CC2)c2c([N+](=O)[O-])cccc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148245,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,Nc1cccc2c(CCC(=O)O)c(C(=O)O)[nH]c12,CHEMBL3393938,nM,50000,CHEMBL3975,4.301029996,FBPase,Nc1cccc2c(CCC(=O)O)c(C(=O)O)[nH]c12,Nc1cccc2c(CCC(=O)O)c(C(=O)O)[nH]c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148246,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cccc2c1CCC(=O)O,CHEMBL3393937,nM,50000,CHEMBL3975,4.301029996,FBPase,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cccc2c1CCC(=O)O,CCOC(=O)c1[nH]c2c([N+](=O)[O-])cccc2c1CCC(=O)O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148247,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Br)cc12,CHEMBL3393936,nM,1290,CHEMBL3975,5.88941029,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Br)cc12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Br)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148248,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Cl)cc12,CHEMBL3393935,nM,2070,CHEMBL3975,5.684029655,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Cl)cc12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cc(Cl)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148249,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(Cl)c12,CHEMBL3393934,nM,880,CHEMBL3975,6.055517328,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(Cl)c12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])ccc(Cl)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148250,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,CHEMBL3393933,nM,5170,CHEMBL3975,5.286509457,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,O=C(O)CCc1c(C(=O)O)[nH]c2c([N+](=O)[O-])cccc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
15148252,CHEMBL3395429,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) Rosetta cells assessed as reduction of NADP+ to NADPH by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupling based spectrophotometry,B,O=C(O)CCc1c(C(=O)O)[nH]c2ccc([N+](=O)[O-])cc12,CHEMBL1950316,nM,50000,CHEMBL3975,4.301029996,FBPase,O=C(O)CCc1c(C(=O)O)[nH]c2ccc([N+](=O)[O-])cc12,O=C(O)CCc1c(C(=O)O)[nH]c2ccc([N+](=O)[O-])cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
18891764,CHEMBL4314376,Inhibition of human FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based spectrophotometry,B,CCCCCCCC/C=C(\CCCCCCCC(=O)O)[N+](=O)[O-],CHEMBL550762,nM,58000,CHEMBL3975,4.236572006,FBPase,CCCCCCCC/C=C(\CCCCCCCC(=O)O)[N+](=O)[O-],CCCCCCCCC=C(CCCCCCCC(=O)O)[N+](=O)[O-],"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
18891766,CHEMBL4314376,Inhibition of human FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based spectrophotometry,B,CCOC(=O)C(C)(C)Oc1ccc(Br)c(/C=C(\Cl)[N+](=O)[O-])c1,CHEMBL4454098,nM,840,CHEMBL3975,6.075720714,FBPase,CCOC(=O)C(C)(C)Oc1ccc(Br)c(/C=C(\Cl)[N+](=O)[O-])c1,CCOC(=O)C(C)(C)Oc1ccc(Br)c(C=C(Cl)[N+](=O)[O-])c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20649105,CHEMBL4615180,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based assay,B,CCN(CC)C(=S)SSC(=S)N(CC)CC,CHEMBL964,nM,1500,CHEMBL3975,5.823908741,FBPase,CCN(CC)C(=S)SSC(=S)N(CC)CC,CCN(CC)C(=S)SSC(=S)N(CC)CC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20649106,CHEMBL4615180,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based assay,B,Clc1ccc(SSc2nccs2)cc1,CHEMBL4127849,nM,540,CHEMBL3975,6.26760624,FBPase,Clc1ccc(SSc2nccs2)cc1,Clc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20649107,CHEMBL4615180,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based assay,B,CCSSc1nc2ccccc2s1,CHEMBL4635138,nM,1600,CHEMBL3975,5.795880017,FBPase,CCSSc1nc2ccccc2s1,CCSSc1nc2ccccc2s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20713201,CHEMBL4629676,Inhibition of human liver FBP1 incubated for 5 mins by fluorescence method,B,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,CHEMBL8260,nM,29000,CHEMBL3975,4.537602002,FBPase,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20713202,CHEMBL4629676,Inhibition of human liver FBP1 incubated for 5 mins by fluorescence method,B,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,CHEMBL55415,nM,38200,CHEMBL3975,4.417936637,FBPase,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20713203,CHEMBL4629676,Inhibition of human liver FBP1 incubated for 5 mins by fluorescence method,B,O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12,CHEMBL611029,nM,8700,CHEMBL3975,5.060480747,FBPase,O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12,O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
20713204,CHEMBL4629676,Inhibition of human liver FBP1 incubated for 5 mins by fluorescence method,B,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12,CHEMBL253570,nM,24000,CHEMBL3975,4.619788758,FBPase,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788045,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCN(CC)C(=S)SCSC(=S)N(CC)CC,CHEMBL570813,nM,10000,CHEMBL3975,5,FBPase,CCN(CC)C(=S)SCSC(=S)N(CC)CC,CCN(CC)C(=S)SCSC(=S)N(CC)CC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788046,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCN(CC)C(=O)SSC(=O)N(CC)CC,CHEMBL4214871,nM,10000,CHEMBL3975,5,FBPase,CCN(CC)C(=O)SSC(=O)N(CC)CC,CCN(CC)C(=O)SSC(=O)N(CC)CC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788047,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCN(CC)C(=O)CSC(=S)N(CC)CC,CHEMBL569414,nM,10000,CHEMBL3975,5,FBPase,CCN(CC)C(=O)CSC(=S)N(CC)CC,CCN(CC)C(=O)CSC(=S)N(CC)CC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788048,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCN(CC)C(=S)CSC(=S)N(CC)CC,CHEMBL582931,nM,10000,CHEMBL3975,5,FBPase,CCN(CC)C(=S)CSC(=S)N(CC)CC,CCN(CC)C(=S)CSC(=S)N(CC)CC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788049,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCN(CC)C(=S)SC(=S)N(CC)CC,CHEMBL2004297,nM,10000,CHEMBL3975,5,FBPase,CCN(CC)C(=S)SC(=S)N(CC)CC,CCN(CC)C(=S)SC(=S)N(CC)CC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788050,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CN(C)C(=S)SSC(=S)N(C)C,CHEMBL120563,nM,2290,CHEMBL3975,5.640164518,FBPase,CN(C)C(=S)SSC(=S)N(C)C,CN(C)C(=S)SSC(=S)N(C)C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788051,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCCN(CCC)C(=S)SSC(=S)N(CCC)CCC,CHEMBL4757113,nM,10000,CHEMBL3975,5,FBPase,CCCN(CCC)C(=S)SSC(=S)N(CCC)CCC,CCCN(CCC)C(=S)SSC(=S)N(CCC)CCC,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788052,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CC(C)N(C(=S)SSC(=S)N(C(C)C)C(C)C)C(C)C,CHEMBL4760573,nM,10000,CHEMBL3975,5,FBPase,CC(C)N(C(=S)SSC(=S)N(C(C)C)C(C)C)C(C)C,CC(C)N(C(=S)SSC(=S)N(C(C)C)C(C)C)C(C)C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788053,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CN(C(=S)SSC(=S)N(C)c1ccccc1)c1ccccc1,CHEMBL570804,nM,10000,CHEMBL3975,5,FBPase,CN(C(=S)SSC(=S)N(C)c1ccccc1)c1ccccc1,CN(C(=S)SSC(=S)N(C)c1ccccc1)c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788054,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CN(C(=S)SSC(=S)N(C)c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1,CHEMBL4789930,nM,10000,CHEMBL3975,5,FBPase,CN(C(=S)SSC(=S)N(C)c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1,CN(C(=S)SSC(=S)N(C)c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788055,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CN(Cc1ccccc1)C(=S)SSC(=S)N(C)Cc1ccccc1,CHEMBL571274,nM,10000,CHEMBL3975,5,FBPase,CN(Cc1ccccc1)C(=S)SSC(=S)N(C)Cc1ccccc1,CN(Cc1ccccc1)C(=S)SSC(=S)N(C)Cc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788056,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCC1)N1CCC1,CHEMBL4780805,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)N1CCC1)N1CCC1,S=C(SSC(=S)N1CCC1)N1CCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788057,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCCC1)N1CCCC1,CHEMBL583959,nM,2280,CHEMBL3975,5.642065153,FBPase,S=C(SSC(=S)N1CCCC1)N1CCCC1,S=C(SSC(=S)N1CCCC1)N1CCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788058,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,CHEMBL121516,nM,8780,CHEMBL3975,5.056505484,FBPase,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788059,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)n1cccc1)n1cccc1,CHEMBL4740651,nM,130,CHEMBL3975,6.886056648,FBPase,S=C(SSC(=S)n1cccc1)n1cccc1,S=C(SSC(=S)n1cccc1)n1cccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788060,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Cc1cccn1C(=S)SSC(=S)n1cccc1C,CHEMBL4776673,nM,10000,CHEMBL3975,5,FBPase,Cc1cccn1C(=S)SSC(=S)n1cccc1C,Cc1cccn1C(=S)SSC(=S)n1cccc1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788061,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)n1cccn1)n1cccn1,CHEMBL4754762,nM,1200,CHEMBL3975,5.920818754,FBPase,S=C(SSC(=S)n1cccn1)n1cccn1,S=C(SSC(=S)n1cccn1)n1cccn1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788062,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CC2CCCCC2C1)N1CC2CCCCC2C1,CHEMBL4750782,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)N1CC2CCCCC2C1)N1CC2CCCCC2C1,S=C(SSC(=S)N1CC2CCCCC2C1)N1CC2CCCCC2C1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788063,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCc2ccccc21)N1CCc2ccccc21,CHEMBL4751677,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)N1CCc2ccccc21)N1CCc2ccccc21,S=C(SSC(=S)N1CCc2ccccc21)N1CCc2ccccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788064,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)n1c2ccccc2c2ccccc21)n1c2ccccc2c2ccccc21,CHEMBL4756189,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)n1c2ccccc2c2ccccc21)n1c2ccccc2c2ccccc21,S=C(SSC(=S)n1c2ccccc2c2ccccc21)n1c2ccccc2c2ccccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788065,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)n1ncc2ccccc21)n1ncc2ccccc21,CHEMBL4758888,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)n1ncc2ccccc21)n1ncc2ccccc21,S=C(SSC(=S)n1ncc2ccccc21)n1ncc2ccccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788066,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCOCC1)N1CCOCC1,CHEMBL121556,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)N1CCOCC1)N1CCOCC1,S=C(SSC(=S)N1CCOCC1)N1CCOCC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788067,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CN1CCN(C(=S)SSC(=S)N2CCN(C)CC2)CC1,CHEMBL571699,nM,10000,CHEMBL3975,5,FBPase,CN1CCN(C(=S)SSC(=S)N2CCN(C)CC2)CC1,CN1CCN(C(=S)SSC(=S)N2CCN(C)CC2)CC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788068,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,O=C(O)C1CCN(C(=S)SSC(=S)N2CCC(C(=O)O)CC2)CC1,CHEMBL4762693,nM,10000,CHEMBL3975,5,FBPase,O=C(O)C1CCN(C(=S)SSC(=S)N2CCC(C(=O)O)CC2)CC1,O=C(O)C1CCN(C(=S)SSC(=S)N2CCC(C(=O)O)CC2)CC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788069,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,C[C@@H]1CN(C(=S)SSC(=S)N2C[C@@H](C)O[C@@H](C)C2)C[C@H](C)O1,CHEMBL4068171,nM,10000,CHEMBL3975,5,FBPase,C[C@@H]1CN(C(=S)SSC(=S)N2C[C@@H](C)O[C@@H](C)C2)C[C@H](C)O1,CC1CN(C(=S)SSC(=S)N2CC(C)OC(C)C2)CC(C)O1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788070,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCCc2ccccc21)N1CCCc2ccccc21,CHEMBL570340,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)N1CCCc2ccccc21)N1CCCc2ccccc21,S=C(SSC(=S)N1CCCc2ccccc21)N1CCCc2ccccc21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788071,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,S=C(SSC(=S)N1CCc2ccccc2C1)N1CCc2ccccc2C1,CHEMBL583524,nM,10000,CHEMBL3975,5,FBPase,S=C(SSC(=S)N1CCc2ccccc2C1)N1CCc2ccccc2C1,S=C(SSC(=S)N1CCc2ccccc2C1)N1CCc2ccccc2C1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788072,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,c1csc(SSc2nccs2)n1,CHEMBL4098129,nM,220,CHEMBL3975,6.657577319,FBPase,c1csc(SSc2nccs2)n1,c1csc(SSc2nccs2)n1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788073,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,c1nnc(SSc2nncs2)s1,CHEMBL4750573,nM,560,CHEMBL3975,6.251811973,FBPase,c1nnc(SSc2nncs2)s1,c1nnc(SSc2nncs2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788074,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,c1csc(SSc2cccs2)c1,CHEMBL3185770,nM,12230,CHEMBL3975,4.912573543,FBPase,c1csc(SSc2cccs2)c1,c1csc(SSc2cccs2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788075,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Cn1ccnc1SSc1nccn1C,CHEMBL4798394,nM,10000,CHEMBL3975,5,FBPase,Cn1ccnc1SSc1nccn1C,Cn1ccnc1SSc1nccn1C,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788076,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,C1CCC(SSC2CCCCC2)CC1,CHEMBL3188833,nM,10000,CHEMBL3975,5,FBPase,C1CCC(SSC2CCCCC2)CC1,C1CCC(SSC2CCCCC2)CC1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788077,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,c1ccc(SSc2ccccc2)cc1,CHEMBL462861,nM,10000,CHEMBL3975,5,FBPase,c1ccc(SSc2ccccc2)cc1,c1ccc(SSc2ccccc2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788078,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1ccc(SSc2ccc(Cl)cc2)cc1,CHEMBL121019,nM,10000,CHEMBL3975,5,FBPase,Clc1ccc(SSc2ccc(Cl)cc2)cc1,Clc1ccc(SSc2ccc(Cl)cc2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788079,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,CHEMBL508112,nM,310,CHEMBL3975,6.508638306,FBPase,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788080,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,C1CCc2sc(SSc3nc4c(s3)CCCC4)nc2C1,CHEMBL4085566,nM,300,CHEMBL3975,6.522878745,FBPase,C1CCc2sc(SSc3nc4c(s3)CCCC4)nc2C1,C1CCc2sc(SSc3nc4c(s3)CCCC4)nc2C1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788081,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,C1Cc2nc(SSc3nc4c(s3)CCC4)sc2C1,CHEMBL4063998,nM,470,CHEMBL3975,6.327902142,FBPase,C1Cc2nc(SSc3nc4c(s3)CCC4)sc2C1,C1Cc2nc(SSc3nc4c(s3)CCC4)sc2C1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788082,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Nc1nnc(SSc2nnc(N)s2)s1,CHEMBL4740022,nM,490,CHEMBL3975,6.30980392,FBPase,N=c1[nH]nc(SSc2n[nH]c(=N)s2)s1,N=c1[nH]nc(SSc2n[nH]c(=N)s2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788083,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1nnc(SSc2nnc(Cl)s2)s1,CHEMBL4799901,nM,3320,CHEMBL3975,5.478861916,FBPase,Clc1nnc(SSc2nnc(Cl)s2)s1,Clc1nnc(SSc2nnc(Cl)s2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788084,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,COc1ccc2nc(SSc3nc4ccc(OC)cc4s3)sc2c1,CHEMBL4092286,nM,10000,CHEMBL3975,5,FBPase,COc1ccc2nc(SSc3nc4ccc(OC)cc4s3)sc2c1,COc1ccc2nc(SSc3nc4ccc(OC)cc4s3)sc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788085,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,O=[N+]([O-])c1ccc2nc(SSc3nc4ccc([N+](=O)[O-])cc4s3)sc2c1,CHEMBL4064600,nM,10000,CHEMBL3975,5,FBPase,O=[N+]([O-])c1ccc2nc(SSc3nc4ccc([N+](=O)[O-])cc4s3)sc2c1,O=[N+]([O-])c1ccc2nc(SSc3nc4ccc([N+](=O)[O-])cc4s3)sc2c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788086,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,c1csc(SSC2CCCC2)n1,CHEMBL4757164,nM,10000,CHEMBL3975,5,FBPase,c1csc(SSC2CCCC2)n1,c1csc(SSC2CCCC2)n1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788087,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,CCSSc1nccs1,CHEMBL4762915,nM,5390,CHEMBL3975,5.268411235,FBPase,CCSSc1nccs1,CCSSc1nccs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788088,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Fc1ccc(SSc2nccs2)cc1,CHEMBL4126492,nM,2050,CHEMBL3975,5.688246139,FBPase,Fc1ccc(SSc2nccs2)cc1,Fc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788089,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Brc1ccc(SSc2nccs2)cc1,CHEMBL4129122,nM,2050,CHEMBL3975,5.688246139,FBPase,Brc1ccc(SSc2nccs2)cc1,Brc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788090,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Nc1ccc(SSc2nccs2)cc1,CHEMBL4794960,nM,7600,CHEMBL3975,5.119186408,FBPase,Nc1ccc(SSc2nccs2)cc1,Nc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788091,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Oc1ccc(SSc2nccs2)cc1,CHEMBL4741096,nM,3790,CHEMBL3975,5.42136079,FBPase,Oc1ccc(SSc2nccs2)cc1,Oc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788092,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,COc1ccc(SSc2nccs2)cc1,CHEMBL4751375,nM,4440,CHEMBL3975,5.35261703,FBPase,COc1ccc(SSc2nccs2)cc1,COc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788093,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,FC(F)(F)c1ccc(SSc2nccs2)cc1,CHEMBL4754477,nM,2500,CHEMBL3975,5.602059991,FBPase,FC(F)(F)c1ccc(SSc2nccs2)cc1,FC(F)(F)c1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788094,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Cc1ccc(SSc2nccs2)cc1,CHEMBL4127883,nM,6640,CHEMBL3975,5.177831921,FBPase,Cc1ccc(SSc2nccs2)cc1,Cc1ccc(SSc2nccs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788095,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1ccccc1SSc1nccs1,CHEMBL4756633,nM,600,CHEMBL3975,6.22184875,FBPase,Clc1ccccc1SSc1nccs1,Clc1ccccc1SSc1nccs1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788096,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1cccc(SSc2nccs2)c1,CHEMBL4752001,nM,1250,CHEMBL3975,5.903089987,FBPase,Clc1cccc(SSc2nccs2)c1,Clc1cccc(SSc2nccs2)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788097,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1ccc(SSc2nccs2)c(Cl)c1,CHEMBL4747571,nM,2250,CHEMBL3975,5.647817482,FBPase,Clc1ccc(SSc2nccs2)c(Cl)c1,Clc1ccc(SSc2nccs2)c(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788098,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1ccc(SSc2nccs2)cc1Cl,CHEMBL4755624,nM,2200,CHEMBL3975,5.657577319,FBPase,Clc1ccc(SSc2nccs2)cc1Cl,Clc1ccc(SSc2nccs2)cc1Cl,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788100,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1ccc(SSc2nc3ccccc3s2)cc1,CHEMBL4080882,nM,2680,CHEMBL3975,5.571865206,FBPase,Clc1ccc(SSc2nc3ccccc3s2)cc1,Clc1ccc(SSc2nc3ccccc3s2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788101,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Clc1ccc(SSc2nncs2)cc1,CHEMBL4784382,nM,1290,CHEMBL3975,5.88941029,FBPase,Clc1ccc(SSc2nncs2)cc1,Clc1ccc(SSc2nncs2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22788102,CHEMBL4708891,Inhibition of wild-type full-length human liver FBPase expressed in Escherichia coli BL21 (DE3) using FBP as substrate by malachite green dye based assay,B,Nc1nnc(SSc2ccc(Cl)cc2)s1,CHEMBL4787013,nM,1940,CHEMBL3975,5.71219827,FBPase,N=c1[nH]nc(SSc2ccc(Cl)cc2)s1,N=c1[nH]nc(SSc2ccc(Cl)cc2)s1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891684,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cccc3[nH]2)cc1,CHEMBL4798806,nM,3700,CHEMBL3975,5.431798276,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cccc3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cccc3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891685,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(C)cc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4741820,nM,950,CHEMBL3975,6.022276395,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(C)cc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(C)cc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891686,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(Cl)cc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4787478,nM,950,CHEMBL3975,6.022276395,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(Cl)cc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(Cl)cc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891687,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(F)cc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4784307,nM,260,CHEMBL3975,6.585026652,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(F)cc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)c(F)cc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891688,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)c(OC)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4787644,nM,200,CHEMBL3975,6.698970004,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)c(OC)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)c(OC)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891689,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(Cl)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4791277,nM,120,CHEMBL3975,6.920818754,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(Cl)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(Cl)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891690,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(F)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4741865,nM,400,CHEMBL3975,6.397940009,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(F)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(F)c(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891691,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(OC)cc4OC)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4765009,nM,1280,CHEMBL3975,5.89279003,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(OC)cc4OC)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(OC)cc4OC)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891692,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4OC)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4758150,nM,1460,CHEMBL3975,5.835647144,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4OC)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4OC)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891693,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)cc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4778169,nM,140,CHEMBL3975,6.853871964,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)cc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)cc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891694,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(N5CCOCC5)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4748941,nM,1090,CHEMBL3975,5.962573502,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(N5CCOCC5)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(N5CCOCC5)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891695,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(N5CCOCC5)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4776022,nM,310,CHEMBL3975,6.508638306,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(N5CCOCC5)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(N5CCOCC5)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891696,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc([N+](=O)[O-])c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4792589,nM,140,CHEMBL3975,6.853871964,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc([N+](=O)[O-])c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc([N+](=O)[O-])c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891697,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc([N+](=O)[O-])cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4786994,nM,350,CHEMBL3975,6.455931956,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc([N+](=O)[O-])cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc([N+](=O)[O-])cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891698,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(C(F)(F)F)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4760429,nM,910,CHEMBL3975,6.040958608,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(C(F)(F)F)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(C(F)(F)F)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891699,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(F)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4796944,nM,1510,CHEMBL3975,5.821023053,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(F)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(F)cc4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891700,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C(F)(F)F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4752702,nM,660,CHEMBL3975,6.180456064,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C(F)(F)F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C(F)(F)F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891701,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4742356,nM,1010,CHEMBL3975,5.995678626,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891702,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C(N)=O)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4744035,nM,160,CHEMBL3975,6.795880017,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C(N)=O)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C(N)=O)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891703,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,CCc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC)cc4)cc23)c1,CHEMBL4760102,nM,430,CHEMBL3975,6.366531544,FBPase,CCc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC)cc4)cc23)c1,CCc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC)cc4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891704,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4749652,nM,150,CHEMBL3975,6.823908741,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891705,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4759251,nM,190,CHEMBL3975,6.721246399,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891706,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,CCOc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC)cc4)cc23)c1,CHEMBL4743304,nM,120,CHEMBL3975,6.920818754,FBPase,CCOc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC)cc4)cc23)c1,CCOc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC)cc4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891707,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC(F)F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4756632,nM,130,CHEMBL3975,6.886056648,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC(F)F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC(F)F)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891708,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4)cc23)c1,CHEMBL4747394,nM,140,CHEMBL3975,6.853871964,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891709,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc23)c1,CHEMBL4751290,nM,210,CHEMBL3975,6.677780705,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891710,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)cc23)c1,CHEMBL4795892,nM,270,CHEMBL3975,6.568636236,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891711,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc(OC)c4)cc23)c1,CHEMBL4740367,nM,150,CHEMBL3975,6.823908741,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc(OC)c4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc(OC)c4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891712,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccccc1Nc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccccc3)cc12,CHEMBL4782493,nM,3100,CHEMBL3975,5.508638306,FBPase,COc1ccccc1Nc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccccc3)cc12,COc1ccccc1Nc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccccc3)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891713,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4)cc23)cc1,CHEMBL4762938,nM,1000,CHEMBL3975,6,FBPase,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4)cc23)cc1,COc1ccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4)cc23)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891714,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4F)cc23)c1,CHEMBL4741542,nM,240,CHEMBL3975,6.619788758,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4F)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccccc4F)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891715,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(C)(=O)=O)cc23)c1,CHEMBL4748637,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(C)(=O)=O)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(C)(=O)=O)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891716,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc5ccccc5c4)cc23)c1,CHEMBL4746499,nM,280,CHEMBL3975,6.552841969,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc5ccccc5c4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc5ccccc5c4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891717,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc(F)c4)cc23)c1,CHEMBL4786333,nM,140,CHEMBL3975,6.853871964,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc(F)c4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc(F)c4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891718,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(F)cc4)cc23)c1,CHEMBL4756676,nM,160,CHEMBL3975,6.795880017,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(F)cc4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4ccc(F)cc4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891719,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc([N+](=O)[O-])c4)cc23)c1,CHEMBL4748284,nM,100,CHEMBL3975,7,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc([N+](=O)[O-])c4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccc([N+](=O)[O-])c4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891720,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)C4CC4)cc23)c1,CHEMBL4763758,nM,2900,CHEMBL3975,5.537602002,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)C4CC4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)C4CC4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891721,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccs4)cc23)c1,CHEMBL4755462,nM,320,CHEMBL3975,6.494850022,FBPase,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccs4)cc23)c1,COc1cccc(Nc2ccc([N+](=O)[O-])c3[nH]c(C(=O)NS(=O)(=O)c4cccs4)cc23)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891723,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(F)cc3[nH]2)cc1,CHEMBL4753292,nM,1200,CHEMBL3975,5.920818754,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(F)cc3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(F)cc3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891724,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(Cl)cc3[nH]2)cc1,CHEMBL4755544,nM,1100,CHEMBL3975,5.958607315,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(Cl)cc3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(Cl)cc3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891725,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(C)cc3[nH]2)cc1,CHEMBL4747143,nM,3600,CHEMBL3975,5.443697499,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(C)cc3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)cc(C)cc3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891726,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(F)c3[nH]2)cc1,CHEMBL4746110,nM,570,CHEMBL3975,6.244125144,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(F)c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(F)c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891727,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3[nH]2)cc1,CHEMBL4764458,nM,160,CHEMBL3975,6.795880017,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891728,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(C#N)c3[nH]2)cc1,CHEMBL4792258,nM,360,CHEMBL3975,6.443697499,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(C#N)c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(C#N)c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891729,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(C(F)(F)F)c3[nH]2)cc1,CHEMBL4791144,nM,510,CHEMBL3975,6.292429824,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(C(F)(F)F)c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(C(F)(F)F)c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891731,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,CHEMBL4784745,nM,40,CHEMBL3975,7.397940009,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891732,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,CCn1c(C(=O)NS(=O)(=O)c2ccc(OC)cc2)cc2c(Nc3cccc(OC)c3)ccc([N+](=O)[O-])c21,CHEMBL4749495,nM,210,CHEMBL3975,6.677780705,FBPase,CCn1c(C(=O)NS(=O)(=O)c2ccc(OC)cc2)cc2c(Nc3cccc(OC)c3)ccc([N+](=O)[O-])c21,CCn1c(C(=O)NS(=O)(=O)c2ccc(OC)cc2)cc2c(Nc3cccc(OC)c3)ccc([N+](=O)[O-])c21,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891733,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3n2CC(C)C)cc1,CHEMBL4745108,nM,400,CHEMBL3975,6.397940009,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3n2CC(C)C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc([N+](=O)[O-])c3n2CC(C)C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891734,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C)c4)ccc([N+](=O)[O-])c3n2C)cc1,CHEMBL4799382,nM,90,CHEMBL3975,7.045757491,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C)c4)ccc([N+](=O)[O-])c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(C)c4)ccc([N+](=O)[O-])c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891735,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,CCOc1cccc(Nc2ccc([N+](=O)[O-])c3c2cc(C(=O)NS(=O)(=O)c2ccc(OC)cc2)n3C)c1,CHEMBL4795527,nM,230,CHEMBL3975,6.638272164,FBPase,CCOc1cccc(Nc2ccc([N+](=O)[O-])c3c2cc(C(=O)NS(=O)(=O)c2ccc(OC)cc2)n3C)c1,CCOc1cccc(Nc2ccc([N+](=O)[O-])c3c2cc(C(=O)NS(=O)(=O)c2ccc(OC)cc2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891736,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(NC(C)=O)c4)ccc([N+](=O)[O-])c3n2C)cc1,CHEMBL4750118,nM,59,CHEMBL3975,7.229147988,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(NC(C)=O)c4)ccc([N+](=O)[O-])c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(NC(C)=O)c4)ccc([N+](=O)[O-])c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891737,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)cc(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,CHEMBL4763100,nM,63,CHEMBL3975,7.200659451,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)cc(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)cc(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891738,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)c(OC)c(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,CHEMBL4748130,nM,1300,CHEMBL3975,5.886056648,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)c(OC)c(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cc(OC)c(OC)c(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891739,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(Cl)c(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,CHEMBL4764972,nM,63,CHEMBL3975,7.200659451,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(Cl)c(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4ccc(Cl)c(OC)c4)ccc([N+](=O)[O-])c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891740,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Oc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4779257,nM,1400,CHEMBL3975,5.853871964,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Oc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Oc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891741,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Sc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4793570,nM,700,CHEMBL3975,6.15490196,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Sc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Sc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891742,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(N(C)c4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4746846,nM,50000,CHEMBL3975,4.301029996,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(N(C)c4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(N(C)c4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891743,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(C(=O)c4ccccc4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4748788,nM,10000,CHEMBL3975,5,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(C(=O)c4ccccc4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(C(=O)c4ccccc4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891744,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NCc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4741890,nM,970,CHEMBL3975,6.013228266,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NCc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NCc4cccc(OC)c4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891745,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NC(=O)c4ccccc4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4753815,nM,870,CHEMBL3975,6.060480747,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NC(=O)c4ccccc4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NC(=O)c4ccccc4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891746,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,CCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,CHEMBL4752768,nM,1400,CHEMBL3975,5.853871964,FBPase,CCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,CCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891747,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,CHEMBL4756467,nM,1700,CHEMBL3975,5.769551079,FBPase,COCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,COCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891748,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COCCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,CHEMBL4749960,nM,1800,CHEMBL3975,5.744727495,FBPase,COCCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,COCCCNc1ccc([N+](=O)[O-])c2[nH]c(C(=O)NS(=O)(=O)c3ccc(OC)cc3)cc12,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891749,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NC4CCCCC4)ccc([N+](=O)[O-])c3[nH]2)cc1,CHEMBL4779877,nM,2000,CHEMBL3975,5.698970004,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NC4CCCCC4)ccc([N+](=O)[O-])c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(NC4CCCCC4)ccc([N+](=O)[O-])c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891750,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,O=C(NS(=O)(=O)c1ccccc1)c1cc2c(N3CCOCC3)ccc([N+](=O)[O-])c2[nH]1,CHEMBL4759529,nM,35600,CHEMBL3975,4.448550002,FBPase,O=C(NS(=O)(=O)c1ccccc1)c1cc2c(N3CCOCC3)ccc([N+](=O)[O-])c2[nH]1,O=C(NS(=O)(=O)c1ccccc1)c1cc2c(N3CCOCC3)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891751,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,O=C(NS(=O)(=O)c1ccccc1)c1cc2c(Cl)ccc([N+](=O)[O-])c2[nH]1,CHEMBL4750488,nM,24300,CHEMBL3975,4.614393726,FBPase,O=C(NS(=O)(=O)c1ccccc1)c1cc2c(Cl)ccc([N+](=O)[O-])c2[nH]1,O=C(NS(=O)(=O)c1ccccc1)c1cc2c(Cl)ccc([N+](=O)[O-])c2[nH]1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891752,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,CHEMBL4747278,nM,52,CHEMBL3975,7.283996656,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891753,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2)n3C)c1,CHEMBL4752882,nM,180,CHEMBL3975,6.744727495,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891754,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(OC)c2)n3C)c1,CHEMBL4748117,nM,150,CHEMBL3975,6.823908741,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(OC)c2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(OC)c2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891755,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2F)n3C)c1,CHEMBL4790364,nM,140,CHEMBL3975,6.853871964,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2F)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2F)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891756,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(F)c2)n3C)c1,CHEMBL4784026,nM,230,CHEMBL3975,6.638272164,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(F)c2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(F)c2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891757,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(F)cc2)n3C)c1,CHEMBL4754167,nM,470,CHEMBL3975,6.327902142,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(F)cc2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(F)cc2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891758,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(Br)c2)n3C)c1,CHEMBL4790616,nM,140,CHEMBL3975,6.853871964,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(Br)c2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(Br)c2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891759,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(C)cc2)n3C)c1,CHEMBL4759549,nM,71,CHEMBL3975,7.148741651,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(C)cc2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(C)cc2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891760,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2OC(F)(F)F)n3C)c1,CHEMBL4758944,nM,770,CHEMBL3975,6.113509275,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2OC(F)(F)F)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccccc2OC(F)(F)F)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891761,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(OC(F)(F)F)c2)n3C)c1,CHEMBL4745214,nM,85,CHEMBL3975,7.070581074,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(OC(F)(F)F)c2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(OC(F)(F)F)c2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891762,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)n3C)c1,CHEMBL4760200,nM,70,CHEMBL3975,7.15490196,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891763,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(C#N)c2)n3C)c1,CHEMBL4762728,nM,56,CHEMBL3975,7.251811973,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(C#N)c2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(C#N)c2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891764,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(CC(C)C)c2)n3C)c1,CHEMBL4792810,nM,940,CHEMBL3975,6.026872146,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(CC(C)C)c2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccc(CC(C)C)c2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891765,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccnc2)n3C)c1,CHEMBL4749376,nM,220,CHEMBL3975,6.657577319,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccnc2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2cccnc2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891766,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(CC(C)C)s2)n3C)c1,CHEMBL4792830,nM,130,CHEMBL3975,6.886056648,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(CC(C)C)s2)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc(CC(C)C)s2)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891767,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)CCN4C)n3C)c1,CHEMBL4758681,nM,590,CHEMBL3975,6.229147988,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)CCN4C)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)CCN4C)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891768,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)CCCN4C)n3C)c1,CHEMBL4739933,nM,540,CHEMBL3975,6.26760624,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)CCCN4C)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)CCCN4C)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891769,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)N(C)CCC4)n3C)c1,CHEMBL4797929,nM,670,CHEMBL3975,6.173925197,FBPase,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)N(C)CCC4)n3C)c1,COc1cccc(Nc2ccc(Cl)c3c2cc(C(=O)NS(=O)(=O)c2ccc4c(c2)N(C)CCC4)n3C)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891770,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Cl)ccc(Nc4cccc(OC)c4)c3[nH]2)cc1,CHEMBL4776774,nM,100,CHEMBL3975,7,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Cl)ccc(Nc4cccc(OC)c4)c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Cl)ccc(Nc4cccc(OC)c4)c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891771,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Cl)ccc(Nc4cccc(OC)c4)c3n2C)cc1,CHEMBL4799206,nM,10000,CHEMBL3975,5,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Cl)ccc(Nc4cccc(OC)c4)c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Cl)ccc(Nc4cccc(OC)c4)c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891772,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2nc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,CHEMBL4755209,nM,27,CHEMBL3975,7.568636236,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2nc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2nc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891773,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccnc3[nH]2)cc1,CHEMBL4790795,nM,710,CHEMBL3975,6.148741651,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(=Nc4cccc(OC)c4)cc[nH]c3[nH]2)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(=Nc4cccc(OC)c4)cc[nH]c3[nH]2)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891774,CHEMBL4729629,Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method,B,COc1ccc(S(=O)(=O)[N-]C(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1.[Na+],CHEMBL4759496,nM,29,CHEMBL3975,7.537602002,FBPase,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,COc1ccc(S(=O)(=O)NC(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22891908,CHEMBL4729675,Inhibition of FBPase (unknown origin),B,CC(C)(C)C(=O)c1sc(N)nc1-c1ccc(P(=O)(O)O)o1,CHEMBL4784789,nM,24,CHEMBL3975,7.619788758,FBPase,CC(C)(C)C(=O)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,CC(C)(C)C(=O)c1sc(=N)[nH]c1-c1ccc([PH](=O)(=O)O)o1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892453,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,C/C(=C\c1ccccc1)[N+](=O)[O-],CHEMBL3188060,nM,16000,CHEMBL3975,4.795880017,FBPase,C/C(=C\c1ccccc1)[N+](=O)[O-],CC(=Cc1ccccc1)[N+](=O)[O-],"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892454,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,C/C(=C\c1ccc(C#N)cc1)[N+](=O)[O-],CHEMBL4787540,nM,5100,CHEMBL3975,5.292429824,FBPase,C/C(=C\c1ccc(C#N)cc1)[N+](=O)[O-],CC(=Cc1ccc(C#N)cc1)[N+](=O)[O-],"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892455,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Br)=C/c1ccccc1,CHEMBL4752812,nM,210,CHEMBL3975,6.677780705,FBPase,O=[N+]([O-])/C(Br)=C/c1ccccc1,O=[N+]([O-])C(Br)=Cc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892456,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Cl)=C/c1ccccc1,CHEMBL4753651,nM,160,CHEMBL3975,6.795880017,FBPase,O=[N+]([O-])/C(Cl)=C/c1ccccc1,O=[N+]([O-])C(Cl)=Cc1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892457,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,N#Cc1cccc(/C=C(\Br)[N+](=O)[O-])c1,CHEMBL4744158,nM,230,CHEMBL3975,6.638272164,FBPase,N#Cc1cccc(/C=C(\Br)[N+](=O)[O-])c1,N#Cc1cccc(C=C(Br)[N+](=O)[O-])c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892458,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,N#Cc1ccc(/C=C(\Br)[N+](=O)[O-])cc1,CHEMBL4786135,nM,270,CHEMBL3975,6.568636236,FBPase,N#Cc1ccc(/C=C(\Br)[N+](=O)[O-])cc1,N#Cc1ccc(C=C(Br)[N+](=O)[O-])cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892459,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Br)=C/c1cccc(F)c1,CHEMBL4758085,nM,230,CHEMBL3975,6.638272164,FBPase,O=[N+]([O-])/C(Br)=C/c1cccc(F)c1,O=[N+]([O-])C(Br)=Cc1cccc(F)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892460,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Br)=C/c1ccc(F)cc1,CHEMBL4794383,nM,640,CHEMBL3975,6.193820026,FBPase,O=[N+]([O-])/C(Br)=C/c1ccc(F)cc1,O=[N+]([O-])C(Br)=Cc1ccc(F)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892461,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Cl)=C/c1cccc(Cl)c1,CHEMBL4746071,nM,340,CHEMBL3975,6.468521083,FBPase,O=[N+]([O-])/C(Cl)=C/c1cccc(Cl)c1,O=[N+]([O-])C(Cl)=Cc1cccc(Cl)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892462,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Cl)=C/c1ccc(Cl)cc1,CHEMBL4742871,nM,540,CHEMBL3975,6.26760624,FBPase,O=[N+]([O-])/C(Cl)=C/c1ccc(Cl)cc1,O=[N+]([O-])C(Cl)=Cc1ccc(Cl)cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892463,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,N#Cc1cccc(/C=C(\Cl)[N+](=O)[O-])c1,CHEMBL4798228,nM,210,CHEMBL3975,6.677780705,FBPase,N#Cc1cccc(/C=C(\Cl)[N+](=O)[O-])c1,N#Cc1cccc(C=C(Cl)[N+](=O)[O-])c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892464,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,N#Cc1ccc(/C=C(\Cl)[N+](=O)[O-])cc1,CHEMBL4790006,nM,300,CHEMBL3975,6.522878745,FBPase,N#Cc1ccc(/C=C(\Cl)[N+](=O)[O-])cc1,N#Cc1ccc(C=C(Cl)[N+](=O)[O-])cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892465,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Cl)=C/c1cccc([N+](=O)[O-])c1,CHEMBL4764109,nM,370,CHEMBL3975,6.431798276,FBPase,O=[N+]([O-])/C(Cl)=C/c1cccc([N+](=O)[O-])c1,O=[N+]([O-])C(Cl)=Cc1cccc([N+](=O)[O-])c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
22892466,CHEMBL4729761,Inhibition of human wild type FBPase expressed in Escherichia coli BL12 (DE3) by malachite green method,B,O=[N+]([O-])/C(Cl)=C/c1ccc([N+](=O)[O-])cc1,CHEMBL4753037,nM,150,CHEMBL3975,6.823908741,FBPase,O=[N+]([O-])/C(Cl)=C/c1ccc([N+](=O)[O-])cc1,O=[N+]([O-])C(Cl)=Cc1ccc([N+](=O)[O-])cc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858028,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,O=C(NCC1CCCCC1)N1C(=O)c2ccccc2S1(=O)=O,CHEMBL5190194,nM,16400,CHEMBL3975,4.785156152,FBPase,O=C(NCC1CCCCC1)N1C(=O)c2ccccc2S1(=O)=O,O=C(NCC1CCCCC1)N1C(=O)c2ccccc2S1(=O)=O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858029,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,CC(NC(=O)N1C(=O)c2ccccc2S1(=O)=O)c1ccccc1,CHEMBL5195989,nM,8700,CHEMBL3975,5.060480747,FBPase,CC(NC(=O)N1C(=O)c2ccccc2S1(=O)=O)c1ccccc1,CC(NC(=O)N1C(=O)c2ccccc2S1(=O)=O)c1ccccc1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858030,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,O=C(NCc1ccccc1F)N1C(=O)c2ccccc2S1(=O)=O,CHEMBL5200188,nM,4200,CHEMBL3975,5.37675071,FBPase,O=C(NCc1ccccc1F)N1C(=O)c2ccccc2S1(=O)=O,O=C(NCc1ccccc1F)N1C(=O)c2ccccc2S1(=O)=O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858031,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,Cc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O,CHEMBL5190125,nM,3600,CHEMBL3975,5.443697499,FBPase,Cc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O,Cc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858032,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,COc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O,CHEMBL5184346,nM,1700,CHEMBL3975,5.769551079,FBPase,COc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O,COc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858033,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,COc1cccc(CNC(=O)N2C(=O)c3ccccc3S2(=O)=O)c1,CHEMBL5207512,nM,1900,CHEMBL3975,5.721246399,FBPase,COc1cccc(CNC(=O)N2C(=O)c3ccccc3S2(=O)=O)c1,COc1cccc(CNC(=O)N2C(=O)c3ccccc3S2(=O)=O)c1,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
24858034,CHEMBL5149237,Inhibition of human FBPase expressed Escherichia coli BL21 in by malachite green dye based spectrophotometry,B,O=C(NCc1ccccc1)N1C(=O)c2ccccc2S1(=O)=O,CHEMBL5186829,nM,3400,CHEMBL3975,5.468521083,FBPase,O=C(NCc1ccccc1)N1C(=O)c2ccccc2S1(=O)=O,O=C(NCc1ccccc1)N1C(=O)c2ccccc2S1(=O)=O,"Fructose 1,6-bisphosphatase (FBPase)","Fructose 1,6-bisphosphatase (FBPase)"
3523038,CHEMBL1273541,Inhibition of ketohexokinase assessed as conversion of D-fructose to fructose-1-phosphate after 60 mins,B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNCC3)ccc12,CHEMBL1236391,nM,5000,CHEMBL1275212,5.301029996,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296038,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(C3CCNCC3)ccc12,CHEMBL1809150,nM,330,CHEMBL1275212,6.48148606,FK,CSc1nn(-c2ccccc2)c2cc(C3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296039,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,CHEMBL1809151,nM,560,CHEMBL1275212,6.251811973,FK,CSc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296040,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809152,nM,80,CHEMBL1275212,7.096910013,FK,CSc1nn(-c2ccccc2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296041,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(-c3ccncc3)ccc12,CHEMBL1809153,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2)c2cc(-c3ccncc3)ccc12,CSc1nn(-c2ccccc2)c2cc(-c3ccncc3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296042,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(N3CC4CC3CN4)ccc12,CHEMBL1809154,nM,710,CHEMBL1275212,6.148741651,FK,CSc1nn(-c2ccccc2)c2cc(N3CC4CC3CN4)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CC4CC3CN4)ccc12,Fructokinase (FK),Fructokinase (FK)
6296043,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(OC3CCNCC3)ccc12,CHEMBL1809155,nM,710,CHEMBL1275212,6.148741651,FK,CSc1nn(-c2ccccc2)c2cc(OC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(OC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296044,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(OCC3CCNCC3)ccc12,CHEMBL1809156,nM,440,CHEMBL1275212,6.356547324,FK,CSc1nn(-c2ccccc2)c2cc(OCC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(OCC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296046,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCCNC3)ccc12,CHEMBL1809157,nM,310,CHEMBL1275212,6.508638306,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCCNC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCCNC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296047,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNC3)ccc12,CHEMBL1809158,nM,590,CHEMBL1275212,6.229147988,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCNC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296048,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CNC3)ccc12,CHEMBL1809159,nM,220,CHEMBL1275212,6.657577319,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CNC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CNC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296049,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(NC(=O)CC3CCNCC3)ccc12,CHEMBL1809160,nM,680,CHEMBL1275212,6.167491087,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)CC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)CC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296050,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(NC(=O)CCN3CCNCC3)ccc12,CHEMBL1809161,nM,380,CHEMBL1275212,6.420216403,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)CCN3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)CCN3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296051,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL1809162,nM,670,CHEMBL1275212,6.173925197,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296052,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCNCC4)CC3)ccc12,CHEMBL1809163,nM,830,CHEMBL1275212,6.080921908,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCNCC4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296053,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2c(C3=CCNCC3)cccc12,CHEMBL1809164,nM,11500,CHEMBL1275212,4.93930216,FK,CSc1nn(-c2ccccc2)c2c(C3=CCNCC3)cccc12,CSc1nn(-c2ccccc2)c2c(C3=CCNCC3)cccc12,Fructokinase (FK),Fructokinase (FK)
6296054,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2c(OC3CCNCC3)cccc12,CHEMBL1809165,nM,1680,CHEMBL1275212,5.774690718,FK,CSc1nn(-c2ccccc2)c2c(OC3CCNCC3)cccc12,CSc1nn(-c2ccccc2)c2c(OC3CCNCC3)cccc12,Fructokinase (FK),Fructokinase (FK)
6296055,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccccc2)c2c(OCC3CCNCC3)cccc12,CHEMBL1809166,nM,240,CHEMBL1275212,6.619788758,FK,CSc1nn(-c2ccccc2)c2c(OCC3CCNCC3)cccc12,CSc1nn(-c2ccccc2)c2c(OCC3CCNCC3)cccc12,Fructokinase (FK),Fructokinase (FK)
6296056,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2cccc(F)c2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809167,nM,42,CHEMBL1275212,7.37675071,FK,CSc1nn(-c2cccc(F)c2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2cccc(F)c2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296057,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccc(F)cc2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809168,nM,23,CHEMBL1275212,7.638272164,FK,CSc1nn(-c2ccc(F)cc2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2ccc(F)cc2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296058,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2cccc(C)c2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809169,nM,34,CHEMBL1275212,7.468521083,FK,CSc1nn(-c2cccc(C)c2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2cccc(C)c2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296059,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccc(C)cc2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809170,nM,40,CHEMBL1275212,7.397940009,FK,CSc1nn(-c2ccc(C)cc2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2ccc(C)cc2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296060,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,COc1ccc(-n2nc(SC)c3ccc(C4=CCNCC4)cc32)cc1,CHEMBL1809171,nM,87,CHEMBL1275212,7.060480747,FK,COc1ccc(-n2nc(SC)c3ccc(C4=CCNCC4)cc32)cc1,COc1ccc(-n2nc(SC)c3ccc(C4=CCNCC4)cc32)cc1,Fructokinase (FK),Fructokinase (FK)
6296061,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809172,nM,480,CHEMBL1275212,6.318758763,FK,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296062,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CSc1nn(-c2ccc(N)cc2)c2cc(C3=CCNCC3)ccc12,CHEMBL1809173,nM,160,CHEMBL1275212,6.795880017,FK,CSc1nn(-c2ccc(N)cc2)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2ccc(N)cc2)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296063,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,Cc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,CHEMBL1809174,nM,1280,CHEMBL1275212,5.89279003,FK,Cc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296064,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,Cc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,CHEMBL1809175,nM,3200,CHEMBL1275212,5.494850022,FK,Cc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296065,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL1809176,nM,1380,CHEMBL1275212,5.860120914,FK,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296066,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,CHEMBL1809177,nM,570,CHEMBL1275212,6.244125144,FK,CCc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296067,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL1809178,nM,560,CHEMBL1275212,6.251811973,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296068,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCNC(C)C3)ccc12,CHEMBL1809179,nM,860,CHEMBL1275212,6.065501549,FK,CCc1nn(-c2ccccc2)c2cc(N3CCNC(C)C3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCNC(C)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296069,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCN(C)CC3)ccc12,CHEMBL1809180,nM,4520,CHEMBL1275212,5.344861565,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(C)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(C)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296070,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCN(CC)CC3)ccc12,CHEMBL1809181,nM,11500,CHEMBL1275212,4.93930216,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(CC)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(CC)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296071,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CC4CNCC4C3)ccc12,CHEMBL1809182,nM,590,CHEMBL1275212,6.229147988,FK,CCc1nn(-c2ccccc2)c2cc(N3CC4CNCC4C3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CC4CNCC4C3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296072,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,CHEMBL1809183,nM,920,CHEMBL1275212,6.036212173,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296073,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,CHEMBL1809184,nM,3520,CHEMBL1275212,5.453457337,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296074,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,CHEMBL1809185,nM,9800,CHEMBL1275212,5.008773924,FK,CCc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,CCc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296075,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(NC(=O)c3cccc(C(=N)N)c3)ccc12,CHEMBL1809186,nM,680,CHEMBL1275212,6.167491087,FK,CCc1nn(-c2ccccc2)c2cc(NC(=O)c3cccc(C(=N)N)c3)ccc12,CCc1nn(-c2ccccc2)c2cc(NC(=O)c3cccc(C(=N)N)c3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296076,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4nc[nH]c4c3)ccc12,CHEMBL1809187,nM,940,CHEMBL1275212,6.026872146,FK,CCc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4[nH]cnc4c3)ccc12,CCc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4[nH]cnc4c3)ccc12,Fructokinase (FK),Fructokinase (FK)
6296077,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,Cn1nc(-c2ccccc2)c2cc(N3CCNCC3)ccc21,CHEMBL1809188,nM,1280,CHEMBL1275212,5.89279003,FK,Cn1nc(-c2ccccc2)c2cc(N3CCNCC3)ccc21,Cn1nc(-c2ccccc2)c2cc(N3CCNCC3)ccc21,Fructokinase (FK),Fructokinase (FK)
6296078,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,Cc1nn(-c2ccccc2)c2nc(C3CCNCC3)[nH]c(=O)c12,CHEMBL1809189,nM,6100,CHEMBL1275212,5.214670165,FK,Cc1nn(-c2ccccc2)c2[nH]c(C3CCNCC3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(C3CCNCC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
6296079,CHEMBL1810789,Inhibition of KHK-mediated conversion of D-fructose to fructose-1-phosphate after 60 mins by high throughput mass spectrometry analysis,B,CCc1nc(-c2ccccc2)n2cc(N3CCNCC3)ccc12,CHEMBL1809190,nM,20000,CHEMBL1275212,4.698970004,FK,CCc1nc(-c2ccccc2)n2cc(N3CCNCC3)ccc12,CCc1nc(-c2ccccc2)n2cc(N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
10849640,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CNc1ncnc2c(Nc3ccccc3C)nc(N3CCNCC3)nc12,CHEMBL2017208,nM,400,CHEMBL1275212,6.397940009,FK,CN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,CN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,Fructokinase (FK),Fructokinase (FK)
10849641,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017209,nM,210,CHEMBL1275212,6.677780705,FK,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849642,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,c1ccc(Nc2nc(N3CCNCC3)nc3c(NCC4CC4)ncnc23)cc1,CHEMBL2017210,nM,3200,CHEMBL1275212,5.494850022,FK,c1ccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)cc1,c1ccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)cc1,Fructokinase (FK),Fructokinase (FK)
10849643,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1cccc(Nc2nc(N3CCNCC3)nc3c(NCC4CC4)ncnc23)c1,CHEMBL2017211,nM,2800,CHEMBL1275212,5.552841969,FK,Cc1cccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)c1,Cc1cccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)c1,Fructokinase (FK),Fructokinase (FK)
10849644,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,COc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017212,nM,100,CHEMBL1275212,7,FK,COc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,COc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849645,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CCOc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017213,nM,200,CHEMBL1275212,6.698970004,FK,CCOc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CCOc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849646,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017214,nM,12,CHEMBL1275212,7.920818754,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849647,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1cccc(Nc2nc(N3CCNCC3)nc3c(NCC4CC4)ncnc23)c1,CHEMBL2017215,nM,2000,CHEMBL1275212,5.698970004,FK,CSc1cccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)c1,CSc1cccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)c1,Fructokinase (FK),Fructokinase (FK)
10849648,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccc(Nc2nc(N3CCNCC3)nc3c(NCC4CC4)ncnc23)cc1,CHEMBL2017216,nM,9000,CHEMBL1275212,5.045757491,FK,CSc1ccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)cc1,CSc1ccc(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)cc1,Fructokinase (FK),Fructokinase (FK)
10849649,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CS(=O)(=O)c1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017217,nM,9000,CHEMBL1275212,5.045757491,FK,CS(=O)(=O)c1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CS(=O)(=O)c1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849650,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CCSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017218,nM,9000,CHEMBL1275212,5.045757491,FK,CCSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CCSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849651,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,FC(F)(F)Sc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017219,nM,3000,CHEMBL1275212,5.522878745,FK,FC(F)(F)Sc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,FC(F)(F)Sc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849652,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CCc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017220,nM,130,CHEMBL1275212,6.886056648,FK,CCc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CCc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849653,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CC(C)c1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017221,nM,5000,CHEMBL1275212,5.301029996,FK,CC(C)c1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CC(C)c1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849654,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,c1ccc(C2CC2)c(Nc2nc(N3CCNCC3)nc3c(NCC4CC4)ncnc23)c1,CHEMBL2017222,nM,380,CHEMBL1275212,6.420216403,FK,c1ccc(C2CC2)c(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)c1,c1ccc(C2CC2)c(N=c2[nH]c(N3CCNCC3)nc3c(=NCC4CC4)[nH]cnc23)c1,Fructokinase (FK),Fructokinase (FK)
10849655,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Fc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017223,nM,1500,CHEMBL1275212,5.823908741,FK,Fc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849656,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Clc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017224,nM,540,CHEMBL1275212,6.26760624,FK,Clc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Clc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849657,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Brc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017225,nM,170,CHEMBL1275212,6.769551079,FK,Brc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Brc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849658,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,c1nc(NCC2CC2)c2nc(N3CCNCC3)nc(NC3CC3)c2n1,CHEMBL2017226,nM,9000,CHEMBL1275212,5.045757491,FK,c1nc(=NCC2CC2)c2c([nH]1)C(N=c1cc1)NC(N1CCNCC1)N2,c1nc(=NCC2CC2)c2c([nH]1)C(N=c1cc1)NC(N1CCNCC1)N2,Fructokinase (FK),Fructokinase (FK)
10849659,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,c1nc(NCC2CC2)c2nc(N3CCNCC3)nc(NC3CCCCC3)c2n1,CHEMBL2017227,nM,9000,CHEMBL1275212,5.045757491,FK,c1nc(=NCC2CC2)c2[nH]c(N3CCNCC3)nc(=NC3CCCCC3)c2[nH]1,c1nc(=NCC2CC2)c2[nH]c(N3CCNCC3)nc(=NC3CCCCC3)c2[nH]1,Fructokinase (FK),Fructokinase (FK)
10849660,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CCCNc1ncnc2c(Nc3ccccc3C)nc(N3CCNCC3)nc12,CHEMBL2017228,nM,400,CHEMBL1275212,6.397940009,FK,CCCN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,CCCN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,Fructokinase (FK),Fructokinase (FK)
10849661,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CCCCCCNc1ncnc2c(Nc3ccccc3C)nc(N3CCNCC3)nc12,CHEMBL2017229,nM,1600,CHEMBL1275212,5.795880017,FK,CCCCCCN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,CCCCCCN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,Fructokinase (FK),Fructokinase (FK)
10849662,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCNCC2)nc2c(NC3CCCCC3)ncnc12,CHEMBL2017230,nM,2300,CHEMBL1275212,5.638272164,FK,Cc1ccccc1NC1N=C(N2CCNCC2)N=C2C(Nc3ccccc3)NCNC21,Cc1ccccc1NC1N=C(N2CCNCC2)N=C2C(Nc3ccccc3)NCNC21,Fructokinase (FK),Fructokinase (FK)
10849663,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CCN(CC)c1ncnc2c(Nc3ccccc3C)nc(N3CCNCC3)nc12,CHEMBL2017231,nM,1700,CHEMBL1275212,5.769551079,FK,CCN(CC)c1ncnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,CCN(CC)c1ncnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,Fructokinase (FK),Fructokinase (FK)
10849664,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,C#CCNc1ncnc2c(Nc3ccccc3C)nc(N3CCNCC3)nc12,CHEMBL2017232,nM,300,CHEMBL1275212,6.522878745,FK,C#CCN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,C#CCN=c1[nH]cnc2c(=Nc3ccccc3C)[nH]c(N3CCNCC3)nc12,Fructokinase (FK),Fructokinase (FK)
10849665,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCc3ccccc3)ncnc12,CHEMBL2017233,nM,400,CHEMBL1275212,6.397940009,FK,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3ccccc3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3ccccc3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849666,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCc3cccs3)ncnc12,CHEMBL2017234,nM,300,CHEMBL1275212,6.522878745,FK,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3cccs3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3cccs3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849667,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCc3nccs3)ncnc12,CHEMBL2017235,nM,60,CHEMBL1275212,7.22184875,FK,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3nccs3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3nccs3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849668,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017236,nM,300,CHEMBL1275212,6.522878745,FK,Cc1ccccc1N=c1[nH]c(N2CCCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849669,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCN(C)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017237,nM,1500,CHEMBL1275212,5.823908741,FK,Cc1ccccc1N=c1[nH]c(N2CCN(C)CC2)nc2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCN(C)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849670,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCOCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017238,nM,7000,CHEMBL1275212,5.15490196,FK,Cc1ccccc1N=c1[nH]c(N2CCOCC2)nc2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCOCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849671,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCC(CN)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017239,nM,70,CHEMBL1275212,7.15490196,FK,Cc1ccccc1N=c1[nH]c(N2CCC(CN)CC2)nc2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCC(CN)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849672,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(N2CCC(N)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017240,nM,200,CHEMBL1275212,6.698970004,FK,Cc1ccccc1N=c1[nH]c(N2CCC(N)CC2)nc2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(N2CCC(N)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849673,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,Cc1ccccc1Nc1nc(NC2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017241,nM,710,CHEMBL1275212,6.148741651,FK,Cc1ccccc1N=c1[nH]c(=NC2CCNCC2)[nH]c2c(=NCC3CC3)[nH]cnc12,Cc1ccccc1N=c1[nH]c(=NC2CCNCC2)[nH]c2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849674,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CCC3)ncnc12,CHEMBL2017242,nM,18,CHEMBL1275212,7.744727495,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CCC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCC3CCC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849675,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCCC3CC3)ncnc12,CHEMBL2017243,nM,50,CHEMBL1275212,7.301029996,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849676,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,COCCNc1ncnc2c(Nc3ccccc3SC)nc(N3CCNCC3)nc12,CHEMBL2017244,nM,7,CHEMBL1275212,8.15490196,FK,COCCN=c1[nH]cnc2c(=Nc3ccccc3SC)[nH]c(N3CCNCC3)nc12,COCCN=c1[nH]cnc2c(=Nc3ccccc3SC)[nH]c(N3CCNCC3)nc12,Fructokinase (FK),Fructokinase (FK)
10849677,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCc3cccs3)ncnc12,CHEMBL2017245,nM,30,CHEMBL1275212,7.522878745,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3cccs3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3cccs3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849678,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCc3nccs3)ncnc12,CHEMBL2017246,nM,16,CHEMBL1275212,7.795880017,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3nccs3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3nccs3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849679,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCc3ccccn3)ncnc12,CHEMBL2017247,nM,9.8,CHEMBL1275212,8.008773924,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3ccccn3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=NCc3ccccn3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849680,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(N)ncnc12,CHEMBL2017248,nM,7.1,CHEMBL1275212,8.148741651,FK,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=N)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2)nc2c(=N)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849681,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCC[C@@H](N)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2017249,nM,18,CHEMBL1275212,7.744727495,FK,CSc1ccccc1N=c1[nH]c(N2CCC[C@@H](N)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCCC(N)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849682,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCC[C@H](N)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2017250,nM,23,CHEMBL1275212,7.638272164,FK,CSc1ccccc1N=c1[nH]c(N2CCC[C@H](N)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCCC(N)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849683,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCC(CN)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017251,nM,10,CHEMBL1275212,8,FK,CSc1ccccc1N=c1[nH]c(N2CCC(CN)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC(CN)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849684,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CC(CN)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2017252,nM,30,CHEMBL1275212,7.522878745,FK,CSc1ccccc1N=c1[nH]c(N2CC(CN)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CC(CN)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849685,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2017253,nM,8,CHEMBL1275212,8.096910013,FK,CSc1ccccc1N=c1[nH]c(N2CC3(CNC3)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CC3(CNC3)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849686,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CNCCN(C)c1nc(Nc2ccccc2SC)c2ncnc(NCC3CC3)c2n1,CHEMBL2017254,nM,130,CHEMBL1275212,6.886056648,FK,CNCCN(C)c1nc(=Nc2ccccc2SC)c2[nH]cnc(=NCC3CC3)c2[nH]1,CNCCN(C)c1nc(=Nc2ccccc2SC)c2[nH]cnc(=NCC3CC3)c2[nH]1,Fructokinase (FK),Fructokinase (FK)
10849687,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCC(CN(C)C)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017255,nM,140,CHEMBL1275212,6.853871964,FK,CSc1ccccc1N=c1[nH]c(N2CCC(CN(C)C)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC(CN(C)C)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10849688,CHEMBL2019654,Inhibition of human ketohexokinase isoform C expressed in Escherichia coli BL21 (DE3) cells using D-fructose as substrate after 12 to 15 mins by fluorescence polarization assay,B,CSc1ccccc1Nc1nc(N2CCN(C)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2017256,nM,110,CHEMBL1275212,6.958607315,FK,CSc1ccccc1N=c1[nH]c(N2CCN(C)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCN(C)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980210,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCNC(C)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2063913,nM,70,CHEMBL1275212,7.15490196,FK,CSc1ccccc1N=c1[nH]c(N2CCNC(C)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNC(C)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980211,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCNC[C@H]2C)nc2c(NCC3CC3)ncnc12,CHEMBL2063914,nM,58,CHEMBL1275212,7.236572006,FK,CSc1ccccc1N=c1[nH]c(N2CCNC[C@H]2C)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNCC2C)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980212,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2C[C@@H](C)N[C@@H](C)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2063915,nM,110,CHEMBL1275212,6.958607315,FK,CSc1ccccc1N=c1[nH]c(N2C[C@@H](C)N[C@@H](C)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CC(C)NC(C)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980213,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCNC(C)(C)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2063916,nM,40,CHEMBL1275212,7.397940009,FK,CSc1ccccc1N=c1[nH]c(N2CCNC(C)(C)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNC(C)(C)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980214,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N(C)CC2CCNCC2)nc2c(NCC3CC3)ncnc12,CHEMBL2063917,nM,66,CHEMBL1275212,7.180456064,FK,CSc1ccccc1N=c1[nH]c(N(C)CC2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N(C)CC2CCNCC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980215,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC[C@@H]3CNC[C@@H]32)nc2c(NCC3CC3)ncnc12,CHEMBL2063918,nM,440,CHEMBL1275212,6.356547324,FK,CSc1ccccc1N=c1[nH]c(N2CCC[C@@H]3CNC[C@@H]32)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCCC3CNCC32)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980216,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC[C@H]3CNC[C@H]32)nc2c(NCC3CC3)ncnc12,CHEMBL2063919,nM,300,CHEMBL1275212,6.522878745,FK,CSc1ccccc1N=c1[nH]c(N2CCC[C@H]3CNC[C@H]32)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCCC3CNCC32)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980217,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2C[C@@H]3C[C@H]2CN3)nc2c(NCC3CC3)ncnc12,CHEMBL2063920,nM,4600,CHEMBL1275212,5.337242168,FK,CSc1ccccc1N=c1[nH]c(N2C[C@@H]3C[C@H]2CN3)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CC3CC2CN3)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980218,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2C3CCC2CC(N)C3)nc2c(NCC3CC3)ncnc12,CHEMBL2063921,nM,800,CHEMBL1275212,6.096910013,FK,CSc1ccccc1N=c1[nH]c(N2C3CCC2CC(N)C3)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2C3CCC2CC(N)C3)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980219,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCNc3ccccc3C2)nc2c(NCC3CC3)ncnc12,CHEMBL2063922,nM,6000,CHEMBL1275212,5.22184875,FK,CSc1ccccc1N=c1[nH]c(N2CCNc3ccccc3C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCNc3ccccc3C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980220,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC3(CCNC3)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2063923,nM,43,CHEMBL1275212,7.366531544,FK,CSc1ccccc1N=c1[nH]c(N2CCC3(CCNC3)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC3(CCNC3)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980221,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC3(CNC3)C2)nc2c(NCC3CC3)ncnc12,CHEMBL2063924,nM,2,CHEMBL1275212,8.698970004,FK,CSc1ccccc1N=c1[nH]c(N2CCC3(CNC3)C2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC3(CNC3)C2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980222,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC3(CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2063925,nM,15,CHEMBL1275212,7.823908741,FK,CSc1ccccc1N=c1[nH]c(N2CCC3(CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC3(CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980223,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2063926,nM,48,CHEMBL1275212,7.318758763,FK,CSc1ccccc1N=c1[nH]c(N2CCN(C3CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCN(C3CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980224,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC(N3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2063927,nM,28,CHEMBL1275212,7.552841969,FK,CSc1ccccc1N=c1[nH]c(N2CCC(N3CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC(N3CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980225,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2063928,nM,50,CHEMBL1275212,7.301029996,FK,CSc1ccccc1N=c1[nH]c(N2CCC(C3CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC(C3CCNCC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
10980226,CHEMBL2065101,Inhibition of recombinant human hepatic KHKC,B,CSc1ccccc1Nc1nc(N2CCC(N3CCN(C)CC3)CC2)nc2c(NCC3CC3)ncnc12,CHEMBL2063929,nM,30,CHEMBL1275212,7.522878745,FK,CSc1ccccc1N=c1[nH]c(N2CCC(N3CCN(C)CC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,CSc1ccccc1N=c1[nH]c(N2CCC(N3CCN(C)CC3)CC2)nc2c(=NCC3CC3)[nH]cnc12,Fructokinase (FK),Fructokinase (FK)
17644909,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)CC3CCCCN3)ccc12,CHEMBL3666069,nM,860,CHEMBL1275212,6.065501549,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)CC3CCCCN3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)CC3CCCCN3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644910,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)NC3CCNC3)ccc12,CHEMBL3666070,nM,450,CHEMBL1275212,6.346787486,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)NC3CCNC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)NC3CCNC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644913,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)NC3CCNCC3)ccc12,CHEMBL3666071,nM,700,CHEMBL1275212,6.15490196,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)NC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)NC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644914,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)c3ccncc3)ccc12,CHEMBL3666072,nM,1010,CHEMBL1275212,5.995678626,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)c3ccncc3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)c3ccncc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644915,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)Cc3ccncc3)ccc12,CHEMBL3666073,nM,2680,CHEMBL1275212,5.571865206,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)Cc3ccncc3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)Cc3ccncc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644917,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCCNCC3)ccc12,CHEMBL3666074,nM,540,CHEMBL1275212,6.26760624,FK,CSc1nn(-c2ccccc2)c2cc(N3CCCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644919,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCCN3)ccc12,CHEMBL3666075,nM,260,CHEMBL1275212,6.585026652,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCCN3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3CCCN3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644920,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)c3cccnc3)ccc12,CHEMBL3666076,nM,230,CHEMBL1275212,6.638272164,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)c3cccnc3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)c3cccnc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644921,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,CHEMBL3666077,nM,560,CHEMBL1275212,6.251811973,FK,CSc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644922,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCNC4)CC3)ccc12,CHEMBL3666078,nM,2890,CHEMBL1275212,5.539102157,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCNC4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644923,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4ccncc4)CC3)ccc12,CHEMBL3666079,nM,2030,CHEMBL1275212,5.692503962,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4ccncc4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4ccncc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644924,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(Cc4ccncc4)CC3)ccc12,CHEMBL3666080,nM,2030,CHEMBL1275212,5.692503962,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(Cc4ccncc4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(Cc4ccncc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644925,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,CHEMBL3666081,nM,560,CHEMBL1275212,6.251811973,FK,CSc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644926,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,CHEMBL3666082,nM,670,CHEMBL1275212,6.173925197,FK,CSc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644927,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,CHEMBL3666083,nM,2820,CHEMBL1275212,5.549750892,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644928,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,CHEMBL3666084,nM,4450,CHEMBL1275212,5.351639989,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644930,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(c4ccccn4)CC3)ccc12,CHEMBL3666085,nM,1560,CHEMBL1275212,5.806875402,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(c4ccccn4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(c4ccccn4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644931,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)C3=O)ccc12,CHEMBL3666086,nM,460,CHEMBL1275212,6.337242168,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)C3=O)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644932,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,CHEMBL3666087,nM,1470,CHEMBL1275212,5.832682665,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644933,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(CC4CCNC4)C3=O)ccc12,CHEMBL3666088,nM,5170,CHEMBL1275212,5.286509457,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(CC4CCNC4)C3=O)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(CC4CCNC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644934,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(CC4CCCNC4)C3=O)ccc12,CHEMBL3666089,nM,3040,CHEMBL1275212,5.517126416,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(CC4CCCNC4)C3=O)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(CC4CCCNC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644935,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,CHEMBL3666090,nM,300,CHEMBL1275212,6.522878745,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644936,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4ccccn4)CC3)ccc12,CHEMBL3666091,nM,16400,CHEMBL1275212,4.785156152,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4ccccn4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4ccccn4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644937,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4cccnc4)CC3)ccc12,CHEMBL3666092,nM,4950,CHEMBL1275212,5.305394801,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4cccnc4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)c4cccnc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644938,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(Cc4cccnc4)CC3)ccc12,CHEMBL3666093,nM,6060,CHEMBL1275212,5.217527376,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(Cc4cccnc4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(Cc4cccnc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644939,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCN4)CC3)ccc12,CHEMBL3666094,nM,5340,CHEMBL1275212,5.272458743,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCN4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCN4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644941,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCCN4)CC3)ccc12,CHEMBL3666095,nM,430,CHEMBL1275212,6.366531544,FK,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCCN4)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(N3CCN(C(=O)C4CCCCN4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644942,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,CHEMBL3666096,nM,890,CHEMBL1275212,6.050609993,FK,CCc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644943,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(-c3ccc(OC4CCNCC4)cc3)ccc12,CHEMBL3666097,nM,5870,CHEMBL1275212,5.231361899,FK,CCc1nn(-c2ccccc2)c2cc(-c3ccc(OC4CCNCC4)cc3)ccc12,CCc1nn(-c2ccccc2)c2cc(-c3ccc(OC4CCNCC4)cc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644946,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(OC3CN(C4CCNCC4)C3)ccc12,CHEMBL3666098,nM,30000,CHEMBL1275212,4.522878745,FK,CCc1nn(-c2ccccc2)c2cc(OC3CN(C4CCNCC4)C3)ccc12,CCc1nn(-c2ccccc2)c2cc(OC3CN(C4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644948,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,CHEMBL3666099,nM,2350,CHEMBL1275212,5.628932138,FK,CCc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644949,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,CHEMBL3666100,nM,2400,CHEMBL1275212,5.619788758,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644953,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)C3=O)ccc12,CHEMBL3666101,nM,2370,CHEMBL1275212,5.625251654,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)C3=O)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644954,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,CHEMBL3666102,nM,1800,CHEMBL1275212,5.744727495,FK,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644956,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(N3CCC4(CCNC4)C3)ccc12,CHEMBL3666103,nM,1470,CHEMBL1275212,5.832682665,FK,CCc1nn(-c2ccccc2)c2cc(N3CCC4(CCNC4)C3)ccc12,CCc1nn(-c2ccccc2)c2cc(N3CCC4(CCNC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644958,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2cc(-c3ccc(C4CCNC4)cc3)ccc12,CHEMBL3666104,nM,4810,CHEMBL1275212,5.317854924,FK,CCc1nn(-c2ccccc2)c2cc(-c3ccc(C4CCNC4)cc3)ccc12,CCc1nn(-c2ccccc2)c2cc(-c3ccc(C4CCNC4)cc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644962,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(C3CCC(N4CCNCC4)CC3)ccc12,CHEMBL3666105,nM,3200,CHEMBL1275212,5.494850022,FK,Cc1nn(-c2ccccc2)c2cc(C3CCC(N4CCNCC4)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(C3CCC(N4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644963,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,CHEMBL3666106,nM,7500,CHEMBL1275212,5.124938737,FK,Cc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,Cc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644965,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,CHEMBL3666107,nM,2300,CHEMBL1275212,5.638272164,FK,Cc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644966,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,CHEMBL3666108,nM,1010,CHEMBL1275212,5.995678626,FK,Cc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCC(N4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644967,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,CHEMBL3666109,nM,1600,CHEMBL1275212,5.795880017,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644968,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,CHEMBL3666110,nM,3750,CHEMBL1275212,5.425968732,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644969,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL3666111,nM,9060,CHEMBL1275212,5.042871802,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644970,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,CHEMBL3666112,nM,7730,CHEMBL1275212,5.111820506,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644971,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4nc[nH]c4c3)ccc12,CHEMBL3666113,nM,160,CHEMBL1275212,6.795880017,FK,Cc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4[nH]cnc4c3)ccc12,Cc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4[nH]cnc4c3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644972,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,CHEMBL3666114,nM,1230,CHEMBL1275212,5.910094889,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644973,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(C)CC3)ccc12,CHEMBL3666115,nM,1570,CHEMBL1275212,5.804100348,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(C)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(C)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644974,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCN1CCN(c2ccc3c(C)nn(-c4ccccc4)c3c2)CC1,CHEMBL3666116,nM,14200,CHEMBL1275212,4.847711656,FK,CCN1CCN(c2ccc3c(C)nn(-c4ccccc4)c3c2)CC1,CCN1CCN(c2ccc3c(C)nn(-c4ccccc4)c3c2)CC1,Fructokinase (FK),Fructokinase (FK)
17644975,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCN(C(C)C)CC3)ccc12,CHEMBL3666117,nM,14700,CHEMBL1275212,4.832682665,FK,Cc1nn(-c2ccccc2)c2cc(N3CCN(C(C)C)CC3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCN(C(C)C)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644976,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCNC(C)C3)ccc12,CHEMBL3666118,nM,400,CHEMBL1275212,6.397940009,FK,Cc1nn(-c2ccccc2)c2cc(N3CCNC(C)C3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCNC(C)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644977,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2cc(N3CCC(N)C3)ccc12,CHEMBL3666119,nM,680,CHEMBL1275212,6.167491087,FK,Cc1nn(-c2ccccc2)c2cc(N3CCC(N)C3)ccc12,Cc1nn(-c2ccccc2)c2cc(N3CCC(N)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644978,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,CHEMBL3666120,nM,390,CHEMBL1275212,6.408935393,FK,COc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,COc1nn(-c2ccccc2)c2cc(N3CC(N4CCNCC4)C3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644979,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,CHEMBL3666121,nM,5960,CHEMBL1275212,5.22475374,FK,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644980,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,CHEMBL3666122,nM,310,CHEMBL1275212,6.508638306,FK,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644982,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,CHEMBL3666123,nM,8100,CHEMBL1275212,5.091514981,FK,COc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,COc1nn(-c2ccccc2)c2cc(N3CCN(c4ccncc4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644983,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,CHEMBL3666124,nM,4420,CHEMBL1275212,5.354577731,FK,COc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,COc1nn(-c2ccccc2)c2cc(-c3ccc(N4CCNCC4)cc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644984,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(-c3ccc(-n4ccnc4)cc3)ccc12,CHEMBL3666125,nM,30000,CHEMBL1275212,4.522878745,FK,COc1nn(-c2ccccc2)c2cc(-c3ccc(-n4ccnc4)cc3)ccc12,COc1nn(-c2ccccc2)c2cc(-c3ccc(-n4ccnc4)cc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644985,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4nc[nH]c4c3)ccc12,CHEMBL3666126,nM,4500,CHEMBL1275212,5.346787486,FK,COc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4[nH]cnc4c3)ccc12,COc1nn(-c2ccccc2)c2cc(NC(=O)c3ccc4[nH]cnc4c3)ccc12,Fructokinase (FK),Fructokinase (FK)
17644986,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,CHEMBL3666127,nM,30000,CHEMBL1275212,4.522878745,FK,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,COc1nn(-c2ccccc2)c2cc(N3CCN(C4CCNCC4)C3=O)ccc12,Fructokinase (FK),Fructokinase (FK)
17644987,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(N3CCN(C4CNC4)CC3)ncc12,CHEMBL3666128,nM,23000,CHEMBL1275212,4.638272164,FK,CCc1nn(-c2ccccc2)c2nc(N3CCN(C4CNC4)CC3)ncc12,CCc1nn(-c2ccccc2)c2nc(N3CCN(C4CNC4)CC3)ncc12,Fructokinase (FK),Fructokinase (FK)
17644988,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(N3CCN(c4cccnc4)CC3)ncc12,CHEMBL3666129,nM,30000,CHEMBL1275212,4.522878745,FK,CCc1nn(-c2ccccc2)c2nc(N3CCN(c4cccnc4)CC3)ncc12,CCc1nn(-c2ccccc2)c2nc(N3CCN(c4cccnc4)CC3)ncc12,Fructokinase (FK),Fructokinase (FK)
17644989,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(C3CCN(c4cccnc4)CC3)[nH]c(=O)c12,CHEMBL3666130,nM,30000,CHEMBL1275212,4.522878745,FK,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(c4cccnc4)CC3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(c4cccnc4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644990,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(C3CCCN(C4CNC4)C3)[nH]c(=O)c12,CHEMBL3666131,nM,7450,CHEMBL1275212,5.127843727,FK,Cc1nn(-c2ccccc2)c2[nH]c(C3CCCN(C4CNC4)C3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(C3CCCN(C4CNC4)C3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644992,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(C3CCN(C(=O)C4CCNCC4)CC3)[nH]c(=O)c12,CHEMBL3666132,nM,30000,CHEMBL1275212,4.522878745,FK,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(C(=O)C4CCNCC4)CC3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(C(=O)C4CCNCC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644993,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(C3CCN(C4CCNC4)CC3)[nH]c(=O)c12,CHEMBL3666133,nM,1510,CHEMBL1275212,5.821023053,FK,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNC4)CC3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644994,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(C3CCN(C4CCNCC4)CC3)[nH]c(=O)c12,CHEMBL3666134,nM,14000,CHEMBL1275212,4.853871964,FK,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNCC4)CC3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNCC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644995,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(CC3CCN(C4CNC4)CC3)[nH]c(=O)c12,CHEMBL3666135,nM,30000,CHEMBL1275212,4.522878745,FK,Cc1nn(-c2ccccc2)c2[nH]c(CC3CCN(C4CNC4)CC3)nc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(CC3CCN(C4CNC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644996,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(C3CCNCC3)[nH]c(=O)c12,CHEMBL3666136,nM,2400,CHEMBL1275212,5.619788758,FK,CCc1nn(-c2ccccc2)c2[nH]c(C3CCNCC3)nc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(C3CCNCC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644997,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(C3CCN(c4ccncc4)CC3)[nH]c(=O)c12,CHEMBL3666137,nM,1670,CHEMBL1275212,5.777283529,FK,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(c4ccncc4)CC3)nc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(c4ccncc4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644998,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(C3CCN(c4cccnc4)CC3)[nH]c(=O)c12,CHEMBL3666138,nM,7900,CHEMBL1275212,5.102372909,FK,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(c4cccnc4)CC3)nc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(c4cccnc4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17644999,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(C3CCN(C4CCNC4)CC3)[nH]c(=O)c12,CHEMBL3666139,nM,5270,CHEMBL1275212,5.278189385,FK,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNC4)CC3)nc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17645000,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(C3CCN(C4CCNCC4)CC3)[nH]c(=O)c12,CHEMBL3666140,nM,11500,CHEMBL1275212,4.93930216,FK,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNCC4)CC3)nc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(C4CCNCC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17645001,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(C3CCN(C(=O)C4CCNCC4)CC3)[nH]c(=O)c12,CHEMBL3666141,nM,30000,CHEMBL1275212,4.522878745,FK,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(C(=O)C4CCNCC4)CC3)nc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(C3CCN(C(=O)C4CCNCC4)CC3)nc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17645002,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(-c3ccc(N4CCNCC4)cc3)cc(O)c12,CHEMBL3666142,nM,2710,CHEMBL1275212,5.567030709,FK,Cc1nn(-c2ccccc2)c2[nH]c(-c3ccc(N4CCNCC4)cc3)cc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(-c3ccc(N4CCNCC4)cc3)cc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17645003,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(-c3ccc(N4CC(C)NC(C)C4)cc3)cc(OC)c12,CHEMBL3639650,nM,300,CHEMBL1275212,6.522878745,FK,CCc1nn(-c2ccccc2)c2nc(-c3ccc(N4CC(C)NC(C)C4)cc3)cc(OC)c12,CCc1nn(-c2ccccc2)c2nc(-c3ccc(N4CC(C)NC(C)C4)cc3)cc(OC)c12,Fructokinase (FK),Fructokinase (FK)
17645004,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(-c3ccc(N4CCNCC4)cc3)cc(CO)c12,CHEMBL3666143,nM,600,CHEMBL1275212,6.22184875,FK,Cc1nn(-c2ccccc2)c2nc(-c3ccc(N4CCNCC4)cc3)cc(CO)c12,Cc1nn(-c2ccccc2)c2nc(-c3ccc(N4CCNCC4)cc3)cc(CO)c12,Fructokinase (FK),Fructokinase (FK)
17645005,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCc1nn(-c2ccccc2)c2nc(-c3ccc(NC4CCNCC4)cc3)cc(O)c12,CHEMBL3666144,nM,1720,CHEMBL1275212,5.764471553,FK,CCc1nn(-c2ccccc2)c2[nH]c(-c3ccc(NC4CCNCC4)cc3)cc(=O)c12,CCc1nn(-c2ccccc2)c2[nH]c(-c3ccc(NC4CCNCC4)cc3)cc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17645006,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,Cc1nn(-c2ccccc2)c2nc(-c3ccc(NC4CCNCC4)cc3)cc(O)c12,CHEMBL3666145,nM,890,CHEMBL1275212,6.050609993,FK,Cc1nn(-c2ccccc2)c2[nH]c(-c3ccc(NC4CCNCC4)cc3)cc(=O)c12,Cc1nn(-c2ccccc2)c2[nH]c(-c3ccc(NC4CCNCC4)cc3)cc(=O)c12,Fructokinase (FK),Fructokinase (FK)
17645007,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCOc1cc(-c2ccc(N3CCNCC3)cc2)nc2c1c(CC)nn2-c1ccccc1,CHEMBL3666146,nM,1430,CHEMBL1275212,5.844663963,FK,CCOc1cc(-c2ccc(N3CCNCC3)cc2)nc2c1c(CC)nn2-c1ccccc1,CCOc1cc(-c2ccc(N3CCNCC3)cc2)nc2c1c(CC)nn2-c1ccccc1,Fructokinase (FK),Fructokinase (FK)
17645008,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCOc1cc(-c2ccc(N3CCN(C)CC3)cc2)nc2c1c(CC)nn2-c1ccccc1,CHEMBL3666147,nM,660,CHEMBL1275212,6.180456064,FK,CCOc1cc(-c2ccc(N3CCN(C)CC3)cc2)nc2c1c(CC)nn2-c1ccccc1,CCOc1cc(-c2ccc(N3CCN(C)CC3)cc2)nc2c1c(CC)nn2-c1ccccc1,Fructokinase (FK),Fructokinase (FK)
17645009,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCOc1cc(-c2ccc(N3CC(C)NC(C)C3)cc2)nc2c1c(CC)nn2-c1ccccc1,CHEMBL3666148,nM,14700,CHEMBL1275212,4.832682665,FK,CCOc1cc(-c2ccc(N3CC(C)NC(C)C3)cc2)nc2c1c(CC)nn2-c1ccccc1,CCOc1cc(-c2ccc(N3CC(C)NC(C)C3)cc2)nc2c1c(CC)nn2-c1ccccc1,Fructokinase (FK),Fructokinase (FK)
17645012,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CCN(CC1CCNCC1)c1ccc2c(SC)nn(-c3ccccc3)c2c1,CHEMBL3666149,nM,890,CHEMBL1275212,6.050609993,FK,CCN(CC1CCNCC1)c1ccc2c(SC)nn(-c3ccccc3)c2c1,CCN(CC1CCNCC1)c1ccc2c(SC)nn(-c3ccccc3)c2c1,Fructokinase (FK),Fructokinase (FK)
17645013,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC3CCNCC3)ccc12,CHEMBL3666150,nM,770,CHEMBL1275212,6.113509275,FK,CSc1nn(-c2ccccc2)c2cc(NC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645014,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)NC3CCNCC3)ccc12,CHEMBL3666151,nM,9830,CHEMBL1275212,5.007446482,FK,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)NC3CCNCC3)ccc12,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)NC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645015,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc(N)cc2)c2cc(C(=O)NC3CCNCC3)ccc12,CHEMBL3666152,nM,2610,CHEMBL1275212,5.583359493,FK,CSc1nn(-c2ccc(N)cc2)c2cc(C(=O)NC3CCNCC3)ccc12,CSc1nn(-c2ccc(N)cc2)c2cc(C(=O)NC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645016,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NCC3CCNCC3)ccc12,CHEMBL3666153,nM,420,CHEMBL1275212,6.37675071,FK,CSc1nn(-c2ccccc2)c2cc(NCC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NCC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645017,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc(N)cc2)c2cc(CN3CCNCC3)ccc12,CHEMBL3666154,nM,51000,CHEMBL1275212,4.292429824,FK,CSc1nn(-c2ccc(N)cc2)c2cc(CN3CCNCC3)ccc12,CSc1nn(-c2ccc(N)cc2)c2cc(CN3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645019,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2cccc(C)c2)c2cc(N3CCNCC3)ccc12,CHEMBL3666155,nM,4120,CHEMBL1275212,5.385102784,FK,CSc1nn(-c2cccc(C)c2)c2cc(N3CCNCC3)ccc12,CSc1nn(-c2cccc(C)c2)c2cc(N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645020,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2cccc(C)c2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL3666156,nM,380,CHEMBL1275212,6.420216403,FK,CSc1nn(-c2cccc(C)c2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CSc1nn(-c2cccc(C)c2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645022,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1ccc(-n2nc(SC)c3ccc(N4CCNCC4)cc32)cc1,CHEMBL3666157,nM,830,CHEMBL1275212,6.080921908,FK,COc1ccc(-n2nc(SC)c3ccc(N4CCNCC4)cc32)cc1,COc1ccc(-n2nc(SC)c3ccc(N4CCNCC4)cc32)cc1,Fructokinase (FK),Fructokinase (FK)
17645024,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2cc(F)cc(F)c2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL3666158,nM,4220,CHEMBL1275212,5.374687549,FK,CSc1nn(-c2cc(F)cc(F)c2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CSc1nn(-c2cc(F)cc(F)c2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645025,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc(Br)cc2)c2cc(OC3CCNCC3)ccc12,CHEMBL3666159,nM,2050,CHEMBL1275212,5.688246139,FK,CSc1nn(-c2ccc(Br)cc2)c2cc(OC3CCNCC3)ccc12,CSc1nn(-c2ccc(Br)cc2)c2cc(OC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645026,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc(Br)cc2)c2cc(OCC3CCNCC3)ccc12,CHEMBL3666160,nM,920,CHEMBL1275212,6.036212173,FK,CSc1nn(-c2ccc(Br)cc2)c2cc(OCC3CCNCC3)ccc12,CSc1nn(-c2ccc(Br)cc2)c2cc(OCC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645027,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(CN3CCNCC3)ccc12,CHEMBL3666161,nM,44940,CHEMBL1275212,4.347366932,FK,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(CN3CCNCC3)ccc12,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(CN3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645028,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)CN3CCNCC3)ccc12,CHEMBL3666162,nM,680,CHEMBL1275212,6.167491087,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)CN3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)CN3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645030,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)N3CCNCC3)ccc12,CHEMBL3666163,nM,51000,CHEMBL1275212,4.292429824,FK,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)N3CCNCC3)ccc12,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645031,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc(F)cc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CHEMBL3666164,nM,1650,CHEMBL1275212,5.782516056,FK,CSc1nn(-c2ccc(F)cc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,CSc1nn(-c2ccc(F)cc2)c2cc(N3CCN(C4CCNCC4)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645032,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(O)C3CCNCC3)ccc12,CHEMBL3666165,nM,2000,CHEMBL1275212,5.698970004,FK,CSc1nn(-c2ccccc2)c2cc(C(O)C3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(O)C3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645033,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(O)c3ccncc3)ccc12,CHEMBL3666166,nM,2000,CHEMBL1275212,5.698970004,FK,CSc1nn(-c2ccccc2)c2cc(C(O)c3ccncc3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(O)c3ccncc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645036,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/C3CCNCC3)ccc12,CHEMBL3666167,nM,230,CHEMBL1275212,6.638272164,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/C3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=CC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645037,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(=O)C3CCNCC3)ccc12,CHEMBL3666168,nM,670,CHEMBL1275212,6.173925197,FK,CSc1nn(-c2ccccc2)c2cc(C(=O)C3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(=O)C3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645038,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C3=CCN(C(=O)CN)CC3)ccc12,CHEMBL3666169,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C3=CCN(C(=O)CN)CC3)ccc12,CSc1nn(-c2ccc([N+](=O)[O-])cc2)c2cc(C3=CCN(C(=O)CN)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645039,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C3=CCN(C(=O)CCN)CC3)ccc12,CHEMBL3666170,nM,480,CHEMBL1275212,6.318758763,FK,CSc1nn(-c2ccccc2)c2cc(C3=CCN(C(=O)CCN)CC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C3=CCN(C(=O)CCN)CC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645040,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/n3cncn3)ccc12,CHEMBL3666171,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/n3cncn3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=Cn3cncn3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645042,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/c3ccncc3)ccc12,CHEMBL3666172,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/c3ccncc3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=Cc3ccncc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645043,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/c3ccccn3)ccc12,CHEMBL3666173,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/c3ccccn3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=Cc3ccccn3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645044,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(N)CCNCC3)ccc12,CHEMBL3666174,nM,300,CHEMBL1275212,6.522878745,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(N)CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(N)CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645045,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(C)CCNCC3)ccc12,CHEMBL3666175,nM,700,CHEMBL1275212,6.15490196,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(C)CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(C)CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645046,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCNCC3)ccc12,CHEMBL3666176,nM,1000,CHEMBL1275212,6,FK,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645047,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCCNC3)ccc12,CHEMBL3666177,nM,6620,CHEMBL1275212,5.179142011,FK,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCCNC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCCNC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645048,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCCN3)ccc12,CHEMBL3666178,nM,8280,CHEMBL1275212,5.081969663,FK,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCCN3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(=O)CC3CCCN3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645050,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NCCN3CCNCC3)ccc12,CHEMBL3666179,nM,890,CHEMBL1275212,6.050609993,FK,CSc1nn(-c2ccccc2)c2cc(NCCN3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NCCN3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645051,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NCCC3CCNCC3)ccc12,CHEMBL3666180,nM,600,CHEMBL1275212,6.22184875,FK,CSc1nn(-c2ccccc2)c2cc(NCCC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NCCC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645052,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(F)CCNCC3)ccc12,CHEMBL3666181,nM,660,CHEMBL1275212,6.180456064,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(F)CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(F)CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645053,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(=O)C(=O)N3CCNCC3)ccc12,CHEMBL3666182,nM,4120,CHEMBL1275212,5.385102784,FK,CSc1nn(-c2ccccc2)c2cc(C(=O)C(=O)N3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(=O)C(=O)N3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645054,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(C(=O)c3ccc4ncn(C)c4c3)ccc12,CHEMBL3666183,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2)c2cc(C(=O)c3ccc4ncn(C)c4c3)ccc12,CSc1nn(-c2ccccc2)c2cc(C(=O)c3ccc4ncn(C)c4c3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645055,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(c4ccccc4)CCNCC3)ccc12,CHEMBL3666184,nM,2150,CHEMBL1275212,5.66756154,FK,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(c4ccccc4)CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(NC(=O)C3(c4ccccc4)CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645056,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,COc1ccc(-n2nc(SC)c3ccc(C(=O)c4ccc5ncn(C)c5c4)cc32)cc1,CHEMBL3666185,nM,10000,CHEMBL1275212,5,FK,COc1ccc(-n2nc(SC)c3ccc(C(=O)c4ccc5ncn(C)c5c4)cc32)cc1,COc1ccc(-n2nc(SC)c3ccc(C(=O)c4ccc5ncn(C)c5c4)cc32)cc1,Fructokinase (FK),Fructokinase (FK)
17645057,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/C3CCCN3)ccc12,CHEMBL3666186,nM,610,CHEMBL1275212,6.214670165,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/C3CCCN3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=CC3CCCN3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645058,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/C3CCCNC3)ccc12,CHEMBL3666187,nM,790,CHEMBL1275212,6.102372909,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/C3CCCNC3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=CC3CCCNC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645059,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(/C=C/c3ccc(C)nc3)ccc12,CHEMBL3666188,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2)c2cc(/C=C/c3ccc(C)nc3)ccc12,CSc1nn(-c2ccccc2)c2cc(C=Cc3ccc(C)nc3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645060,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2C)c2cc(C3=CCNCC3)ccc12,CHEMBL3666189,nM,10000,CHEMBL1275212,5,FK,CSc1nn(-c2ccccc2C)c2cc(C3=CCNCC3)ccc12,CSc1nn(-c2ccccc2C)c2cc(C3=CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
17645061,CHEMBL3705469,"Enzyme Assay: An enzymatic assay was developed to measure KHK-mediated conversion of D-fructose to Fructose-1-P (F-1-P) using High Throughput Mass Spectroscopy (HTMS) as a means of product detection. This assay served as a primary screen to evaluate the ability to inhibit KHK enzyme activity and it has been adapted to high throughput mass spectrometry (HTMS, BioTrove RapidFire) format for higher throughput.The compounds to be tested were dosed in 12-points concentration from 511 uM to 0.5 uM. Inhibition of the fragment, IC50, was determined in a dose-response curve under the established steady-state conditions of 200 uM fructose, 100 uM ATP and 2 nM KHK for 60 min at 25 C. The assay was carried out in 384-well plate format.",B,CSc1nn(-c2ccccc2)c2cc(CCC3CCNCC3)ccc12,CHEMBL3666190,nM,920,CHEMBL1275212,6.036212173,FK,CSc1nn(-c2ccccc2)c2cc(CCC3CCNCC3)ccc12,CSc1nn(-c2ccccc2)c2cc(CCC3CCNCC3)ccc12,Fructokinase (FK),Fructokinase (FK)
18089347,CHEMBL4019532,Inhibition of recombinant human N-terminal His-tagged KHK expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,C[C@]1(O)CCN(c2nc(N3CCN(CCO)CC3)cc(C(F)(F)F)c2C#N)C1,CHEMBL4072209,nM,1030,CHEMBL1275212,5.987162775,FK,C[C@]1(O)CCN(c2nc(N3CCN(CCO)CC3)cc(C(F)(F)F)c2C#N)C1,CC1(O)CCN(c2nc(N3CCN(CCO)CC3)cc(C(F)(F)F)c2C#N)C1,Fructokinase (FK),Fructokinase (FK)
18089348,CHEMBL4019532,Inhibition of recombinant human N-terminal His-tagged KHK expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,C[C@@]1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1,CHEMBL4092972,nM,24210,CHEMBL1275212,4.616005211,FK,C[C@@]1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1,CC1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1,Fructokinase (FK),Fructokinase (FK)
18089349,CHEMBL4019532,Inhibition of recombinant human N-terminal His-tagged KHK expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,C[C@]1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1,CHEMBL4063606,nM,670,CHEMBL1275212,6.173925197,FK,C[C@]1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1,CC1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1,Fructokinase (FK),Fructokinase (FK)
18089350,CHEMBL4019532,Inhibition of recombinant human N-terminal His-tagged KHK expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,N#Cc1c(C(F)(F)F)cc(N2CCN(CCO)CC2)nc1N1CCCC(CO)C1,CHEMBL4085228,nM,16790,CHEMBL1275212,4.774949304,FK,N#Cc1c(C(F)(F)F)cc(N2CCN(CCO)CC2)nc1N1CCCC(CO)C1,N#Cc1c(C(F)(F)F)cc(N2CCN(CCO)CC2)nc1N1CCCC(CO)C1,Fructokinase (FK),Fructokinase (FK)
18089351,CHEMBL4019532,Inhibition of recombinant human N-terminal His-tagged KHK expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,CCc1cc2nc(C(F)(F)F)c(C#N)c(N3CCC(C)(O)C3)c2[nH]1,CHEMBL4101660,nM,1480,CHEMBL1275212,5.829738285,FK,CCc1cc2nc(C(F)(F)F)c(C#N)c(N3CCC(C)(O)C3)c2[nH]1,CCc1cc2nc(C(F)(F)F)c(C#N)c(N3CCC(C)(O)C3)c2[nH]1,Fructokinase (FK),Fructokinase (FK)
18089353,CHEMBL4019532,Inhibition of recombinant human N-terminal His-tagged KHK expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,Oc1nc2ccccc2nc1C(F)(F)F,CHEMBL1463512,nM,100000,CHEMBL1275212,4,FK,O=c1[nH]c2ccccc2nc1C(F)(F)F,O=c1[nH]c2ccccc2nc1C(F)(F)F,Fructokinase (FK),Fructokinase (FK)
18089364,CHEMBL4019530,Inhibition of recombinant human N-terminal His-tagged KHK-C expressed in Escherichia coli BL21(DE3) using fructose as substrate incubated for 30 mins followed by ATP addition measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled enzyme assay,B,C[C@]1(O)CCN(c2nc(N3C[C@H](O)[C@@H](O)C3)cc(C(F)(F)F)c2C#N)C1,CHEMBL4070442,nM,450,CHEMBL1275212,6.346787486,FK,C[C@]1(O)CCN(c2nc(N3C[C@H](O)[C@@H](O)C3)cc(C(F)(F)F)c2C#N)C1,CC1(O)CCN(c2nc(N3CC(O)C(O)C3)cc(C(F)(F)F)c2C#N)C1,Fructokinase (FK),Fructokinase (FK)
19005379,CHEMBL4344288,Inhibition of recombinant His-tagged human KHK expressed in Escherichia coli in presence of NADPH,B,C[C@H]1CCN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)n1,CHEMBL4549658,nM,14,CHEMBL1275212,7.853871964,FK,C[C@H]1CCN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)n1,CC1CCN1c1nc(N2CC3C(CC(=O)O)C3C2)cc(C(F)(F)F)n1,Fructokinase (FK),Fructokinase (FK)
22429748,CHEMBL4676054,Inhibition of 10 nM recombinant human N-terminal His-tagged KHKC expressed in Escherichia coli BL21 (DE3) using fructose as substrate preincubated for 30 mins followed by ATP addition and measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled assay,B,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@H](C2)[C@H]3C(=O)O)cc(C(F)(F)F)c1C#N,CHEMBL4793621,nM,390,CHEMBL1275212,6.408935393,FK,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3C(C(=O)O)[C@@H]3C2)cc(C(F)(F)F)c1C#N,CC1C(O)CN1c1nc(N2CC3C(C2)C3C(=O)O)cc(C(F)(F)F)c1C#N,Fructokinase (FK),Fructokinase (FK)
22429749,CHEMBL4676054,Inhibition of 10 nM recombinant human N-terminal His-tagged KHKC expressed in Escherichia coli BL21 (DE3) using fructose as substrate preincubated for 30 mins followed by ATP addition and measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled assay,B,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)c1C#N,CHEMBL4754053,nM,6,CHEMBL1275212,8.22184875,FK,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)c1C#N,CC1C(O)CN1c1nc(N2CC3C(CC(=O)O)C3C2)cc(C(F)(F)F)c1C#N,Fructokinase (FK),Fructokinase (FK)
22429751,CHEMBL4676054,Inhibition of 10 nM recombinant human N-terminal His-tagged KHKC expressed in Escherichia coli BL21 (DE3) using fructose as substrate preincubated for 30 mins followed by ATP addition and measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled assay,B,C[C@]1(O)CCN(c2nc(N3C[C@@H](O)[C@@H](O)C3)cc(C(F)(F)F)c2C#N)C1,CHEMBL4762437,nM,410,CHEMBL1275212,6.387216143,FK,C[C@]1(O)CCN(c2nc(N3C[C@@H](O)[C@@H](O)C3)cc(C(F)(F)F)c2C#N)C1,CC1(O)CCN(c2nc(N3CC(O)C(O)C3)cc(C(F)(F)F)c2C#N)C1,Fructokinase (FK),Fructokinase (FK)
22429752,CHEMBL4676054,Inhibition of 10 nM recombinant human N-terminal His-tagged KHKC expressed in Escherichia coli BL21 (DE3) using fructose as substrate preincubated for 30 mins followed by ATP addition and measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled assay,B,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H](O)[C@@H](O)C2)cc(C(F)(F)F)c1C#N,CHEMBL4798024,nM,470,CHEMBL1275212,6.327902142,FK,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H](O)[C@@H](O)C2)cc(C(F)(F)F)c1C#N,CC1C(O)CN1c1nc(N2CC(O)C(O)C2)cc(C(F)(F)F)c1C#N,Fructokinase (FK),Fructokinase (FK)
22429753,CHEMBL4676054,Inhibition of 10 nM recombinant human N-terminal His-tagged KHKC expressed in Escherichia coli BL21 (DE3) using fructose as substrate preincubated for 30 mins followed by ATP addition and measured for 30 mins by pyruvate kinase-lactate dehydrogenase coupled assay,B,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@@H](CO)[C@@H]3C2)cc(C(F)(F)F)c1C#N,CHEMBL4760155,nM,140,CHEMBL1275212,6.853871964,FK,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@@H](CO)[C@@H]3C2)cc(C(F)(F)F)c1C#N,CC1C(O)CN1c1nc(N2CC3C(CO)C3C2)cc(C(F)(F)F)c1C#N,Fructokinase (FK),Fructokinase (FK)
22429755,CHEMBL4676055,Inhibition of 1 nM recombinant human N-terminal His-tagged KHKC expressed in Escherichia coli BL21 (DE3) using fructose as substrate preincubated for 30 mins followed by ATP addition and measured for 3 hrs by pyruvate kinase-lactate dehydrogenase coupled assay,B,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)n1,CHEMBL4782925,nM,14,CHEMBL1275212,7.853871964,FK,C[C@H]1[C@H](O)CN1c1nc(N2C[C@@H]3[C@@H](CC(=O)O)[C@@H]3C2)cc(C(F)(F)F)n1,CC1C(O)CN1c1nc(N2CC3C(CC(=O)O)C3C2)cc(C(F)(F)F)n1,Fructokinase (FK),Fructokinase (FK)
13922592,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1cc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)ccn1,CHEMBL3113999,nM,8630,CHEMBL3820,5.063989204,GK_IC50,N=c1cc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cc[nH]1,N=c1cc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cc[nH]1,Glucokinase (GK),Glucokinase (GK)
13922615,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(C)(C)C#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CHEMBL3114190,nM,1430,CHEMBL3820,5.844663963,GK_IC50,CC(C)(C)C#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CC(C)(C)C#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922616,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,CHEMBL3113992,nM,1420,CHEMBL3820,5.847711656,GK_IC50,O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,Glucokinase (GK),Glucokinase (GK)
13922621,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,O=S(=O)(c1ccccc1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,CHEMBL3113993,nM,1010,CHEMBL3820,5.995678626,GK_IC50,O=S(=O)(c1ccccc1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,O=S(=O)(c1ccccc1)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,Glucokinase (GK),Glucokinase (GK)
13922626,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)C(C#CC3CC3)C2)cn1,CHEMBL3114189,nM,779,CHEMBL3820,6.108462542,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)C(C#CC3CC3)C2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)C(C#CC3CC3)C2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
13922628,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1cccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c1,CHEMBL3113997,nM,645,CHEMBL3820,6.190440285,GK_IC50,Nc1cccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c1,Nc1cccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c1,Glucokinase (GK),Glucokinase (GK)
13922629,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2CC3(COC3)C2)cc1)C(F)(F)F,CHEMBL3113984,nM,524,CHEMBL3820,6.280668713,GK_IC50,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2CC3(COC3)C2)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2CC3(COC3)C2)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922630,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC#C[C@@H]1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CHEMBL3114184,nM,484,CHEMBL3820,6.315154638,GK_IC50,CC#C[C@@H]1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922631,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cc1,CHEMBL3113998,nM,484,CHEMBL3820,6.315154638,GK_IC50,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cc1,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cc1,Glucokinase (GK),Glucokinase (GK)
13922633,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1ccccc1S(=O)(=O)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,CHEMBL3113996,nM,445,CHEMBL3820,6.351639989,GK_IC50,Nc1ccccc1S(=O)(=O)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,Nc1ccccc1S(=O)(=O)N1CCN(c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1,Glucokinase (GK),Glucokinase (GK)
13922634,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2CCC(F)(F)CC2)cc1)C(F)(F)F,CHEMBL3113981,nM,439,CHEMBL3820,6.35753548,GK_IC50,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2CCC(F)(F)CC2)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2CCC(F)(F)CC2)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922636,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2CCS(=O)(=O)CC2)cc1)C(F)(F)F,CHEMBL3113982,nM,343,CHEMBL3820,6.46470588,GK_IC50,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2CCS(=O)(=O)CC2)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2CCS(=O)(=O)CC2)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922637,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1csc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c1,CHEMBL3113995,nM,324,CHEMBL3820,6.48945499,GK_IC50,Nc1csc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c1,Nc1csc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c1,Glucokinase (GK),Glucokinase (GK)
13922638,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1ncc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cn1,CHEMBL3114001,nM,316,CHEMBL3820,6.500312917,GK_IC50,N=c1ncc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c[nH]1,N=c1ncc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
13922640,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)s1,CHEMBL3113994,nM,252,CHEMBL3820,6.598599459,GK_IC50,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)s1,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)s1,Glucokinase (GK),Glucokinase (GK)
13922953,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC1CS(=O)(=O)CCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,CHEMBL3113983,nM,90,CHEMBL3820,7.045757491,GK_IC50,CC1CS(=O)(=O)CCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,CC1CS(=O)(=O)CCN1CC1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922954,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cn1,CHEMBL3114000,nM,87,CHEMBL3820,7.060480747,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
13922957,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CCC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CHEMBL3114188,nM,56,CHEMBL3820,7.251811973,GK_IC50,CCC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CCC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922958,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,C[C@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@@H]3COC[C@H]2[C@@H](O)C3)cc1)C(F)(F)F,CHEMBL3113991,nM,56,CHEMBL3820,7.251811973,GK_IC50,C[C@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@@H]3COC[C@H]2[C@@H](O)C3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3COCC2C(O)C3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922959,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@H]2[C@H](O)C3)cc1)C(F)(F)F,CHEMBL3113986,nM,44,CHEMBL3820,7.356547324,GK_IC50,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@H]2[C@H](O)C3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3COCC2C(O)C3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922961,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@H]2[C@@H](O)C3)cc1)C(F)(F)F,CHEMBL3113987,nM,26,CHEMBL3820,7.585026652,GK_IC50,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@H]2[C@@H](O)C3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3COCC2C(O)C3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922962,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,C[C@@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@@H]3COC[C@H]2[C@@H](O)C3)cc1)C(F)(F)F,CHEMBL3113990,nM,25,CHEMBL3820,7.602059991,GK_IC50,C[C@@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@@H]3COC[C@H]2[C@@H](O)C3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3COCC2C(O)C3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922963,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,C[C@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@@H]2[C@H](O)C3)cc1)C(F)(F)F,CHEMBL3113989,nM,16,CHEMBL3820,7.795880017,GK_IC50,C[C@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@@H]2[C@H](O)C3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3COCC2C(O)C3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922964,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,C[C@@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@@H]2[C@H](O)C3)cc1)C(F)(F)F,CHEMBL3113988,nM,14,CHEMBL3820,7.853871964,GK_IC50,C[C@@](O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2[C@H]3COC[C@@H]2[C@H](O)C3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3COCC2C(O)C3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
13922965,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC#C[C@H]1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc([C@@](C)(O)C(F)(F)F)cc1,CHEMBL3114187,nM,9,CHEMBL3820,8.045757491,GK_IC50,CC#C[C@H]1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc([C@@](C)(O)C(F)(F)F)cc1,CC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922966,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,C[C@H]1COCCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,CHEMBL3113980,nM,7,CHEMBL3820,8.15490196,GK_IC50,C[C@H]1COCCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,CC1COCCN1CC1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922967,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC#C[C@H]1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc([C@](C)(O)C(F)(F)F)cc1,CHEMBL3114186,nM,6,CHEMBL3820,8.22184875,GK_IC50,CC#C[C@H]1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc([C@](C)(O)C(F)(F)F)cc1,CC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922968,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC#CC1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CHEMBL3114183,nM,6,CHEMBL3820,8.22184875,GK_IC50,CC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922969,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC#C[C@H]1CN(S(=O)(=O)c2ccc(N)nc2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CHEMBL3114185,nM,4,CHEMBL3820,8.397940009,GK_IC50,CC#C[C@H]1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,CC#CC1CN(S(=O)(=O)c2ccc(=N)[nH]c2)CCN1c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1,Glucokinase (GK),Glucokinase (GK)
13922970,CHEMBL3117036,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by Alpha Screen assay,B,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2C3CCC2COC3)cc1)C(F)(F)F,CHEMBL3113985,nM,2,CHEMBL3820,8.698970004,GK_IC50,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CN2C3CCC2COC3)cc1)C(F)(F)F,CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)CC2CN2C3CCC2COC3)cc1)C(F)(F)F,Glucokinase (GK),Glucokinase (GK)
15020637,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc[nH]n3)CC2)cn1,CHEMBL3319532,nM,201,CHEMBL3820,6.696803943,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc[nH]n3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc[nH]n3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020638,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CCCO)CC2)cn1,CHEMBL3319531,nM,17,CHEMBL3820,7.769551079,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CCCO)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CCCO)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020639,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CC(C)(O)C#Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(N)nc2)CC1,CHEMBL3319530,nM,49,CHEMBL3820,7.30980392,GK_IC50,CC(C)(O)C#Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(=N)[nH]c2)CC1,CC(C)(O)C#Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(=N)[nH]c2)CC1,Glucokinase (GK),Glucokinase (GK)
15020640,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,COCC#Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(N)nc2)CC1,CHEMBL3319529,nM,5,CHEMBL3820,8.301029996,GK_IC50,COCC#Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(=N)[nH]c2)CC1,COCC#Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(=N)[nH]c2)CC1,Glucokinase (GK),Glucokinase (GK)
15020641,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CCO)CC2)cn1,CHEMBL3319528,nM,14,CHEMBL3820,7.853871964,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CCO)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CCO)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020642,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CC3CC3)CC2)cn1,CHEMBL3319527,nM,33,CHEMBL3820,7.48148606,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CC3CC3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C#CC3CC3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020643,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C3CC3)CC2)cn1,CHEMBL3319526,nM,601,CHEMBL3820,6.221125528,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C3CC3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3C3CC3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020644,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,COc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(N)nc2)CC1,CHEMBL3319525,nM,1110,CHEMBL3820,5.954677021,GK_IC50,COc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(=N)[nH]c2)CC1,COc1cc(C(O)(C(F)(F)F)C(F)(F)F)cnc1N1CCN(S(=O)(=O)c2ccc(=N)[nH]c2)CC1,Glucokinase (GK),Glucokinase (GK)
15020645,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Br)CC2)cn1,CHEMBL3319524,nM,112,CHEMBL3820,6.950781977,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Br)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Br)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020646,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Cl)CC2)cn1,CHEMBL3319523,nM,201,CHEMBL3820,6.696803943,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Cl)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Cl)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020647,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cn3)CC2)cn1,CHEMBL3319522,nM,176,CHEMBL3820,6.754487332,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cn3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ccc(C(O)(C(F)(F)F)C(F)(F)F)cn3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020730,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4[nH]ncc4c3)CC2)cn1,CHEMBL3319562,nM,60,CHEMBL3820,7.22184875,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4[nH]ncc4c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4[nH]ncc4c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020731,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc4[nH]ncc34)CC2)cn1,CHEMBL3319563,nM,1950,CHEMBL3820,5.709965389,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc4[nH]ncc34)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc4[nH]ncc34)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020732,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc4ccccc4[nH]3)CC2)cn1,CHEMBL3319564,nM,27,CHEMBL3820,7.568636236,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc4ccccc4[nH]3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc4ccccc4[nH]3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15020733,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc4ccccc4s3)CC2)cn1,CHEMBL3319565,nM,48,CHEMBL3820,7.318758763,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc4ccccc4s3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cc4ccccc4s3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024598,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4c(c3)CC(=O)N4)CC2)cn1,CHEMBL3319561,nM,33,CHEMBL3820,7.48148606,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4[nH]c(O)cc4c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4[nH]c(O)cc4c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024599,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CN1C(=O)Cc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(N)nc4)CC3)ccc21,CHEMBL3319560,nM,20,CHEMBL3820,7.698970004,GK_IC50,Cn1c(O)cc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(=N)[nH]c4)CC3)ccc21,Cn1c(O)cc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(=N)[nH]c4)CC3)ccc21,Glucokinase (GK),Glucokinase (GK)
15024600,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cc1nc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(N)nc4)CC3)ccc2o1,CHEMBL3319559,nM,15,CHEMBL3820,7.823908741,GK_IC50,Cc1nc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(=N)[nH]c4)CC3)ccc2o1,Cc1nc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(=N)[nH]c4)CC3)ccc2o1,Glucokinase (GK),Glucokinase (GK)
15024601,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4ocnc4c3)CC2)cn1,CHEMBL3319558,nM,20,CHEMBL3820,7.698970004,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4ocnc4c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4ocnc4c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024602,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4scnc4c3)CC2)cn1,CHEMBL3319557,nM,35,CHEMBL3820,7.455931956,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4scnc4c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4scnc4c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024603,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4sccc4c3)CC2)cn1,CHEMBL3319556,nM,47,CHEMBL3820,7.327902142,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4sccc4c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc4sccc4c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024604,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,COc1cncc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)c1,CHEMBL3319555,nM,17,CHEMBL3820,7.769551079,GK_IC50,COc1cncc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,COc1cncc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,Glucokinase (GK),Glucokinase (GK)
15024605,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,COc1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cn1,CHEMBL3319554,nM,16,CHEMBL3820,7.795880017,GK_IC50,COc1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,COc1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Glucokinase (GK),Glucokinase (GK)
15024606,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cc1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cn1,CHEMBL3319553,nM,40,CHEMBL3820,7.397940009,GK_IC50,Cc1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Cc1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Glucokinase (GK),Glucokinase (GK)
15024607,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cc1cncc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)c1,CHEMBL3319552,nM,29,CHEMBL3820,7.537602002,GK_IC50,Cc1cncc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,Cc1cncc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,Glucokinase (GK),Glucokinase (GK)
15024608,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cncc(F)c3)CC2)cn1,CHEMBL3319551,nM,11,CHEMBL3820,7.958607315,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cncc(F)c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cncc(F)c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024609,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cnccc3F)CC2)cn1,CHEMBL3319550,nM,24,CHEMBL3820,7.619788758,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cnccc3F)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cnccc3F)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024610,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccnc3)CC2)cn1,CHEMBL3319549,nM,5,CHEMBL3820,8.301029996,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccnc3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccnc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024611,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccncc3)CC2)cn1,CHEMBL3319548,nM,21,CHEMBL3820,7.677780705,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccncc3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccncc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024612,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CS(=O)(=O)c1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cc1,CHEMBL3319547,nM,42,CHEMBL3820,7.37675071,GK_IC50,CS(=O)(=O)c1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cc1,CS(=O)(=O)c1ccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cc1,Glucokinase (GK),Glucokinase (GK)
15024613,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,NC(=O)c1cccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)c1,CHEMBL3319546,nM,50,CHEMBL3820,7.301029996,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc(C(N)=O)c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc(C(N)=O)c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024614,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CS(=O)(=O)Nc1cccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)c1,CHEMBL3319545,nM,309,CHEMBL3820,6.510041521,GK_IC50,CS(=O)(=O)Nc1cccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,CS(=O)(=O)Nc1cccc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,Glucokinase (GK),Glucokinase (GK)
15024615,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3O)CC2)cn1,CHEMBL3319544,nM,6,CHEMBL3820,8.22184875,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3O)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3O)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024616,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc(F)cc3)CC2)cn1,CHEMBL3317472,nM,11,CHEMBL3820,7.958607315,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc(F)cc3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccc(F)cc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024617,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc(F)c3)CC2)cn1,CHEMBL3319543,nM,8,CHEMBL3820,8.096910013,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc(F)c3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3cccc(F)c3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024618,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3F)CC2)cn1,CHEMBL3319542,nM,7,CHEMBL3820,8.15490196,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3F)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3F)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024619,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3)CC2)cn1,CHEMBL3319541,nM,7,CHEMBL3820,8.15490196,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccccc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024620,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cc1csc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)c1,CHEMBL3319540,nM,5,CHEMBL3820,8.301029996,GK_IC50,Cc1csc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,Cc1csc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c1,Glucokinase (GK),Glucokinase (GK)
15024621,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccoc3)CC2)cn1,CHEMBL3319539,nM,19,CHEMBL3820,7.721246399,GK_IC50,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccoc3)CC2)c[nH]1,N=c1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3-c3ccoc3)CC2)c[nH]1,Glucokinase (GK),Glucokinase (GK)
15024622,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)c(C(F)(F)F)n1,CHEMBL3319538,nM,30000,CHEMBL3820,4.522878745,GK_IC50,Cn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c(C(F)(F)F)n1,Cn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)c(C(F)(F)F)n1,Glucokinase (GK),Glucokinase (GK)
15024623,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cc1c(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cnn1C,CHEMBL3319537,nM,40,CHEMBL3820,7.397940009,GK_IC50,Cc1c(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cnn1C,Cc1c(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cnn1C,Glucokinase (GK),Glucokinase (GK)
15024624,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CC(C)(C)n1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cn1,CHEMBL3319536,nM,87,CHEMBL3820,7.060480747,GK_IC50,CC(C)(C)n1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,CC(C)(C)n1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Glucokinase (GK),Glucokinase (GK)
15024625,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CC(C)n1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cn1,CHEMBL3319535,nM,23,CHEMBL3820,7.638272164,GK_IC50,CC(C)n1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,CC(C)n1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Glucokinase (GK),Glucokinase (GK)
15024626,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,CCn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cn1,CHEMBL3319534,nM,5,CHEMBL3820,8.301029996,GK_IC50,CCn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,CCn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Glucokinase (GK),Glucokinase (GK)
15024627,CHEMBL3364949,Inhibition of fluorescein-labeled human GK interaction with biotin-labeled human GKRP compound incubated for 20 mins prior to addition of fluorescein-labeled GK measured after 2 to 4 hrs by AlphaScreen assay,B,Cn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(N)nc3)CC2)cn1,CHEMBL3319533,nM,1,CHEMBL3820,9,GK_IC50,Cn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Cn1cc(-c2cc(C(O)(C(F)(F)F)C(F)(F)F)cnc2N2CCN(S(=O)(=O)c3ccc(=N)[nH]c3)CC2)cn1,Glucokinase (GK),Glucokinase (GK)
16591822,CHEMBL3807041,Inhibition of HK4 (unknown origin),B,O=C(N[C@H]1C(O)O[C@H](CNS(=O)(=O)c2cccc(Cl)c2Cl)[C@@H](O)[C@@H]1O)c1cccc(-c2ccccc2)c1,CHEMBL3805905,nM,3500,CHEMBL3820,5.455931956,GK_IC50,O=C(N[C@H]1C(O)O[C@H](CNS(=O)(=O)c2cccc(Cl)c2Cl)[C@@H](O)[C@@H]1O)c1cccc(-c2ccccc2)c1,O=C(NC1C(O)OC(CNS(=O)(=O)c2cccc(Cl)c2Cl)C(O)C1O)c1cccc(-c2ccccc2)c1,Glucokinase (GK),Glucokinase (GK)
18938924,CHEMBL4328430,Inhibition of human GCK using MBP as substrate by [gamma-33P]-ATP assay,B,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL388978,nM,0.81,CHEMBL3820,9.091514981,GK_IC50,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Glucokinase (GK),Glucokinase (GK)
18955253,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2cccnc21,CHEMBL4559482,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2cccnc21,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2cccnc21,Glucokinase (GK),Glucokinase (GK)
18955254,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cc1ccc2c(C3=C(c4nn(C)c5ncccc45)C(=O)NC3=O)cn(CCCn3ccnc3)c2c1,CHEMBL4476190,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cc1ccc2c(C3=C(c4nn(C)c5ncccc45)C(=O)NC3=O)cn(CCCn3ccnc3)c2c1,Cc1ccc2c(C3=C(c4nn(C)c5ncccc45)C(=O)NC3=O)cn(CCCn3ccnc3)c2c1,Glucokinase (GK),Glucokinase (GK)
18955255,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(Br)ccc34)C(=O)NC2=O)c2cccnc21,CHEMBL4556914,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(Br)ccc34)C(=O)NC2=O)c2cccnc21,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(Br)ccc34)C(=O)NC2=O)c2cccnc21,Glucokinase (GK),Glucokinase (GK)
18955256,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(Cl)ccc34)C(=O)NC2=O)c2cccnc21,CHEMBL4514241,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(Cl)ccc34)C(=O)NC2=O)c2cccnc21,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(Cl)ccc34)C(=O)NC2=O)c2cccnc21,Glucokinase (GK),Glucokinase (GK)
18955257,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(F)ccc34)C(=O)NC2=O)c2cccnc21,CHEMBL4465287,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(F)ccc34)C(=O)NC2=O)c2cccnc21,Cn1nc(C2=C(c3cn(CCCn4ccnc4)c4cc(F)ccc34)C(=O)NC2=O)c2cccnc21,Glucokinase (GK),Glucokinase (GK)
18955258,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cn1nc(C2=C(c3cn(CCCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2cccnc21,CHEMBL4469450,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cn1nc(C2=C(c3cn(CCCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2cccnc21,Cn1nc(C2=C(c3cn(CCCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2cccnc21,Glucokinase (GK),Glucokinase (GK)
18955259,CHEMBL4332276,Inhibition of recombinant human N-terminal GST-fused glucokinase expressed in Escherichia coli using glucose-6-phosphatedehydrogenase as substrate by spectrophotometric assay,B,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,CHEMBL2180727,nM,20000,CHEMBL3820,4.698970004,GK_IC50,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,Glucokinase (GK),Glucokinase (GK)
19147864,CHEMBL4379338,Inhibition of recombinant human GCK (1 to 473 residues) using myelin basic protein as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis,B,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,CHEMBL4438748,nM,10000,CHEMBL3820,5,GK_IC50,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,Glucokinase (GK),Glucokinase (GK)
22423052,CHEMBL4674071,Inhibition of human GCK using MBP as substrate by [gamma-33P]-ATP assay,B,CCN1CCC(c2ncc(-c3cnc(N)c(OCc4ccncc4)c3)s2)CC1,CHEMBL4793665,nM,10.2,CHEMBL3820,7.991399828,GK_IC50,CCN1CCC(c2ncc(-c3c[nH]c(=N)c(OCc4ccncc4)c3)s2)CC1,CCN1CCC(c2ncc(-c3c[nH]c(=N)c(OCc4ccncc4)c3)s2)CC1,Glucokinase (GK),Glucokinase (GK)
23372791,CHEMBL4884756,GCK(M4K2LGY1) Takeda global kinase panel,B,CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,CHEMBL4088216,nM,1000,CHEMBL3820,6,GK_IC50,CN1C(=O)C(N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,CN1C(=O)C(N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,Glucokinase (GK),Glucokinase (GK)
23373200,CHEMBL4885047,GCK(M4K2LGY1) Takeda global kinase panel,B,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,CHEMBL4549667,nM,1000,CHEMBL3820,6,GK_IC50,CN1C(=O)C(N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,CN1C(=O)C(N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,Glucokinase (GK),Glucokinase (GK)
23373560,CHEMBL4885337,GCK(M4K2LGY1) Takeda global kinase panel,B,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,CHEMBL4097778,nM,1000,CHEMBL3820,6,GK_IC50,CN1C(=O)C(N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,CN1C(=O)C(N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,Glucokinase (GK),Glucokinase (GK)
24421558,CHEMBL5048925,Displacement of fluorescent labeled derivative from recombinant human hepatic glucokinase incubated for 30 mins in presence of 12 mM glucose by fluorescent polarization assay,B,CCOP(=O)(Cc1csc(NC(=O)c2cc(Oc3ccc(S(C)(=O)=O)cc3)cc(O[C@@H](C)COC)c2)n1)OCC,CHEMBL5091943,nM,122,CHEMBL3820,6.913640169,GK_IC50,CCOP(=O)(Cc1csc(=NC(=O)c2cc(Oc3ccc(S(C)(=O)=O)cc3)cc(O[C@@H](C)COC)c2)[nH]1)OCC,CCOP(=O)(Cc1csc(=NC(=O)c2cc(Oc3ccc(S(C)(=O)=O)cc3)cc(OC(C)COC)c2)[nH]1)OCC,Glucokinase (GK),Glucokinase (GK)
24421559,CHEMBL5048925,Displacement of fluorescent labeled derivative from recombinant human hepatic glucokinase incubated for 30 mins in presence of 12 mM glucose by fluorescent polarization assay,B,CCOP(=O)(Cn1ccc(NC(=O)c2cc(Oc3cnc(C(=O)N4CCC4)cn3)cc(OC(C)C)c2)n1)OCC,CHEMBL5072532,nM,123,CHEMBL3820,6.910094889,GK_IC50,CCOP(=O)(Cn1ccc(=NC(=O)c2cc(Oc3cnc(C(=O)N4CCC4)cn3)cc(OC(C)C)c2)[nH]1)OCC,CCOP(=O)(Cn1ccc(=NC(=O)c2cc(Oc3cnc(C(=O)N4CCC4)cn3)cc(OC(C)C)c2)[nH]1)OCC,Glucokinase (GK),Glucokinase (GK)
24885021,CHEMBL5156973,Inhibition of human recombinant GCK (1 to 473 residues) using myelin basic protein as substrate in presence of ATP incubated for 40 mins by radiometric based scintillation method,B,O=C1c2ccc(-c3cnc4[nH]ccc4c3)cc2OCCN1Cc1ccc(F)cc1,CHEMBL5181357,nM,3657,CHEMBL3820,5.43687504,GK_IC50,O=C1c2ccc(-c3cnc4[nH]ccc4c3)cc2OCCN1Cc1ccc(F)cc1,O=C1c2ccc(-c3cnc4[nH]ccc4c3)cc2OCCN1Cc1ccc(F)cc1,Glucokinase (GK),Glucokinase (GK)
